Clustering O 0 0.09565062820911407
of O 0 0.008319279178977013
missense O 1 0.9994977712631226
mutations O 1 0.9943231344223022
in O 0 0.0020649207290261984
the O 0 0.009388930164277554
ataxia B-Disease 1 1.0
- I-Disease 1 0.9981803894042969
telangiectasia I-Disease 1 1.0
gene O 1 0.9944503307342529
in O 0 0.002317597856745124
a O 0 0.009973620995879173
sporadic B-Disease 1 0.9914563298225403
T I-Disease 1 0.9999485015869141
- I-Disease 0 0.1825743019580841
cell I-Disease 1 0.8877744078636169
leukaemia I-Disease 1 0.9999994039535522
. O 0 0.014492339454591274

Ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9987843632698059
telangiectasia I-Disease 1 1.0
( O 0 0.010570911690592766
A B-Disease 1 0.9977771639823914
- I-Disease 1 0.952265202999115
T I-Disease 1 0.9999486207962036
) O 0 0.003694249549880624
is O 0 0.0025561421643942595
a O 0 0.0141642140224576
recessive B-Disease 1 1.0
multi I-Disease 1 0.9958030581474304
- I-Disease 1 0.7272266745567322
system I-Disease 1 0.7160542011260986
disorder I-Disease 1 1.0
caused O 1 0.9999344348907471
by O 0 0.005532923154532909
mutations O 1 0.9996157884597778
in O 0 0.00181299087125808
the O 0 0.004764203913509846
ATM O 1 0.9786303639411926
gene O 1 0.967246413230896
at O 0 0.011204609647393227
11q22 O 1 0.9996143579483032
- O 0 0.07058635354042053
q23 O 1 0.9951502680778503
( O 0 0.017067164182662964
ref O 1 0.9954421520233154
. O 0 0.004703742451965809
3 O 0 0.01602407917380333
) O 0 0.005652185529470444
. O 0 0.0070532746613025665

The O 0 0.009903640486299992
risk O 1 0.9195693731307983
of O 0 0.007910262793302536
cancer B-Disease 1 1.0
, O 0 0.0032983971759676933
especially O 0 0.014096073806285858
lymphoid B-Disease 1 0.999997615814209
neoplasias I-Disease 1 0.999915599822998
, O 0 0.0020906743593513966
is O 0 0.0032386681996285915
substantially O 0 0.03960028290748596
elevated O 1 0.9893247485160828
in O 0 0.003029464976862073
A B-Disease 1 0.9997492432594299
- I-Disease 1 0.9998568296432495
T I-Disease 1 1.0
patients O 1 0.9999904632568359
and O 0 0.002429058775305748
has O 0 0.0037264320999383926
long O 0 0.008571118116378784
been O 0 0.00483426870778203
associated O 0 0.007691897917538881
with O 0 0.004917332902550697
chromosomal O 1 0.9999995231628418
instability O 1 0.9997842907905579
. O 0 0.008971232920885086

By O 0 0.013624243438243866
analysing O 0 0.13864967226982117
tumour B-Disease 1 0.9999998807907104
DNA O 0 0.05897998437285423
from O 0 0.007879595272243023
patients O 1 0.9999423027038574
with O 0 0.003972048871219158
sporadic B-Disease 1 0.9957738518714905
T I-Disease 1 0.9999797344207764
- I-Disease 0 0.16166986525058746
cell I-Disease 1 0.6705456376075745
prolymphocytic I-Disease 1 0.9999940395355225
leukaemia I-Disease 1 1.0
( O 0 0.0319514237344265
T B-Disease 1 0.9999721050262451
- I-Disease 1 0.7893630862236023
PLL I-Disease 1 0.9999363422393799
) O 0 0.005955671891570091
, O 0 0.0015999707393348217
a O 0 0.00812450423836708
rare O 0 0.22317707538604736
clonal B-Disease 1 0.999901533126831
malignancy I-Disease 1 0.999998927116394
with O 0 0.0021652996074408293
similarities O 0 0.008801761083304882
to O 0 0.0014057194348424673
a O 0 0.009115230292081833
mature B-Disease 1 0.8981025218963623
T I-Disease 1 0.9999583959579468
- I-Disease 0 0.4348492920398712
cell I-Disease 1 0.9849727153778076
leukaemia I-Disease 1 0.9999998807907104
seen O 0 0.012142902240157127
in O 0 0.0026736364234238863
A B-Disease 1 0.9968427419662476
- I-Disease 1 0.9971742630004883
T I-Disease 1 0.9999977350234985
, O 0 0.001426086644642055
we O 0 0.0011627470375970006
demonstrate O 0 0.004288757685571909
a O 0 0.00494187418371439
high O 0 0.0060209957882761955
frequency O 0 0.020462727174162865
of O 0 0.0027572971303015947
ATM O 1 0.9942203760147095
mutations O 1 0.9995618462562561
in O 0 0.006973229348659515
T B-Disease 1 0.9999603033065796
- I-Disease 0 0.17626953125
PLL I-Disease 1 0.9999210834503174
. O 0 0.012818950228393078

In O 0 0.005793219897896051
marked O 0 0.019912859424948692
contrast O 0 0.00787308532744646
to O 0 0.0015044730389490724
the O 0 0.0047475919127464294
ATM O 1 0.9890620112419128
mutation O 1 0.9998925924301147
pattern O 0 0.02332383766770363
in O 0 0.0032991936895996332
A B-Disease 1 0.9843028783798218
- I-Disease 1 0.9769247770309448
T I-Disease 1 0.9999918937683105
, O 0 0.001687959535047412
the O 0 0.002037068596109748
most O 0 0.003305097809061408
frequent O 0 0.033935949206352234
nucleotide O 0 0.07877323776483536
changes O 0 0.005620734300464392
in O 0 0.001623573713004589
this O 0 0.005124667659401894
leukaemia B-Disease 1 1.0
were O 0 0.009689143858850002
missense O 1 0.9997734427452087
mutations O 1 0.999565064907074
. O 0 0.00882852915674448

These O 0 0.0034538661129772663
clustered O 0 0.025484289973974228
in O 0 0.0019648803863674402
the O 0 0.002632532734423876
region O 0 0.009444039314985275
corresponding O 0 0.007140320725739002
to O 0 0.001679575419984758
the O 0 0.005881179589778185
kinase O 1 0.9967479705810547
domain O 0 0.029639992862939835
, O 0 0.002034297911450267
which O 0 0.0019243895076215267
is O 0 0.0029992111958563328
highly O 0 0.011071397922933102
conserved O 0 0.02620185911655426
in O 0 0.0035600855480879545
ATM O 1 0.6168360114097595
- O 0 0.03249537944793701
related O 0 0.013514058664441109
proteins O 0 0.02205481007695198
in O 0 0.0038353721611201763
mouse O 1 0.9991913437843323
, O 0 0.005344409495592117
yeast O 0 0.4365624189376831
and O 0 0.004125974141061306
Drosophila O 1 0.89766925573349
. O 0 0.008901064284145832

The O 0 0.008378821425139904
resulting O 0 0.054785456508398056
amino O 0 0.08026537299156189
- O 0 0.05205928906798363
acid O 0 0.1393001228570938
substitutions O 0 0.024441484361886978
are O 0 0.0015439423732459545
predicted O 0 0.011924433521926403
to O 0 0.0015515213599428535
interfere O 0 0.015793580561876297
with O 0 0.003121273824945092
ATP O 1 0.9973859190940857
binding O 0 0.024332178756594658
or O 0 0.005576872266829014
substrate O 0 0.06657521426677704
recognition O 0 0.02431187964975834
. O 0 0.007199265994131565

Two O 0 0.0031977358739823103
of O 0 0.0028658024966716766
seventeen O 1 0.6770000457763672
mutated O 1 0.9999899864196777
T B-Disease 1 0.9998955726623535
- I-Disease 0 0.07819513976573944
PLL I-Disease 1 0.999029278755188
samples O 0 0.016747912392020226
had O 0 0.003852112451568246
a O 0 0.004518160130828619
previously O 0 0.006423770450055599
reported O 0 0.01841999590396881
A B-Disease 1 0.9314231276512146
- I-Disease 1 0.9449799656867981
T I-Disease 1 0.9999439716339111
allele O 1 0.9993409514427185
. O 0 0.012806219048798084

In O 0 0.005145968869328499
contrast O 0 0.01213438343256712
, O 0 0.002361322520300746
no O 0 0.005545239895582199
mutations O 1 0.9995232820510864
were O 0 0.002733027096837759
detected O 0 0.041704386472702026
in O 0 0.0019444746430963278
the O 0 0.006145756226032972
p53 O 1 0.9999985694885254
gene O 1 0.994086742401123
, O 0 0.00203453516587615
suggesting O 0 0.011008237488567829
that O 0 0.001585702528245747
this O 0 0.007472750265151262
tumour B-Disease 1 1.0
suppressor O 1 0.9999995231628418
is O 0 0.004176842048764229
not O 0 0.0019836334977298975
frequently O 0 0.008778694085776806
altered O 0 0.02341248095035553
in O 0 0.002272221492603421
this O 0 0.005618866533041
leukaemia B-Disease 1 0.9999996423721313
. O 0 0.011509346775710583

Occasional O 0 0.15588171780109406
missense O 1 0.9997557997703552
mutations O 1 0.9979142546653748
in O 0 0.004549714736640453
ATM O 0 0.23533053696155548
were O 0 0.0017807529075071216
also O 0 0.0016848199302330613
found O 0 0.005001843441277742
in O 0 0.005257424432784319
tumour B-Disease 1 1.0
DNA O 0 0.05021275579929352
from O 0 0.007443495560437441
patients O 1 0.999971866607666
with O 0 0.0035894387401640415
B B-Disease 1 0.9993646740913391
- I-Disease 0 0.03943642973899841
cell I-Disease 0 0.06300367414951324
non I-Disease 0 0.03031267412006855
- I-Disease 1 0.9954807758331299
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9999972581863403
( O 0 0.01871517300605774
B B-Disease 1 0.9959912896156311
- I-Disease 0 0.04050223156809807
NHL I-Disease 0 0.33839547634124756
) O 0 0.003544954815879464
and O 0 0.0013060432393103838
a O 0 0.00916637759655714
B B-Disease 1 0.9610885977745056
- I-Disease 0 0.048773542046546936
NHL I-Disease 1 0.8746258020401001
cell O 0 0.05918359011411667
line O 0 0.016714245080947876
. O 0 0.007358612027019262

The O 0 0.003625200828537345
evidence O 0 0.0022235135547816753
of O 0 0.0012784864520654082
a O 0 0.005369187798351049
significant O 0 0.006372966803610325
proportion O 0 0.011210368946194649
of O 0 0.002230115467682481
loss O 0 0.3876965641975403
- O 0 0.015824783593416214
of O 0 0.002508684294298291
- O 0 0.03392387181520462
function O 0 0.029844464734196663
mutations O 1 0.9998531341552734
and O 0 0.0009747057338245213
a O 0 0.004045788664370775
complete O 0 0.0055577936582267284
absence O 0 0.00994015857577324
of O 0 0.001032197498716414
the O 0 0.0028390383813530207
normal O 0 0.016286619007587433
copy O 0 0.011335428804159164
of O 0 0.0020167091861367226
ATM O 0 0.13282181322574615
in O 0 0.0016834664857015014
the O 0 0.002055753953754902
majority O 0 0.00894155353307724
of O 0 0.005858330521732569
mutated O 1 0.9999995231628418
tumours B-Disease 1 0.9999998807907104
establishes O 1 0.6718843579292297
somatic O 1 0.9950512051582336
inactivation O 1 0.9992660880088806
of O 0 0.0018196494784206152
this O 0 0.002466641366481781
gene O 1 0.9705698490142822
in O 0 0.0013697330141440034
the O 0 0.004196419380605221
pathogenesis O 1 0.9999665021896362
of O 0 0.0037612481974065304
sporadic B-Disease 1 0.99930739402771
T I-Disease 1 0.9999936819076538
- I-Disease 1 0.8076795339584351
PLL I-Disease 1 0.9999843835830688
and O 0 0.0030130723025649786
suggests O 0 0.010284707881510258
that O 0 0.001903126947581768
ATM O 0 0.0861552506685257
acts O 0 0.007495787926018238
as O 0 0.0031493441201746464
a O 0 0.036671947687864304
tumour B-Disease 1 1.0
suppressor O 1 0.9999972581863403
. O 0 0.013112356886267662

As O 0 0.006685300730168819
constitutional O 0 0.01303548738360405
DNA O 0 0.036171216517686844
was O 0 0.007039279211312532
not O 0 0.0013573230244219303
available O 0 0.0019645828288048506
, O 0 0.0015067760832607746
a O 0 0.009389320388436317
putative O 1 0.999464213848114
hereditary O 1 0.9999994039535522
predisposition O 1 0.9999992847442627
to O 0 0.008747595362365246
T B-Disease 1 0.9999501705169678
- I-Disease 0 0.11304815113544464
PLL I-Disease 1 0.9999550580978394
will O 0 0.0034074715804308653
require O 0 0.006515673827379942
further O 0 0.004887719172984362
investigation O 0 0.01395536307245493
. O 0 0.0039724623784422874
. O 0 0.006103923078626394

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 1 0.9078084230422974
kinase O 1 0.9990285634994507
is O 0 0.004029319155961275
involved O 0 0.004848883021622896
in O 0 0.0014843676472082734
the O 0 0.003527370048686862
modulation O 0 0.0840051919221878
of O 0 0.0019256757805123925
the O 0 0.008513344451785088
Ca2 O 1 0.9998382329940796
+ O 1 0.6322756409645081
homeostasis O 1 0.9990817308425903
in O 0 0.011934473179280758
skeletal O 1 0.999994158744812
muscle O 1 0.999987006187439
cells O 0 0.11071894317865372
. O 0 0.008973704650998116

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.3715474307537079
DM B-Disease 1 1.0
) O 0 0.006557787302881479
, O 0 0.0012996960431337357
the O 0 0.002494226908311248
most O 0 0.006906748283654451
prevalent O 1 0.9999890327453613
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 0.005327465478330851
adults O 1 0.9984993934631348
, O 0 0.002181094838306308
is O 0 0.0049976445734500885
caused O 1 0.9993569254875183
by O 0 0.004774637520313263
( O 0 0.009276107884943485
CTG O 1 0.9999219179153442
) O 0 0.007707723882049322
n O 0 0.032522350549697876
- O 0 0.02525489404797554
repeat O 0 0.04456859827041626
expansion O 0 0.007880090735852718
in O 0 0.0016654895152896643
a O 0 0.009302455931901932
gene O 0 0.2991638779640198
encoding O 0 0.04238969460129738
a O 0 0.01418766938149929
protein O 0 0.10246650129556656
kinase O 1 0.9977918863296509
( O 0 0.02744355797767639
DM B-Disease 1 0.9999983310699463
protein O 0 0.17420539259910583
kinase O 1 0.9985350370407104
; O 0 0.013903471641242504
DMPK O 1 0.9998962879180908
) O 0 0.005013259127736092
and O 0 0.0014727420639246702
involves O 0 0.012762335129082203
changes O 0 0.0061775133945047855
in O 0 0.0028339549899101257
cytoarchitecture O 1 0.9996938705444336
and O 0 0.005228799302130938
ion O 1 0.777357280254364
homeostasis O 1 0.9988502264022827
. O 0 0.010564342141151428

To O 0 0.003553347894921899
obtain O 0 0.006009847857058048
clues O 0 0.009901387616991997
to O 0 0.001305895741097629
the O 0 0.0028212277684360743
normal O 0 0.017998961731791496
biological O 0 0.007979455403983593
role O 0 0.008178792893886566
of O 0 0.003206228604540229
DMPK O 1 0.9998898506164551
in O 0 0.005040899384766817
cellular O 0 0.26996126770973206
ion O 1 0.9140775799751282
homeostasis O 1 0.9997134804725647
, O 0 0.0023921108804643154
we O 0 0.0014299252070486546
have O 0 0.0015202369540929794
compared O 0 0.007816258817911148
the O 0 0.004361653700470924
resting O 1 0.9924765229225159
[ O 0 0.2474249005317688
Ca2 O 1 0.9998685121536255
+ O 0 0.16653040051460266
] O 0 0.04930790141224861
i O 0 0.006755920127034187
, O 0 0.0014578187838196754
the O 0 0.0033354260958731174
amplitude O 0 0.048494964838027954
and O 0 0.0017915911739692092
shape O 0 0.016162371262907982
of O 0 0.003888626117259264
depolarization O 1 0.9999867677688599
- O 1 0.9447638392448425
induced O 1 0.9999876022338867
Ca2 O 1 0.9992865920066833
+ O 1 0.586208164691925
transients O 1 0.9948785305023193
, O 0 0.002048184396699071
and O 0 0.0007577610667794943
the O 0 0.0016934614395722747
content O 0 0.0042596240527927876
of O 0 0.002915475284680724
ATP O 1 0.9973272085189819
- O 0 0.03862381726503372
driven O 0 0.0522291362285614
ion O 0 0.10911272466182709
pumps O 0 0.06888903677463531
in O 0 0.005406012758612633
cultured O 1 0.9673947691917419
skeletal O 1 0.9999933242797852
muscle O 1 0.999991774559021
cells O 0 0.03902393952012062
of O 0 0.0022769307252019644
wild O 0 0.07754121720790863
- O 0 0.026074698194861412
type O 0 0.044210392981767654
and O 0 0.0032930404413491488
DMPK O 1 0.9999867677688599
[ O 0 0.07010448724031448
- O 0 0.057117823511362076
/ O 1 0.5031949281692505
- O 0 0.04807480797171593
] O 0 0.09156738221645355
knockout O 1 0.999016284942627
mice O 1 0.999295711517334
. O 0 0.008105816319584846

In O 0 0.00793664250522852
vitro O 0 0.10909237712621689
- O 0 0.06318517029285431
differentiated O 1 0.9969905614852905
DMPK O 1 0.9999337196350098
[ O 0 0.06705188751220703
- O 0 0.05577719211578369
/ O 0 0.18536174297332764
- O 0 0.057140693068504333
] O 0 0.07453326880931854
myotubes O 1 0.9929338693618774
exhibit O 0 0.018043383955955505
a O 0 0.007070671301335096
higher O 0 0.014907616190612316
resting O 1 0.8377848267555237
[ O 0 0.09903370589017868
Ca2 O 1 0.9985911250114441
+ O 0 0.1391015350818634
] O 0 0.05080794543027878
i O 0 0.008290881291031837
than O 0 0.0030592982657253742
do O 0 0.004751464817672968
wild O 0 0.032277051359415054
- O 0 0.0440996028482914
type O 0 0.32603558897972107
myotubes O 1 0.9992208480834961
because O 0 0.004333468619734049
of O 0 0.001248670625500381
an O 0 0.0031294790096580982
altered O 0 0.03296462073922157
open O 0 0.010977815836668015
probability O 0 0.009696059860289097
of O 0 0.002011342206969857
voltage O 0 0.05167584866285324
- O 0 0.03448867052793503
dependent O 0 0.050944529473781586
l O 0 0.141402930021286
- O 0 0.05855033919215202
type O 0 0.15010663866996765
Ca2 O 1 0.999358594417572
+ O 0 0.08513161540031433
and O 0 0.006169550120830536
Na O 1 0.990851104259491
+ O 0 0.08556021749973297
channels O 0 0.02532038651406765
. O 0 0.008115760050714016

The O 0 0.017207033932209015
mutant O 1 0.9989523887634277
myotubes O 1 0.9956225752830505
exhibit O 0 0.025401368737220764
smaller O 0 0.008146164007484913
and O 0 0.002620672807097435
slower O 0 0.04746297001838684
Ca2 O 1 0.9920096397399902
+ O 0 0.09223799407482147
responses O 0 0.027134202420711517
upon O 0 0.01013614609837532
triggering O 1 0.9964929223060608
by O 0 0.009693185798823833
acetylcholine O 1 0.9981093406677246
or O 0 0.005824480205774307
high O 0 0.009628976695239544
external O 0 0.017737463116645813
K O 0 0.38056665658950806
+ O 0 0.08344893902540207
. O 0 0.007283731363713741

In O 0 0.004574980586767197
addition O 0 0.0044255866669118404
, O 0 0.0013329694047570229
we O 0 0.0014491291949525476
observed O 0 0.007566340733319521
that O 0 0.0012997925514355302
these O 0 0.003143354319036007
Ca2 O 1 0.9998594522476196
+ O 1 0.6293265223503113
transients O 1 0.9982353448867798
partially O 0 0.07429057359695435
result O 0 0.0111800292506814
from O 0 0.002273482270538807
an O 0 0.002701896708458662
influx O 0 0.04071978107094765
of O 0 0.0036567561328411102
extracellular O 1 0.8526600003242493
Ca2 O 1 0.998445451259613
+ O 0 0.058949343860149384
through O 0 0.004372261930257082
the O 0 0.006742364261299372
l O 1 0.7452784180641174
- O 0 0.06468687206506729
type O 0 0.19488109648227692
Ca2 O 1 0.9956468939781189
+ O 0 0.11784983426332474
channel O 0 0.04541665315628052
. O 0 0.00844224076718092

Neither O 0 0.01599874161183834
the O 0 0.003330665873363614
content O 0 0.005832775495946407
nor O 0 0.006215263623744249
the O 0 0.002406013198196888
activity O 0 0.008577274158596992
of O 0 0.004181763622909784
Na O 1 0.9988138675689697
+ O 0 0.2135196328163147
/ O 0 0.13610415160655975
K O 0 0.136188343167305
+ O 0 0.11621493101119995
ATPase O 1 0.9162589311599731
and O 0 0.01531887985765934
sarcoplasmic O 1 0.9999903440475464
reticulum O 1 0.9995529055595398
Ca2 O 1 0.9980220794677734
+ O 0 0.14441120624542236
- O 0 0.06678702682256699
ATPase O 1 0.9752928614616394
are O 0 0.003120828652754426
affected O 0 0.03706792742013931
by O 0 0.00930782314389944
DMPK O 1 0.9999805688858032
absence O 0 0.04369688034057617
. O 0 0.007897459901869297

In O 0 0.0051257130689918995
conclusion O 0 0.008628117851912975
, O 0 0.0013983792159706354
our O 0 0.002119639189913869
data O 0 0.0023046210408210754
suggest O 0 0.007606650702655315
that O 0 0.0033786860294640064
DMPK O 1 0.9999293088912964
is O 0 0.004258017987012863
involved O 0 0.006732752546668053
in O 0 0.002760247327387333
modulating O 1 0.9867058396339417
the O 0 0.0035523471888154745
initial O 0 0.012033042497932911
events O 0 0.00405991030856967
of O 0 0.002911748830229044
excitation O 1 0.8145027160644531
- O 0 0.05860453099012375
contraction O 1 0.9822015166282654
coupling O 0 0.0876912772655487
in O 0 0.010272983461618423
skeletal O 1 0.9999971389770508
muscle O 1 0.9999536275863647
. O 0 0.004811389371752739
. O 0 0.005787814501672983

Constitutional O 0 0.08049750328063965
RB1 O 1 0.9999977350234985
- O 1 0.9323090314865112
gene O 1 0.9996515512466431
mutations O 1 0.9998490810394287
in O 0 0.0056977346539497375
patients O 1 0.9999899864196777
with O 0 0.004104659426957369
isolated O 1 0.9681211113929749
unilateral B-Disease 1 0.993815541267395
retinoblastoma I-Disease 1 0.9999973773956299
. O 0 0.009427602402865887

In O 0 0.004953447263687849
most O 0 0.007537264842540026
patients O 1 0.9999768733978271
with O 0 0.0032318485900759697
isolated O 1 0.9902099370956421
unilateral B-Disease 1 0.9975553154945374
retinoblastoma I-Disease 1 0.9999985694885254
, O 0 0.00847291573882103
tumor B-Disease 1 0.9999997615814209
development O 0 0.005181840620934963
is O 0 0.003398685483261943
initiated O 0 0.027568921446800232
by O 0 0.005275157280266285
somatic O 1 0.9901543855667114
inactivation O 1 0.998484194278717
of O 0 0.001992247998714447
both O 0 0.003070404753088951
alleles O 1 0.9952860474586487
of O 0 0.002719279145821929
the O 0 0.013103283941745758
RB1 O 1 0.9999997615814209
gene O 1 0.996000349521637
. O 0 0.010480492375791073

However O 0 0.006921242922544479
, O 0 0.0011981112184002995
some O 0 0.0009779669344425201
of O 0 0.0011196378618478775
these O 0 0.002320248866453767
patients O 1 0.9999982118606567
can O 0 0.005927002523094416
transmit O 1 0.9920781254768372
retinoblastoma B-Disease 1 0.9999998807907104
predisposition O 1 0.9999879598617554
to O 0 0.0026775135193020105
their O 0 0.003938266076147556
offspring O 1 0.9881151914596558
. O 0 0.007588249631226063

To O 0 0.0032757448498159647
determine O 0 0.0053531331941485405
the O 0 0.002739556599408388
frequency O 0 0.019889287650585175
and O 0 0.0009499114821664989
nature O 0 0.0031753499060869217
of O 0 0.0016622948460280895
constitutional O 0 0.3901987075805664
RB1 O 1 0.9999998807907104
- O 1 0.9750540256500244
gene O 1 0.9999216794967651
mutations O 1 0.9998883008956909
in O 0 0.005089377518743277
patients O 1 0.9999951124191284
with O 0 0.0029861959628760815
isolated O 1 0.9914280772209167
unilateral B-Disease 1 0.9972538352012634
retinoblastoma I-Disease 1 0.9999984502792358
, O 0 0.002013598335906863
we O 0 0.0015280471416190267
analyzed O 0 0.016157442703843117
DNA O 0 0.03173117712140083
from O 0 0.0059503247030079365
peripheral O 1 0.9999939203262329
blood O 1 0.9983432292938232
and O 0 0.0031173236202448606
from O 0 0.015446002595126629
tumor B-Disease 1 1.0
tissue O 1 0.9999358654022217
. O 0 0.009029184468090534

The O 0 0.006291574332863092
analysis O 0 0.008341559208929539
of O 0 0.006215739995241165
tumors B-Disease 1 0.9999997615814209
from O 0 0.006844707764685154
54 O 0 0.0477423295378685
( O 0 0.008416212163865566
71 O 0 0.06027752161026001
% O 0 0.006035739090293646
) O 0 0.002920303260907531
of O 0 0.002183737466111779
76 O 0 0.43744194507598877
informative O 0 0.05207404866814613
patients O 1 0.9999725818634033
showed O 0 0.015712466090917587
loss O 0 0.025913819670677185
of O 0 0.0018769634189084172
constitutional O 0 0.0205514095723629
heterozygosity O 1 0.9999740123748779
( O 0 0.017423218116164207
LOH O 1 0.9999997615814209
) O 0 0.006574013736099005
at O 0 0.00807217974215746
intragenic O 1 0.999301552772522
loci O 1 0.9966500401496887
. O 0 0.010005532763898373

Three O 0 0.004052751697599888
of O 0 0.002671623369678855
13 O 0 0.02372542768716812
uninformative O 1 0.9999452829360962
patients O 1 0.9999891519546509
had O 0 0.0067888586781919
constitutional O 0 0.016554387286305428
deletions O 1 0.9798938035964966
. O 0 0.006844616029411554

For O 0 0.004641762003302574
39 O 0 0.03207738324999809
randomly O 0 0.04318925365805626
selected O 0 0.02479291707277298
tumors B-Disease 1 0.999998927116394
, O 0 0.006118412595242262
SSCP O 1 0.9999732971191406
, O 0 0.009785829111933708
hetero O 1 0.9995808005332947
- O 0 0.06145458295941353
duplex O 0 0.44485095143318176
analysis O 0 0.009275415912270546
, O 0 0.0026976140215992928
sequencing O 0 0.03817039355635643
, O 0 0.0019219411769881845
and O 0 0.0013563461834564805
Southern O 0 0.017189383506774902
blot O 1 0.9985899329185486
analysis O 0 0.004638973623514175
were O 0 0.001181660103611648
used O 0 0.001406127936206758
to O 0 0.0019996147602796555
identify O 0 0.028928544372320175
mutations O 1 0.9972889423370361
. O 0 0.00841448176652193

Mutations O 1 0.9994363188743591
were O 0 0.005253899842500687
detected O 0 0.06088799983263016
in O 0 0.003234462346881628
21 O 0 0.02172256074845791
( O 0 0.007985667325556278
91 O 0 0.0778711661696434
% O 0 0.006196497939527035
) O 0 0.003187856636941433
of O 0 0.0029965888243168592
23 O 1 0.7123900651931763
tumors B-Disease 1 0.9999997615814209
with O 0 0.007747196592390537
LOH O 1 0.999997615814209
. O 0 0.01109508890658617

In O 0 0.009438135661184788
6 O 0 0.024124454706907272
( O 0 0.008234065026044846
38 O 0 0.026091881096363068
% O 0 0.005983646959066391
) O 0 0.002428335603326559
of O 0 0.0021762042306363583
16 O 0 0.04870302975177765
tumors B-Disease 1 0.9999998807907104
without O 0 0.012645323760807514
LOH O 1 0.9999995231628418
, O 0 0.002913903910666704
one O 0 0.00675274059176445
mutation O 1 0.9999945163726807
was O 0 0.01564480923116207
detected O 0 0.09118877351284027
, O 0 0.0015325805870816112
and O 0 0.0009400738053955138
in O 0 0.0023505878634750843
9 O 0 0.017533699050545692
( O 0 0.006013022270053625
56 O 0 0.023689623922109604
% O 0 0.004704264923930168
) O 0 0.0020390977151691914
of O 0 0.001340301358141005
the O 0 0.008312538266181946
tumors B-Disease 1 1.0
without O 0 0.013254440389573574
LOH O 1 0.9999998807907104
, O 0 0.0024629717227071524
both O 0 0.003327095415443182
mutations O 1 0.9999614953994751
were O 0 0.00236162799410522
found O 0 0.0070159039460122585
. O 0 0.0057028355076909065

Thus O 0 0.011433758772909641
, O 0 0.0016373767284676433
a O 0 0.004179325886070728
total O 0 0.0035923155955970287
of O 0 0.001937139080837369
45 O 0 0.019897159188985825
mutations O 1 0.9996067881584167
were O 0 0.0027412897907197475
identified O 0 0.014549083076417446
in O 0 0.005006961990147829
tumors B-Disease 1 0.9999995231628418
of O 0 0.0033699176274240017
36 O 0 0.35523295402526855
patients O 1 0.9999892711639404
. O 0 0.008853834122419357

Thirty O 0 0.054446425288915634
- O 0 0.0256449356675148
nine O 0 0.0070127882063388824
of O 0 0.0022520124912261963
the O 0 0.008422044105827808
mutations O 1 0.9995354413986206
- O 0 0.02456437423825264
including O 0 0.0031609146390110254
34 O 0 0.01987844705581665
small O 0 0.011643964797258377
mutations O 1 0.9996281862258911
, O 0 0.002362924860790372
2 O 0 0.006943081971257925
large O 0 0.0041488041169941425
structural O 0 0.06152850389480591
alterations O 0 0.04527178406715393
, O 0 0.0016196409706026316
and O 0 0.0027989752124994993
hypermethylation O 1 0.9999837875366211
in O 0 0.005595883820205927
3 O 0 0.06165293604135513
tumors O 1 0.9999998807907104
- O 0 0.020164648070931435
were O 0 0.0020719070453196764
not O 0 0.0020468379370868206
detected O 0 0.03632150962948799
in O 0 0.001237716875039041
the O 0 0.003432089928537607
corresponding O 0 0.02819468080997467
peripheral O 1 0.9999767541885376
blood O 1 0.9990100860595703
DNA O 0 0.0683044046163559
. O 0 0.008406034670770168

In O 0 0.007971144281327724
6 O 0 0.022138772532343864
( O 0 0.0064219324849545956
17 O 0 0.014726953580975533
% O 0 0.004502906929701567
) O 0 0.0021222196519374847
of O 0 0.0010691682109609246
the O 0 0.0038654268719255924
36 O 0 0.12081260979175568
patients O 1 0.9999637603759766
, O 0 0.002123915823176503
a O 0 0.011602292768657207
mutation O 1 0.9999982118606567
was O 0 0.010689551942050457
detected O 0 0.04391717165708542
in O 0 0.001845017308369279
constitutional O 0 0.012615286745131016
DNA O 0 0.033108972012996674
, O 0 0.0015347893349826336
and O 0 0.0011232799151912332
1 O 0 0.005878827068954706
of O 0 0.0011558148544281721
these O 0 0.0024699147325009108
mutations O 1 0.9999178647994995
is O 0 0.0035849562846124172
known O 0 0.005345658399164677
to O 0 0.0011542822467163205
be O 0 0.0016430097166448832
associated O 0 0.006072167307138443
with O 0 0.002357055665925145
reduced O 0 0.07476222515106201
expressivity O 1 0.9999773502349854
. O 0 0.00912296399474144

The O 0 0.004753278102725744
presence O 0 0.0063417754136025906
of O 0 0.0012248287675902247
a O 0 0.007219093851745129
constitutional O 0 0.05688091367483139
mutation O 1 0.9999960660934448
was O 0 0.008114743046462536
not O 0 0.001582473050802946
associated O 0 0.005319017451256514
with O 0 0.0012609089026227593
an O 0 0.002257643500342965
early O 0 0.009560360573232174
age O 0 0.013458617962896824
at O 0 0.008533083833754063
treatment O 1 0.9989597797393799
. O 0 0.006487125996500254

In O 0 0.0068480465561151505
1 O 0 0.030515579506754875
patient O 1 0.9999451637268066
, O 0 0.006032907869666815
somatic O 1 0.9986366629600525
mosaicism O 1 0.9999537467956543
was O 0 0.009432191029191017
demonstrated O 0 0.012260830961167812
by O 0 0.0034194490872323513
molecular O 0 0.015596731565892696
analysis O 0 0.003461200511083007
of O 0 0.0014408344868570566
DNA O 0 0.030777426436543465
and O 0 0.0023487969301640987
RNA O 0 0.09879105538129807
from O 0 0.009691981598734856
peripheral O 1 0.9999911785125732
blood O 1 0.9991926550865173
. O 0 0.009898118674755096

In O 0 0.00665754359215498
2 O 0 0.023155739530920982
patients O 1 0.9998319149017334
without O 0 0.003653189167380333
a O 0 0.010915091261267662
detectable O 1 0.9996606111526489
mutation O 1 0.9999622106552124
in O 0 0.006068461108952761
peripheral O 1 0.9999986886978149
blood O 1 0.9997207522392273
, O 0 0.004831353668123484
mosaicism O 1 0.9999933242797852
was O 0 0.009247933514416218
suggested O 0 0.00646787928417325
because O 0 0.004172231070697308
1 O 0 0.004499153234064579
of O 0 0.0010662762215361
the O 0 0.00565735949203372
patients O 1 0.9999998807907104
showed O 1 0.9959251880645752
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 0.0013161321403458714
the O 0 0.0012058336287736893
other O 0 0.0006468557985499501
later O 0 0.004960220772773027
developed O 0 0.014297563582658768
bilateral B-Disease 0 0.01772245578467846
retinoblastoma I-Disease 1 0.9999932050704956
. O 0 0.008258410729467869

In O 0 0.004114618059247732
conclusion O 0 0.008960939943790436
, O 0 0.0015883180312812328
our O 0 0.002422504359856248
results O 0 0.0056709591299295425
emphasize O 0 0.009289974346756935
that O 0 0.0011830407893285155
the O 0 0.003383808769285679
manifestation O 1 0.9897416830062866
and O 0 0.0033575419802218676
transmissibility O 1 0.9998595714569092
of O 0 0.005765295121818781
retinoblastoma B-Disease 1 0.9999991655349731
depend O 0 0.008164508268237114
on O 0 0.0012143769999966025
the O 0 0.0016269764164462686
nature O 0 0.0035241080913692713
of O 0 0.0010879646288231015
the O 0 0.0029549733735620975
first O 0 0.010318019427359104
mutation O 1 0.9999934434890747
, O 0 0.00174797885119915
its O 0 0.0019880637992173433
time O 0 0.002324891509488225
in O 0 0.0010850747348740697
development O 0 0.002406269544735551
, O 0 0.0011172163067385554
and O 0 0.0007284393650479615
the O 0 0.0016858107410371304
number O 0 0.002075090305879712
and O 0 0.0011772094294428825
types O 0 0.006278104614466429
of O 0 0.0020528133027255535
cells O 1 0.5397554636001587
that O 0 0.001566098304465413
are O 0 0.0016274304362013936
affected O 0 0.3951264023780823
. O 0 0.003322137286886573
. O 0 0.005734224803745747

Hereditary B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999998807907104
of I-Disease 0 0.0024748044088482857
the I-Disease 0 0.003178497077897191
fifth I-Disease 0 0.02114293724298477
component I-Disease 0 0.01872224546968937
of I-Disease 0 0.0022140382789075375
complement I-Disease 0 0.019396550953388214
in O 0 0.0027651884593069553
man O 0 0.022938812151551247
. O 0 0.008302655071020126

I O 0 0.04076317325234413
. O 0 0.009472925215959549

Clinical O 1 0.9968003034591675
, O 0 0.006269899662584066
immunochemical O 1 0.9999758005142212
, O 0 0.002120640128850937
and O 0 0.001627931953407824
family O 0 0.011879297904670238
studies O 0 0.007943770848214626
. O 0 0.0065239486284554005

The O 0 0.004422550089657307
first O 0 0.004568090662360191
recognized O 0 0.01247067004442215
human O 0 0.011938465759158134
kindred O 1 0.9999706745147705
with O 0 0.006959180347621441
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 0 0.0015733548207208514
the I-Disease 0 0.002347832079976797
fifth I-Disease 0 0.019421998411417007
component I-Disease 0 0.017322581261396408
of I-Disease 0 0.00204933388158679
complement I-Disease 0 0.032715920358896255
( O 0 0.012545563280582428
C5 O 1 0.9999784231185913
) O 0 0.005621273070573807
is O 0 0.004417134448885918
described O 0 0.014918971806764603
. O 0 0.006318273022770882

The O 0 0.011224601417779922
proband O 1 0.9969621300697327
, O 0 0.00249504204839468
a O 0 0.005370252765715122
20 O 0 0.007740052416920662
- O 0 0.016839630901813507
year O 0 0.008055542595684528
- O 0 0.022247951477766037
old O 0 0.016109907999634743
black O 0 0.02592458389699459
female O 0 0.02575104683637619
with O 0 0.0493001863360405
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 0 0.0359443724155426
age O 0 0.015103843063116074
11 O 0 0.00819135271012783
, O 0 0.00255690049380064
lacked O 1 0.9874166250228882
serum O 1 0.9999974966049194
hemolytic O 1 1.0
complement O 0 0.03775954246520996
activity O 0 0.011301496997475624
, O 0 0.001832301844842732
even O 0 0.004471713677048683
during O 0 0.02009211853146553
remission O 1 0.9999982118606567
. O 0 0.00971841998398304

C5 O 1 0.9994032382965088
was O 0 0.023863306269049644
undetectable O 1 0.8896803259849548
in O 0 0.00269809877499938
her O 0 0.011363830417394638
serum O 1 0.9751919507980347
by O 0 0.003787209279835224
both O 0 0.004264282062649727
immunodiffusion O 1 0.9999257326126099
and O 0 0.009240408428013325
hemolytic O 1 1.0
assays O 0 0.15168701112270355
. O 0 0.009320552460849285

Other O 0 0.003102443180978298
complement O 0 0.016175387427210808
components O 0 0.005635797046124935
were O 0 0.0024468060582876205
normal O 0 0.018723778426647186
during O 0 0.01489658560603857
remission O 1 0.9999979734420776
of O 0 0.012538135051727295
lupus O 1 1.0
, O 0 0.004483682569116354
but O 0 0.006272734142839909
C1 O 1 0.9999997615814209
, O 0 0.005685674957931042
C4 O 1 0.999123752117157
, O 0 0.006448176223784685
C2 O 1 0.9999988079071045
, O 0 0.0029561705887317657
and O 0 0.0032570315524935722
C3 O 1 0.9999804496765137
levels O 0 0.02329639159142971
fell O 0 0.1934185028076172
during O 0 0.02520543336868286
exacerbations O 1 0.9999957084655762
. O 0 0.010332969948649406

A O 0 0.02876586839556694
younger O 0 0.037144389003515244
half O 0 0.013187721371650696
- O 0 0.04324726387858391
sister O 1 0.909827709197998
, O 0 0.0017257269937545061
who O 0 0.0027797031216323376
had O 0 0.00420633889734745
no O 0 0.003914593253284693
underlying O 1 0.9998226761817932
disease O 1 1.0
, O 0 0.0022576807532459497
was O 0 0.005241274833679199
also O 0 0.0016358582070097327
found O 0 0.0037454080302268267
to O 0 0.0019895723089575768
lack O 0 0.023286083713173866
immunochemically O 1 0.9999252557754517
detectable O 1 0.9984105825424194
C5 O 1 0.9993270635604858
. O 0 0.013422773219645023

By O 0 0.03511953353881836
hemolytic O 1 1.0
assay O 1 0.6452142596244812
, O 0 0.0037462017498910427
she O 0 0.006339270155876875
exhibited O 0 0.020959801971912384
1 O 0 0.014329256489872932
- O 0 0.01606028527021408
2 O 0 0.00793074257671833
% O 0 0.002419869415462017
of O 0 0.0008491517510265112
the O 0 0.0035760861355811357
normal O 0 0.059827789664268494
serum O 1 0.999737560749054
C5 O 1 0.9997361302375793
level O 0 0.007522561587393284
and O 0 0.0018578971503302455
normal O 0 0.02033037133514881
concentrations O 0 0.02090027555823326
of O 0 0.0011021464597433805
other O 0 0.001491994014941156
complement O 0 0.022484594956040382
components O 0 0.011020251549780369
. O 0 0.006797563750296831

C5 O 1 0.9982776641845703
levels O 0 0.020426815375685692
of O 0 0.0018152238335460424
other O 0 0.0012650266289710999
family O 0 0.009679879993200302
members O 0 0.0025058635510504246
were O 0 0.0015932399546727538
either O 0 0.006077075842767954
normal O 0 0.016939591616392136
or O 0 0.003358971793204546
approximately O 0 0.007475643418729305
half O 0 0.010618993081152439
- O 0 0.029973838478326797
normal O 0 0.019216811284422874
, O 0 0.0018837819807231426
consistent O 0 0.011318604461848736
with O 0 0.005488069262355566
autosomal O 1 0.9999998807907104
codominant O 1 0.9999758005142212
inheritance O 0 0.2759576141834259
of O 0 0.0017365324310958385
the O 0 0.005450916476547718
gene O 1 0.9996262788772583
determining O 0 0.0603368915617466
C5 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
. O 0 0.011257694102823734

Normal O 1 0.9588476419448853
hemolytic O 1 1.0
titers O 1 0.9986000657081604
were O 0 0.0025096843019127846
restored O 0 0.014012286439538002
to O 0 0.0013974725734442472
both O 0 0.004671297036111355
homozygous O 1 0.9999054670333862
C5 B-Disease 1 0.9999960660934448
- I-Disease 1 0.843535840511322
deficient I-Disease 1 0.9999730587005615
( O 0 0.019504858180880547
C5D B-Disease 1 0.9999990463256836
) O 0 0.0068650804460048676
sera O 0 0.060875844210386276
by O 0 0.0025702249258756638
addition O 0 0.0029804911464452744
of O 0 0.001649332232773304
highly O 0 0.018310213461518288
purified O 1 0.6918482780456543
human O 0 0.028540993109345436
C5 O 1 0.9997125267982483
. O 0 0.009254414588212967

In O 0 0.005036471877247095
specific O 0 0.011508018709719181
C5 O 1 0.9999959468841553
titrations O 1 0.9999701976776123
, O 0 0.003206225810572505
however O 0 0.003147280542179942
, O 0 0.0012884860625490546
it O 0 0.0016292924992740154
was O 0 0.005942110903561115
noted O 0 0.0034123719669878483
that O 0 0.0011982287978753448
when O 0 0.004870148375630379
limited O 0 0.0055079287849366665
amounts O 0 0.0064832307398319244
of O 0 0.0030827452428638935
C5 O 1 0.9999912977218628
were O 0 0.0032837754115462303
assayed O 0 0.09639774262905121
in O 0 0.0015961850294843316
the O 0 0.002130127977579832
presence O 0 0.006367174442857504
of O 0 0.001967159565538168
low O 0 0.03523269295692444
dilutions O 1 0.9939947724342346
of O 0 0.003450593678280711
either O 0 0.014655795879662037
C5D B-Disease 1 0.9999996423721313
serum O 1 0.998835027217865
, O 0 0.004320837557315826
curving O 0 0.05022807791829109
rather O 0 0.004014798440039158
than O 0 0.004451224580407143
linear O 0 0.045480795204639435
dose O 1 0.9998044371604919
- O 0 0.0386117659509182
response O 0 0.01944504678249359
plots O 0 0.014174244366586208
were O 0 0.0023211517836898565
consistently O 0 0.011880580335855484
obtained O 0 0.00426105223596096
, O 0 0.00212883111089468
suggesting O 0 0.015460975468158722
some O 0 0.004661614540964365
inhibitory O 1 0.7579398155212402
effect O 0 0.0284433513879776
. O 0 0.008429832756519318

Further O 0 0.01237486395984888
studies O 0 0.006954611279070377
suggested O 0 0.0069706737995147705
that O 0 0.002140511991456151
low O 0 0.029498592019081116
dilutions O 1 0.9943903088569641
of O 0 0.008126688189804554
C5D B-Disease 1 0.9999995231628418
serum O 1 0.9982560276985168
contain O 0 0.01365505438297987
a O 0 0.009175711311399937
factor O 0 0.04732220247387886
( O 0 0.00637632142752409
or O 0 0.004363486543297768
factors O 0 0.013288190588355064
) O 0 0.003995658829808235
interfering O 0 0.022220076993107796
at O 0 0.0025407555513083935
some O 0 0.0014047914883121848
step O 0 0.007426871452480555
in O 0 0.002124565886333585
the O 0 0.010123600251972675
hemolytic O 1 1.0
assay O 0 0.32984599471092224
of O 0 0.005006957333534956
C5 O 1 0.9999943971633911
, O 0 0.0020986213348805904
rather O 0 0.0024236661847680807
than O 0 0.00168080092407763
a O 0 0.006544263102114201
true O 0 0.019414404407143593
C5 O 1 0.9999948740005493
inhibitor O 1 0.9998075366020203
or O 0 0.012767341919243336
inactivator O 1 0.9900941252708435
. O 0 0.009195835329592228

Of O 0 0.00661613792181015
clinical O 0 0.17390038073062897
interest O 0 0.004628924652934074
are O 0 0.0015787993324920535
( O 0 0.0042303018271923065
a O 0 0.005489581264555454
) O 0 0.0021993322297930717
the O 0 0.001588443643413484
documentation O 0 0.006968680303543806
of O 0 0.004716434516012669
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 0 0.02913837879896164
vasculitis B-Disease 1 1.0
, O 0 0.003731729229912162
and O 0 0.007338650058954954
arthritis B-Disease 1 1.0
in O 0 0.0022341329604387283
an O 0 0.002502662828192115
individual O 0 0.006663844920694828
lacking O 1 0.9640686511993408
C5 O 1 0.9999959468841553
( O 0 0.004980343859642744
and O 0 0.0012796309310942888
its O 0 0.005479869432747364
biologic O 1 0.9922806024551392
functions O 0 0.00954868271946907
) O 0 0.0043950919061899185
, O 0 0.0019596656784415245
and O 0 0.0018954650731757283
( O 0 0.006865660194307566
b O 0 0.21059733629226685
) O 0 0.0036307303234934807
a O 0 0.006322890520095825
remarkable O 0 0.019434377551078796
propensity O 1 0.9847041368484497
to O 0 0.01029458548873663
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 0.002706528641283512
the O 0 0.0060919178649783134
proband O 1 0.9999853372573853
, O 0 0.002198426518589258
even O 0 0.0031105722300708294
during O 0 0.006542431656271219
periods O 0 0.010286431759595871
of O 0 0.0022935387678444386
low O 0 0.03771928325295448
- O 0 0.055037662386894226
dose O 1 0.9982684850692749
or O 0 0.005300934426486492
alternate O 0 0.013397708535194397
- O 0 0.035121817141771317
day O 0 0.02651144750416279
corticosteroid O 1 0.9999959468841553
therapy O 1 0.9992458820343018
. O 0 0.00957108661532402

Other O 0 0.0029127292800694704
observations O 0 0.007499045226722956
indicate O 0 0.007649561390280724
that O 0 0.0012660499196499586
the O 0 0.004553631413727999
C5D B-Disease 1 0.9999990463256836
state O 0 0.0030230728443711996
is O 0 0.003137392457574606
compatible O 0 0.013542870990931988
with O 0 0.0028614469338208437
normal O 0 0.0374523289501667
coagulation O 1 0.9998856782913208
function O 0 0.016985246911644936
and O 0 0.0009423281881026924
the O 0 0.0014053520280867815
capacity O 0 0.0025582851376384497
to O 0 0.0014314067084342241
mount O 0 0.040869999676942825
a O 0 0.021756786853075027
neutrophilic O 1 0.9999994039535522
leukocytosis O 1 0.9999977350234985
during O 1 0.7459312677383423
pyogenic B-Disease 1 0.9999995231628418
infection I-Disease 1 1.0
. O 0 0.0050561800599098206
. O 0 0.005979312118142843

Susceptibility O 1 0.9999252557754517
to O 0 0.02360985428094864
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.007318980060517788
twins O 1 0.9296087622642517
: O 0 0.0032031910959631205
the O 0 0.0020663579925894737
role O 0 0.006305974908173084
of O 0 0.002823678543791175
genes O 1 0.966133177280426
, O 0 0.00653122179210186
HLA O 1 0.9999997615814209
, O 0 0.0021754857152700424
and O 0 0.0009254738688468933
the O 0 0.0029776275623589754
environment O 0 0.009630763903260231
. O 0 0.006415576674044132

OBJECTIVE O 0 0.024907274171710014
To O 0 0.0022480152547359467
determine O 0 0.005268435925245285
the O 0 0.003046345664188266
relative O 0 0.016750458627939224
effects O 0 0.029776204377412796
of O 0 0.002127014799043536
genetic O 0 0.3031606078147888
and O 0 0.0014951989287510514
environmental O 0 0.007751850411295891
factors O 0 0.007015002891421318
in O 0 0.0036036628298461437
susceptibility O 1 0.999998927116394
to O 0 0.012833410874009132
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 0.01877513900399208
AS B-Disease 0 0.03294367343187332
) O 0 0.004908926784992218
. O 0 0.005475892219692469

METHODS O 0 0.02888365089893341
Twins O 1 0.6285898089408875
with O 0 0.002525211777538061
AS B-Disease 0 0.0068345824256539345
were O 0 0.0015080608427524567
identified O 0 0.007180008105933666
from O 0 0.0015278136124834418
the O 0 0.0022577401250600815
Royal O 0 0.16341793537139893
National O 0 0.031192723661661148
Hospital O 1 0.9999998807907104
for O 0 0.020852871239185333
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 0.03392934799194336
. O 0 0.006994425784796476

Clinical O 1 0.9521704912185669
and O 0 0.004417847841978073
radiographic O 1 0.9973324537277222
examinations O 0 0.03533172607421875
were O 0 0.0015229397686198354
performed O 0 0.006271534599363804
to O 0 0.0013717813417315483
establish O 0 0.009896849282085896
diagnoses O 1 0.9999905824661255
, O 0 0.0028148191049695015
and O 0 0.00596646498888731
disease O 1 1.0
severity O 1 0.9999942779541016
was O 0 0.009064417332410812
assessed O 0 0.016460182145237923
using O 0 0.002475595800206065
a O 0 0.00515896687284112
combination O 0 0.018528467044234276
of O 0 0.0017795955063775182
validated O 0 0.03408792242407799
scoring O 0 0.013945321552455425
systems O 0 0.015464751981198788
. O 0 0.007431639824062586

HLA O 1 0.9999454021453857
typing O 0 0.1195496991276741
for O 0 0.008090335875749588
HLA O 1 0.999994158744812
- O 0 0.07564564794301987
B27 O 1 0.9988971948623657
, O 0 0.009354007430374622
HLA O 1 0.9999974966049194
- O 0 0.06521902978420258
B60 O 1 0.9994070529937744
, O 0 0.0027076127007603645
and O 0 0.003997526131570339
HLA O 1 0.9999997615814209
- O 0 0.2625470757484436
DR1 O 1 0.9999557733535767
was O 0 0.013118467293679714
performed O 0 0.012559612281620502
by O 0 0.0063767810352146626
polymerase O 1 0.8541949391365051
chain O 0 0.08009688556194305
reaction O 0 0.021666144952178
with O 0 0.002719981363043189
sequence O 0 0.028697023168206215
- O 0 0.02326146326959133
specific O 0 0.0062197535298764706
primers O 0 0.0685596838593483
, O 0 0.002367182169109583
and O 0 0.0025369110517203808
zygosity O 1 0.9995566010475159
was O 0 0.008620037697255611
assessed O 0 0.02554098702967167
using O 0 0.008158301003277302
microsatellite O 1 0.9938021898269653
markers O 0 0.05732836574316025
. O 0 0.008507384918630123

Genetic O 0 0.08739061653614044
and O 0 0.0024231187999248505
environmental O 0 0.010863938368856907
variance O 0 0.02190498635172844
components O 0 0.004827824421226978
were O 0 0.0018876688554883003
assessed O 0 0.014762282371520996
with O 0 0.0013253202196210623
the O 0 0.002651079325005412
program O 0 0.017665304243564606
Mx O 1 0.999783456325531
, O 0 0.0020263581536710262
using O 0 0.002282632514834404
data O 0 0.001833236892707646
from O 0 0.0019122825469821692
this O 0 0.0012105382047593594
and O 0 0.0012176444288343191
previous O 0 0.004277999047189951
studies O 0 0.003896266222000122
of O 0 0.002373514696955681
twins O 1 0.9945740103721619
with O 0 0.002427144907414913
AS B-Disease 0 0.01616370491683483
. O 0 0.005810497794300318

RESULTS O 0 0.025348417460918427
Six O 0 0.0057138716802001
of O 0 0.002959261182695627
8 O 0 0.03006891906261444
monozygotic O 1 0.9994478821754456
( O 0 0.019773265346884727
MZ O 1 0.9999966621398926
) O 0 0.011659207753837109
twin O 1 0.9057343602180481
pairs O 0 0.020847732201218605
were O 0 0.007183401379734278
disease O 1 1.0
concordant O 1 0.9996697902679443
, O 0 0.0025152384769171476
compared O 0 0.008154786191880703
with O 0 0.0015123607590794563
4 O 0 0.0066842976957559586
of O 0 0.0016915117157623172
15 O 0 0.01502610556781292
B27 O 1 0.9993093013763428
- O 0 0.04387225955724716
positive O 0 0.041082218289375305
dizygotic O 1 0.9877966046333313
( O 0 0.01822028122842312
DZ O 1 0.9999575614929199
) O 0 0.011076562106609344
twin O 1 0.8306951522827148
pairs O 0 0.02375018037855625
( O 0 0.007670671213418245
27 O 0 0.018801294267177582
% O 0 0.006004449911415577
) O 0 0.0030216833110898733
and O 0 0.0012101717293262482
4 O 0 0.008272642269730568
of O 0 0.0027932554949074984
32 O 0 0.04007364436984062
DZ O 1 0.9999456405639648
twin O 1 0.747032880783081
pairs O 0 0.023108631372451782
overall O 0 0.020670445635914803
( O 0 0.0064884331077337265
12 O 0 0.009164438582956791
. O 0 0.003036914160475135
5 O 0 0.012576370500028133
% O 0 0.0059355637058615685
) O 0 0.005384217016398907
. O 0 0.005615290254354477

Nonsignificant O 1 0.9986251592636108
increases O 0 0.02569158934056759
in O 0 0.0024725855328142643
similarity O 0 0.015303020365536213
with O 0 0.0012067656498402357
regard O 0 0.00387550494633615
to O 0 0.0016951527213677764
age O 0 0.021773135289549828
at O 0 0.060534920543432236
disease O 1 1.0
onset O 1 0.9999998807907104
and O 0 0.001106585026718676
all O 0 0.0006236385088413954
of O 0 0.0011801841901615262
the O 0 0.019141681492328644
disease O 1 1.0
severity O 1 0.9999856948852539
scores O 0 0.01609588786959648
assessed O 0 0.014734059572219849
were O 0 0.0013877948513254523
noted O 0 0.004014588426798582
in O 0 0.004770956467837095
disease O 1 1.0
- O 1 0.9224547743797302
concordant O 1 0.9994344115257263
MZ O 1 0.9999988079071045
twins O 1 0.9822647571563721
compared O 0 0.018537383526563644
with O 0 0.00497812544927001
concordant O 1 0.9983957409858704
DZ O 1 0.9999685287475586
twins O 1 0.9729519486427307
. O 0 0.01037012878805399

HLA O 1 0.9999629259109497
- O 0 0.11554957181215286
B27 O 1 0.9943481087684631
and O 0 0.0065746307373046875
B60 O 1 0.998518168926239
were O 0 0.0024621402844786644
associated O 0 0.006583662703633308
with O 0 0.0014834152534604073
the O 0 0.010191818699240685
disease O 1 1.0
in O 0 0.004305810201913118
probands O 1 0.9999865293502808
, O 0 0.0014097903622314334
and O 0 0.0007997562061063945
the O 0 0.0016856767470017076
rate O 0 0.008500163443386555
of O 0 0.005256148055195808
disease O 1 1.0
concordance O 1 0.800548791885376
was O 0 0.010465821251273155
significantly O 0 0.021387603133916855
increased O 0 0.012524317018687725
among O 0 0.01185259036719799
DZ O 1 0.9999746084213257
twin O 1 0.9006929397583008
pairs O 0 0.012641002424061298
in O 0 0.00140111125074327
which O 0 0.0015687084523960948
the O 0 0.003464094828814268
co O 0 0.17443065345287323
- O 0 0.037135422229766846
twin O 1 0.857389509677887
was O 0 0.008096345700323582
positive O 0 0.0098011689260602
for O 0 0.001445303438231349
both O 0 0.004090600647032261
B27 O 1 0.999602735042572
and O 0 0.006635849364101887
DR1 O 1 0.9999587535858154
. O 0 0.011441058479249477

Additive O 0 0.2450151890516281
genetic O 0 0.1749960482120514
effects O 0 0.04216552898287773
were O 0 0.002301456406712532
estimated O 0 0.00857447274029255
to O 0 0.0027145049534738064
contribute O 0 0.0171220563352108
97 O 0 0.04165187105536461
% O 0 0.00472842575982213
of O 0 0.0014859288930892944
the O 0 0.004315122030675411
population O 0 0.013720041140913963
variance O 0 0.045620791614055634
. O 0 0.007672544103115797

CONCLUSION O 0 0.06564102321863174
Susceptibility O 1 0.9998990297317505
to O 0 0.0033554460387676954
AS B-Disease 0 0.008816019631922245
is O 0 0.0038557567168027163
largely O 0 0.012994276359677315
genetically O 0 0.09077297896146774
determined O 0 0.010746622458100319
, O 0 0.0012590301921591163
and O 0 0.0008722814382053912
the O 0 0.002479574177414179
environmental O 0 0.01300519797950983
trigger O 1 0.9907838106155396
for O 0 0.002437460469081998
the O 0 0.0095168836414814
disease O 1 1.0
is O 0 0.006376068107783794
probably O 0 0.02239421010017395
ubiquitous O 1 0.9069942235946655
. O 0 0.007679434958845377

HLA O 1 0.9999895095825195
- O 0 0.08414935320615768
B27 O 1 0.9449459314346313
accounts O 0 0.0062124659307301044
for O 0 0.0015800670953467488
a O 0 0.005048349034041166
minority O 0 0.010608659125864506
of O 0 0.0010901765199378133
the O 0 0.0028493686113506556
overall O 0 0.023257728666067123
genetic O 1 0.9841141700744629
susceptibility O 1 0.9999926090240479
to O 0 0.0027980529703199863
AS B-Disease 0 0.011428715661168098
. O 0 0.006191894877701998

Cell O 0 0.10021687299013138
cycle O 0 0.09386991709470749
- O 0 0.04700184613466263
dependent O 0 0.04382723942399025
colocalization O 1 0.9512021541595459
of O 0 0.004709756001830101
BARD1 O 1 0.999961256980896
and O 0 0.00881869625300169
BRCA1 O 1 0.9999996423721313
proteins O 0 0.022118018940091133
in O 0 0.002365671331062913
discrete O 0 0.02594919502735138
nuclear O 0 0.007874001748859882
domains O 0 0.039199572056531906
. O 0 0.008004342205822468

Germ O 1 0.9840917587280273
- O 0 0.04263661429286003
line O 0 0.017585687339305878
mutations O 1 0.9757852554321289
of O 0 0.002194088650867343
the O 0 0.009349214844405651
BRCA1 O 1 1.0
gene O 1 0.9998956918716431
predispose O 1 0.9996620416641235
women O 0 0.00664404546841979
to O 0 0.0013642682461068034
early O 0 0.014599408954381943
- O 1 0.9993396401405334
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.7202484011650085
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 0.004112191963940859
compromising O 0 0.028424618765711784
the O 0 0.005283367820084095
genes O 1 0.987299382686615
presumptive O 1 0.9999616146087646
function O 0 0.013592145405709743
as O 0 0.0033232441637665033
a O 0 0.03210480883717537
tumor B-Disease 1 1.0
suppressor O 1 0.9999973773956299
. O 0 0.012897977605462074

Although O 0 0.0071579948998987675
the O 0 0.0038205452729016542
biochemical O 0 0.03693780675530434
properties O 0 0.008489841595292091
of O 0 0.004751987289637327
BRCA1 O 1 1.0
polypeptides O 1 0.9749411344528198
are O 0 0.0014392848825082183
not O 0 0.0015603600768372416
understood O 0 0.010639593936502934
, O 0 0.001339233131147921
their O 0 0.0017224185867235065
expression O 0 0.020517056807875633
pattern O 0 0.02044927142560482
and O 0 0.0020015358459204435
subcellular O 0 0.07844754308462143
localization O 0 0.053175825625658035
suggest O 0 0.008344391360878944
a O 0 0.004703231155872345
role O 0 0.007383948657661676
in O 0 0.0032512363977730274
cell O 0 0.0544678159058094
- O 0 0.04387616366147995
cycle O 0 0.07592908293008804
regulation O 0 0.036408137530088425
. O 0 0.00825346540659666

When O 0 0.029415922239422798
resting O 1 0.997138500213623
cells O 0 0.1391502171754837
are O 0 0.004078878089785576
induced O 1 0.9989883303642273
to O 0 0.0034519070759415627
proliferate O 0 0.05668937787413597
, O 0 0.0018293563043698668
the O 0 0.002704277401790023
steady O 0 0.02833390235900879
- O 0 0.016110211610794067
state O 0 0.002531522884964943
levels O 0 0.009826278313994408
of O 0 0.0039910199120640755
BRCA1 O 1 0.9999998807907104
increase O 0 0.008264248259365559
in O 0 0.002505136886611581
late O 0 0.02219420298933983
G1 O 1 0.9999366998672485
and O 0 0.0016675693914294243
reach O 0 0.007085996679961681
a O 0 0.006624266039580107
maximum O 0 0.017706582322716713
during O 0 0.016618335619568825
S O 0 0.4984152913093567
phase O 0 0.055307164788246155
. O 0 0.010193935595452785

Moreover O 0 0.026437165215611458
, O 0 0.002636060817167163
in O 0 0.0034784339368343353
S O 1 0.9808046221733093
phase O 0 0.061684150248765945
cells O 0 0.07669581472873688
, O 0 0.009083595126867294
BRCA1 O 1 0.9999997615814209
polypeptides O 1 0.8404637575149536
are O 0 0.002639392390847206
hyperphosphorylated O 1 0.9995096921920776
and O 0 0.002844506409019232
accumulate O 0 0.04774584621191025
into O 0 0.0065111201256513596
discrete O 0 0.055225227028131485
subnuclear O 1 0.9982069730758667
foci O 1 0.9136077761650085
termed O 0 0.0904429629445076
" O 0 0.02404744178056717
BRCA1 O 1 0.9999991655349731
nuclear O 0 0.018138578161597252
dots O 0 0.07004889845848083
. O 0 0.007668472360819578

" O 0 0.037033695727586746
BRCA1 O 1 0.9999997615814209
associates O 0 0.030653074383735657
in O 0 0.0034914046991616488
vivo O 0 0.05975746735930443
with O 0 0.0016045987140387297
a O 0 0.009979330003261566
structurally O 0 0.1701587289571762
related O 0 0.01717739924788475
protein O 0 0.08186165988445282
termed O 0 0.3209938704967499
BARD1 O 1 0.9999171495437622
. O 0 0.009362463839352131

Here O 0 0.003883377183228731
we O 0 0.0019118202617391944
show O 0 0.004547233693301678
that O 0 0.001242017257027328
the O 0 0.003082049312070012
steady O 0 0.02890503965318203
- O 0 0.018071606755256653
state O 0 0.00310307159088552
levels O 0 0.010366199538111687
of O 0 0.003709143493324518
BARD1 O 1 0.9999916553497314
, O 0 0.0030624994542449713
unlike O 0 0.007916390895843506
those O 0 0.00148052629083395
of O 0 0.004707163665443659
BRCA1 O 1 1.0
, O 0 0.002889655064791441
remain O 0 0.0048281727358698845
relatively O 0 0.00903809629380703
constant O 0 0.019723746925592422
during O 0 0.013735206797719002
cell O 0 0.05991581827402115
cycle O 0 0.1291051059961319
progression O 1 0.997804582118988
. O 0 0.010192208923399448

However O 0 0.01044386811554432
, O 0 0.004872043617069721
immunostaining O 1 0.999700665473938
revealed O 0 0.020173007622361183
that O 0 0.0029363250359892845
BARD1 O 1 0.9998018145561218
resides O 0 0.03710688650608063
within O 0 0.01080396119505167
BRCA1 O 1 0.9999980926513672
nuclear O 0 0.013989156112074852
dots O 0 0.0641355961561203
during O 0 0.014887616969645023
S O 0 0.3544003963470459
phase O 0 0.02041621133685112
of O 0 0.001332552987150848
the O 0 0.004784451797604561
cell O 0 0.09695205837488174
cycle O 0 0.04733959585428238
, O 0 0.0020380206406116486
but O 0 0.0017403778620064259
not O 0 0.0012262879172340035
during O 0 0.005924622993916273
the O 0 0.006912539713084698
G1 O 1 0.999977707862854
phase O 0 0.05957083776593208
. O 0 0.009225652553141117

Nevertheless O 0 0.03914165869355202
, O 0 0.007272256072610617
BARD1 O 1 0.9999880790710449
polypeptides O 0 0.20349451899528503
are O 0 0.0014270193642005324
found O 0 0.004003642126917839
exclusively O 0 0.00374040799215436
in O 0 0.0009287449065595865
the O 0 0.001589640392921865
nuclear O 0 0.003497960977256298
fractions O 0 0.011723924428224564
of O 0 0.0013325256295502186
both O 0 0.004306943155825138
G1 O 1 0.9999656677246094
- O 0 0.026325440034270287
and O 0 0.0032527355942875147
S O 1 0.9957005381584167
- O 0 0.04360301420092583
phase O 0 0.0783521756529808
cells O 0 0.08223242312669754
. O 0 0.008228684775531292

Therefore O 0 0.013054382055997849
, O 0 0.0045766266994178295
progression O 1 0.9981441497802734
to O 0 0.0047896611504256725
S O 1 0.5975185036659241
phase O 0 0.032051585614681244
is O 0 0.004572626668959856
accompanied O 0 0.009692279621958733
by O 0 0.0023335511796176434
the O 0 0.002511837286874652
aggregation O 0 0.052327997982501984
of O 0 0.0019067696994170547
nuclear O 0 0.011653526686131954
BARD1 O 1 0.9997350573539734
polypeptides O 0 0.2662855088710785
into O 0 0.02048156037926674
BRCA1 O 1 0.9999960660934448
nuclear O 0 0.02218862622976303
dots O 0 0.07391387969255447
. O 0 0.00791229773312807

This O 0 0.00743296230211854
cell O 0 0.05584384873509407
cycle O 0 0.07043960690498352
- O 0 0.037622515112161636
dependent O 0 0.04002298042178154
colocalization O 1 0.7487107515335083
of O 0 0.005855051334947348
BARD1 O 1 0.9999816417694092
and O 0 0.008356908336281776
BRCA1 O 1 0.9999998807907104
indicates O 0 0.017504554241895676
a O 0 0.0049453736282885075
role O 0 0.005642598494887352
for O 0 0.0026231943629682064
BARD1 O 1 0.9999936819076538
in O 0 0.00820790696889162
BRCA1 O 1 1.0
- O 1 0.9971396923065186
mediated O 1 0.9998278617858887
tumor B-Disease 1 0.9999997615814209
suppression O 1 0.9392484426498413
. O 0 0.00988325197249651

Ethnic O 0 0.012514784932136536
differences O 0 0.006201195530593395
in O 0 0.0019228149903938174
the O 0 0.007372508756816387
HFE O 1 0.9999656677246094
codon O 1 0.9258860349655151
282 O 0 0.37179288268089294
( O 0 0.020550023764371872
Cys O 1 0.9999762773513794
/ O 1 0.9234744310379028
Tyr O 1 0.999866247177124
) O 0 0.014463049359619617
polymorphism O 1 0.737877607345581
. O 0 0.008901862427592278

Recent O 0 0.013167710043489933
studies O 0 0.004804161377251148
have O 0 0.001865734113380313
shown O 0 0.006580974441021681
that O 0 0.004362011328339577
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 0.3260487914085388
HH B-Disease 1 1.0
) O 0 0.005878359079360962
is O 0 0.0028400481678545475
likely O 0 0.005712885409593582
to O 0 0.0013044157531112432
be O 0 0.0025465290527790785
caused O 1 0.9829640984535217
by O 0 0.005286491475999355
homozygosity O 1 0.9987390637397766
for O 0 0.002576279453933239
a O 0 0.013842875137925148
Cys282Tyr O 1 0.9998118281364441
mutation O 1 0.9990341663360596
in O 0 0.003765946952626109
the O 0 0.010345648974180222
HFE O 1 0.9999958276748657
gene O 1 0.9637944102287292
located O 0 0.017907781526446342
4 O 0 0.016714561730623245
. O 0 0.006432047579437494

5 O 0 0.04205698519945145
Mb O 1 0.9946990013122559
telomeric O 1 0.9925939440727234
to O 0 0.01225232146680355
HLA O 1 0.9999858140945435
- O 0 0.04406201094388962
A O 0 0.02208426594734192
. O 0 0.007511618547141552

Population O 0 0.01700424589216709
studies O 0 0.004576579201966524
of O 0 0.0014118420658633113
this O 0 0.0033105798065662384
polymorphism O 1 0.9641748070716858
are O 0 0.001216204254887998
facilitated O 0 0.01816881261765957
by O 0 0.001998531399294734
the O 0 0.0016146240523084998
fact O 0 0.0027190321125090122
that O 0 0.0011990616330876946
the O 0 0.004686403553932905
Cys282Tyr O 1 0.9999963045120239
mutation O 1 0.9999605417251587
creates O 0 0.0279032364487648
a O 0 0.013944408856332302
Rsal O 1 0.9994257688522339
restriction O 0 0.04381241649389267
site O 0 0.014231151901185513
. O 0 0.007086926139891148

We O 0 0.004164503887295723
have O 0 0.0018277931958436966
studied O 0 0.005519242025911808
the O 0 0.005830481182783842
codon O 1 0.866603434085846
282 O 0 0.43350061774253845
( O 0 0.022466376423835754
Cys O 1 0.9999903440475464
/ O 1 0.9904311299324036
Tyr O 1 0.9998902082443237
) O 0 0.011010407470166683
polymorphism O 0 0.29897165298461914
in O 0 0.0019236385123804212
different O 0 0.0014609121717512608
ethnic O 0 0.006300508975982666
groups O 0 0.005116398446261883
. O 0 0.005986370611935854

In O 0 0.0038904184475541115
agreement O 0 0.0023018440697342157
with O 0 0.0013003213098272681
previous O 0 0.0051764873787760735
observations O 0 0.006660934537649155
the O 0 0.006805565673857927
Tyr O 1 0.9999979734420776
allele O 1 0.9999648332595825
appeared O 0 0.013995280489325523
to O 0 0.0017553360667079687
be O 0 0.0025623522233217955
rare O 0 0.01647736132144928
or O 0 0.004229582846164703
absent O 0 0.24133801460266113
in O 0 0.004323702771216631
Asiatic O 1 0.9999939203262329
( O 0 0.007234708871692419
Indian O 0 0.007724788039922714
, O 0 0.0017570564523339272
Chinese O 0 0.00408395379781723
) O 0 0.005423135124146938
populations O 0 0.03996942937374115
. O 0 0.00704912468791008

The O 0 0.008436568081378937
highest O 0 0.03455091267824173
allele O 1 0.999340832233429
frequency O 0 0.06142391264438629
( O 0 0.007029393687844276
7 O 0 0.013693908229470253
. O 0 0.0027995745185762644
5 O 0 0.011406847275793552
% O 0 0.0051336647011339664
) O 0 0.0036046598106622696
was O 0 0.007456446532160044
found O 0 0.0049294717609882355
in O 0 0.0027063279412686825
Swedes O 1 0.7925524115562439
. O 0 0.006396861746907234

Saamis O 1 0.9986761212348938
( O 0 0.01364897470921278
2 O 0 0.015316592529416084
% O 0 0.006301907356828451
) O 0 0.004046826157718897
and O 0 0.0028904909268021584
Mordvinians O 1 0.9999645948410034
( O 0 0.008267276920378208
1 O 0 0.012542994692921638
. O 0 0.0026705816853791475
8 O 0 0.013958524912595749
% O 0 0.005049171857535839
) O 0 0.0032605910673737526
had O 0 0.005934538785368204
significantly O 0 0.02430158108472824
lower O 0 0.012678468599915504
frequencies O 0 0.011917761527001858
of O 0 0.001715691527351737
the O 0 0.009391325525939465
Tyr O 1 0.9999901056289673
allele O 1 0.9997612833976746
. O 0 0.01060014870017767

Comparisons O 0 0.023982392624020576
with O 0 0.006167922168970108
allele O 1 0.9980042576789856
frequencies O 0 0.02381822280585766
based O 0 0.002991168759763241
on O 0 0.003310870612040162
prevalence O 1 0.9986714124679565
estimates O 0 0.010039782151579857
of O 0 0.004248708486557007
HH B-Disease 1 0.9999998807907104
showed O 0 0.013394550420343876
some O 0 0.0021711282897740602
disagreements O 0 0.013294420205056667
with O 0 0.001494776108302176
the O 0 0.005323176737874746
RFLP O 1 0.9989884495735168
data O 0 0.004073706921190023
, O 0 0.001969199627637863
particularly O 0 0.006374053657054901
in O 0 0.002672408474609256
Finns O 0 0.4883127212524414
. O 0 0.007844370789825916

The O 0 0.009342540055513382
newly O 0 0.028891004621982574
described O 0 0.03707380220293999
HFE O 1 0.9999821186065674
marker O 0 0.2266322523355484
provides O 0 0.005987538956105709
a O 0 0.004361592698842287
new O 0 0.002088520908728242
approach O 0 0.005605728831142187
to O 0 0.0011853363830596209
the O 0 0.0034683048725128174
screening O 0 0.04671052470803261
of O 0 0.004371109884232283
HH B-Disease 1 0.9999998807907104
as O 0 0.0032073501497507095
well O 0 0.0015686003025621176
as O 0 0.0013764932518824935
studies O 0 0.0024440563283860683
of O 0 0.0007868328248150647
the O 0 0.00211650924757123
relationship O 0 0.006740473676472902
between O 0 0.0026845959946513176
the O 0 0.009786445647478104
HFE O 1 0.9999997615814209
Tyr O 1 0.999991774559021
allele O 1 0.9999326467514038
and O 0 0.0028612397145479918
different O 0 0.00403312174603343
disorders O 1 1.0
including O 0 0.012202084995806217
cancer B-Disease 1 1.0

Autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 0.9997382760047913
neurohypophyseal I-Disease 1 0.9999996423721313
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
associated O 0 0.012217456474900246
with O 0 0.00163821573369205
a O 0 0.011513395234942436
missense O 1 0.9995593428611755
mutation O 1 0.9992713332176208
encoding O 0 0.08136548846960068
Gly23 O 1 0.9997043013572693
- O 0 0.05958099290728569
- O 0 0.07510972768068314
> O 1 0.9944995641708374
Val O 1 0.9998705387115479
in O 0 0.006863208021968603
neurophysin O 1 0.9999556541442871
II O 1 0.9995778203010559
. O 0 0.008447832427918911

Autosomal B-Disease 1 0.9999992847442627
dominant I-Disease 1 0.999452531337738
neurohypophyseal I-Disease 1 0.9999998807907104
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 0.0229154285043478
ADNDI B-Disease 1 0.9999986886978149
) O 0 0.004618161357939243
is O 0 0.0028047841042280197
an O 0 0.006328531540930271
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9999873638153076
by O 0 0.007574846502393484
progressive O 1 0.999995231628418
degeneration O 1 1.0
of O 0 0.0024392688646912575
the O 0 0.006834530271589756
magnocellular O 1 0.9999194145202637
neurons O 0 0.15798909962177277
of O 0 0.001655401661992073
the O 0 0.005454760976135731
hypothalamus O 1 0.9999840259552002
leading O 0 0.01194709725677967
to O 0 0.0032790564000606537
decreased O 1 0.5324636101722717
ability O 0 0.007545666303485632
to O 0 0.0015663285739719868
produce O 0 0.0042162006720900536
the O 0 0.007073250133544207
hormone O 1 0.9991044402122498
arginine O 1 0.9733073711395264
vasopressin O 1 0.9972202777862549
( O 0 0.022210007533431053
AVP O 1 0.9997324347496033
) O 0 0.010377760045230389
. O 0 0.006790987215936184

Affected O 0 0.10873645544052124
individuals O 0 0.006009295582771301
are O 0 0.0013671799097210169
not O 0 0.0030054571107029915
symptomatic O 1 0.9999995231628418
at O 0 0.006088278256356716
birth O 1 0.9840937256813049
, O 0 0.0015676842303946614
but O 0 0.002440406009554863
usually O 0 0.010852864943444729
develop O 1 0.8492352366447449
diabetes B-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
at O 0 0.010203360579907894
1 O 0 0.018721025437116623
- O 0 0.031609077006578445
6 O 0 0.02734004706144333
yr O 1 0.9965919256210327
of O 0 0.0035280974116176367
age O 0 0.01922701671719551
. O 0 0.0070234849117696285

The O 0 0.009247558191418648
genetic O 0 0.2546483278274536
locus O 1 0.9973561763763428
of O 0 0.0027981209568679333
the O 0 0.008411227725446224
disease O 1 1.0
is O 0 0.003933512140065432
the O 0 0.006506664678454399
AVP O 1 0.9999957084655762
- O 0 0.1445740908384323
neurophysin O 1 0.9997654557228088
II O 1 0.9997652173042297
( O 0 0.015286329202353954
NPII O 1 0.999987006187439
) O 0 0.010863280855119228
gene O 1 0.9983990788459778
, O 0 0.0018176429439336061
and O 0 0.0025354924146085978
mutations O 1 0.9999651908874512
that O 0 0.0032371417619287968
cause O 1 0.9998507499694824
ADNDI B-Disease 1 0.9999964237213135
have O 0 0.002798602683469653
been O 0 0.003970952704548836
found O 0 0.003167553339153528
in O 0 0.0010031502461060882
both O 0 0.0011385862017050385
the O 0 0.0028734307270497084
signal O 0 0.031104447320103645
peptide O 0 0.06978064030408859
of O 0 0.0013359147123992443
the O 0 0.0052488758228719234
prepro O 1 0.999884843826294
- O 1 0.5358321070671082
AVP O 1 0.9999815225601196
- O 0 0.09604433923959732
NPII O 1 0.9997392296791077
precursor O 0 0.056704554706811905
and O 0 0.0021483623422682285
within O 0 0.007012285757809877
NPII O 1 0.9998538494110107
itself O 0 0.02264338918030262
. O 0 0.0093215461820364

An O 0 0.011679168790578842
affected O 1 0.8418832421302795
girl O 1 0.9582282304763794
who O 0 0.00508491275832057
presented O 0 0.005190461408346891
at O 0 0.004626431968063116
9 O 0 0.011414764449000359
months O 0 0.008515053428709507
of O 0 0.00139243237208575
age O 0 0.008867352269589901
and O 0 0.0013494439190253615
her O 0 0.008325095288455486
similarly O 0 0.1327291578054428
affected O 1 0.9921951293945312
younger O 1 0.9681050777435303
brother O 1 0.5563828349113464
and O 0 0.001915798638947308
father O 0 0.05817696452140808
were O 0 0.0011930878972634673
all O 0 0.0009030475048348308
found O 0 0.002478991635143757
to O 0 0.0008546122116968036
have O 0 0.0014370887074619532
a O 0 0.0064382487908005714
novel O 0 0.04624350741505623
missense O 1 0.9995822310447693
mutation O 1 0.9999431371688843
( O 0 0.013836521655321121
G1758 O 1 0.9988417029380798
- O 0 0.06843151152133942
- O 0 0.11008124053478241
> O 1 0.9970927238464355
T O 1 0.9944981932640076
) O 0 0.004851580131798983
encoding O 0 0.02793010137975216
the O 0 0.004343883134424686
amino O 0 0.05551370233297348
acid O 0 0.1108219176530838
substitution O 0 0.07895711809396744
Gly23 O 1 0.9953455328941345
- O 0 0.07357840985059738
- O 0 0.07307655364274979
> O 1 0.9746739268302917
Val O 1 0.9993942975997925
within O 0 0.014855475164949894
NPII O 1 0.9997918009757996
. O 0 0.01067363377660513

The O 0 0.017303744331002235
mutation O 1 0.9997336268424988
was O 0 0.013507720082998276
confirmed O 0 0.01786603406071663
by O 0 0.005406689364463091
restriction O 0 0.06636087596416473
endonuclease O 1 0.986234724521637
analysis O 0 0.011857851408421993
. O 0 0.007871114648878574

A O 0 0.0554976649582386
T1 O 1 0.994178056716919
- O 0 0.047673821449279785
weighted O 0 0.04518669843673706
magnetic O 0 0.03012918122112751
resonance O 0 0.056036435067653656
imaging O 0 0.04581671953201294
of O 0 0.0017709494568407536
the O 0 0.004353736061602831
fathers O 1 0.5545890927314758
pituitary O 1 0.9999971389770508
gland O 1 0.9999607801437378
demonstrates O 0 0.033923108130693436
an O 0 0.007311657071113586
attenuated O 1 0.9999511241912842
posterior O 1 0.9999892711639404
pituitary O 1 0.9999858140945435
bright O 0 0.12463600933551788
spot O 0 0.03901444375514984
. O 0 0.006222601514309645

This O 0 0.011654136702418327
mutation O 1 0.9999716281890869
may O 0 0.007681804709136486
be O 0 0.0013055382296442986
valuable O 0 0.0038717256393283606
for O 0 0.0011867649154737592
developing O 0 0.006863475777208805
models O 0 0.006137740332633257
of O 0 0.004274533595889807
dominantly B-Disease 1 0.999995231628418
inherited I-Disease 1 0.9999997615814209
neurodegeneration I-Disease 1 1.0
, O 0 0.002554484410211444
as O 0 0.0020390439312905073
the O 0 0.0022322223521769047
early O 0 0.0075221555307507515
age O 0 0.010142429731786251
of O 0 0.003686160547658801
onset O 1 1.0
of O 0 0.008378368802368641
symptoms O 1 1.0
suggests O 0 0.012477912940084934
that O 0 0.0011189309880137444
this O 0 0.003778057871386409
mutation O 1 0.9999969005584717
may O 0 0.008159280754625797
be O 0 0.0019241742556914687
particularly O 0 0.009624820202589035
deleterious O 1 0.9975787997245789
to O 0 0.001992551377043128
the O 0 0.006328654941171408
magnocellular O 1 0.999981164932251
neuron O 1 0.9998910427093506
. O 0 0.004485909827053547
. O 0 0.0064826831221580505

Frequent O 0 0.10402020812034607
inactivation O 1 0.9966385364532471
of O 0 0.009980790317058563
PTEN O 1 0.9999998807907104
/ O 1 0.9952865242958069
MMAC1 O 1 0.999961256980896
in O 0 0.007428169250488281
primary O 1 0.9999728202819824
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.010801366530358791

Sporadic B-Disease 1 0.99997878074646
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.0042565991170704365
the O 0 0.002051320392638445
most O 0 0.003298175986856222
common O 1 0.5158876180648804
male B-Disease 1 0.9999476671218872
cancer I-Disease 1 1.0
in O 0 0.0020229851361364126
the O 0 0.0022442303597927094
Western O 0 0.006459819618612528
world O 0 0.004389149136841297
, O 0 0.0016706587048247457
yet O 0 0.0026977856177836657
many O 0 0.0008078145328909159
of O 0 0.0009856936521828175
the O 0 0.003038509516045451
major O 0 0.014492780901491642
genetic O 0 0.17014500498771667
events O 0 0.00406104838475585
involved O 0 0.004622937645763159
in O 0 0.0012820245465263724
the O 0 0.0031261262483894825
progression O 1 0.9993293285369873
of O 0 0.0012089814990758896
this O 0 0.002689088461920619
often O 0 0.04942956566810608
fatal O 1 1.0
cancer B-Disease 1 1.0
remain O 0 0.006104681175202131
to O 0 0.0013925197999924421
be O 0 0.003070149105042219
elucidated O 1 0.684070348739624
. O 0 0.008061648346483707

Numerous O 0 0.021934039890766144
cytogenetic O 1 0.9949793219566345
and O 0 0.004036175552755594
allelotype O 1 0.999883770942688
studies O 0 0.006420021876692772
have O 0 0.0023006093688309193
reported O 0 0.014725860208272934
frequent O 0 0.03016817755997181
loss O 0 0.03351477533578873
of O 0 0.0033815454225987196
heterozygosity O 1 0.9999045133590698
on O 0 0.007504349108785391
chromosomal O 1 0.9999895095825195
arm O 1 0.9987467527389526
10q O 1 0.9991902709007263
in O 0 0.00910269282758236
sporadic B-Disease 1 0.999957799911499
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.01018429920077324

Deletion O 1 0.9238365888595581
mapping O 0 0.030343718826770782
studies O 0 0.006735227536410093
have O 0 0.002808515215292573
unambiguously O 0 0.0377427339553833
identified O 0 0.011637977324426174
a O 0 0.005572051275521517
region O 0 0.009686441160738468
of O 0 0.005064078141003847
chromosome O 1 0.9999935626983643
10q23 O 1 0.9991472959518433
to O 0 0.0015339937526732683
be O 0 0.0013280323473736644
the O 0 0.002812429564073682
minimal O 0 0.026165131479501724
area O 0 0.00814817938953638
of O 0 0.002944206353276968
loss O 1 0.7344685792922974
. O 0 0.00804842822253704

A O 0 0.02300243265926838
new O 0 0.015661561861634254
tumor B-Disease 1 1.0
suppressor O 1 0.9999990463256836
gene O 1 0.9987362027168274
, O 0 0.009327114559710026
PTEN O 1 0.9999995231628418
/ O 1 0.9986662864685059
MMAC1 O 1 0.9999555349349976
, O 0 0.003787644673138857
was O 0 0.010875635780394077
isolated O 0 0.06205974891781807
recently O 0 0.012103315442800522
at O 0 0.0029163446743041277
this O 0 0.0017325493972748518
region O 0 0.008743570186197758
of O 0 0.0050970991142094135
chromosome O 1 0.9999938011169434
10q23 O 1 0.9998316764831543
and O 0 0.001563346479088068
found O 0 0.0036333322059363127
to O 0 0.0011817028280347586
be O 0 0.0026017194613814354
inactivated O 1 0.9966513514518738
by O 0 0.0047710854560136795
mutation O 1 0.9998911619186401
in O 0 0.003371272934600711
three O 0 0.1905541718006134
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.3350381553173065
lines O 0 0.015294616110622883
. O 0 0.006749949883669615

We O 0 0.007639837916940451
screened O 1 0.5919185280799866
80 O 1 0.9297968745231628
prostate B-Disease 1 1.0
tumors I-Disease 1 0.9999997615814209
by O 0 0.007943078875541687
microsatellite O 1 0.9828643798828125
analysis O 0 0.0073447623290121555
and O 0 0.0019794809632003307
found O 0 0.014943196438252926
chromosome O 1 0.9999265670776367
10q23 O 1 0.9919725656509399
to O 0 0.002041042782366276
be O 0 0.002753759268671274
deleted O 0 0.034394003450870514
in O 0 0.0032102905679494143
23 O 0 0.018793081864714622
cases O 0 0.015124504454433918
. O 0 0.007396289613097906

We O 0 0.004576379433274269
then O 0 0.004609772935509682
proceeded O 0 0.011786925606429577
with O 0 0.0015302262036129832
sequence O 0 0.011875716038048267
analysis O 0 0.003011515596881509
of O 0 0.0010325300972908735
the O 0 0.0038149903994053602
entire O 0 0.12582522630691528
PTEN O 1 0.9999997615814209
/ O 1 0.9909656047821045
MMAC1 O 1 0.9999521970748901
coding O 0 0.09396243840456009
region O 0 0.008336381055414677
and O 0 0.0015237354673445225
tested O 0 0.031074602156877518
for O 0 0.004620550666004419
homozygous O 1 0.9997604489326477
deletion O 1 0.9785706400871277
with O 0 0.002776761306449771
new O 0 0.0060349381528794765
intragenic O 1 0.9997792840003967
markers O 0 0.03223935514688492
in O 0 0.0016248488100245595
these O 0 0.001388820237480104
23 O 0 0.013184587471187115
cases O 0 0.008403639309108257
with O 0 0.0034680147655308247
10q23 O 1 0.999779999256134
loss O 0 0.38559234142303467
of O 0 0.004899125080555677
heterozygosity O 1 0.9999294281005859
. O 0 0.009395443834364414

The O 0 0.004632316064089537
identification O 0 0.006446446757763624
of O 0 0.001003787387162447
the O 0 0.0025730503257364035
second O 0 0.01741769164800644
mutational O 1 0.9997802376747131
event O 0 0.013612412847578526
in O 0 0.0025108614936470985
10 O 0 0.008187828585505486
( O 0 0.006423125509172678
43 O 0 0.024201679974794388
% O 0 0.00908416137099266
) O 0 0.013666962273418903
tumors B-Disease 1 0.9999998807907104
establishes O 1 0.988520622253418
PTEN O 1 0.9999997615814209
/ O 1 0.9586349725723267
MMAC1 O 1 0.9995293617248535
as O 0 0.0031541683711111546
a O 0 0.005559256765991449
main O 0 0.011191880330443382
inactivation O 1 0.9993394017219543
target O 0 0.011722968891263008
of O 0 0.0029880008660256863
10q O 1 0.9999399185180664
loss O 1 0.6647276878356934
in O 0 0.005835435353219509
sporadic B-Disease 1 0.9999978542327881
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.004950284957885742
. O 0 0.006266649812459946

Risk O 1 0.9214403033256531
reversals O 0 0.11093702167272568
in O 0 0.003636924782767892
predictive O 0 0.09969959408044815
testing O 0 0.029708655551075935
for O 0 0.00909044686704874
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.00921181496232748

The O 0 0.00495535833761096
first O 0 0.006125686224550009
predictive O 0 0.09146913886070251
testing O 0 0.030617499724030495
for O 0 0.01129871141165495
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.022323494777083397
HD B-Disease 1 0.9996707439422607
) O 0 0.004550295881927013
was O 0 0.004931717645376921
based O 0 0.001706366310827434
on O 0 0.0011219740845263004
analysis O 0 0.003183647058904171
of O 0 0.0023100720718503
linked O 1 0.7731639742851257
polymorphic O 1 0.9998862743377686
DNA O 0 0.056799620389938354
markers O 0 0.026263050734996796
to O 0 0.0016908562975004315
estimate O 0 0.006112938281148672
the O 0 0.002505422802641988
likelihood O 0 0.025694960728287697
of O 0 0.0028930341359227896
inheriting O 1 0.9981086254119873
the O 0 0.008186153136193752
mutation O 1 0.9998816251754761
for O 0 0.00629048328846693
HD B-Disease 1 0.9848933815956116
. O 0 0.011425655335187912

Limits O 0 0.011888543143868446
to O 0 0.0017642428865656257
accuracy O 0 0.006864342838525772
included O 0 0.004054615274071693
recombination O 0 0.08279020339250565
between O 0 0.0026114103384315968
the O 0 0.0036090053617954254
DNA O 0 0.04168716445565224
markers O 0 0.028008174151182175
and O 0 0.0016353888204321265
the O 0 0.005703781731426716
mutation O 1 0.9999959468841553
, O 0 0.004603642039000988
pedigree O 1 0.7784518599510193
structure O 0 0.00786677747964859
, O 0 0.0014024549163877964
and O 0 0.0010714164236560464
whether O 0 0.0035964068956673145
DNA O 0 0.029653718695044518
samples O 0 0.011124106124043465
were O 0 0.0017115239752456546
available O 0 0.0023928300943225622
from O 0 0.003486683126538992
family O 0 0.01164988148957491
members O 0 0.0039867074228823185
. O 0 0.006719939410686493

With O 0 0.0034940470941364765
direct O 0 0.007685436401516199
tests O 0 0.0077935559675097466
for O 0 0.0014418597565963864
the O 0 0.0065818787552416325
HD B-Disease 1 0.9999719858169556
mutation O 1 0.9999871253967285
, O 0 0.00201539508998394
we O 0 0.0011019038502126932
have O 0 0.001718412502668798
assessed O 0 0.014061696827411652
the O 0 0.002048277063295245
accuracy O 0 0.005019816104322672
of O 0 0.0013474802253767848
results O 0 0.006276783999055624
obtained O 0 0.0033177128061652184
by O 0 0.0036037040408700705
linkage O 0 0.08903245627880096
approaches O 0 0.022387921810150146
when O 0 0.00551216397434473
requested O 0 0.0065969740971922874
to O 0 0.0014854167820885777
do O 0 0.002252435777336359
so O 0 0.002017728751525283
by O 0 0.002106596017256379
the O 0 0.0031829148065298796
test O 0 0.01585645042359829
individuals O 0 0.0067429873161017895
. O 0 0.00636807968840003

For O 0 0.003378840396180749
six O 0 0.0041190399788320065
such O 0 0.0013650661567226052
individuals O 0 0.003911149688065052
, O 0 0.0012142348568886518
there O 0 0.0016849675448611379
was O 0 0.006459157448261976
significant O 0 0.008268855512142181
disparity O 0 0.035968996584415436
between O 0 0.0024242866784334183
the O 0 0.003245247295126319
tests O 0 0.0153374457731843
. O 0 0.006346181966364384

Three O 0 0.005845281295478344
went O 0 0.007963094860315323
from O 0 0.003090817015618086
a O 0 0.009808632545173168
decreased O 1 0.9984729886054993
risk O 1 0.7637227177619934
to O 0 0.0014618015848100185
an O 0 0.0027850857004523277
increased O 0 0.027282441034913063
risk O 1 0.9988532066345215
, O 0 0.0015656390460208058
while O 0 0.0015079000731930137
in O 0 0.0011267414083704352
another O 0 0.004751258995383978
three O 0 0.0017268122173845768
the O 0 0.0038759433664381504
risk O 1 0.9993060827255249
was O 0 0.014010211452841759
decreased O 1 0.7890834212303162
. O 0 0.006936769001185894

Knowledge O 0 0.005310854874551296
of O 0 0.001250757253728807
the O 0 0.0030317327473312616
potential O 0 0.009825773537158966
reasons O 0 0.005063285585492849
for O 0 0.0009430270292796195
these O 0 0.0007394696003757417
changes O 0 0.004186110571026802
in O 0 0.0014101058477535844
results O 0 0.005665949545800686
and O 0 0.0012025050818920135
impact O 0 0.008207741193473339
of O 0 0.0011004542466253042
these O 0 0.0018217519391328096
risk O 1 0.9991021156311035
reversals O 1 0.9547809362411499
on O 0 0.0025875053834170103
both O 0 0.003848176682367921
patients O 1 0.999993085861206
and O 0 0.0013747102348133922
the O 0 0.003395301755517721
counseling O 1 0.9950544834136963
team O 0 0.005841818638145924
can O 0 0.002156116534024477
assist O 0 0.00792902521789074
in O 0 0.0012194616720080376
the O 0 0.0017482100520282984
development O 0 0.0021538916043937206
of O 0 0.001457593753002584
strategies O 0 0.011654015630483627
for O 0 0.0014749750262126327
the O 0 0.004096066113561392
prevention O 1 0.9997641444206238
and O 0 0.001526762149296701
, O 0 0.00139586441218853
where O 0 0.002516437554731965
necessary O 0 0.0033604952041059732
, O 0 0.0015402474673464894
management O 0 0.007845076732337475
of O 0 0.0016927729593589902
a O 0 0.01053596381098032
risk O 1 0.9976081848144531
reversal O 0 0.042389385402202606
in O 0 0.001552868983708322
any O 0 0.003250842448323965
predictive O 0 0.10691184550523758
testing O 0 0.02484925650060177
program O 0 0.010288538411259651
. O 0 0.0032413078006356955
. O 0 0.005356785841286182

A O 0 0.025342533364892006
novel O 0 0.031143609434366226
common O 0 0.021450158208608627
missense O 1 0.9999064207077026
mutation O 1 0.9999017715454102
G301C O 1 0.9682249426841736
in O 0 0.0021132242400199175
the O 0 0.004116101190447807
N O 0 0.10827773809432983
- O 0 0.05319157987833023
acetylgalactosamine O 1 0.9993078708648682
- O 0 0.04359186813235283
6 O 0 0.028908289968967438
- O 0 0.0738396868109703
sulfate O 1 0.9963591694831848
sulfatase O 1 0.999788224697113
gene O 1 0.9331997632980347
in O 0 0.008153926581144333
mucopolysaccharidosis B-Disease 1 0.9999700784683228
IVA I-Disease 1 0.9999901056289673
. O 0 0.010429071262478828

Mucopolysaccharidosis B-Disease 1 0.9987657070159912
IVA I-Disease 1 0.9999518394470215
( O 0 0.02083800919353962
MPS B-Disease 1 0.9990952014923096
IVA I-Disease 1 0.9999984502792358
) O 0 0.005034273955971003
is O 0 0.0033371129538863897
an O 0 0.008350414223968983
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 0.9999991655349731
storage I-Disease 1 0.9724575877189636
disorder I-Disease 1 1.0
caused O 1 0.9998382329940796
by O 0 0.003475250443443656
a O 0 0.011310985311865807
genetic B-Disease 1 0.9990013241767883
defect I-Disease 1 0.9998657703399658
in O 0 0.004705179948359728
N O 0 0.15485461056232452
- O 0 0.049448661506175995
acetylgalactosamine O 1 0.9993108510971069
- O 0 0.04319325461983681
6 O 0 0.02686327137053013
- O 0 0.08187795430421829
sulfate O 1 0.9994255304336548
sulfatase O 1 0.9999698400497437
( O 0 0.020945750176906586
GALNS O 1 0.9999756813049316
) O 0 0.006793386302888393
. O 0 0.006261461414396763

In O 0 0.004555555526167154
previous O 0 0.006716572213917971
studies O 0 0.004763096105307341
, O 0 0.0012103250483050942
we O 0 0.0010593356564640999
have O 0 0.0014616191620007157
found O 0 0.003404847579076886
two O 0 0.0017393369926139712
common O 0 0.0154186449944973
mutations O 1 0.9998220801353455
in O 0 0.0038253481034189463
Caucasians O 1 0.9977071285247803
and O 0 0.0019303857116028666
Japanese O 0 0.009515248239040375
, O 0 0.0021364071872085333
respectively O 0 0.009174437262117863
. O 0 0.0057228622026741505

To O 0 0.006199314724653959
characterize O 0 0.054328739643096924
the O 0 0.011053608730435371
mutational O 1 0.9997441172599792
spectrum O 0 0.0503237247467041
in O 0 0.0016648806631565094
various O 0 0.0011874448973685503
ethnic O 0 0.005092067644000053
groups O 0 0.0035681738518178463
, O 0 0.003862739307805896
mutations O 1 0.9986467957496643
in O 0 0.0019654075149446726
the O 0 0.005370542407035828
GALNS O 1 0.9999985694885254
gene O 1 0.9844490885734558
in O 0 0.004296771716326475
Colombian O 1 0.8394555449485779
MPS B-Disease 1 0.9999185800552368
IVA I-Disease 1 1.0
patients O 1 0.9999847412109375
were O 0 0.003459216095507145
investigated O 0 0.02557808719575405
, O 0 0.0016599077498540282
and O 0 0.0020364734809845686
genetic O 0 0.08326760679483414
backgrounds O 0 0.007124949246644974
were O 0 0.0019630242604762316
extensively O 0 0.009568650275468826
analyzed O 0 0.01282836776226759
to O 0 0.0018722944660112262
identify O 0 0.011817717924714088
racial O 0 0.014536370523273945
origin O 0 0.007113806903362274
, O 0 0.0015985667705535889
based O 0 0.002635822631418705
on O 0 0.003988230135291815
mitochondrial O 1 0.6378394961357117
DNA O 0 0.06771861761808395
( O 0 0.010939457453787327
mtDNA O 0 0.1334076225757599
) O 0 0.009883970953524113
lineages O 0 0.11170367896556854
. O 0 0.007937836460769176

Three O 0 0.008527549915015697
novel O 0 0.06189560890197754
missense O 1 0.9999356269836426
mutations O 1 0.9998738765716553
never O 0 0.012761235237121582
identified O 0 0.013349110260605812
previously O 0 0.0050484188832342625
in O 0 0.0012820872943848372
other O 0 0.0013849178794771433
populations O 0 0.02205374836921692
and O 0 0.0012086855713278055
found O 0 0.004290146753191948
in O 0 0.0016088830307126045
16 O 0 0.006349051371216774
out O 0 0.0020564075093716383
of O 0 0.0015698203351348639
19 O 0 0.01979011669754982
Colombian O 0 0.1749172955751419
MPS B-Disease 1 0.9983526468276978
IVA I-Disease 1 0.9999932050704956
unrelated O 0 0.12213917821645737
alleles O 1 0.9923287034034729
account O 0 0.0067817880772054195
for O 0 0.003178986720740795
84 O 0 0.0564473532140255
. O 0 0.008671238087117672

2 O 0 0.016837839037179947
% O 0 0.004518398083746433
of O 0 0.0016113680321723223
the O 0 0.005405548494309187
alleles O 1 0.9998301267623901
in O 0 0.002136087045073509
this O 0 0.00216537993401289
study O 0 0.005910379346460104
. O 0 0.005512927658855915

The O 0 0.011004563421010971
G301C O 1 0.9992994070053101
and O 0 0.006109913811087608
S162F O 1 0.9998753070831299
mutations O 1 0.9985633492469788
account O 0 0.0053171152248978615
for O 0 0.0029606008902192116
68 O 0 0.0465901680290699
. O 0 0.009148189797997475

4 O 0 0.024565648287534714
% O 0 0.0062321387231349945
and O 0 0.002104179933667183
10 O 0 0.007980789057910442
. O 0 0.007254146505147219

5 O 0 0.022788986563682556
% O 0 0.0066408454440534115
of O 0 0.004235994070768356
mutations O 1 0.9999619722366333
, O 0 0.002632883144542575
respectively O 0 0.006600900087505579
, O 0 0.0017607009503990412
whereas O 0 0.008582526817917824
the O 0 0.0025729218032211065
remaining O 0 0.013177666813135147
F69V O 1 0.9999637603759766
is O 0 0.004627121612429619
limited O 0 0.005189663730561733
to O 0 0.0014154580421745777
a O 0 0.007939435541629791
single O 0 0.027037475258111954
allele O 1 0.9987461566925049
. O 0 0.010006860829889774

The O 0 0.01321569923311472
skewed O 0 0.12497980147600174
prevalence O 1 0.9887046217918396
of O 0 0.004228643141686916
G301C O 1 0.9983181953430176
in O 0 0.002492221537977457
only O 0 0.004145137500017881
Colombian O 1 0.5927755236625671
patients O 1 0.9999443292617798
and O 0 0.004086173605173826
haplotype O 1 0.9990768432617188
analysis O 0 0.006437120493501425
by O 0 0.004383955616503954
restriction O 0 0.04244047403335571
fragment O 0 0.08421042561531067
length O 0 0.018365949392318726
polymorphisms O 0 0.17686589062213898
in O 0 0.0023210039362311363
the O 0 0.0072173248045146465
GALNS O 1 0.9999973773956299
gene O 1 0.9977307915687561
suggest O 0 0.010922600515186787
that O 0 0.002735330956056714
G301C O 1 0.9948074221611023
originated O 0 0.018417170271277428
from O 0 0.0030916843097656965
a O 0 0.0073840259574353695
common O 0 0.014514516107738018
ancestor O 0 0.4496130347251892
. O 0 0.0077448152005672455

Investigation O 0 0.01866682432591915
of O 0 0.002219339134171605
the O 0 0.004904874600470066
genetic O 0 0.09213869273662567
background O 0 0.00622103875502944
by O 0 0.0022750881034880877
means O 0 0.0038575928192585707
of O 0 0.00234048324637115
mtDNA O 1 0.8680340647697449
lineages O 1 0.6790116429328918
indicate O 0 0.007469151169061661
that O 0 0.0010805936763063073
all O 0 0.0012793634086847305
our O 0 0.006333037279546261
patients O 1 0.9999922513961792
are O 0 0.0013541075168177485
probably O 0 0.006495188921689987
of O 0 0.0016698796534910798
native O 0 0.008042034693062305
American O 0 0.015024525113403797
descent O 0 0.22244687378406525

Low O 0 0.039778005331754684
frequency O 0 0.03622554987668991
of O 0 0.0073079196736216545
BRCA1 O 1 1.0
germline O 1 0.9999898672103882
mutations O 1 0.9995003938674927
in O 0 0.0026039034128189087
45 O 0 0.013317437842488289
German O 1 0.993407130241394
breast B-Disease 1 1.0
/ I-Disease 1 0.9999991655349731
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.016044856980443
. O 0 0.006420058198273182

In O 0 0.003195599652826786
this O 0 0.0016694406513124704
study O 0 0.0031842326279729605
we O 0 0.001490397029556334
investigated O 0 0.017786353826522827
45 O 0 0.013276590965688229
German O 1 0.9035815596580505
breast B-Disease 1 1.0
/ I-Disease 1 0.9999995231628418
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.013004792854189873
for O 0 0.005359532777220011
germline O 1 0.9999761581420898
mutations O 1 0.9994584918022156
in O 0 0.002763324184343219
the O 0 0.010732513852417469
BRCA1 O 1 1.0
gene O 1 0.9975762963294983
. O 0 0.00895178597420454

We O 0 0.004405503161251545
identified O 0 0.012839822098612785
four O 0 0.007175865583121777
germline O 1 0.9999439716339111
mutations O 1 0.9988409876823425
in O 0 0.003521097358316183
three O 0 0.012673256918787956
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.007335412781685591
and O 0 0.0009640633943490684
in O 0 0.001717332866974175
one O 0 0.37346506118774414
breast B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.029856376349925995
. O 0 0.001579039846546948
among O 0 0.0020906557328999043
these O 0 0.0005448885494843125
were O 0 0.0010711126960814
one O 0 0.005734969861805439
frameshift O 1 0.9999986886978149
mutation O 1 0.9999933242797852
, O 0 0.0022406699135899544
one O 0 0.0042069535702466965
nonsense O 1 0.9043592810630798
mutation O 1 0.9999812841415405
, O 0 0.001758860656991601
one O 0 0.00246471562422812
novel O 0 0.026122787967324257
splice O 1 0.9846783876419067
site O 0 0.023952137678861618
mutation O 1 0.9999741315841675
, O 0 0.001754163415171206
and O 0 0.001155214966274798
one O 0 0.007869971916079521
missense O 1 0.9998611211776733
mutation O 1 0.999893069267273
. O 0 0.009589736349880695

The O 0 0.014922140166163445
missense O 1 0.9999020099639893
mutation O 1 0.9999409914016724
was O 0 0.008164210245013237
also O 0 0.0020892731845378876
found O 0 0.004130691755563021
in O 0 0.0018192309653386474
2 O 0 0.010561136528849602
. O 0 0.005323704332113266

8 O 0 0.024274403229355812
% O 0 0.004716116935014725
of O 0 0.0011437076609581709
the O 0 0.0028592017479240894
general O 0 0.006504624150693417
population O 0 0.007524815853685141
, O 0 0.0017557699466124177
suggesting O 0 0.009863579645752907
that O 0 0.0010214331559836864
it O 0 0.0015613692812621593
is O 0 0.0036895107477903366
not O 0 0.005681689362972975
disease O 1 1.0
associated O 0 0.013770339079201221
. O 0 0.005838809069246054

The O 0 0.006949009373784065
average O 0 0.014201282523572445
age O 0 0.017180249094963074
of O 0 0.007530169561505318
disease O 1 1.0
onset O 1 0.9999998807907104
in O 0 0.0023802502546459436
those O 0 0.0017608838388696313
families O 0 0.011565124616026878
harbouring O 1 0.9999791383743286
causative O 1 0.9999920129776001
mutations O 1 0.9998252987861633
was O 0 0.009548118337988853
between O 0 0.003583423560485244
32 O 0 0.024278005585074425
. O 0 0.00671141454949975

3 O 0 0.023646829649806023
and O 0 0.0029328817036002874
37 O 0 0.028476133942604065
. O 0 0.007100817747414112

4 O 0 0.026307638734579086
years O 0 0.006368227303028107
, O 0 0.0021042446605861187
whereas O 0 0.010503591038286686
the O 0 0.0028539791237562895
family O 0 0.016363758593797684
harbouring O 1 0.9993003606796265
the O 0 0.009948830120265484
missense O 1 0.9999569654464722
mutation O 1 0.9999274015426636
had O 0 0.006394201423972845
an O 0 0.0030243161600083113
average O 0 0.011890950612723827
age O 0 0.013955125585198402
of O 0 0.005579385906457901
onset O 1 0.9999945163726807
of O 0 0.005087967496365309
51 O 0 0.05915367230772972
. O 0 0.006671354174613953

2 O 0 0.022307703271508217
years O 0 0.008956296369433403
. O 0 0.00703298207372427

These O 0 0.003190284827724099
findings O 0 0.010843342170119286
show O 0 0.008916151709854603
that O 0 0.005134225822985172
BRCA1 O 1 0.9999998807907104
is O 0 0.0065851593390107155
implicated O 1 0.6757513880729675
in O 0 0.0016965208342298865
a O 0 0.00425039092078805
small O 0 0.0039915768429636955
fraction O 0 0.024650096893310547
of O 0 0.010149038396775723
breast B-Disease 1 1.0
/ I-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.00940337311476469
suggesting O 0 0.010279390029609203
the O 0 0.0022912006825208664
involvement O 0 0.012128164991736412
of O 0 0.0018836717354133725
another O 0 0.13524894416332245
susceptibility O 1 0.9999985694885254
gene O 1 0.9996516704559326
( O 0 0.013301689177751541
s O 0 0.08568473905324936
) O 0 0.012331000529229641

Paternal O 1 0.9985552430152893
transmission O 1 0.9540248513221741
of O 0 0.020550714805722237
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.013324557803571224

We O 0 0.004024912137538195
report O 0 0.004592014942318201
a O 0 0.0066754696890711784
rare O 0 0.01448630541563034
case O 0 0.00675651291385293
of O 0 0.003992357756942511
paternally O 1 0.9999992847442627
transmitted O 1 0.9999990463256836
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.8681657314300537
DM B-Disease 1 1.0
) O 0 0.010356777347624302
. O 0 0.006627201102674007

The O 0 0.00916321761906147
proband O 1 0.9983470439910889
is O 0 0.003944902680814266
a O 0 0.005712409503757954
23 O 0 0.010204366408288479
year O 0 0.0047873156145215034
old O 0 0.0166186336427927
, O 0 0.004960794933140278
mentally B-Disease 1 0.9999990463256836
retarded I-Disease 1 0.9999946355819702
male O 1 0.9421727657318115
who O 1 0.8857198357582092
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 0.9999972581863403
. O 0 0.008149119094014168

He O 0 0.004248611629009247
presented O 0 0.005464058369398117
with O 0 0.004845911171287298
respiratory O 1 1.0
and O 0 0.0027318657375872135
feeding O 1 0.9984706044197083
difficulties O 0 0.23421242833137512
at O 0 0.0074841538444161415
birth O 1 0.6985587477684021
. O 0 0.00682644359767437

His O 0 0.007543930783867836
two O 0 0.00669855298474431
sibs O 1 0.9999935626983643
suffer O 1 0.9999508857727051
from O 0 0.010420875623822212
childhood O 1 0.9999916553497314
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 0.01605103351175785

Their O 0 0.006451894529163837
late O 0 0.01820831187069416
father O 0 0.02341921254992485
had O 0 0.005916322581470013
the O 0 0.004233319777995348
adult O 0 0.038834430277347565
type O 0 0.03941887989640236
of O 0 0.00657310476526618
DM B-Disease 1 1.0
, O 0 0.0034183799289166927
with O 0 0.004959794692695141
onset O 1 0.9999998807907104
around O 0 0.006980417761951685
30 O 0 0.010242238640785217
years O 0 0.005679408088326454
. O 0 0.006561170797795057

Only O 0 0.0036913955118507147
six O 0 0.003050935920327902
other O 0 0.0009790615877136588
cases O 0 0.005700585898011923
of O 0 0.0019386368803679943
paternal O 1 0.999950647354126
transmission O 1 0.9907317757606506
of O 0 0.011021838523447514
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.004374092910438776
been O 0 0.006671322509646416
reported O 0 0.01736989989876747
recently O 0 0.019998719915747643
. O 0 0.00720176100730896

We O 0 0.003661987604573369
review O 0 0.005776852369308472
the O 0 0.0029765518847852945
sex O 0 0.015103678219020367
related O 0 0.00991978868842125
effects O 0 0.027421865612268448
on O 0 0.003529729088768363
transmission O 0 0.4575051963329315
of O 0 0.012384380213916302
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.013753375969827175

Decreased O 1 0.7728357315063477
fertility O 0 0.11348338425159454
of O 0 0.003489742986857891
males O 0 0.04916214197874069
with O 0 0.004808064084500074
adult O 1 0.9990366697311401
onset O 1 1.0
DM B-Disease 1 1.0
and O 0 0.005061705131083727
contraction O 1 0.5681783556938171
of O 0 0.0014089032774791121
the O 0 0.0029866560362279415
repeat O 0 0.27431172132492065
upon O 0 0.008463159203529358
male O 0 0.056827113032341
transmission O 0 0.18136467039585114
contribute O 0 0.010937384329736233
to O 0 0.001288665342144668
the O 0 0.0023039313964545727
almost O 0 0.008187894709408283
absent O 0 0.0815514549612999
occurrence O 0 0.04471108317375183
of O 0 0.00277679692953825
paternal O 1 0.9988915324211121
transmission O 1 0.9920476078987122
of O 0 0.012985887937247753
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.014843100681900978

Also O 0 0.004342661704868078
the O 0 0.0029249037615954876
fathers O 0 0.015144633129239082
of O 0 0.0013031144626438618
the O 0 0.003865922335535288
reported O 0 0.16561463475227356
congenitally O 1 0.9999984502792358
affected O 1 0.9912996888160706
children O 0 0.01359209418296814
showed O 0 0.009334735572338104
, O 0 0.0012355925282463431
on O 0 0.0015768192242830992
average O 0 0.008107265457510948
, O 0 0.0023672364186495543
shorter O 0 0.040044624358415604
CTG O 1 0.9997196793556213
repeat O 0 0.07709749042987823
lengths O 0 0.02240070328116417
and O 0 0.0016937670297920704
hence O 0 0.014461234211921692
less O 0 0.01676798053085804
severe O 1 1.0
clinical O 1 0.9999963045120239
symptoms O 1 1.0
than O 0 0.0026685832999646664
the O 0 0.00339718209579587
mothers O 0 0.08914820104837418
of O 0 0.0018289247527718544
children O 0 0.44914326071739197
with O 0 0.03012203983962536
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.013980160467326641

We O 0 0.003986953757703304
conclude O 0 0.014108492061495781
that O 0 0.0021974127739667892
paternal O 1 0.9973179697990417
transmission O 1 0.7254994511604309
of O 0 0.010202286764979362
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 0.007830300368368626
rare O 0 0.03383580222725868
and O 0 0.002064897445961833
preferentially O 1 0.9774332642555237
occurs O 0 0.026376519352197647
with O 0 0.004178817383944988
onset O 1 0.9999997615814209
of O 0 0.007331022527068853
DM B-Disease 1 1.0
past O 0 0.01140347495675087
30 O 0 0.00904166791588068
years O 0 0.0035828719846904278
in O 0 0.0017802261281758547
the O 0 0.003441629698500037
father O 0 0.3940041661262512
. O 0 0.0031521387863904238
. O 0 0.0049979668110609055

The O 0 0.024897297844290733
RB1 O 1 0.9999988079071045
gene O 1 0.9992819428443909
mutation O 1 0.9989227652549744
in O 0 0.00245700404047966
a O 0 0.006411286070942879
child O 0 0.04562249034643173
with O 0 0.00879228487610817
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 0.9999959468841553
. O 0 0.012170078232884407

The O 0 0.03011932782828808
RB1 O 1 0.9999967813491821
gene O 1 0.9984656572341919
mutation O 1 0.9999016523361206
was O 0 0.009638950228691101
investigated O 0 0.016057254746556282
in O 0 0.0016217390075325966
a O 0 0.0060861059464514256
child O 0 0.07928505539894104
with O 0 0.008214027620851994
ectopic B-Disease 1 0.9999998807907104
intracranial I-Disease 1 0.9999998807907104
retinoblastoma I-Disease 1 0.999967098236084
using O 0 0.008506708778440952
DNA O 0 0.027643650770187378
obtained O 0 0.0034503641072660685
from O 0 0.0014873924665153027
both O 0 0.001361065311357379
the O 0 0.004622281063348055
pineal B-Disease 1 0.999964714050293
and I-Disease 0 0.00929952971637249
retinal I-Disease 1 1.0
tumours I-Disease 1 0.9999998807907104
of O 0 0.0026295108254998922
the O 0 0.006146629340946674
patient O 1 0.9999855756759644
. O 0 0.007366362493485212

A O 0 0.03455780819058418
nonsense O 0 0.14629758894443512
mutation O 1 0.9986690282821655
in O 0 0.007108513731509447
exon O 1 0.9925855994224548
17 O 0 0.026877770200371742
( O 0 0.009129414334893227
codon O 0 0.4986337423324585
556 O 0 0.15379759669303894
) O 0 0.0039628348313272
of O 0 0.0018148835515603423
the O 0 0.009717218577861786
RB1 O 1 0.9999998807907104
gene O 1 0.9990113973617554
was O 0 0.010151990689337254
found O 0 0.004534068983048201
to O 0 0.0012121559120714664
be O 0 0.0015128013910725713
present O 0 0.004312834702432156
homozygously O 1 0.9970257878303528
in O 0 0.0014926581643521786
both O 0 0.0016402588225901127
the O 0 0.0049980091862380505
retinal B-Disease 1 0.9999960660934448
and I-Disease 0 0.0021806114818900824
the I-Disease 0 0.010323810391128063
pineal I-Disease 1 0.9999996423721313
tumours I-Disease 1 0.9999998807907104
. O 0 0.013953767716884613

The O 0 0.007086772006005049
same O 0 0.009471557103097439
mutation O 1 0.9999568462371826
was O 0 0.009031692519783974
present O 0 0.005584737751632929
heterozygously O 1 0.997204065322876
in O 0 0.0018512820824980736
the O 0 0.0027355575002729893
DNA O 0 0.029758771881461143
from O 0 0.002093944000080228
the O 0 0.002870656084269285
constitutional O 0 0.012859698385000229
cells O 0 0.026613285765051842
of O 0 0.0016801034798845649
the O 0 0.006616194732487202
patient O 1 0.9999924898147583
, O 0 0.0030185533687472343
proving O 0 0.025227012112736702
it O 0 0.0012927257921546698
to O 0 0.000931548944208771
be O 0 0.0015288498252630234
of O 0 0.0037091467529535294
germline O 1 0.9994633793830872
origin O 0 0.013749586418271065
. O 0 0.006845497991889715

The O 0 0.00887482799589634
initial O 0 0.05187395587563515
mutation O 1 0.999969482421875
was O 0 0.009839974343776703
shown O 0 0.006244557909667492
to O 0 0.001366939628496766
have O 0 0.0018208067631348968
occurred O 0 0.013714726082980633
in O 0 0.0013624868588522077
the O 0 0.005223663058131933
paternally O 1 0.9996160268783569
derived O 0 0.056188710033893585
RB1 O 1 0.9999986886978149
allele O 1 0.9994375109672546
. O 0 0.013091924600303173

The O 0 0.017928550019860268
mutation O 1 0.9997735619544983
is O 0 0.004162680823355913
in O 0 0.0014505622675642371
an O 0 0.002064142841845751
area O 0 0.0055158198811113834
of O 0 0.0015473386738449335
the O 0 0.005152730271220207
gene O 1 0.9617508053779602
that O 0 0.003188717644661665
encodes O 0 0.07010097801685333
the O 0 0.006321402732282877
protein O 0 0.055440034717321396
- O 0 0.023025959730148315
binding O 0 0.01742604747414589
region O 0 0.010323191992938519
known O 0 0.006181396543979645
as O 0 0.0016165929846465588
the O 0 0.004116205032914877
pocket O 1 0.9920700192451477
region O 0 0.009249869734048843
and O 0 0.0014001622330397367
has O 0 0.0037340058479458094
been O 0 0.005709680262953043
detected O 0 0.07457974553108215
in O 0 0.0013514553429558873
other O 0 0.0009670503786765039
cases O 0 0.008615353144705296
of O 0 0.004269727971404791
retinoblastoma B-Disease 1 0.9999998807907104
. O 0 0.003864365629851818
. O 0 0.00591094046831131

Low O 0 0.04114753380417824
levels O 0 0.011919379234313965
of O 0 0.0034570321440696716
beta O 0 0.12012612819671631
hexosaminidase O 1 0.9991663694381714
A O 0 0.012192392721772194
in O 0 0.0038202020805329084
healthy O 1 0.7882645130157471
individuals O 0 0.004455269314348698
with O 0 0.002839804859831929
apparent O 1 0.9997817873954773
deficiency O 1 1.0
of O 0 0.0028289947658777237
this O 0 0.00399255333468318
enzyme O 0 0.28579866886138916
. O 0 0.008367549628019333

Appreciable O 0 0.25600746273994446
beta O 0 0.13030906021595
hexosaminidase O 1 0.9719572067260742
A O 0 0.021555684506893158
( O 0 0.007148689590394497
hex O 1 0.8855518698692322
A O 0 0.015535491518676281
) O 0 0.0038273802492767572
activity O 0 0.00848385039716959
has O 0 0.003532984061166644
been O 0 0.005692026577889919
detected O 0 0.0561954602599144
in O 0 0.0038730024825781584
cultured O 1 0.9978734254837036
skin O 1 1.0
fibroblasts O 1 0.9999958276748657
and O 0 0.03878690302371979
melanoma B-Disease 1 1.0
tissue O 1 0.9999982118606567
from O 0 0.006979842204600573
healthy O 1 0.987007200717926
individuals O 0 0.005375185515731573
previously O 0 0.007005038671195507
reported O 0 0.012153659015893936
as O 0 0.003284790087491274
having O 0 0.2572723627090454
deficiency B-Disease 1 1.0
of I-Disease 0 0.002794326050207019
hex I-Disease 1 0.9829795360565186
A I-Disease 0 0.015108395367860794
activity O 0 0.01402045227587223
indistinguishable O 0 0.039474889636039734
from O 0 0.001874092617072165
that O 0 0.00108096725307405
of O 0 0.002364620566368103
patients O 1 0.9999934434890747
with O 0 0.008301093243062496
Tay B-Disease 1 1.0
- I-Disease 1 0.9999457597732544
Sachs I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
( O 0 0.034919675439596176
TSD B-Disease 1 0.9999990463256836
) O 0 0.009515463374555111
. O 0 0.006172612309455872

Identification O 0 0.021271558478474617
and O 0 0.002993362257257104
quantitation O 1 0.9730414748191833
of O 0 0.0033296989277005196
hex O 0 0.42945370078086853
A O 0 0.014965349808335304
, O 0 0.002828306285664439
amounting O 0 0.03244226053357124
to O 0 0.0030084275640547276
3 O 0 0.012907344847917557
. O 0 0.006993849761784077

5 O 0 0.027802666649222374
% O 0 0.01081862673163414
- O 0 0.032296322286129
6 O 0 0.020787686109542847
. O 0 0.006946423090994358

9 O 0 0.021571822464466095
% O 0 0.0035470391158014536
of O 0 0.001610202481970191
total O 0 0.0102390730753541
beta O 0 0.14253918826580048
hexosaminidase O 1 0.9980428218841553
activity O 0 0.015129349194467068
, O 0 0.002025280147790909
has O 0 0.0027510314248502254
been O 0 0.003594848792999983
obtained O 0 0.003760106861591339
by O 0 0.005381978582590818
cellulose O 0 0.1124534159898758
acetate O 0 0.24435940384864807
gel O 1 0.986004650592804
electrophoresis O 0 0.3251956105232239
, O 0 0.008158192969858646
DEAE O 1 0.9993247985839844
- O 0 0.06869690120220184
cellulose O 0 0.14958946406841278
ion O 0 0.11482352763414383
- O 0 0.03193928301334381
exchange O 0 0.012885953299701214
chromatography O 0 0.0723051130771637
, O 0 0.006000847090035677
radial O 1 0.9965270161628723
immunodiffusion O 1 0.9994066953659058
, O 0 0.003272103378549218
and O 0 0.0034985325764864683
radioimmunoassay O 1 0.9996541738510132
. O 0 0.008339405059814453

Previous O 0 0.02143201045691967
family O 0 0.018177207559347153
studies O 0 0.007208883296698332
suggested O 0 0.006355700083076954
that O 0 0.0011684736236929893
these O 0 0.0011321293422952294
individuals O 0 0.00414629140868783
may O 0 0.006979519035667181
be O 0 0.0024103503674268723
compound O 0 0.027280891314148903
heterozygotes O 1 0.9964902997016907
for O 0 0.0015659222844988108
the O 0 0.0028587256092578173
common O 0 0.024390559643507004
mutant O 1 0.9999798536300659
TSD B-Disease 1 0.999996542930603
gene O 1 0.9923858642578125
and O 0 0.002201106632128358
a O 0 0.008559191599488258
rare O 0 0.029441237449645996
( O 0 0.01171924639493227
allelic O 1 0.999171257019043
) O 0 0.014055543579161167
mutant O 1 0.9997380375862122
gene O 1 0.9673349857330322
. O 0 0.008729249238967896

Thus O 0 0.010638403706252575
, O 0 0.0018632493447512388
the O 0 0.0036159357987344265
postulated O 0 0.20197074115276337
rate O 0 0.026667466387152672
mutant O 1 0.9997538924217224
gene O 1 0.997989296913147
appears O 0 0.019728051498532295
to O 0 0.0018678351771086454
code O 0 0.005424480885267258
for O 0 0.001096106949262321
the O 0 0.002289034426212311
expression O 0 0.01674102246761322
of O 0 0.001603637239895761
low O 0 0.01641857996582985
amounts O 0 0.006841103546321392
of O 0 0.0025717730168253183
hex O 0 0.26280397176742554
A O 0 0.02066059596836567
. O 0 0.008488581515848637

Heterozygotes O 1 0.9978764057159424
for O 0 0.0019317201804369688
the O 0 0.0037248285952955484
rare O 0 0.24978157877922058
mutant O 1 0.9999784231185913
may O 0 0.008593136444687843
be O 0 0.0021825151052325964
indistinguishable O 0 0.052264101803302765
from O 0 0.004669439513236284
heterozygotes O 1 0.9916941523551941
for O 0 0.0016951712314039469
the O 0 0.003648759564384818
common O 0 0.06888432800769806
TSD B-Disease 1 0.9999991655349731
mutant O 1 0.9997391104698181
. O 0 0.010859737172722816

However O 0 0.007559494581073523
, O 0 0.0017071675974875689
direct O 0 0.0070480164140462875
visualization O 0 0.02873028814792633
and O 0 0.002428000560030341
quantitation O 1 0.9794765114784241
of O 0 0.0032265055924654007
hex O 0 0.3853175938129425
A O 0 0.009159970097243786
by O 0 0.002169618383049965
the O 0 0.0022235584910959005
methods O 0 0.005023828241974115
described O 0 0.011079755611717701
may O 0 0.008200535550713539
prevent O 0 0.0242319293320179
false O 0 0.008798545226454735
- O 0 0.03603107109665871
positive O 0 0.03835027664899826
prenatal O 1 0.9999496936798096
diagnosis O 1 0.9999971389770508
of O 0 0.0046286024153232574
TSD B-Disease 1 0.9999974966049194
in O 0 0.005229111760854721
fetuses O 1 0.9997572302818298
having O 0 0.005446347873657942
the O 0 0.0022419034503400326
incomplete O 0 0.018198031932115555
hex B-Disease 1 0.9717257618904114
A I-Disease 0 0.330549955368042
deficiency I-Disease 1 0.9999997615814209
of O 0 0.00182768190279603
the O 0 0.004174942150712013
type O 0 0.14610011875629425
described O 0 0.007172119338065386
in O 0 0.0010395996505394578
the O 0 0.0023456683848053217
four O 0 0.004977667238563299
healthy O 1 0.9918369650840759
individuals O 0 0.015713360160589218

The O 0 0.0272362157702446
tumor B-Disease 1 0.9999998807907104
suppressor O 1 0.9999983310699463
gene O 1 0.9988040924072266
Smad4 O 1 0.9999473094940186
/ O 1 0.9269716739654541
Dpc4 O 1 0.9982435703277588
is O 0 0.0042359596118330956
required O 0 0.0037171002477407455
for O 0 0.002989130327478051
gastrulation O 1 0.9994242191314697
and O 0 0.0020330939441919327
later O 0 0.004828630480915308
for O 0 0.003539945697411895
anterior O 1 0.9999029636383057
development O 0 0.0031023987103253603
of O 0 0.0016862889751791954
the O 0 0.006534332409501076
mouse O 1 0.9999809265136719
embryo O 1 0.977158784866333
. O 0 0.008675366640090942

Mutations O 1 0.9664062261581421
in O 0 0.0027720830403268337
the O 0 0.005998390261083841
SMAD4 O 1 0.999997615814209
/ O 1 0.9996935129165649
DPC4 O 1 0.9999997615814209
tumor B-Disease 1 1.0
suppressor O 1 0.9999997615814209
gene O 1 0.9968211650848389
, O 0 0.0016698206309229136
a O 0 0.004249378107488155
key O 0 0.007683189585804939
signal O 0 0.03270787373185158
transducer O 0 0.2101883739233017
in O 0 0.0024162346962839365
most O 0 0.005576434079557657
TGFbeta O 1 0.9999638795852661
- O 0 0.04057580605149269
related O 0 0.01758216880261898
pathways O 0 0.3436203598976135
, O 0 0.001898762653581798
are O 0 0.0007900124765001237
involved O 0 0.004804093390703201
in O 0 0.0016070441342890263
50 O 0 0.0068473233841359615
% O 0 0.004676048643887043
of O 0 0.007978186942636967
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.008547869510948658

Homozygous O 1 0.9998161196708679
Smad4 O 1 0.9998317956924438
mutant O 1 0.9998427629470825
mice O 1 0.9998979568481445
die O 1 0.9966762065887451
before O 0 0.008496154099702835
day O 0 0.012276257388293743
7 O 0 0.019802773371338844
. O 0 0.007452255114912987

5 O 0 0.020092874765396118
of O 0 0.006470880005508661
embryogenesis O 1 0.9691076874732971
. O 0 0.010697956196963787

Mutant O 1 0.9970809817314148
embryos O 0 0.039240047335624695
have O 0 0.004373752512037754
reduced O 0 0.028162458911538124
size O 0 0.0076575870625674725
, O 0 0.0025595605839043856
fail O 0 0.02541825734078884
to O 0 0.003728057723492384
gastrulate O 1 0.9986597299575806
or O 0 0.005072638392448425
express O 0 0.019206052646040916
a O 0 0.013520002365112305
mesodermal O 1 0.996685802936554
marker O 0 0.47237592935562134
, O 0 0.002249196171760559
and O 0 0.001682128058746457
show O 0 0.016621969640254974
abnormal O 1 0.9992098808288574
visceral O 1 0.999692440032959
endoderm O 1 0.9833579659461975
development O 0 0.00933641567826271
. O 0 0.006570147350430489

Growth B-Disease 0 0.06358702480792999
retardation I-Disease 1 0.9995007514953613
of O 0 0.002417775336652994
the O 0 0.006489397492259741
Smad4 O 1 0.9999951124191284
- O 1 0.8479375243186951
deficient O 1 0.9996590614318848
embryos O 0 0.02756263129413128
results O 0 0.008180300705134869
from O 0 0.004601700697094202
reduced O 0 0.038736797869205475
cell O 0 0.04736218973994255
proliferation O 0 0.027651533484458923
rather O 0 0.004954949952661991
than O 0 0.004442605189979076
increased O 0 0.02765251323580742
apoptosis O 1 0.9989815354347229
. O 0 0.008365013636648655

Aggregation O 0 0.09960471093654633
of O 0 0.005603926721960306
mutant O 1 0.9996132254600525
Smad4 O 1 0.9998308420181274
ES O 1 0.99945467710495
cells O 0 0.05625856667757034
with O 0 0.0034413286484777927
wild O 0 0.03377131000161171
- O 0 0.04335644096136093
type O 0 0.40350988507270813
tetraploid O 1 0.9991911053657532
morulae O 1 0.9993131160736084
rescues O 1 0.9329250454902649
the O 0 0.014790408313274384
gastrulation B-Disease 1 0.999805748462677
defect I-Disease 1 0.9996033310890198
. O 0 0.012378456071019173

These O 0 0.0032373261637985706
results O 0 0.009832961484789848
indicate O 0 0.010072422213852406
that O 0 0.003346855053678155
Smad4 O 1 0.999799907207489
is O 0 0.004712268710136414
initially O 0 0.009720457717776299
required O 0 0.0023188034538179636
for O 0 0.0009222653461620212
the O 0 0.002744840458035469
differentiation O 0 0.034244854003190994
of O 0 0.001468544825911522
the O 0 0.005564154125750065
visceral O 1 0.999976634979248
endoderm O 1 0.9985005855560303
and O 0 0.0016422432381659746
that O 0 0.0012875291286036372
the O 0 0.005489906761795282
gastrulation B-Disease 1 0.999962329864502
defect I-Disease 1 0.9990205764770508
in O 0 0.0024815083015710115
the O 0 0.00658844830468297
epiblast O 1 0.9999635219573975
is O 0 0.005321677308529615
secondary O 0 0.01918494701385498
and O 0 0.0020436448976397514
non O 0 0.012383919209241867
- O 0 0.0407358855009079
cell O 0 0.047706570476293564
autonomous O 0 0.016870368272066116
. O 0 0.008303781971335411

Rescued O 1 0.9910573959350586
embryos O 0 0.06183486431837082
show O 0 0.03189590200781822
severe O 1 0.9999996423721313
anterior O 1 0.9999990463256836
truncations O 1 0.9991216063499451
, O 0 0.003175490302965045
indicating O 0 0.014157542958855629
a O 0 0.0045910123735666275
second O 0 0.005879557691514492
important O 0 0.0024674839805811644
role O 0 0.006533765234053135
for O 0 0.0026676252018660307
Smad4 O 1 0.9999231100082397
in O 0 0.006915683392435312
anterior O 1 0.9999940395355225
patterning O 1 0.9987554550170898
during O 0 0.026580199599266052
embryogenesis O 1 0.9238391518592834
. O 0 0.009383095428347588

Prevalence O 1 0.9958754181861877
of O 0 0.006811640225350857
p16 O 1 0.999235987663269
and O 0 0.007298965938389301
CDK4 O 1 0.9999946355819702
germline O 1 0.9999649524688721
mutations O 1 0.9990803003311157
in O 0 0.004407984204590321
48 O 1 0.9442041516304016
melanoma B-Disease 1 1.0
- O 1 0.8845154047012329
prone O 1 0.9997453093528748
families O 0 0.007420866750180721
in O 0 0.0030605520587414503
France O 0 0.02709433063864708
. O 0 0.006663484498858452

The O 0 0.009678316302597523
French O 1 0.9924842715263367
Familial B-Disease 1 1.0
Melanoma I-Disease 1 1.0
Study O 0 0.013942697085440159
Group O 0 0.011201129294931889
. O 0 0.006021360866725445

Germline O 1 0.9991905093193054
mutations O 1 0.9716784358024597
in O 0 0.0030749270226806402
the O 0 0.006189615931361914
p16 O 1 0.9999492168426514
and O 0 0.00602176645770669
CDK4 O 1 0.9999935626983643
genes O 1 0.8081772923469543
have O 0 0.002293963450938463
been O 0 0.0041856830939650536
reported O 0 0.008189568296074867
in O 0 0.0012860242277383804
a O 0 0.006783002056181431
subset O 0 0.0497678741812706
of O 0 0.006749668158590794
melanoma B-Disease 1 1.0
pedigrees O 1 0.9988811612129211
, O 0 0.0024610687978565693
but O 0 0.002206378849223256
their O 0 0.00338069349527359
prevalence O 1 0.9999517202377319
is O 0 0.0033698941115289927
not O 0 0.0017684325575828552
well O 0 0.002805397380143404
known O 0 0.012831115163862705
. O 0 0.007062333170324564

We O 0 0.004477064125239849
searched O 0 0.01791982911527157
for O 0 0.0019276326056569815
such O 0 0.0035164726432412863
germline O 1 0.9999257326126099
mutations O 1 0.9973516464233398
in O 0 0.004304726608097553
48 O 0 0.033766843378543854
French O 1 0.9972789883613586
melanoma B-Disease 1 1.0
- O 1 0.867834210395813
prone O 1 0.9981263279914856
families O 0 0.008568592369556427
selected O 0 0.005834024865180254
according O 0 0.0018223397200927138
to O 0 0.00113154505379498
two O 0 0.0014406993286684155
major O 0 0.009008684195578098
criteria O 0 0.008317406289279461
families O 0 0.004975239746272564
with O 0 0.0013348959619179368
at O 0 0.003022163175046444
least O 0 0.006336987018585205
three O 0 0.003263285383582115
affected O 0 0.4870622754096985
members O 0 0.004769270773977041
( O 0 0.008171631954610348
n O 0 0.05267246440052986
= O 0 0.05048300698399544
20 O 0 0.011076652444899082
) O 0 0.004108748864382505
or O 0 0.0031635211780667305
families O 0 0.00504998117685318
with O 0 0.001578412251546979
two O 0 0.0026409667916595936
affected O 0 0.17923641204833984
members O 0 0.0029060093220323324
, O 0 0.001286582788452506
one O 0 0.0017316968878731132
of O 0 0.0009753457270562649
them O 0 0.0014974799705669284
affected O 0 0.22736112773418427
before O 0 0.0032730058301240206
the O 0 0.0024850245099514723
age O 0 0.008417999371886253
of O 0 0.0019428393570706248
50 O 0 0.011615846306085587
( O 0 0.008624263107776642
n O 0 0.052015580236911774
= O 0 0.056762922555208206
28 O 0 0.01914798654615879
) O 0 0.0035494433250278234
, O 0 0.001081843045540154
and O 0 0.0008983060833998024
one O 0 0.002779925474897027
additional O 0 0.00722236605361104
minor O 1 0.9330233931541443
criterion O 0 0.0549827478826046
. O 0 0.007445517927408218

Sixteen O 0 0.036359719932079315
different O 0 0.007501224987208843
p16 O 1 0.9999439716339111
germline O 1 0.9999185800552368
mutations O 1 0.999884843826294
were O 0 0.0026683637406677008
found O 0 0.005218729376792908
in O 0 0.0023331106640398502
21 O 0 0.014681966044008732
families O 0 0.005637216381728649
, O 0 0.0016360912704840302
while O 0 0.003269178094342351
one O 0 0.010170099325478077
germline O 1 0.999994158744812
mutation O 1 0.9999889135360718
, O 0 0.004736879374831915
Arg24His O 1 0.9998962879180908
, O 0 0.0023971982300281525
was O 0 0.008271844126284122
detected O 0 0.048208460211753845
in O 0 0.002422271529212594
the O 0 0.007120194844901562
CDK4 O 1 0.9999855756759644
gene O 1 0.9943467974662781
. O 0 0.010285023599863052

The O 0 0.0056107840500772
frequency O 0 0.02748803235590458
of O 0 0.006180026102811098
p16 O 1 0.9999619722366333
gene O 1 0.9996351003646851
mutation O 1 0.9979578256607056
in O 0 0.001965953968465328
our O 0 0.003468835726380348
sample O 0 0.016561802476644516
( O 0 0.007178373169153929
44 O 0 0.022566618397831917
% O 0 0.007132522761821747
) O 0 0.003008982865139842
is O 0 0.002329978160560131
among O 0 0.0027756402269005775
the O 0 0.002338720252737403
highest O 0 0.011959334835410118
rates O 0 0.012678319588303566
yet O 0 0.006485650781542063
reported O 0 0.009768974035978317
and O 0 0.001107304124161601
the O 0 0.005598408170044422
CDK4 O 1 0.9999994039535522
mutation O 1 0.9999526739120483
is O 0 0.003414856968447566
the O 0 0.0029103232081979513
second O 0 0.02122640237212181
mutation O 1 0.9999380111694336
detected O 0 0.06988274306058884
in O 0 0.0025506915990263224
this O 0 0.005151542369276285
gene O 1 0.9576005935668945
worldwide O 0 0.037406764924526215
. O 0 0.008844570256769657

In O 0 0.005599712021648884
summary O 0 0.01961216703057289
, O 0 0.001764228567481041
our O 0 0.002782324096187949
results O 0 0.00746679725125432
show O 0 0.007754076272249222
frequent O 0 0.02371642366051674
involvement O 0 0.01446609292179346
of O 0 0.00171566940844059
the O 0 0.007578209042549133
p16 O 1 0.9999963045120239
gene O 1 0.9992573857307434
in O 0 0.00894138589501381
familial B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 0 0.002411492634564638
confirm O 0 0.0071211387403309345
the O 0 0.0014446718851104379
role O 0 0.003551393747329712
of O 0 0.0010226453887298703
the O 0 0.004848928656429052
CDK4 O 1 0.9999979734420776
gene O 1 0.9931526184082031
as O 0 0.00369827076792717
a O 0 0.07017755508422852
melanoma B-Disease 1 1.0
- O 1 0.9464114904403687
predisposing O 1 0.9998831748962402
gene O 1 0.9952183365821838
. O 0 0.004336024168878794
. O 0 0.005805999040603638

Progression O 1 0.9494105577468872
of O 0 0.008605803363025188
somatic O 1 0.9784462451934814
CTG O 1 0.9964879751205444
repeat O 0 0.09515870362520218
length O 0 0.017164960503578186
heterogeneity O 0 0.06851083785295486
in O 0 0.0017510950565338135
the O 0 0.005147235933691263
blood O 1 0.9997779726982117
cells O 1 0.5211414694786072
of O 0 0.014184095896780491
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999997615814209
. O 0 0.009318781085312366

The O 0 0.0078810453414917
genetic O 0 0.039849188178777695
basis O 0 0.0039213113486766815
of O 0 0.010138988494873047
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9492843151092529
DM B-Disease 1 1.0
) O 0 0.005505941342562437
is O 0 0.0023880612570792437
the O 0 0.0017147811595350504
expansion O 0 0.005423541646450758
of O 0 0.0013658518437296152
an O 0 0.004413404036313295
unstable O 1 0.9996719360351562
CTG O 1 0.9996743202209473
repeat O 0 0.054949697107076645
in O 0 0.002325858687981963
the O 0 0.003259563585743308
34 O 0 0.024911336600780487
UTR O 1 0.6572735905647278
of O 0 0.0034112429711967707
the O 0 0.013121814467012882
DM B-Disease 1 0.9999998807907104
protein O 0 0.4302331805229187
kinase O 1 0.9968225955963135
gene O 1 0.7660126686096191
on O 0 0.009723962284624577
chromosome O 1 0.9985826015472412
19 O 0 0.027218971401453018
. O 0 0.007432357408106327

One O 0 0.004210188984870911
of O 0 0.0012863855808973312
the O 0 0.002364865969866514
principal O 0 0.007661087438464165
features O 0 0.004196166526526213
of O 0 0.0019305585883557796
the O 0 0.013862969353795052
DM B-Disease 1 1.0
mutation O 1 0.9999796152114868
is O 0 0.004696176387369633
an O 0 0.003968464210629463
extraordinarily O 0 0.06004519388079643
high O 0 0.007018213160336018
level O 0 0.005189663730561733
of O 0 0.004590219352394342
somatic O 1 0.999854326248169
mosaicism O 1 0.9999960660934448
, O 0 0.003276398405432701
due O 0 0.008024604059755802
to O 0 0.0012129117967560887
an O 0 0.002508058911189437
extremely O 0 0.014432298019528389
high O 0 0.005415008869022131
degree O 0 0.004820427857339382
of O 0 0.0027129407972097397
somatic O 1 0.998484194278717
instability O 1 0.9774681329727173
both O 0 0.001726258429698646
within O 0 0.0022689916659146547
and O 0 0.000938792887609452
between O 0 0.0022180175874382257
different O 0 0.0027442844584584236
tissues O 1 0.9997760653495789
. O 0 0.007757738698273897

This O 0 0.008543889969587326
instability O 1 0.988646388053894
appears O 0 0.01734880916774273
to O 0 0.0014586198376491666
be O 0 0.0019099023193120956
biased O 0 0.015372051857411861
towards O 0 0.004470732994377613
further O 0 0.004181394353508949
expansion O 0 0.008063510060310364
and O 0 0.0014793467707931995
continuous O 0 0.016007915139198303
throughout O 0 0.0030422385316342115
the O 0 0.0019719714764505625
life O 0 0.003963936120271683
of O 0 0.0012636200990527868
an O 0 0.002005025278776884
individual O 0 0.003828125772997737
, O 0 0.0014942040434107184
features O 0 0.0037940156180411577
that O 0 0.0011205471819266677
could O 0 0.00270152953453362
be O 0 0.0018905623583123088
associated O 0 0.005271553061902523
with O 0 0.0010497525800019503
the O 0 0.003556957934051752
progressive O 1 0.9886686205863953
nature O 0 0.004838146734982729
of O 0 0.0016127540729939938
the O 0 0.012651516124606133
disease O 1 1.0
. O 0 0.008223048411309719

Although O 0 0.008822714909911156
increasing O 0 0.016084957867860794
measured O 0 0.03153137117624283
allele O 1 0.999458372592926
size O 0 0.015119305811822414
between O 0 0.0064127324149012566
patients O 1 0.9999679327011108
clearly O 0 0.011096653528511524
correlates O 0 0.04999436065554619
with O 0 0.0013990206643939018
an O 0 0.002820903668180108
increased O 0 0.01908406801521778
severity O 1 0.9999653100967407
of O 0 0.006206166464835405
symptoms O 1 1.0
and O 0 0.0012757908552885056
an O 0 0.0018412224017083645
earlier O 0 0.00543171213939786
age O 0 0.010023549199104309
of O 0 0.0035517532378435135
onset O 1 1.0
, O 0 0.001717662438750267
this O 0 0.002002424094825983
correlation O 0 0.022483741864562035
is O 0 0.0017758142203092575
not O 0 0.0010624900460243225
precise O 0 0.005881498102098703
and O 0 0.0014761018101125956
measured O 0 0.027979839593172073
allele O 1 0.9984210729598999
length O 0 0.019870810210704803
cannot O 0 0.005713417194783688
be O 0 0.0012204720405861735
used O 0 0.0014501403784379363
as O 0 0.0012706309789791703
an O 0 0.0018385517178103328
accurate O 0 0.009268442168831825
predictor O 1 0.9778386354446411
of O 0 0.0028525921516120434
age O 0 0.012830257415771484
of O 0 0.005627748090773821
onset O 1 0.9999998807907104
. O 0 0.008611276745796204

In O 0 0.00379275088198483
order O 0 0.0028787092305719852
to O 0 0.0011839348590001464
further O 0 0.004605791065841913
characterize O 0 0.025537442415952682
the O 0 0.0037294216454029083
dynamics O 0 0.025215787813067436
of O 0 0.008403094485402107
DM B-Disease 1 1.0
CTG O 1 0.9998817443847656
repeat O 1 0.9591408967971802
somatic O 1 0.9885636568069458
instability O 1 0.9938496947288513
, O 0 0.002761091571301222
we O 0 0.0015585663495585322
have O 0 0.0019293129444122314
studied O 0 0.006924340035766363
repeat O 0 0.041945792734622955
length O 0 0.00949718989431858
changes O 0 0.00413135439157486
over O 0 0.0018867852631956339
time O 0 0.002674875082448125
in O 0 0.004595817532390356
111 O 1 0.9999713897705078
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999977350234985
with O 0 0.00289810448884964
varying O 0 0.013520518317818642
clinical O 1 0.9999388456344604
severity O 1 0.9999918937683105
and O 0 0.005643877666443586
CTG O 1 0.9998059868812561
repeat O 0 0.06826720386743546
size O 0 0.00757631566375494
over O 0 0.0025161157827824354
time O 0 0.00404598843306303
intervals O 0 0.015473696403205395
of O 0 0.0023600482381880283
1 O 0 0.017737679183483124
- O 0 0.026670483872294426
7 O 0 0.016279879957437515
years O 0 0.006116088014096022
. O 0 0.006761685945093632

We O 0 0.0031794158276170492
have O 0 0.0016103527741506696
found O 0 0.003896776819601655
a O 0 0.004913265351206064
direct O 0 0.008755745366215706
progression O 1 0.9968770742416382
of O 0 0.0013110121944919229
the O 0 0.0028519334737211466
size O 0 0.0106155164539814
heterogeneity O 0 0.2689385414123535
over O 0 0.003208649344742298
time O 0 0.002715463051572442
related O 0 0.004560869187116623
to O 0 0.002274817321449518
initial O 0 0.03355181962251663
CTG O 1 0.9996115565299988
repeat O 0 0.07286389172077179
size O 0 0.007663658354431391
and O 0 0.0010996107012033463
the O 0 0.0020572238136082888
time O 0 0.004616830963641405
interval O 0 0.026763034984469414
and O 0 0.0015208625700324774
always O 0 0.0055617112666368484
biased O 0 0.018728921189904213
towards O 0 0.00620455713942647
further O 0 0.006065402179956436
expansion O 0 0.015770455822348595
. O 0 0.006877019070088863

Attempts O 0 0.022362159565091133
to O 0 0.0038104443810880184
mathematically O 0 0.025708278641104698
model O 0 0.008534085005521774
the O 0 0.003856077790260315
dynamics O 0 0.02725476399064064
have O 0 0.0031014580745249987
proved O 0 0.015386789105832577
only O 0 0.0036515758838504553
partially O 0 0.07575488835573196
successful O 0 0.018467992544174194
suggesting O 0 0.011203770525753498
that O 0 0.001344214309938252
individual O 0 0.0028094076551496983
specific O 0 0.004870416130870581
genetic O 0 0.42328235507011414
and O 0 0.0029103371780365705
/ O 1 0.8907772302627563
or O 0 0.004174197092652321
environmental O 0 0.00958599615842104
factors O 0 0.007807004731148481
also O 0 0.001484849606640637
play O 0 0.0023588973563164473
a O 0 0.004368004854768515
role O 0 0.008323166519403458
in O 0 0.005461260676383972
somatic O 1 0.9994553923606873
mosaicism O 1 0.999931812286377
. O 0 0.006475007627159357
. O 0 0.007099043112248182

Aspartylglucosaminuria B-Disease 1 0.9998501539230347
among O 0 0.010301968082785606
Palestinian O 0 0.02400129847228527
Arabs O 0 0.03147585317492485
. O 0 0.008938643150031567

Aspartylglucosaminuria B-Disease 1 0.9999932050704956
( O 0 0.04070402681827545
AGU B-Disease 1 0.9999996423721313
) O 0 0.006554281339049339
is O 0 0.0027625730726867914
a O 0 0.007611482869833708
rare O 1 0.9663486480712891
disorder B-Disease 1 1.0
of I-Disease 0 0.004571824334561825
glycoprotein I-Disease 1 0.9999715089797974
metabolism I-Disease 1 0.9999191761016846
caused O 1 0.9749559760093689
by O 0 0.0038434634916484356
the O 0 0.007186673581600189
deficiency B-Disease 1 0.9999997615814209
of I-Disease 0 0.0022197498474270105
the I-Disease 0 0.006919735576957464
lysosomal I-Disease 1 0.9999967813491821
enzyme I-Disease 1 0.9953404664993286
aspartylglucosaminidase I-Disease 1 0.9996269941329956
( O 0 0.017445215955376625
AGA O 1 0.9993793964385986
) O 0 0.007661338429898024
. O 0 0.006280926056206226

AGU B-Disease 1 0.9999986886978149
is O 0 0.014938452281057835
inherited O 1 0.9997991919517517
as O 0 0.004465028177946806
an O 0 0.011485200375318527
autosomal O 1 1.0
recessive O 1 1.0
trait O 1 0.9999855756759644
and O 0 0.0025483244098722935
occurs O 0 0.022554852068424225
with O 0 0.0011393954046070576
a O 0 0.005040731746703386
high O 0 0.006825124379247427
frequency O 0 0.01974615454673767
in O 0 0.001623278483748436
Finland O 0 0.01137805636972189
because O 0 0.002760209608823061
of O 0 0.0015251768054440618
a O 0 0.008025269024074078
founder O 0 0.224472314119339
effect O 0 0.023001110181212425
. O 0 0.006211023777723312

While O 0 0.0065981741063296795
very O 0 0.005091932136565447
few O 0 0.009433393366634846
patients O 1 0.9999830722808838
with O 0 0.0062750861980021
AGU B-Disease 1 1.0
have O 0 0.0036567270290106535
been O 0 0.0043183607049286366
reported O 0 0.01098061166703701
from O 0 0.0032286597415804863
non O 0 0.011532420292496681
- O 0 0.023315006867051125
Finnish O 0 0.027966666966676712
origin O 0 0.007492248434573412
, O 0 0.0022331615909934044
we O 0 0.005509036127477884
diagnosed O 1 1.0
the O 0 0.010480666533112526
disorder O 1 1.0
in O 0 0.003798535093665123
8 O 1 0.7326539158821106
patients O 1 0.9999791383743286
originating O 0 0.02549321949481964
from O 0 0.005123636219650507
3 O 0 0.01561246532946825
unrelated O 0 0.03675263002514839
families O 0 0.00722218444570899
, O 0 0.0014353591250255704
all O 0 0.001151978736743331
Palestinian O 0 0.013225696049630642
Arabs O 0 0.014680004678666592
from O 0 0.002328078029677272
the O 0 0.0024116646964102983
region O 0 0.007220961153507233
of O 0 0.002251947997137904
Jerusalem O 0 0.018383463844656944
. O 0 0.0069696842692792416

The O 0 0.012647639028728008
clinical O 1 0.9997746348381042
diagnosis O 1 0.9999966621398926
of O 0 0.006824924144893885
AGU B-Disease 1 1.0
is O 0 0.0060396078042685986
often O 0 0.004035166930407286
difficult O 0 0.005578597541898489
, O 0 0.0011316840536892414
in O 0 0.0013944389065727592
particular O 0 0.0050379871390759945
early O 0 0.005141112953424454
in O 0 0.001199078164063394
the O 0 0.0019385640043765306
course O 0 0.00751104298979044
of O 0 0.0017241215100511909
the O 0 0.013873860239982605
disease O 1 1.0
, O 0 0.0015735734486952424
and O 0 0.0008244297932833433
most O 0 0.001185934292152524
of O 0 0.0012344609713181853
the O 0 0.007917091250419617
patients O 1 1.0
are O 0 0.005222355481237173
diagnosed O 1 1.0
after O 0 0.012770779430866241
the O 0 0.0033991942182183266
age O 0 0.009307765401899815
of O 0 0.002153135137632489
5 O 0 0.011635970324277878
years O 0 0.006748948711901903
. O 0 0.006310909986495972

However O 0 0.007026584818959236
, O 0 0.0019196073990315199
since O 0 0.007012001238763332
these O 0 0.003129685763269663
patients O 1 0.9999991655349731
excrete O 1 0.999555766582489
early O 0 0.007913900539278984
large O 0 0.004179016221314669
amounts O 0 0.005902934819459915
of O 0 0.002337416633963585
aspartylglucosamine O 1 0.9995766282081604
in O 0 0.004083639942109585
urine O 1 0.9681117534637451
, O 0 0.0029745828360319138
biochemical O 0 0.05996663123369217
screening O 0 0.05510985106229782
is O 0 0.0035136130172759295
easy O 0 0.00680790888145566
by O 0 0.0052886661142110825
urine O 1 0.9307249188423157
chromatography O 0 0.08580370247364044
. O 0 0.0038789596874266863
. O 0 0.006270404439419508

Detection O 0 0.05663527920842171
of O 0 0.004728066269308329
heterozygous O 1 0.9996935129165649
carriers O 0 0.04763857647776604
of O 0 0.0017585159512236714
the O 0 0.007932025007903576
ataxia B-Disease 1 1.0
- I-Disease 1 0.9996838569641113
telangiectasia I-Disease 1 1.0
( O 0 0.014752449467778206
ATM O 1 0.9867972135543823
) O 0 0.00621070247143507
gene O 0 0.37151408195495605
by O 0 0.007777699269354343
G2 O 1 0.9999313354492188
phase O 0 0.08603072166442871
chromosomal O 1 0.9991387128829956
radiosensitivity O 1 0.9877628087997437
of O 0 0.008459647186100483
peripheral O 1 0.9999988079071045
blood O 1 0.9999805688858032
lymphocytes O 1 0.9999853372573853
. O 0 0.012694175355136395

In O 0 0.016914913430809975
ataxia B-Disease 1 1.0
- I-Disease 1 0.9954934120178223
telangiectasia I-Disease 1 1.0
( O 0 0.013416333124041557
A B-Disease 1 0.9989639520645142
- I-Disease 1 0.9994499087333679
T I-Disease 1 0.9999979734420776
) O 0 0.013029869645833969
patients O 1 0.9999798536300659
, O 0 0.004562693182379007
mutations O 1 0.9974767565727234
in O 0 0.001589725143276155
a O 0 0.0068620843812823296
single O 0 0.02580087259411812
gene O 1 0.9890342950820923
, O 0 0.0032147266902029514
ATM O 1 0.7701687812805176
, O 0 0.0015860905405133963
result O 0 0.0059610516764223576
in O 0 0.0016935740131884813
an O 0 0.023023413494229317
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 0.0032382463105022907
embraces O 0 0.1102321669459343
a O 0 0.004503657575696707
variety O 0 0.003747668582946062
of O 0 0.0019478877075016499
clinical O 1 0.9912647604942322
features O 0 0.005771812051534653
and O 0 0.002397002186626196
manifests O 1 0.999231219291687
extreme O 1 0.9454724788665771
radiosensitivity O 1 0.9996065497398376
and O 0 0.0015815406804904342
a O 0 0.005057293921709061
strong O 0 0.007309227716177702
pre O 0 0.06692830473184586
- O 0 0.03959488123655319
disposition O 1 0.8735266923904419
to O 0 0.006367669440805912
malignancy B-Disease 1 0.9999963045120239
. O 0 0.00944546703249216

Heterozygotes O 1 0.983347475528717
for O 0 0.0023182230070233345
the O 0 0.004728119820356369
ATM O 1 0.9987485408782959
gene O 1 0.9978219270706177
have O 0 0.0025419029407203197
no O 0 0.0035892378073185682
clinical O 0 0.08513239026069641
expression O 0 0.013040948659181595
of O 0 0.002103864448145032
A B-Disease 1 0.9991362690925598
- I-Disease 1 0.9994553923606873
T I-Disease 1 0.999998927116394
but O 0 0.003238985314965248
may O 0 0.011923018842935562
be O 0 0.007308051455765963
cancer B-Disease 1 1.0
prone O 1 0.9998852014541626
with O 0 0.0018857060931622982
a O 0 0.00726522970944643
moderate O 0 0.034241318702697754
increase O 0 0.005277227144688368
in O 0 0.0018258439376950264
in O 0 0.0033102757297456264
vitro O 1 0.5000068545341492
radiosensitivity O 1 0.9995613694190979
. O 0 0.008897833526134491

We O 0 0.004283613059669733
performed O 0 0.01312076486647129
a O 0 0.012026281096041203
blind O 1 0.9989472031593323
chromosomal O 1 0.9978961944580078
analysis O 0 0.0077106342650949955
on O 0 0.005251353606581688
G2 O 1 0.9998975992202759
- O 0 0.05240738019347191
phase O 0 0.07655160129070282
lymphocytes O 1 0.9987950325012207
from O 0 0.004830612801015377
7 O 0 0.015151184052228928
unrelated O 0 0.0382775217294693
A B-Disease 1 0.9876672029495239
- I-Disease 1 0.9973325729370117
T I-Disease 1 0.9999982118606567
patients O 1 0.9999864101409912
, O 0 0.0023289655800908804
13 O 0 0.011366353370249271
obligate O 1 0.998120129108429
A B-Disease 1 0.9939231276512146
- I-Disease 1 0.9961174726486206
T I-Disease 1 0.9999977350234985
heterozygotes O 1 0.9996830224990845
( O 0 0.009034739807248116
parents O 0 0.010067066177725792
of O 0 0.0018297397764399648
the O 0 0.009880592115223408
patients O 1 0.9999997615814209
) O 0 0.004184826742857695
, O 0 0.001208025962114334
and O 0 0.001204311498440802
14 O 0 0.00926212128251791
normal O 0 0.01840153895318508
controls O 0 0.026865804567933083
following O 0 0.0180823877453804
X O 1 0.9576257467269897
- O 0 0.0456942580640316
irradiation O 0 0.14206740260124207
with O 0 0.003724469570443034
1 O 0 0.02096339873969555
Gy O 1 0.9931731820106506
in O 0 0.0022979972418397665
order O 0 0.0024096337147057056
to O 0 0.0011825045803561807
evaluate O 0 0.01533446554094553
this O 0 0.004072848707437515
cytogenetic O 1 0.9307858347892761
method O 0 0.008067461661994457
as O 0 0.002184536773711443
a O 0 0.004749583546072245
tool O 0 0.010741027072072029
for O 0 0.0018154692370444536
detection O 0 0.03584527224302292
of O 0 0.003757515922188759
ATM O 1 0.9946894645690918
carriers O 1 0.7907736897468567
. O 0 0.00824990589171648

Both O 0 0.006987583823502064
A B-Disease 1 0.7741597294807434
- I-Disease 1 0.9295262098312378
T I-Disease 1 0.999990701675415
homozygotes O 1 0.9999328851699829
and O 0 0.004800018388777971
heterozygotes O 1 0.9998900890350342
showed O 0 0.013903379440307617
significantly O 0 0.022388631477952003
increased O 0 0.00908951461315155
levels O 0 0.008459335193037987
of O 0 0.0034404275938868523
radiation O 1 0.9993202686309814
- O 1 0.9508770704269409
induced O 1 0.9999827146530151
chromatid O 1 0.9999741315841675
damage O 1 0.9739495515823364
relative O 0 0.010361656546592712
to O 0 0.0012041233712807298
that O 0 0.0010268042096868157
of O 0 0.002299272222444415
normal O 0 0.027552535757422447
controls O 0 0.02993869036436081
. O 0 0.008211363106966019

These O 0 0.0031014462001621723
results O 0 0.007251303642988205
show O 0 0.004919101949781179
that O 0 0.0013512931764125824
the O 0 0.004974342882633209
G2 O 1 0.9999966621398926
- O 0 0.05156196653842926
phase O 0 0.09386233240365982
chromosomal O 1 0.9998424053192139
radiosensitivity O 1 0.9997840523719788
assay O 0 0.10055098682641983
can O 0 0.002601003274321556
be O 0 0.000969654880464077
used O 0 0.0010837631998583674
for O 0 0.0008082657586783171
the O 0 0.0023153573274612427
detection O 0 0.027677442878484726
of O 0 0.002884611487388611
A B-Disease 1 0.9861536026000977
- I-Disease 1 0.9758021235466003
T I-Disease 1 0.9999819993972778
heterozygotes O 1 0.997912585735321
. O 0 0.010521170683205128

In O 0 0.005742975044995546
combination O 0 0.027296213433146477
with O 0 0.002891342621296644
molecular O 0 0.04020465910434723
genetic O 0 0.06978019326925278
analyses O 0 0.010240025818347931
, O 0 0.00139893451705575
this O 0 0.0018141735345125198
test O 0 0.01305646076798439
may O 0 0.0056917970068752766
be O 0 0.001299637951888144
of O 0 0.000934784475248307
value O 0 0.002560819499194622
in O 0 0.0015015803510323167
studies O 0 0.004017151892185211
of O 0 0.002955307951197028
familial B-Disease 1 0.9999997615814209
and I-Disease 0 0.004071500618010759
sporadic I-Disease 1 0.9997774958610535
cancers I-Disease 1 0.9999996423721313
aimed O 0 0.012267720885574818
at O 0 0.0035827120300382376
determination O 0 0.00790549535304308
of O 0 0.0010895451996475458
the O 0 0.002337656682357192
potential O 0 0.007637990638613701
involvement O 0 0.016211578622460365
of O 0 0.0028716742526739836
ATM O 1 0.9993683695793152
mutations O 1 0.9999114274978638
in O 0 0.010519204661250114
tumor B-Disease 1 1.0
risk O 1 0.9982767105102539
or O 0 0.0034072448033839464
development O 0 0.0038285914342850447
. O 0 0.002829918172210455
. O 0 0.00635937787592411

Ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9918352365493774
telangiectasia I-Disease 1 0.9999991655349731
: O 0 0.00808477308601141
identification O 0 0.009786829352378845
and O 0 0.0017171039944514632
detection O 0 0.026996398344635963
of O 0 0.0019437021110206842
founder O 1 0.5783583521842957
- O 0 0.032649584114551544
effect O 0 0.031045477837324142
mutations O 1 0.9985173344612122
in O 0 0.0021558499429374933
the O 0 0.004986228421330452
ATM O 1 0.9073053598403931
gene O 1 0.8394142389297485
in O 0 0.0026726205833256245
ethnic O 0 0.01039118692278862
populations O 0 0.042897410690784454
. O 0 0.006575639825314283

To O 0 0.0033755567856132984
facilitate O 0 0.007406938821077347
the O 0 0.002514926251024008
evaluation O 0 0.014752748422324657
of O 0 0.00269152969121933
ATM O 1 0.9979579448699951
heterozygotes O 1 0.9996848106384277
for O 0 0.0054559046402573586
susceptibility O 1 0.999969482421875
to O 0 0.0024102849420160055
other O 0 0.0027081971056759357
diseases O 1 1.0
, O 0 0.0015077694552019238
such O 0 0.0016110398573800921
as O 0 0.1814538836479187
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.001988664735108614
we O 0 0.0011023810366168618
have O 0 0.001522250473499298
attempted O 0 0.009970171377062798
to O 0 0.0014390352880582213
define O 0 0.0055215852335095406
the O 0 0.002234210493043065
most O 0 0.0039862473495304585
common O 0 0.01602613925933838
mutations O 1 0.999671220779419
and O 0 0.0010215378133580089
their O 0 0.0015424899756908417
frequencies O 0 0.01633751578629017
in O 0 0.00519454525783658
ataxia B-Disease 1 1.0
- I-Disease 1 0.9994069337844849
telangiectasia I-Disease 1 1.0
( O 0 0.013852030970156193
A B-Disease 1 0.9979596138000488
- I-Disease 1 0.9864761233329773
T I-Disease 1 0.999975323677063
) O 0 0.011534160003066063
homozygotes O 1 0.9986578226089478
from O 0 0.004400488920509815
10 O 0 0.007222197949886322
ethnic O 0 0.011353355832397938
populations O 0 0.04096345603466034
. O 0 0.007576947566121817

Both O 0 0.011828905902802944
genomic O 1 0.9687652587890625
mutations O 1 0.9983851909637451
and O 0 0.0015232980949804187
their O 0 0.002028974937275052
effects O 0 0.03366832435131073
on O 0 0.0032931563910096884
cDNA O 0 0.1107434332370758
were O 0 0.004760609939694405
characterized O 0 0.08561719954013824
. O 0 0.007002193946391344

Protein O 0 0.14272966980934143
- O 0 0.05559626594185829
truncation O 0 0.4990175664424896
testing O 0 0.015809396281838417
of O 0 0.0014674054691568017
the O 0 0.0033730585128068924
entire O 0 0.028651433065533638
ATM O 0 0.2357051819562912
cDNA O 0 0.20222599804401398
detected O 0 0.11865400522947311
92 O 0 0.07154269516468048
( O 0 0.008043871261179447
66 O 0 0.042464882135391235
% O 0 0.008264576084911823
) O 0 0.008581789210438728
truncating O 1 0.9990854263305664
mutations O 1 0.9934505224227905
in O 0 0.005032922141253948
140 O 0 0.05750668793916702
mutant O 1 0.9997993111610413
alleles O 1 0.9991462230682373
screened O 0 0.10514948517084122
. O 0 0.009054203517735004

The O 0 0.010179882869124413
haplotyping O 1 0.9964446425437927
of O 0 0.005360099487006664
patients O 1 0.9999971389770508
with O 0 0.003134732833132148
identical O 0 0.029251914471387863
mutations O 1 0.9999802112579346
indicates O 0 0.01504514366388321
that O 0 0.001132678589783609
almost O 0 0.0031420604791492224
all O 0 0.00056935113389045
of O 0 0.0008226241916418076
these O 0 0.0007980946684256196
represent O 0 0.003000366035848856
common O 0 0.008347955532371998
ancestry O 0 0.08185042440891266
and O 0 0.001098279026336968
that O 0 0.001047520898282528
very O 0 0.00312795746140182
few O 0 0.004903614055365324
spontaneously O 1 0.9972566962242126
recurring O 1 0.9997522234916687
ATM O 1 0.9992973804473877
mutations O 1 0.9988086223602295
exist O 0 0.00866912305355072
. O 0 0.0057838838547468185

Assays O 0 0.14777132868766785
requiring O 0 0.03258584812283516
minimal O 0 0.027404513210058212
amounts O 0 0.008379106409847736
of O 0 0.0033400782849639654
genomic O 0 0.22329235076904297
DNA O 0 0.03764372318983078
were O 0 0.0020775580778717995
designed O 0 0.004452309105545282
to O 0 0.001489908085204661
allow O 0 0.0049335234798491
rapid O 0 0.03801876679062843
screening O 0 0.04028097912669182
for O 0 0.002105417661368847
common O 0 0.01019606739282608
ethnic O 0 0.017124373465776443
mutations O 1 0.9999525547027588
. O 0 0.007453468162566423

These O 0 0.004272697027772665
rapid O 0 0.051904402673244476
assays O 0 0.10647078603506088
detected O 0 0.4070395231246948
mutations O 1 0.9800108671188354
in O 0 0.004391659051179886
76 O 0 0.05736875534057617
% O 0 0.004961103666573763
of O 0 0.0026040582451969385
Costa O 0 0.13970789313316345
Rican O 1 0.9975638389587402
patients O 1 0.9999926090240479
( O 0 0.009150359779596329
3 O 0 0.016309455037117004
) O 0 0.0038335081189870834
, O 0 0.0018093272810801864
50 O 0 0.0062113357707858086
% O 0 0.0031044348143041134
of O 0 0.0020993214566260576
Norwegian O 1 0.7031551599502563
patients O 1 0.999997615814209
( O 0 0.008170696906745434
1 O 0 0.014383235014975071
) O 0 0.003752421587705612
, O 0 0.0017875382909551263
25 O 0 0.0058382912538945675
% O 0 0.0031801320146769285
of O 0 0.002855106955394149
Polish O 1 0.9969785213470459
patients O 1 0.9999996423721313
( O 0 0.008186917752027512
4 O 0 0.01857859641313553
) O 0 0.0036168876104056835
, O 0 0.0015936701092869043
and O 0 0.0013507888652384281
14 O 0 0.007616865914314985
% O 0 0.0035753282718360424
of O 0 0.0025486471131443977
Italian O 1 0.9991651773452759
patients O 1 0.9999995231628418
( O 0 0.009044292382895947
1 O 0 0.015001284889876842
) O 0 0.0033007855527102947
, O 0 0.001212590141221881
as O 0 0.0012426588218659163
well O 0 0.0010456567397341132
as O 0 0.001773544354364276
in O 0 0.002697714138776064
patients O 1 0.9999314546585083
of O 0 0.003301141783595085
Amish O 1 0.9950745701789856
/ O 1 0.82538902759552
Mennonite O 0 0.08449164032936096
and O 0 0.0021182659547775984
Irish O 0 0.02996920794248581
English O 0 0.008742024190723896
backgrounds O 0 0.013448711484670639
. O 0 0.007818388752639294

Additional O 0 0.019791657105088234
mutations O 1 0.9946698546409607
were O 0 0.0026778129395097494
observed O 0 0.010811761021614075
in O 0 0.0018766222056001425
Japanese O 0 0.009499181061983109
, O 0 0.002238224493339658
Utah O 0 0.02606809325516224
Mormon O 0 0.03050501085817814
, O 0 0.0015865042805671692
and O 0 0.0015879854327067733
African O 0 0.01791153848171234
American O 0 0.03468817099928856
patients O 1 0.9999982118606567
. O 0 0.006513075437396765

These O 0 0.0036939585115760565
assays O 0 0.04259725287556648
should O 0 0.003947018645703793
facilitate O 0 0.013191593810915947
screening O 0 0.03762013092637062
for O 0 0.00303998333401978
A B-Disease 1 0.7651561498641968
- I-Disease 1 0.9881533980369568
T I-Disease 1 0.9999902248382568
heterozygotes O 1 0.9967474937438965
in O 0 0.003583968384191394
the O 0 0.004714523442089558
populations O 0 0.03347136825323105
studied O 0 0.006910294760018587
. O 0 0.003024983685463667
. O 0 0.005307359620928764

The O 0 0.011987973935902119
von B-Disease 1 0.9923005104064941
Hippel I-Disease 1 0.9999922513961792
- I-Disease 1 0.9944937825202942
Lindau I-Disease 1 0.9999984502792358
tumor I-Disease 1 0.9999998807907104
suppressor O 1 0.9999977350234985
gene O 1 0.9535847902297974
is O 0 0.003805573331192136
required O 0 0.0033295818138867617
for O 0 0.002366575412452221
cell O 0 0.042239267379045486
cycle O 0 0.05636187642812729
exit O 0 0.0479234978556633
upon O 0 0.013732933439314365
serum O 1 0.9868003129959106
withdrawal O 0 0.06949322670698166
. O 0 0.00803342740982771

The O 0 0.010656949132680893
inactivation O 1 0.9994408488273621
of O 0 0.0019730040803551674
the O 0 0.005129395518451929
von B-Disease 1 0.9967827796936035
Hippel I-Disease 1 0.9999775886535645
- I-Disease 1 0.9027279019355774
Lindau I-Disease 1 0.9999748468399048
( I-Disease 0 0.022800233215093613
VHL I-Disease 1 0.9999994039535522
) I-Disease 0 0.02410152554512024
tumor I-Disease 1 1.0
suppressor O 1 0.9999997615814209
gene O 1 0.9999569654464722
predisposes O 1 0.9999977350234985
affected O 0 0.4964545965194702
individuals O 0 0.0030030349735170603
to O 0 0.0010165994754061103
the O 0 0.003539565484970808
human O 1 0.7736438512802124
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.0020518407691270113
is O 0 0.0024398514069616795
associated O 0 0.005315705668181181
with O 0 0.0026645027101039886
sporadic B-Disease 1 0.9999821186065674
renal I-Disease 1 1.0
cell I-Disease 1 0.9998711347579956
carcinomas I-Disease 1 1.0
( O 0 0.02563367784023285
RCC B-Disease 1 0.9999990463256836
) O 0 0.00787161011248827
and O 0 0.00605460349470377
brain B-Disease 1 0.9999986886978149
hemangioblastomas I-Disease 1 0.9993150234222412
. O 0 0.011007286608219147

VHL O 1 0.9999740123748779
- O 0 0.06997016817331314
negative O 0 0.07359282672405243
786 O 1 0.998969554901123
- O 0 0.07569210231304169
0 O 0 0.10695891082286835
RCC B-Disease 1 0.9999955892562866
cells O 0 0.07515944540500641
are O 0 0.0032080409582704306
tumorigenic O 1 0.9949540495872498
in O 0 0.005631594453006983
nude O 1 0.9221239686012268
mice O 1 0.9977606534957886
which O 0 0.0030591352842748165
is O 0 0.00437895068898797
suppressed O 0 0.273512601852417
by O 0 0.0026702743489295244
the O 0 0.003634409746155143
reintroduction O 1 0.9834988713264465
of O 0 0.008554920554161072
VHL B-Disease 1 0.9999979734420776
. O 0 0.01339051779359579

Remarkably O 0 0.0737048014998436
, O 0 0.0034820260480046272
this O 0 0.0031207662541419268
occurs O 0 0.024311859160661697
without O 0 0.004625773057341576
affecting O 0 0.04510260745882988
the O 0 0.0026798369362950325
growth O 0 0.008818208239972591
rate O 0 0.007682229392230511
and O 0 0.0025152554735541344
cell O 0 0.04302817955613136
cycle O 0 0.051648594439029694
profile O 0 0.02775382623076439
of O 0 0.0019305943278595805
these O 0 0.002081311075016856
cells O 0 0.033430036157369614
in O 0 0.0021834454964846373
culture O 0 0.008870265446603298
. O 0 0.005584917962551117

The O 0 0.014200513251125813
786 O 1 0.9995207786560059
- O 0 0.0648851990699768
0 O 0 0.045899733901023865
cell O 0 0.043558087199926376
line O 0 0.009426658041775227
, O 0 0.001961001893505454
like O 0 0.004763868637382984
many O 0 0.007661349140107632
cancer B-Disease 1 1.0
cells O 1 0.5462570190429688
, O 0 0.0025463616475462914
fails O 0 0.02605368383228779
to O 0 0.0018312677275389433
exit O 0 0.030343689024448395
the O 0 0.003882627934217453
cell O 0 0.04126282036304474
cycle O 0 0.05620894208550453
upon O 0 0.016164835542440414
serum O 1 0.9954085946083069
withdrawal O 0 0.0739966332912445
. O 0 0.007399132940918207

Here O 0 0.006452986039221287
, O 0 0.0020468009170144796
it O 0 0.0017632815288379788
is O 0 0.0028123892843723297
shown O 0 0.005449158605188131
that O 0 0.0017951952759176493
reintroduction O 1 0.6238555312156677
of O 0 0.0015958762960508466
the O 0 0.0036720135249197483
wild O 0 0.03565145656466484
- O 0 0.060045838356018066
type O 1 0.9810959696769714
VHL B-Disease 1 0.9999979734420776
gene O 1 0.9880033731460571
restores O 0 0.06601212918758392
the O 0 0.002740945667028427
ability O 0 0.008115760050714016
of O 0 0.0036923931911587715
VHL O 1 0.9999994039535522
- O 1 0.8888353705406189
negative O 1 0.977829098701477
RCC B-Disease 1 0.9999998807907104
cancer I-Disease 1 1.0
cells O 0 0.047604355961084366
to O 0 0.002240063389763236
exit O 0 0.027774149551987648
the O 0 0.004219481255859137
cell O 0 0.044124435633420944
cycle O 0 0.035452280193567276
and O 0 0.0026713742408901453
enter O 0 0.026668932288885117
G0 O 1 0.9999419450759888
/ O 1 0.748815655708313
quiescence O 1 0.9978237152099609
in O 0 0.0063254619017243385
low O 0 0.0448133759200573
serum O 1 0.9861878752708435
. O 0 0.010606980882585049

Both O 0 0.014637206681072712
VHL O 1 0.9999902248382568
- O 0 0.03988752141594887
positive O 0 0.016863053664565086
and O 0 0.00555475102737546
VHL O 1 0.9999992847442627
- O 0 0.059981174767017365
negative O 0 0.08839927613735199
RCC B-Disease 1 0.9999864101409912
cells O 0 0.07334065437316895
exit O 0 0.03223583102226257
the O 0 0.004183558747172356
cell O 0 0.0390913300216198
cycle O 0 0.04522090032696724
by O 0 0.0057692984119057655
contact O 0 0.03343580290675163
inhibition O 1 0.9803199768066406
. O 0 0.009830593131482601

The O 0 0.02172049880027771
cyclin O 1 0.992336094379425
- O 0 0.0716845765709877
dependent O 0 0.07370204478502274
kinase O 1 0.9988332390785217
inhibitor O 1 0.9987195730209351
, O 0 0.008400834165513515
p27 O 1 0.9990660548210144
, O 0 0.00570274842903018
accumulates O 1 0.799577534198761
upon O 0 0.013907864689826965
serum O 1 0.9998273253440857
withdrawal O 0 0.059405114501714706
, O 0 0.001587657374329865
only O 0 0.0014374636812135577
in O 0 0.0010929721174761653
the O 0 0.002240918343886733
presence O 0 0.009715534746646881
of O 0 0.004359771031886339
VHL B-Disease 1 0.9999998807907104
, O 0 0.0023749987594783306
as O 0 0.002025199355557561
a O 0 0.004183745477348566
result O 0 0.006269290577620268
of O 0 0.001132090692408383
the O 0 0.0025498836766928434
stabilization O 0 0.0508357509970665
of O 0 0.002012761076912284
the O 0 0.005834849085658789
protein O 0 0.07502102106809616
. O 0 0.006897511892020702

We O 0 0.004299902357161045
propose O 0 0.013028925284743309
that O 0 0.001183803891763091
the O 0 0.00277150422334671
loss O 0 0.02255350723862648
of O 0 0.002577175386250019
wild O 1 0.6341084241867065
- O 1 0.7718042135238647
type O 1 0.9948974251747131
VHL B-Disease 1 0.9999986886978149
gene O 1 0.9962007403373718
results O 0 0.007346765138208866
in O 0 0.0014637223212048411
a O 0 0.00435672327876091
specific O 0 0.005615337751805782
cellular O 0 0.12195146828889847
defect O 1 0.9966399669647217
in O 0 0.00558748934417963
serum O 1 0.9995589852333069
- O 0 0.03395671397447586
dependent O 0 0.023528899997472763
growth O 0 0.011654349975287914
control O 0 0.01641291193664074
, O 0 0.0013797685969620943
which O 0 0.001970898127183318
may O 0 0.023046499118208885
initiate O 1 0.9963358640670776
tumor B-Disease 1 0.9999992847442627
formation O 0 0.04418792948126793
. O 0 0.0077990200370550156

This O 0 0.0039306641556322575
is O 0 0.005043310578912497
corrected O 0 0.0544690303504467
by O 0 0.003077366156503558
the O 0 0.00417645089328289
reintroduction O 1 0.6225379705429077
of O 0 0.0036224285140633583
wild O 0 0.041863709688186646
- O 0 0.058313362300395966
type O 1 0.9692609906196594
VHL B-Disease 1 0.9999940395355225
, O 0 0.006349989678710699
implicating O 1 0.92194002866745
VHL B-Disease 1 0.9999938011169434
as O 0 0.0025874904822558165
the O 0 0.003102888585999608
first O 0 0.01700400561094284
tumor B-Disease 1 0.9999998807907104
suppressor O 1 0.9999845027923584
involved O 0 0.011378239840269089
in O 0 0.001541757257655263
the O 0 0.002458845730870962
regulation O 0 0.011706638149917126
of O 0 0.0023880316875874996
cell O 0 0.0647251084446907
cycle O 0 0.25735852122306824
exit O 0 0.08647169172763824
, O 0 0.0017108567990362644
which O 0 0.0015080766752362251
is O 0 0.0021620565094053745
consistent O 0 0.0061335936188697815
with O 0 0.0011709382524713874
its O 0 0.004496104083955288
gatekeeper O 1 0.9999828338623047
function O 0 0.013878140598535538
in O 0 0.0023905932903289795
the O 0 0.008383069187402725
kidney O 1 1.0
. O 0 0.004736468195915222
. O 0 0.006381185259670019

Piebaldism B-Disease 1 0.999985933303833
with O 0 0.01569479890167713
deafness B-Disease 1 1.0
: O 0 0.007187602575868368
molecular O 0 0.01673700287938118
evidence O 0 0.0019264676375314593
for O 0 0.0014883943367749453
an O 0 0.0038253103848546743
expanded O 0 0.08803416043519974
syndrome O 1 1.0
. O 0 0.010991922579705715

In O 0 0.0034057653974741697
a O 0 0.006748827639967203
South O 0 0.008242192678153515
African O 0 0.02070006914436817
girl O 0 0.15171204507350922
of O 0 0.0035312871914356947
Xhosa O 1 0.9999772310256958
stock O 0 0.058877620846033096
with O 0 0.005111320875585079
severe O 1 1.0
piebaldism B-Disease 1 0.9999862909317017
and O 0 0.0039603738114237785
profound O 1 0.9999988079071045
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 0.002182980300858617
identified O 0 0.008909501135349274
a O 0 0.006095129530876875
novel O 0 0.030422763898968697
missense O 1 0.9990021586418152
substitution O 0 0.030141500756144524
at O 0 0.0033352121245115995
a O 0 0.006104340311139822
highly O 0 0.013430573046207428
conserved O 0 0.0346914678812027
residue O 0 0.05373925715684891
in O 0 0.001900809584185481
the O 0 0.005342429969459772
intracellular O 1 0.9682968258857727
kinase O 1 0.9499282240867615
domain O 0 0.018830375745892525
of O 0 0.0015422498108819127
the O 0 0.005757084582000971
KIT O 1 0.9995773434638977
proto O 1 0.9999659061431885
- O 1 0.7552860975265503
oncogene O 1 0.9999804496765137
, O 0 0.0077535551972687244
R796G O 1 0.9975261092185974
. O 0 0.00946425087749958

Though O 0 0.027865786105394363
auditory B-Disease 1 0.9961844086647034
anomalies I-Disease 1 0.9764720797538757
have O 0 0.002974345115944743
been O 0 0.004053652752190828
observed O 0 0.009498351253569126
in O 0 0.0030611022375524044
mice O 1 0.9991016387939453
with O 0 0.003598335199058056
dominant O 1 0.8494567275047302
white O 0 0.0325944647192955
spotting O 1 0.9985482096672058
( O 0 0.016416477039456367
W O 1 0.9995597004890442
) O 0 0.004059320315718651
due O 0 0.008221684955060482
to O 0 0.0032211553771048784
KIT O 1 0.9999603033065796
mutations O 1 0.9999954700469971
, O 0 0.008152978494763374
deafness B-Disease 1 1.0
is O 0 0.003891309490427375
not O 0 0.001904466305859387
typical O 0 0.012289685197174549
in O 0 0.002456560032442212
human O 0 0.017367923632264137
piebaldism B-Disease 1 0.999804675579071
. O 0 0.008568617515265942

Thus O 0 0.01003974862396717
, O 0 0.0016124346293509007
the O 0 0.0028597249183803797
occurrence O 1 0.9291895627975464
of O 0 0.006080432329326868
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 0.002811901504173875
this O 0 0.003968822304159403
patient O 1 0.9999892711639404
extends O 0 0.03621681034564972
considerably O 0 0.02398965135216713
the O 0 0.004173776600509882
phenotypic O 1 0.9883610010147095
range O 0 0.005047767423093319
of O 0 0.0026079523377120495
piebaldism B-Disease 1 0.9995731711387634
due O 0 0.011606690473854542
to O 0 0.0032719355076551437
KIT O 1 0.9999008178710938
gene O 1 0.9999032020568848
mutation O 1 0.9999439716339111
in O 0 0.00337763293646276
humans O 0 0.023765472695231438
and O 0 0.002428968669846654
tightens O 1 0.9999346733093262
the O 0 0.005522132385522127
clinical O 1 0.9600120186805725
similarity O 0 0.023924512788653374
between O 0 0.0040489621460437775
piebaldism B-Disease 1 0.9998266100883484
and O 0 0.0010100904619321227
the O 0 0.0010976598132401705
various O 0 0.001050657476298511
forms O 0 0.006045123562216759
of O 0 0.008440908044576645
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.006217325571924448
. O 0 0.006243648938834667

Cycloheximide O 1 0.9960273504257202
facilitates O 0 0.05196131020784378
the O 0 0.0037868961226195097
identification O 0 0.00944505725055933
of O 0 0.003290552878752351
aberrant O 1 0.7514158487319946
transcripts O 0 0.017636094242334366
resulting O 0 0.021438920870423317
from O 0 0.002358417259529233
a O 0 0.006876970641314983
novel O 0 0.031251441687345505
splice O 1 0.9951058626174927
- O 0 0.04082499444484711
site O 0 0.023431949317455292
mutation O 1 0.9966071844100952
in O 0 0.004596568178385496
COL17A1 O 1 0.9998683929443359
in O 0 0.0030875278171151876
a O 0 0.010995915159583092
patient O 1 0.9999634027481079
with O 0 0.005440072156488895
generalized O 1 0.9999948740005493
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999969005584717
. O 0 0.015743589028716087

Patients O 1 0.9999109506607056
with O 0 0.008518436923623085
generalized O 1 0.999992847442627
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999964237213135
often O 0 0.011775651015341282
show O 0 0.011174806393682957
decreased O 0 0.0839536264538765
expression O 0 0.0212233979254961
of O 0 0.0039164177142083645
type O 1 0.9994526505470276
XVII O 1 1.0
collagen O 1 0.9999920129776001
, O 0 0.002896216232329607
a O 0 0.01144195906817913
transmembrane O 1 0.9985307455062866
hemidesmosomal O 1 0.995618462562561
protein O 0 0.06518717110157013
encoded O 0 0.02844218537211418
by O 0 0.007261602208018303
COL17A1 O 1 0.9998008608818054
. O 0 0.010191424749791622

This O 0 0.0038142006378620863
report O 0 0.0028439064044505358
documents O 0 0.0017694361740723252
a O 0 0.005508275702595711
novel O 0 0.031440336257219315
splice O 1 0.9866932034492493
- O 0 0.03926553949713707
site O 0 0.02427111193537712
mutation O 1 0.9993711113929749
in O 0 0.004871830809861422
COL17A1 O 1 0.9999492168426514
in O 0 0.002292357385158539
a O 0 0.011962630786001682
patient O 1 0.999873161315918
with O 0 0.007155854254961014
generalized O 1 0.9999921321868896
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999995231628418
, O 0 0.004547684919089079
and O 0 0.0017006432171911001
applies O 0 0.008258187212049961
a O 0 0.003992676269263029
new O 0 0.0022411614190787077
methodology O 0 0.008922180160880089
to O 0 0.0014352970756590366
define O 0 0.005948682781308889
and O 0 0.0016804663464426994
characterize O 0 0.029315682128071785
the O 0 0.004451252520084381
resulting O 0 0.05032259598374367
mRNA O 0 0.09937550872564316
splice O 1 0.9009066820144653
variants O 0 0.07910767942667007
. O 0 0.007552053779363632

Mutational O 1 0.9518300890922546
analysis O 0 0.010072926059365273
of O 0 0.0037738909013569355
COL17A1 O 1 0.9998894929885864
identified O 0 0.020441023632884026
a O 0 0.014629341661930084
maternally O 1 0.9994543194770813
inherited O 1 0.9999654293060303
G O 1 0.998871386051178
- O 0 0.02666834369301796
to O 0 0.005453010089695454
- O 0 0.29032817482948303
T O 1 0.9996260404586792
transversion O 1 0.9893006682395935
at O 0 0.004708271473646164
the O 0 0.003888404695317149
- O 0 0.020123982802033424
1 O 0 0.009490031749010086
position O 0 0.00468778982758522
of O 0 0.0032029689755290747
exon O 1 0.999017596244812
32 O 0 0.03257409483194351
. O 0 0.007431449834257364

This O 0 0.01074614655226469
acceptor O 1 0.7553161382675171
splice O 1 0.983693540096283
- O 0 0.04543823003768921
site O 0 0.0247862059623003
mutation O 1 0.9985485672950745
led O 0 0.009791270829737186
to O 0 0.0015849191695451736
the O 0 0.0026551673654466867
formation O 0 0.020275969058275223
of O 0 0.002654121955856681
aberrant O 1 0.9714611768722534
transcripts O 0 0.012512297369539738
present O 0 0.003818032331764698
at O 0 0.0053678411059081554
extremely O 0 0.0235592070966959
low O 0 0.0309340488165617
levels O 0 0.02152872644364834
. O 0 0.007246444933116436

Based O 0 0.005213884636759758
on O 0 0.0016522516962140799
our O 0 0.002796115353703499
recent O 0 0.005497149657458067
finding O 0 0.008615690283477306
that O 0 0.0034383926540613174
cycloheximide O 1 0.9998295307159424
stabilized O 1 0.9993081092834473
mutant O 1 0.9957570433616638
COL17A1 O 1 0.9975753426551819
transcripts O 0 0.01700262725353241
in O 0 0.0047904979437589645
keratinocytes O 1 0.9993115663528442
homozygous O 1 0.9971959590911865
for O 0 0.0031682776752859354
a O 0 0.01635942980647087
frameshift O 1 0.9999918937683105
mutation O 1 0.9999310970306396
, O 0 0.0020273670088499784
the O 0 0.002798967296257615
effects O 0 0.02000049501657486
of O 0 0.0011375942267477512
the O 0 0.0038214800879359245
splice O 1 0.9960764050483704
- O 0 0.0349300317466259
site O 0 0.018059030175209045
mutation O 1 0.9920001029968262
on O 0 0.0040373834781348705
splicing O 0 0.08140953630208969
of O 0 0.004338182043284178
COL17A1 O 1 0.9999281167984009
transcripts O 0 0.013007327914237976
were O 0 0.001731184427626431
determined O 0 0.008039722219109535
using O 0 0.004970051348209381
reverse O 0 0.07624521106481552
transcriptase O 1 0.9756805896759033
polymerase O 0 0.3906486928462982
chain O 0 0.07696953415870667
reaction O 0 0.020238356664776802
of O 0 0.0017326049273833632
total O 0 0.0091111920773983
RNA O 0 0.10476318746805191
from O 0 0.00845955777913332
keratinocytes O 1 0.9959510564804077
incubated O 0 0.07727328687906265
for O 0 0.003159577725455165
2 O 0 0.01403459720313549
. O 0 0.006742652039974928

5 O 0 0.03384082019329071
h O 0 0.06609418988227844
in O 0 0.0019439085153862834
the O 0 0.0029889142606407404
presence O 0 0.009728866629302502
or O 0 0.002802952192723751
absence O 0 0.012885043397545815
of O 0 0.0016359509900212288
10 O 0 0.010282869450747967
microg O 1 0.9999361038208008
cycloheximide O 1 0.9987912774085999
per O 0 0.015128560364246368
ml O 1 0.9977260231971741
. O 0 0.008584260009229183

Using O 0 0.006323351990431547
this O 0 0.002440080977976322
approach O 0 0.00868996512144804
, O 0 0.0018186639063060284
an O 0 0.0050615849904716015
abnormally O 1 0.9987571239471436
spliced O 0 0.16209915280342102
transcript O 0 0.035712845623493195
was O 0 0.008129025809466839
identified O 0 0.01054241880774498
that O 0 0.0013533791061490774
contains O 0 0.002994957845658064
an O 0 0.0020427978597581387
extra O 0 0.011181083507835865
264 O 0 0.057080864906311035
bases O 0 0.013520167209208012
upstream O 0 0.03675903007388115
from O 0 0.006162554956972599
exon O 1 0.9966901540756226
32 O 0 0.02242443710565567
, O 0 0.002254531718790531
resulting O 0 0.018197666853666306
in O 0 0.00205379631370306
a O 0 0.011006816290318966
premature O 1 0.9994392991065979
termination O 1 0.9498047232627869
codon O 1 0.6517281532287598
27 O 0 0.02747633494436741
bp O 0 0.05399034917354584
downstream O 0 0.030898233875632286
from O 0 0.0030433221254497766
the O 0 0.004633023869246244
cryptic O 1 0.9818779230117798
splice O 1 0.9636089205741882
site O 0 0.018880289047956467
. O 0 0.006830499041825533

Three O 0 0.004986812826246023
other O 0 0.0027032848447561264
splice O 1 0.9940844178199768
variants O 0 0.05812827870249748
, O 0 0.0015342355472967029
including O 0 0.0012555458815768361
one O 0 0.002217560540884733
derived O 0 0.008279557339847088
from O 0 0.0019193944754078984
the O 0 0.0028210533782839775
skipping O 0 0.05924873799085617
of O 0 0.004520011134445667
exon O 1 0.998881995677948
32 O 0 0.02555042877793312
, O 0 0.0020243313629180193
were O 0 0.001420838525518775
also O 0 0.0027057062834501266
identified O 0 0.016738805919885635
. O 0 0.006424841936677694

These O 0 0.0027834319043904543
results O 0 0.0072129862383008
indicate O 0 0.007112664170563221
the O 0 0.002976846182718873
usefulness O 0 0.051614806056022644
of O 0 0.003996251150965691
cycloheximide O 1 0.9999960660934448
treatment O 1 0.9882572293281555
in O 0 0.0026120897382497787
evaluating O 0 0.01955338567495346
the O 0 0.005439274944365025
abnormal O 0 0.3762054145336151
processing O 0 0.006178819574415684
of O 0 0.002126146573573351
mRNA O 0 0.04081176593899727
due O 0 0.00847207847982645
to O 0 0.003049949649721384
splice O 1 0.9730151891708374
- O 0 0.04567941650748253
site O 0 0.02988138422369957
mutations O 1 0.9996258020401001
, O 0 0.0031597642228007317
because O 0 0.006818088237196207
( O 0 0.005700110457837582
i O 0 0.009171013720333576
) O 0 0.006448572967201471
aberrant O 1 0.9621172547340393
splicing O 0 0.11391307413578033
often O 0 0.0056731319054961205
generates O 0 0.031366705894470215
a O 0 0.018557017669081688
premature O 1 0.996483564376831
termination O 1 0.8832597136497498
codon O 0 0.47690269351005554
, O 0 0.004823615308851004
( O 0 0.007029619533568621
ii O 1 0.8393424153327942
) O 0 0.0030538812279701233
transcripts O 0 0.008611565455794334
with O 0 0.00413089944049716
premature O 1 0.9999736547470093
termination O 1 0.9990842342376709
codons O 1 0.7711542248725891
can O 0 0.005345666315406561
occur O 0 0.012394297868013382
at O 0 0.00390632776543498
low O 0 0.020206429064273834
or O 0 0.006557771936058998
undetectable O 1 0.999408483505249
levels O 0 0.014029551297426224
due O 0 0.008044666610658169
to O 0 0.002467615529894829
nonsense O 0 0.052839599549770355
- O 0 0.04712529107928276
mediated O 0 0.15827248990535736
mRNA O 0 0.09512951225042343
decay O 0 0.07175000011920929
, O 0 0.0024443375878036022
and O 0 0.0024814715143293142
( O 0 0.008892570622265339
iii O 1 0.9188724160194397
) O 0 0.0034316726960241795
the O 0 0.002633501775562763
levels O 0 0.00815634150058031
of O 0 0.0009806327288970351
these O 0 0.0008625707705505192
transcripts O 0 0.008347343653440475
can O 0 0.0023640538565814495
be O 0 0.001939194044098258
increased O 0 0.010886866599321365
by O 0 0.006632250268012285
cycloheximide O 1 0.9997064471244812
. O 0 0.009551040828227997

A O 0 0.04939059913158417
deletion O 1 0.9990119934082031
mutation O 1 0.9998389482498169
in O 0 0.0053217727690935135
COL17A1 O 1 0.9991552829742432
in O 0 0.0022879380267113447
five O 0 0.003965657204389572
Austrian O 0 0.20026762783527374
families O 0 0.008450428023934364
with O 0 0.006006772164255381
generalized O 1 0.9999895095825195
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999996423721313
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999879598617554
represents O 0 0.02689170464873314
propagation O 0 0.03499193117022514
of O 0 0.001660505193285644
an O 0 0.0042084283195436
ancestral O 0 0.2295980155467987
allele O 1 0.9997183680534363
. O 0 0.00949818454682827

Patients O 1 0.9998345375061035
with O 0 0.008761067874729633
generalized O 1 0.9999926090240479
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999992847442627
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999991655349731
, O 0 0.004268475342541933
a O 0 0.006835443899035454
usually O 0 0.007210112176835537
nonlethal O 0 0.05428721010684967
form O 0 0.007929346524178982
of O 0 0.0049857888370752335
junctional B-Disease 1 0.9999977350234985
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999997615814209
, O 0 0.0036604199558496475
have O 0 0.0032877670601010323
generalized O 1 0.9991742968559265
blistering B-Disease 1 0.9989504218101501
, O 0 0.0081881582736969
nail B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
, O 0 0.009524086490273476
patchy B-Disease 1 0.9999957084655762
alopecia I-Disease 1 1.0
, O 0 0.004488132894039154
and O 0 0.005317206494510174
dental B-Disease 1 0.9999994039535522
abnormalities I-Disease 1 0.9999991655349731
. O 0 0.007632531225681305

Skin B-Disease 1 1.0
fragility I-Disease 1 0.999908447265625
in O 0 0.0028708374593406916
most O 0 0.0035209311172366142
cases O 0 0.00881163403391838
is O 0 0.0031490882392972708
due O 0 0.007644610479474068
to O 0 0.0028643382247537374
mutations O 1 0.9974443912506104
in O 0 0.0017520622350275517
the O 0 0.004327184986323118
gene O 1 0.990189254283905
encoding O 0 0.09205783903598785
type O 1 0.9937240481376648
XVII O 1 0.9999997615814209
collagen O 1 0.999997615814209
( O 0 0.018692150712013245
COL17A1 O 1 0.999970555305481
) O 0 0.009542069397866726
. O 0 0.006532289087772369

Recently O 0 0.032696403563022614
, O 0 0.0023506921716034412
we O 0 0.0014802056830376387
reported O 0 0.010034807957708836
five O 0 0.004479098599404097
Austrian O 0 0.051229480654001236
families O 0 0.005745153408497572
with O 0 0.004226755816489458
generalized O 1 0.9999988079071045
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999994039535522
who O 0 0.006916743703186512
share O 0 0.00498035317286849
the O 0 0.0024802961852401495
same O 0 0.009741745889186859
COL17A1 O 1 0.9999958276748657
mutation O 1 0.9999674558639526
. O 0 0.010274767875671387

Affected O 0 0.2752484083175659
individuals O 0 0.005516811273992062
in O 0 0.002088606357574463
three O 0 0.002331741154193878
families O 0 0.00608828105032444
are O 0 0.0026083877310156822
homozygous O 1 0.9999293088912964
for O 0 0.004988736938685179
4003delTC O 1 0.9999587535858154
, O 0 0.0029336372390389442
whereas O 0 0.009607047773897648
those O 0 0.001153478748165071
in O 0 0.0013124644756317139
two O 0 0.001563764875754714
others O 0 0.0040283165872097015
are O 0 0.0025889293756335974
compound O 0 0.05529581755399704
heterozygotes O 1 0.9949507713317871
. O 0 0.012731761671602726

To O 0 0.003357706358656287
determine O 0 0.0056921918876469135
if O 0 0.0030012321658432484
the O 0 0.003207521280273795
occurrence O 0 0.07775096595287323
of O 0 0.003112576436251402
4003delTC O 1 0.9997462630271912
in O 0 0.0017367235850542784
these O 0 0.0015477909473702312
unrelated O 0 0.023437565192580223
families O 0 0.008600377477705479
signifies O 1 0.5287248492240906
propagation O 0 0.032159727066755295
of O 0 0.0012904535979032516
an O 0 0.0032493334729224443
ancestral O 0 0.12735886871814728
allele O 1 0.999869704246521
or O 0 0.005047245416790247
a O 0 0.012912709265947342
mutational O 1 0.9999244213104248
hot O 0 0.1450919806957245
spot O 0 0.03576819971203804
, O 0 0.003985166549682617
haplotypes O 1 0.9860877394676208
were O 0 0.0028059794567525387
determined O 0 0.010222950018942356
for O 0 0.003258387790992856
polymorphisms O 1 0.8887551426887512
both O 0 0.001697739353403449
within O 0 0.002669951878488064
and O 0 0.002858895342797041
flanking O 1 0.9994377493858337
COL17A1 O 1 0.9999572038650513
. O 0 0.011029141955077648

Five O 0 0.02169652283191681
intragenic O 1 0.9993477463722229
polymorphisms O 1 0.9446895718574524
were O 0 0.0022734333761036396
chosen O 0 0.004372100345790386
based O 0 0.0017460910603404045
on O 0 0.001560861011967063
their O 0 0.00438622897490859
informativeness O 1 0.9997065663337708
. O 0 0.009944124147295952

One O 0 0.004760982468724251
of O 0 0.0014657685533165932
these O 0 0.0009773328201845288
, O 0 0.0012657401384785771
not O 0 0.0013467803364619613
previously O 0 0.005613032728433609
reported O 0 0.011214552447199821
, O 0 0.0017963028512895107
was O 0 0.010485735721886158
2988 O 1 0.999882698059082
A O 0 0.01718895696103573
or O 0 0.005619199480861425
C O 0 0.07111659646034241
that O 0 0.0017349859699606895
introduces O 0 0.024226630106568336
a O 0 0.0051760063506662846
new O 0 0.0035882587544620037
restriction O 0 0.02548208087682724
site O 0 0.007875413633883
for O 0 0.004014618694782257
Eco0109 O 1 0.9997996687889099
I O 0 0.026074042543768883
. O 0 0.008003759197890759

All O 0 0.0031577281188219786
the O 0 0.00844707153737545
4003delTC O 1 0.999915361404419
alleles O 1 0.9991279244422913
showed O 0 0.01184144802391529
the O 0 0.002260468667373061
same O 0 0.005669867619872093
haplotype O 1 0.9950333833694458
for O 0 0.001521877944469452
these O 0 0.0012471076333895326
five O 0 0.008763321675360203
polymorphic O 1 0.999800980091095
markers O 0 0.060039274394512177
. O 0 0.0071772425435483456

Fourteen O 0 0.07842724770307541
microsatellite O 1 0.951410710811615
polymorphisms O 0 0.2624812126159668
were O 0 0.002820973051711917
selected O 0 0.0037023210898041725
based O 0 0.0017711685504764318
on O 0 0.001387186930514872
their O 0 0.001999154221266508
high O 0 0.01075820717960596
heterozygosity O 1 0.9975520968437195
and O 0 0.0014593723462894559
their O 0 0.0012440395075827837
location O 0 0.005882796831429005
within O 0 0.005068462807685137
10q23 O 1 0.9998533725738525
- O 0 0.07539088279008865
q25 O 1 0.9994879961013794
near O 0 0.043877262622117996
COL17A1 O 1 0.9999051094055176
. O 0 0.012694965116679668

Three O 0 0.005987681448459625
families O 0 0.009468695148825645
shared O 0 0.022078020498156548
microsatellite O 1 0.9980689883232117
polymorphisms O 1 0.9823452830314636
covering O 0 0.015855863690376282
at O 0 0.004900162108242512
most O 0 0.004947218112647533
19 O 0 0.027780819684267044
cM O 0 0.11775574833154678
, O 0 0.0020864647813141346
whereas O 0 0.009382249787449837
the O 0 0.002111630281433463
others O 0 0.003581445664167404
shared O 0 0.006902109365910292
smaller O 0 0.007603638339787722
regions O 0 0.008519886061549187
consistent O 0 0.010869969613850117
with O 0 0.002514380030333996
cross O 0 0.014323822222650051
- O 0 0.016052212566137314
over O 0 0.0035574883222579956
events O 0 0.005651472136378288
during O 0 0.007048163563013077
passage O 0 0.009950459934771061
of O 0 0.0015410996275022626
this O 0 0.004736366216093302
mutation O 1 0.999737560749054
through O 0 0.004912630654871464
several O 0 0.003314648987725377
generations O 0 0.024095553904771805
. O 0 0.007292380556464195

These O 0 0.002868928713724017
results O 0 0.008053194731473923
indicate O 0 0.009178685955703259
that O 0 0.003128266893327236
4003delTC O 1 0.9991102814674377
occurs O 0 0.02632860094308853
on O 0 0.0017613992094993591
a O 0 0.00596590805798769
single O 0 0.018954817205667496
ancestral O 0 0.29316121339797974
allele O 1 0.999860405921936
. O 0 0.004599850624799728
. O 0 0.006516538560390472

The O 0 0.016772527247667313
haptoglobin O 1 0.990561306476593
- O 0 0.11284676194190979
gene O 1 0.9883937239646912
deletion O 1 0.9653657078742981
responsible O 0 0.024965370073914528
for O 0 0.00541074201464653
anhaptoglobinemia B-Disease 1 0.999168872833252
. O 0 0.009867986664175987

We O 0 0.0036647843662649393
have O 0 0.002080463571473956
found O 0 0.004721065983176231
an O 0 0.004839577712118626
allelic O 1 0.9959732890129089
deletion O 1 0.9368644952774048
of O 0 0.002856637118384242
the O 0 0.007569797337055206
haptoglobin O 1 0.9994872808456421
( O 0 0.013257409445941448
Hp O 1 0.7593579888343811
) O 0 0.0074666631408035755
gene O 1 0.8570117354393005
from O 0 0.0029800806660205126
an O 0 0.002127217361703515
individual O 0 0.003703450784087181
with O 0 0.0039045880548655987
anhaptoglobinemia B-Disease 1 0.9999306201934814
. O 0 0.007972716353833675

The O 0 0.012523297220468521
Hp O 1 0.9099968075752258
gene O 1 0.9785789847373962
cluster O 0 0.040434330701828
consists O 0 0.005220235325396061
of O 0 0.001993456156924367
coding O 0 0.0687505230307579
regions O 0 0.006385470740497112
of O 0 0.0012346801813691854
the O 0 0.00382572622038424
alpha O 1 0.6883973479270935
chain O 0 0.0708322674036026
and O 0 0.0024831860791891813
beta O 0 0.06856023520231247
chain O 0 0.03143935650587082
of O 0 0.0017221694579347968
the O 0 0.006674811709672213
haptoglobin O 1 0.9998834133148193
gene O 1 0.9964391589164734
( O 0 0.011592213064432144
Hp O 0 0.37731385231018066
) O 0 0.003184561152011156
and O 0 0.0006872882950119674
of O 0 0.001022743759676814
the O 0 0.004403098486363888
alpha O 1 0.5673839449882507
chain O 0 0.06640799343585968
and O 0 0.0030344806145876646
beta O 0 0.07089564204216003
chain O 0 0.0365140438079834
of O 0 0.0013775895349681377
the O 0 0.004684907384216785
haptoglobin O 1 0.9997424483299255
- O 0 0.05335945263504982
related O 0 0.025269364938139915
gene O 1 0.9988019466400146
( O 0 0.0155013557523489
Hpr O 1 0.9999711513519287
) O 0 0.005058481823652983
, O 0 0.0014016003115102649
in O 0 0.0020564808510243893
tandem O 0 0.040435947477817535
from O 0 0.002888968214392662
the O 0 0.0035263223107904196
5 O 0 0.014323641546070576
side O 0 0.014234879054129124
. O 0 0.007284145336598158

Southern O 0 0.045900799334049225
blot O 1 0.9955215454101562
and O 0 0.004392279777675867
PCR O 1 0.8560529351234436
analyses O 0 0.009516753256320953
have O 0 0.002149961655959487
indicated O 0 0.006277455948293209
that O 0 0.0007133373292163014
the O 0 0.0016954680904746056
individual O 0 0.0026837827172130346
with O 0 0.002516878303140402
anhaptoglobinemia B-Disease 1 0.9999516010284424
was O 0 0.01337369717657566
homozygous O 1 0.9969682097434998
for O 0 0.002109326422214508
the O 0 0.005284077487885952
gene O 1 0.9953147172927856
deletion O 1 0.9830762147903442
and O 0 0.0015584758948534727
that O 0 0.001386386575177312
the O 0 0.00537906726822257
gene O 1 0.9953716397285461
deletion O 1 0.9973905682563782
was O 0 0.007591500412672758
included O 0 0.0024616823066025972
at O 0 0.0038089680019766092
least O 0 0.005221512634307146
from O 0 0.0024628336541354656
the O 0 0.005187649745494127
promoter O 1 0.9897772669792175
region O 0 0.009683249518275261
of O 0 0.002325652865692973
Hp O 1 0.9804900288581848
to O 0 0.00573709374293685
Hpr O 1 0.9997712969779968
alpha O 0 0.08257202059030533
but O 0 0.00215465622022748
not O 0 0.0015100555028766394
to O 0 0.0036423492711037397
Hpr O 1 0.9998302459716797
beta O 0 0.15474671125411987
( O 0 0.018189968541264534
Hpdel O 1 0.9994460940361023
) O 0 0.00818595103919506
. O 0 0.00721902959048748

In O 0 0.005014088936150074
addition O 0 0.005396222695708275
, O 0 0.0013983779354020953
we O 0 0.0013787589268758893
found O 0 0.00403083860874176
seven O 0 0.003941158764064312
individuals O 0 0.0038908696733415127
with O 0 0.0027045034803450108
hypohaptoglobinemia B-Disease 1 0.9998072981834412
in O 0 0.001965585397556424
three O 0 0.002191853942349553
families O 0 0.005511562805622816
, O 0 0.0015154477441683412
and O 0 0.0010675792582333088
the O 0 0.004100986756384373
genotypes O 1 0.9994727969169617
of O 0 0.0015848074108362198
six O 0 0.0025301820132881403
of O 0 0.0009570923866704106
the O 0 0.002000842709094286
seven O 0 0.003240799531340599
individuals O 0 0.003486537141725421
were O 0 0.0014019226655364037
found O 0 0.003561941673979163
to O 0 0.001359547022730112
be O 0 0.004297632724046707
Hp2 O 1 0.9999366998672485
/ O 1 0.9102969169616699
Hpdel O 1 0.9989420771598816
. O 0 0.011809631250798702

The O 0 0.01267639547586441
phenotypes O 1 0.9993798732757568
and O 0 0.005318790208548307
genotypes O 1 0.9998722076416016
in O 0 0.002002008492127061
one O 0 0.001953297993168235
of O 0 0.0010817291913554072
these O 0 0.0007856677984818816
three O 0 0.002005454385653138
families O 0 0.005773783195763826
showed O 0 0.009050753898918629
the O 0 0.0029352447018027306
father O 0 0.015454865992069244
to O 0 0.0018993066623806953
be O 0 0.004427155014127493
hypohaptoglobinemic B-Disease 1 0.9996519088745117
( O 0 0.011859058402478695
Hp2 O 1 0.9999098777770996
) O 0 0.005103882402181625
and O 0 0.00321100652217865
Hp2 O 1 0.9999803304672241
/ O 1 0.9794314503669739
Hpdel O 1 0.9996955394744873
, O 0 0.002367524430155754
the O 0 0.003014175221323967
mother O 0 0.028944749385118484
to O 0 0.0016057356260716915
be O 0 0.004325474612414837
Hp2 O 1 0.9997151494026184
- O 0 0.024843968451023102
1 O 0 0.013066080398857594
and O 0 0.0037729551550000906
Hp1 O 1 0.9999628067016602
/ O 1 0.9170680046081543
Hp2 O 1 0.9995154142379761
, O 0 0.0017109832260757685
one O 0 0.0015616979217156768
of O 0 0.0008238260052166879
the O 0 0.0017099296674132347
two O 0 0.0014391607837751508
children O 0 0.006030455231666565
to O 0 0.0016171602765098214
be O 0 0.004183527082204819
hypohaptoglobinemic B-Disease 1 0.9998121857643127
( O 0 0.012529277242720127
Hp2 O 1 0.9998971223831177
) O 0 0.004722610116004944
and O 0 0.0031556200701743364
Hp2 O 1 0.99998939037323
/ O 1 0.9934484362602234
Hpdel O 1 0.9999004602432251
, O 0 0.002323569031432271
and O 0 0.0006734760827384889
the O 0 0.0016181853134185076
other O 0 0.0009271022281609476
child O 0 0.024761192500591278
to O 0 0.0012896561529487371
be O 0 0.003104848088696599
Hp1 O 1 0.9998711347579956
and O 0 0.005574969574809074
Hp1 O 1 0.9999948740005493
/ O 1 0.9941078424453735
Hpdel O 1 0.999883770942688
, O 0 0.0029305038042366505
showing O 0 0.009785660542547703
an O 0 0.0038234952371567488
anomalous O 1 0.5248746275901794
inheritance O 0 0.19064584374427795
of O 0 0.0038683542516082525
Hp O 1 0.9982835054397583
phenotypes O 1 0.9988974332809448
in O 0 0.0018503933679312468
the O 0 0.003140985267236829
child O 0 0.3356739282608032
with O 0 0.004720035474747419
Hp1 O 1 0.999886155128479
. O 0 0.009299156256020069

The O 0 0.017808090895414352
Hp2 O 1 0.9998252987861633
/ O 1 0.997441291809082
Hpdel O 1 0.9998750686645508
individuals O 0 0.007340762298554182
had O 0 0.004805643577128649
an O 0 0.0030934130772948265
extremely O 0 0.018042810261249542
low O 0 0.016764003783464432
level O 0 0.005490735173225403
of O 0 0.002973089925944805
Hp O 1 0.8617299199104309
( O 0 0.009645924903452396
mean O 0 0.020647717639803886
+ O 0 0.09505841135978699
/ O 0 0.08861970901489258
- O 0 0.07693123817443848
SD O 1 0.9991336464881897
= O 0 0.07241266220808029
0 O 0 0.0335661880671978
. O 0 0.007788653485476971
049 O 1 0.9998648166656494
+ O 0 0.16272884607315063
/ O 0 0.08835713565349579
- O 0 0.04171192646026611
0 O 0 0.037502024322748184
. O 0 0.008758229203522205
043 O 1 0.9999206066131592
mg O 1 0.9996676445007324
/ O 1 0.6010491251945496
ml O 1 0.9838733077049255
; O 0 0.010748322121798992
n O 0 0.05561530217528343
= O 0 0.05905844643712044
6 O 0 0.021902810782194138
) O 0 0.00424703024327755
, O 0 0.001978879561647773
compared O 0 0.006843164563179016
with O 0 0.0012630689889192581
the O 0 0.0030928661581128836
level O 0 0.0071690985932946205
( O 0 0.005105262156575918
1 O 0 0.010083810426294804
. O 0 0.002582484157755971
64 O 0 0.0354212187230587
+ O 0 0.10209967941045761
/ O 0 0.08565350621938705
- O 0 0.031914953142404556
1 O 0 0.016938859596848488
. O 0 0.006702024955302477
07 O 1 0.9976469874382019
mg O 1 0.999670147895813
/ O 1 0.7850143909454346
ml O 1 0.9819217920303345
) O 0 0.0044731637462973595
obtained O 0 0.0036634705029428005
from O 0 0.003213099902495742
52 O 0 0.032141994684934616
healthy O 1 0.6999431252479553
volunteers O 0 0.033988431096076965
having O 0 0.03359917923808098
phenotype O 1 0.9999991655349731
Hp2 O 1 0.9997140765190125
, O 0 0.0030373353511095047
whereas O 0 0.011667193844914436
the O 0 0.004797645844519138
serum O 1 0.9996601343154907
Hp O 0 0.08850031346082687
level O 0 0.004243595525622368
of O 0 0.0009276288328692317
an O 0 0.0016354183899238706
individual O 0 0.002945322310552001
with O 0 0.0033152226824313402
Hp1 O 1 0.9999927282333374
/ O 1 0.990802526473999
Hpdel O 1 0.9999463558197021
was O 0 0.013424919918179512
0 O 0 0.030265793204307556
. O 0 0.005380383692681789

50 O 0 0.04982529953122139
mg O 1 0.9997566342353821
/ O 1 0.9322348237037659
ml O 1 0.9981573224067688
, O 0 0.0027864230796694756
which O 0 0.002216476248577237
was O 0 0.006462377961724997
approximately O 0 0.006528753321617842
half O 0 0.0052155437879264355
the O 0 0.0021360048558562994
level O 0 0.004392167553305626
of O 0 0.00234864535741508
Hp O 0 0.3686792254447937
in O 0 0.003104225266724825
control O 0 0.021602438762784004
sera O 0 0.09154574573040009
from O 0 0.0031472297850996256
the O 0 0.008820950984954834
Hp1 O 1 0.9999924898147583
phenotype O 1 0.9999949932098389
( O 0 0.009119839407503605
1 O 0 0.013179097324609756
. O 0 0.003678510431200266
26 O 0 0.026616277173161507
+ O 0 0.09702158719301224
/ O 0 0.06877360492944717
- O 0 0.03703281283378601
0 O 0 0.02818729542195797
. O 0 0.004143680911511183
33 O 0 0.045167841017246246
mg O 1 0.9998669624328613
/ O 1 0.6891463398933411
ml O 1 0.990455687046051
; O 0 0.011019670404493809
n O 0 0.05534571036696434
= O 0 0.05132697895169258
9 O 0 0.019252445548772812
) O 0 0.0031491334084421396
, O 0 0.0015665210084989667
showing O 0 0.011138907633721828
a O 0 0.014650900848209858
gene O 1 0.9985666871070862
- O 0 0.07139186561107635
dosage O 1 0.9987951517105103
effect O 0 0.02491038665175438
. O 0 0.007500976324081421

The O 0 0.006715280935168266
other O 0 0.004789876751601696
allele O 1 0.9998188614845276
( O 0 0.015488299541175365
Hp2 O 1 0.9997466206550598
) O 0 0.004058527760207653
of O 0 0.0013669596519321203
individuals O 0 0.004751727916300297
with O 0 0.0036242189817130566
Hp2 O 1 0.9999902248382568
/ O 1 0.9961859583854675
Hpdel O 1 0.9999489784240723
was O 0 0.009561634622514248
found O 0 0.0041612181812524796
to O 0 0.0011130585335195065
have O 0 0.0014255254063755274
, O 0 0.001012116321362555
in O 0 0.0013555389596149325
all O 0 0.002013296587392688
exons O 1 0.9411976933479309
, O 0 0.002792619401589036
no O 0 0.005203596316277981
mutation O 1 0.9999579191207886
, O 0 0.0019557378254830837
by O 0 0.004293361678719521
DNA O 0 0.051769502460956573
sequencing O 0 0.06727162003517151
. O 0 0.0076546017080545425

On O 0 0.003362763673067093
the O 0 0.0021562313195317984
basis O 0 0.001596124260686338
of O 0 0.0011943982681259513
the O 0 0.002533387392759323
present O 0 0.003082233713939786
study O 0 0.002959872130304575
, O 0 0.0009756683721207082
the O 0 0.0016895351000130177
mechanism O 0 0.01536596193909645
of O 0 0.0023057747166603804
anhaptoglobinemia B-Disease 1 0.9999672174453735
and O 0 0.0012581030605360866
the O 0 0.002433986868709326
mechanism O 0 0.014028810895979404
of O 0 0.002462569624185562
anomalous O 1 0.8287875652313232
inheritance O 1 0.6221548914909363
of O 0 0.0032574094366282225
Hp O 1 0.9996770620346069
phenotypes O 1 0.9998974800109863
were O 0 0.002344149397686124
well O 0 0.002533743856474757
explained O 0 0.014020279981195927
. O 0 0.006201623938977718

However O 0 0.00783156044781208
, O 0 0.001548340660519898
the O 0 0.002430484862998128
mechanism O 0 0.01948382891714573
of O 0 0.003568258136510849
hypohaptoglobinemia B-Disease 1 0.9997016787528992
remains O 0 0.02752530761063099
unknown O 0 0.04939476400613785

ATM O 1 0.946139395236969
mutations O 1 0.9989157915115356
and O 0 0.004193889442831278
phenotypes O 1 0.9994214773178101
in O 0 0.010054384358227253
ataxia B-Disease 1 1.0
- I-Disease 1 0.998604953289032
telangiectasia I-Disease 1 0.9999998807907104
families O 0 0.010539066046476364
in O 0 0.0016877908492460847
the O 0 0.0032135271467268467
British O 0 0.04887247085571289
Isles O 1 0.9994126558303833
: O 0 0.004033044446259737
expression O 0 0.016614161431789398
of O 0 0.002731584943830967
mutant O 1 0.9996800422668457
ATM O 0 0.2907758057117462
and O 0 0.0013410430401563644
the O 0 0.003011922352015972
risk O 1 0.9950659275054932
of O 0 0.006644976790994406
leukemia B-Disease 1 1.0
, O 1 0.9204626679420471
lymphoma B-Disease 1 1.0
, O 0 0.004827673081308603
and O 0 0.048327166587114334
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.009021532721817493

We O 0 0.0028514410369098186
report O 0 0.002958878641948104
the O 0 0.0028583435341715813
spectrum O 0 0.029658060520887375
of O 0 0.002208106918260455
59 O 0 0.18513906002044678
ATM O 1 0.9754325747489929
mutations O 1 0.9961328506469727
observed O 0 0.01625513657927513
in O 0 0.006061243824660778
ataxia B-Disease 1 1.0
- I-Disease 1 0.9978522062301636
telangiectasia I-Disease 1 1.0
( O 0 0.010829384438693523
A B-Disease 1 0.9996906518936157
- I-Disease 1 0.9981328845024109
T I-Disease 1 0.9999983310699463
) O 0 0.012697577476501465
patients O 1 0.9997134804725647
in O 0 0.001884978380985558
the O 0 0.0035086944699287415
British O 0 0.07570531964302063
Isles O 1 0.9987204074859619
. O 0 0.007783231791108847

Of O 0 0.008119569160044193
51 O 0 0.08275554329156876
ATM O 1 0.9960426092147827
mutations O 1 0.999543309211731
identified O 0 0.015009274706244469
in O 0 0.0021156026050448418
families O 0 0.005820041988044977
native O 0 0.004519693553447723
to O 0 0.00122113770339638
the O 0 0.0034162234514951706
British O 0 0.03228434547781944
Isles O 1 0.9983421564102173
, O 0 0.002647614339366555
11 O 0 0.00768615584820509
were O 0 0.003123919013887644
founder O 1 0.9918402433395386
mutations O 1 0.9997852444648743
, O 0 0.0017206650227308273
and O 0 0.0012273231986910105
2 O 0 0.004934324882924557
of O 0 0.0008977455436252058
these O 0 0.0008675948483869433
11 O 0 0.0074955178424716
conferred O 0 0.08267179876565933
a O 0 0.014553568325936794
milder O 1 0.9999749660491943
clinical O 1 0.9999256134033203
phenotype O 1 0.9999954700469971
with O 0 0.001830309978686273
respect O 0 0.0028425215277820826
to O 0 0.0016080912901088595
both O 0 0.005275009665638208
cerebellar B-Disease 1 0.9999991655349731
degeneration I-Disease 1 1.0
and O 0 0.003596468595787883
cellular O 0 0.2856961786746979
features O 0 0.009771374054253101
. O 0 0.0068963877856731415

We O 0 0.003533912356942892
report O 0 0.0035834440495818853
, O 0 0.001095204264856875
in O 0 0.0011251389514654875
two O 0 0.0021464538294821978
A B-Disease 1 0.9844719767570496
- I-Disease 1 0.9954227805137634
T I-Disease 1 0.9999954700469971
families O 0 0.007055869325995445
, O 0 0.0014986955793574452
an O 0 0.003491239156574011
ATM O 1 0.9990766048431396
mutation O 1 0.9999798536300659
( O 0 0.010465499944984913
7271T O 1 0.9999016523361206
- O 0 0.059772782027721405
- O 0 0.21290452778339386
> O 1 0.9985137581825256
G O 1 0.997312068939209
) O 0 0.003911464940756559
that O 0 0.001458586659282446
may O 0 0.00494714779779315
be O 0 0.001424068002961576
associated O 0 0.004207267425954342
with O 0 0.0007686213939450681
an O 0 0.002083803527057171
increased O 0 0.014615098014473915
risk O 1 0.9968522191047668
of O 0 0.009851488284766674
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0024737264029681683
both O 0 0.0037450934760272503
homozygotes O 1 0.9999845027923584
and O 0 0.004956882447004318
heterozygotes O 1 0.9999862909317017
( O 0 0.007829463109374046
relative O 0 0.02213284745812416
risk O 1 0.9957951307296753
12 O 0 0.009106030687689781
. O 0 0.002793028252199292
7 O 0 0.016728781163692474
; O 0 0.007344734389334917
P O 1 0.9734880924224854
= O 0 0.06790618598461151
. O 0 0.009836132638156414
0025 O 1 0.9999778270721436
) O 0 0.006088146008551121
, O 0 0.0016478898469358683
although O 0 0.0027655933517962694
there O 0 0.0010339129948988557
is O 0 0.0018374178325757384
a O 0 0.004680986981838942
less O 0 0.01090187020599842
severe O 1 0.9999997615814209
A B-Disease 1 0.9996100068092346
- I-Disease 1 0.9986768364906311
T I-Disease 1 0.9999990463256836
phenotype O 1 0.9999849796295166
in O 0 0.0019113997695967555
terms O 0 0.0013709022896364331
of O 0 0.0009091611136682332
the O 0 0.0022430813405662775
degree O 0 0.005666873883455992
of O 0 0.005328026600182056
cerebellar B-Disease 1 0.9999997615814209
degeneration I-Disease 1 1.0
. O 0 0.01195009145885706

This O 0 0.012497777119278908
mutation O 1 0.9991796612739563
( O 0 0.015703324228525162
7271T O 1 0.9995492100715637
- O 0 0.06493652611970901
- O 0 0.08039339631795883
> O 1 0.9951716065406799
G O 1 0.9978895783424377
) O 0 0.0034195708576589823
also O 0 0.0018671988509595394
allows O 0 0.0045007807202637196
expression O 0 0.012519770301878452
of O 0 0.00128958432469517
full O 0 0.007562675047665834
- O 0 0.03119652159512043
length O 0 0.021249154582619667
ATM O 0 0.2601342797279358
protein O 0 0.04030338302254677
at O 0 0.003610034240409732
a O 0 0.0059912302531301975
level O 0 0.00528348796069622
comparable O 0 0.012673884630203247
with O 0 0.0015720310620963573
that O 0 0.0012692265445366502
in O 0 0.003154880367219448
unaffected O 1 0.999736487865448
individuals O 0 0.009446831420063972
. O 0 0.006316159851849079

In O 0 0.00481639476493001
addition O 0 0.004780428484082222
, O 0 0.0014323359355330467
we O 0 0.0010045728413388133
have O 0 0.0014709729002788663
studied O 0 0.004466882906854153
18 O 0 0.009396903216838837
A B-Disease 1 0.9986510872840881
- I-Disease 1 0.9998158812522888
T I-Disease 1 0.9999998807907104
patients O 1 0.9999974966049194
, O 0 0.0018167381640523672
in O 0 0.0015581613406538963
15 O 0 0.006562682334333658
families O 0 0.00477168383076787
, O 0 0.0015420905547216535
who O 0 0.00806646142154932
developed O 1 0.9996891021728516
leukemia B-Disease 1 1.0
, O 0 0.3658429980278015
lymphoma B-Disease 1 1.0
, O 0 0.008896298706531525
preleukemic O 1 0.9999998807907104
T O 1 0.9999887943267822
- O 0 0.05132884532213211
cell O 0 0.053436096757650375
proliferation O 0 0.03088131733238697
, O 0 0.004051647149026394
or O 1 0.6593506932258606
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.003576206974685192
mostly O 0 0.003888866165652871
in O 0 0.003800411708652973
childhood O 1 0.9992142915725708
. O 0 0.00872468575835228

A O 0 0.01830206997692585
wide O 0 0.011028222739696503
variety O 0 0.004128608386963606
of O 0 0.002514554187655449
ATM O 1 0.9997817873954773
mutation O 1 0.9999878406524658
types O 0 0.009629854001104832
, O 0 0.0015696221962571144
including O 0 0.0034425880294293165
missense O 1 0.9999953508377075
mutations O 1 0.9999157190322876
and O 0 0.001420217682607472
in O 0 0.002350033260881901
- O 0 0.029192274436354637
frame O 0 0.03319637104868889
deletions O 1 0.6260709166526794
, O 0 0.0018941800808534026
were O 0 0.0014288716483861208
seen O 0 0.00710550881922245
in O 0 0.0020191040821373463
these O 0 0.0035740649327635765
patients O 1 0.9999955892562866
. O 0 0.007148181088268757

We O 0 0.003136664628982544
also O 0 0.0022098601330071688
show O 0 0.0052248029969632626
that O 0 0.0012058302527293563
25 O 0 0.004961854312568903
% O 0 0.0020438646897673607
of O 0 0.0008521913550794125
all O 0 0.0015854125376790762
A B-Disease 1 0.9961856007575989
- I-Disease 1 0.9995253086090088
T I-Disease 1 0.9999997615814209
patients O 1 0.9999518394470215
carried O 0 0.007602192461490631
in O 0 0.002609437331557274
- O 0 0.025901159271597862
frame O 0 0.03406587243080139
deletions O 1 0.9704136848449707
or O 0 0.01328292116522789
missense O 1 0.9999783039093018
mutations O 1 0.9995177984237671
, O 0 0.002075550379231572
many O 0 0.0010514770401641726
of O 0 0.0011309609981253743
which O 0 0.0017364994855597615
were O 0 0.0011965431040152907
also O 0 0.0015928478678688407
associated O 0 0.004819478373974562
with O 0 0.0015223294030874968
expression O 0 0.016030142083764076
of O 0 0.0037832639645785093
mutant O 1 0.999935507774353
ATM O 1 0.6149020195007324
protein O 0 0.07402598112821579
. O 0 0.008530477993190289

The O 0 0.017174767330288887
DMPK O 1 0.9999356269836426
gene O 1 0.9847054481506348
of O 0 0.00629423139616847
severely O 1 0.9999996423721313
affected O 1 0.9999967813491821
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999996423721313
is O 0 0.012131952680647373
hypermethylated O 1 0.999988317489624
proximal O 1 0.999993085861206
to O 0 0.0017947525484487414
the O 0 0.0027677009347826242
largely O 0 0.00933167152106762
expanded O 0 0.01970672607421875
CTG O 1 0.9994989633560181
repeat O 0 0.1340162754058838
. O 0 0.008296752348542213

Using O 0 0.013409391976892948
methylation O 0 0.11621221154928207
- O 0 0.04443501681089401
sensitive O 0 0.02865617163479328
restriction O 0 0.044311974197626114
enzymes O 0 0.04632102698087692
, O 0 0.0016281581483781338
we O 0 0.001977019477635622
characterized O 0 0.027698475867509842
the O 0 0.0051773106679320335
methylation O 0 0.098434217274189
pattern O 0 0.022839566692709923
on O 0 0.001757448655553162
the O 0 0.0030463070143014193
5 O 0 0.008944360539317131
side O 0 0.005488022696226835
of O 0 0.0013322439044713974
the O 0 0.0055871689692139626
CTG O 1 0.9999406337738037
repeat O 0 0.04274420067667961
in O 0 0.0017713878769427538
the O 0 0.005323393736034632
DMPK O 1 0.9999979734420776
gene O 1 0.9745326042175293
of O 0 0.0025073671713471413
normal O 0 0.015457418747246265
individuals O 0 0.0031468092929571867
and O 0 0.0010300816502422094
of O 0 0.002692553913220763
patients O 1 0.9999997615814209
affected O 1 0.9993540644645691
with O 0 0.021609585732221603
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.004632516298443079
showing O 0 0.014660065993666649
expansions O 0 0.02282910794019699
of O 0 0.001739395665936172
the O 0 0.006327908951789141
repetitive O 1 0.9988728165626526
sequence O 0 0.030956584960222244
. O 0 0.006441086530685425

The O 0 0.017914054915308952
gene O 1 0.8311397433280945
segment O 0 0.05272245034575462
analyzed O 0 0.022931620478630066
corresponds O 0 0.013033697381615639
to O 0 0.0014211592497304082
the O 0 0.004462236538529396
genomic O 0 0.34430205821990967
SacI O 1 0.9904926419258118
- O 0 0.06940924376249313
HindIII O 1 0.9939984083175659
fragment O 0 0.10013560205698013
carrying O 0 0.020164312794804573
exons O 0 0.31301507353782654
11 O 0 0.021004891023039818
- O 0 0.029823368415236473
15 O 0 0.01434609666466713
. O 0 0.007087315432727337

There O 0 0.0051281447522342205
is O 0 0.005821753293275833
constitutive O 0 0.14164170622825623
methylation O 0 0.08318055421113968
in O 0 0.005049820523709059
intron O 1 0.9982397556304932
12 O 0 0.012337838299572468
at O 0 0.0052843354642391205
restriction O 0 0.02081741765141487
sites O 0 0.003354517975822091
of O 0 0.003101615933701396
SacII O 1 0.9997720122337341
and O 0 0.005049420055001974
HhaI O 1 0.9998965263366699
, O 0 0.0061888364143669605
localized O 1 0.9909819960594177
1 O 0 0.0144331194460392
, O 0 0.003768706461414695
159 O 0 0.12799371778964996
- O 0 0.027573511004447937
1 O 0 0.013763573952019215
, O 0 0.003638229565694928
232 O 0 0.08579157292842865
bp O 0 0.06130579113960266
upstream O 0 0.023545142263174057
of O 0 0.0017987723695114255
the O 0 0.006189615931361914
CTG O 1 0.9999547004699707
repeat O 1 0.6167615056037903
, O 0 0.003277277108281851
whereas O 0 0.016152506694197655
most O 0 0.0029459455981850624
, O 0 0.001677788677625358
if O 0 0.002529018558561802
not O 0 0.0009811792988330126
all O 0 0.0007328667561523616
, O 0 0.0009417501860298216
of O 0 0.000957972661126405
the O 0 0.0017480977112427354
other O 0 0.0007874809671193361
sites O 0 0.003408631542697549
of O 0 0.0025894171558320522
SacII O 1 0.9999892711639404
, O 0 0.006169474218040705
HhaI O 1 0.9999222755432129
, O 0 0.0022966922260820866
and O 0 0.00206675729714334
HpaII O 1 0.9998871088027954
in O 0 0.0019587427377700806
this O 0 0.0019920391496270895
region O 0 0.008698759600520134
are O 0 0.002188163110986352
unmethylated O 1 0.999731719493866
, O 0 0.002101870020851493
in O 0 0.0021347040310502052
normal O 0 0.020811164751648903
individuals O 0 0.0038734807167202234
and O 0 0.0009740206296555698
most O 0 0.001935776905156672
of O 0 0.0016215043142437935
the O 0 0.006523867603391409
patients O 1 0.999995231628418
. O 0 0.007378330919891596

In O 0 0.0031031896360218525
a O 0 0.004969676490873098
number O 0 0.002038720063865185
of O 0 0.001590514904819429
young O 0 0.018004531040787697
and O 0 0.005605239886790514
severely O 1 0.9999995231628418
affected O 1 0.9998949766159058
patients O 1 0.9999986886978149
, O 0 0.00206899456679821
however O 0 0.003050433937460184
, O 0 0.0013397446600720286
complete O 0 0.0062637352384626865
methylation O 0 0.040118325501680374
of O 0 0.0013637091033160686
these O 0 0.00130295695271343
restriction O 0 0.021366093307733536
sites O 0 0.004475780762732029
was O 0 0.006241744849830866
found O 0 0.003885878948494792
in O 0 0.00159370806068182
the O 0 0.007793688680976629
mutated O 1 0.9999840259552002
allele O 1 0.9997188448905945
. O 0 0.009079908020794392

In O 0 0.003315375419333577
most O 0 0.0020894701592624187
of O 0 0.0012587514938786626
these O 0 0.0026332037523388863
patients O 1 0.9999926090240479
, O 0 0.001845183433033526
the O 0 0.004243688657879829
onset O 1 0.9999996423721313
of O 0 0.002233314560726285
the O 0 0.24576285481452942
disease O 1 1.0
was O 1 0.9996182918548584
congenital O 1 1.0
. O 0 0.010099329985678196

Preliminary O 0 0.015808580443263054
in O 0 0.006873871199786663
vivo O 0 0.3266944885253906
footprinting O 1 0.9968507885932922
data O 0 0.005277617368847132
gave O 0 0.005407745949923992
evidence O 0 0.0024946669582277536
for O 0 0.0027539399452507496
protein O 0 0.06703094393014908
- O 0 0.03320601209998131
DNA O 0 0.038955193012952805
contact O 0 0.014640199020504951
in O 0 0.0024874829687178135
normal O 0 0.024077029898762703
genes O 0 0.06102592870593071
at O 0 0.004159874748438597
an O 0 0.004958902485668659
Sp1 O 1 0.9998083710670471
consensus O 0 0.012228903360664845
binding O 0 0.012378199025988579
site O 0 0.008032530546188354
upstream O 0 0.019793318584561348
of O 0 0.0017830500146374106
the O 0 0.005889088846743107
CTG O 1 0.9999016523361206
repeat O 0 0.056799981743097305
and O 0 0.0010379544692113996
for O 0 0.0010582584654912353
a O 0 0.004538620822131634
significant O 0 0.0066225407645106316
reduction O 0 0.014001328498125076
of O 0 0.0009614006266929209
this O 0 0.0014658488798886538
interaction O 0 0.006393783260136843
in O 0 0.0017415654147043824
cells O 0 0.032207876443862915
with O 0 0.0017265896312892437
a O 0 0.014710466377437115
hypermethylated O 1 0.9999947547912598
DMPK O 1 0.999998927116394
gene O 1 0.9970711469650269
. O 0 0.0045531434006989
. O 0 0.006346801295876503

The O 0 0.03077206388115883
hemochromatosis B-Disease 1 1.0
gene O 1 0.9992340803146362
product O 0 0.015250138007104397
complexes O 0 0.018363388255238533
with O 0 0.001473589101806283
the O 0 0.0059947725385427475
transferrin O 1 0.9989356398582458
receptor O 1 0.9754303097724915
and O 0 0.0033146021887660027
lowers O 1 0.9403234124183655
its O 0 0.005718490108847618
affinity O 0 0.042481351643800735
for O 0 0.0038038836792111397
ligand O 0 0.10364773124456406
binding O 0 0.025620009750127792
. O 0 0.006721015088260174

We O 0 0.00511331669986248
recently O 0 0.016162855550646782
reported O 0 0.013262705877423286
the O 0 0.003544178791344166
positional O 0 0.06155458092689514
cloning O 0 0.027831068262457848
of O 0 0.0016094291349872947
a O 0 0.006971630733460188
candidate O 0 0.02552681975066662
gene O 1 0.9934712648391724
for O 0 0.008816283196210861
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 0 0.10868179798126221
HFE O 1 0.9999914169311523
. O 0 0.010581236332654953

The O 0 0.014728005044162273
gene O 1 0.9877700805664062
product O 0 0.009267049841582775
, O 0 0.0015518137952312827
a O 0 0.003715172642841935
member O 0 0.0030708354897797108
of O 0 0.001053527696058154
the O 0 0.0033930777572095394
major O 0 0.03678499162197113
histocompatibility O 1 0.9999967813491821
complex O 0 0.024155840277671814
class O 0 0.03353692963719368
I O 0 0.04634969308972359
- O 0 0.024849653244018555
like O 0 0.007089335937052965
family O 0 0.01295017171651125
, O 0 0.0021302171517163515
was O 0 0.005079901777207851
found O 0 0.0027841755654662848
to O 0 0.000888269511051476
have O 0 0.0016240113181993365
a O 0 0.009759394451975822
mutation O 1 0.9999247789382935
, O 0 0.005918810609728098
Cys O 1 0.999823272228241
- O 0 0.04850313067436218
282 O 1 0.6717724204063416
- O 0 0.059387024492025375
- O 0 0.08869175612926483
> O 1 0.9950522780418396
Tyr O 1 0.999961256980896
( O 0 0.018510183319449425
C282Y O 1 0.9990156888961792
) O 0 0.004979627672582865
, O 0 0.0014112209901213646
in O 0 0.0019755184184759855
85 O 0 0.02532830648124218
% O 0 0.005100558511912823
of O 0 0.0036206396762281656
patient O 1 0.999951958656311
chromosomes O 0 0.1402529776096344
. O 0 0.007395666558295488

This O 0 0.014595546759665012
mutation O 1 0.9994292855262756
eliminates O 0 0.0787878930568695
the O 0 0.003782924497500062
ability O 0 0.00930285919457674
of O 0 0.003715730272233486
HFE O 1 0.9999884366989136
to O 0 0.0030061518773436546
associate O 0 0.010361122898757458
with O 0 0.0037323073484003544
beta2 O 1 0.9999606609344482
- O 0 0.31790846586227417
microglobulin O 1 0.9998594522476196
( O 0 0.013528374023735523
beta2m O 1 0.999683141708374
) O 0 0.004369796719402075
and O 0 0.002226373879238963
prevents O 1 0.9799685478210449
cell O 0 0.05966358631849289
- O 0 0.02941029705107212
surface O 0 0.021088911220431328
expression O 0 0.03257402405142784
. O 0 0.006281500216573477

A O 0 0.02565206214785576
second O 0 0.023610392585396767
mutation O 1 0.9999237060546875
that O 0 0.0020737971644848585
has O 0 0.0029066200368106365
no O 0 0.002253882586956024
effect O 0 0.01223236508667469
on O 0 0.0035791732370853424
beta2m O 1 0.9999481439590454
association O 0 0.020353039726614952
, O 0 0.004187854006886482
H63D O 1 0.9999938011169434
, O 0 0.0029003305826336145
was O 0 0.006387782283127308
found O 0 0.0033841626718640327
in O 0 0.0010242180433124304
eight O 0 0.002247392665594816
out O 0 0.001707577146589756
of O 0 0.001410829951055348
nine O 0 0.012261114083230495
patients O 1 0.9999957084655762
heterozygous O 1 0.9998138546943665
for O 0 0.002038557780906558
the O 0 0.006760193035006523
C282Y O 1 0.9999890327453613
mutant O 1 0.9992443323135376
. O 0 0.007886365056037903

In O 0 0.0035067631397396326
this O 0 0.002210125094279647
report O 0 0.003433068748563528
, O 0 0.0011948671890422702
we O 0 0.0012557050213217735
demonstrate O 0 0.005696916487067938
in O 0 0.002565566683188081
cultured O 0 0.2746565341949463
293 O 1 0.9807899594306946
cells O 0 0.47647109627723694
overexpressing O 1 0.9989476799964905
wild O 0 0.06895110756158829
- O 0 0.0450982041656971
type O 0 0.04692060872912407
or O 0 0.010473552159965038
mutant O 1 0.9997047781944275
HFE O 1 0.999988317489624
proteins O 0 0.021142223849892616
that O 0 0.0010385401546955109
both O 0 0.001069199643097818
the O 0 0.0028861179016530514
wild O 0 0.0360909104347229
- O 0 0.03427090123295784
type O 0 0.04955533519387245
and O 0 0.004976252093911171
H63D O 1 0.9999991655349731
HFE O 1 0.9999986886978149
proteins O 0 0.04185652360320091
form O 0 0.012705422006547451
stable O 0 0.04281097650527954
complexes O 0 0.02131883054971695
with O 0 0.0015598608879372478
the O 0 0.006396886892616749
transferrin O 1 0.9999140501022339
receptor O 1 0.9991432428359985
( O 0 0.01585805043578148
TfR O 1 0.9998168349266052
) O 0 0.007618494797497988
. O 0 0.006654281169176102

The O 0 0.01148412749171257
C282Y O 1 0.999798595905304
mutation O 1 0.9998617172241211
nearly O 0 0.02521972544491291
completely O 0 0.02332836017012596
prevents O 0 0.048179347068071365
the O 0 0.0027595453429967165
association O 0 0.006936640944331884
of O 0 0.0014888060977682471
the O 0 0.006693948060274124
mutant O 1 0.9999836683273315
HFE O 1 0.9999947547912598
protein O 0 0.05483540892601013
with O 0 0.0018860201817005873
the O 0 0.006460529752075672
TfR O 1 0.9998311996459961
. O 0 0.009918042458593845

Studies O 0 0.009407629258930683
on O 0 0.003969659563153982
cell O 0 0.0574435330927372
- O 0 0.04129638895392418
associated O 0 0.02184394747018814
transferrin O 1 0.8534398674964905
at O 0 0.007463779300451279
37 O 0 0.02571845054626465
degrees O 0 0.013531536795198917
C O 0 0.06694748997688293
suggest O 0 0.006676962599158287
that O 0 0.0015487299533560872
the O 0 0.005272143520414829
overexpressed O 1 0.9982399940490723
wild O 0 0.048890095204114914
- O 0 0.05650724470615387
type O 0 0.47958439588546753
HFE O 1 0.9999783039093018
protein O 0 0.09977538883686066
decreases O 0 0.04490255191922188
the O 0 0.0033756529446691275
affinity O 0 0.021787239238619804
of O 0 0.0015001490246504545
the O 0 0.006081735249608755
TfR O 1 0.9999349117279053
for O 0 0.007810625247657299
transferrin O 1 0.9949440360069275
. O 0 0.009674117900431156

The O 0 0.0203559547662735
overexpressed O 1 0.9997712969779968
H63D O 1 0.9999808073043823
protein O 0 0.06658320128917694
does O 0 0.004660322330892086
not O 0 0.0015804148279130459
have O 0 0.0013427480589598417
this O 0 0.0020153506193310022
effect O 0 0.01083005778491497
, O 0 0.001273030648007989
providing O 0 0.003486401867121458
the O 0 0.0017368830740451813
first O 0 0.0030755263287574053
direct O 0 0.00401959428563714
evidence O 0 0.0016304609598591924
for O 0 0.0011046933941543102
a O 0 0.005215905141085386
functional O 0 0.02493644878268242
consequence O 0 0.030683180317282677
of O 0 0.0015759787056595087
the O 0 0.007218068931251764
H63D O 1 0.9999997615814209
mutation O 1 0.9999520778656006
. O 0 0.010200581513345242

Addition O 0 0.008341377601027489
of O 0 0.0028430488891899586
soluble O 0 0.3368169367313385
wild O 0 0.038129378110170364
- O 0 0.07097116857767105
type O 1 0.9458110332489014
HFE O 1 0.9999983310699463
/ O 1 0.9943215847015381
beta2m O 1 0.99991774559021
heterodimers O 1 0.9991825222969055
to O 0 0.005716795101761818
cultured O 1 0.526663601398468
cells O 0 0.04938153550028801
also O 0 0.0034786472097039223
decreased O 0 0.060120198875665665
the O 0 0.0035837264731526375
apparent O 0 0.04642949625849724
affinity O 0 0.028298083692789078
of O 0 0.0018355209613218904
the O 0 0.005413509439677
TfR O 1 0.9995396137237549
for O 0 0.0021254324819892645
its O 0 0.003902318887412548
ligand O 0 0.06781695038080215
under O 0 0.004844747018069029
steady O 0 0.027996720746159554
- O 0 0.020873218774795532
state O 0 0.00251574139110744
conditions O 0 0.007359455339610577
, O 0 0.0011331113055348396
both O 0 0.0013903506333008409
in O 0 0.0026486169081181288
293 O 1 0.9993783235549927
cells O 0 0.09864585101604462
and O 0 0.001340949791483581
in O 0 0.00406287657096982
HeLa O 1 0.9999994039535522
cells O 0 0.42205649614334106
. O 0 0.00650453194975853

Furthermore O 0 0.030478302389383316
, O 0 0.002384292660281062
at O 0 0.004544609691947699
4 O 0 0.013883812353014946
degrees O 0 0.011210987344384193
C O 0 0.0603657141327858
, O 0 0.0014264126075431705
the O 0 0.002413228852674365
added O 0 0.006698933895677328
soluble O 0 0.0677533969283104
complex O 0 0.009542505256831646
of O 0 0.004821457900106907
HFE O 1 0.9999997615814209
/ O 1 0.9968944787979126
beta2m O 1 0.9998217225074768
inhibited O 1 0.94014972448349
binding O 0 0.014947070740163326
of O 0 0.0032718204893171787
transferrin O 1 0.983945906162262
to O 0 0.006478517781943083
HeLa O 1 0.9999167919158936
cell O 0 0.09610146284103394
TfR O 1 0.9909893870353699
in O 0 0.0035598627291619778
a O 0 0.010425661690533161
concentration O 0 0.047822583466768265
- O 0 0.03461230546236038
dependent O 0 0.0317007414996624
manner O 0 0.014626426622271538
. O 0 0.007324757985770702

Scatchard O 0 0.18925371766090393
plots O 0 0.0219385027885437
of O 0 0.0016742972657084465
these O 0 0.0010505719110369682
data O 0 0.002348855137825012
indicate O 0 0.005876548588275909
that O 0 0.0008803147356957197
the O 0 0.0021519779693335295
added O 0 0.008547564037144184
heterodimer O 1 0.9991716146469116
substantially O 0 0.04297398030757904
reduced O 0 0.020267605781555176
the O 0 0.003810348454862833
affinity O 0 0.038224682211875916
of O 0 0.004401857033371925
TfR O 1 0.99979168176651
for O 0 0.006193160079419613
transferrin O 1 0.9971234202384949
. O 0 0.009501352906227112

These O 0 0.0025878045707941055
results O 0 0.006325420457869768
establish O 0 0.006130228750407696
a O 0 0.007715882733464241
molecular O 0 0.029408829286694527
link O 0 0.02598789520561695
between O 0 0.007007118780165911
HFE O 1 0.9999842643737793
and O 0 0.0023508360609412193
a O 0 0.005706437863409519
key O 0 0.011158729903399944
protein O 0 0.04490293189883232
involved O 0 0.008407171815633774
in O 0 0.0029331869445741177
iron O 0 0.11995305120944977
transport O 0 0.010981316678225994
, O 0 0.0022235370706766844
the O 0 0.005912834778428078
TfR O 1 0.9999938011169434
, O 0 0.0021035673562437296
and O 0 0.0009808485629037023
raise O 0 0.007366410456597805
the O 0 0.002531655365601182
possibility O 0 0.009606266394257545
that O 0 0.002026287605985999
alterations O 0 0.025535425171256065
in O 0 0.001699748681858182
this O 0 0.002252796897664666
regulatory O 0 0.03771493583917618
mechanism O 0 0.02738605998456478
may O 0 0.006218660622835159
play O 0 0.0023672396782785654
a O 0 0.003638089634478092
role O 0 0.005868531297892332
in O 0 0.0014678890584036708
the O 0 0.005030406638979912
pathogenesis O 1 0.9999988079071045
of O 0 0.010472693480551243
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.006442361976951361
. O 0 0.006408765912055969

Genomic O 0 0.1620689034461975
organization O 0 0.00903615728020668
of O 0 0.001715145306661725
the O 0 0.008487987332046032
UBE3A O 1 0.9999990463256836
/ O 1 0.9890465140342712
E6 O 1 0.9995284080505371
- O 0 0.06618043780326843
AP O 0 0.09907720237970352
gene O 1 0.8336278796195984
and O 0 0.0032932059839367867
related O 0 0.017869798466563225
pseudogenes O 1 0.9926462173461914
. O 0 0.008182900957763195

The O 0 0.023561833426356316
UBE3A O 1 0.999966025352478
gene O 1 0.9788724780082703
encodes O 0 0.104084812104702
the O 0 0.009374129585921764
E6 O 1 0.9973574280738831
- O 0 0.05487016215920448
AP O 0 0.08208651840686798
ubiquitin O 0 0.16376736760139465
- O 0 0.05115242674946785
protein O 0 0.07727988809347153
ligase O 0 0.048735518008470535
and O 0 0.002025713212788105
has O 0 0.004262140952050686
recently O 0 0.011648518033325672
been O 0 0.0031287248712033033
shown O 0 0.003988527227193117
to O 0 0.0010613985359668732
be O 0 0.003558306721970439
mutated O 1 0.9999901056289673
in O 0 0.026085954159498215
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999998807907104
who O 0 0.007831819355487823
lack O 0 0.02255924604833126
15q11 O 1 0.9999665021896362
- O 0 0.35236260294914246
q13 O 1 0.9997071623802185
deletions O 1 0.8226590752601624
or O 0 0.009026223793625832
chromosome O 1 0.9995984435081482
15 O 0 0.0210640337318182
paternal O 1 0.9998807907104492
uniparental B-Disease 1 0.999996542930603
disomy I-Disease 1 0.9996898174285889
. O 0 0.01272975280880928

Previous O 0 0.04661666974425316
UBE3A O 1 0.9996582269668579
cDNA O 0 0.14227749407291412
analysis O 0 0.008157290518283844
has O 0 0.003927032928913832
shown O 0 0.006510221865028143
a O 0 0.007408225908875465
coding O 0 0.06401646882295609
region O 0 0.008074753917753696
of O 0 0.001984897768124938
approximately O 0 0.01075444184243679
2 O 0 0.013576376251876354
. O 0 0.006312935147434473

6 O 0 0.03773351013660431
kb O 0 0.22703774273395538
and O 0 0.001980234170332551
a O 0 0.007965611293911934
3 O 0 0.01781589910387993
- O 0 0.037628594785928726
untranslated O 1 0.7833927273750305
region O 0 0.02219701185822487
( O 0 0.009115945547819138
UTR O 1 0.9729965329170227
) O 0 0.004871003329753876
of O 0 0.003748440882191062
< O 1 0.989879846572876
50 O 0 0.015438491478562355
bp O 0 0.058969028294086456
, O 0 0.0028352164663374424
whereas O 0 0.015978312119841576
Northern O 0 0.011567478068172932
analysis O 0 0.006284605246037245
has O 0 0.005082466173917055
indicated O 0 0.017531029880046844
mRNA O 0 0.04344039782881737
sizes O 0 0.008157806470990181
of O 0 0.0018189394613727927
5 O 0 0.015929201617836952
- O 0 0.03128931671380997
8 O 0 0.025263508781790733
kb O 1 0.8228532075881958
. O 0 0.007882424630224705

We O 0 0.0036652577109634876
have O 0 0.002448237966746092
analyzed O 0 0.01654858887195587
additional O 0 0.008385812863707542
cDNA O 0 0.1722889542579651
clones O 0 0.47394898533821106
and O 0 0.0016527733532711864
provide O 0 0.0019310631323605776
evidence O 0 0.002094848779961467
for O 0 0.0014346595853567123
an O 0 0.0025858457665890455
additional O 0 0.007448267191648483
0 O 0 0.032869286835193634
. O 0 0.006189723964780569

5 O 0 0.029930565506219864
kb O 0 0.10307842493057251
of O 0 0.0036609875969588757
5 O 0 0.017677059397101402
- O 0 0.040903061628341675
UTR O 1 0.9408788084983826
and O 0 0.005270450375974178
> O 1 0.964633047580719
2 O 0 0.015960440039634705
kb O 0 0.0953805223107338
of O 0 0.003514224197715521
3 O 0 0.022006113082170486
- O 0 0.05417221412062645
UTR O 1 0.9936819076538086
. O 0 0.010860863141715527

We O 0 0.003992823883891106
have O 0 0.0019835294224321842
established O 0 0.005513941869139671
the O 0 0.004156600683927536
genomic O 0 0.1098344549536705
organization O 0 0.008752765133976936
of O 0 0.004070706199854612
UBE3A O 1 0.9999911785125732
and O 0 0.0013209435855969787
the O 0 0.0021398253738880157
sequence O 0 0.012895029969513416
of O 0 0.003921255469322205
intron O 1 0.9998635053634644
- O 0 0.09943287819623947
exon O 1 0.9922741055488586
borders O 0 0.020080069079995155
. O 0 0.0068064420484006405

We O 0 0.003567594103515148
have O 0 0.0017936271615326405
also O 0 0.0018661424983292818
mapped O 0 0.022623863071203232
two O 0 0.0023364971857517958
highly O 0 0.018435239791870117
homologous O 0 0.1375235617160797
processed O 0 0.031141024082899094
pseudogenes O 1 0.996293842792511
, O 0 0.005846969783306122
UBE3AP1 O 1 0.9999432563781738
and O 0 0.004634519573301077
UBE3AP2 O 1 0.9999816417694092
, O 0 0.0022264388389885426
to O 0 0.0021296709310263395
chromosomes O 0 0.07785190641880035
2 O 0 0.009135516360402107
and O 0 0.0017741319024935365
21 O 0 0.013031614944338799
, O 0 0.0021625831723213196
respectively O 0 0.006749073509126902
, O 0 0.0013728667981922626
and O 0 0.0013095331378281116
determined O 0 0.009814569726586342
their O 0 0.0030179996974766254
genomic O 0 0.1571800857782364
organization O 0 0.013203013688325882
. O 0 0.006264097057282925

These O 0 0.002920056227594614
results O 0 0.007354531902819872
will O 0 0.0015391213819384575
form O 0 0.004024128895252943
the O 0 0.0014732539420947433
basis O 0 0.0011680495226755738
for O 0 0.001054330263286829
studies O 0 0.0030957369599491358
of O 0 0.003044170094653964
mutation O 1 0.9999754428863525
and O 0 0.003881363198161125
imprinting O 1 0.9994064569473267
of O 0 0.007644474506378174
UBE3A O 1 0.9999978542327881
. O 0 0.011774690821766853

Mutation O 1 0.9998199343681335
spectrum O 0 0.06040675565600395
and O 0 0.0052858442068099976
genotype O 1 0.9999889135360718
- O 0 0.47374778985977173
phenotype O 1 0.9999878406524658
analyses O 0 0.014027057215571404
in O 0 0.006365087814629078
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.004670525901019573
Bannayan B-Disease 1 0.9999990463256836
- I-Disease 1 0.9997963309288025
Zonana I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
, O 0 0.0035514661576598883
two O 0 0.007873614318668842
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 0.9999998807907104
with O 0 0.016206201165914536
germline O 1 0.9999974966049194
PTEN O 1 1.0
mutation O 1 0.9999431371688843
. O 0 0.012704996392130852

The O 0 0.035258788615465164
tumour B-Disease 1 1.0
suppressor O 1 0.9999995231628418
gene O 1 0.9998799562454224
PTEN O 1 0.9999991655349731
, O 0 0.0024638143368065357
which O 0 0.0015735269989818335
maps O 0 0.00429269764572382
to O 0 0.0031705633737146854
10q23 O 1 0.9955201148986816
. O 0 0.01094362698495388

3 O 0 0.017356403172016144
and O 0 0.0025252634659409523
encodes O 0 0.07505376636981964
a O 0 0.010656069964170456
403 O 0 0.0959484875202179
amino O 0 0.06905089318752289
acid O 0 0.0961875319480896
dual O 0 0.04152703657746315
specificity O 0 0.10070298612117767
phosphatase O 1 0.9983812570571899
( O 0 0.014904907904565334
protein O 0 0.10378235578536987
tyrosine O 1 0.9560748934745789
phosphatase O 1 0.9985677003860474
; O 0 0.012319633737206459
PTPase O 1 0.9997658133506775
) O 0 0.0057076881639659405
, O 0 0.001849635038524866
was O 0 0.0063701532781124115
shown O 0 0.0065998053178191185
recently O 0 0.007593781687319279
to O 0 0.0012915701372548938
play O 0 0.0029415227472782135
a O 0 0.0051287878304719925
broad O 0 0.015039804391562939
role O 0 0.007250610273331404
in O 0 0.0030314151663333178
human O 0 0.030749941244721413
malignancy B-Disease 1 0.9999998807907104
. O 0 0.008728526532649994

Somatic O 1 0.9986009001731873
PTEN O 1 0.9999929666519165
deletions O 1 0.7259873747825623
and O 0 0.005138552747666836
mutations O 1 0.9994553923606873
were O 0 0.0020153902005404234
observed O 0 0.007434532046318054
in O 0 0.002857152372598648
sporadic B-Disease 1 0.9997997879981995
breast I-Disease 1 1.0
, I-Disease 0 0.007953712716698647
brain I-Disease 1 0.9999998807907104
, I-Disease 0 0.01101504173129797
prostate I-Disease 1 1.0
and I-Disease 1 0.7663536071777344
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.4779294729232788
lines O 0 0.0059327902272343636
and O 0 0.0006513774278573692
in O 0 0.0010440417099744081
several O 0 0.0021280674263834953
primary O 1 0.9584048390388489
tumours B-Disease 1 0.9999997615814209
such O 0 0.0023791443090885878
as O 0 0.009931100532412529
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 0.9596412181854248
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.8516111373901367
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.009004649706184864

In O 0 0.0055017187260091305
addition O 0 0.006695946212857962
, O 0 0.005395664367824793
PTEN O 1 0.9999997615814209
was O 0 0.008958200924098492
identified O 0 0.008979630656540394
as O 0 0.0015358931850641966
the O 0 0.004491501022130251
susceptibility O 1 0.9999819993972778
gene O 1 0.9700217247009277
for O 0 0.002582162618637085
two O 0 0.007518738508224487
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.010191958397626877
CD B-Disease 0 0.23258601129055023
; O 0 0.010173249989748001
MIM O 1 0.9999936819076538
158350 O 1 0.9988728165626526
) O 0 0.005705863703042269
and O 0 0.0033303038217127323
Bannayan B-Disease 1 0.999817430973053
- I-Disease 0 0.165439173579216
Zonana I-Disease 1 0.9997749924659729
( I-Disease 0 0.017895977944135666
BZS I-Disease 1 0.9986230134963989
) I-Disease 0 0.0069553363136947155
or I-Disease 0 0.007604821585118771
Ruvalcaba I-Disease 1 0.9999829530715942
- I-Disease 0 0.07561154663562775
Riley I-Disease 1 0.9989266991615295
- I-Disease 1 0.871202826499939
Smith I-Disease 1 0.9995917677879333
syndrome I-Disease 1 1.0
( O 0 0.030029114335775375
MIM O 1 0.9999995231628418
153480 O 1 0.9998410940170288
) O 0 0.008029631339013577
. O 0 0.0054614185355603695

Constitutive O 0 0.2743670344352722
DNA O 0 0.05104633420705795
from O 0 0.00531243160367012
37 O 0 0.02515522763133049
CD B-Disease 0 0.03530801087617874
families O 0 0.006728971842676401
and O 0 0.0017031625611707568
seven O 0 0.008841143921017647
BZS B-Disease 1 0.9992324113845825
families O 0 0.009217867627739906
was O 0 0.009252273477613926
screened O 0 0.07947968691587448
for O 0 0.008435338735580444
germline O 1 0.9999951124191284
PTEN O 1 0.9999997615814209
mutations O 1 0.999089241027832
. O 0 0.00991444755345583

PTEN O 1 0.9999977350234985
mutations O 1 0.9988347887992859
were O 0 0.0034906649962067604
identified O 0 0.009756551124155521
in O 0 0.0021443467121571302
30 O 0 0.008381206542253494
of O 0 0.0027135175187140703
37 O 0 0.033672526478767395
( O 0 0.008218356408178806
81 O 0 0.05570540949702263
% O 0 0.007280760444700718
) O 0 0.005020387936383486
CD B-Disease 0 0.030477583408355713
families O 0 0.006250238046050072
, O 0 0.001675314619205892
including O 0 0.0029239056166261435
missense O 1 0.9992936849594116
and O 0 0.0027131910901516676
nonsense O 0 0.07220205664634705
point O 0 0.010907655581831932
mutations O 1 0.9998759031295776
, O 0 0.00313821854069829
deletions O 1 0.5610315203666687
, O 0 0.002365331631153822
insertions O 1 0.9570761919021606
, O 0 0.001928100478835404
a O 0 0.010198714211583138
deletion O 1 0.9995890259742737
/ O 0 0.28722766041755676
insertion O 1 0.7302297353744507
and O 0 0.0031524701043963432
splice O 1 0.9920759201049805
site O 0 0.02616625465452671
mutations O 1 0.9980633854866028
. O 0 0.006851427257061005

These O 0 0.009072043001651764
mutations O 1 0.9978194236755371
were O 0 0.0024563779588788748
scattered O 0 0.00733494758605957
over O 0 0.0021117939613759518
the O 0 0.0022885685320943594
entire O 0 0.01368157472461462
length O 0 0.010747835040092468
of O 0 0.004264938645064831
PTEN O 1 0.9999998807907104
, O 0 0.002126810373738408
with O 0 0.0011775463353842497
the O 0 0.0022646000143140554
exception O 0 0.008208389393985271
of O 0 0.0011272062547504902
the O 0 0.002046158304437995
first O 0 0.0034184905234724283
, O 0 0.001759473467245698
fourth O 0 0.009676489047706127
and O 0 0.0016945338575169444
last O 0 0.013922370970249176
exons O 1 0.661586582660675
. O 0 0.008545211516320705

A O 0 0.02878197468817234
hot O 0 0.05214226618409157
spot O 0 0.03350214660167694
for O 0 0.006968693342059851
PTEN O 1 0.9999992847442627
mutation O 1 0.9997300505638123
in O 0 0.0028852648101747036
CD B-Disease 0 0.025426361709833145
was O 0 0.007291009183973074
identified O 0 0.010871082544326782
in O 0 0.003057289170101285
exon O 1 0.9972060322761536
5 O 0 0.008398582227528095
that O 0 0.0014635482802987099
contains O 0 0.003705759532749653
the O 0 0.0045926994644105434
PTPase O 1 0.99956876039505
core O 0 0.02715744823217392
motif O 0 0.11130265146493912
, O 0 0.0017337911995127797
with O 0 0.001692964811809361
13 O 0 0.008362404070794582
of O 0 0.0019706031307578087
30 O 0 0.012359756976366043
( O 0 0.006804333534091711
43 O 0 0.026240548118948936
% O 0 0.007931065745651722
) O 0 0.006135751027613878
CD B-Disease 0 0.07183220237493515
mutations O 1 0.9983274340629578
identified O 0 0.01179017499089241
in O 0 0.0019389006774872541
this O 0 0.004982719197869301
exon O 1 0.9910345673561096
. O 0 0.009028633125126362

Seven O 0 0.008987178094685078
of O 0 0.003150399774312973
30 O 0 0.016797833144664764
( O 0 0.0077880206517875195
23 O 0 0.019665557891130447
% O 0 0.006364152766764164
) O 0 0.0032450563739985228
were O 0 0.0012705824337899685
within O 0 0.00246545672416687
the O 0 0.0033935161773115396
core O 0 0.02175077237188816
motif O 0 0.1278238594532013
, O 0 0.0021113408729434013
the O 0 0.003422565758228302
majority O 0 0.012937609106302261
( O 0 0.0033619836904108524
five O 0 0.0019542446825653315
of O 0 0.0014248860534280539
seven O 0 0.004091248847544193
) O 0 0.0020817213226109743
of O 0 0.0009647066472098231
which O 0 0.0018265113467350602
were O 0 0.004438166506588459
missense O 1 0.9999946355819702
mutations O 1 0.9999856948852539
, O 0 0.0031097489409148693
possibly O 0 0.013748757541179657
pointing O 0 0.008820783346891403
to O 0 0.0013072944711893797
the O 0 0.0030184900388121605
functional O 0 0.017723610624670982
significance O 0 0.004247958306223154
of O 0 0.001021242467686534
this O 0 0.002216114429756999
region O 0 0.014801719225943089
. O 0 0.006715421099215746

Germline O 1 0.9999321699142456
PTEN O 1 0.9999984502792358
mutations O 1 0.9984626770019531
were O 0 0.003498889971524477
identified O 0 0.010196746326982975
in O 0 0.0011672750115394592
four O 0 0.001735687954351306
of O 0 0.0013476393651217222
seven O 0 0.005698169581592083
( O 0 0.0071096173487603664
57 O 0 0.03444156050682068
% O 0 0.007889595814049244
) O 0 0.008525987155735493
BZS B-Disease 1 0.9983997941017151
families O 0 0.012849295511841774
studied O 0 0.01052007731050253
. O 0 0.007022772915661335

Interestingly O 0 0.27455270290374756
, O 0 0.0025983452796936035
none O 0 0.004328448791056871
of O 0 0.00130619911942631
these O 0 0.0022292742505669594
mutations O 1 0.999958872795105
was O 0 0.007024595979601145
observed O 0 0.007367861457169056
in O 0 0.001284560072235763
the O 0 0.0047709280624985695
PTPase O 1 0.9998922348022461
core O 0 0.028222881257534027
motif O 0 0.14883385598659515
. O 0 0.006042424589395523

It O 0 0.0056958794593811035
is O 0 0.0038279134314507246
also O 0 0.0025539095513522625
worthy O 0 0.019848326221108437
of O 0 0.001735217054374516
note O 0 0.009595361538231373
that O 0 0.0012385230511426926
a O 0 0.004691032692790031
single O 0 0.013233738951385021
nonsense O 0 0.041736941784620285
point O 0 0.012653536163270473
mutation O 1 0.9999268054962158
, O 0 0.004851395729929209
R233X O 1 0.9994534850120544
, O 0 0.0020755722653120756
was O 0 0.006422650534659624
observed O 0 0.007492269389331341
in O 0 0.0013335839612409472
the O 0 0.004882781766355038
germline O 1 0.9998798370361328
DNA O 0 0.04116949811577797
from O 0 0.002806211356073618
two O 0 0.002284321701154113
unrelated O 0 0.03395731747150421
CD B-Disease 0 0.03631564602255821
families O 0 0.006378328427672386
and O 0 0.0018740686355158687
one O 0 0.007469461765140295
BZS B-Disease 1 0.9994744658470154
family O 0 0.026085641235113144
. O 0 0.007893955335021019

Genotype O 1 0.9999281167984009
- O 1 0.6405028700828552
phenotype O 1 0.9998931884765625
studies O 0 0.007622620556503534
were O 0 0.0015604879008606076
not O 0 0.001209283247590065
performed O 0 0.005515438038855791
on O 0 0.0012484542094171047
this O 0 0.0017346274107694626
small O 0 0.004074928350746632
group O 0 0.005479289684444666
of O 0 0.0041641914285719395
BZS B-Disease 1 0.9999109506607056
families O 0 0.015119229443371296
. O 0 0.00846196711063385

However O 0 0.008462182246148586
, O 0 0.006418845150619745
genotype O 1 0.9999310970306396
- O 0 0.2685507535934448
phenotype O 1 0.999934196472168
analysis O 0 0.017030343413352966
inthe O 1 0.9771094918251038
group O 0 0.006897518411278725
of O 0 0.002379094483330846
CD B-Disease 0 0.0418328233063221
families O 0 0.00823097862303257
revealed O 0 0.016477221623063087
two O 0 0.0017179453279823065
possible O 0 0.005622765980660915
associations O 0 0.012447314336895943
worthy O 0 0.02431093156337738
of O 0 0.002057094592601061
follow O 0 0.007470801938325167
- O 0 0.013981100171804428
up O 0 0.003304356476292014
in O 0 0.0021471811924129725
independent O 0 0.007948282174766064
analyses O 0 0.014219316653907299
. O 0 0.007369759026914835

The O 0 0.006365636363625526
first O 0 0.005018073134124279
was O 0 0.006908678449690342
an O 0 0.0033673245925456285
association O 0 0.011384601704776287
noted O 0 0.0036739662755280733
in O 0 0.0012074289843440056
the O 0 0.0019596265628933907
group O 0 0.004693092778325081
of O 0 0.001933992258273065
CD B-Disease 0 0.08479336649179459
families O 0 0.012183098122477531
with O 0 0.018023984506726265
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.009623262099921703

A O 0 0.030260030180215836
correlation O 0 0.04345645010471344
was O 0 0.010210269130766392
observed O 0 0.010413502342998981
between O 0 0.002019315492361784
the O 0 0.0031602145172655582
presence O 0 0.01704118773341179
/ O 0 0.04612765833735466
absence O 0 0.013135683722794056
of O 0 0.0020469771698117256
a O 0 0.024682801216840744
PTEN O 1 1.0
mutation O 1 0.9999744892120361
and O 0 0.0011447786819189787
the O 0 0.003122205613180995
type O 0 0.06445037573575974
of O 0 0.004583924543112516
breast O 1 1.0
involvement O 0 0.09060132503509521
( O 0 0.012012985534965992
unaffected O 1 0.9999347925186157
versus O 1 0.9957987666130066
benign O 1 0.9999915361404419
versus O 1 0.9994004964828491
malignant O 1 0.9999998807907104
) O 0 0.009454804472625256
. O 0 0.00577732315286994

Specifically O 0 0.013853585347533226
and O 0 0.0012936987914144993
more O 0 0.0014749524416401982
directly O 0 0.004163258243352175
, O 0 0.0017562319990247488
an O 0 0.0032128554303199053
association O 0 0.012872681021690369
was O 0 0.007403140421956778
also O 0 0.0019725130405277014
observed O 0 0.00777452765032649
between O 0 0.001353107625618577
the O 0 0.0017323829233646393
presence O 0 0.005746245384216309
of O 0 0.0017713726265355945
a O 0 0.022850126028060913
PTEN O 1 1.0
mutation O 1 0.9999998807907104
and O 0 0.40599602460861206
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.009834629483520985

Secondly O 0 0.35730552673339844
, O 0 0.0025738042313605547
there O 0 0.002059535589069128
appeared O 0 0.007379364687949419
to O 0 0.0011114251101389527
be O 0 0.0015334556810557842
an O 0 0.0032939419616013765
interdependent O 0 0.43057113885879517
association O 0 0.01645738072693348
between O 0 0.008109061047434807
mutations O 1 0.9998413324356079
upstream O 0 0.030227402225136757
and O 0 0.0012486397754400969
within O 0 0.0022450739052146673
the O 0 0.0047593312337994576
PTPase O 1 0.9998452663421631
core O 0 0.028496153652668
motif O 0 0.06893331557512283
, O 0 0.0016225854633376002
the O 0 0.002620479790493846
core O 0 0.014403745532035828
motif O 0 0.05275982990860939
containing O 0 0.005837444681674242
the O 0 0.0021723145619034767
majority O 0 0.008708493784070015
of O 0 0.004303545691072941
missense O 1 0.9999963045120239
mutations O 1 0.9999507665634155
, O 0 0.0018327537691220641
and O 0 0.0008276522858068347
the O 0 0.0021732032764703035
involvement O 0 0.013708599843084812
of O 0 0.0009807037422433496
all O 0 0.00130401027854532
major O 0 0.014026880264282227
organ O 1 0.9947968125343323
systems O 0 0.012048015370965004
( O 0 0.004925306886434555
central O 0 0.009158005937933922
nervous O 1 0.9999947547912598
system O 0 0.015402755700051785
, O 0 0.007181745022535324
thyroid O 1 1.0
, O 0 0.015992645174264908
breast O 1 1.0
, O 0 0.0176387932151556
skin O 1 1.0
and O 0 0.42722657322883606
gastrointestinal O 1 1.0
tract O 1 1.0
) O 0 0.00757265230640769
. O 0 0.0053286985494196415

However O 0 0.007196131162345409
, O 0 0.0015442388830706477
these O 0 0.0008655255660414696
observations O 0 0.004295005463063717
would O 0 0.0017115190858021379
need O 0 0.0025593098253011703
to O 0 0.0012629679404199123
be O 0 0.0020037908107042313
confirmed O 0 0.012742397375404835
by O 0 0.0026096419896930456
studying O 0 0.0037198064383119345
a O 0 0.004717402160167694
larger O 0 0.005573829635977745
number O 0 0.002254683757200837
of O 0 0.002096648095175624
CD B-Disease 0 0.046133216470479965
families O 0 0.011421208269894123
. O 0 0.008514844812452793

Molecular O 0 0.1074095144867897
defects O 1 0.9996762275695801
leading O 0 0.009788736701011658
to O 0 0.001694527454674244
human O 0 0.008148356340825558
complement B-Disease 0 0.03428461402654648
component I-Disease 1 0.9912775754928589
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.0031354243401437998
an O 0 0.003303723642602563
African O 0 0.02426130510866642
- O 0 0.026780113577842712
American O 0 0.012140591628849506
family O 0 0.017533371224999428
. O 0 0.006386716850101948

Complement B-Disease 0 0.07681956142187119
component I-Disease 1 0.9272351264953613
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 0.02373386360704899
C6D B-Disease 1 0.9999908208847046
) O 0 0.009401844814419746
was O 0 0.17207854986190796
diagnosed O 1 1.0
in O 0 0.0022800916340202093
a O 0 0.006714047398418188
16 O 0 0.011216581799089909
- O 0 0.01915053091943264
year O 0 0.009068619459867477
- O 0 0.022730296477675438
old O 0 0.01562761329114437
African O 0 0.020649027079343796
- O 0 0.024829238653182983
American O 0 0.010847000405192375
male O 0 0.048799749463796616
with O 0 0.012980669736862183
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.014265141449868679

The O 0 0.02036011591553688
patients O 1 0.9999935626983643
father O 0 0.03117397241294384
and O 0 0.0015121864853426814
two O 0 0.0019112481968477368
brothers O 0 0.03645075112581253
also O 0 0.003556485055014491
had O 0 0.012097489088773727
C6D B-Disease 1 0.9999978542327881
, O 0 0.0019184410339221358
but O 0 0.0020442581735551357
gave O 0 0.004594231955707073
no O 0 0.002002765191718936
history O 0 0.004885838832706213
of O 0 0.006449006963521242
meningitis B-Disease 1 1.0
or O 0 0.006856744177639484
other O 0 0.0035836619790643454
neisserial B-Disease 1 0.9999990463256836
infection I-Disease 1 1.0
. O 0 0.010158470831811428

By O 0 0.006842386443167925
using O 0 0.007671179715543985
exon O 1 0.9789968729019165
- O 0 0.03629335016012192
specific O 0 0.012872263789176941
polymerase O 1 0.8255821466445923
chain O 0 0.12391838431358337
reaction O 0 0.04549967870116234
( O 0 0.012069063261151314
PCR O 0 0.1924675703048706
) O 0 0.007160939741879702
/ O 0 0.0452914722263813
single O 0 0.020276304334402084
- O 0 0.0427011214196682
strand O 0 0.12556003034114838
conformation O 1 0.7252300381660461
polymorphism O 0 0.17615827918052673
as O 0 0.0028622373938560486
a O 0 0.007475452963262796
screening O 0 0.04846379905939102
step O 0 0.012316449545323849
and O 0 0.0022479314357042313
nucleotide O 0 0.0778096616268158
sequencing O 0 0.036696065217256546
of O 0 0.002392960013821721
target O 0 0.021205594763159752
exons O 1 0.9586875438690186
, O 0 0.0020890485029667616
we O 0 0.0012994192074984312
determined O 0 0.0075645362958312035
that O 0 0.001266881125047803
the O 0 0.003512960160151124
proband O 1 0.999144434928894
was O 0 0.007306750398129225
a O 0 0.007682174909859896
compound O 0 0.03274215757846832
heterozygote O 1 0.9305844306945801
for O 0 0.003091598628088832
two O 0 0.007054219953715801
C6 O 1 0.9999991655349731
gene O 1 0.9996042847633362
mutations O 1 0.9988844990730286
. O 0 0.008830728009343147

The O 0 0.0066994125954806805
first O 0 0.005613529123365879
, O 0 0.003632352454587817
1195delC O 1 0.9987230896949768
located O 0 0.014689113013446331
in O 0 0.004714760463684797
exon O 1 0.9985429048538208
7 O 0 0.01759100891649723
, O 0 0.0017571517964825034
is O 0 0.002934657270088792
a O 0 0.009833792224526405
novel O 0 0.12835398316383362
mutation O 1 0.9999295473098755
, O 0 0.0023238081485033035
while O 0 0.0019687237218022346
the O 0 0.0024637978058308363
second O 0 0.008873401209712029
, O 0 0.0030144178308546543
1936delG O 1 0.9995991587638855
in O 0 0.005235336720943451
exon O 1 0.9990849494934082
12 O 0 0.011741213500499725
, O 0 0.0018429304473102093
has O 0 0.0034354235976934433
been O 0 0.004045048728585243
described O 0 0.008737917989492416
before O 0 0.003879258409142494
to O 0 0.0030904102604836226
cause O 1 0.9964375495910645
C6D B-Disease 1 0.9992786049842834
in O 0 0.0029040812514722347
an O 0 0.0033644645009189844
unrelated O 0 0.036193761974573135
African O 0 0.026594001799821854
- O 0 0.0298718623816967
American O 0 0.009949096478521824
individual O 0 0.005412400234490633
. O 0 0.005897678900510073

Both O 0 0.012802361510694027
mutations O 1 0.9992831349372864
result O 0 0.01537574827671051
in O 0 0.00462917098775506
premature O 1 0.9998061060905457
termination O 1 0.9911022186279297
codons O 0 0.21822993457317352
and O 0 0.005868063773959875
C6 O 1 0.9999945163726807
null O 1 0.9622796177864075
alleles O 1 0.999508261680603
. O 0 0.010105977766215801

Allele O 1 0.9985760450363159
- O 0 0.04756520688533783
specific O 0 0.00951586663722992
PCR O 1 0.6223041415214539
indicated O 0 0.010420835576951504
that O 0 0.000972292385995388
the O 0 0.003166493959724903
probands O 1 0.9998325109481812
two O 0 0.002484976314008236
brothers O 0 0.021082144230604172
also O 0 0.003262776415795088
inherited O 1 0.9998008608818054
the O 0 0.0062935627065598965
1195delC O 1 0.9999822378158569
mutation O 1 0.9999381303787231
from O 0 0.003450829768553376
their O 0 0.003488237736746669
heterozygous O 1 0.9997692704200745
mother O 0 0.03931672126054764
and O 0 0.0012429712805896997
the O 0 0.005120579618960619
1936delG O 1 0.9999899864196777
mutation O 1 0.9996991157531738
from O 0 0.003942188806831837
their O 0 0.003982760012149811
homozygous O 1 0.999933123588562
father O 0 0.041747793555259705
. O 0 0.0033503121230751276
. O 0 0.006340080872178078

PAX6 O 1 0.9999819993972778
mutations O 1 0.9982166886329651
reviewed O 0 0.030749594792723656
. O 0 0.008426640182733536

Mutations O 1 0.9995701909065247
in O 0 0.009010566398501396
PAX6 O 1 0.9999910593032837
are O 0 0.0024310965090990067
responsible O 0 0.010537256486713886
for O 0 0.0025315021630376577
human O 0 0.020521527156233788
aniridia B-Disease 1 0.9999970197677612
and O 0 0.0018121723551303148
have O 0 0.0012440048158168793
also O 0 0.001292342902161181
been O 0 0.0029640800785273314
found O 0 0.004110907204449177
in O 0 0.0024221311323344707
patients O 1 0.999998927116394
with O 0 0.00365250906907022
Peters B-Disease 1 0.9999905824661255
anomaly I-Disease 1 0.9999690055847168
, O 0 0.003408323274925351
with O 0 0.011982130818068981
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 0.003213680349290371
with O 0 0.0055968365631997585
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999821186065674
keratitis I-Disease 1 1.0
, O 0 0.0022570558357983828
and O 0 0.0009773423662409186
with O 0 0.002976424293592572
isolated B-Disease 1 0.9996743202209473
foveal I-Disease 1 0.9999988079071045
hypoplasia I-Disease 1 0.9999994039535522
. O 0 0.01073474157601595

No O 0 0.01220744289457798
locus O 1 0.9975960850715637
other O 0 0.0023428425192832947
than O 0 0.007311712019145489
chromosome O 1 0.999984860420227
11p13 O 1 0.999900221824646
has O 0 0.006125309504568577
been O 0 0.00661065336316824
implicated O 1 0.7479403614997864
in O 0 0.004921155981719494
aniridia B-Disease 1 0.9999954700469971
, O 0 0.0029192008078098297
and O 0 0.0037781924474984407
PAX6 O 1 0.9999996423721313
is O 0 0.004502460360527039
clearly O 0 0.004677240736782551
the O 0 0.00193160236813128
major O 0 0.00897985976189375
, O 0 0.0012743674451485276
if O 0 0.0017858679639175534
not O 0 0.001004223944619298
only O 0 0.0019679823890328407
, O 0 0.003690615063533187
gene O 1 0.9989400506019592
responsible O 0 0.020499415695667267
. O 0 0.007052095606923103

Twenty O 0 0.047520916908979416
- O 0 0.023741692304611206
eight O 0 0.005634994711726904
percent O 0 0.006297715473920107
of O 0 0.0031636955682188272
identified O 0 0.048393264412879944
PAX6 O 1 0.9999977350234985
mutations O 1 0.9984489679336548
are O 0 0.0037269312888383865
C O 1 0.9919552206993103
- O 0 0.09124121069908142
T O 1 0.9951398372650146
changes O 0 0.0111925033852458
at O 0 0.010780523531138897
CpG O 1 0.998336672782898
dinucleotides O 1 0.9974586367607117
, O 0 0.00328389136120677
20 O 0 0.0063598123379051685
% O 0 0.0037045329809188843
are O 0 0.0019489772384986281
splicing O 0 0.13203062117099762
errors O 0 0.02195913903415203
, O 0 0.0016608609585091472
and O 0 0.0010662873974069953
more O 0 0.0014699663734063506
than O 0 0.002133097965270281
30 O 0 0.007033811416476965
% O 0 0.004012919031083584
are O 0 0.002157200127840042
deletion O 1 0.9936177730560303
or O 0 0.007270813453942537
insertion O 1 0.6469091773033142
events O 0 0.008863702416419983
. O 0 0.005772904027253389

There O 0 0.0035618930123746395
is O 0 0.0034601595252752304
a O 0 0.010031795129179955
noticeably O 1 0.9792688488960266
elevated O 1 0.9892371296882629
level O 0 0.005565408151596785
of O 0 0.0031524670775979757
mutation O 1 0.9998924732208252
in O 0 0.0020343309734016657
the O 0 0.004016636870801449
paired O 0 0.397458016872406
domain O 0 0.02462925761938095
compared O 0 0.0075103892013430595
with O 0 0.0011061790864914656
the O 0 0.0019624338019639254
rest O 0 0.005455778446048498
of O 0 0.001860187971033156
the O 0 0.005970485042780638
gene O 1 0.998446524143219
. O 0 0.007229614071547985

Increased O 0 0.04904631897807121
mutation O 1 0.997710108757019
in O 0 0.00327670737169683
the O 0 0.005609339103102684
homeodomain O 1 0.9981011748313904
is O 0 0.0046570925042033195
accounted O 0 0.013398527167737484
for O 0 0.001321386662311852
by O 0 0.0029060589149594307
the O 0 0.00802843552082777
hypermutable O 1 0.998388409614563
CpG O 1 0.9851621985435486
dinucleotide O 0 0.2643977403640747
in O 0 0.006729450076818466
codon O 0 0.19466477632522583
240 O 0 0.051061101257801056
. O 0 0.008559294044971466

Very O 0 0.008560390211641788
nearly O 0 0.016034888103604317
all O 0 0.005163540132343769
mutations O 1 0.9998238682746887
appear O 0 0.010598442517220974
to O 0 0.0032708814833313227
cause O 1 0.9685579538345337
loss O 0 0.026081476360559464
of O 0 0.0015570534160360694
function O 0 0.0062344130128622055
of O 0 0.001231158385053277
the O 0 0.0058300551027059555
mutant O 1 0.9999887943267822
allele O 1 0.9999587535858154
, O 0 0.0019300018902868032
and O 0 0.001019013929180801
more O 0 0.0012598356697708368
than O 0 0.002413859125226736
80 O 0 0.01100156456232071
% O 0 0.003899446688592434
of O 0 0.0029192036017775536
exonic O 1 0.9998959302902222
substitutions O 0 0.03362031653523445
result O 0 0.008995238691568375
in O 0 0.0032616974785923958
nonsense O 0 0.11082575470209122
codons O 1 0.6811554431915283
. O 0 0.008407642133533955

In O 0 0.004618980456143618
a O 0 0.013596570119261742
gene O 1 0.7553414702415466
with O 0 0.001956106396391988
such O 0 0.0019475113367661834
extraordinarily O 0 0.1544959396123886
high O 0 0.010320590808987617
sequence O 0 0.021212130784988403
conservation O 0 0.012979941442608833
throughout O 0 0.005105691496282816
evolution O 0 0.011190498247742653
, O 0 0.0012367782182991505
there O 0 0.0012994991848245263
are O 0 0.00174976687412709
presumed O 1 0.8808304071426392
undiscovered O 1 0.9963172674179077
missense O 1 0.9999803304672241
mutations O 1 0.9995972514152527
, O 0 0.001948016695678234
these O 0 0.0009086255449801683
are O 0 0.0011480569373816252
hypothesized O 1 0.7211233377456665
to O 0 0.0012038643471896648
exist O 0 0.0019278592662885785
in O 0 0.001276733004488051
as O 0 0.0029080798849463463
- O 0 0.020175673067569733
yet O 0 0.009602874517440796
unidentified O 0 0.061470843851566315
phenotypes O 1 0.9990293979644775
. O 0 0.0038474458269774914
. O 0 0.006973925977945328

Genetic O 0 0.32390058040618896
heterogeneity O 0 0.14106465876102448
and O 0 0.0035739392042160034
penetrance O 1 0.9912737011909485
analysis O 0 0.003557360265403986
of O 0 0.00132734642829746
the O 0 0.006670336239039898
BRCA1 O 1 1.0
and O 0 0.007103473413735628
BRCA2 O 1 1.0
genes O 1 0.9981143474578857
in O 0 0.018631180748343468
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.014628615230321884
. O 0 0.006375750992447138

The O 1 0.5001035928726196
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9810938835144043
Consortium O 0 0.05782267451286316
. O 0 0.007839003577828407

The O 0 0.004403918515890837
contribution O 0 0.008414938114583492
of O 0 0.0035898310597985983
BRCA1 O 1 1.0
and O 0 0.006024983245879412
BRCA2 O 1 1.0
to O 0 0.011809229850769043
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 0.010047576390206814
assessed O 0 0.018875611945986748
by O 0 0.0035916496999561787
linkage O 0 0.05929591879248619
and O 0 0.003880570875480771
mutation O 1 0.9999138116836548
analysis O 0 0.006316926330327988
in O 0 0.0032158070243895054
237 O 1 0.5865195393562317
families O 0 0.007523864973336458
, O 0 0.0014690399402752519
each O 0 0.0014489262830466032
with O 0 0.0010301287984475493
at O 0 0.00262998859398067
least O 0 0.004481120500713587
four O 0 0.0024482032749801874
cases O 0 0.010256294161081314
of O 0 0.009726343676447868
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0015007377369329333
collected O 0 0.002150084590539336
by O 0 0.0031135412864387035
the O 0 0.38519760966300964
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9342021942138672
Consortium O 0 0.053807199001312256
. O 0 0.008290288969874382

Families O 0 0.014433546923100948
were O 0 0.0022255820222198963
included O 0 0.0024601384066045284
without O 0 0.0027701619546860456
regard O 0 0.004345017485320568
to O 0 0.0010763013269752264
the O 0 0.0034362792503088713
occurrence O 1 0.9142950773239136
of O 0 0.007695093285292387
ovarian B-Disease 1 1.0
or I-Disease 0 0.007303963880985975
other I-Disease 0 0.004593196790665388
cancers I-Disease 1 0.9999994039535522
. O 0 0.008869145065546036

Overall O 0 0.04216349124908447
, O 0 0.00792612973600626
disease O 1 1.0
was O 0 0.011419086717069149
linked O 0 0.0463470034301281
to O 0 0.005599987227469683
BRCA1 O 1 0.9999998807907104
in O 0 0.0023971025366336107
an O 0 0.0029711397364735603
estimated O 0 0.01536470651626587
52 O 0 0.023854006081819534
% O 0 0.0036276557948440313
of O 0 0.0013855438446626067
families O 0 0.005651702638715506
, O 0 0.0018835110822692513
to O 0 0.004563312511891127
BRCA2 O 1 0.9999996423721313
in O 0 0.004037494771182537
32 O 0 0.01805228739976883
% O 0 0.003483763663098216
of O 0 0.0016341155860573053
families O 0 0.005572075489908457
, O 0 0.0013222639681771398
and O 0 0.0008678181329742074
to O 0 0.001794680836610496
neither O 0 0.01727473922073841
gene O 1 0.9336577653884888
in O 0 0.0032009233254939318
16 O 0 0.011271391063928604
% O 0 0.006413138937205076
( O 0 0.005064823664724827
95 O 0 0.016535131260752678
% O 0 0.004824371077120304
confidence O 0 0.022707119584083557
interval O 0 0.05776430666446686
[ O 0 0.0624757818877697
CI O 1 0.99970942735672
] O 0 0.06230812519788742
6 O 0 0.018776768818497658
% O 0 0.007761950138956308
- O 0 0.028933245688676834
28 O 0 0.02059556171298027
% O 0 0.00684628589078784
) O 0 0.0035340602044016123
, O 0 0.0016716438112780452
suggesting O 0 0.015640785917639732
other O 0 0.00352646317332983
predisposition O 1 0.99998939037323
genes O 0 0.4856051504611969
. O 0 0.008161323145031929

The O 0 0.008463279344141483
majority O 0 0.021608153358101845
( O 0 0.00862791296094656
81 O 0 0.04513276368379593
% O 0 0.004939135629683733
) O 0 0.0019050879636779428
of O 0 0.0013424960197880864
the O 0 0.03155668079853058
breast B-Disease 1 1.0
- I-Disease 1 0.9999992847442627
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.009321697056293488
were O 0 0.0021034039091318846
due O 0 0.011596065945923328
to O 0 0.004726728890091181
BRCA1 O 1 1.0
, O 0 0.0021344705019146204
with O 0 0.0013776838313788176
most O 0 0.0035955049097537994
others O 0 0.006631405092775822
( O 0 0.005648857913911343
14 O 0 0.011296197772026062
% O 0 0.005734654609113932
) O 0 0.0039824689738452435
due O 0 0.012757710181176662
to O 0 0.007025639992207289
BRCA2 O 1 0.9999998807907104
. O 0 0.012167613953351974

Conversely O 0 0.08008841425180435
, O 0 0.002068971050903201
the O 0 0.0021994304843246937
majority O 0 0.006479496601969004
of O 0 0.001252964953891933
families O 0 0.004773703869432211
with O 0 0.0018504839390516281
male B-Disease 0 0.3292665183544159
and I-Disease 0 0.003031905507668853
female I-Disease 1 0.9999603033065796
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.002841509645804763
due O 0 0.010726029984652996
to O 0 0.005990139674395323
BRCA2 O 1 1.0
( O 0 0.012897984124720097
76 O 0 0.288088321685791
% O 0 0.008232452906668186
) O 0 0.005077564623206854
. O 0 0.006022377870976925

The O 0 0.008015351369976997
largest O 0 0.02661050297319889
proportion O 0 0.03385161980986595
( O 0 0.010131177492439747
67 O 0 0.043872565031051636
% O 0 0.006569751538336277
) O 0 0.002573902253061533
of O 0 0.0014388721901923418
families O 0 0.006664712447673082
due O 0 0.009318790398538113
to O 0 0.0015354757197201252
other O 0 0.0019463151693344116
genes O 0 0.3603465259075165
was O 0 0.008170588873326778
found O 0 0.0046230824664235115
in O 0 0.0015080521116033196
families O 0 0.004484417382627726
with O 0 0.0014383909292519093
four O 0 0.0023701905738562346
or O 0 0.002955645089969039
five O 0 0.0032159294933080673
cases O 0 0.007349616847932339
of O 0 0.0041673858650028706
female O 1 0.9999505281448364
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
only O 0 0.005074376706033945
. O 0 0.00556978490203619

These O 0 0.002628068206831813
estimates O 0 0.0064062029123306274
were O 0 0.0017496119253337383
not O 0 0.0026986352168023586
substantially O 0 0.03769147768616676
affected O 0 0.03266238048672676
either O 0 0.005154740065336227
by O 0 0.00276967347599566
changing O 0 0.007543438114225864
the O 0 0.0035500521771609783
assumed O 0 0.09461487829685211
penetrance O 1 0.9992759823799133
model O 0 0.01599421352148056
for O 0 0.005751126911491156
BRCA1 O 1 0.9999998807907104
or O 0 0.0037259983364492655
by O 0 0.001895903842523694
including O 0 0.0016686510061845183
or O 0 0.003969199489802122
excluding O 0 0.031215259805321693
BRCA1 O 1 1.0
mutation O 1 0.9986068606376648
data O 0 0.0076209320686757565
. O 0 0.006362398155033588

Among O 0 0.008622515015304089
those O 0 0.002266257768496871
families O 0 0.007261368446052074
with O 0 0.006090800743550062
disease O 1 1.0
due O 0 0.07784190028905869
to O 0 0.0051500857807695866
BRCA1 O 1 1.0
that O 0 0.0023547064047306776
were O 0 0.0021826396696269512
tested O 0 0.020381886512041092
by O 0 0.0019339423161000013
one O 0 0.0013428592355921865
of O 0 0.0008486992446705699
the O 0 0.0025635664351284504
standard O 0 0.012515927664935589
screening O 0 0.07325082272291183
methods O 0 0.005776421632617712
, O 0 0.0034005646593868732
mutations O 1 0.9998571872711182
were O 0 0.002773985965177417
detected O 0 0.03851991519331932
in O 0 0.0012801935663446784
the O 0 0.003575005801394582
coding O 0 0.08342669159173965
sequence O 0 0.022156018763780594
or O 0 0.0053990688174963
splice O 0 0.2870897650718689
sites O 0 0.005326808430254459
in O 0 0.0014585728058591485
an O 0 0.0031272585038095713
estimated O 0 0.021816402673721313
63 O 0 0.04935537278652191
% O 0 0.008905768394470215
( O 0 0.0058263689279556274
95 O 0 0.02348708175122738
% O 0 0.009945588186383247
CI O 1 0.9997525811195374
51 O 0 0.047318704426288605
% O 0 0.011905487626791
- O 0 0.03738029673695564
77 O 0 0.06662526726722717
% O 0 0.010220922529697418
) O 0 0.006218492519110441
. O 0 0.006441561970859766

The O 0 0.008258344605565071
estimated O 0 0.020395586267113686
sensitivity O 0 0.03793581947684288
was O 0 0.008633298799395561
identical O 0 0.009228006936609745
for O 0 0.0017217349959537387
direct O 0 0.008501362055540085
sequencing O 0 0.04889361932873726
and O 0 0.0013119796058163047
other O 0 0.0011201404267922044
techniques O 0 0.008509032428264618
. O 0 0.006186062470078468

The O 0 0.01231408305466175
penetrance O 1 0.9980411529541016
of O 0 0.010103884153068066
BRCA2 O 1 1.0
was O 0 0.009535216726362705
estimated O 0 0.00834409985691309
by O 0 0.0033516495022922754
maximizing O 0 0.03628423810005188
the O 0 0.005422934424132109
LOD O 1 0.9993777275085449
score O 0 0.00978132151067257
in O 0 0.006638295017182827
BRCA2 O 1 1.0
- O 1 0.9732221961021423
mutation O 1 0.9999603033065796
families O 0 0.009535977616906166
, O 0 0.001620573690161109
over O 0 0.001978700514882803
all O 0 0.0016281458083540201
possible O 0 0.011732961982488632
penetrance O 1 0.997298538684845
functions O 0 0.012957560829818249
. O 0 0.006736509967595339

The O 0 0.005118700210005045
estimated O 0 0.0189236830919981
cumulative O 0 0.1730288565158844
risk O 1 0.9946371912956238
of O 0 0.012469579465687275
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
reached O 0 0.01602640375494957
28 O 0 0.018012480810284615
% O 0 0.0065528652630746365
( O 0 0.0052540418691933155
95 O 0 0.02111981436610222
% O 0 0.009760860353708267
CI O 1 0.9997896552085876
9 O 0 0.020642461255192757
% O 0 0.007803855463862419
- O 0 0.02664848603308201
44 O 0 0.0223008394241333
% O 0 0.007376023568212986
) O 0 0.003541796701028943
by O 0 0.0036261032801121473
age O 0 0.012688793241977692
50 O 0 0.009075670503079891
years O 0 0.004431193694472313
and O 0 0.0022982049267739058
84 O 0 0.05054667592048645
% O 0 0.008518794551491737
( O 0 0.006181678269058466
95 O 0 0.02288668416440487
% O 0 0.010894520208239555
CI O 1 0.9999223947525024
43 O 0 0.03425200283527374
% O 0 0.009474598802626133
- O 0 0.026149941608309746
95 O 0 0.02972390130162239
% O 0 0.006808533798903227
) O 0 0.0035482749808579683
by O 0 0.003831316716969013
age O 0 0.016161583364009857
70 O 0 0.017170559614896774
years O 0 0.008106207475066185
. O 0 0.007279098965227604

The O 0 0.013598315417766571
corresponding O 1 0.9707673192024231
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9934378266334534
were O 0 0.004100694786757231
0 O 0 0.029397545382380486
. O 0 0.004997542127966881

4 O 0 0.03177934139966965
% O 0 0.010319339111447334
( O 0 0.007698276545852423
95 O 0 0.025140514597296715
% O 0 0.011767945252358913
CI O 1 0.9991968274116516
0 O 0 0.04090997204184532
% O 0 0.007928787730634212
- O 0 0.0275279451161623
1 O 0 0.016952285543084145
% O 0 0.007046408485621214
) O 0 0.004252098500728607
by O 0 0.00437578372657299
age O 0 0.015016467310488224
50 O 0 0.009869244880974293
years O 0 0.005154314450919628
and O 0 0.0020562296267598867
27 O 0 0.016581324860453606
% O 0 0.006395113654434681
( O 0 0.005773284938186407
95 O 0 0.022330891340970993
% O 0 0.009952290914952755
CI O 1 0.9996321201324463
0 O 0 0.041232720017433167
% O 0 0.009409992955625057
- O 0 0.031035946682095528
47 O 0 0.035320527851581573
% O 0 0.006735054776072502
) O 0 0.0038298864383250475
by O 0 0.004144290927797556
age O 0 0.015452862717211246
70 O 0 0.016419650986790657
years O 0 0.008106824941933155
. O 0 0.006612428929656744

The O 0 0.008071759715676308
lifetime O 0 0.4084005653858185
risk O 1 0.9988073110580444
of O 0 0.013532567769289017
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
appears O 0 0.03040243312716484
similar O 0 0.0037906761281192303
to O 0 0.0009964596247300506
the O 0 0.002729726955294609
risk O 1 0.9988594055175781
in O 0 0.008200590498745441
BRCA1 O 1 1.0
carriers O 1 0.9989991784095764
, O 0 0.002045620931312442
but O 0 0.0014982796274125576
there O 0 0.0013609591405838728
was O 0 0.003672428894788027
some O 0 0.0013321684673428535
suggestion O 0 0.009678568691015244
of O 0 0.0012318931985646486
a O 0 0.006999753415584564
lower O 0 0.028060147538781166
risk O 1 0.993887722492218
in O 0 0.009031769819557667
BRCA2 O 1 1.0
carriers O 1 0.9966351389884949
< O 1 0.9748695492744446
50 O 0 0.012766901403665543
years O 0 0.003970053978264332
of O 0 0.0024203481152653694
age O 0 0.020301317796111107
. O 0 0.007879083976149559

Eye B-Disease 1 0.9998377561569214
movement I-Disease 0 0.05114152282476425
abnormalities I-Disease 1 0.9999675750732422
correlate O 0 0.044417090713977814
with O 0 0.004539073444902897
genotype O 1 0.9998791217803955
in O 0 0.00941354501992464
autosomal O 1 0.9999997615814209
dominant O 1 0.9995414018630981
cerebellar B-Disease 1 0.9999997615814209
ataxia I-Disease 1 1.0
type I-Disease 1 0.9983811378479004
I I-Disease 0 0.07142774015665054
. O 0 0.006122784223407507

We O 0 0.005678062327206135
compared O 0 0.02492484077811241
horizontal O 0 0.3435022532939911
eye O 1 0.999637246131897
movements O 0 0.017832906916737556
( O 0 0.0076049878261983395
visually O 0 0.049752384424209595
guided O 0 0.03546229377388954
saccades O 1 0.9999871253967285
, O 0 0.005739703308790922
antisaccades O 1 0.9998955726623535
, O 0 0.0022178865037858486
and O 0 0.0018107228679582477
smooth O 0 0.03797740116715431
pursuit O 0 0.040652502328157425
) O 0 0.003441253211349249
in O 0 0.002396488795056939
control O 0 0.024997809901833534
subjects O 0 0.014166876673698425
( O 0 0.008995565585792065
n O 0 0.05022277683019638
= O 0 0.05317901447415352
14 O 0 0.016076989471912384
) O 0 0.0047746323980391026
and O 0 0.0033073006197810173
patients O 1 0.9999613761901855
with O 0 0.0013487809337675571
three O 0 0.0017307772068306804
forms O 0 0.00474539352580905
of O 0 0.003999647684395313
autosomal O 1 1.0
dominant O 1 0.9998168349266052
cerebellar B-Disease 1 0.9999984502792358
ataxias I-Disease 1 0.9999904632568359
type I-Disease 1 0.985418438911438
I I-Disease 1 0.9364535808563232
spinocerebellar B-Disease 1 0.9999994039535522
ataxias I-Disease 1 0.9996393918991089
1 I-Disease 0 0.015028971247375011
and I-Disease 0 0.0020152288489043713
2 I-Disease 0 0.012866956181824207
( O 0 0.009847973473370075
SCA1 B-Disease 1 0.9999809265136719
, O 0 0.005609876476228237
n O 0 0.04799007624387741
= O 0 0.043947551399469376
11 O 0 0.01487739011645317
; O 0 0.007708409335464239
SCA2 B-Disease 1 0.999761164188385
, O 0 0.00480367848649621
n O 0 0.047309961169958115
= O 0 0.04357491433620453
10 O 0 0.007252443581819534
) O 0 0.004102782811969519
and O 0 0.003953166771680117
SCA3 B-Disease 1 0.9999995231628418
/ O 1 0.9737551808357239
Machado B-Disease 1 0.9994878768920898
- I-Disease 1 0.6006771922111511
Joseph I-Disease 1 0.9996297359466553
disease I-Disease 1 1.0
( O 0 0.022903217002749443
MJD B-Disease 1 0.9999998807907104
) O 0 0.008201497606933117
( O 0 0.007956587709486485
n O 0 0.04416197910904884
= O 0 0.04724005237221718
16 O 0 0.012571960687637329
) O 0 0.00518455496057868
. O 0 0.005721624940633774

In O 0 0.01239548809826374
SCA1 B-Disease 1 0.9998704195022583
, O 0 0.008496290072798729
saccade O 1 0.992830216884613
amplitude O 0 0.12022285163402557
was O 0 0.010539146140217781
significantly O 0 0.026934459805488586
increased O 0 0.010303276591002941
, O 0 0.002329916227608919
resulting O 0 0.030233271420001984
in O 0 0.00421554408967495
hypermetria B-Disease 1 0.9996827840805054
. O 0 0.009633174166083336

The O 0 0.008514884859323502
smooth O 0 0.039168547838926315
pursuit O 0 0.039165712893009186
gain O 0 0.022865457460284233
was O 0 0.018435880541801453
decreased O 0 0.3439713716506958
. O 0 0.00936892256140709

In O 0 0.009616765193641186
SCA2 B-Disease 1 0.9999369382858276
, O 0 0.006789854262024164
saccade O 1 0.9876161217689514
velocity O 0 0.05043594166636467
was O 0 0.018055740743875504
markedly O 0 0.2536899447441101
decreased O 0 0.2431507259607315
. O 0 0.010197496972978115

The O 0 0.005793488584458828
percentage O 0 0.009977025911211967
of O 0 0.0021800696849823
errors O 0 0.02019224688410759
in O 0 0.0039051962085068226
antisaccades O 1 0.9999388456344604
was O 0 0.01090297568589449
greatly O 0 0.01930568926036358
increased O 0 0.008372273296117783
and O 0 0.0014035912463441491
was O 0 0.00972964707762003
significantly O 0 0.029692992568016052
correlated O 0 0.0496816486120224
with O 0 0.003137413412332535
age O 0 0.020883632823824883
at O 0 0.04704054072499275
disease O 1 1.0
onset O 1 0.9999998807907104
. O 0 0.010427417233586311

In O 0 0.0041975355707108974
addition O 0 0.0039022720884531736
, O 0 0.0014961246633902192
a O 0 0.005817649886012077
correlation O 0 0.024877648800611496
between O 0 0.0038049749564379454
smooth O 0 0.0338241383433342
pursuit O 0 0.034211013466119766
gain O 0 0.009192642755806446
and O 0 0.0011020130477845669
the O 0 0.0017380185890942812
number O 0 0.0025227954611182213
of O 0 0.004008811432868242
trinucleotide O 1 0.9999597072601318
repeats O 0 0.09498005360364914
was O 0 0.010943745262920856
found O 0 0.008582579903304577
. O 0 0.005773682147264481

In O 0 0.010849702171981335
SCA3 B-Disease 1 0.9999988079071045
, O 0 0.005786505993455648
gaze B-Disease 1 0.9942750334739685
- I-Disease 0 0.1124168410897255
evoked I-Disease 1 0.9981417655944824
nystagmus I-Disease 1 0.9999980926513672
was O 0 0.01208554022014141
often O 0 0.003477812511846423
present O 0 0.002378984587267041
as O 0 0.0024198831524699926
was O 0 0.014552651904523373
saccade O 1 0.9997261166572571
hypometria O 1 0.9972993731498718
and O 0 0.0033824967686086893
smooth O 0 0.03203155845403671
pursuit O 0 0.03340395167469978
gain O 0 0.01575729250907898
was O 0 0.015363537706434727
markedly O 1 0.9441759586334229
decreased O 1 0.5185356736183167
. O 0 0.008869895711541176

Three O 0 0.005696592386811972
major O 0 0.011118023656308651
criteria O 0 0.009210092015564442
, O 0 0.004247615113854408
saccade O 1 0.9978899359703064
amplitude O 0 0.11477291584014893
, O 0 0.005537309683859348
saccade O 1 0.9951663017272949
velocity O 0 0.033831533044576645
, O 0 0.0015687706181779504
and O 0 0.001241797930561006
presence O 0 0.007996879518032074
of O 0 0.003095825668424368
gaze B-Disease 1 0.99783855676651
- I-Disease 0 0.342043399810791
evoked I-Disease 1 0.9992474317550659
nystagmus I-Disease 1 0.9999947547912598
, O 0 0.0029171945061534643
permitted O 0 0.004279450047761202
the O 0 0.003135864157229662
correct O 0 0.019440079107880592
assignment O 0 0.025220682844519615
of O 0 0.0017709477106109262
90 O 0 0.011216253973543644
% O 0 0.0032589114271104336
of O 0 0.0015477292472496629
the O 0 0.006086908280849457
SCA1 B-Disease 1 0.9999786615371704
, O 0 0.0034734639339149
90 O 0 0.01125933974981308
% O 0 0.0036358535289764404
of O 0 0.0013903083745390177
the O 0 0.005887737963348627
SCA2 B-Disease 1 0.9999984502792358
, O 0 0.002648596651852131
and O 0 0.001803674502298236
93 O 0 0.03025136888027191
% O 0 0.0032593202777206898
of O 0 0.0013380233431234956
the O 0 0.00595216965302825
patients O 1 0.9999986886978149
with O 0 0.0036569125950336456
SCA3 B-Disease 1 0.9999998807907104
to O 0 0.002278038300573826
their O 0 0.002586997114121914
genetically O 1 0.9274651408195496
confirmed O 1 0.9388850331306458
patient O 1 0.9999785423278809
group O 0 0.007124112918972969
and O 0 0.0015755151398479939
, O 0 0.0018395791994407773
therefore O 0 0.004411670845001936
, O 0 0.00158765132073313
may O 0 0.006158403120934963
help O 0 0.0066916970536112785
orient O 0 0.081061452627182
diagnoses O 1 0.9998855590820312
of O 0 0.004892411641776562
SCA1 B-Disease 1 0.999998927116394
, O 0 0.006172061897814274
SCA2 B-Disease 1 0.999997615814209
, O 0 0.0027761103119701147
and O 0 0.002829083940014243
SCA3 B-Disease 1 0.9999995231628418
at O 0 0.0054458677768707275
early O 0 0.011422214098274708
clinical O 0 0.2626250386238098
stages O 0 0.018571455031633377
of O 0 0.0017148774350062013
the O 0 0.010554701089859009
diseases O 1 1.0
. O 0 0.0039483122527599335
. O 0 0.0057898531667888165

Genetic O 0 0.0666135922074318
basis O 0 0.0028010627720505
and O 0 0.0015748986043035984
molecular O 0 0.021751413121819496
mechanism O 0 0.021997416391968727
for O 0 0.009803936816751957
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 0.015057148411870003

Ventricular B-Disease 1 0.9999998807907104
fibrillation I-Disease 1 0.9999998807907104
causes O 1 0.9994710087776184
more O 0 0.002939554862678051
than O 0 0.003176572732627392
300 O 0 0.010810364037752151
, O 0 0.003564139362424612
000 O 0 0.12398429214954376
sudden O 1 0.9999188184738159
deaths O 1 0.7898911833763123
each O 0 0.002802653703838587
year O 0 0.00419175298884511
in O 0 0.0019681034609675407
the O 0 0.00532241677865386
USA O 0 0.05553947389125824
alone O 0 0.016424456611275673
. O 0 0.008209732361137867

In O 0 0.005542384926229715
approximately O 0 0.013688690960407257
5 O 0 0.017970383167266846
- O 0 0.025158941745758057
12 O 0 0.0099564790725708
% O 0 0.003819650737568736
of O 0 0.0013077098410576582
these O 0 0.001414408441632986
cases O 0 0.007867262698709965
, O 0 0.001202730811201036
there O 0 0.001298235496506095
are O 0 0.0007629970205016434
no O 0 0.004244385752826929
demonstrable O 1 0.9999918937683105
cardiac O 1 1.0
or O 0 0.006599017884582281
non O 0 0.02096511796116829
- O 1 0.9990965127944946
cardiac O 1 1.0
causes O 1 0.9998306035995483
to O 0 0.0013334131799638271
account O 0 0.0027535550761967897
for O 0 0.0012571854749694467
the O 0 0.0035525700077414513
episode O 1 0.5935971736907959
, O 0 0.0016032998682931066
which O 0 0.00158166722394526
is O 0 0.002146880840882659
therefore O 0 0.0035804281942546368
classified O 0 0.00975840911269188
as O 0 0.010655973106622696
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 0.051990777254104614
IVF B-Disease 1 0.9999990463256836
) O 0 0.009583511389791965
. O 0 0.0063302116468548775

A O 0 0.02533923089504242
distinct O 0 0.014406486414372921
group O 0 0.006212442182004452
of O 0 0.00568515807390213
IVF B-Disease 1 1.0
patients O 1 0.9999990463256836
has O 0 0.0043318187817931175
been O 0 0.003495651064440608
found O 0 0.003402977716177702
to O 0 0.0008856799686327577
present O 0 0.0021814133506268263
with O 0 0.0012846322497352958
a O 0 0.008682097308337688
characteristic O 0 0.40117397904396057
electrocardiographic O 1 0.9999687671661377
pattern O 0 0.04918795824050903
. O 0 0.0058079008013010025

Because O 0 0.008951954543590546
of O 0 0.0015405465383082628
the O 0 0.0030030664056539536
small O 0 0.004176887217909098
size O 0 0.004504688084125519
of O 0 0.0012995536671951413
most O 0 0.0031972802244126797
pedigrees O 1 0.8082851767539978
and O 0 0.0011228076182305813
the O 0 0.002586918417364359
high O 0 0.011244247667491436
incidence O 1 0.9998916387557983
of O 0 0.003995529841631651
sudden B-Disease 1 0.9999983310699463
death I-Disease 1 0.9986326098442078
, O 0 0.0016185228014364839
however O 0 0.002352433744817972
, O 0 0.0021014162339270115
molecular O 0 0.02830183506011963
genetic O 0 0.040197428315877914
studies O 0 0.005334615707397461
of O 0 0.003457547863945365
IVF B-Disease 1 0.9999995231628418
have O 0 0.002891749842092395
not O 0 0.002045930363237858
yet O 0 0.00455549918115139
been O 0 0.004517087712883949
done O 0 0.007183585315942764
. O 0 0.005448419135063887

Because O 0 0.034614741802215576
IVF B-Disease 1 0.9999986886978149
causes O 1 0.9999979734420776
cardiac O 1 1.0
rhythm O 1 0.9997617602348328
disturbance O 1 0.9992146492004395
, O 0 0.0017501016845926642
we O 0 0.0013447150122374296
investigated O 0 0.017389394342899323
whether O 0 0.006153251510113478
malfunction O 1 0.998909592628479
of O 0 0.0028711198829114437
ion O 0 0.07739339023828506
channels O 0 0.016654230654239655
could O 0 0.005770643707364798
cause O 1 0.8086146712303162
the O 0 0.007065604440867901
disorder O 1 0.9999998807907104
by O 0 0.0036431278567761183
studying O 0 0.00712208915501833
mutations O 1 0.999779999256134
in O 0 0.0019474325235933065
the O 0 0.00787362176924944
cardiac O 1 0.9999998807907104
sodium O 1 0.9699646234512329
channel O 0 0.06814615428447723
gene O 1 0.9972941279411316
SCN5A O 1 0.9997987151145935
. O 0 0.009294004179537296

We O 0 0.003810987574979663
have O 0 0.0022311839275062084
now O 0 0.0042922780849039555
identified O 0 0.013483723625540733
a O 0 0.012209903448820114
missense O 1 0.9991260170936584
mutation O 1 0.9997997879981995
, O 0 0.0023835499305278063
a O 0 0.009121446870267391
splice O 1 0.9960379600524902
- O 0 0.07610567659139633
donor O 1 0.9891899824142456
mutation O 1 0.9999716281890869
, O 0 0.0019664845895022154
and O 0 0.001294026616960764
a O 0 0.015269141644239426
frameshift O 1 0.9999984502792358
mutation O 1 0.9998202919960022
in O 0 0.0018826463492587209
the O 0 0.003459037048742175
coding O 0 0.059178758412599564
region O 0 0.007321863900870085
of O 0 0.0024023512378335
SCN5A O 1 0.9999945163726807
in O 0 0.002707096515223384
three O 0 0.0049276212230324745
IVF B-Disease 1 0.999990701675415
families O 0 0.014598771929740906
. O 0 0.008118167519569397

We O 0 0.004847230389714241
show O 0 0.00834630150347948
that O 0 0.003346554934978485
sodium O 0 0.10149960964918137
channels O 0 0.010171174071729183
with O 0 0.0015348816523328424
the O 0 0.008083014748990536
missense O 1 0.9999556541442871
mutation O 1 0.9999898672103882
recover O 1 0.9469419121742249
from O 0 0.00714022945612669
inactivation O 1 0.9999552965164185
more O 0 0.002953352639451623
rapidly O 0 0.021328454837203026
than O 0 0.002946046181023121
normal O 0 0.011635608039796352
and O 0 0.0008081316482275724
that O 0 0.0010282981675118208
the O 0 0.006643314845860004
frameshift O 1 0.999998927116394
mutation O 1 0.9999868869781494
causes O 1 0.9973432421684265
the O 0 0.005264341831207275
sodium O 0 0.41270753741264343
channel O 0 0.017937082797288895
to O 0 0.0013159322552382946
be O 0 0.002050172071903944
non O 0 0.012821383774280548
- O 0 0.03448969125747681
functional O 0 0.044342298060655594
. O 0 0.007313017267733812

Our O 0 0.007909259758889675
results O 0 0.008907603099942207
indicate O 0 0.008005356416106224
that O 0 0.00271238898858428
mutations O 1 0.9996994733810425
in O 0 0.006098735146224499
cardiac O 1 0.9999998807907104
ion O 0 0.3947514295578003
- O 0 0.04282824322581291
channel O 0 0.04576878249645233
genes O 0 0.06746696680784225
contribute O 0 0.009321511723101139
to O 0 0.0014501066179946065
the O 0 0.003859790274873376
risk O 0 0.4111763834953308
of O 0 0.002659307327121496
developing O 0 0.03710533678531647
IVF B-Disease 1 0.9999979734420776
. O 0 0.00461175199598074
. O 0 0.00551189249381423

Molecular O 0 0.07406098395586014
heterogeneity O 0 0.10964114964008331
in O 0 0.007594007533043623
mucopolysaccharidosis B-Disease 1 0.9999902248382568
IVA I-Disease 1 0.9999562501907349
in O 0 0.0031156023032963276
Australia O 0 0.004728348925709724
and O 0 0.0015499620931223035
Northern O 0 0.011169390752911568
Ireland O 0 0.013765326701104641
: O 0 0.003553445916622877
nine O 0 0.006496312562376261
novel O 0 0.036887310445308685
mutations O 1 0.998630940914154
including O 0 0.0036541474983096123
T312S O 1 0.9999260902404785
, O 0 0.0016803096514195204
a O 0 0.004931619390845299
common O 0 0.014031272381544113
allele O 1 0.999962568283081
that O 0 0.0029458377975970507
confers O 1 0.995288610458374
a O 0 0.021018803119659424
mild O 1 0.9999880790710449
phenotype O 1 0.9999954700469971
. O 0 0.009125705808401108

Mucopolysaccharidosis B-Disease 1 0.9999878406524658
IVA I-Disease 1 0.9999979734420776
( O 0 0.018899530172348022
MPS B-Disease 1 0.9997438788414001
IVA I-Disease 1 0.9999995231628418
) O 0 0.004198141396045685
is O 0 0.003242847276851535
an O 0 0.007627209648489952
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 0.9999994039535522
storage I-Disease 1 0.9927599430084229
disorder I-Disease 1 1.0
caused O 1 0.9996720552444458
by O 0 0.0032230359502136707
a O 0 0.012044589035212994
genetic B-Disease 1 0.9992305040359497
defect I-Disease 1 0.9999452829360962
in O 0 0.003348392201587558
N O 0 0.12191848456859589
- O 0 0.04361426457762718
acetylgalactosamine O 1 0.9994456171989441
- O 0 0.04313460364937782
6 O 0 0.029910439625382423
- O 0 0.07455597817897797
sulfate O 1 0.9970244765281677
sulfatase O 1 0.9998596906661987
( O 0 0.024961035698652267
GALNS O 1 0.9999302625656128
) O 0 0.008873854763805866
. O 0 0.005829226225614548

Previous O 0 0.013903279788792133
studies O 0 0.006510315462946892
of O 0 0.003981496673077345
patients O 1 0.9999661445617676
from O 0 0.0033663229551166296
a O 0 0.007692596409469843
British O 0 0.02384454384446144
- O 0 0.028061844408512115
Irish O 0 0.033876631408929825
population O 0 0.008462706580758095
showed O 0 0.006924457848072052
that O 0 0.001366801094263792
the O 0 0.004721868317574263
I113F O 1 0.9999916553497314
mutation O 1 0.9999412298202515
is O 0 0.002656139899045229
the O 0 0.0017278674058616161
most O 0 0.002441404853016138
common O 0 0.007526664063334465
single O 0 0.021037084981799126
mutation O 1 0.9999808073043823
among O 0 0.011460949666798115
MPS B-Disease 1 0.9999575614929199
IVA I-Disease 1 1.0
patients O 1 0.9999960660934448
and O 0 0.0024751366581767797
produces O 0 0.02429267205297947
a O 0 0.023555969819426537
severe O 1 0.9999998807907104
clinical O 1 0.999942421913147
phenotype O 1 0.9999991655349731
. O 0 0.008557865396142006

We O 0 0.005636341404169798
studied O 0 0.013229741714894772
mutations O 1 0.9850452542304993
in O 0 0.0020201182924211025
the O 0 0.006254116073250771
GALNS O 1 0.9999890327453613
gene O 1 0.9857093095779419
from O 0 0.004048296250402927
23 O 0 0.012566686607897282
additional O 0 0.007561139762401581
MPS B-Disease 1 0.999946117401123
IVA I-Disease 1 1.0
patients O 1 0.9999991655349731
( O 0 0.006575954612344503
15 O 0 0.007282621692866087
from O 0 0.0029311752878129482
Australia O 0 0.007383669726550579
, O 0 0.0024603677447885275
8 O 0 0.010066432878375053
from O 0 0.0030923811718821526
Northern O 0 0.01384129747748375
Ireland O 0 0.019793594256043434
) O 0 0.0035412900615483522
, O 0 0.000996040995232761
with O 0 0.0011683154152706265
various O 0 0.0024714579340070486
clinical O 1 0.999955415725708
phenotypes O 1 0.9999970197677612
( O 0 0.02139056660234928
severe O 1 1.0
, O 0 0.002744696568697691
16 O 0 0.011487510986626148
cases O 0 0.009903060272336006
; O 0 0.003323300974443555
intermediate O 0 0.027374709025025368
, O 0 0.0023440090008080006
4 O 0 0.015345126390457153
cases O 0 0.015281951054930687
; O 0 0.0061664520762860775
mild O 1 0.9999839067459106
, O 0 0.003156371647492051
3 O 0 0.014266099780797958
cases O 0 0.01371761690825224
) O 0 0.005834321491420269
. O 0 0.005798627156764269

We O 0 0.003482770174741745
found O 0 0.005176263861358166
two O 0 0.0021601964253932238
common O 0 0.015484794974327087
mutations O 1 0.9997214674949646
that O 0 0.00171275797765702
together O 0 0.0022128650452941656
accounted O 0 0.017353564500808716
for O 0 0.002474599750712514
32 O 0 0.016169415786862373
% O 0 0.0030940293800085783
of O 0 0.0011990189086645842
the O 0 0.0030485172756016254
44 O 0 0.02573089674115181
unrelated O 0 0.15845076739788055
alleles O 1 0.9994298815727234
in O 0 0.0026973511558026075
these O 0 0.002914056181907654
patients O 1 0.9999806880950928
. O 0 0.0072244140319526196

One O 0 0.005606143269687891
is O 0 0.003006531624123454
the O 0 0.006220075301826
T312S O 1 0.9999294281005859
mutation O 1 0.9999716281890869
, O 0 0.0023212360683828592
a O 0 0.007662558928132057
novel O 0 0.045072756707668304
mutation O 1 0.999944806098938
found O 0 0.007000231184065342
exclusively O 0 0.006206722464412451
in O 0 0.005163827445358038
milder O 1 0.9999836683273315
patients O 1 0.9999922513961792
. O 0 0.008073683828115463

The O 0 0.00410622451454401
other O 0 0.001051725004799664
is O 0 0.0022099653724581003
the O 0 0.0022185049019753933
previously O 0 0.006964059080928564
described O 0 0.01526775024831295
I113F O 1 0.9974913597106934
that O 0 0.002409756649285555
produces O 0 0.02104351669549942
a O 0 0.02414517104625702
severe O 1 1.0
phenotype O 1 0.9999996423721313
. O 0 0.009336926974356174

The O 0 0.013781766407191753
I113F O 1 0.9972386360168457
and O 0 0.007742583751678467
T312S O 1 0.9999445676803589
mutations O 1 0.999619722366333
accounted O 0 0.02624085731804371
for O 0 0.0031351412180811167
8 O 0 0.01666291616857052
( O 0 0.006006373092532158
18 O 0 0.010592789389193058
% O 0 0.006215150933712721
) O 0 0.0037991267163306475
and O 0 0.001986690331250429
6 O 0 0.016793658956885338
( O 0 0.005739028565585613
14 O 0 0.010665313340723515
% O 0 0.0048658400774002075
) O 0 0.0024404549039900303
of O 0 0.0017526461742818356
44 O 0 0.02564144693315029
unrelated O 0 0.1692240983247757
alleles O 1 0.9997650980949402
, O 0 0.003770876908674836
respectively O 0 0.010155930183827877
. O 0 0.006286990828812122

The O 0 0.006908245850354433
relatively O 0 0.013687854632735252
high O 0 0.014543245546519756
residual O 1 0.9690161347389221
GALNS O 1 0.9998036026954651
activity O 0 0.01703118160367012
seen O 0 0.009075306355953217
when O 0 0.005298325326293707
the O 0 0.005138908978551626
T312S O 1 0.9996286630630493
mutant O 1 0.9977933168411255
cDNA O 0 0.13901203870773315
is O 0 0.008651748299598694
overexpressed O 1 0.9942852854728699
in O 0 0.006177426315844059
mutant O 1 0.9998496770858765
cells O 0 0.050538402050733566
provides O 0 0.004351303447037935
an O 0 0.0018843389116227627
explanation O 0 0.006998408120125532
for O 0 0.0013825194910168648
the O 0 0.005623768083751202
mild O 1 0.9999997615814209
phenotype O 1 0.9999996423721313
in O 0 0.006556591019034386
patients O 1 0.9999958276748657
with O 0 0.0019404051126912236
this O 0 0.005348783452063799
mutation O 1 0.9999803304672241
. O 0 0.00921568088233471

The O 0 0.006240122951567173
distribution O 0 0.007282193284481764
and O 0 0.0016582048265263438
relative O 0 0.011203890666365623
frequencies O 0 0.012074011377990246
of O 0 0.0013521364890038967
the O 0 0.0050363377667963505
I113F O 1 0.999808132648468
and O 0 0.005554029252380133
T312S O 1 0.9999474287033081
mutations O 1 0.9994199275970459
in O 0 0.00263278023339808
Australia O 0 0.008459149859845638
corresponded O 0 0.02278059907257557
to O 0 0.00160940398927778
those O 0 0.0016465660883113742
observed O 0 0.01045763585716486
in O 0 0.0022225198335945606
Northern O 0 0.012420468032360077
Ireland O 0 0.013663453049957752
and O 0 0.001129738288000226
are O 0 0.0008288271492347121
unique O 0 0.0027365852147340775
to O 0 0.0007771746022626758
these O 0 0.0006303999689407647
two O 0 0.001757722464390099
populations O 0 0.029791751876473427
, O 0 0.0017935638315975666
suggesting O 0 0.011532431468367577
that O 0 0.001486913999542594
both O 0 0.0040208203718066216
mutations O 1 0.9998947381973267
were O 0 0.003093430772423744
probably O 0 0.011355716735124588
introduced O 0 0.008728968910872936
to O 0 0.001974346349015832
Australia O 0 0.005640001501888037
by O 0 0.003668268211185932
Irish O 0 0.02936960756778717
migrants O 0 0.016662219539284706
during O 0 0.007424196694046259
the O 0 0.0032457553315907717
19th O 0 0.01337425597012043
century O 0 0.009901555255055428
. O 0 0.006925822701305151

Haplotype O 1 0.860264003276825
analysis O 0 0.010908694937825203
using O 0 0.005923062097281218
6 O 0 0.02209632843732834
RFLPs O 1 0.9900254011154175
provides O 0 0.004890918731689453
additional O 0 0.002481654519215226
data O 0 0.00164485489949584
that O 0 0.0011829743161797523
the O 0 0.005014898255467415
I113F O 1 0.9998171925544739
mutation O 1 0.9998469352722168
originated O 0 0.020006569102406502
from O 0 0.0028486372902989388
a O 0 0.0061951735988259315
common O 0 0.012231118977069855
ancestor O 1 0.9179778099060059
. O 0 0.007323856931179762

The O 0 0.004682258237153292
other O 0 0.0020837895572185516
9 O 0 0.016792701557278633
novel O 0 0.054707132279872894
mutations O 1 0.9984228610992432
identified O 0 0.012795493006706238
in O 0 0.0015995275462046266
these O 0 0.0018228663830086589
23 O 0 0.07611926645040512
patients O 1 0.9999749660491943
were O 0 0.0013030637055635452
each O 0 0.0014745633816346526
limited O 0 0.004258301574736834
to O 0 0.0012861932627856731
a O 0 0.006332881283015013
single O 0 0.017755772918462753
family O 0 0.016588391736149788
. O 0 0.00806561578065157

These O 0 0.002095317468047142
data O 0 0.0017350732814520597
provide O 0 0.0017894947668537498
further O 0 0.0023122027050703764
evidence O 0 0.0016813802067190409
for O 0 0.0017595709068700671
extensive O 0 0.026538487523794174
allelic O 1 0.9993005990982056
heterogeneity O 1 0.6653401851654053
in O 0 0.0059757535345852375
MPS B-Disease 1 0.9997835755348206
IVA I-Disease 1 0.9999992847442627
in O 0 0.004075255244970322
British O 0 0.21297316253185272
- O 0 0.23431143164634705
Irish O 1 0.993591845035553
patients O 1 0.9999889135360718
and O 0 0.0010950644500553608
provide O 0 0.0017831585137173533
evidence O 0 0.0014655187260359526
for O 0 0.0010536350309848785
their O 0 0.0021752105094492435
transmission O 0 0.07995320856571198
to O 0 0.001641743816435337
Australia O 0 0.004960988182574511
by O 0 0.0034540535416454077
British O 0 0.020598167553544044
- O 0 0.029440272599458694
Irish O 0 0.03953040391206741
migrants O 0 0.01908992975950241
. O 0 0.0031003246549516916
. O 0 0.005481120198965073

Identification O 0 0.020381733775138855
of O 0 0.002954356838017702
constitutional O 0 0.1570209413766861
WT1 O 1 1.0
mutations O 1 0.999913215637207
, O 0 0.002181348158046603
in O 0 0.003246735082939267
patients O 1 0.9999969005584717
with O 0 0.003961359616369009
isolated O 1 0.9998260140419006
diffuse B-Disease 1 0.9999991655349731
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.002749275416135788
and O 0 0.0011037476360797882
analysis O 0 0.003640460316091776
of O 0 0.0035364958457648754
genotype O 1 0.9999994039535522
/ O 1 0.9997214674949646
phenotype O 1 0.9999955892562866
correlations O 0 0.03118293173611164
by O 0 0.0018308877479285002
use O 0 0.0010803064797073603
of O 0 0.0009245546534657478
a O 0 0.008104866370558739
computerized O 1 0.9154666662216187
mutation O 1 0.999932050704956
database O 0 0.02876134030520916
. O 0 0.007845336571335793

Constitutional O 0 0.037646062672138214
mutations O 1 0.88947993516922
of O 0 0.002176799578592181
the O 0 0.008103080093860626
WT1 O 1 0.9999994039535522
gene O 1 0.9838680028915405
, O 0 0.0024158277083188295
encoding O 0 0.03087558224797249
a O 0 0.010685467161238194
zinc O 1 0.9917648434638977
- O 0 0.04211440682411194
finger O 1 0.981245756149292
transcription O 0 0.10180699080228806
factor O 0 0.03839939087629318
involved O 0 0.011629951186478138
in O 0 0.00831049494445324
renal O 1 1.0
and O 0 0.006144270300865173
gonadal O 1 0.9999905824661255
development O 0 0.0057865711860358715
, O 0 0.0013654159847646952
are O 0 0.0006541652255691588
found O 0 0.002936028875410557
in O 0 0.00141088105738163
most O 0 0.004430386237800121
patients O 1 0.9999850988388062
with O 0 0.004040782805532217
Denys B-Disease 1 0.9999998807907104
- I-Disease 1 0.999924898147583
Drash I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
( O 0 0.05268515273928642
DDS B-Disease 1 0.9999998807907104
) O 0 0.005327485501766205
, O 0 0.0021709215361624956
or O 0 0.010375596582889557
diffuse B-Disease 1 0.9999995231628418
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 0.055327147245407104
DMS B-Disease 1 0.9999980926513672
) O 0 0.005810040980577469
associated O 0 0.00800120085477829
with O 0 0.003025797661393881
pseudohermaphroditism B-Disease 1 0.9999953508377075
and O 0 0.00386847578920424
/ O 1 0.9975737929344177
or O 0 0.021691562607884407
Wilms B-Disease 1 1.0
tumor I-Disease 1 0.9999998807907104
( O 0 0.028695350512862206
WT B-Disease 1 0.999995231628418
) O 0 0.008231418207287788
. O 0 0.0068585691042244434

Most O 0 0.01720508374273777
mutations O 1 0.9995018243789673
in O 0 0.01035534031689167
DDS B-Disease 1 1.0
patients O 1 0.9999760389328003
lie O 0 0.015228785574436188
in O 0 0.003909891936928034
exon O 1 0.9953498840332031
8 O 0 0.018880421295762062
or O 0 0.005956295877695084
exon O 1 0.9855875968933105
9 O 0 0.01464046724140644
, O 0 0.0031184249091893435
encoding O 0 0.06537813693284988
zinc O 1 0.9874425530433655
finger O 1 0.9198393225669861
2 O 0 0.014577014371752739
or O 0 0.00845804251730442
zinc O 1 0.9962940812110901
finger O 1 0.9919384121894836
3 O 0 0.014246111735701561
, O 0 0.002121015451848507
respectively O 0 0.006208437029272318
, O 0 0.0012788042658939958
with O 0 0.0014608759665861726
a O 0 0.008367358706891537
hot O 0 0.15356819331645966
spot O 0 0.05180520936846733
( O 0 0.013680601492524147
R394W O 1 0.9990704655647278
) O 0 0.004927570000290871
in O 0 0.0041037146002054214
exon O 1 0.9965152740478516
9 O 0 0.026209775358438492
. O 0 0.007151583209633827

We O 0 0.004349966999143362
analyzed O 0 0.015893006697297096
a O 0 0.005425407085567713
series O 0 0.008049143478274345
of O 0 0.0030173195991665125
24 O 0 0.0373368114233017
patients O 1 0.9999741315841675
, O 0 0.0019733046647161245
10 O 0 0.005061059724539518
with O 0 0.004093841649591923
isolated B-Disease 1 0.9966511130332947
DMS I-Disease 1 0.9999908208847046
( O 0 0.02646569535136223
IDMS B-Disease 1 0.9999946355819702
) O 0 0.007769294548779726
, O 0 0.002064736094325781
10 O 0 0.005149930249899626
with O 0 0.0042454516515135765
DDS B-Disease 1 0.9999998807907104
, O 0 0.002130399690940976
and O 0 0.0011276594595983624
4 O 0 0.009600520133972168
with O 0 0.004890629556030035
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 0.9999998807907104
and O 0 0.003372154664248228
/ O 1 0.9823369979858398
or O 0 0.01137297973036766
WT B-Disease 1 0.999995231628418
. O 0 0.010666248388588428

We O 0 0.004793958738446236
report O 0 0.012926189228892326
WT1 O 1 0.9999961853027344
heterozygous O 1 0.999812662601471
mutations O 1 0.9994465708732605
in O 0 0.004883407615125179
16 O 0 0.027776720002293587
patients O 1 0.9999486207962036
, O 0 0.0024263933300971985
4 O 0 0.007646723184734583
of O 0 0.001728432602249086
whom O 0 0.010388050228357315
presented O 0 0.005940751172602177
with O 0 0.006080962251871824
IDMS B-Disease 1 0.9999960660934448
. O 0 0.009554469957947731

One O 0 0.00988413393497467
male O 0 0.022019147872924805
and O 0 0.0011796109611168504
two O 0 0.0025211195461452007
female O 1 0.5854820013046265
IDMS B-Disease 1 1.0
patients O 1 0.9999955892562866
with O 0 0.010231026448309422
WT1 O 1 1.0
mutations O 1 0.9999942779541016
underwent O 1 0.9999955892562866
normal O 0 0.08641016483306885
puberty O 1 0.9978156089782715
. O 0 0.010003475472331047

Two O 0 0.009695058688521385
mutations O 1 0.999768078327179
associated O 0 0.01559391338378191
with O 0 0.005670572631061077
IDMS B-Disease 1 0.9999971389770508
are O 0 0.0014972391072660685
different O 0 0.0008983538718894124
from O 0 0.0018862950382754207
those O 0 0.0019104748498648405
described O 0 0.015028653666377068
in O 0 0.009141267277300358
DDS B-Disease 1 1.0
patients O 1 0.9999929666519165
. O 0 0.00832592323422432

No O 0 0.030908780172467232
WT1 O 1 0.9999871253967285
mutations O 1 0.9997277855873108
were O 0 0.0040920148603618145
detected O 0 0.04105303809046745
in O 0 0.0009894100949168205
the O 0 0.00163918302860111
six O 0 0.003987305797636509
other O 0 0.004283588845282793
IDMS B-Disease 1 1.0
patients O 1 0.9999990463256836
, O 0 0.002768053440377116
suggesting O 0 0.025385133922100067
genetic O 0 0.10472174733877182
heterogeneity O 0 0.14924246072769165
of O 0 0.0026477172505110502
this O 0 0.00878436304628849
disease O 1 1.0
. O 0 0.010049782693386078

We O 0 0.006592131685465574
analyzed O 0 0.05411297455430031
genotype O 1 0.9999247789382935
/ O 1 0.9963793158531189
phenotype O 1 0.9999732971191406
correlations O 0 0.04674968495965004
, O 0 0.001422140863724053
on O 0 0.0010015247389674187
the O 0 0.0010490866843611002
basis O 0 0.00106170738581568
of O 0 0.0007588927401229739
the O 0 0.0019939893390983343
constitution O 0 0.0035030972212553024
of O 0 0.0013200266985222697
a O 0 0.015260870568454266
WT1 O 1 0.9999995231628418
mutation O 1 0.9996237754821777
database O 0 0.01618991792201996
of O 0 0.0026955108623951674
84 O 1 0.8091121912002563
germ O 1 0.9937826991081238
- O 0 0.05129585042595863
line O 0 0.026893239468336105
mutations O 1 0.9997604489326477
, O 0 0.0015563017223030329
to O 0 0.0015062160091474652
compare O 0 0.011531747877597809
the O 0 0.0025672477204352617
distribution O 0 0.005154639482498169
and O 0 0.0015461751027032733
type O 0 0.027620069682598114
of O 0 0.003450111486017704
mutations O 1 0.9999747276306152
, O 0 0.0014081238768994808
according O 0 0.0013036304153501987
to O 0 0.0010258430847898126
the O 0 0.002561028813943267
different O 0 0.004708732012659311
symptoms O 1 1.0
. O 0 0.007680430077016354

This O 0 0.009213526733219624
demonstrated O 0 0.025086253881454468
( O 0 0.007525923196226358
1 O 0 0.01415509544312954
) O 0 0.003160100430250168
the O 0 0.0033424620050936937
association O 0 0.011251937597990036
between O 0 0.00490195257589221
mutations O 1 0.9996424913406372
in O 0 0.004385945852845907
exons O 1 0.9340110421180725
8 O 0 0.014220847748219967
and O 0 0.0018319477094337344
9 O 0 0.014537137933075428
and O 0 0.00432950584217906
DMS B-Disease 1 0.9999953508377075
; O 0 0.0075929732993245125
( O 0 0.006086526904255152
2 O 0 0.010750115849077702
) O 0 0.0034097004681825638
among O 0 0.007971687242388725
patients O 1 0.9999979734420776
with O 0 0.004661718849092722
DMS B-Disease 1 0.999998927116394
, O 0 0.0018812097841873765
a O 0 0.004855195991694927
higher O 0 0.006339831277728081
frequency O 0 0.023991091176867485
of O 0 0.0035690548829734325
exon O 1 0.9982389211654663
8 O 0 0.030554359778761864
mutations O 1 0.9978027939796448
among O 0 0.007263994310051203
46 O 0 0.025532318279147148
, O 0 0.008456747978925705
XY O 1 0.9999995231628418
patients O 1 0.9999417066574097
with O 0 0.004353173542767763
female O 0 0.056099507957696915
phenotype O 1 0.9999972581863403
than O 0 0.003986605443060398
among O 0 0.005934156943112612
46 O 0 0.02478789910674095
, O 0 0.00841733068227768
XY O 1 0.9999997615814209
patients O 1 0.9999898672103882
with O 0 0.0029624607414007187
sexual O 0 0.01522498857229948
ambiguity O 0 0.021044639870524406
or O 0 0.006625885609537363
male O 1 0.9915739893913269
phenotype O 1 0.9999997615814209
; O 0 0.004567949566990137
and O 0 0.0017605191096663475
( O 0 0.006112268660217524
3 O 0 0.011727731674909592
) O 0 0.003607549937441945
statistically O 0 0.016584163531661034
significant O 0 0.0049856798723340034
evidence O 0 0.002209360944107175
that O 0 0.002965085906907916
mutations O 1 0.999026894569397
in O 0 0.0032982470002025366
exons O 1 0.9663586020469666
8 O 0 0.013916924595832825
and O 0 0.0022892544511705637
9 O 0 0.01932194083929062
preferentially O 0 0.2696455419063568
affect O 0 0.031752221286296844
amino O 0 0.05591791123151779
acids O 0 0.033331241458654404
with O 0 0.0014024014817550778
different O 0 0.001311569008976221
functions O 0 0.005032779183238745
. O 0 0.0028336693067103624
. O 0 0.006051286589354277

The O 0 0.01983177475631237
185delAG O 1 0.9999772310256958
BRCA1 O 1 1.0
mutation O 1 0.9998210072517395
originated O 0 0.02777234837412834
before O 0 0.00579790398478508
the O 0 0.004207517020404339
dispersion O 0 0.045189689844846725
of O 0 0.0020636694971472025
Jews O 0 0.00491741206496954
in O 0 0.001634991611354053
the O 0 0.002601311542093754
diaspora O 0 0.020446110516786575
and O 0 0.0012886050390079618
is O 0 0.0022708489559590816
not O 0 0.0015229028649628162
limited O 0 0.006122436374425888
to O 0 0.00271520740352571
Ashkenazim O 1 0.999481737613678
. O 0 0.009620449505746365

The O 0 0.016361594200134277
185delAG O 1 0.9997656941413879
mutation O 1 0.9998670816421509
in O 0 0.008687623776495457
BRCA1 O 1 0.9999998807907104
is O 0 0.009515651501715183
detected O 0 0.061348654329776764
in O 0 0.0032281868625432253
Ashkenazi O 1 0.9937716126441956
Jews O 0 0.005063890945166349
both O 0 0.0016295990208163857
in O 0 0.005372973624616861
familial B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9959461092948914
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.001828304142691195
in O 0 0.0013198169181123376
the O 0 0.002552869962528348
general O 0 0.006762179080396891
population O 0 0.011336028575897217
. O 0 0.00586733827367425

All O 0 0.0075855860486626625
tested O 0 0.13136336207389832
Ashkenazi O 1 0.9997544884681702
mutation O 1 0.9999387264251709
carriers O 0 0.07240385562181473
share O 0 0.006242276635020971
the O 0 0.0027407112065702677
same O 0 0.0066284723579883575
allelic O 1 0.9864476919174194
pattern O 0 0.02545168437063694
at O 0 0.005489901639521122
the O 0 0.010501004755496979
BRCA1 O 1 1.0
locus O 1 0.9999688863754272
. O 0 0.011957407929003239

Our O 0 0.007356415037065744
previous O 0 0.0069142417050898075
study O 0 0.005949464160948992
showed O 0 0.008008288219571114
that O 0 0.001589494408108294
this O 0 0.004086794797331095
Ashkenazi O 1 0.9998948574066162
mutation O 1 0.999954342842102
also O 0 0.0040546804666519165
occurs O 0 0.01872202195227146
in O 0 0.0018422778230160475
Iraqi O 0 0.008029886521399021
Jews O 0 0.004828149918466806
with O 0 0.0014755199663341045
a O 0 0.007306952029466629
similar O 0 0.011760711669921875
allelic O 1 0.9988160133361816
pattern O 0 0.04763011634349823
. O 0 0.006853773258626461

We O 0 0.005138082895427942
extended O 0 0.011679493822157383
our O 0 0.003119940171018243
analysis O 0 0.0036309820134192705
to O 0 0.0011020927922800183
other O 0 0.001217341865412891
non O 0 0.012412060983479023
- O 0 0.04009200260043144
Ashkenazi O 1 0.9441658854484558
subsets O 0 0.050209566950798035
354 O 0 0.05588711053133011
of O 0 0.002431332366541028
Moroccan O 0 0.04437313973903656
origin O 0 0.006979806814342737
, O 0 0.002121957251802087
200 O 0 0.015420554205775261
Yemenites O 1 0.9954701662063599
and O 0 0.0026033930480480194
150 O 0 0.00971921905875206
Iranian O 0 0.005913568660616875
Jews O 0 0.009143195115029812
. O 0 0.007324618753045797

Heteroduplex O 1 0.9471846222877502
analysis O 0 0.011032414622604847
complemented O 0 0.029006147757172585
by O 0 0.004030284006148577
direct O 0 0.008492259308695793
DNA O 0 0.04429839551448822
sequencing O 0 0.052411846816539764
of O 0 0.00495954742655158
abnormally O 1 0.998608410358429
migrating O 0 0.07183368504047394
bands O 0 0.021645227447152138
were O 0 0.002773740328848362
employed O 0 0.013963377103209496
. O 0 0.00634847953915596

Four O 0 0.0043580722995102406
of O 0 0.002474291482940316
Moroccan O 0 0.05772919952869415
origin O 0 0.012696250341832638
( O 0 0.00694051431491971
1 O 0 0.013087748549878597
. O 0 0.00277335150167346
1 O 0 0.012325416319072247
% O 0 0.005718928761780262
) O 0 0.0026055036578327417
and O 0 0.0010925489477813244
none O 0 0.004676439333707094
of O 0 0.0014880698872730136
the O 0 0.005258467514067888
Yemenites O 1 0.9999163150787354
or O 0 0.004300608765333891
Iranians O 0 0.007226487156003714
was O 0 0.005327202379703522
a O 0 0.006562980357557535
carrier O 0 0.06997305154800415
of O 0 0.0017865600530058146
the O 0 0.006496438756585121
185delAG O 1 0.9999880790710449
mutation O 1 0.9999551773071289
. O 0 0.009565025568008423

BRCA1 O 1 0.9999974966049194
allelic O 1 0.9960867166519165
patterns O 0 0.020387375727295876
were O 0 0.0018655688036233187
determined O 0 0.006167872343212366
for O 0 0.0011228054063394666
four O 0 0.001641049049794674
of O 0 0.0009669334394857287
these O 0 0.0008908826275728643
individuals O 0 0.0026823575608432293
and O 0 0.0008267135126516223
for O 0 0.0012937233550474048
12 O 0 0.005647073499858379
additional O 0 0.0038298137951642275
non O 0 0.011951184831559658
- O 0 0.04138527438044548
Ashkenazi O 1 0.9988682270050049
185delAG O 1 0.999890923500061
mutation O 1 0.9999833106994629
carriers O 1 0.973131000995636
who O 0 0.009004512801766396
had O 1 0.7612819671630859
breast B-Disease 1 1.0
/ I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.01005310844630003

Six O 0 0.014045164920389652
non O 0 0.021844977512955666
- O 0 0.05144908279180527
Ashkenazi O 1 0.9963313937187195
individuals O 0 0.004942044615745544
shared O 0 0.005777580197900534
the O 0 0.0035239458084106445
common O 0 0.04217962175607681
Ashkenazi O 1 0.9999420642852783
haplotype O 1 0.9998574256896973
, O 0 0.0016859150491654873
four O 0 0.0019706105813384056
had O 0 0.003789332928135991
a O 0 0.0051126861944794655
closely O 0 0.006166375707834959
related O 0 0.010323917493224144
pattern O 0 0.022461241111159325
, O 0 0.001464664819650352
and O 0 0.0009092518012039363
the O 0 0.0031851986423134804
rest O 0 0.01436103880405426
( O 0 0.009866678155958652
n O 0 0.052806440740823746
= O 0 0.05068832263350487
6 O 0 0.016400977969169617
) O 0 0.0030459763947874308
displayed O 0 0.006696669384837151
a O 0 0.010160219855606556
distinct O 0 0.048141367733478546
BRCA1 O 1 0.9999998807907104
allelic O 1 0.99870765209198
pattern O 0 0.06058051809668541
. O 0 0.008090335875749588

We O 0 0.003586503444239497
conclude O 0 0.011616229079663754
that O 0 0.0018675340106710792
the O 0 0.006595011800527573
185delAG O 1 0.9999927282333374
BRCA1 O 1 1.0
mutation O 1 0.9999889135360718
occurs O 0 0.03370729088783264
in O 0 0.001498301629908383
some O 0 0.0022493137512356043
non O 0 0.014886449091136456
- O 0 0.10770148038864136
Ashkenazi O 1 0.9983822107315063
populations O 0 0.03457792103290558
at O 0 0.005318452604115009
rates O 0 0.013540852814912796
comparable O 0 0.010639522224664688
with O 0 0.0011807037517428398
that O 0 0.0011722014751285315
of O 0 0.002643275074660778
Ashkenazim O 1 0.999825656414032
. O 0 0.00825049914419651

The O 0 0.006392207462340593
majority O 0 0.009288807399570942
of O 0 0.0023898850195109844
Jewish O 0 0.02874675579369068
185delAG O 1 0.9999902248382568
mutation O 1 0.9999948740005493
carriers O 1 0.6970363259315491
have O 0 0.002788013778626919
a O 0 0.007190614938735962
common O 0 0.018558606505393982
allelic O 1 0.9997004270553589
pattern O 0 0.03560027480125427
, O 0 0.0022663979325443506
supporting O 0 0.007865886203944683
the O 0 0.003638905705884099
founder O 0 0.2478911429643631
effect O 0 0.01757301390171051
notion O 0 0.011344784870743752
, O 0 0.0016265878221020103
but O 0 0.00198525027371943
dating O 0 0.009799530729651451
the O 0 0.004982575308531523
mutations O 1 0.9992389678955078
origin O 0 0.005415096413344145
to O 0 0.0011388259008526802
an O 0 0.001877377973869443
earlier O 0 0.004697348456829786
date O 0 0.0051410323940217495
than O 0 0.0022465160582214594
currently O 0 0.0048169638030231
estimated O 0 0.015444711782038212
. O 0 0.00735819386318326

However O 0 0.006745456252247095
, O 0 0.0014529589097946882
the O 0 0.0020277220755815506
different O 0 0.0022825479973107576
allelic O 1 0.9933851361274719
pattern O 0 0.0225910022854805
at O 0 0.004162471275776625
the O 0 0.008877546526491642
BRCA1 O 1 1.0
locus O 1 0.9999878406524658
even O 0 0.0034886852372437716
in O 0 0.0011741778580471873
some O 0 0.0018070500809699297
Jewish O 0 0.030118711292743683
mutation O 1 0.9999994039535522
carriers O 1 0.9973873496055603
, O 0 0.002257588319480419
might O 0 0.005850632209330797
suggest O 0 0.005170516204088926
that O 0 0.0010662372224032879
the O 0 0.004791506566107273
mutation O 1 0.9999794960021973
arose O 0 0.027880417183041573
independently O 0 0.00975101999938488
. O 0 0.003025777405127883
. O 0 0.005910054314881563

Crystal O 0 0.038017407059669495
structure O 0 0.006755264475941658
of O 0 0.002265423070639372
the O 0 0.012602671980857849
hemochromatosis B-Disease 1 1.0
protein O 1 0.8833598494529724
HFE O 1 0.9999849796295166
and O 0 0.002702567493543029
characterization O 0 0.0211379062384367
of O 0 0.0012991155963391066
its O 0 0.0025947168469429016
interaction O 0 0.010294118896126747
with O 0 0.005257509183138609
transferrin O 1 0.9987462759017944
receptor O 1 0.9333257079124451
. O 0 0.009258691221475601

HFE O 1 0.9999514818191528
is O 0 0.010674645192921162
an O 0 0.01131904125213623
MHC O 1 0.9998854398727417
- O 0 0.0402846522629261
related O 0 0.014291212894022465
protein O 0 0.0331914909183979
that O 0 0.0011694824788719416
is O 0 0.0037194706965237856
mutated O 1 0.9997223019599915
in O 0 0.0012934720143675804
the O 0 0.0029465502593666315
iron B-Disease 1 0.9987257122993469
- I-Disease 1 0.9995303153991699
overload I-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.013908780179917812

HFE O 1 0.9998675584793091
binds O 0 0.11418797075748444
to O 0 0.008124089799821377
transferrin O 1 0.998363196849823
receptor O 1 0.986236035823822
( O 0 0.017620740458369255
TfR O 1 0.9998075366020203
) O 0 0.005349665880203247
and O 0 0.0020582126453518867
reduces O 0 0.052625156939029694
its O 0 0.004524153657257557
affinity O 0 0.03270672634243965
for O 0 0.0025521209463477135
iron O 0 0.09779959172010422
- O 0 0.028722690418362617
loaded O 0 0.033474672585725784
transferrin O 1 0.9942992925643921
, O 0 0.005558597389608622
implicating O 1 0.533001720905304
HFE O 1 0.999981164932251
in O 0 0.008236137218773365
iron O 1 0.907156229019165
metabolism O 1 0.9985828399658203
. O 0 0.008314917795360088

The O 0 0.010739447548985481
2 O 0 0.015901613980531693
. O 0 0.007688957266509533

6 O 0 0.028814196586608887
A O 0 0.01697087287902832
crystal O 0 0.02190144546329975
structure O 0 0.007457882631570101
of O 0 0.004124164581298828
HFE O 1 0.9999971389770508
reveals O 0 0.034443099051713943
the O 0 0.002515286672860384
locations O 0 0.00543680414557457
of O 0 0.005641395226120949
hemochromatosis B-Disease 1 1.0
mutations O 1 0.9999831914901733
and O 0 0.0018213184084743261
a O 0 0.010855639353394508
patch O 1 0.9999535083770752
of O 0 0.003506337758153677
histidines O 1 0.9999220371246338
that O 0 0.0018645018571987748
could O 0 0.0023603748995810747
be O 0 0.001554706715978682
involved O 0 0.005962795112282038
in O 0 0.004775489680469036
pH O 1 0.997829020023346
- O 0 0.04634318873286247
dependent O 0 0.04112981632351875
interactions O 0 0.02214292250573635
. O 0 0.008423112332820892

We O 0 0.0035040758084505796
also O 0 0.002112783957272768
demonstrate O 0 0.006136780139058828
that O 0 0.003184754867106676
soluble O 1 0.5611080527305603
TfR O 1 0.9998577833175659
and O 0 0.007908065803349018
HFE O 1 0.9999988079071045
bind O 0 0.0826084092259407
tightly O 0 0.020916122943162918
at O 0 0.002556100720539689
the O 0 0.0025736845564097166
basic O 0 0.010244593024253845
pH O 1 0.846920371055603
of O 0 0.0015263493405655026
the O 0 0.0044144620187580585
cell O 0 0.149607315659523
surface O 0 0.01439661718904972
, O 0 0.001737670274451375
but O 0 0.0017616054974496365
not O 0 0.001054015476256609
at O 0 0.002759939059615135
the O 0 0.004696376621723175
acidic O 1 0.9984499216079712
pH O 1 0.9600000381469727
of O 0 0.005423057824373245
intracellular O 1 0.990565299987793
vesicles O 1 0.9227991700172424
. O 0 0.011729135178029537

TfR O 1 0.9988803267478943
HFE O 1 0.9998579025268555
stoichiometry O 1 0.7306541204452515
( O 0 0.010988050140440464
2 O 0 0.014745756052434444
1 O 0 0.016042344272136688
) O 0 0.0041085900738835335
differs O 0 0.02154984138906002
from O 0 0.007613031193614006
TfR O 1 0.9998389482498169
transferrin O 1 0.9958871006965637
stoichiometry O 0 0.30235427618026733
( O 0 0.009659281000494957
2 O 0 0.01275716908276081
2 O 0 0.01323077455163002
) O 0 0.0036296709440648556
, O 0 0.0018783039413392544
implying O 0 0.02261553332209587
a O 0 0.004094117786735296
different O 0 0.0016369528602808714
mode O 0 0.021220317110419273
of O 0 0.0017085601575672626
binding O 0 0.014707316644489765
for O 0 0.004639709368348122
HFE O 1 0.9999884366989136
and O 0 0.004962678533047438
transferrin O 1 0.998173713684082
to O 0 0.00533895380795002
TfR O 1 0.9999550580978394
, O 0 0.002387920394539833
consistent O 0 0.007002776954323053
with O 0 0.0011421536328271031
our O 0 0.0026703414041548967
demonstration O 0 0.014102252200245857
that O 0 0.004481741692870855
HFE O 1 0.9999982118606567
, O 0 0.006423101294785738
transferrin O 1 0.9963066577911377
, O 0 0.0025971406139433384
and O 0 0.0035552342887967825
TfR O 1 0.9996811151504517
form O 0 0.009202880784869194
a O 0 0.009728862904012203
ternary O 0 0.18881343305110931
complex O 0 0.016957975924015045
. O 0 0.006703113671392202

Identification O 0 0.014863014221191406
of O 0 0.0014581935247406363
three O 0 0.0029979282990098
novel O 0 0.042769867926836014
mutations O 1 0.9993190765380859
and O 0 0.0012622139183804393
a O 0 0.004237458109855652
high O 0 0.006011215038597584
frequency O 0 0.014759854413568974
of O 0 0.001001625438220799
the O 0 0.003962993156164885
Arg778Leu O 1 0.9999873638153076
mutation O 1 0.9998971223831177
in O 0 0.003693056758493185
Korean O 0 0.030175337567925453
patients O 1 0.9999990463256836
with O 0 0.005315554793924093
Wilson B-Disease 1 0.999992847442627
disease I-Disease 1 1.0
. O 0 0.009972208179533482

Four O 0 0.019624048843979836
mutations O 1 0.9981691837310791
- O 0 0.06464731693267822
- O 0 0.072258859872818
R778L O 1 0.9960328936576843
, O 0 0.007060374598950148
A874V O 1 0.9973959922790527
, O 0 0.005818643607199192
L1083F O 1 0.9981389045715332
, O 0 0.0028712786734104156
and O 0 0.0031547248363494873
2304delC O 1 0.9997935891151428
- O 0 0.031071068719029427
- O 0 0.015117097645998001
in O 0 0.0019436401780694723
the O 0 0.003668435849249363
copper O 0 0.04031764343380928
- O 0 0.029575183987617493
transporting O 0 0.033670589327812195
enzyme O 0 0.11312886327505112
, O 0 0.0056330072693526745
P O 1 0.947635293006897
- O 0 0.05589715391397476
type O 0 0.18268892168998718
ATPase O 1 0.9988910555839539
( O 0 0.021554620936512947
ATP7B O 1 0.9999518394470215
) O 0 0.005820248741656542
, O 0 0.0013926856918260455
were O 0 0.0013135632034391165
identified O 0 0.009298211894929409
in O 0 0.00262365466915071
Korean O 0 0.057734545320272446
Patients O 1 0.9999973773956299
with O 0 0.0063318670727312565
Wilson B-Disease 1 0.9999955892562866
disease I-Disease 1 1.0
. O 0 0.00855167768895626

Arg778Leu O 1 0.996491014957428
, O 0 0.00334148365072906
the O 0 0.0027704136446118355
most O 0 0.004436679650098085
frequently O 0 0.012317841872572899
reported O 0 0.029583686962723732
mutation O 1 0.9995244741439819
of O 0 0.001935151289217174
this O 0 0.0038010114803910255
enzyme O 1 0.7414463758468628
, O 0 0.002068410161882639
was O 0 0.0051263985224068165
found O 0 0.0035433031152933836
in O 0 0.0010862610070034862
six O 0 0.0020460549276322126
of O 0 0.0013753465609624982
eight O 0 0.007791993208229542
unrelated O 1 0.8942762613296509
patients O 1 0.9999866485595703
studied O 0 0.0076929740607738495
, O 0 0.0016779899597167969
an O 0 0.0043220361694693565
allele O 1 0.9998791217803955
frequency O 0 0.03301890939474106
of O 0 0.003104623407125473
37 O 0 0.030443770810961723
. O 0 0.008270733058452606

5 O 0 0.02310868538916111
% O 0 0.006436687428504229
, O 0 0.0016213096678256989
which O 0 0.002001877874135971
is O 0 0.003577836789190769
considerably O 0 0.03091317042708397
higher O 0 0.006179735530167818
than O 0 0.0018438393017277122
those O 0 0.0011346654500812292
in O 0 0.0013878068421036005
other O 0 0.0015624677762389183
Asian O 0 0.02299974299967289
populations O 0 0.043321721255779266
. O 0 0.007462649140506983

The O 0 0.005816958379000425
novel O 0 0.020933086052536964
single O 0 0.024931373074650764
nucleotide O 0 0.15157261490821838
deletion O 1 0.986577033996582
, O 0 0.004249604418873787
2304delC O 1 0.9998512268066406
, O 0 0.00229129521176219
was O 0 0.005314543377608061
found O 0 0.0038883162196725607
in O 0 0.0016142074018716812
one O 0 0.007564872968941927
patient O 1 0.9998239874839783
. O 0 0.009076382964849472

Since O 0 0.021457960829138756
a O 0 0.018703583627939224
mutation O 1 0.995609700679779
at O 0 0.011606707237660885
cDNA O 0 0.1929427683353424
nucleotide O 0 0.23498600721359253
2302 O 1 0.9987793564796448
( O 0 0.017133869230747223
2302insC O 1 0.9986370205879211
) O 0 0.005731626413762569
had O 0 0.005210398230701685
been O 0 0.004603463690727949
previously O 0 0.0066145057789981365
described O 0 0.008793553337454796
, O 0 0.0010790814412757754
this O 0 0.0010658761020749807
region O 0 0.003648544428870082
of O 0 0.0011344195809215307
the O 0 0.0062263947911560535
ATP7B O 1 0.9999998807907104
gene O 1 0.9999549388885498
may O 0 0.007499736733734608
be O 0 0.0025864681228995323
susceptible O 1 0.9999406337738037
to O 0 0.0030637485906481743
gene O 1 0.9997162222862244
rearrangements O 1 0.9998469352722168
causing O 1 0.9999823570251465
Wilson B-Disease 1 0.9999816417694092
disease I-Disease 1 1.0
. O 0 0.0100410720333457

Disruption O 0 0.12049634009599686
of O 0 0.004657549783587456
splicing O 0 0.12363395094871521
regulated O 0 0.02281375043094158
by O 0 0.003401183057576418
a O 0 0.014114846475422382
CUG O 1 0.9999614953994751
- O 0 0.04367750138044357
binding O 0 0.031176520511507988
protein O 0 0.06534454971551895
in O 0 0.012784823775291443
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.013388344086706638

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.4287275969982147
DM B-Disease 1 1.0
) O 0 0.008097761310636997
is O 0 0.005164290312677622
caused O 1 0.9815918207168579
by O 0 0.0040276204235851765
a O 0 0.011891591362655163
CTG O 1 0.9982051849365234
expansion O 0 0.01255694031715393
in O 0 0.0016993549652397633
the O 0 0.003183674067258835
3 O 0 0.014741150662302971
untranslated O 0 0.1486974060535431
region O 0 0.009102852083742619
of O 0 0.002060417551547289
the O 0 0.014068057760596275
DM B-Disease 1 1.0
gene O 1 0.999338686466217
. O 0 0.009609542787075043

One O 0 0.0066589852795004845
model O 0 0.013518813997507095
of O 0 0.009797504171729088
DM B-Disease 1 1.0
pathogenesis O 1 0.9999955892562866
suggests O 0 0.02295754663646221
that O 0 0.0029206532053649426
RNAs O 0 0.07763056457042694
from O 0 0.002207721583545208
the O 0 0.003440544009208679
expanded O 0 0.01583995670080185
allele O 1 0.9983651041984558
create O 0 0.006919709034264088
a O 0 0.006148063112050295
gain O 0 0.014333189465105534
- O 0 0.014237897470593452
of O 0 0.002067528199404478
- O 0 0.027176395058631897
function O 0 0.030114246532320976
mutation O 1 0.9998433589935303
by O 0 0.0027470733039081097
the O 0 0.0023347828537225723
inappropriate O 0 0.01837245002388954
binding O 0 0.010743926279246807
of O 0 0.0018322232645004988
proteins O 0 0.01427240390330553
to O 0 0.0015120094176381826
the O 0 0.00673585245385766
CUG O 1 0.9999104738235474
repeats O 0 0.09887725114822388
. O 0 0.010264032520353794

Data O 0 0.005944815464317799
presented O 0 0.005135029554367065
here O 0 0.0022379711735993624
indicate O 0 0.006362427957355976
that O 0 0.001124800299294293
the O 0 0.002817547880113125
conserved O 0 0.03987842798233032
heterogeneous O 0 0.060156598687171936
nuclear O 0 0.017234910279512405
ribonucleoprotein O 1 0.8851197957992554
, O 0 0.007515334524214268
CUG O 1 0.9997921586036682
- O 0 0.0467979721724987
binding O 0 0.03431065008044243
protein O 0 0.0746384710073471
( O 0 0.01259770616889
CUG O 1 0.9997861981391907
- O 0 0.06505349278450012
BP O 0 0.4858390688896179
) O 0 0.005482406355440617
, O 0 0.0022753120865672827
may O 0 0.008521255105733871
mediate O 0 0.042395852506160736
the O 0 0.0073052565567195415
trans O 1 0.9631487727165222
- O 0 0.04088880494236946
dominant O 0 0.060540471225976944
effect O 0 0.011597536504268646
of O 0 0.001725509180687368
the O 0 0.005717698018997908
RNA O 0 0.15478745102882385
. O 0 0.008198709227144718

CUG O 1 0.9998944997787476
- O 0 0.06932036578655243
BP O 1 0.6740403175354004
was O 0 0.010059772990643978
found O 0 0.004727505147457123
to O 0 0.0016416758298873901
bind O 0 0.020947450771927834
to O 0 0.0015095343114808202
the O 0 0.004392845090478659
human O 0 0.0344059020280838
cardiac O 1 0.9999998807907104
troponin O 1 0.9999991655349731
T O 1 0.9999182224273682
( O 0 0.013211396522819996
cTNT O 1 0.9994733929634094
) O 0 0.006828817073255777
pre O 0 0.054277535527944565
- O 0 0.044089242815971375
messenger O 0 0.10863320529460907
RNA O 0 0.08628655225038528
and O 0 0.0024224238004535437
regulate O 0 0.021018223837018013
its O 0 0.003958636429160833
alternative O 0 0.021487964317202568
splicing O 0 0.13497567176818848
. O 0 0.007645811885595322

Splicing O 0 0.148346945643425
of O 0 0.005608392879366875
cTNT O 1 0.9980156421661377
was O 0 0.014125999994575977
disrupted O 0 0.23699578642845154
in O 0 0.014683771878480911
DM B-Disease 1 1.0
striated O 1 0.9999991655349731
muscle O 1 0.9999963045120239
and O 0 0.0020163217559456825
in O 0 0.002401556121185422
normal O 0 0.025450915098190308
cells O 0 0.04441339522600174
expressing O 0 0.02083994634449482
transcripts O 0 0.010881537571549416
that O 0 0.0024796873331069946
contain O 0 0.02297612838447094
CUG O 1 0.9999412298202515
repeats O 0 0.09497807919979095
. O 0 0.007796809542924166

Altered O 0 0.07563155144453049
expression O 0 0.02491219900548458
of O 0 0.0026160890702158213
genes O 0 0.09767815470695496
regulated O 0 0.036367982625961304
posttranscriptionally O 1 0.9930607080459595
by O 0 0.00882044993340969
CUG O 1 0.9999514818191528
- O 0 0.05425044894218445
BP O 1 0.8174968957901001
therefore O 0 0.006615223363041878
may O 0 0.007946759462356567
contribute O 0 0.015201408416032791
to O 0 0.00862265843898058
DM B-Disease 1 1.0
pathogenesis O 1 0.9999946355819702
. O 0 0.005999453831464052
. O 0 0.0064606270752847195

Identification O 0 0.01583150587975979
of O 0 0.00160659896209836
a O 0 0.007467906456440687
novel O 0 0.027689078822731972
nonsense O 1 0.82134610414505
mutation O 1 0.9998990297317505
and O 0 0.001638064393773675
a O 0 0.009321732446551323
missense O 1 0.9984014630317688
substitution O 0 0.029209764674305916
in O 0 0.0018745012348517776
the O 0 0.005704587325453758
vasopressin O 1 0.9999254941940308
- O 0 0.1740502268075943
neurophysin O 1 0.9998196959495544
II O 1 0.9998472929000854
gene O 1 0.7618346810340881
in O 0 0.001952698570676148
two O 0 0.0018162117339670658
Spanish O 0 0.0240346547216177
kindreds O 1 0.9984685778617859
with O 0 0.007956128567457199
familial B-Disease 1 0.9999998807907104
neurohypophyseal I-Disease 1 0.9999998807907104
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 0 0.013500715605914593

Familial B-Disease 1 0.9999992847442627
neurohypophyseal I-Disease 1 0.9999995231628418
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 0.03316909447312355
FNDI B-Disease 1 0.9999996423721313
) O 0 0.0038933646865189075
is O 0 0.0027185173239558935
an O 0 0.0053729224018752575
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999984502792358
disease I-Disease 1 1.0
caused O 1 0.9999984502792358
by O 0 0.010935620404779911
deficiency O 1 1.0
in O 0 0.002821246860548854
the O 0 0.007252470590174198
antidiuretic O 1 0.9999256134033203
hormone O 1 0.9993571639060974
arginine O 1 0.977976381778717
vasopressin O 1 0.9984258413314819
( O 0 0.018949994817376137
AVP O 1 0.9996277093887329
) O 0 0.004763265606015921
encoded O 0 0.016238080337643623
by O 0 0.0026365944650024176
the O 0 0.0061335936188697815
AVP O 1 0.999957799911499
- O 0 0.10894124954938889
neurophysin O 1 0.999595582485199
II O 1 0.9991828799247742
( O 0 0.015563609078526497
AVP O 1 0.9999886751174927
- O 0 0.2400791198015213
NPII O 1 0.9999574422836304
) O 0 0.010565713047981262
gene O 1 0.7110189199447632
on O 0 0.00779264559969306
chromosome O 1 0.9998747110366821
20p13 O 1 0.9933561086654663
. O 0 0.011514892801642418

In O 0 0.0037020749878138304
this O 0 0.002195619745180011
study O 0 0.00418375339359045
, O 0 0.001320881419815123
we O 0 0.0012125519569963217
analyzed O 0 0.01118389330804348
two O 0 0.0017111964989453554
families O 0 0.006520685739815235
with O 0 0.0036687038373202085
FNDI B-Disease 1 0.999991774559021
using O 0 0.005000177770853043
direct O 0 0.010367607697844505
automated O 0 0.04829633980989456
fluorescent O 0 0.07740183919668198
, O 0 0.0022307338658720255
solid O 0 0.0122672775760293
phase O 0 0.026238206773996353
, O 0 0.0020624755416065454
single O 0 0.01606440357863903
- O 0 0.03590160980820656
stranded O 0 0.1460661143064499
DNA O 0 0.04853617027401924
sequencing O 0 0.04391784593462944
of O 0 0.004555918741971254
PCR O 0 0.2446223795413971
- O 0 0.05361463502049446
amplified O 1 0.7743445038795471
AVP O 1 0.9999505281448364
- O 0 0.11717654764652252
NPII O 1 0.9992614388465881
DNA O 0 0.08352924138307571
. O 0 0.010254653170704842

In O 0 0.003636192297562957
one O 0 0.002680965233594179
of O 0 0.0012557379668578506
the O 0 0.002886987989768386
families O 0 0.006755463313311338
, O 0 0.0029458364006131887
affected O 1 0.555824875831604
individuals O 0 0.004564286209642887
presented O 0 0.004370855167508125
a O 0 0.007277424447238445
novel O 0 0.03104786016047001
nonsense O 0 0.41283199191093445
mutation O 1 0.9988771080970764
in O 0 0.005410455167293549
exon O 1 0.9918805956840515
3 O 0 0.009011955000460148
of O 0 0.0016254622023552656
the O 0 0.005723854526877403
gene O 1 0.9979801774024963
, O 0 0.0020851355511695147
consisting O 0 0.0051293764263391495
in O 0 0.0020194167736917734
a O 0 0.010662640444934368
G O 1 0.9974950551986694
to O 0 0.004870915785431862
T O 1 0.9942798614501953
transition O 0 0.022893749177455902
at O 0 0.010083154775202274
nucleotide O 0 0.16369591653347015
2101 O 1 0.9943292737007141
, O 0 0.0031398481223732233
which O 0 0.002653819043189287
produces O 0 0.01595127582550049
a O 0 0.0062902239151299
stop O 0 0.014801224693655968
signal O 0 0.022199654951691628
in O 0 0.004476439207792282
codon O 0 0.33716675639152527
82 O 0 0.07837942242622375
( O 0 0.017312973737716675
Glu O 1 0.9998182654380798
) O 0 0.006539686117321253
of O 0 0.004201636649668217
NPII O 1 0.9999333620071411
. O 0 0.010667899623513222

The O 0 0.013618823140859604
premature O 1 0.999372661113739
termination O 1 0.9814448952674866
eliminates O 0 0.07182206958532333
part O 0 0.005092446692287922
of O 0 0.0017717723967507482
the O 0 0.006252057384699583
C O 1 0.8537163138389587
- O 0 0.048938170075416565
terminal O 0 0.12392888218164444
domain O 0 0.023532835766673088
of O 0 0.0036798303481191397
NPII O 1 0.9998925924301147
, O 0 0.002049084287136793
including O 0 0.0016100752400234342
a O 0 0.0077615538612008095
cysteine O 0 0.08774683624505997
residue O 0 0.0660216212272644
in O 0 0.0023597953841090202
position O 0 0.008294139988720417
85 O 0 0.03470577672123909
, O 0 0.0017018779180943966
which O 0 0.0018163059139624238
could O 0 0.002595658414065838
be O 0 0.0013589980080723763
involved O 0 0.004011538811028004
in O 0 0.0012334971688687801
the O 0 0.0028723329305648804
correct O 0 0.022759893909096718
folding O 0 0.04714003577828407
of O 0 0.002319471910595894
the O 0 0.007038012612611055
prohormone O 1 0.9999322891235352
. O 0 0.011853964999318123

In O 0 0.003224601736292243
the O 0 0.003083769464865327
second O 0 0.01173215452581644
family O 0 0.012397831305861473
, O 0 0.0020811636932194233
a O 0 0.010552006773650646
G279A O 1 0.9978981018066406
substitution O 0 0.040694378316402435
at O 0 0.005038718227297068
position O 0 0.007478333543986082
- O 0 0.018168915063142776
1 O 0 0.0068909525871276855
of O 0 0.0013999314978718758
the O 0 0.0038648867048323154
signal O 0 0.04586871713399887
peptide O 0 0.19090956449508667
was O 0 0.009630659595131874
observed O 0 0.010309959761798382
in O 0 0.001553195295855403
all O 0 0.0020189022179692984
affected O 0 0.43789246678352356
individuals O 0 0.0076271588914096355
. O 0 0.006670147180557251

This O 0 0.01126123033463955
missense O 1 0.9996486902236938
mutation O 1 0.9999258518218994
, O 0 0.0032980963587760925
which O 0 0.003587178187444806
replaces O 1 0.9990745782852173
Ala O 1 0.9998844861984253
with O 0 0.008243502117693424
Thr O 1 0.9999978542327881
, O 0 0.0024316294584423304
is O 0 0.003740511368960142
frequent O 0 0.18346282839775085
among O 0 0.06237274408340454
FNDI B-Disease 1 1.0
patients O 1 0.9999995231628418
and O 0 0.0017767702229321003
is O 0 0.0031110472045838833
thought O 0 0.006761237978935242
to O 0 0.0012864737072959542
reduce O 0 0.01051673386245966
the O 0 0.0021655363962054253
efficiency O 0 0.008557485416531563
of O 0 0.003080124733969569
cleavage O 1 0.99460369348526
by O 0 0.0062590353190898895
signal O 0 0.044332846999168396
peptidases O 1 0.9852395057678223
. O 0 0.004451142158359289
. O 0 0.007104584015905857

Genetic O 0 0.12240361422300339
heterogeneity O 0 0.095782570540905
of O 0 0.00553813436999917
Saethre B-Disease 1 0.9999819993972778
- I-Disease 1 0.9987730383872986
Chotzen I-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
, O 0 0.0037399905268102884
due O 0 0.00910117942839861
to O 0 0.002495532389730215
TWIST O 1 0.9898091554641724
and O 0 0.00431818375363946
FGFR O 1 0.9999984502792358
mutations O 1 0.9997565150260925
. O 0 0.009460334666073322

Thirty O 0 0.050597481429576874
- O 0 0.028680022805929184
two O 0 0.004453268833458424
unrelated O 1 0.5906081795692444
patients O 1 0.999907374382019
with O 0 0.0014221741585060954
features O 0 0.004013851284980774
of O 0 0.0027513611130416393
Saethre B-Disease 1 0.9999986886978149
- I-Disease 1 0.9998370409011841
Chotzen I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
, O 0 0.002036597579717636
a O 0 0.006503619719296694
common O 1 0.6843299865722656
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9981127977371216
condition I-Disease 1 0.9863052368164062
of O 0 0.004282042849808931
craniosynostosis B-Disease 1 1.0
and O 0 0.013324013911187649
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9997277855873108
, O 0 0.0017283206107094884
were O 0 0.0019598763901740313
screened O 0 0.1017390787601471
for O 0 0.0034465689677745104
mutations O 1 0.9992753863334656
in O 0 0.003939059097319841
TWIST O 1 0.9959534406661987
, O 0 0.00550080044195056
FGFR2 O 1 0.99994957447052
, O 0 0.003436202649027109
and O 0 0.003900239011272788
FGFR3 O 1 0.9999884366989136
. O 0 0.009590158239006996

Nine O 0 0.014672324061393738
novel O 0 0.02050790749490261
and O 0 0.0015971624525263906
three O 0 0.005437562242150307
recurrent O 1 0.9999908208847046
TWIST O 1 0.9998629093170166
mutations O 1 0.9995543360710144
were O 0 0.0023110040929168463
found O 0 0.004804612603038549
in O 0 0.001944220159202814
12 O 0 0.009600217454135418
families O 0 0.011384601704776287
. O 0 0.007708391174674034

Seven O 0 0.009714566171169281
families O 0 0.0067910607904195786
were O 0 0.0018414993537589908
found O 0 0.0036547069903463125
to O 0 0.0009599800105206668
have O 0 0.0017979128751903772
the O 0 0.006620834115892649
FGFR3 O 1 0.9999997615814209
P250R O 1 0.9999755620956421
mutation O 1 0.9999872446060181
, O 0 0.0023656038101762533
and O 0 0.0009360054973512888
one O 0 0.002215924672782421
individual O 0 0.0026483144611120224
was O 0 0.006209331564605236
found O 0 0.003131471574306488
to O 0 0.0008049544994719326
have O 0 0.0014378847554326057
an O 0 0.004575145430862904
FGFR2 O 1 0.999995231628418
VV269 O 1 0.999092698097229
- O 0 0.061828646808862686
270 O 0 0.1108659878373146
deletion O 1 0.9900600910186768
. O 0 0.010052530094981194

To O 0 0.003755977377295494
date O 0 0.005029051098972559
, O 0 0.0016166423447430134
our O 0 0.0035578333772718906
detection O 0 0.0324774868786335
rate O 0 0.008189141750335693
for O 0 0.0028915901202708483
TWIST O 1 0.9908646941184998
or O 0 0.01207911316305399
FGFR O 1 0.9999958276748657
mutations O 1 0.9997319579124451
is O 0 0.004997969139367342
68 O 0 0.023750972002744675
% O 0 0.00334103568457067
in O 0 0.0015383471036329865
our O 0 0.005983193404972553
Saethre B-Disease 1 0.9999960660934448
- I-Disease 1 0.9996544122695923
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999998807907104
, O 0 0.001559011870995164
including O 0 0.0011111096246168017
our O 0 0.003085638163611293
five O 0 0.007419900503009558
patients O 1 0.9999853372573853
elsewhere O 0 0.010376667603850365
reported O 0 0.013546338304877281
with O 0 0.0038719738367944956
TWIST O 1 0.9997754693031311
mutations O 1 0.9999159574508667
. O 0 0.007211689371615648

More O 0 0.005027404986321926
than O 0 0.004163266159594059
35 O 0 0.011986732482910156
different O 0 0.002901635365560651
TWIST O 1 0.9995691180229187
mutations O 1 0.9999315738677979
are O 0 0.0015963474288582802
now O 0 0.004354860167950392
known O 0 0.005858954973518848
in O 0 0.0012788712047040462
the O 0 0.00214725686237216
literature O 0 0.00612932164222002
. O 0 0.005621448624879122

The O 0 0.005999630782753229
most O 0 0.004058578051626682
common O 0 0.01599452644586563
phenotypic O 1 0.9994584918022156
features O 0 0.007078408729285002
, O 0 0.0011946867452934384
present O 0 0.002003238070756197
in O 0 0.001071819569915533
more O 0 0.0010576779022812843
than O 0 0.001744321547448635
a O 0 0.003569442080333829
third O 0 0.005555449053645134
of O 0 0.0016084527596831322
our O 0 0.007126137148588896
patients O 1 0.9999951124191284
with O 0 0.003842888865619898
TWIST O 1 0.9999597072601318
mutations O 1 0.9999374151229858
, O 0 0.001877427101135254
are O 0 0.0016603406984359026
coronal B-Disease 1 0.9934593439102173
synostosis I-Disease 1 0.9984188079833984
, O 0 0.00425216369330883
brachycephaly B-Disease 1 0.999531626701355
, O 0 0.003952958155423403
low B-Disease 0 0.4948239028453827
frontal I-Disease 1 0.9999995231628418
hairline I-Disease 1 1.0
, O 0 0.009761404246091843
facial B-Disease 1 0.9999988079071045
asymmetry I-Disease 1 0.9997134804725647
, O 0 0.00920243188738823
ptosis B-Disease 1 1.0
, O 0 0.007432089652866125
hypertelorism B-Disease 1 0.9999831914901733
, O 0 0.0033971078228205442
broad B-Disease 0 0.028361419215798378
great I-Disease 0 0.025069359689950943
toes I-Disease 1 0.9999845027923584
, O 0 0.0024594012647867203
and O 0 0.003363256109878421
clinodactyly B-Disease 1 0.9999505281448364
. O 0 0.009270031936466694

Significant O 0 0.026023931801319122
intra O 0 0.15382789075374603
- O 0 0.032721228897571564
and O 0 0.004681671503931284
interfamilial O 1 0.9999204874038696
phenotypic O 1 0.9996941089630127
variability O 0 0.08545463532209396
is O 0 0.002570329001173377
present O 0 0.001584221376106143
for O 0 0.0011472951155155897
either O 0 0.0070798033848404884
TWIST O 1 0.9992904663085938
mutations O 1 0.9998551607131958
or O 0 0.016051800921559334
FGFR O 1 0.9999970197677612
mutations O 1 0.9997875094413757
. O 0 0.008322427049279213

The O 0 0.008200214244425297
overlap O 0 0.022396691143512726
in O 0 0.002983363810926676
clinical O 1 0.9622004628181458
features O 0 0.005804017651826143
and O 0 0.0010511876316741109
the O 0 0.002605263376608491
presence O 0 0.009237589314579964
, O 0 0.0009546052897349
in O 0 0.0008177691488526762
the O 0 0.002101714024320245
same O 0 0.004984567873179913
genes O 0 0.3454679250717163
, O 0 0.0014560172567144036
of O 0 0.002665570005774498
mutations O 1 0.9997218251228333
for O 0 0.0011673304252326488
more O 0 0.0010982576059177518
than O 0 0.0021145078353583813
one O 0 0.007034084759652615
craniosynostotic B-Disease 1 0.9999754428863525
condition I-Disease 1 0.9137687087059021
- O 0 0.01429507602006197
such O 0 0.0016444409266114235
as O 0 0.004461872391402721
Saethre B-Disease 1 0.9999562501907349
- I-Disease 0 0.11611278355121613
Chotzen I-Disease 1 0.9999170303344727
, I-Disease 0 0.005580735392868519
Crouzon I-Disease 1 0.9998692274093628
, I-Disease 0 0.002749792765825987
and I-Disease 0 0.004621724132448435
Pfeiffer I-Disease 1 0.9999992847442627
syndromes I-Disease 1 1.0
- O 0 0.02815302647650242
support O 0 0.004730162210762501
the O 0 0.0035784898791462183
hypothesis O 0 0.03481399267911911
that O 0 0.0032785546500235796
TWIST O 1 0.9595198631286621
and O 0 0.004113547503948212
FGFRs O 1 0.9997195601463318
are O 0 0.0011429741280153394
components O 0 0.0028901633340865374
of O 0 0.0010413541458547115
the O 0 0.002143299439921975
same O 0 0.005710806231945753
molecular O 0 0.03219417855143547
pathway O 0 0.06602292507886887
involved O 0 0.0057968623004853725
in O 0 0.0016155698103830218
the O 0 0.0034925080835819244
modulation O 0 0.36916929483413696
of O 0 0.00556426215916872
craniofacial O 1 0.9999997615814209
and O 0 0.006018039770424366
limb O 1 0.9999998807907104
development O 0 0.005057019647210836
in O 0 0.002898144768550992
humans O 0 0.029007485136389732
. O 0 0.002796791959553957
. O 0 0.005560485180467367

Mutation O 1 0.9922710657119751
analysis O 0 0.008256266824901104
of O 0 0.004185251891613007
UBE3A O 1 0.9999996423721313
in O 0 0.13455761969089508
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999996423721313
. O 0 0.008758808486163616

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.015816088765859604
AS B-Disease 0 0.061252694576978683
) O 0 0.0035750768147408962
is O 0 0.0039131841622292995
caused O 1 0.9991239905357361
by O 0 0.007906184531748295
chromosome O 1 0.999984860420227
15q11 O 1 0.9994375109672546
- O 0 0.057548459619283676
q13 O 1 0.9983546137809753
deletions O 0 0.09787798672914505
of O 0 0.0026820795610547066
maternal O 1 0.9992284774780273
origin O 0 0.005540981888771057
, O 0 0.0012645163806155324
by O 0 0.004862082656472921
paternal O 1 0.9999821186065674
uniparental B-Disease 1 0.9999995231628418
disomy I-Disease 1 0.9999713897705078
( O 0 0.020674491301178932
UPD B-Disease 1 0.9999990463256836
) O 0 0.0072293467819690704
15 O 0 0.007574140559881926
, O 0 0.0020602422300726175
by O 0 0.008119672536849976
imprinting O 1 0.9999879598617554
defects O 1 0.9999798536300659
, O 0 0.0022380584850907326
and O 0 0.0014097609091550112
by O 0 0.005028940737247467
mutations O 1 0.9986065030097961
in O 0 0.002387876156717539
the O 0 0.010654697194695473
UBE3A O 1 0.9999996423721313
gene O 1 0.9969298243522644
. O 0 0.009891687892377377

UBE3A O 1 0.9991276860237122
encodes O 0 0.1780550330877304
a O 0 0.020714499056339264
ubiquitin O 0 0.15253859758377075
- O 0 0.048907019197940826
protein O 0 0.06673374772071838
ligase O 0 0.04677262157201767
and O 0 0.0022162599489092827
shows O 0 0.016423340886831284
brain O 1 0.9999891519546509
- O 0 0.031310368329286575
specific O 0 0.010929242707788944
imprinting O 1 0.9967201352119446
. O 0 0.009450232610106468

Here O 0 0.004479679279029369
we O 0 0.0026464182883501053
describe O 0 0.023522524163126945
UBE3A O 1 0.9999213218688965
coding O 0 0.17651620507240295
- O 0 0.04332265630364418
region O 0 0.031919922679662704
mutations O 1 0.9998637437820435
detected O 0 0.08331635594367981
by O 0 0.007425894029438496
SSCP O 1 0.9989309906959534
analysis O 0 0.006727977190166712
in O 0 0.00277890102006495
13 O 0 0.01302409265190363
AS B-Disease 0 0.010380581952631474
individuals O 0 0.00511199701577425
or O 0 0.0048166848719120026
families O 0 0.010327835567295551
. O 0 0.006722017657011747

Two O 0 0.005111856386065483
identical O 0 0.018626181408762932
de O 0 0.03673258423805237
novo O 0 0.13616740703582764
5 O 0 0.018176190555095673
- O 0 0.034007053822278976
bp O 0 0.07467076182365417
duplications O 0 0.18242833018302917
in O 0 0.005709638819098473
exon O 1 0.9891379475593567
16 O 0 0.013669880107045174
were O 0 0.0023126734886318445
found O 0 0.007735227234661579
. O 0 0.006128811277449131

Among O 0 0.007125482428818941
the O 0 0.0024765683338046074
other O 0 0.0012073104735463858
11 O 0 0.010453305207192898
unique O 0 0.013596613891422749
mutations O 1 0.9999414682388306
, O 0 0.002472319407388568
8 O 0 0.009054288268089294
were O 0 0.0015450476203113794
small O 0 0.005779222119599581
deletions O 0 0.28548306226730347
or O 0 0.006794927641749382
insertions O 1 0.9287155866622925
predicted O 0 0.01982024312019348
to O 0 0.003425201401114464
cause O 1 0.9990257024765015
frameshifts O 1 0.9995473027229309
, O 0 0.0028752812650054693
1 O 0 0.00874294899404049
was O 0 0.006330433301627636
a O 0 0.00947966706007719
mutation O 1 0.9998480081558228
to O 0 0.001862440723925829
a O 0 0.007217802572995424
stop O 0 0.02740190550684929
codon O 0 0.16212043166160583
, O 0 0.002785297343507409
1 O 0 0.00824013352394104
was O 0 0.006801286246627569
a O 0 0.01349751278758049
missense O 1 0.9999756813049316
mutation O 1 0.9999696016311646
, O 0 0.0023080571554601192
and O 0 0.001403573201969266
1 O 0 0.009832793846726418
was O 0 0.007225716486573219
predicted O 0 0.014493489637970924
to O 0 0.003232756396755576
cause O 0 0.22482816874980927
insertion O 0 0.08656733483076096
of O 0 0.0018094228580594063
an O 0 0.003735787235200405
isoleucine O 1 0.995911717414856
in O 0 0.0024096532724797726
the O 0 0.004735328257083893
hect O 1 0.9959872364997864
domain O 0 0.020191049203276634
of O 0 0.0018377903616055846
the O 0 0.008439264260232449
UBE3A O 1 0.9999995231628418
protein O 0 0.06791971623897552
, O 0 0.0018135536229237914
which O 0 0.001693712081760168
functions O 0 0.004472452215850353
in O 0 0.004435828886926174
E2 O 1 0.9994681477546692
binding O 0 0.019629735499620438
and O 0 0.0028019356541335583
ubiquitin O 0 0.09527202695608139
transfer O 0 0.01243510376662016
. O 0 0.006902099121361971

Eight O 0 0.00778134586289525
of O 0 0.0015891212970018387
the O 0 0.003299152944236994
cases O 0 0.01071262639015913
were O 0 0.004009380470961332
familial O 1 0.9999996423721313
, O 0 0.001873489934951067
and O 0 0.001016313792206347
five O 0 0.002526232972741127
were O 0 0.002792053623124957
sporadic O 0 0.3678061068058014
. O 0 0.007545115891844034

In O 0 0.004681244492530823
two O 0 0.005490106996148825
familial O 1 0.9999986886978149
cases O 0 0.012423083186149597
and O 0 0.0013315166579559445
one O 0 0.003834367962554097
sporadic O 1 0.7597049474716187
case O 0 0.007943305186927319
, O 0 0.0037640295922756195
mosaicism O 1 0.9999417066574097
for O 0 0.008731468580663204
UBE3A O 1 0.9999997615814209
mutations O 1 0.9999420642852783
was O 0 0.012813370674848557
detected O 0 0.04419366642832756
in O 0 0.001343201263807714
the O 0 0.0025925789959728718
mother O 0 0.03306734189391136
of O 0 0.0012243236415088177
three O 0 0.0021206745877861977
AS B-Disease 0 0.06534601002931595
sons O 1 0.7579548954963684
, O 0 0.0013305487809702754
in O 0 0.001245039515197277
the O 0 0.003703188616782427
maternal O 1 0.9997833371162415
grandfather O 0 0.27401915192604065
of O 0 0.0013871709816157818
two O 0 0.00166441616602242
AS B-Disease 0 0.009297886863350868
first O 0 0.0066442121751606464
cousins O 1 0.9877347350120544
, O 0 0.0015379962278530002
and O 0 0.0007981141097843647
in O 0 0.0010825734352692962
the O 0 0.0026232670061290264
mother O 0 0.21334296464920044
of O 0 0.001233816728927195
an O 0 0.0031980157364159822
AS B-Disease 0 0.17581892013549805
daughter O 1 0.9975762963294983
. O 0 0.0067006670869886875

The O 0 0.007487874012440443
frequencies O 0 0.02001981995999813
with O 0 0.0013167019933462143
which O 0 0.0022711451165378094
we O 0 0.0038088266737759113
detected O 1 0.6905297636985779
mutations O 1 0.9944676160812378
were O 0 0.0039155674166977406
5 O 0 0.016141759231686592
( O 0 0.0075828395783901215
14 O 0 0.01318257674574852
% O 0 0.006060011684894562
) O 0 0.003042115829885006
of O 0 0.0016761523438617587
35 O 0 0.01022676657885313
in O 0 0.0026948365848511457
sporadic O 0 0.18172092735767365
cases O 0 0.012880033813416958
and O 0 0.0025541563518345356
8 O 0 0.01605989970266819
( O 0 0.005661443807184696
80 O 0 0.015015164390206337
% O 0 0.0055870418436825275
) O 0 0.002382220234721899
of O 0 0.001605938421562314
10 O 0 0.006532991770654917
in O 0 0.004817615263164043
familial O 1 0.9999980926513672
cases O 0 0.01647079363465309
. O 0 0.003346114419400692
. O 0 0.005679117515683174

The O 0 0.026010937988758087
hemochromatosis B-Disease 1 1.0
845 O 1 0.9997923970222473
G O 1 0.9994921684265137
- O 0 0.0649225264787674
- O 0 0.05455171316862106
> O 0 0.4503925144672394
A O 0 0.011095439083874226
and O 0 0.002319070277735591
187 O 0 0.07118803262710571
C O 1 0.5805720090866089
- O 0 0.04679030552506447
- O 0 0.0801219642162323
> O 1 0.9985003471374512
G O 1 0.9995160102844238
mutations O 1 0.9995075464248657
: O 0 0.008476990275084972
prevalence O 1 0.9917945265769958
in O 0 0.0035364185459911823
non O 0 0.017129022628068924
- O 0 0.06106442213058472
Caucasian O 1 0.9987245202064514
populations O 0 0.057507310062646866
. O 0 0.007666509598493576

Hemochromatosis B-Disease 1 0.9999998807907104
, O 0 0.003946748562157154
the O 0 0.009168379008769989
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 0 0.0047017429023981094
iron I-Disease 1 0.9999631643295288
metabolism I-Disease 1 0.9999756813049316
, O 0 0.0024996830616146326
leads O 0 0.015301310457289219
, O 0 0.0023436194751411676
if O 0 0.007132658269256353
untreated O 1 0.9999991655349731
, O 0 0.0018469274509698153
to O 0 0.0025960439816117287
progressive O 1 0.9999196529388428
iron B-Disease 1 0.998916745185852
overload I-Disease 1 0.9999799728393555
and O 0 0.005504242144525051
premature B-Disease 1 0.9999885559082031
death I-Disease 1 0.9493792653083801
. O 0 0.006408983841538429

The O 0 0.03270919620990753
hemochromatosis B-Disease 1 1.0
gene O 1 0.999346911907196
, O 0 0.007710795383900404
HFE O 1 0.9999990463256836
, O 0 0.0037436559796333313
recently O 0 0.01591534912586212
has O 0 0.003444066969677806
been O 0 0.004125014878809452
identified O 0 0.009929229505360126
, O 0 0.0014040064997971058
and O 0 0.0011691816616803408
characterization O 0 0.01680682972073555
of O 0 0.0012923594331368804
this O 0 0.00390734663233161
gene O 1 0.9990414977073669
has O 0 0.003820194862782955
shown O 0 0.005904149264097214
that O 0 0.001005607540719211
it O 0 0.001314307563006878
contains O 0 0.003846740582957864
two O 0 0.0028469040989875793
mutations O 1 0.999542236328125
that O 0 0.0016374702099710703
result O 0 0.006967287976294756
in O 0 0.003057140624150634
amino O 0 0.057278648018836975
acid O 0 0.1003492921590805
substitutions O 0 0.04069198668003082
- O 0 0.03945864364504814
cDNA O 0 0.16046369075775146
nucleotides O 0 0.10738290846347809
845 O 1 0.9871599674224854
G O 1 0.9930062294006348
- O 0 0.05201449245214462
- O 0 0.05711924284696579
> O 1 0.7946404218673706
A O 0 0.027000537142157555
( O 0 0.013692967593669891
C282Y O 1 0.9971011281013489
) O 0 0.004632892087101936
and O 0 0.0025984379462897778
187 O 0 0.0951908603310585
C O 0 0.14169786870479584
- O 0 0.05385807529091835
- O 0 0.08192306756973267
> O 1 0.9928285479545593
G O 1 0.997276246547699
( O 0 0.017621509730815887
H63D O 1 0.9997674822807312
) O 0 0.009152023121714592
. O 0 0.0060070282779634

Although O 0 0.0365767739713192
hemochromatosis B-Disease 1 1.0
is O 0 0.006821492221206427
common O 0 0.008445282466709614
in O 0 0.003058447502553463
Caucasians O 1 0.9997467398643494
, O 0 0.005193194840103388
affecting O 1 0.8491684198379517
> O 1 0.9987536668777466
= O 0 0.07072651386260986
1 O 0 0.02730494737625122
/ O 0 0.060601118952035904
300 O 0 0.012308835051953793
individuals O 0 0.0038888962008059025
of O 0 0.0017964893486350775
northern O 0 0.00934063270688057
European O 0 0.0053604962304234505
origin O 0 0.006350648123770952
, O 0 0.0015629283152520657
it O 0 0.0016189682064577937
has O 0 0.0023606151808053255
not O 0 0.0012616008752956986
been O 0 0.0033593710977584124
recognized O 0 0.007245093584060669
in O 0 0.0014491265174001455
other O 0 0.0018561910837888718
populations O 0 0.04830050840973854
. O 0 0.0071661327965557575

The O 0 0.005740438122302294
present O 0 0.003983845468610525
study O 0 0.0059983679093420506
used O 0 0.004776954185217619
PCR O 0 0.13484607636928558
and O 0 0.0029076735954731703
restriction O 0 0.04827209562063217
- O 0 0.046279340982437134
enzyme O 0 0.29414182901382446
digestion O 1 0.8467292785644531
to O 0 0.0023037174250930548
analyze O 0 0.009897877462208271
the O 0 0.002785689430311322
frequency O 0 0.01688501425087452
of O 0 0.001570216380059719
the O 0 0.00598163390532136
845 O 1 0.9999074935913086
G O 1 0.9994139671325684
- O 0 0.043783459812402725
- O 0 0.04864055663347244
> O 0 0.45637720823287964
A O 0 0.012075943872332573
and O 0 0.002624931512400508
187 O 0 0.07827838510274887
C O 0 0.22149667143821716
- O 0 0.04456757754087448
- O 0 0.06461373716592789
> O 1 0.9895647764205933
G O 1 0.9940887689590454
mutations O 1 0.9929057359695435
in O 0 0.008388770744204521
HLA O 1 0.9999902248382568
- O 0 0.04062216728925705
typed O 0 0.060201868414878845
samples O 0 0.01569000631570816
from O 0 0.0038912263698875904
non O 0 0.01764848828315735
- O 0 0.06251250952482224
Caucasian O 1 0.9903934597969055
populations O 0 0.03812331333756447
, O 0 0.0018993961857631803
comprising O 0 0.00814529974013567
Australian O 0 0.02721203863620758
Aboriginal O 0 0.03689556196331978
, O 0 0.0017758967587724328
Chinese O 0 0.002584667643532157
, O 0 0.001630915212444961
and O 0 0.0019071982242166996
Pacific O 0 0.03905205428600311
Islanders O 1 0.9056630730628967
. O 0 0.008982584811747074

Results O 0 0.016262779012322426
showed O 0 0.008856463246047497
that O 0 0.0012114275014027953
the O 0 0.005033514462411404
845 O 1 0.999963641166687
G O 1 0.9994387030601501
- O 0 0.05634305998682976
- O 0 0.06289437413215637
> O 1 0.9807877540588379
A O 0 0.03648519515991211
mutation O 1 0.9998785257339478
was O 0 0.007745723240077496
present O 0 0.0025699459947645664
in O 0 0.0017203978495672345
these O 0 0.001932406099513173
populations O 0 0.0369369313120842
( O 0 0.011755314655601978
allele O 1 0.9991245865821838
frequency O 0 0.06086486950516701
0 O 0 0.029413016512989998
. O 0 0.003221436869353056
32 O 0 0.02045571058988571
% O 0 0.007063707802444696
) O 0 0.003759997896850109
, O 0 0.0016703883884474635
and O 0 0.0014263754710555077
, O 0 0.001964971888810396
furthermore O 0 0.011544282548129559
, O 0 0.0012799722608178854
it O 0 0.0015105701750144362
was O 0 0.006069531664252281
always O 0 0.0040447525680065155
seen O 0 0.006630564108490944
in O 0 0.0016229761531576514
conjunction O 0 0.020027905702590942
with O 0 0.006532134488224983
HLA O 1 0.9999997615814209
haplotypes O 1 0.9979761242866516
common O 0 0.010686464607715607
in O 0 0.0029601254500448704
Caucasians O 1 0.9988670349121094
, O 0 0.0024703447706997395
suggesting O 0 0.014050713740289211
that O 0 0.003602128941565752
845 O 1 0.9997469782829285
G O 1 0.9992208480834961
- O 0 0.06583677977323532
- O 0 0.06894358992576599
> O 1 0.9728920459747314
A O 0 0.019144760444760323
may O 0 0.007597077637910843
have O 0 0.001514898962341249
been O 0 0.0033091744408011436
introduced O 0 0.0054028648883104324
into O 0 0.002358692232519388
these O 0 0.0015710598090663552
populations O 0 0.02575111761689186
by O 0 0.006723466794937849
Caucasian O 1 0.9972810745239258
admixture O 1 0.9917801022529602
. O 0 0.00987700093537569

187 O 0 0.14346538484096527
C O 0 0.313651442527771
- O 0 0.059928346425294876
- O 0 0.07088902592658997
> O 1 0.9910160303115845
G O 1 0.9005792140960693
was O 0 0.007080708164721727
present O 0 0.0026681008748710155
at O 0 0.003585723228752613
an O 0 0.006030180491507053
allele O 1 0.9957985281944275
frequency O 0 0.03414518013596535
of O 0 0.0025850117672234774
2 O 0 0.01397627778351307
. O 0 0.006075649987906218

68 O 0 0.05770445987582207
% O 0 0.005972723942250013
in O 0 0.001543219550512731
the O 0 0.002288640011101961
two O 0 0.0023383551742881536
populations O 0 0.03452116996049881
analyzed O 0 0.02169250324368477
( O 0 0.0060951728373765945
Australian O 0 0.020802456885576248
Aboriginal O 0 0.03120066411793232
and O 0 0.0019061038037762046
Chinese O 0 0.0050475639291107655
) O 0 0.005246284417808056
. O 0 0.005699207540601492

In O 0 0.003506934503093362
the O 0 0.0035145143046975136
Australian O 0 0.02179529331624508
Aboriginal O 0 0.03579379990696907
samples O 0 0.01755288988351822
, O 0 0.003662100527435541
187 O 0 0.09509232640266418
C O 0 0.49622678756713867
- O 0 0.05486820638179779
- O 0 0.070550337433815
> O 1 0.9953984618186951
G O 1 0.9937269687652588
was O 0 0.008280415087938309
found O 0 0.0038175787776708603
to O 0 0.0010343287140130997
be O 0 0.0016665552975609899
associated O 0 0.0068520051427185535
with O 0 0.005677109118551016
HLA O 1 0.9999998807907104
haplotypes O 1 0.9996433258056641
common O 0 0.01224098727107048
in O 0 0.003686078591272235
Caucasians O 1 0.9999544620513916
, O 0 0.0020523504354059696
suggesting O 0 0.01086097676306963
that O 0 0.0010673138312995434
it O 0 0.001822156016714871
was O 0 0.005745180416852236
introduced O 0 0.007885669358074665
by O 0 0.0032403923105448484
recent O 0 0.014760934747755527
admixture O 1 0.9492090940475464
. O 0 0.008285214193165302

In O 0 0.003187944646924734
the O 0 0.0027858088724315166
Chinese O 0 0.004269890021532774
samples O 0 0.01364901289343834
analyzed O 0 0.019769079983234406
, O 0 0.0035219204146414995
187 O 0 0.0767781138420105
C O 0 0.212614506483078
- O 0 0.05751950666308403
- O 0 0.07890156656503677
> O 1 0.9976484179496765
G O 1 0.9985707998275757
was O 0 0.007899163290858269
present O 0 0.002957213670015335
in O 0 0.0018532719695940614
association O 0 0.009062930010259151
with O 0 0.0014340064954012632
a O 0 0.004417965188622475
wide O 0 0.00828376691788435
variety O 0 0.004741840995848179
of O 0 0.005637533962726593
HLA O 1 1.0
haplotypes O 1 0.9996926784515381
, O 0 0.0022709614131599665
showing O 0 0.010065206326544285
this O 0 0.004080771002918482
mutation O 1 0.9999622106552124
to O 0 0.0023263078182935715
be O 0 0.0020334715954959393
widespread O 0 0.024811331182718277
and O 0 0.0016024420037865639
likely O 0 0.0072486610151827335
to O 0 0.0023622752632945776
predate O 0 0.051970239728689194
the O 0 0.0023463761899620295
more O 0 0.002576469210907817
genetically O 0 0.05514194443821907
restricted O 0 0.02931869402527809
845 O 1 0.9998488426208496
G O 1 0.9987524747848511
- O 0 0.04815945401787758
- O 0 0.05815441533923149
> O 1 0.9471918940544128
A O 0 0.0421721450984478
mutation O 1 0.9996581077575684
. O 0 0.010101495310664177

Genotype O 1 0.9999642372131348
- O 1 0.6446053385734558
phenotype O 1 0.999992847442627
correlations O 0 0.05634878948330879
in O 0 0.009994751773774624
attenuated B-Disease 1 0.9999983310699463
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 0.015667825937271118

Germ O 1 0.9890963435173035
- O 0 0.04338463395833969
line O 0 0.021675990894436836
mutations O 1 0.9048868417739868
of O 0 0.0021189928520470858
the O 0 0.009991119615733624
tumor B-Disease 1 1.0
suppressor O 1 0.9999998807907104
APC O 1 0.9999767541885376
are O 0 0.002382313134148717
implicated O 1 0.7710962295532227
in O 0 0.007533898111432791
attenuated B-Disease 1 0.9999997615814209
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 0.15045511722564697
AAPC B-Disease 1 0.9999998807907104
) O 0 0.005039291922003031
, O 0 0.001404905109666288
a O 0 0.007377067115157843
variant O 1 0.9974340796470642
of O 0 0.008599848486483097
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.8612908124923706
FAP B-Disease 1 1.0
) O 0 0.009148366749286652
. O 0 0.00609885947778821

AAPC B-Disease 1 0.9996763467788696
is O 0 0.008475388400256634
recognized O 0 0.011699771508574486
by O 0 0.0023418059572577477
the O 0 0.003371606348082423
occurrence O 0 0.07901317626237869
of O 0 0.003460297826677561
< O 1 0.9985370635986328
100 O 0 0.02474781684577465
colonic B-Disease 1 0.999984622001648
adenomas I-Disease 1 0.9999663829803467
and O 0 0.0016848520608618855
a O 0 0.0066182916052639484
later O 0 0.011680671945214272
onset O 1 0.9999995231628418
of O 0 0.20131680369377136
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.01241039577871561
age O 0 0.03888319060206413
> O 1 0.9982206225395203
40 O 0 0.011990448459982872
years O 0 0.005715828854590654
) O 0 0.004189705476164818
. O 0 0.005104562267661095

The O 0 0.004922664724290371
aim O 0 0.010014316998422146
of O 0 0.0011265621287748218
this O 0 0.0013827023794874549
study O 0 0.0030790853779762983
was O 0 0.0036516955588012934
to O 0 0.002377954078838229
assess O 0 0.04969314858317375
genotype O 1 0.9999830722808838
- O 1 0.5578296184539795
phenotype O 1 0.9999750852584839
correlations O 0 0.06955324858427048
in O 0 0.00897437147796154
AAPC B-Disease 1 0.9999910593032837
families O 0 0.021016830578446388
. O 0 0.007049158215522766

By O 0 0.015470894053578377
protein O 0 0.08595113456249237
- O 0 0.0499676913022995
truncation O 1 0.961846113204956
test O 0 0.02824757620692253
( O 0 0.009596417658030987
PTT O 1 0.9943215847015381
) O 0 0.00640232814475894
assay O 0 0.05178062617778778
, O 0 0.001655501895584166
the O 0 0.0029582118149846792
entire O 0 0.021083766594529152
coding O 0 0.058388203382492065
region O 0 0.007431590463966131
of O 0 0.001596610527485609
the O 0 0.008440843783318996
APC B-Disease 1 0.9999997615814209
gene O 1 0.9992660880088806
was O 0 0.011685010977089405
screened O 0 0.0487077571451664
in O 0 0.003260293509811163
affected O 0 0.05554566532373428
individuals O 0 0.004284646362066269
from O 0 0.005127639044076204
11 O 0 0.040793199092149734
AAPC B-Disease 1 0.9999998807907104
kindreds O 1 0.9992695450782776
, O 0 0.002422518329694867
and O 0 0.0011939950054511428
their O 0 0.0034196283668279648
phenotypic O 1 0.9989481568336487
differences O 0 0.009151102975010872
were O 0 0.0034298060927540064
examined O 0 0.041384339332580566
. O 0 0.00640897499397397

Five O 0 0.00929236225783825
novel O 0 0.04327116161584854
germ O 1 0.965783953666687
- O 0 0.048569630831480026
line O 0 0.03060692735016346
APC B-Disease 1 0.9999994039535522
mutations O 1 0.999313473701477
were O 0 0.0026338438037782907
identified O 0 0.008941621519625187
in O 0 0.001954013016074896
seven O 0 0.008959251455962658
kindreds O 1 0.9986768364906311
. O 0 0.008995221927762032

Mutations O 1 0.9994683861732483
were O 0 0.0032810205593705177
located O 0 0.006122029386460781
in O 0 0.0009978408925235271
three O 0 0.0010822758777067065
different O 0 0.0008346057729795575
regions O 0 0.005170811433345079
of O 0 0.0017248127842321992
the O 0 0.009661826305091381
APC B-Disease 1 0.9999991655349731
gene O 1 0.9979571104049683
( O 0 0.011250754818320274
1 O 0 0.01504480466246605
) O 0 0.0035797820892184973
at O 0 0.003022808115929365
the O 0 0.002881209598854184
5 O 0 0.010616268962621689
end O 0 0.01290866732597351
spanning O 0 0.04242273047566414
exons O 1 0.8880906105041504
4 O 0 0.016837365925312042
and O 0 0.0024027605541050434
5 O 0 0.011290756054222584
, O 0 0.0024565435014665127
( O 0 0.0056392718106508255
2 O 0 0.009468212723731995
) O 0 0.0029105558060109615
within O 0 0.005579345393925905
exon O 1 0.998736560344696
9 O 0 0.017268743366003036
, O 0 0.001823425991460681
and O 0 0.0018024164019152522
( O 0 0.006272702477872372
3 O 0 0.011054505594074726
) O 0 0.0029973583295941353
at O 0 0.0033886751625686884
the O 0 0.0042629302479326725
3 O 0 0.02841687761247158
distal O 1 0.9999399185180664
end O 0 0.009012253023684025
of O 0 0.002066652989014983
the O 0 0.006678151432424784
gene O 1 0.9893626570701599
. O 0 0.008779589086771011

Variability O 0 0.06666091829538345
in O 0 0.001631182967685163
the O 0 0.0018322775140404701
number O 0 0.0032153441570699215
of O 0 0.008944813162088394
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 0.014019113965332508
most O 0 0.0038241147994995117
apparent O 0 0.029816802591085434
in O 0 0.0018648169934749603
individuals O 0 0.004271277226507664
with O 0 0.003224276704713702
mutations O 1 0.999735414981842
in O 0 0.002538482192903757
region O 0 0.009006683714687824
1 O 0 0.008513524197041988
, O 0 0.001524375518783927
and O 0 0.0022068710532039404
upper O 1 0.999955415725708
- O 1 0.9997767806053162
gastrointestinal O 1 1.0
manifestations O 1 0.9973660111427307
were O 0 0.002046847715973854
more O 0 0.0033147060312330723
severe O 1 0.9999997615814209
in O 0 0.0018629850819706917
them O 0 0.0016927601536735892
. O 0 0.004814934451133013

In O 0 0.004936202894896269
individuals O 0 0.0049781580455601215
with O 0 0.003454281482845545
mutations O 1 0.9998859167098999
in O 0 0.0020061368122696877
either O 0 0.005032937042415142
region O 0 0.010820669122040272
2 O 0 0.010435578413307667
or O 0 0.004187897313386202
region O 0 0.012826060876250267
3 O 0 0.009571989066898823
, O 0 0.0014242917532101274
the O 0 0.001953789498656988
average O 0 0.006391163449734449
number O 0 0.0027937497943639755
of O 0 0.0037806520704180002
adenomas B-Disease 1 0.9999995231628418
tended O 0 0.024904968217015266
to O 0 0.0014753935392946005
be O 0 0.0023610969074070454
lower O 0 0.01093116495758295
than O 0 0.0020564778242260218
those O 0 0.0008847984136082232
in O 0 0.0012503106845542789
individuals O 0 0.003242282662540674
with O 0 0.003103292779996991
mutations O 1 0.9996784925460815
in O 0 0.0022526211105287075
region O 0 0.011684482917189598
1 O 0 0.009667477570474148
, O 0 0.0016761315055191517
although O 0 0.0045436653308570385
age O 0 0.011400552466511726
at O 0 0.008559341542422771
diagnosis O 1 0.9999983310699463
was O 0 0.010125386528670788
similar O 0 0.00793534331023693
. O 0 0.005541959311813116

In O 0 0.004896637983620167
all O 0 0.006226371042430401
AAPC B-Disease 1 0.9999995231628418
kindreds O 1 0.9970263838768005
, O 0 0.0023068960290402174
a O 0 0.00618769833818078
predominance O 1 0.676784336566925
of O 0 0.0024468107149004936
right O 1 0.8250972628593445
- O 1 0.9972346425056458
sided O 1 0.9999723434448242
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 0.013394822366535664
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 1 0.999101996421814
was O 0 0.015017188154160976
observed O 0 0.019216394051909447
. O 0 0.007526593282818794

No O 0 0.021414490416646004
desmoid B-Disease 1 0.9999957084655762
tumors I-Disease 1 0.9999998807907104
were O 0 0.00256301905028522
found O 0 0.004215292166918516
in O 0 0.0018352570477873087
these O 0 0.0024796000216156244
kindreds O 1 0.9967131614685059
. O 0 0.009874511510133743

Our O 0 0.005846035201102495
data O 0 0.0035480184014886618
suggest O 0 0.007493751589208841
that O 0 0.0017658333526924253
, O 0 0.0026378489565104246
in O 0 0.006807846948504448
AAPC B-Disease 1 0.9999997615814209
families O 0 0.011709067039191723
, O 0 0.0013972017914056778
the O 0 0.0018576689762994647
location O 0 0.0041531831957399845
of O 0 0.0014405916444957256
the O 0 0.007489971816539764
APC B-Disease 1 0.9999998807907104
mutation O 1 0.9999809265136719
may O 0 0.018124032765626907
partially O 0 0.05331839993596077
predict O 0 0.020854175090789795
specific O 0 0.009657972492277622
phenotypic O 1 0.9973835349082947
expression O 0 0.03962435573339462
. O 0 0.006941516418009996

This O 0 0.004043533466756344
should O 0 0.002194939646869898
help O 0 0.0035955358762294054
in O 0 0.0011929451720789075
the O 0 0.0018402894493192434
design O 0 0.0036807325668632984
of O 0 0.0022570558357983828
tailored O 0 0.1879827380180359
clinical O 1 0.9985431432723999
- O 0 0.03340461105108261
management O 0 0.016565920785069466
protocols O 0 0.011757596395909786
in O 0 0.0013465347001329064
this O 0 0.0024163706693798304
subset O 0 0.04766469448804855
of O 0 0.007739891763776541
FAP B-Disease 1 1.0
patients O 1 0.9999988079071045
. O 0 0.004299722611904144
. O 0 0.006453089881688356

Wilms B-Disease 1 0.9999979734420776
' I-Disease 1 0.9071081876754761
tumor I-Disease 1 0.9999922513961792
1 O 0 0.015586866065859795
and O 0 0.0028636339120566845
Dax O 1 0.9996015429496765
- O 0 0.028061402961611748
1 O 0 0.01775076985359192
modulate O 1 0.8099936246871948
the O 0 0.006446355022490025
orphan O 1 0.9993282556533813
nuclear O 0 0.02254893258213997
receptor O 1 0.9917235970497131
SF O 1 0.999858021736145
- O 0 0.03764254227280617
1 O 0 0.011207621544599533
in O 0 0.00295314216054976
sex O 0 0.023155922070145607
- O 0 0.026630787178874016
specific O 0 0.010705620050430298
gene O 1 0.9523023962974548
expression O 0 0.04365524277091026
. O 0 0.0063646710477769375

Products O 0 0.013564076274633408
of O 0 0.004695427604019642
steroidogenic O 1 0.9999754428863525
factor O 0 0.07182873040437698
1 O 0 0.020171795040369034
( O 0 0.011133840307593346
SF O 1 0.9999698400497437
- O 0 0.03613788262009621
1 O 0 0.01697961613535881
) O 0 0.005595737602561712
and O 0 0.0071876258589327335
Wilms B-Disease 1 1.0
tumor I-Disease 1 0.9999997615814209
1 O 0 0.03349706903100014
( O 0 0.015475239604711533
WT1 O 1 0.9999970197677612
) O 0 0.010653908364474773
genes O 0 0.06467372924089432
are O 0 0.001371819875203073
essential O 0 0.005733939819037914
for O 0 0.0029019045177847147
mammalian O 1 0.9965775609016418
gonadogenesis O 1 0.9982466697692871
prior O 0 0.009768610820174217
to O 0 0.002914909739047289
sexual O 0 0.02263220027089119
differentiation O 0 0.11043784022331238
. O 0 0.008239572867751122

In O 0 0.008176896721124649
males O 0 0.09483157843351364
, O 0 0.008164129219949245
SF O 1 0.9999979734420776
- O 0 0.04221546649932861
1 O 0 0.019152067601680756
participates O 0 0.03367486968636513
in O 0 0.0024647742975503206
sexual O 0 0.011100557632744312
development O 0 0.0029055478516966105
by O 0 0.003477249061688781
regulating O 0 0.03201042488217354
expression O 0 0.016361404210329056
of O 0 0.0014982267748564482
the O 0 0.007203125394880772
polypeptide O 1 0.9993334412574768
hormone O 1 0.9994378685951233
Mullerian O 1 0.9997220635414124
inhibiting O 1 0.9952574372291565
substance O 0 0.09809253364801407
( O 0 0.018759196624159813
MIS O 1 0.999811589717865
) O 0 0.010379818268120289
. O 0 0.00591132091358304

Here O 0 0.004967194050550461
, O 0 0.0018556928262114525
we O 0 0.0017419918440282345
show O 0 0.007052199449390173
that O 0 0.004657762125134468
WT1 O 1 0.9999971389770508
- O 0 0.16903990507125854
KTS O 1 0.9999314546585083
isoforms O 0 0.16859014332294464
associate O 0 0.013728095218539238
and O 0 0.0025317443069070578
synergize O 1 0.9965627789497375
with O 0 0.00874981191009283
SF O 1 0.9999691247940063
- O 0 0.03588882088661194
1 O 0 0.011217067949473858
to O 0 0.002853633835911751
promote O 0 0.02078021503984928
MIS O 1 0.9991669654846191
expression O 0 0.04552998021245003
. O 0 0.006707512307912111

In O 0 0.005431088153272867
contrast O 0 0.012934820726513863
, O 0 0.007980931550264359
WT1 O 1 0.9999998807907104
missense O 1 0.9999606609344482
mutations O 1 0.9997133612632751
, O 0 0.0026972396299242973
associated O 0 0.006159448996186256
with O 0 0.002194973174482584
male B-Disease 0 0.2336542308330536
pseudohermaphroditism I-Disease 1 0.9999785423278809
in O 0 0.006531809456646442
Denys B-Disease 1 0.9999978542327881
- I-Disease 1 0.9998564720153809
Drash I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
, O 0 0.004117592703551054
fail O 0 0.03570595756173134
to O 0 0.0026831079740077257
synergize O 1 0.9988335967063904
with O 0 0.007740016095340252
SF O 1 0.9999814033508301
- O 0 0.04082832112908363
1 O 0 0.021338429301977158
. O 0 0.006248485296964645

Additionally O 0 0.027939358726143837
, O 0 0.002694101072847843
the O 0 0.00557000981643796
X O 1 0.9953775405883789
- O 0 0.034556467086076736
linked O 0 0.038593586534261703
, O 0 0.003450003219768405
candidate O 0 0.030517978593707085
dosage O 1 0.9985906481742859
- O 0 0.033542390912771225
sensitive O 0 0.023973677307367325
sex O 0 0.026902003213763237
- O 0 0.04226915165781975
reversal O 1 0.5430903434753418
gene O 1 0.9656267166137695
, O 0 0.004852574318647385
Dax O 1 0.9997816681861877
- O 0 0.03164571523666382
1 O 0 0.016257576644420624
, O 0 0.004161376506090164
antagonizes O 1 0.9979971051216125
synergy O 0 0.16158896684646606
between O 0 0.011949708685278893
SF O 1 0.9999377727508545
- O 0 0.04621465876698494
1 O 0 0.02076590806245804
and O 0 0.005408577620983124
WT1 O 1 0.9999960660934448
, O 0 0.0030254393350332975
most O 0 0.002718366216868162
likely O 0 0.007115133572369814
through O 0 0.002781192073598504
a O 0 0.005498118698596954
direct O 0 0.007523925043642521
interaction O 0 0.012025781907141209
with O 0 0.006585817784070969
SF O 1 0.999983549118042
- O 0 0.04802827537059784
1 O 0 0.02073357068002224
. O 0 0.008438142016530037

We O 0 0.005322211887687445
propose O 0 0.022497622296214104
that O 0 0.005130751524120569
WT1 O 1 0.9999932050704956
and O 0 0.005326207261532545
Dax O 1 0.9999724626541138
- O 0 0.04067114368081093
1 O 0 0.026821592822670937
functionally O 1 0.80199134349823
oppose O 0 0.01466754823923111
each O 0 0.001872404245659709
other O 0 0.001017619390040636
in O 0 0.003573973197489977
testis O 1 0.9994938373565674
development O 0 0.006190836429595947
by O 0 0.007467185612767935
modulating O 1 0.9997478127479553
SF O 1 0.999962329864502
- O 0 0.041617728769779205
1 O 0 0.023246396332979202
- O 0 0.054095279425382614
mediated O 1 0.8061338067054749
transactivation O 1 0.9978904128074646
. O 0 0.006118920631706715
. O 0 0.00753822410479188

A O 0 0.03416162356734276
mouse O 1 0.9732822775840759
model O 0 0.01338335033506155
for O 0 0.0062028588727116585
Prader B-Disease 1 0.9999998807907104
- I-Disease 1 0.9998408555984497
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9999556541442871
- O 0 0.11742300540208817
centre O 0 0.05795041099190712
mutations O 1 0.9996693134307861
. O 0 0.007906109094619751

Imprinting O 1 0.9260808825492859
in O 0 0.0037827505730092525
the O 0 0.007071438245475292
15q11 O 1 0.9996615648269653
- O 0 0.06231418624520302
q13 O 1 0.9775920510292053
region O 0 0.0192719716578722
involves O 0 0.02171746827661991
an O 0 0.006888176314532757
imprinting O 1 0.9989814162254333
centre O 0 0.0339355543255806
( O 0 0.01388106495141983
IC O 1 0.9996339082717896
) O 0 0.004518123343586922
, O 0 0.00156257557682693
mapping O 0 0.013132859952747822
in O 0 0.0011913009220734239
part O 0 0.0032209286000579596
to O 0 0.0014879676746204495
the O 0 0.0044133784249424934
promoter O 1 0.9655005931854248
and O 0 0.0018285783007740974
first O 0 0.007123478688299656
exon O 1 0.9634237885475159
of O 0 0.005790231749415398
SNRPN O 1 0.9999926090240479
. O 0 0.012313885614275932

Deletion O 1 0.885744035243988
of O 0 0.0030189179815351963
this O 0 0.005676467902958393
IC O 1 0.9998005032539368
abolishes O 1 0.997660756111145
local O 0 0.014664990827441216
paternally O 1 0.9879944324493408
derived O 0 0.031543634831905365
gene O 1 0.9689489006996155
expression O 0 0.018430767580866814
and O 0 0.0010993927717208862
results O 0 0.005696759559214115
in O 0 0.00474420003592968
Prader B-Disease 1 1.0
- I-Disease 1 0.9999814033508301
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.5439165830612183
PWS B-Disease 1 1.0
) O 0 0.011323978193104267
. O 0 0.006795600056648254

We O 0 0.002731494139879942
have O 0 0.00169347261544317
created O 0 0.005292498040944338
two O 0 0.0036261999048292637
deletion O 1 0.9997323155403137
mutations O 1 0.9995777010917664
in O 0 0.0047120447270572186
mice O 1 0.9996516704559326
to O 0 0.0029396957252174616
understand O 0 0.020372163504362106
PWS B-Disease 1 0.9999998807907104
and O 0 0.0017354070441797376
the O 0 0.0024670124985277653
mechanism O 0 0.016140440478920937
of O 0 0.0021293580066412687
this O 0 0.0052623744122684
IC O 1 0.9994899034500122
. O 0 0.007791975513100624

Mice O 1 0.995684027671814
harbouring O 1 0.8674198389053345
an O 0 0.009743614122271538
intragenic O 1 0.9991142153739929
deletion O 1 0.9880425930023193
in O 0 0.005110804457217455
Snrpn O 1 0.9997480511665344
are O 0 0.0033389534801244736
phenotypically O 1 0.9984556436538696
normal O 0 0.023095177486538887
, O 0 0.0020092527847737074
suggesting O 0 0.013782194815576077
that O 0 0.0028597929049283266
mutations O 1 0.9991543292999268
of O 0 0.0031000045128166676
SNRPN O 1 0.9999986886978149
are O 0 0.0011418956564739347
not O 0 0.0011428386205807328
sufficient O 0 0.00568547286093235
to O 0 0.004606934264302254
induce O 1 0.9892343282699585
PWS B-Disease 1 0.9999996423721313
. O 0 0.016069358214735985

Mice O 1 0.9976270794868469
with O 0 0.0031312955543398857
a O 0 0.008330418728291988
larger O 0 0.016973959282040596
deletion O 1 0.979532778263092
involving O 0 0.01290552131831646
both O 0 0.00351440766826272
Snrpn O 1 0.9994482398033142
and O 0 0.002225287491455674
the O 0 0.00662502646446228
putative O 1 0.999893307685852
PWS O 1 0.9999996423721313
- O 0 0.11885900795459747
IC O 1 0.9970470070838928
lack O 0 0.019309906288981438
expression O 0 0.017292525619268417
of O 0 0.0014450496528297663
the O 0 0.0058908588252961636
imprinted O 1 0.9999457597732544
genes O 1 0.9817764163017273
Zfp127 O 1 0.9999066591262817
( O 0 0.015357336029410362
mouse O 1 0.998701810836792
homologue O 1 0.9966801404953003
of O 0 0.0067213973961770535
ZNF127 O 1 0.9999840259552002
) O 0 0.007464436814188957
, O 0 0.004250532481819391
Ndn O 1 0.9999352693557739
and O 0 0.004155572969466448
Ipw O 1 0.9991224408149719
, O 0 0.001821481273509562
and O 0 0.0014519859105348587
manifest O 0 0.04124154523015022
several O 0 0.003809174057096243
phenotypes O 1 0.9998676776885986
common O 0 0.012756545096635818
to O 0 0.009442749433219433
PWS B-Disease 1 1.0
infants O 1 0.9999932050704956
. O 0 0.010215619578957558

These O 0 0.002280808985233307
data O 0 0.0027568619698286057
demonstrate O 0 0.0057336268946528435
that O 0 0.0009864084422588348
both O 0 0.001104089431464672
the O 0 0.00163004279602319
position O 0 0.0035401207860559225
of O 0 0.0014110597549006343
the O 0 0.004751662723720074
IC O 1 0.9996353387832642
and O 0 0.0013824383495375514
its O 0 0.0021106840576976538
role O 0 0.005230416543781757
in O 0 0.001184430904686451
the O 0 0.0023904014378786087
coordinate O 0 0.014172685332596302
expression O 0 0.01864434778690338
of O 0 0.0023797499015927315
genes O 0 0.1250821352005005
is O 0 0.003686535404995084
conserved O 0 0.03160941228270531
between O 0 0.004482137970626354
mouse O 1 0.9999268054962158
and O 0 0.0020281970500946045
human O 0 0.006584585644304752
, O 0 0.0009736454230733216
and O 0 0.0008419977966696024
indicate O 0 0.005494712386280298
that O 0 0.0011072709457948804
the O 0 0.004180032294243574
mouse O 1 0.9997828602790833
is O 0 0.0029127984307706356
a O 0 0.005028602667152882
suitable O 0 0.010659277439117432
model O 0 0.007842401042580605
system O 0 0.005819175858050585
in O 0 0.0013946420513093472
which O 0 0.0014546043239533901
to O 0 0.001434014760889113
investigate O 0 0.011528552509844303
the O 0 0.003632921725511551
molecular O 0 0.026737671345472336
mechanisms O 0 0.01478236448019743
of O 0 0.002665336476638913
imprinting O 1 0.9968520998954773
in O 0 0.0020767792593687773
this O 0 0.001590930507518351
region O 0 0.005510026589035988
of O 0 0.0011016405187547207
the O 0 0.005177664570510387
genome O 1 0.9533840417861938
. O 0 0.0027966161724179983
. O 0 0.005693924613296986

Mutations O 1 0.9900269508361816
of O 0 0.0021821630652993917
the O 0 0.005458199884742498
ATM O 1 0.9866814613342285
gene O 1 0.9958670139312744
detected O 0 0.0593748614192009
in O 0 0.0031035668216645718
Japanese O 0 0.040237318724393845
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999821186065674
telangiectasia I-Disease 1 1.0
patients O 1 0.9999996423721313
: O 0 0.0036760279908776283
possible O 0 0.005779716651886702
preponderance O 0 0.06370418518781662
of O 0 0.001121344743296504
the O 0 0.002102586207911372
two O 0 0.002571313176304102
founder O 1 0.8806331157684326
mutations O 1 0.9999301433563232
4612del165 O 1 0.9995073080062866
and O 0 0.004895643796771765
7883del5 O 1 0.9985039234161377
. O 0 0.010594663210213184

The O 0 0.010374914854764938
ATM O 0 0.36796000599861145
( O 0 0.008464823476970196
A O 1 0.9915265440940857
- O 1 0.9888745546340942
T O 1 0.9999963045120239
, O 0 0.006278003565967083
mutated O 1 0.999963641166687
) O 0 0.0073063974268734455
gene O 1 0.8625215888023376
on O 0 0.0031980418134480715
human O 0 0.022505613043904305
chromosome O 1 0.9998530149459839
11q22 O 1 0.998256504535675
. O 0 0.009417498484253883

3 O 0 0.01912807486951351
has O 0 0.005265176296234131
recently O 0 0.012834353372454643
been O 0 0.003939714282751083
identified O 0 0.007922748103737831
as O 0 0.0016780274454504251
the O 0 0.003873937064781785
gene O 1 0.9949926733970642
responsible O 0 0.009479685686528683
for O 0 0.0011471342295408249
the O 0 0.003284023841843009
human O 1 0.9657737016677856
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.999893307685852
telangiectasia I-Disease 1 1.0
( O 0 0.015123297460377216
A B-Disease 1 0.9992963075637817
- I-Disease 1 0.9961005449295044
T I-Disease 1 0.999993085861206
) O 0 0.007998868823051453
. O 0 0.006012794096022844

In O 0 0.0033891985658556223
order O 0 0.00257235043682158
to O 0 0.0011729151010513306
define O 0 0.00557698355987668
the O 0 0.0024165865033864975
types O 0 0.007347186096012592
of O 0 0.004239923786371946
disease O 1 1.0
- O 1 0.9947011470794678
causing O 1 0.9999239444732666
ATM O 1 0.9962510466575623
mutations O 1 0.9966490864753723
in O 0 0.0024584748316556215
Japanese O 0 0.012506872415542603
A B-Disease 1 0.9994900226593018
- I-Disease 1 0.9999359846115112
T I-Disease 1 0.9999998807907104
patients O 1 0.9999887943267822
as O 0 0.0020611451473087072
well O 0 0.0012429511407390237
as O 0 0.001142573542892933
to O 0 0.001190429087728262
look O 0 0.003941729664802551
for O 0 0.0013651286717504263
possible O 0 0.0093974145129323
mutational O 1 0.9999637603759766
hotspots O 1 0.994865357875824
, O 0 0.004021721892058849
reverse O 0 0.04655388742685318
- O 0 0.03381595015525818
transcribed O 0 0.07091889530420303
RNA O 0 0.09979191422462463
derived O 0 0.013119838200509548
from O 0 0.0038552808109670877
ten O 0 0.015326907858252525
patients O 1 0.9998230338096619
belonging O 0 0.014834734611213207
to O 0 0.0016607627039775252
eight O 0 0.005350219551473856
unrelated O 0 0.02737240120768547
Japanese O 0 0.013306153006851673
A B-Disease 1 0.9647378921508789
- I-Disease 1 0.9958943128585815
T I-Disease 1 0.9999911785125732
families O 0 0.00870190653949976
was O 0 0.007240186911076307
analyzed O 0 0.01449745986610651
for O 0 0.003443483030423522
mutations O 1 0.9976670742034912
by O 0 0.0033529670909047127
the O 0 0.004212202504277229
restriction O 0 0.067596934735775
endonuclease O 1 0.9946444034576416
fingerprinting O 0 0.06174157187342644
method O 0 0.018569691106677055
. O 0 0.007520382292568684

As O 0 0.005187773611396551
has O 0 0.00463224109262228
been O 0 0.005378702189773321
reported O 0 0.011866649612784386
by O 0 0.0030037329997867346
others O 0 0.004833724815398455
, O 0 0.00360704748891294
mutations O 1 0.9998393058776855
that O 0 0.0015270732110366225
lead O 0 0.008636204525828362
to O 0 0.00357245234772563
exon O 1 0.9967213273048401
skipping O 0 0.11799353361129761
or O 0 0.011432277038693428
premature O 1 0.9983697533607483
protein O 0 0.08006157726049423
truncation O 1 0.969072699546814
were O 0 0.0017698726151138544
also O 0 0.0019371535163372755
predominant O 0 0.027808183804154396
in O 0 0.0016873007407411933
our O 0 0.005354438442736864
mutants O 1 0.9994763731956482
. O 0 0.008339019492268562

Six O 0 0.010776852257549763
different O 0 0.005087709054350853
mutations O 1 0.9992350339889526
were O 0 0.0020629665814340115
identified O 0 0.00814661756157875
on O 0 0.001520061050541699
12 O 0 0.004008229356259108
of O 0 0.0010728002525866032
the O 0 0.0033637068700045347
16 O 0 0.022780610248446465
alleles O 1 0.9997770190238953
examined O 0 0.059546757489442825
. O 0 0.008373633027076721

Four O 0 0.006962687708437443
were O 0 0.003452814184129238
deletions O 0 0.23731398582458496
involving O 0 0.011643177829682827
a O 0 0.0073753418400883675
loss O 0 0.02329782024025917
of O 0 0.0016538233030587435
a O 0 0.006795307621359825
single O 0 0.023977085947990417
exon O 1 0.9983957409858704
exon O 1 0.9973452687263489
7 O 0 0.01994827203452587
, O 0 0.0037980552297085524
exon O 1 0.9808957576751709
16 O 0 0.012295695021748543
, O 0 0.0037566593382507563
exon O 1 0.9982033967971802
33 O 0 0.02743801474571228
or O 0 0.0072359349578619
exon O 1 0.9928721785545349
35 O 0 0.02483033388853073
. O 0 0.007601993624120951

The O 0 0.005101851187646389
others O 0 0.004654593300074339
were O 0 0.0022022193297743797
minute O 0 0.02058819867670536
deletions O 0 0.2534596025943756
, O 0 0.0035774523857980967
4649delA O 1 0.997421145439148
in O 0 0.004324150271713734
exon O 1 0.9980314373970032
33 O 0 0.021388936787843704
and O 0 0.0028422854375094175
7883del5 O 1 0.9962770342826843
in O 0 0.005338921211659908
exon O 1 0.993128776550293
55 O 0 0.042831528931856155
. O 0 0.008440245874226093

The O 0 0.020209532231092453
mutations O 1 0.9996815919876099
4612del165 O 1 0.999171257019043
and O 0 0.004420583602041006
7883del5 O 1 0.9989224672317505
were O 0 0.0025071108248084784
found O 0 0.0046243201941251755
in O 0 0.0011366333346813917
more O 0 0.001594759989529848
than O 0 0.0024763683322817087
two O 0 0.0027237138710916042
unrelated O 0 0.0355558767914772
families O 0 0.01124489028006792
; O 0 0.005118647124618292
44 O 0 0.0209647286683321
% O 0 0.008548572659492493
( O 0 0.006683543790131807
7 O 0 0.010635974816977978
of O 0 0.002157163107767701
16 O 0 0.010161342099308968
) O 0 0.0022867314983159304
of O 0 0.001184677123092115
the O 0 0.006781498435884714
mutant O 1 0.9999463558197021
alleles O 1 0.99953293800354
had O 0 0.005134571343660355
one O 0 0.0015597230521962047
of O 0 0.000842034351080656
the O 0 0.0020542889833450317
two O 0 0.003681536763906479
mutations O 1 0.9993756413459778
. O 0 0.008625291287899017

The O 0 0.017384475097060204
4612del165 O 1 0.999966025352478
mutations O 1 0.9994091987609863
in O 0 0.002112224232405424
three O 0 0.0018389663891866803
different O 0 0.001244872808456421
families O 0 0.00366165186278522
were O 0 0.0010729669593274593
all O 0 0.0011827332200482488
ascribed O 0 0.029161594808101654
to O 0 0.0010850912658497691
the O 0 0.002781567396596074
same O 0 0.00916206557303667
T O 1 0.9996460676193237
- O 0 0.056148823350667953
- O 0 0.055796194821596146
> O 1 0.6989580392837524
A O 0 0.015157425776124
substitution O 0 0.029364442452788353
at O 0 0.00418603653088212
the O 0 0.006522619631141424
splice O 1 0.9944446682929993
donor O 0 0.07987472414970398
site O 0 0.010429730638861656
in O 0 0.005411794874817133
intron O 1 0.9997690320014954
33 O 0 0.03913799673318863
. O 0 0.0078477393835783

Microsatellite O 1 0.9893792271614075
genotyping O 0 0.37461140751838684
around O 0 0.005988544784486294
the O 0 0.00566102983430028
ATM O 1 0.994259238243103
locus O 1 0.9999740123748779
also O 0 0.0030156015418469906
indicated O 0 0.007287649437785149
that O 0 0.001118236337788403
a O 0 0.005836246535181999
common O 0 0.013278422877192497
haplotype O 1 0.9983258843421936
was O 0 0.006335210520774126
shared O 0 0.0053188735619187355
by O 0 0.002693401649594307
the O 0 0.005641886964440346
mutant O 1 0.9999467134475708
alleles O 1 0.9994776844978333
in O 0 0.003423976246267557
both O 0 0.006456735078245401
mutations O 1 0.9997219443321228
. O 0 0.008829042315483093

This O 0 0.005338518880307674
suggests O 0 0.010501748882234097
that O 0 0.0008966649766080081
these O 0 0.000821453460957855
two O 0 0.002144260099157691
founder O 1 0.9796319603919983
mutations O 1 0.9999871253967285
may O 0 0.009245658293366432
be O 0 0.0021099045407027006
predominant O 0 0.03357360139489174
among O 0 0.005763983353972435
Japanese O 0 0.01749599352478981
ATM O 1 0.9862720966339111
mutant O 1 0.9992597699165344
alleles O 1 0.9988289475440979
. O 0 0.011562343686819077

W474C O 1 0.9699808955192566
amino O 0 0.11670789122581482
acid O 0 0.1598377674818039
substitution O 0 0.08551286160945892
affects O 0 0.2990984320640564
early O 0 0.008932659402489662
processing O 0 0.005161992274224758
of O 0 0.001406703144311905
the O 0 0.004917533602565527
alpha O 0 0.0917605459690094
- O 0 0.03386100381612778
subunit O 0 0.10454782843589783
of O 0 0.004669478163123131
beta O 0 0.10421933233737946
- O 0 0.05512377247214317
hexosaminidase O 1 0.9951764345169067
A O 0 0.01251599658280611
and O 0 0.001694709761068225
is O 0 0.0037378505803644657
associated O 0 0.010103627108037472
with O 0 0.007669408805668354
subacute O 1 1.0
G B-Disease 1 0.9999167919158936
( I-Disease 0 0.016923852264881134
M2 I-Disease 1 0.9968414306640625
) I-Disease 0 0.010328395292162895
gangliosidosis I-Disease 1 0.9994922876358032
. O 0 0.007952569052577019

Mutations O 1 0.9945993423461914
in O 0 0.0037992459256201982
the O 0 0.010107633657753468
HEXA O 1 0.9999995231628418
gene O 1 0.9788845777511597
, O 0 0.0027448299806565046
encoding O 0 0.02785603515803814
the O 0 0.00480507779866457
alpha O 0 0.08396001160144806
- O 0 0.029549898579716682
subunit O 0 0.10409979522228241
of O 0 0.004101876635104418
beta O 0 0.093318872153759
- O 0 0.058546606451272964
hexosaminidase O 1 0.996405839920044
A O 0 0.02163252793252468
( O 0 0.007756739854812622
Hex O 1 0.7384929060935974
A O 0 0.017698176205158234
) O 0 0.003244484541937709
, O 0 0.001039788592606783
that O 0 0.0014786685351282358
abolish O 0 0.051116179674863815
Hex O 0 0.13361608982086182
A O 0 0.018367325887084007
enzyme O 0 0.11119019985198975
activity O 0 0.02386736311018467
cause O 1 0.9997641444206238
Tay B-Disease 1 1.0
- I-Disease 1 0.9997308850288391
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.030735475942492485
TSD B-Disease 1 0.9999998807907104
) O 0 0.0044964030385017395
, O 0 0.0014823024393990636
the O 0 0.00776218855753541
fatal O 1 1.0
infantile B-Disease 1 0.9999998807907104
form I-Disease 0 0.011378668248653412
of I-Disease 0 0.004498422611504793
G I-Disease 1 0.9999446868896484
( I-Disease 0 0.011914302594959736
M2 I-Disease 1 0.998915433883667
) I-Disease 0 0.010754077695310116
gangliosidosis I-Disease 1 0.9994458556175232
, I-Disease 0 0.004201244097203016
Type I-Disease 0 0.053403522819280624
1 I-Disease 0 0.015245428308844566
. O 0 0.007120252121239901

Less O 0 0.03404902294278145
severe O 1 0.999996542930603
, O 0 0.009195397607982159
subacute O 1 0.9999998807907104
( O 0 0.019116545096039772
juvenile O 1 0.9999749660491943
- O 1 0.9937412142753601
onset O 1 0.9999998807907104
) O 0 0.005549364723265171
and O 0 0.0047469837591052055
chronic O 1 1.0
( O 0 0.017349330708384514
adult O 1 0.9959153532981873
- O 1 0.9973141551017761
onset O 1 0.9999996423721313
) O 0 0.007066139951348305
variants O 0 0.04480833560228348
are O 0 0.0014305367367342114
characterized O 0 0.03888576105237007
by O 0 0.0024158144369721413
a O 0 0.007586641702800989
broad O 0 0.0208204984664917
spectrum O 0 0.04043266922235489
of O 0 0.003613947192206979
clinical O 1 0.9995536208152771
manifestations O 1 0.986711323261261
and O 0 0.0012368595926091075
are O 0 0.0007770982338115573
associated O 0 0.0056418925523757935
with O 0 0.00149522942956537
residual O 1 0.5199528932571411
levels O 0 0.010337671265006065
of O 0 0.0027827927842736244
Hex O 1 0.7816071510314941
A O 0 0.02568316087126732
enzyme O 0 0.13070048391819
activity O 0 0.019304823130369186
. O 0 0.00750714773312211

We O 0 0.005521273706108332
identified O 0 0.015345844440162182
a O 0 0.017954031005501747
1422 O 1 0.9999839067459106
G O 1 0.9971672892570496
- O 0 0.06404329836368561
- O 0 0.07984495908021927
> O 1 0.9868740439414978
C O 0 0.30093926191329956
( O 0 0.010457484051585197
amino O 0 0.07963090389966965
acid O 0 0.36860209703445435
W474C O 1 0.9940810799598694
) O 0 0.0059806304052472115
substitution O 0 0.0228208489716053
in O 0 0.0011900566751137376
the O 0 0.0015014023520052433
first O 0 0.0030109372455626726
position O 0 0.003909869585186243
of O 0 0.0023941395338624716
exon O 1 0.998288094997406
13 O 0 0.011040064506232738
of O 0 0.0040678768418729305
HEXA O 1 0.9999879598617554
of O 0 0.002590544056147337
a O 0 0.00829286128282547
non O 0 0.012640941888093948
- O 0 0.029288457706570625
Jewish O 0 0.02145121805369854
proband O 1 0.9997426867485046
who O 0 0.00983044970780611
manifested O 1 0.9941030144691467
a O 0 0.023808220401406288
subacute O 1 0.9999998807907104
variant O 1 0.9925228953361511
of O 0 0.0065044816583395
G B-Disease 1 0.9994115829467773
( I-Disease 0 0.01491579134017229
M2 I-Disease 1 0.9969257712364197
) I-Disease 0 0.011319056153297424
gangliosidosis I-Disease 1 0.9983665347099304
. O 0 0.010429765097796917

On O 0 0.003020847449079156
the O 0 0.0029150154441595078
second O 0 0.019490934908390045
maternally O 1 0.999962568283081
inherited O 1 0.999990701675415
allele O 1 0.9999077320098877
, O 0 0.002011431148275733
we O 0 0.0012220365460962057
identified O 0 0.007386347278952599
the O 0 0.002890177071094513
common O 1 0.9234430193901062
infantile O 1 1.0
disease O 1 1.0
- O 1 0.9780594110488892
causing O 1 0.999579131603241
4 O 0 0.021411048248410225
- O 0 0.03805699944496155
bp O 0 0.08607947826385498
insertion O 0 0.15642951428890228
, O 0 0.006943291984498501
+ O 0 0.4477955400943756
TATC O 1 0.9999467134475708
1278 O 1 0.9998594522476196
, O 0 0.00315504870377481
in O 0 0.0035296750720590353
exon O 1 0.9940851926803589
11 O 0 0.01782991737127304
. O 0 0.0071275201626122

Pulse O 1 0.9319006204605103
- O 0 0.060048907995224
chase O 0 0.08407038450241089
analysis O 0 0.009107486344873905
using O 0 0.010089829564094543
proband O 1 0.997846245765686
fibroblasts O 1 0.9985716342926025
revealed O 0 0.016055507585406303
that O 0 0.0014066991861909628
the O 0 0.004339896608144045
W474C O 1 0.9990875720977783
- O 0 0.031388163566589355
containing O 0 0.018358789384365082
alpha O 0 0.09521307796239853
- O 0 0.04848570376634598
subunit O 0 0.19064955413341522
precursor O 0 0.06563284993171692
was O 0 0.011435355059802532
normally O 0 0.015160986222326756
synthesized O 0 0.04438125342130661
, O 0 0.0019047156674787402
but O 0 0.00199777539819479
not O 0 0.002627946902066469
phosphorylated O 1 0.9715292453765869
or O 0 0.00713255675509572
secreted O 1 0.8039840459823608
, O 0 0.001406168914400041
and O 0 0.0011057230876758695
the O 0 0.00432737497612834
mature O 0 0.3384156823158264
lysosomal O 1 0.9997511506080627
alpha O 0 0.1582404375076294
- O 0 0.044832341372966766
subunit O 0 0.16896362602710724
was O 0 0.010340778157114983
not O 0 0.003962298389524221
detected O 0 0.08512131869792938
. O 0 0.008376016281545162

When O 0 0.013099061325192451
the O 0 0.008300029672682285
W474C O 1 0.9915851354598999
- O 0 0.035347044467926025
containing O 0 0.016660179942846298
alpha O 0 0.09502284973859787
- O 0 0.04343516752123833
subunit O 0 0.1690407246351242
was O 0 0.02094872295856476
transiently O 1 0.9955058097839355
co O 0 0.04127389192581177
- O 0 0.024675991386175156
expressed O 0 0.007849862799048424
with O 0 0.0016445622313767672
the O 0 0.004785269033163786
beta O 0 0.09338761121034622
- O 0 0.036114245653152466
subunit O 0 0.12003293633460999
to O 0 0.00310081266798079
produce O 0 0.008550586178898811
Hex O 0 0.14720898866653442
A O 0 0.02704748511314392
( O 0 0.012720545753836632
alphabeta O 1 0.9929653406143188
) O 0 0.005985059309750795
in O 0 0.005775348749011755
COS O 1 0.9999628067016602
- O 0 0.047677792608737946
7 O 0 0.030751964077353477
cells O 0 0.04343925788998604
, O 0 0.0018772691255435348
the O 0 0.004318901337683201
mature O 0 0.07903984934091568
alpha O 0 0.1208370104432106
- O 0 0.04918808862566948
subunit O 0 0.1510581374168396
was O 0 0.009388922713696957
present O 0 0.003423751564696431
, O 0 0.0015459881396964192
but O 0 0.0015386627055704594
its O 0 0.002284252317622304
level O 0 0.005234373267740011
was O 0 0.007116367109119892
much O 0 0.005473161116242409
lower O 0 0.01196192018687725
than O 0 0.0019115399336442351
that O 0 0.0009281618986278772
from O 0 0.003205951303243637
normal O 0 0.02363312616944313
alpha O 0 0.10456176847219467
- O 0 0.05879552662372589
subunit O 1 0.8880656957626343
transfections O 1 0.9989591836929321
, O 0 0.002694006310775876
although O 0 0.003176442813128233
higher O 0 0.004234015010297298
than O 0 0.0015425251331180334
in O 0 0.0014272178523242474
those O 0 0.002479501301422715
cells O 0 0.3585844039916992
transfected O 1 0.9865009188652039
with O 0 0.002514365827664733
an O 0 0.004241395741701126
alpha O 0 0.10610545426607132
- O 0 0.050826165825128555
subunit O 0 0.16430708765983582
associated O 0 0.014398843981325626
with O 0 0.007513489108532667
infantile O 1 0.9999997615814209
TSD B-Disease 1 0.9999784231185913
. O 0 0.01450152788311243

Furthermore O 0 0.027837097644805908
, O 0 0.0017715058056637645
the O 0 0.0030925541650503874
precursor O 0 0.03817414864897728
level O 0 0.0039020369295030832
of O 0 0.0015608713729307055
the O 0 0.0058120740577578545
W474C O 1 0.9989662170410156
alpha O 0 0.13211312890052795
- O 0 0.04823577404022217
subunit O 0 0.16354669630527496
was O 0 0.008819100446999073
found O 0 0.004786834120750427
to O 0 0.001795274787582457
accumulate O 0 0.03970713168382645
in O 0 0.0018052463419735432
comparison O 0 0.0057444884441792965
to O 0 0.0009772572666406631
the O 0 0.003186011454090476
normal O 0 0.03070523403584957
alpha O 0 0.09995590895414352
- O 0 0.05580770969390869
subunit O 0 0.19571825861930847
precursor O 0 0.08636462688446045
levels O 0 0.02377662993967533
. O 0 0.008452114649116993

We O 0 0.0037769058253616095
conclude O 0 0.012820085510611534
that O 0 0.0015974810812622309
the O 0 0.0051325848326087
1422 O 1 0.9999780654907227
G O 1 0.9990930557250977
- O 0 0.05241580307483673
- O 0 0.06674207746982574
> O 1 0.9800312519073486
C O 1 0.9597946405410767
mutation O 1 0.9996939897537231
is O 0 0.0036193490959703922
the O 0 0.0031860144808888435
cause O 0 0.04746580868959427
of O 0 0.0025114836171269417
Hex B-Disease 1 0.990578830242157
A I-Disease 0 0.06927481293678284
enzyme I-Disease 1 0.9996482133865356
deficiency I-Disease 1 0.9999998807907104
in O 0 0.0035966516006737947
the O 0 0.007340025622397661
proband O 1 0.9997450709342957
. O 0 0.011947114951908588

The O 0 0.011835617944598198
resulting O 0 0.06544101238250732
W474C O 1 0.993999719619751
substitution O 0 0.05426833778619766
clearly O 0 0.014331639744341373
interferes O 0 0.07931611686944962
with O 0 0.0037111046258360147
alpha O 0 0.09263057261705399
- O 0 0.04303823783993721
subunit O 0 0.14580038189888
processing O 0 0.010310474783182144
, O 0 0.0016627571312710643
but O 0 0.0018569458043202758
because O 0 0.003615317167714238
the O 0 0.002790949074551463
base O 0 0.016602883115410805
substitution O 0 0.05560353770852089
falls O 0 0.038213666528463364
at O 0 0.0030300323851406574
the O 0 0.002064056694507599
first O 0 0.0036861009430140257
position O 0 0.005072530824691057
of O 0 0.0034630284644663334
exon O 1 0.9986086487770081
13 O 0 0.016328681260347366
, O 0 0.0046605393290519714
aberrant O 1 0.9967292547225952
splicing O 0 0.20524640381336212
may O 0 0.008335351943969727
also O 0 0.001579931122250855
contribute O 0 0.006965592969208956
to O 0 0.002290967386215925
Hex B-Disease 1 0.994184672832489
A I-Disease 1 0.5996217131614685
deficiency I-Disease 1 1.0
in O 0 0.0029010421130806208
this O 0 0.004012202378362417
proband O 1 0.999863862991333
. O 0 0.0039047731552273035
. O 0 0.005589114502072334

Two O 0 0.007018458563834429
frequent O 0 0.06533819437026978
missense O 1 0.9995982050895691
mutations O 1 0.9999281167984009
in O 0 0.012127229012548923
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.010085557587444782

Pendred B-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
is O 0 0.008739574812352657
an O 0 0.09675338119268417
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9992955923080444
by O 0 0.004722670651972294
early O 0 0.029713356867432594
childhood O 1 0.9999985694885254
deafness B-Disease 1 1.0
and O 0 0.01152859441936016
goiter B-Disease 1 1.0
. O 0 0.008917231112718582

A O 0 0.017545079812407494
century O 0 0.007822614163160324
after O 0 0.007728663273155689
its O 0 0.002597659360617399
recognition O 0 0.009726478718221188
as O 0 0.002832470228895545
a O 0 0.2357318252325058
syndrome O 1 1.0
by O 0 0.006877120118588209
Vaughan O 1 0.9999833106994629
Pendred O 1 0.9999500513076782
, O 0 0.0030042657162994146
the O 0 0.011175712570548058
disease O 1 1.0
gene O 1 0.9999822378158569
( O 0 0.012452924624085426
PDS O 1 0.9999998807907104
) O 0 0.004027922172099352
was O 0 0.005522150546312332
mapped O 0 0.02450421452522278
to O 0 0.004605572205036879
chromosome O 1 0.9997294545173645
7q22 O 1 0.999595582485199
- O 0 0.08250977098941803
q31 O 1 0.997489333152771
. O 0 0.011342421174049377

1 O 0 0.02242845855653286
and O 0 0.0021317482460290194
, O 0 0.002252258826047182
recently O 0 0.012028842233121395
, O 0 0.0015522483736276627
found O 0 0.0033084454480558634
to O 0 0.0016517522744834423
encode O 0 0.029763372614979744
a O 0 0.016424894332885742
putative O 1 0.9898968935012817
sulfate O 1 0.9948779344558716
transporter O 1 0.9381433129310608
. O 0 0.013376514427363873

We O 0 0.006454493384808302
performed O 0 0.024133963510394096
mutation O 1 0.9959173798561096
analysis O 0 0.003903245320543647
of O 0 0.0012449275236576796
the O 0 0.006530166603624821
PDS B-Disease 1 1.0
gene O 1 0.9996426105499268
in O 0 0.006186436861753464
patients O 1 0.9999785423278809
from O 0 0.005512556526809931
14 O 0 0.02301301248371601
Pendred B-Disease 1 0.9998018145561218
families O 0 0.01143486425280571
originating O 0 0.021020490676164627
from O 0 0.002723263343796134
seven O 0 0.002705375896766782
countries O 0 0.0011603378225117922
and O 0 0.0015065609477460384
identified O 0 0.013034726493060589
all O 0 0.004269521217793226
mutations O 1 0.9997816681861877
. O 0 0.0068083894439041615

The O 0 0.014288392849266529
mutations O 1 0.9871011972427368
include O 0 0.0029531053733080626
three O 0 0.0021309491712599993
single O 0 0.014517094939947128
base O 0 0.02010411024093628
deletions O 0 0.3676142394542694
, O 0 0.002269522752612829
one O 0 0.005557825788855553
splice O 1 0.9517496228218079
site O 0 0.027072569355368614
mutation O 1 0.9997277855873108
and O 0 0.003224949585273862
10 O 0 0.01374367717653513
missense O 1 0.9993711113929749
mutations O 1 0.9992579817771912
. O 0 0.009418139234185219

One O 0 0.018920276314020157
missense O 1 0.9997650980949402
mutation O 1 0.9999052286148071
( O 0 0.018521921709179878
L236P O 1 0.9995643496513367
) O 0 0.004474001005291939
was O 0 0.005805236753076315
found O 0 0.003992242272943258
in O 0 0.001736198551952839
a O 0 0.009621771983802319
homozygous O 1 0.9976803064346313
state O 0 0.0019393953261896968
in O 0 0.0016487528337165713
two O 0 0.003358975052833557
consanguineous O 1 0.9998160004615784
families O 0 0.007768016308546066
and O 0 0.001121231005527079
in O 0 0.001784241059795022
a O 0 0.010311000049114227
heterozygous O 1 0.9956314563751221
state O 0 0.0022304155863821507
in O 0 0.001312989043071866
five O 0 0.0028157976921647787
additional O 0 0.005206988658756018
non O 0 0.018710413947701454
- O 0 0.0562979094684124
consanguineous O 1 0.9980902075767517
families O 0 0.01815897598862648
. O 0 0.008252286352217197

Another O 0 0.05839534476399422
missense O 1 0.999445378780365
mutation O 1 0.9999643564224243
( O 0 0.01850515976548195
T416P O 1 0.9995471835136414
) O 0 0.005534128285944462
was O 0 0.005789535120129585
found O 0 0.0036122628953307867
in O 0 0.0016276512760668993
a O 0 0.011205190792679787
homozygous O 1 0.9994679093360901
state O 0 0.002260463312268257
in O 0 0.0017076227813959122
one O 0 0.003103832481428981
family O 0 0.008392270654439926
and O 0 0.0010321817826479673
in O 0 0.0016356605337932706
a O 0 0.009873038157820702
heterozygous O 1 0.9937562942504883
state O 0 0.0023299185559153557
in O 0 0.001702110399492085
four O 0 0.0034229608718305826
families O 0 0.010861381888389587
. O 0 0.007856267504394054

Pendred B-Disease 1 0.9999655485153198
patients O 1 0.9994057416915894
in O 0 0.0029524178244173527
three O 0 0.0038099864032119513
non O 0 0.020663326606154442
- O 0 0.06213204190135002
consanguineous O 1 0.9978575110435486
families O 0 0.01190879289060831
were O 0 0.0021156147122383118
shown O 0 0.005616889800876379
to O 0 0.001453682198189199
be O 0 0.002629148308187723
compound O 0 0.03965352475643158
heterozygotes O 1 0.9973415732383728
for O 0 0.005594862625002861
L236P O 1 0.9987882971763611
and O 0 0.004991613328456879
T416P O 1 0.9980760812759399
. O 0 0.009425830096006393

In O 0 0.004879849497228861
total O 0 0.005661153234541416
, O 0 0.0018871409120038152
one O 0 0.002707788022235036
or O 0 0.0022261037956923246
both O 0 0.001167824724689126
of O 0 0.0014152316143736243
these O 0 0.0026822583749890327
mutations O 1 0.9993114471435547
were O 0 0.0022241994738578796
found O 0 0.003772446420043707
in O 0 0.001219969941303134
nine O 0 0.0031835807021707296
of O 0 0.0009894430404528975
the O 0 0.0027950131334364414
14 O 0 0.010761633515357971
families O 0 0.008282734081149101
analyzed O 0 0.024456780403852463
. O 0 0.0075301132164895535

The O 0 0.004061062820255756
identification O 0 0.007158144377171993
of O 0 0.0010235157096758485
two O 0 0.0023954042699187994
frequent O 1 0.978513240814209
PDS B-Disease 1 0.9999996423721313
mutations O 1 0.9998971223831177
will O 0 0.0016023856587707996
facilitate O 0 0.00491116289049387
the O 0 0.003017971059307456
molecular O 0 0.05044441670179367
diagnosis O 1 0.9999967813491821
of O 0 0.007795503828674555
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.011160999536514282

Insertional O 1 0.9995179176330566
mutation O 1 0.9984641075134277
by O 0 0.010210341773927212
transposable O 1 0.9625633955001831
element O 0 0.025448745116591454
, O 0 0.004199258517473936
L1 O 1 0.998526930809021
, O 0 0.0020445873960852623
in O 0 0.0018467499176040292
the O 0 0.01215667650103569
DMD B-Disease 1 1.0
gene O 1 0.9937831163406372
results O 0 0.008900301530957222
in O 0 0.002853786339983344
X B-Disease 1 0.9962496161460876
- I-Disease 0 0.45399659872055054
linked I-Disease 1 0.9981257319450378
dilated I-Disease 1 0.9999997615814209
cardiomyopathy I-Disease 1 1.0
. O 0 0.01166309230029583

X B-Disease 1 0.9952347874641418
- I-Disease 0 0.406873881816864
linked I-Disease 1 0.9985697269439697
dilated I-Disease 1 0.9999998807907104
cardiomyopathy I-Disease 1 1.0
( O 0 0.020336326211690903
XLDCM B-Disease 1 0.9999854564666748
) O 0 0.004452370572835207
is O 0 0.003336331108585
a O 0 0.009645004756748676
clinical O 1 0.9957457184791565
phenotype O 1 0.9999862909317017
of O 0 0.0040133073925971985
dystrophinopathy B-Disease 1 0.999850869178772
which O 0 0.002508015837520361
is O 0 0.003730789991095662
characterized O 0 0.04259627312421799
by O 0 0.005518409889191389
preferential O 1 0.9948635697364807
myocardial B-Disease 1 1.0
involvement I-Disease 0 0.028445281088352203
without O 0 0.003708217991515994
any O 0 0.003255607560276985
overt O 0 0.2787233591079712
clinical O 1 0.9938902854919434
signs O 0 0.02327559143304825
of O 0 0.006977727636694908
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 0.013756118714809418

To O 0 0.003858124138787389
date O 0 0.005378608126193285
, O 0 0.0014747594250366092
several O 0 0.0029771181289106607
mutations O 1 0.9997522234916687
in O 0 0.0021483707241714
the O 0 0.012599622830748558
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9999929666519165
, O 0 0.015967488288879395
DMD O 1 1.0
, O 0 0.002269056160002947
have O 0 0.0014837542548775673
been O 0 0.003592055756598711
identified O 0 0.010308684781193733
in O 0 0.0037388557102531195
patients O 1 0.9999961853027344
with O 0 0.004777783993631601
XLDCM B-Disease 1 0.9999996423721313
, O 0 0.0020487625151872635
but O 0 0.0020188342314213514
a O 0 0.0071973553858697414
pathogenic O 1 0.9985935091972351
correlation O 0 0.02485640160739422
of O 0 0.001315880916081369
these O 0 0.002184733049944043
cardiospecific O 1 0.999961256980896
mutations O 1 0.9998905658721924
in O 0 0.008398224599659443
DMD O 1 1.0
with O 0 0.003159164683893323
the O 0 0.008602870628237724
XLDCM B-Disease 1 0.9999998807907104
phenotype O 1 0.9999997615814209
has O 0 0.005947296041995287
remained O 0 0.00844426080584526
to O 0 0.0012940309243276715
be O 0 0.0032189481426030397
elucidated O 1 0.7948707938194275
. O 0 0.00784771703183651

We O 0 0.0035861043725162745
report O 0 0.003351110965013504
here O 0 0.001844959449954331
the O 0 0.0018718070350587368
identification O 0 0.007744264788925648
of O 0 0.0011807290138676763
a O 0 0.0051483591087162495
unique O 0 0.008986476808786392
de O 0 0.04219458997249603
novo O 0 0.4618792235851288
L1 O 1 0.9926701784133911
insertion O 0 0.10797759890556335
in O 0 0.0028220706153661013
the O 0 0.009397254325449467
muscle O 1 0.9999773502349854
exon O 1 0.9967093467712402
1 O 0 0.01858479715883732
in O 0 0.006505258847028017
DMD O 1 1.0
in O 0 0.003435539547353983
three O 0 0.006457328796386719
XLDCM B-Disease 1 0.9999997615814209
patients O 1 0.9999920129776001
from O 0 0.003108867909759283
two O 0 0.002218336332589388
unrelated O 0 0.028140876442193985
Japanese O 0 0.01089482195675373
families O 0 0.009688216261565685
. O 0 0.007311376743018627

The O 0 0.01097189448773861
insertion O 0 0.24275866150856018
was O 0 0.010136811062693596
a O 0 0.008112636394798756
5 O 0 0.017114032059907913
- O 0 0.03490903973579407
truncated O 0 0.13684388995170593
form O 0 0.00716412765905261
of O 0 0.002284337067976594
human O 0 0.01781972125172615
L1 O 1 0.9973850846290588
inversely O 0 0.08035983145236969
integrated O 0 0.01745006814599037
in O 0 0.0016423012129962444
the O 0 0.0031583074014633894
5 O 0 0.014666836708784103
- O 0 0.031843703240156174
untranslated O 0 0.3289111852645874
region O 0 0.011314612813293934
in O 0 0.002211306244134903
the O 0 0.009361633099615574
muscle O 1 0.9999960660934448
exon O 1 0.9986055493354797
1 O 0 0.014837425202131271
, O 0 0.0015164432115852833
which O 0 0.0023381526116281748
affected O 0 0.03243413195014
the O 0 0.00346377887763083
transcription O 0 0.056955788284540176
or O 0 0.002420447301119566
the O 0 0.0020412905141711235
stability O 0 0.008953389711678028
of O 0 0.001829650835134089
the O 0 0.0073683010414242744
muscle O 1 0.9999814033508301
form O 0 0.007617427967488766
of O 0 0.0035276899579912424
dystrophin O 1 0.9999918937683105
transcripts O 0 0.014217679388821125
but O 0 0.001550605520606041
not O 0 0.0007374654524028301
that O 0 0.0006049131625331938
of O 0 0.0011664029443636537
the O 0 0.006666028872132301
brain O 1 0.9999998807907104
or O 0 0.01109732873737812
Purkinje O 1 0.9997764229774475
cell O 0 0.06773418933153152
form O 0 0.010076740756630898
, O 0 0.002331722527742386
probably O 0 0.010295333340764046
due O 0 0.00711096404120326
to O 0 0.000972795533016324
its O 0 0.0019334603566676378
unique O 0 0.004223470110446215
site O 0 0.005328129976987839
of O 0 0.0015813028439879417
integration O 0 0.014390820637345314
. O 0 0.006709412671625614

We O 0 0.006056055426597595
speculate O 0 0.021442696452140808
that O 0 0.0014679771848022938
this O 0 0.002626272616907954
insertion O 0 0.07097500562667847
of O 0 0.0017480103997513652
an O 0 0.00514485128223896
L1 O 1 0.9975718855857849
sequence O 0 0.0338178351521492
in O 0 0.008897270075976849
DMD O 1 1.0
is O 0 0.005756075028330088
responsible O 0 0.008513081818819046
for O 0 0.0010858821915462613
some O 0 0.0011775263119488955
of O 0 0.0009350231848657131
the O 0 0.0024863651487976313
population O 0 0.007248228881508112
of O 0 0.0024027398321777582
Japanese O 0 0.04920053854584694
patients O 1 0.9999916553497314
with O 0 0.005330260843038559
XLDCM B-Disease 1 0.9999978542327881
. O 0 0.004356675781309605
. O 0 0.007017053198069334

Severe O 1 0.9999853372573853
early O 0 0.02905513532459736
- O 1 0.9983335137367249
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 0.010832883417606354
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 0.0038626918103545904
red O 1 0.9998993873596191
hair O 1 0.9999985694885254
pigmentation O 1 1.0
caused O 1 0.9999754428863525
by O 0 0.012322884052991867
POMC O 1 0.9999998807907104
mutations O 1 0.9998607635498047
in O 0 0.004237784538418055
humans O 0 0.03563264012336731
. O 0 0.0064137279987335205

Sequential O 0 0.09452084451913834
cleavage O 0 0.1702939122915268
of O 0 0.0023199529387056828
the O 0 0.004426510073244572
precursor O 0 0.07287613302469254
protein O 0 0.05869894474744797
pre O 0 0.051370229572057724
- O 0 0.03588750958442688
pro O 0 0.05692875757813454
- O 0 0.07227157801389694
opiomelanocortin O 1 0.9984853863716125
( O 0 0.01979496330022812
POMC O 1 0.999977707862854
) O 0 0.007868706248700619
generates O 0 0.029949689283967018
the O 0 0.010891560465097427
melanocortin O 1 0.9995866417884827
peptides O 0 0.3519667387008667
adrenocorticotrophin O 1 0.9978012442588806
( O 0 0.01816725917160511
ACTH O 1 0.9998310804367065
) O 0 0.0071805622428655624
, O 0 0.0050979312509298325
melanocyte O 1 0.9999476671218872
- O 0 0.08289739489555359
stimulating O 1 0.9651650190353394
hormones O 1 0.9935264587402344
( O 0 0.022113511338829994
MSH O 1 0.9999837875366211
) O 0 0.012313787825405598
alpha O 0 0.07546201348304749
, O 0 0.0037782536819577217
beta O 0 0.059389613568782806
and O 0 0.0029352642595767975
gamma O 0 0.0714828222990036
as O 0 0.0021701327059417963
well O 0 0.0015704227844253182
as O 0 0.0021521858870983124
the O 0 0.0065671722404658794
opioid O 1 0.9988946318626404
- O 0 0.0706295445561409
receptor O 1 0.8555527329444885
ligand O 0 0.15038734674453735
beta O 0 0.12827996909618378
- O 0 0.08282279968261719
endorphin O 1 0.9983385801315308
. O 0 0.013008601032197475

While O 0 0.005252392031252384
a O 0 0.0052281152456998825
few O 0 0.0034170662984251976
cases O 0 0.007282717619091272
of O 0 0.003184219356626272
isolated O 1 0.9996753931045532
ACTH B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
have O 0 0.004297951236367226
been O 0 0.006436388473957777
reported O 0 0.021437790244817734
( O 0 0.01700115203857422
OMIM O 1 0.9999995231628418
201400 O 1 0.9997753500938416
) O 0 0.005025261081755161
, O 0 0.0017013297183439136
an O 0 0.005767993628978729
inherited O 1 0.9999998807907104
POMC O 1 1.0
defect O 1 0.9999935626983643
has O 0 0.004939695820212364
not O 0 0.0012979060411453247
been O 0 0.0037974361330270767
described O 0 0.01186971552670002
so O 0 0.0038240982685238123
far O 0 0.005404602736234665
. O 0 0.005205560941249132

Recent O 0 0.015131218358874321
studies O 0 0.005939554423093796
in O 0 0.0025970442220568657
animal O 0 0.027021363377571106
models O 0 0.01192415226250887
elucidated O 1 0.8212099075317383
a O 0 0.0044335247948765755
central O 0 0.0031285625882446766
role O 0 0.005750800017267466
of O 0 0.0029027974233031273
alpha O 1 0.9313249588012695
- O 0 0.12392736226320267
MSH O 1 0.9999831914901733
in O 0 0.0025360253639519215
the O 0 0.0026737842708826065
regulation O 0 0.010473709553480148
of O 0 0.0017835625912994146
food O 0 0.013597676530480385
intake O 0 0.3422788083553314
by O 0 0.003639230504631996
activation O 0 0.04783536493778229
of O 0 0.0020114972721785307
the O 0 0.008296649903059006
brain O 1 0.9999992847442627
melanocortin O 1 0.9999552965164185
- O 0 0.047124557197093964
4 O 0 0.023941997438669205
- O 0 0.06346507370471954
receptor O 1 0.9441392421722412
( O 0 0.021178672090172768
MC4 O 1 0.9999613761901855
- O 0 0.08848211914300919
R O 0 0.16115166246891022
; O 0 0.008483943529427052
refs O 0 0.15336444973945618
3 O 0 0.020733870565891266
- O 0 0.03024199604988098
5 O 0 0.013225939124822617
) O 0 0.002302380744367838
and O 0 0.0006586855161003768
the O 0 0.0024316771887242794
linkage O 0 0.04339512437582016
of O 0 0.00239828834310174
human O 0 0.1148439571261406
obesity B-Disease 1 1.0
to O 0 0.004703037440776825
chromosome O 1 0.9998836517333984
2 O 0 0.007392107509076595
in O 0 0.0017067554872483015
close O 0 0.006212661042809486
proximity O 0 0.010819591581821442
to O 0 0.0017963576829060912
the O 0 0.00921576377004385
POMC O 1 0.9999998807907104
locus O 1 0.9999856948852539
, O 0 0.0033058016560971737
led O 0 0.006583200301975012
to O 0 0.000984645215794444
the O 0 0.0019189906306564808
proposal O 0 0.005360686685889959
of O 0 0.0011707441881299019
an O 0 0.0023719456512480974
association O 0 0.011172635480761528
of O 0 0.005312873050570488
POMC O 1 0.9999990463256836
with O 0 0.006363423075526953
human O 0 0.0422615110874176
obesity B-Disease 1 0.9999998807907104
. O 0 0.010460943914949894

The O 0 0.006030654069036245
dual O 0 0.022454408928751945
role O 0 0.008223095908761024
of O 0 0.0036687562242150307
alpha O 0 0.2751257121562958
- O 0 0.09991584718227386
MSH O 1 0.9999727010726929
in O 0 0.005549351219087839
regulating O 0 0.03552545607089996
food O 0 0.017073046416044235
intake O 0 0.44805386662483215
and O 0 0.002555269282311201
influencing O 1 0.630124568939209
hair O 1 0.9998992681503296
pigmentation O 1 0.9999990463256836
predicts O 0 0.03734573349356651
that O 0 0.001811521127820015
the O 0 0.006711980327963829
phenotype O 1 0.9999996423721313
associated O 0 0.008408722467720509
with O 0 0.00138164684176445
a O 0 0.009127448312938213
defect O 1 0.999893069267273
in O 0 0.006060037761926651
POMC O 1 0.9999967813491821
function O 0 0.014497557654976845
would O 0 0.002552795922383666
include O 0 0.007557588629424572
obesity B-Disease 1 1.0
, O 0 0.004268001299351454
alteration O 1 0.9209288954734802
in O 0 0.004650657996535301
pigmentation O 1 1.0
and O 0 0.009773257188498974
ACTH B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
. O 0 0.011460339650511742

The O 0 0.006530473008751869
observation O 0 0.018697474151849747
of O 0 0.001964792376384139
these O 0 0.0034381740260869265
symptoms O 1 1.0
in O 0 0.002052608411759138
two O 0 0.003244337858632207
probands O 1 0.9999732971191406
prompted O 0 0.04609377309679985
us O 0 0.004900538828223944
to O 0 0.0014401458902284503
search O 0 0.010375321842730045
for O 0 0.0039010506588965654
mutations O 1 0.9987521171569824
within O 0 0.004407557658851147
their O 0 0.007322477176785469
POMC O 1 0.9999973773956299
genes O 1 0.9094331860542297
. O 0 0.008589942939579487

Patient O 1 0.9998300075531006
1 O 0 0.018459370359778404
was O 0 0.00712109450250864
found O 0 0.00372882978990674
to O 0 0.0009735353523865342
be O 0 0.0012978492304682732
a O 0 0.006172421853989363
compound O 0 0.03614632040262222
heterozygote O 1 0.9615764021873474
for O 0 0.0019091579597443342
two O 0 0.0032471423037350178
mutations O 1 0.999516487121582
in O 0 0.0040977937169373035
exon O 1 0.9990257024765015
3 O 0 0.022461816668510437
( O 0 0.010876622051000595
G7013T O 1 0.9998576641082764
, O 0 0.006536954082548618
C7133delta O 1 0.9999520778656006
) O 0 0.0038808819372206926
which O 0 0.002081260783597827
interfere O 0 0.013391600921750069
with O 0 0.0012871160870417953
appropriate O 0 0.004732964560389519
synthesis O 0 0.021829940378665924
of O 0 0.0037325129378587008
ACTH O 1 0.9998936653137207
and O 0 0.005787531845271587
alpha O 0 0.31032049655914307
- O 0 0.1503515988588333
MSH O 1 0.9999380111694336
. O 0 0.013441812247037888

Patient O 1 0.9995249509811401
2 O 0 0.014774130657315254
was O 0 0.011599887162446976
homozygous O 1 0.9988846182823181
for O 0 0.001988069387152791
a O 0 0.011390035040676594
mutation O 1 0.9997830986976624
in O 0 0.006122891325503588
exon O 1 0.9945042133331299
2 O 0 0.018315520137548447
( O 0 0.008418867364525795
C3804A O 1 0.9996820688247681
) O 0 0.005622507072985172
which O 0 0.005970023572444916
abolishes O 1 0.9999744892120361
POMC O 1 0.999964714050293
translation O 0 0.02554204873740673
. O 0 0.00800823513418436

These O 0 0.002702157711610198
findings O 0 0.007366438861936331
represent O 0 0.0025509209372103214
the O 0 0.0017832604935392737
first O 0 0.0023605432361364365
examples O 0 0.002602834952995181
of O 0 0.0014303649077191949
a O 0 0.014042643830180168
genetic B-Disease 1 0.9992915391921997
defect I-Disease 1 0.9998243451118469
within O 0 0.005759809166193008
the O 0 0.010368568822741508
POMC O 1 0.9999979734420776
gene O 1 0.9702440500259399
and O 0 0.001838999567553401
define O 0 0.006500028073787689
a O 0 0.006458472926169634
new O 0 0.012066608294844627
monogenic B-Disease 1 0.9999998807907104
endocrine I-Disease 1 1.0
disorder I-Disease 1 1.0
resulting O 0 0.07000672072172165
in O 0 0.002277171239256859
early O 0 0.015722006559371948
- O 1 0.9970417618751526
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 0.01322496123611927
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 0.00545592000707984
red O 1 0.999966025352478
hair O 1 0.9999933242797852
pigmentation O 1 0.9999998807907104
. O 0 0.0035289456136524677
. O 0 0.004766646306961775

A O 0 0.02030108869075775
European O 0 0.011814306490123272
multicenter O 1 0.9928836822509766
study O 0 0.007505030836910009
of O 0 0.004679795820266008
phenylalanine B-Disease 1 0.9999938011169434
hydroxylase I-Disease 1 0.9999850988388062
deficiency I-Disease 1 1.0
: O 0 0.006612034048885107
classification O 0 0.02170628122985363
of O 0 0.00243878411129117
105 O 0 0.2628154754638672
mutations O 1 0.9998966455459595
and O 0 0.0011348730186000466
a O 0 0.0037229820154607296
general O 0 0.004402024671435356
system O 0 0.0071738180704414845
for O 0 0.0033756208140403032
genotype O 1 0.9999182224273682
- O 0 0.02187001146376133
based O 0 0.004234775435179472
prediction O 0 0.025588415563106537
of O 0 0.004781612195074558
metabolic O 1 0.9999953508377075
phenotype O 1 0.9999902248382568
. O 0 0.010407224297523499

Phenylketonuria B-Disease 1 0.9999986886978149
( O 0 0.03965907543897629
PKU B-Disease 1 0.9999998807907104
) O 0 0.007462466135621071
and O 0 0.003861749079078436
mild B-Disease 1 0.9999991655349731
hyperphenylalaninemia I-Disease 1 0.9999995231628418
( O 0 0.04114832729101181
MHP B-Disease 1 1.0
) O 0 0.005769503302872181
are O 0 0.004043932538479567
allelic B-Disease 1 0.9999920129776001
disorders I-Disease 1 1.0
caused O 1 0.999743640422821
by O 0 0.007408335339277983
mutations O 1 0.9984959363937378
in O 0 0.0021047426853328943
the O 0 0.005154123064130545
gene O 1 0.967488169670105
encoding O 0 0.0923224687576294
phenylalanine O 1 0.9763615131378174
hydroxylase O 1 0.9935821890830994
( O 0 0.031322892755270004
PAH O 1 0.9999953508377075
) O 0 0.011415282264351845
. O 0 0.00816606730222702

Previous O 0 0.015006513334810734
studies O 0 0.006179604213684797
have O 0 0.0016415289137512445
suggested O 0 0.004056861158460379
that O 0 0.0009483442408964038
the O 0 0.002401352860033512
highly O 0 0.015985870733857155
variable O 0 0.3196782171726227
metabolic O 1 0.9999563694000244
phenotypes O 1 0.9993172883987427
of O 0 0.009584339335560799
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 0 0.09468916803598404
with O 0 0.010757903568446636
PAH O 1 1.0
genotypes O 1 0.9999746084213257
. O 0 0.01082589104771614

We O 0 0.004162083845585585
identified O 0 0.01201191172003746
both O 0 0.0045424834825098515
causative O 1 0.9999092817306519
mutations O 1 0.9998937845230103
in O 0 0.007039712276309729
686 O 1 0.9999662637710571
patients O 1 0.9999884366989136
from O 0 0.003156339982524514
seven O 0 0.004047081805765629
European O 0 0.005675892345607281
centers O 0 0.013638298027217388
. O 0 0.006275487598031759

On O 0 0.003496913705021143
the O 0 0.0017234906554222107
basis O 0 0.0013976043555885553
of O 0 0.0011828324059024453
the O 0 0.003720331471413374
phenotypic O 1 0.9992508292198181
characteristics O 0 0.012586282566189766
of O 0 0.002921933541074395
297 O 1 0.9998531341552734
functionally O 1 0.9999644756317139
hemizygous O 1 0.999997615814209
patients O 1 0.9999662637710571
, O 0 0.002696750685572624
105 O 0 0.017950449138879776
of O 0 0.0017862888053059578
the O 0 0.0056626517325639725
mutations O 1 0.9999202489852905
were O 0 0.002102910540997982
assigned O 0 0.007556822616606951
to O 0 0.0010081666987389326
one O 0 0.0013123264070600271
of O 0 0.0011909101158380508
four O 0 0.0032185320742428303
arbitrary O 0 0.02330436185002327
phenotype O 1 0.9999707937240601
categories O 0 0.017492633312940598
. O 0 0.007658594287931919

We O 0 0.004137082956731319
proposed O 0 0.007283282931894064
and O 0 0.0017305384390056133
tested O 0 0.03245176374912262
a O 0 0.006093199830502272
simple O 0 0.005945488810539246
model O 0 0.006916141603142023
for O 0 0.0020425235852599144
correlation O 0 0.03000905178487301
between O 0 0.007170069497078657
genotype O 1 0.9999544620513916
and O 0 0.003975895699113607
phenotypic O 1 0.9971892237663269
outcome O 0 0.023058511316776276
. O 0 0.006768551655113697

The O 0 0.009015166200697422
observed O 0 0.031841639429330826
phenotype O 1 0.9999712705612183
matched O 0 0.026596421375870705
the O 0 0.005126880016177893
predicted O 0 0.04696889966726303
phenotype O 1 0.9999829530715942
in O 0 0.004607651848345995
79 O 0 0.05208387225866318
% O 0 0.0038855872116982937
of O 0 0.001305477344430983
the O 0 0.00334451487287879
cases O 0 0.01099459733814001
, O 0 0.0014771366259083152
and O 0 0.0009335472714155912
in O 0 0.0013036613818258047
only O 0 0.0018212697468698025
5 O 0 0.006676194723695517
of O 0 0.0025942171923816204
184 O 1 0.9991663694381714
patients O 1 0.9999961853027344
was O 0 0.0060647642239928246
the O 0 0.0037260339595377445
observed O 0 0.02792343683540821
phenotype O 1 0.9999949932098389
more O 0 0.001999856671318412
than O 0 0.002102592494338751
one O 0 0.0031987971160560846
category O 0 0.015965405851602554
away O 0 0.0053670876659452915
from O 0 0.0024801366962492466
that O 0 0.00147195253521204
expected O 0 0.005405702628195286
. O 0 0.005402511451393366

Among O 0 0.008070171810686588
the O 0 0.003507274203002453
seven O 0 0.005504876375198364
contributing O 0 0.028550049290060997
centers O 0 0.010812622494995594
, O 0 0.0017041066894307733
the O 0 0.0028833476826548576
proportion O 0 0.014992225915193558
of O 0 0.004077001474797726
patients O 1 0.9999951124191284
for O 0 0.001888134516775608
whom O 0 0.009324449114501476
the O 0 0.00389026734046638
observed O 0 0.034278061240911484
phenotype O 1 0.9999980926513672
did O 0 0.0040953620336949825
not O 0 0.001535561284981668
match O 0 0.005103956907987595
the O 0 0.0037435898557305336
predicted O 0 0.044797953218221664
phenotype O 1 0.9999823570251465
was O 0 0.012000647373497486
4 O 0 0.013441070914268494
% O 0 0.007583755999803543
- O 0 0.022900938987731934
23 O 0 0.020551461726427078
% O 0 0.008572558872401714
( O 0 0.011985929682850838
P O 1 0.9958605170249939
< O 1 0.9779589176177979
. O 0 0.009056530892848969
0001 O 1 0.9973040819168091
) O 0 0.006064287386834621
, O 0 0.0020653591491281986
suggesting O 0 0.010878662578761578
that O 0 0.0011505805887281895
differences O 0 0.0034381854347884655
in O 0 0.0009970094542950392
methods O 0 0.0025529125705361366
used O 0 0.0015616792952641845
for O 0 0.0032023706007748842
mutation O 1 0.9999974966049194
detection O 0 0.43321770429611206
or O 0 0.01044948399066925
phenotype O 1 0.9999996423721313
classification O 0 0.26825687289237976
may O 0 0.005577888339757919
account O 0 0.00223718979395926
for O 0 0.0008613584213890135
a O 0 0.004186217673122883
considerable O 0 0.010896517895162106
proportion O 0 0.013197728432714939
of O 0 0.0054820505902171135
genotype O 1 0.999997615814209
- O 1 0.8822104930877686
phenotype O 1 0.999977707862854
inconsistencies O 0 0.03421047329902649
. O 0 0.007164097856730223

Our O 0 0.004925519693642855
data O 0 0.0027003155555576086
indicate O 0 0.005755916237831116
that O 0 0.0013220877153798938
the O 0 0.008378146216273308
PAH O 1 1.0
- O 1 0.9743117690086365
mutation O 1 0.9999864101409912
genotype O 1 0.9993575215339661
is O 0 0.0032120856922119856
the O 0 0.0023270694073289633
main O 0 0.007940397597849369
determinant O 1 0.989193856716156
of O 0 0.004540763795375824
metabolic O 1 0.9999940395355225
phenotype O 1 0.9999955892562866
in O 0 0.0027466947212815285
most O 0 0.006482324562966824
patients O 1 0.9999994039535522
with O 0 0.012075608596205711
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.010888622142374516

In O 0 0.003784328233450651
the O 0 0.002937696408480406
present O 0 0.0030385630670934916
study O 0 0.0033792818430811167
, O 0 0.001046048360876739
the O 0 0.00239636842161417
classification O 0 0.018818562850356102
of O 0 0.0031009598169475794
105 O 1 0.9959450364112854
PAH O 1 1.0
mutations O 1 0.9999948740005493
may O 0 0.006525159347802401
allow O 0 0.0021358225494623184
the O 0 0.0016093204030767083
prediction O 0 0.01812472939491272
of O 0 0.0012698123464360833
the O 0 0.005098712630569935
biochemical O 1 0.679524302482605
phenotype O 1 0.9999531507492065
in O 0 0.0057247173972427845
> O 1 0.9943444728851318
10 O 0 0.006931695621460676
, O 0 0.0031344350427389145
000 O 0 0.149814173579216
genotypes O 1 0.9999707937240601
, O 0 0.0027945281472057104
which O 0 0.0025528129190206528
may O 0 0.005435938481241465
be O 0 0.0010820904280990362
useful O 0 0.0026008388958871365
for O 0 0.0008427570573985577
the O 0 0.0023073216434568167
management O 0 0.009213782846927643
of O 0 0.0035948522854596376
hyperphenylalaninemia B-Disease 1 0.9999990463256836
in O 0 0.007648439612239599
newborns O 1 0.9999908208847046
. O 0 0.007607557810842991

Somatic O 1 0.9005892872810364
instability O 0 0.07991639524698257
of O 0 0.0022533563897013664
the O 0 0.005027851089835167
CTG O 1 0.999767005443573
repeat O 0 0.05722283199429512
in O 0 0.004309901036322117
mice O 1 0.9987310767173767
transgenic O 0 0.06012771651148796
for O 0 0.0024609107058495283
the O 0 0.016910331323742867
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 0.02955661341547966
is O 0 0.005653063766658306
age O 0 0.017337685450911522
dependent O 0 0.019523629918694496
but O 0 0.0019919131882488728
not O 0 0.0019006667425855994
correlated O 0 0.035942744463682175
to O 0 0.0012401744024828076
the O 0 0.0026811333373188972
relative O 0 0.02178393490612507
intertissue O 1 0.9985439777374268
transcription O 0 0.1273755580186844
levels O 0 0.01991364359855652
and O 0 0.005084468051791191
proliferative O 1 0.9999771118164062
capacities O 0 0.03419274091720581
. O 0 0.007998800836503506

A O 0 0.0395582839846611
( O 0 0.014815118163824081
CTG O 1 0.9995595812797546
) O 0 0.009305549785494804
nexpansion O 1 0.995214581489563
in O 0 0.002081835176795721
the O 0 0.0033352661412209272
3 O 0 0.015188678167760372
- O 0 0.03839336335659027
untranslated O 1 0.6936610341072083
region O 0 0.02029375173151493
( O 0 0.009553062729537487
UTR O 1 0.9863633513450623
) O 0 0.003466950496658683
of O 0 0.0018214067677035928
the O 0 0.011170449666678905
DM O 1 1.0
protein O 0 0.3888261020183563
kinase O 1 0.9987221360206604
gene O 1 0.9603378772735596
( O 0 0.016619527712464333
DMPK O 1 0.9999704360961914
) O 0 0.00462593138217926
is O 0 0.002816234016790986
responsible O 0 0.011357787996530533
for O 0 0.005585437174886465
causing O 1 0.9999949932098389
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.8772938847541809
DM B-Disease 1 1.0
) O 0 0.01086224615573883
. O 0 0.0073445746675133705

Major O 0 0.037866152822971344
instability O 1 0.996384859085083
, O 0 0.002423645695671439
with O 0 0.0014876958448439837
very O 0 0.0038109549786895514
large O 0 0.005302812904119492
expansions O 0 0.02682695910334587
between O 0 0.003101764712482691
generations O 0 0.015266933478415012
and O 0 0.0017430094303563237
high O 0 0.0073683010414242744
levels O 0 0.013409998267889023
of O 0 0.0052409665659070015
somatic O 1 0.9991100430488586
mosaicism O 1 0.9999645948410034
, O 0 0.002909197472035885
is O 0 0.003964462783187628
observed O 0 0.013811486773192883
in O 0 0.004603585693985224
patients O 1 0.9999929666519165
. O 0 0.007466386537998915

There O 0 0.005480896681547165
is O 0 0.0032737134024500847
a O 0 0.005800328683108091
good O 0 0.007388368248939514
correlation O 0 0.027930984273552895
between O 0 0.004487331956624985
repeat O 0 0.06085306406021118
size O 0 0.012043981812894344
( O 0 0.004766426514834166
at O 0 0.0036858401726931334
least O 0 0.006732650566846132
in O 0 0.0038834228180348873
leucocytes O 1 0.9998822212219238
) O 0 0.004714116454124451
, O 0 0.0028036904986947775
clinical O 1 0.9998753070831299
severity O 1 0.9999868869781494
and O 0 0.0018163808854296803
age O 0 0.01089016254991293
of O 0 0.004916507285088301
onset O 1 0.9999998807907104
. O 0 0.008402212522923946

The O 0 0.014742916449904442
trinucleotide O 1 0.9999192953109741
repeat O 1 0.8036465644836426
instability O 1 0.9937965869903564
mechanisms O 0 0.023309409618377686
involved O 0 0.009570837952196598
in O 0 0.005347860045731068
DM B-Disease 1 1.0
and O 0 0.002205467550083995
other O 0 0.0015459881396964192
human O 0 0.03417224436998367
genetic B-Disease 1 0.9999957084655762
diseases I-Disease 1 1.0
are O 0 0.0023694669362157583
unknown O 0 0.021443543955683708
. O 0 0.006324479356408119

We O 0 0.004858450032770634
studied O 0 0.012383002787828445
somatic O 1 0.8305630683898926
instability O 0 0.18181350827217102
by O 0 0.004626179113984108
measuring O 0 0.019279658794403076
the O 0 0.006635571829974651
CTG O 1 0.9999494552612305
repeat O 0 0.1181756854057312
length O 0 0.013186417520046234
at O 0 0.0035366336815059185
several O 0 0.002152502303943038
ages O 0 0.01141244638711214
in O 0 0.0017243005568161607
various O 0 0.0019162747776135802
tissues O 1 0.9942162036895752
of O 0 0.003059461247175932
transgenic O 1 0.9945275187492371
mice O 1 0.9989913105964661
carrying O 0 0.013257397338747978
a O 0 0.011161873117089272
( O 0 0.012643366120755672
CTG O 1 0.9997574687004089
) O 0 0.013079799711704254
55expansion O 1 0.9984252452850342
surrounded O 0 0.02141747437417507
by O 0 0.0034789908677339554
45 O 0 0.012127799913287163
kb O 0 0.11659355461597443
of O 0 0.0018141113687306643
the O 0 0.00456409202888608
human O 0 0.046458516269922256
DM B-Disease 1 1.0
region O 0 0.016957085579633713
, O 0 0.00197953125461936
using O 0 0.003414219245314598
small O 0 0.007663470692932606
- O 0 0.035480644553899765
pool O 0 0.0729505643248558
PCR O 0 0.4305650293827057
. O 0 0.009285956621170044

These O 0 0.00826212577521801
mice O 1 0.9995967745780945
have O 0 0.002973924158141017
been O 0 0.0043058558367192745
shown O 0 0.005150103475898504
to O 0 0.0018121610628440976
reproduce O 0 0.029918314889073372
the O 0 0.004489552695304155
intergenerational O 1 0.9316838979721069
and O 0 0.004106792621314526
somatic O 1 0.9230818748474121
instability O 0 0.15285314619541168
of O 0 0.0017305936198681593
the O 0 0.004078527446836233
55 O 0 0.04127863422036171
CTG O 1 0.9998722076416016
repeat O 0 0.1710359752178192
suggesting O 0 0.015900807455182076
that O 0 0.0017004405381157994
surrounding O 0 0.011038929224014282
sequences O 0 0.019856823608279228
and O 0 0.0010541562223806977
the O 0 0.0040566567331552505
chromatin O 0 0.07368279248476028
environment O 0 0.008123386651277542
are O 0 0.0010798084549605846
involved O 0 0.006009135395288467
in O 0 0.003116721985861659
instability O 1 0.9963531494140625
mechanisms O 0 0.03893271088600159
. O 0 0.008833860047161579

As O 0 0.005675671622157097
observed O 0 0.010831723921000957
in O 0 0.001093786209821701
some O 0 0.0011015250347554684
of O 0 0.0010634722420945764
the O 0 0.004012034274637699
tissues O 1 0.9999490976333618
of O 0 0.013474835082888603
DM B-Disease 1 1.0
patients O 1 0.9999998807907104
, O 0 0.0017907250439748168
there O 0 0.0014349531847983599
is O 0 0.0022006691433489323
a O 0 0.0061952644027769566
tendency O 0 0.03806756064295769
for O 0 0.002122742822393775
repeat O 0 0.07144320011138916
length O 0 0.00980006717145443
and O 0 0.0030084834434092045
somatic O 1 0.999806821346283
mosaicism O 1 0.9999732971191406
to O 0 0.002098438562825322
increase O 0 0.0039049771148711443
with O 0 0.0011886627180501819
the O 0 0.0025650516618043184
age O 0 0.008130759000778198
of O 0 0.001684136688709259
the O 0 0.007011329755187035
mouse O 1 0.9999043941497803
. O 0 0.00861930288374424

Furthermore O 0 0.023483242839574814
, O 0 0.0019835294224321842
we O 0 0.0015713861212134361
observed O 0 0.009487218223512173
no O 0 0.0023003772366791964
correlation O 0 0.01414860226213932
between O 0 0.002038051839917898
the O 0 0.004379753023386002
somatic O 1 0.9996527433395386
mutation O 1 0.9999849796295166
rate O 0 0.014463245868682861
and O 0 0.0039838082157075405
tissue O 1 0.9999817609786987
proliferation O 0 0.04284604638814926
capacity O 0 0.010280875489115715
. O 0 0.006426248233765364

The O 0 0.01792483776807785
somatic O 1 0.9873942136764526
mutation O 1 0.9988019466400146
rates O 0 0.01688936911523342
in O 0 0.0022235773503780365
different O 0 0.002570459619164467
tissues O 1 0.9999291896820068
were O 0 0.001487596658989787
also O 0 0.0013413208071142435
not O 0 0.0013766628690063953
correlated O 0 0.029393712058663368
to O 0 0.0012630304554477334
the O 0 0.0029550925828516483
relative O 0 0.019741104915738106
inter O 0 0.04161756858229637
- O 0 0.11000022292137146
tissue O 1 0.9968913197517395
difference O 0 0.009254368022084236
in O 0 0.0028436328284442425
transcriptional O 0 0.17762716114521027
levels O 0 0.008423843421041965
of O 0 0.0009308302542194724
the O 0 0.0022913834545761347
three O 0 0.004107371903955936
genes O 1 0.6317610740661621
( O 0 0.012069291435182095
DMAHP O 1 0.9999933242797852
, O 0 0.005292440298944712
DMPK O 1 0.999987006187439
and O 0 0.0031081335619091988
59 O 0 0.03436451405286789
) O 0 0.004158146679401398
surrounding O 0 0.009155185893177986
the O 0 0.004758220631629229
repeat O 0 0.16607724130153656
. O 0 0.0033535363618284464
. O 0 0.006094806361943483

A O 0 0.030764995142817497
novel O 0 0.05952037125825882
missense O 1 0.9998581409454346
mutation O 1 0.9999454021453857
in O 0 0.006262114737182856
patients O 1 0.9999227523803711
from O 0 0.00459121260792017
a O 0 0.017589405179023743
retinoblastoma B-Disease 1 0.9999990463256836
pedigree O 1 0.9375336766242981
showing O 0 0.015041101723909378
only O 0 0.0040832944214344025
mild O 1 0.998785674571991
expression O 0 0.016455313190817833
of O 0 0.001705349888652563
the O 0 0.013280327431857586
tumor B-Disease 1 1.0
phenotype O 1 0.9999949932098389
. O 0 0.00854753889143467

We O 0 0.0033958086278289557
have O 0 0.0018809519242495298
used O 0 0.0030046014580875635
single O 0 0.017143141478300095
strand O 0 0.1192895770072937
conformation O 0 0.2519562840461731
polymorphism O 0 0.13948555290699005
analysis O 0 0.0042272997088730335
to O 0 0.001307271420955658
study O 0 0.0034683477133512497
the O 0 0.002892955904826522
27 O 0 0.01847102865576744
exons O 0 0.11857494711875916
of O 0 0.0025143343955278397
the O 0 0.010245980694890022
RB1 O 1 0.9999998807907104
gene O 1 0.9858106374740601
in O 0 0.002475734567269683
individuals O 0 0.0034489016979932785
from O 0 0.0024500065483152866
a O 0 0.007510395720601082
family O 0 0.015186167322099209
showing O 0 0.026204047724604607
mild O 1 0.9991682767868042
expression O 0 0.019379490986466408
of O 0 0.0017701891483739018
the O 0 0.00945520680397749
retinoblastoma B-Disease 1 1.0
phenotype O 1 0.9999966621398926
. O 0 0.010575401596724987

In O 0 0.0034493703860789537
this O 0 0.0029184601735323668
family O 0 0.018867718055844307
affected O 1 0.7932169437408447
individuals O 0 0.007141250651329756
developed O 0 0.1615818291902542
unilateral B-Disease 1 0.9998922348022461
tumors I-Disease 1 1.0
and O 0 0.0017843462992459536
, O 0 0.0010291094658896327
as O 0 0.0016449802787974477
a O 0 0.004562848713248968
result O 0 0.007630856242030859
of O 0 0.001908834557980299
linkage O 0 0.04977543279528618
analysis O 0 0.007197576574981213
, O 0 0.00467807799577713
unaffected O 1 0.999962568283081
mutation O 1 0.9999982118606567
carriers O 1 0.8262404203414917
were O 0 0.0017632556846365333
also O 0 0.0016783190658316016
identified O 0 0.007791963405907154
within O 0 0.0025144910905510187
the O 0 0.004353313706815243
pedigree O 1 0.9892774820327759
. O 0 0.008129752241075039

A O 0 0.025599807500839233
single O 0 0.019094696268439293
band O 0 0.03056538850069046
shift O 0 0.028544126078486443
using O 0 0.008451132103800774
SSCP O 1 0.9993956089019775
was O 0 0.010780589655041695
identified O 0 0.01158901210874319
in O 0 0.00390251143835485
exon O 1 0.9951247572898865
21 O 0 0.014487926848232746
which O 0 0.0021696100011467934
resulted O 0 0.013519111089408398
in O 0 0.0014239432057365775
a O 0 0.011554255150258541
missense O 1 0.9993671774864197
mutation O 1 0.9961240887641907
converting O 0 0.02900727093219757
a O 0 0.020453672856092453
cys O 1 0.9998335838317871
- O 0 0.06564363092184067
- O 0 0.06968414783477783
> O 1 0.9854339361190796
arg O 1 0.9924579858779907
at O 0 0.009802408516407013
nucleotide O 0 0.0842089131474495
position O 0 0.007115453481674194
28 O 0 0.00993588287383318
in O 0 0.0019428393570706248
the O 0 0.006026146467775106
exon O 1 0.9948520064353943
. O 0 0.009273641742765903

The O 0 0.015140067785978317
mutation O 1 0.9995977282524109
destroyed O 0 0.036185722798109055
an O 0 0.007989414967596531
NdeI O 1 0.9995734095573425
restriction O 0 0.07459042221307755
enzyme O 0 0.12238583713769913
site O 0 0.015039138495922089
. O 0 0.0072222258895635605

Analysis O 0 0.009226649068295956
of O 0 0.001653286162763834
all O 0 0.0016862844349816442
family O 0 0.009229659102857113
members O 0 0.0023997309617698193
demonstrated O 0 0.008170465007424355
that O 0 0.0011656265705823898
the O 0 0.004679578822106123
missense O 1 0.99997878074646
mutation O 1 0.9999586343765259
co O 0 0.05227090045809746
- O 0 0.03874989226460457
segregated O 0 0.10193704813718796
with O 0 0.006822927389293909
patients O 1 0.9999988079071045
with O 0 0.010062983259558678
tumors B-Disease 1 1.0
or O 0 0.0054489001631736755
who O 0 0.003607424907386303
, O 0 0.0012164493091404438
as O 0 0.0016609708545729518
a O 0 0.004617850296199322
result O 0 0.008063570596277714
of O 0 0.0021519975271075964
linkage O 0 0.06474009156227112
analysis O 0 0.005078182090073824
had O 0 0.004155448172241449
been O 0 0.004035542719066143
predicted O 0 0.009793203324079514
to O 0 0.0009818737162277102
carry O 0 0.005169554613530636
the O 0 0.006886642891913652
predisposing O 1 0.9999591112136841
mutation O 1 0.9999650716781616
. O 0 0.009751359932124615

These O 0 0.0030272924341261387
observations O 0 0.006952826865017414
point O 0 0.0038776190485805273
to O 0 0.0016472041606903076
another O 0 0.006024869158864021
region O 0 0.007683676667511463
of O 0 0.001693415455520153
the O 0 0.012907196767628193
RB1 O 1 0.9999998807907104
gene O 1 0.9990469813346863
where O 0 0.01197355892509222
mutations O 1 0.9951825737953186
only O 0 0.002909844508394599
modify O 0 0.018211903050541878
the O 0 0.0019038172904402018
function O 0 0.008068815805017948
of O 0 0.001253076596185565
the O 0 0.0059096734039485455
gene O 1 0.9987332224845886
and O 0 0.0014285299694165587
raise O 0 0.0068885027430951595
important O 0 0.0025055836886167526
questions O 0 0.004165092948824167
for O 0 0.0027753766626119614
genetic O 0 0.41981202363967896
counseling O 1 0.5686590671539307
in O 0 0.0026608023326843977
families O 0 0.005146950017660856
with O 0 0.0015096190618351102
these O 0 0.0018993392586708069
distinctive O 1 0.8202610611915588
phenotypes O 1 0.9998133778572083
. O 0 0.004731020424515009
. O 0 0.006196994334459305

Maternal B-Disease 1 0.9977402687072754
disomy I-Disease 1 0.9993483424186707
and O 0 0.00945629645138979
Prader B-Disease 1 1.0
- I-Disease 1 0.9999771118164062
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.020853755995631218
with O 0 0.004265776835381985
gamete O 1 0.9981854557991028
complementation O 1 0.9998171925544739
in O 0 0.0026097961235791445
a O 0 0.005427900701761246
case O 0 0.007688542362302542
of O 0 0.005138438660651445
familial O 1 0.9999990463256836
translocation O 1 0.9994964599609375
( O 0 0.01015586219727993
3 O 0 0.016854943707585335
; O 0 0.004226900637149811
15 O 0 0.011772115714848042
) O 0 0.006427819840610027
( O 0 0.011957582086324692
p25 O 1 0.9997468590736389
; O 0 0.010494912974536419
q11 O 1 0.999415397644043
. O 0 0.004615813959389925
2 O 0 0.011164178140461445
) O 0 0.005237830802798271
. O 0 0.006151572335511446

Maternal B-Disease 1 0.9998420476913452
uniparental I-Disease 1 0.9999988079071045
disomy I-Disease 1 0.9999762773513794
( I-Disease 0 0.02932259812951088
UPD I-Disease 1 0.9999960660934448
) I-Disease 0 0.007393328472971916
for I-Disease 0 0.0050783646292984486
chromosome I-Disease 1 0.9999767541885376
15 I-Disease 0 0.009236302226781845
is O 0 0.0030004263389855623
responsible O 0 0.007651051972061396
for O 0 0.0014692966360598803
an O 0 0.0024820228572934866
estimated O 0 0.011311438865959644
30 O 0 0.006845673080533743
% O 0 0.0027206232771277428
of O 0 0.0011763704242184758
cases O 0 0.007165447808802128
of O 0 0.005377995781600475
Prader B-Disease 1 1.0
- I-Disease 1 0.9999910593032837
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.6411746144294739
PWS B-Disease 1 1.0
) O 0 0.010426940396428108
. O 0 0.00693250959739089

We O 0 0.0048931678757071495
report O 0 0.004230061080306768
on O 0 0.0020326324738562107
an O 0 0.0027489003259688616
unusual O 0 0.008452018722891808
case O 0 0.006099585443735123
of O 0 0.0029278520960360765
maternal B-Disease 1 0.9999963045120239
disomy I-Disease 1 0.9999542236328125
15 I-Disease 0 0.01121192891150713
in O 0 0.00576252955943346
PWS B-Disease 1 1.0
that O 0 0.00254079676233232
is O 0 0.0025369059294462204
most O 0 0.0021100854501128197
consistent O 0 0.007675435394048691
with O 0 0.0019384116167202592
adjacent O 0 0.016283098608255386
- O 0 0.022874167189002037
1 O 0 0.014354621060192585
segregation O 0 0.035039205104112625
of O 0 0.0020520458929240704
a O 0 0.014623858034610748
paternal O 1 0.9999493360519409
t O 1 0.9993994235992432
( O 0 0.008493720553815365
3 O 0 0.014729044400155544
; O 0 0.004519571550190449
15 O 0 0.012594171799719334
) O 0 0.005813060328364372
( O 0 0.010611791163682938
p25 O 1 0.9998119473457336
; O 0 0.010079351253807545
q11 O 1 0.9977700710296631
. O 0 0.003331179032102227
2 O 0 0.008501091971993446
) O 0 0.0021169681567698717
with O 0 0.0015243666712194681
simultaneous O 0 0.03825734183192253
maternal O 1 0.999118983745575
meiotic O 1 0.9998807907104492
nondisjunction O 1 0.9997190833091736
for O 0 0.008085553534328938
chromosome O 1 0.9997628331184387
15 O 0 0.013498949818313122
. O 0 0.0050979312509298325

The O 0 0.014993210323154926
patient O 1 0.9999096393585205
( O 0 0.017846981063485146
J O 1 0.999995231628418
. O 0 0.006121298763900995
B O 1 0.9762042164802551
. O 0 0.002871953183785081
) O 0 0.0026918728835880756
, O 0 0.0013224119320511818
a O 0 0.006580968853086233
17 O 0 0.015725230798125267
- O 0 0.023147916421294212
year O 0 0.009980343282222748
- O 0 0.028620397672057152
old O 0 0.022227920591831207
white O 0 0.019795825704932213
male O 0 0.04004868119955063
with O 0 0.00839555636048317
PWS B-Disease 1 1.0
, O 0 0.003661561291664839
was O 0 0.007123006507754326
found O 0 0.00456080911681056
to O 0 0.0012205126695334911
have O 0 0.0021472156513482332
47 O 0 0.027462227270007133
chromosomes O 0 0.05615202710032463
with O 0 0.0023073810152709484
a O 0 0.011636584997177124
supernumerary O 1 0.9996227025985718
, O 0 0.007277342025190592
paternal O 1 0.999948263168335
der O 1 0.9937911629676819
( O 0 0.007637625560164452
15 O 0 0.00855150818824768
) O 0 0.002568851225078106
consisting O 0 0.0036986717022955418
of O 0 0.0010657208040356636
the O 0 0.003389080986380577
short O 0 0.0159394983202219
arm O 1 0.937465488910675
and O 0 0.0016257850220426917
the O 0 0.006328795570880175
proximal O 1 0.9999996423721313
long O 0 0.01868748664855957
arm O 1 0.9900076389312744
of O 0 0.0039606839418411255
chromosome O 1 0.9999854564666748
15 O 0 0.007543491665273905
, O 0 0.0017473713960498571
and O 0 0.003925052937120199
distal O 1 0.9999998807907104
chromosome O 1 0.999994158744812
arm O 1 0.9976564645767212
3p O 1 0.9940305352210999
. O 0 0.01352114137262106

The O 0 0.019408654421567917
t O 1 0.9947336912155151
( O 0 0.009980300441384315
3 O 0 0.017549213021993637
; O 0 0.0042226482182741165
15 O 0 0.009904205799102783
) O 0 0.0035203711595386267
was O 0 0.004838824272155762
present O 0 0.0019776327535510063
in O 0 0.0012023253366351128
the O 0 0.0024467434268444777
balanced O 0 0.009467316791415215
state O 0 0.0017485596472397447
in O 0 0.001767840818502009
the O 0 0.006566308438777924
patients O 1 0.9999996423721313
father O 0 0.11573385447263718
and O 0 0.0016557249473407865
a O 0 0.009617701172828674
sister O 1 0.6445656418800354
. O 0 0.008054003119468689

Fluorescent O 0 0.11316896229982376
in O 0 0.007097449619323015
situ O 0 0.25562623143196106
hybridization O 0 0.05540997162461281
analysis O 0 0.005830541718751192
demonstrated O 0 0.01088428869843483
that O 0 0.0016802025493234396
the O 0 0.007526742294430733
PWS B-Disease 1 0.9999997615814209
critical O 0 0.03045075573027134
region O 0 0.016807034611701965
resided O 0 0.0329817496240139
on O 0 0.002328871050849557
the O 0 0.005284990184009075
derivative O 1 0.5348833203315735
chromosome O 1 0.999356210231781
3 O 0 0.00946073792874813
and O 0 0.0008517660317011178
that O 0 0.0009399725822731853
there O 0 0.001410825876519084
was O 0 0.005625566001981497
no O 0 0.0036353631876409054
deletion O 1 0.9348773956298828
of O 0 0.001679887413047254
the O 0 0.007463221438229084
PWS B-Disease 1 0.9999997615814209
region O 0 0.011232278309762478
on O 0 0.0014927297597751021
the O 0 0.0026543971616774797
normal O 0 0.016516925767064095
pair O 0 0.00822145864367485
of O 0 0.002946270629763603
15s O 1 0.9997785687446594
present O 0 0.006646330468356609
in O 0 0.005381087772548199
J O 1 0.999956488609314
. O 0 0.009676181711256504

B O 0 0.27743926644325256
. O 0 0.010976212099194527

Methylation O 0 0.11576282232999802
analysis O 0 0.009565722197294235
at O 0 0.009890603832900524
exon O 1 0.9249458909034729
alpha O 0 0.05475050210952759
of O 0 0.0014727910747751594
the O 0 0.0027075717225670815
small O 0 0.0051705557852983475
nuclear O 0 0.011365586891770363
ribonucleoprotein O 1 0.9780203700065613
- O 0 0.04889971762895584
associated O 0 0.025180580094456673
polypeptide O 1 0.9946001768112183
N O 0 0.10659556835889816
( O 0 0.014126523397862911
SNRPN O 1 0.9999608993530273
) O 0 0.011573095805943012
gene O 1 0.9482702016830444
showed O 0 0.01164935901761055
a O 0 0.006365708075463772
pattern O 0 0.023730963468551636
characteristic O 0 0.01346432976424694
of O 0 0.0009320781682617962
only O 0 0.001603603595867753
the O 0 0.0039522466249763966
maternal O 1 0.9999908208847046
chromosome O 1 0.9999943971633911
15 O 0 0.010087858885526657
in O 0 0.005200778134167194
J O 1 0.9999922513961792
. O 0 0.008101087063550949

B O 0 0.39039158821105957
. O 0 0.012913700193166733

Maternal B-Disease 1 0.9998382329940796
disomy I-Disease 1 0.9992783665657043
was O 0 0.013652083463966846
confirmed O 0 0.01993190497159958
by O 0 0.00625690259039402
polymerase O 1 0.6317719221115112
chain O 0 0.08380276709794998
reaction O 0 0.023194504901766777
analysis O 0 0.005305688362568617
of O 0 0.0029245885089039803
microsatellite O 1 0.9916167855262756
repeats O 0 0.05826644226908684
at O 0 0.0047002206556499004
the O 0 0.006987487431615591
gamma O 0 0.24174179136753082
- O 0 0.06333629786968231
aminobutyric O 1 0.9943165183067322
acid O 1 0.638035237789154
receptor O 1 0.9705193042755127
beta3 O 1 0.985255241394043
subunit O 0 0.32871365547180176
( O 0 0.018036682158708572
GABRB3 O 1 0.9997718930244446
) O 0 0.014522806741297245
locus O 1 0.9984205961227417
. O 0 0.012519635260105133

A O 0 0.04569908604025841
niece O 1 0.9982829093933105
( O 0 0.01734173111617565
B O 1 0.9841786026954651
. O 0 0.006051274947822094
B O 1 0.9143168330192566
. O 0 0.0034197026398032904
) O 0 0.002728767693042755
with O 0 0.0016370065277442336
45 O 0 0.014414146542549133
chromosomes O 0 0.05508676543831825
and O 0 0.0017179904971271753
the O 0 0.004379740916192532
derivative O 0 0.07110550999641418
3 O 0 0.010851042345166206
but O 0 0.0020742015913128853
without O 0 0.0035588548053056
the O 0 0.005241075996309519
der O 1 0.9647931456565857
( O 0 0.006640439387410879
15 O 0 0.008703391999006271
) O 0 0.003190676448866725
demonstrated O 0 0.011603806167840958
a O 0 0.012660914100706577
phenotype O 1 0.9999972581863403
consistent O 0 0.011867946945130825
with O 0 0.00151283317245543
that O 0 0.0016402134206146002
reported O 0 0.012136371806263924
for O 0 0.0031773371156305075
haploinsufficiency O 1 0.9994617104530334
of O 0 0.008837622590363026
distal O 1 0.9999911785125732
3 O 0 0.030897606164216995
p O 0 0.10903358459472656
. O 0 0.007046341896057129

Uniparental B-Disease 1 0.9999932050704956
disomy I-Disease 1 0.999703586101532
associated O 0 0.016952643170952797
with O 0 0.003518578363582492
unbalanced O 0 0.25518783926963806
segregation O 0 0.04156804457306862
of O 0 0.0024723527021706104
non O 0 0.0163955707103014
- O 0 0.07101268321275711
Robertsonian O 1 0.9999786615371704
translocations O 1 0.9998817443847656
has O 0 0.0055528730154037476
been O 0 0.005425730720162392
reported O 0 0.014217747375369072
previously O 0 0.006274036131799221
but O 0 0.0019784632604569197
has O 0 0.0027369630988687277
not O 0 0.0012349936878308654
, O 0 0.0009507739450782537
to O 0 0.000805731164291501
our O 0 0.0015662728110328317
knowledge O 0 0.002911726711317897
, O 0 0.0014285987708717585
been O 0 0.003614798653870821
observed O 0 0.006892489735037088
in O 0 0.0010137598728761077
a O 0 0.004370236303657293
case O 0 0.007489305920898914
of O 0 0.005958328023552895
PWS B-Disease 1 1.0
. O 0 0.01123106013983488

Furthermore O 0 0.026085156947374344
, O 0 0.0020515320356935263
our O 0 0.0026866383850574493
findings O 0 0.007550188340246677
are O 0 0.0008282692870125175
best O 0 0.0040939501486718655
interpreted O 0 0.006824937183409929
as O 0 0.0028614006005227566
true O 0 0.0146122295409441
gamete O 1 0.9717327356338501
complementation O 1 0.999948263168335
resulting O 0 0.04784566909074783
in O 0 0.005635529290884733
maternal B-Disease 1 0.9999572038650513
UPD I-Disease 1 0.9999996423721313
15 I-Disease 0 0.020853567868471146
and O 0 0.007047545164823532
PWS B-Disease 1 0.9999992847442627

Schwartz B-Disease 1 0.9974727034568787
- I-Disease 1 0.9859697818756104
Jampel I-Disease 1 0.9999980926513672
syndrome I-Disease 1 1.0
type I-Disease 1 0.5115365386009216
2 I-Disease 0 0.0091753164306283
and O 0 0.0029917489737272263
Stuve B-Disease 1 0.9999955892562866
- I-Disease 1 0.9993185997009277
Wiedemann I-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
: O 0 0.006505696568638086
a O 0 0.005293472204357386
case O 0 0.005052688531577587
for O 0 0.001996060833334923
" O 0 0.008228842169046402
lumping O 1 0.6229182481765747
" O 0 0.010506014339625835
. O 0 0.0064136129803955555

Recent O 0 0.017316292971372604
studies O 0 0.006262927781790495
demonstrated O 0 0.009356084279716015
the O 0 0.0017043283442035317
existence O 0 0.0045318398624658585
of O 0 0.0011339231859892607
a O 0 0.007705017924308777
genetically O 1 0.6426414847373962
distinct O 0 0.012967047281563282
, O 0 0.0019509631674736738
usually O 0 0.007895225659012794
lethal O 1 0.6923438310623169
form O 0 0.0037990512792021036
of O 0 0.0011025117710232735
the O 0 0.004783241543918848
Schwartz B-Disease 1 0.9999514818191528
- I-Disease 1 0.9982728958129883
Jampel I-Disease 1 0.9999995231628418
syndrome I-Disease 1 1.0
( O 0 0.13670654594898224
SJS B-Disease 1 1.0
) O 0 0.00533268041908741
of O 0 0.003802559105679393
myotonia B-Disease 1 1.0
and O 0 0.010647687129676342
skeletal B-Disease 1 0.9999998807907104
dysplasia I-Disease 1 1.0
, O 0 0.002213551662862301
which O 0 0.0017452966421842575
we O 0 0.002343500265851617
called O 0 0.024916479364037514
SJS B-Disease 1 0.9999998807907104
type I-Disease 0 0.1250620186328888
2 I-Disease 0 0.01672203838825226
. O 0 0.0062127490527927876

This O 0 0.01529698446393013
disorder O 1 0.9999998807907104
is O 0 0.004967736545950174
reminiscent O 0 0.02740694396197796
of O 0 0.0014755296288058162
another O 0 0.013730743899941444
rare O 1 0.6676427125930786
condition O 1 0.9294887185096741
, O 0 0.0013591754250228405
the O 0 0.005277642514556646
Stuve B-Disease 1 0.9999979734420776
- I-Disease 1 0.9989144802093506
Wiedemann I-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
( O 0 0.09097669273614883
SWS B-Disease 1 1.0
) O 0 0.0052109770476818085
, O 0 0.001299103139899671
which O 0 0.0018028814811259508
comprises O 0 0.011943415738642216
campomelia B-Disease 1 0.9995251893997192
at O 0 0.006898853927850723
birth O 1 0.7185683250427246
with O 0 0.006039281375706196
skeletal B-Disease 1 0.9999998807907104
dysplasia I-Disease 1 1.0
, O 0 0.009231097996234894
contractures B-Disease 1 0.9999995231628418
, O 0 0.002043934306129813
and O 0 0.001495606149546802
early B-Disease 0 0.01042425911873579
death I-Disease 1 0.9167070388793945
. O 0 0.00638015428557992

To O 0 0.003603508695960045
test O 0 0.008711108937859535
for O 0 0.0015952612739056349
possible O 0 0.009019231423735619
nosologic O 1 0.9988419413566589
identity O 0 0.014090117067098618
between O 0 0.003987965174019337
these O 0 0.003939852584153414
disorders O 1 1.0
, O 0 0.0017684189369902015
we O 0 0.0013685966841876507
reviewed O 0 0.0073004309087991714
the O 0 0.0019981232471764088
literature O 0 0.0030799652449786663
and O 0 0.0008876433130353689
obtained O 0 0.0031837134156376123
a O 0 0.004926969297230244
follow O 0 0.0072013926692306995
- O 0 0.012409552931785583
up O 0 0.002184742596000433
of O 0 0.0010680084815248847
the O 0 0.0017801565118134022
only O 0 0.0017088123131543398
two O 0 0.002611963078379631
surviving O 1 0.9995765089988708
patients O 1 0.9999905824661255
, O 0 0.002111907582730055
one O 0 0.0030194458086043596
with O 0 0.006047393195331097
SJS B-Disease 1 1.0
type I-Disease 0 0.23831133544445038
2 I-Disease 0 0.011019976809620857
at O 0 0.0047905705869197845
age O 0 0.01274053193628788
10 O 0 0.005045603029429913
years O 0 0.003322273027151823
and O 0 0.0013403166085481644
another O 0 0.008941089734435081
with O 0 0.004725154489278793
SWS B-Disease 1 0.9999990463256836
at O 0 0.007976433262228966
age O 0 0.016240011900663376
7 O 0 0.014080563560128212
years O 0 0.006297709420323372
. O 0 0.007165325339883566

Patients O 1 0.9999632835388184
reported O 0 0.01724625937640667
as O 0 0.0020735482685267925
having O 0 0.010741371661424637
either O 0 0.02794540300965309
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 0.018484065309166908
SWS B-Disease 1 0.999996542930603
presented O 0 0.006934807635843754
a O 0 0.0055602481588721275
combination O 0 0.016703980043530464
of O 0 0.0016128370771184564
a O 0 0.01400803867727518
severe O 1 0.9999998807907104
, O 0 0.005144206341356039
prenatal O 1 0.9999995231628418
- O 1 0.9999736547470093
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 0.011857719160616398
with O 0 0.010615091770887375
congenital B-Disease 1 1.0
joint I-Disease 1 0.9999243021011353
contractures I-Disease 1 1.0
, O 0 0.05780623108148575
respiratory O 1 1.0
and O 0 0.003369522513821721
feeding O 1 0.9971404075622559
difficulties O 1 0.5047710537910461
, O 0 0.0022422426845878363
tendency O 1 0.9689850211143494
to O 0 0.0035590508487075567
hyperthermia B-Disease 1 0.9999998807907104
, O 0 0.002211816841736436
and O 0 0.001613532891497016
frequent O 0 0.12319669872522354
death O 1 0.9368358254432678
in O 0 0.003738302970305085
infancy O 1 0.9997847676277161
) O 0 0.0030686696991324425
with O 0 0.0010540669318288565
a O 0 0.005416329018771648
distinct O 0 0.02068815939128399
campomelic B-Disease 1 0.9999915361404419
- I-Disease 1 0.9799889326095581
metaphyseal I-Disease 1 0.9999986886978149
skeletal I-Disease 1 0.999996542930603
dysplasia I-Disease 1 1.0
. O 0 0.012902321293950081

The O 0 0.0068445452488958836
similarity O 0 0.020663196220993996
of O 0 0.0016518121119588614
the O 0 0.004592259414494038
clinical O 1 0.9574040770530701
and O 0 0.0027646678499877453
radiographic O 1 0.9993752837181091
findings O 0 0.009069548919796944
is O 0 0.0024677447509020567
so O 0 0.0027108180802315474
extensive O 0 0.008763172663748264
that O 0 0.001618368667550385
these O 0 0.0038201732095330954
disorders O 1 1.0
appear O 0 0.007522319909185171
to O 0 0.0009679915965534747
be O 0 0.0013452285202220082
a O 0 0.005023392383009195
single O 0 0.015244518406689167
entity O 0 0.028041277080774307
. O 0 0.008241934701800346

The O 0 0.006630488205701113
follow O 0 0.009739810600876808
- O 0 0.01619974710047245
up O 0 0.004275493789464235
observation O 0 0.014002218842506409
of O 0 0.0011740352492779493
an O 0 0.002105399500578642
identical O 0 0.006168036255985498
and O 0 0.000822600326500833
unique O 0 0.004416039679199457
pattern O 0 0.02056981436908245
of O 0 0.0036191153340041637
progressive O 1 0.9999998807907104
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 0.002417671959847212
the O 0 0.0027903399895876646
two O 0 0.0043106768280267715
patients O 1 0.9999992847442627
( O 0 0.004132452886551619
one O 0 0.003035479225218296
with O 0 0.005964426789432764
SJS B-Disease 1 1.0
type I-Disease 0 0.3629011809825897
2 I-Disease 0 0.010326228104531765
, O 0 0.0015425399178639054
one O 0 0.0027439477853477
with O 0 0.005206361413002014
SWS B-Disease 1 0.9999991655349731
) O 0 0.008991995826363564
surviving O 0 0.055353377014398575
beyond O 0 0.019060533493757248
infancy O 1 0.9943498969078064
adds O 0 0.016987919807434082
to O 0 0.0013986121630296111
the O 0 0.001985295442864299
evidence O 0 0.002235406544059515
in O 0 0.0014122480060905218
favor O 0 0.0064935460686683655
of O 0 0.0025189139414578676
identity O 0 0.016524752601981163
. O 0 0.007293309085071087

The O 0 0.008995633572340012
hypothesis O 0 0.05056372657418251
that O 0 0.0064097861759364605
SWS B-Disease 1 0.9999945163726807
and O 0 0.012720448896288872
SJS B-Disease 1 0.9999998807907104
type I-Disease 0 0.3740496337413788
2 I-Disease 0 0.00885678082704544
are O 0 0.0008978430996648967
the O 0 0.0030765687115490437
same O 0 0.01214676909148693
disorder O 1 1.0
should O 0 0.0025851153768599033
be O 0 0.002025284105911851
testable O 0 0.03835850581526756
by O 0 0.004604210611432791
molecular O 0 0.023937121033668518
methods O 0 0.006334681995213032
. O 0 0.00343498308211565
. O 0 0.0072161047719419

A O 0 0.03424585983157158
mouse O 1 0.9590848684310913
model O 0 0.012462346814572811
of O 0 0.004607686307281256
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 0.016334151849150658
defects O 1 0.9999991655349731
in O 0 0.0053223129361867905
hemostasis O 1 1.0
and O 0 0.013962260447442532
thrombosis B-Disease 1 1.0
. O 0 0.01147797517478466

von B-Disease 1 0.9981545805931091
Willebrand I-Disease 1 0.9999980926513672
factor I-Disease 0 0.27168142795562744
( I-Disease 0 0.016969982534646988
vWf I-Disease 1 0.9999604225158691
) I-Disease 0 0.028788624331355095
deficiency I-Disease 1 1.0
causes O 1 0.9999998807907104
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 0.006323292851448059
humans O 0 0.24030081927776337
. O 0 0.0070875841192901134

We O 0 0.004170420113950968
generated O 0 0.013769535347819328
a O 0 0.013352679088711739
mouse O 1 0.9914191961288452
model O 0 0.008632360026240349
for O 0 0.0020907847210764885
this O 0 0.004526014439761639
disease O 1 0.9999998807907104
by O 0 0.003916696645319462
using O 0 0.007949568331241608
gene O 1 0.9876028895378113
targeting O 0 0.03800623118877411
. O 0 0.006421436555683613

vWf B-Disease 1 0.9985983967781067
- I-Disease 1 0.8730955719947815
deficient I-Disease 1 0.9999721050262451
mice O 1 0.9997237324714661
appeared O 0 0.023418966680765152
normal O 0 0.023426339030265808
at O 0 0.007637401577085257
birth O 1 0.6517224907875061
; O 0 0.002671155845746398
they O 0 0.0010979013750329614
were O 0 0.0017504367278888822
viable O 0 0.03373750299215317
and O 0 0.0030856290832161903
fertile O 0 0.32512447237968445
. O 0 0.0071537671610713005

Neither O 0 0.05574623495340347
vWf O 1 0.9967448711395264
nor O 0 0.04465712606906891
vWf O 1 0.9990610480308533
propolypeptide O 1 0.9990612864494324
( O 0 0.021549751982092857
von B-Disease 1 0.9996687173843384
Willebrand I-Disease 1 1.0
antigen O 1 0.9999866485595703
II O 1 0.9990367889404297
) O 0 0.004519946873188019
were O 0 0.00274618249386549
detectable O 0 0.457510769367218
in O 0 0.0034653593320399523
plasma O 0 0.05046680197119713
, O 0 0.005701393820345402
platelets O 1 0.9998902082443237
, O 0 0.0035750465467572212
or O 0 0.007362137548625469
endothelial O 1 0.9999743700027466
cells O 0 0.0313265323638916
of O 0 0.0014898569788783789
the O 0 0.006848773453384638
homozygous O 1 0.9999924898147583
mutant O 1 0.999962329864502
mice O 1 0.9989500641822815
. O 0 0.010885660536587238

The O 0 0.01695339009165764
mutant O 1 0.9998939037322998
mice O 1 0.9998565912246704
exhibited O 0 0.10283363610506058
defects O 1 0.9998916387557983
in O 0 0.004824828822165728
hemostasis O 1 0.9999964237213135
with O 0 0.0019846626091748476
a O 0 0.007817386649549007
highly O 0 0.17238855361938477
prolonged O 1 0.9999995231628418
bleeding O 1 1.0
time O 0 0.005381335504353046
and O 0 0.0033853850327432156
spontaneous O 1 0.9998949766159058
bleeding O 1 1.0
events O 0 0.0052902186289429665
in O 0 0.0020250692032277584
approximately O 0 0.008305498398840427
10 O 0 0.005513366777449846
% O 0 0.005036944989115
of O 0 0.00446696300059557
neonates O 1 0.9999865293502808
. O 0 0.009516235440969467

As O 0 0.0038371048867702484
in O 0 0.0016474409494549036
the O 0 0.004210270941257477
human O 0 0.23925992846488953
disease O 1 1.0
, O 0 0.001809743233025074
the O 0 0.0037195205222815275
factor O 1 0.9791192412376404
VIII O 1 0.9999971389770508
level O 0 0.00516373198479414
in O 0 0.0016133961034938693
these O 0 0.0021525637712329626
mice O 1 0.9999704360961914
was O 0 0.009970707818865776
reduced O 0 0.02212405577301979
strongly O 0 0.006232777144759893
as O 0 0.0017871980089694262
a O 0 0.0046569486148655415
result O 0 0.005734325852245092
of O 0 0.001009286381304264
the O 0 0.002288505434989929
lack O 0 0.00862809643149376
of O 0 0.0018162325723096728
protection O 0 0.013245961628854275
provided O 0 0.004815222695469856
by O 0 0.007811150047928095
vWf O 1 0.9990594983100891
. O 0 0.00812446977943182

Defective O 1 0.9999939203262329
thrombosis B-Disease 1 1.0
in O 0 0.012802289798855782
mutant O 1 0.999987006187439
mice O 1 0.9998359680175781
was O 0 0.009301986545324326
also O 0 0.0025750654749572277
evident O 0 0.01200046855956316
in O 0 0.0011852267198264599
an O 0 0.0016986883711069822
in O 0 0.0025871151592582464
vivo O 0 0.07368920743465424
model O 0 0.010430260561406612
of O 0 0.006185076665133238
vascular B-Disease 1 1.0
injury I-Disease 1 0.9999996423721313
. O 0 0.010272130370140076

In O 0 0.003407937940210104
this O 0 0.0025552227161824703
model O 0 0.008134298026561737
, O 0 0.0015304520493373275
the O 0 0.004330776631832123
exteriorized O 1 0.9999626874923706
mesentery O 1 0.9998977184295654
was O 0 0.02194337174296379
superfused O 1 0.9976676106452942
with O 0 0.008963219821453094
ferric O 1 0.9996046423912048
chloride O 0 0.09004063159227371
and O 0 0.0018060008296743035
the O 0 0.0033412424381822348
accumulation O 0 0.05401384457945824
of O 0 0.0047510541044175625
fluorescently O 1 0.9998642206192017
labeled O 1 0.9377478957176208
platelets O 1 0.999601423740387
was O 0 0.011862293817102909
observed O 0 0.01738211326301098
by O 0 0.006789681501686573
intravital O 1 0.9975541234016418
microscopy O 0 0.07862664759159088
. O 0 0.010629618540406227

We O 0 0.0037458103615790606
conclude O 0 0.013041562400758266
that O 0 0.001288376864977181
these O 0 0.0018171222181990743
mice O 1 0.9994227886199951
very O 0 0.00473578879609704
closely O 0 0.011698488146066666
mimic O 1 0.9997891783714294
severe O 1 0.9999997615814209
human O 1 0.6375946998596191
von B-Disease 1 0.9999998807907104
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.0024226196110248566
will O 0 0.0012777267256751657
be O 0 0.0013210705947130919
very O 0 0.002040216466411948
useful O 0 0.0029822546057403088
for O 0 0.001233668066561222
investigating O 0 0.01019648090004921
the O 0 0.0024817076046019793
role O 0 0.0073929475620388985
of O 0 0.003609242383390665
vWf O 1 0.999815046787262
in O 0 0.003959309309720993
normal O 0 0.02756941318511963
physiology O 1 0.9875279068946838
and O 0 0.0014689029194414616
in O 0 0.004627336747944355
disease O 1 1.0
models O 0 0.011584076099097729
. O 0 0.002987590152770281
. O 0 0.0048834593035280704

Oral O 0 0.288756400346756
contraceptives O 1 0.8888199329376221
and O 0 0.0011168288765475154
the O 0 0.0028266957961022854
risk O 1 0.9997343420982361
of O 0 0.008223457261919975
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.010297665372490883

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9988768696784973
Study O 0 0.010708225890994072
Group O 0 0.011852104216814041
. O 0 0.006413886323571205

BACKGROUND O 0 0.02972964569926262
Women O 0 0.010802085511386395
with O 0 0.0031857937574386597
mutations O 1 0.9993798732757568
in O 0 0.0015574464341625571
either O 0 0.00411507161334157
the O 0 0.0063428874127566814
BRCA1 O 1 1.0
or O 0 0.005381450988352299
the O 0 0.008190814405679703
BRCA2 O 1 1.0
gene O 1 0.9990994930267334
have O 0 0.0020004429388791323
a O 0 0.004261873662471771
high O 0 0.008115937002003193
lifetime O 1 0.7233231067657471
risk O 1 0.9978983402252197
of O 0 0.03823250159621239
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.009820437990128994

Oral O 0 0.3597303032875061
contraceptives O 1 0.9935896396636963
protect O 0 0.3394974172115326
against O 1 0.9869374632835388
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.00346005754545331
general O 0 0.00676753930747509
, O 0 0.0014979023253545165
but O 0 0.0016006235964596272
it O 0 0.0014041587710380554
is O 0 0.00246624369174242
not O 0 0.0014052429469302297
known O 0 0.0055872430093586445
whether O 0 0.002099391305819154
they O 0 0.001094271894544363
also O 0 0.002171628177165985
protect O 0 0.012489374727010727
against O 0 0.007422246970236301
hereditary B-Disease 1 0.999992847442627
forms I-Disease 0 0.01266139093786478
of I-Disease 0 0.023582985624670982
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.010890583507716656

METHODS O 0 0.01396769005805254
We O 0 0.003682904876768589
enrolled O 0 0.035475872457027435
207 O 1 0.9452633261680603
women O 0 0.010993804782629013
with O 0 0.008040711283683777
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.002701642457395792
161 O 0 0.041065823286771774
of O 0 0.0011170284124091268
their O 0 0.0016688687028363347
sisters O 0 0.11640089750289917
as O 0 0.0019157504430040717
controls O 0 0.010403606109321117
in O 0 0.0013261156855151057
a O 0 0.005474318750202656
case O 0 0.010602869093418121
- O 0 0.02648659236729145
control O 0 0.021811973303556442
study O 0 0.008769089356064796
. O 0 0.006006908603012562

All O 0 0.003852416528388858
the O 0 0.006064786575734615
patients O 1 0.999921441078186
carried O 0 0.00896857026964426
a O 0 0.011903743259608746
pathogenic O 1 0.9998537302017212
mutation O 1 0.9998445510864258
in O 0 0.003245360217988491
either O 0 0.016431499272584915
BRCA1 O 1 1.0
( O 0 0.010530557483434677
179 O 1 0.6016936302185059
women O 0 0.012383352033793926
) O 0 0.005826082080602646
or O 0 0.010791272856295109
BRCA2 O 1 1.0
( O 0 0.011521494947373867
28 O 0 0.022141465917229652
women O 0 0.010861478745937347
) O 0 0.00435584457591176
. O 0 0.005183323752135038

The O 0 0.00852892640978098
control O 0 0.024120043963193893
women O 0 0.006371351890265942
were O 0 0.002070585498586297
enrolled O 0 0.024265920743346214
regardless O 0 0.00742073729634285
of O 0 0.0013198935193940997
whether O 0 0.00266547710634768
or O 0 0.001901176874525845
not O 0 0.0008575147949159145
they O 0 0.0010581293608993292
had O 0 0.004799759015440941
either O 0 0.01303532812744379
mutation O 1 0.9999090433120728
. O 0 0.007734757848083973

Lifetime O 0 0.08937773108482361
histories O 0 0.03619687631726265
of O 0 0.004280718043446541
oral O 0 0.4459472894668579
- O 0 0.477977991104126
contraceptive O 1 0.9997078776359558
use O 0 0.0023067134898155928
were O 0 0.0013830844545736909
obtained O 0 0.0031448008958250284
by O 0 0.0033457851968705654
interview O 0 0.011357832700014114
or O 0 0.0026844784151762724
by O 0 0.002429522108286619
written O 0 0.004138965625315905
questionnaire O 0 0.032299574464559555
and O 0 0.0013617629883810878
were O 0 0.001557461335323751
compared O 0 0.010772151872515678
between O 0 0.005719579756259918
patients O 1 0.9999984502792358
and O 0 0.0021615629084408283
control O 0 0.49509328603744507
women O 0 0.007126804906874895
, O 0 0.0019171321764588356
after O 0 0.012042972259223461
adjustment O 0 0.02246609702706337
for O 0 0.001773736672475934
year O 0 0.0045928084291517735
of O 0 0.00241120345890522
birth O 0 0.20645888149738312
and O 0 0.00267195887863636
parity O 0 0.06294231116771698
. O 0 0.007365518715232611

RESULTS O 0 0.020428761839866638
The O 0 0.0038539243396371603
adjusted O 0 0.02300516702234745
odds O 0 0.0509834885597229
ratio O 0 0.0352059043943882
for O 0 0.020271653309464455
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 0.009020475670695305
with O 0 0.0011895309435203671
any O 0 0.0013331712689250708
past O 0 0.0034086506348103285
use O 0 0.0014947975287213922
of O 0 0.0023985307198017836
oral O 0 0.2814711630344391
contraceptives O 1 0.994606077671051
was O 0 0.013509601354598999
0 O 0 0.03225250914692879
. O 0 0.00633618887513876

5 O 0 0.02477382868528366
( O 0 0.006220690906047821
95 O 0 0.017180925235152245
percent O 0 0.008681745268404484
confidence O 0 0.019908564165234566
interval O 0 0.044964373111724854
, O 0 0.0033480769488960505
0 O 0 0.023484742268919945
. O 0 0.002523538190871477
3 O 0 0.009205316193401814
to O 0 0.002480912022292614
0 O 0 0.025725414976477623
. O 0 0.0039690094999969006
8 O 0 0.016859205439686775
) O 0 0.004900834057480097
. O 0 0.005360435228794813

The O 0 0.013600182719528675
risk O 1 0.9985613226890564
decreased O 0 0.07413932681083679
with O 0 0.002078116638585925
increasing O 0 0.011776294559240341
duration O 0 0.030129635706543922
of O 0 0.0016131149604916573
use O 0 0.0034285918809473515
( O 0 0.0077474238350987434
P O 1 0.7703894972801208
for O 0 0.0021780480165034533
trend O 0 0.03113343007862568
, O 0 0.005072440952062607
< O 1 0.9941883087158203
0 O 0 0.03645527362823486
. O 0 0.005930287763476372
001 O 1 0.9905283451080322
) O 0 0.006297094747424126
; O 0 0.0022632989566773176
use O 0 0.0014052758924663067
for O 0 0.0013642668491229415
six O 0 0.0036359294317662716
or O 0 0.0024213986471295357
more O 0 0.0015268828719854355
years O 0 0.004433706868439913
was O 0 0.00759107293561101
associated O 0 0.006645679008215666
with O 0 0.0011790402932092547
a O 0 0.006056887563318014
60 O 0 0.011912203393876553
percent O 0 0.009456055238842964
reduction O 0 0.02418927475810051
in O 0 0.004233617335557938
risk O 1 0.9364749193191528
. O 0 0.006097209174185991

Oral O 0 0.12845481932163239
- O 0 0.06869427859783173
contraceptive O 1 0.9962915182113647
use O 0 0.005968880839645863
protected O 0 0.029518967494368553
against O 0 0.43240442872047424
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 0.002470998093485832
for O 0 0.001726788585074246
carriers O 0 0.038137637078762054
of O 0 0.0019756590481847525
the O 0 0.013808741234242916
BRCA1 O 1 1.0
mutation O 1 0.9999945163726807
( O 0 0.011123251169919968
odds O 0 0.06699921190738678
ratio O 0 0.03465571627020836
, O 0 0.0033010977786034346
0 O 0 0.025053342804312706
. O 0 0.0026811971329152584
5 O 0 0.010819954797625542
; O 0 0.0028983266092836857
95 O 0 0.01841675117611885
percent O 0 0.009543295949697495
confidence O 0 0.02153118886053562
interval O 0 0.04133211448788643
, O 0 0.004084046930074692
0 O 0 0.02494208700954914
. O 0 0.002582271583378315
3 O 0 0.009992369450628757
to O 0 0.0027738199569284916
0 O 0 0.026344645768404007
. O 0 0.0030577178113162518
9 O 0 0.013323085382580757
) O 0 0.0027474991511553526
and O 0 0.0008556625689379871
for O 0 0.001655764877796173
carriers O 0 0.032011646777391434
of O 0 0.0014911905163899064
the O 0 0.01007860992103815
BRCA2 O 1 1.0
mutation O 1 0.9999867677688599
( O 0 0.011782139539718628
odds O 0 0.05588162690401077
ratio O 0 0.03125446289777756
, O 0 0.003854074515402317
0 O 0 0.025742918252944946
. O 0 0.0029075792990624905
4 O 0 0.012939595617353916
; O 0 0.00330679165199399
95 O 0 0.01666935347020626
percent O 0 0.009665550664067268
confidence O 0 0.022106194868683815
interval O 0 0.039147358387708664
, O 0 0.0038262461312115192
0 O 0 0.025338223204016685
. O 0 0.002590151270851493
2 O 0 0.006880012806504965
to O 0 0.002374876756221056
1 O 0 0.010874170809984207
. O 0 0.00318890530616045
1 O 0 0.014963986352086067
) O 0 0.004803942516446114
. O 0 0.005637186113744974

CONCLUSIONS O 0 0.03810088708996773
Oral O 0 0.1178089901804924
- O 0 0.0954071655869484
contraceptive O 1 0.9993987083435059
use O 0 0.004700098652392626
may O 0 0.007576276548206806
reduce O 0 0.013877984136343002
the O 0 0.004158977419137955
risk O 1 0.9981106519699097
of O 0 0.018363086506724358
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0027092474047094584
women O 0 0.006253529340028763
with O 0 0.0028299607802182436
pathogenic O 1 0.999991774559021
mutations O 1 0.9998051524162292
in O 0 0.0022825903724879026
the O 0 0.009343378245830536
BRCA1 O 1 1.0
or O 0 0.026671458035707474
BRCA2 O 1 1.0
gene O 1 0.9979037046432495

A O 0 0.023160604760050774
Japanese O 0 0.015455854125320911
family O 0 0.017043529078364372
with O 0 0.005466313101351261
adrenoleukodystrophy B-Disease 1 1.0
with O 0 0.0031564796809107065
a O 0 0.011931650340557098
codon O 1 0.9637890458106995
291 O 1 0.9517396092414856
deletion O 1 0.9976447224617004
: O 0 0.004865782335400581
a O 0 0.008350043557584286
clinical O 1 0.9969066977500916
, O 0 0.0024747622665017843
biochemical O 0 0.06434261053800583
, O 0 0.003252016846090555
pathological O 1 0.9999452829360962
, O 0 0.0016789959045127034
and O 0 0.001960247755050659
genetic O 0 0.30085453391075134
report O 0 0.005331702064722776
. O 0 0.00568808289244771

We O 0 0.0035329891834408045
report O 0 0.003907500300556421
a O 0 0.005678441841155291
Japanese O 0 0.011573751457035542
family O 0 0.016112737357616425
with O 0 0.008823277428746223
adrenoleukodystrophy B-Disease 1 1.0
( O 0 0.3315122127532959
ALD B-Disease 1 1.0
) O 0 0.004612426273524761
with O 0 0.0014035103376954794
a O 0 0.0042153578251600266
three O 0 0.002609184244647622
base O 0 0.015193699859082699
pair O 0 0.024116812273859978
deletion O 1 0.9988413453102112
( O 0 0.01616283319890499
delGAG O 1 0.9990853071212769
291 O 1 0.7638686895370483
) O 0 0.004092290066182613
in O 0 0.002236268250271678
the O 0 0.012440879829227924
ALD B-Disease 1 1.0
gene O 1 0.9989836812019348
. O 0 0.009481949731707573

A O 0 0.019596973434090614
variety O 0 0.007096287328749895
of O 0 0.0037577624898403883
phenotypes O 1 0.9998238682746887
were O 0 0.0025616136845201254
observed O 0 0.008003485389053822
within O 0 0.002093589399009943
this O 0 0.0023031234741210938
family O 0 0.01692674681544304
. O 0 0.006434095092117786

While O 0 0.006795916240662336
the O 0 0.00730085326358676
proband O 1 0.9999449253082275
( O 0 0.016351643949747086
patient O 1 0.9999712705612183
1 O 0 0.018585845828056335
) O 0 0.0039939661510288715
was O 0 0.006813820917159319
classified O 0 0.008543846197426319
as O 0 0.001823592814616859
having O 0 0.006446559447795153
a O 0 0.005245164968073368
rare O 0 0.018674936145544052
intermediate O 0 0.02479778230190277
type O 0 0.025571882724761963
of O 0 0.003555007977411151
adult O 1 0.9959052801132202
cerebral O 1 0.9999997615814209
and O 0 0.004675849340856075
cerebello O 1 0.9999984502792358
- O 1 0.9994600415229797
brain O 1 0.9999996423721313
stem O 1 0.8602061867713928
forms O 0 0.005959401838481426
, O 0 0.0017877154750749469
his O 0 0.005363415461033583
younger O 1 0.9765624403953552
brother O 1 0.9724307656288147
( O 0 0.014750350266695023
patient O 1 0.9999531507492065
2 O 0 0.014219891279935837
) O 0 0.00376514857634902
and O 0 0.002185278804972768
nephew O 1 0.9999779462814331
( O 0 0.0132314283400774
patient O 1 0.9999790191650391
3 O 0 0.01337248831987381
) O 0 0.003220147918909788
had O 0 0.004731945227831602
a O 0 0.016260182484984398
childhood O 1 0.9999523162841797
ALD B-Disease 1 1.0
type O 1 0.931984007358551
. O 0 0.00839067529886961

Another O 0 0.04040488228201866
nephew O 1 0.9974815249443054
( O 0 0.0150342658162117
patient O 1 0.999969482421875
4 O 0 0.015299909748136997
) O 0 0.002666953019797802
of O 0 0.002719893353059888
patient O 1 0.9999850988388062
1 O 0 0.011907248757779598
was O 0 0.006492007989436388
classified O 0 0.00917795766144991
as O 0 0.0022051064297556877
having O 0 0.007979271933436394
an O 0 0.005675397347658873
adolescent O 1 0.9998832941055298
form O 0 0.013398237526416779
. O 0 0.006771411746740341

The O 0 0.008941056206822395
tau O 1 0.9815557599067688
level O 0 0.004016411956399679
in O 0 0.0017363522201776505
the O 0 0.006414101924747229
cerebrospinal O 1 0.9999990463256836
fluid O 1 0.9971086382865906
( O 0 0.01615940034389496
CSF O 1 0.9999886751174927
) O 0 0.004706801846623421
in O 0 0.004012205637991428
patient O 1 0.9999446868896484
1 O 0 0.011350756511092186
was O 0 0.005820395424962044
as O 0 0.0017729965038597584
high O 0 0.0038283257745206356
as O 0 0.001198741258122027
that O 0 0.0009236636688001454
of O 0 0.002431880682706833
patients O 1 0.9999996423721313
with O 0 0.16090328991413116
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.017797496169805527
AD B-Disease 1 0.9409900307655334
) O 0 0.0070269242860376835
. O 0 0.005816859193146229

His O 0 0.029910603538155556
brain O 1 0.9998776912689209
magnetic O 0 0.044062767177820206
resonance O 0 0.07151027023792267
image O 0 0.045637667179107666
( O 0 0.01416698470711708
MRI O 1 0.9999624490737915
) O 0 0.005945424549281597
showed O 0 0.020030763000249863
abnormalities B-Disease 1 0.999734103679657
in I-Disease 0 0.001852946588769555
the I-Disease 0 0.0026434448082000017
bilateral I-Disease 0 0.014034525491297245
cerebellar I-Disease 1 0.9999982118606567
hemispheres I-Disease 1 0.999653697013855
and O 0 0.008054741658270359
brain O 1 0.9999998807907104
stem O 1 0.9400948286056519
, O 0 0.0018086900236085057
but O 0 0.0014272639527916908
not O 0 0.0010001042392104864
in O 0 0.0017895286437124014
the O 0 0.00791096594184637
cerebral O 1 1.0
white O 0 0.021117808297276497
matter O 0 0.004146822728216648
, O 0 0.0014846869744360447
where O 0 0.0027025185991078615
marked O 0 0.015361473895609379
reductions O 0 0.014041760005056858
of O 0 0.0013816488208249211
the O 0 0.007696735206991434
cerebral O 1 1.0
blood O 1 0.9997259974479675
flow O 0 0.01780378818511963
and O 0 0.003259815974161029
oxygen O 1 0.9875361323356628
metabolism O 1 0.9186291098594666
were O 0 0.002691742265596986
clearly O 0 0.008174317888915539
demonstrated O 0 0.016109630465507507
by O 0 0.008653530851006508
positron O 1 0.9987168312072754
emission O 0 0.1986524760723114
tomography O 1 0.9538458585739136
( O 0 0.015791067853569984
PET O 1 0.99906986951828
) O 0 0.006899729836732149
. O 0 0.00650026835501194

In O 0 0.015204155817627907
patients O 1 0.9999091625213623
2 O 0 0.011072792112827301
and O 0 0.0016751154325902462
3 O 0 0.007849408313632011
, O 0 0.0012627345276996493
the O 0 0.002822528127580881
autopsy O 1 0.9918279647827148
findings O 0 0.010386652313172817
showed O 0 0.014624268747866154
massive O 1 0.6424197554588318
demyelination B-Disease 1 0.9999996423721313
of I-Disease 0 0.003513761330395937
the I-Disease 0 0.012654989957809448
cerebral I-Disease 1 1.0
white I-Disease 0 0.016174884513020515
matter I-Disease 0 0.004185601137578487
with O 0 0.002066595945507288
sparing O 0 0.4061152935028076
of O 0 0.0020547073800116777
the O 0 0.005646977573633194
U O 1 0.9993987083435059
- O 0 0.19691495597362518
fibers O 1 0.7935246825218201
, O 0 0.0020566012244671583
compatible O 0 0.009284217841923237
with O 0 0.0010116604389622808
the O 0 0.002504937583580613
findings O 0 0.009888619184494019
of O 0 0.004792687017470598
childhood O 1 0.9999790191650391
ALD B-Disease 1 1.0
. O 0 0.01231355033814907

Oleic O 1 0.9470006823539734
and O 0 0.01020983885973692
erucic O 1 0.9992870688438416
acids O 0 0.0898580476641655
( O 0 0.011440887115895748
Lorenzos O 1 0.9969010353088379
Oil O 0 0.014823421835899353
) O 0 0.0036722926888614893
were O 0 0.001989522948861122
administered O 0 0.0763639584183693
to O 0 0.005663473159074783
patients O 1 0.9998999834060669
1 O 0 0.01156381145119667
and O 0 0.0020408816635608673
4 O 0 0.011042606085538864
, O 0 0.0015048978384584188
but O 0 0.0017904541455209255
sufficient O 0 0.007391837425529957
effectiveness O 0 0.032844528555870056
was O 0 0.006835099775344133
not O 0 0.001583673758432269
obtained O 0 0.005204988177865744
. O 0 0.0060615395195782185

The O 0 0.007413708604872227
findings O 0 0.008653641678392887
in O 0 0.0017277448205277324
this O 0 0.0024118893779814243
family O 0 0.010848765261471272
suggest O 0 0.00729528721421957
that O 0 0.0026686466298997402
delGAG291 O 1 0.9997318387031555
is O 0 0.0029442033264786005
part O 0 0.003495946992188692
of O 0 0.00122177810408175
the O 0 0.0037168902345001698
cause O 1 0.9782854318618774
of O 0 0.0026940114330500364
Japanese O 0 0.16692642867565155
ALD B-Disease 1 1.0
with O 0 0.007203718181699514
phenotypic O 1 0.9998880624771118
variations O 0 0.019388727843761444
. O 0 0.0056821503676474094

Moreover O 0 0.029620010405778885
, O 0 0.0024980581365525723
although O 0 0.0030258663464337587
the O 0 0.0022455789148807526
scale O 0 0.006080708932131529
of O 0 0.0012403515866026282
the O 0 0.0024739806540310383
study O 0 0.004462296608835459
is O 0 0.0030359644442796707
limited O 0 0.0055284700356423855
, O 0 0.0012855501845479012
there O 0 0.001227455330081284
is O 0 0.0022553103044629097
a O 0 0.003949427977204323
possibility O 0 0.008945637382566929
that O 0 0.002465327735990286
PET O 1 0.9999558925628662
can O 0 0.004418703727424145
detect O 0 0.03481762856245041
an O 0 0.0064896345138549805
insidious B-Disease 1 0.9999961853027344
lesion I-Disease 1 0.9999977350234985
which O 0 0.004147917497903109
is O 0 0.004759426228702068
undetectable O 1 0.9800100922584534
by O 0 0.006523930002003908
computed O 0 0.09610600024461746
tomogram O 1 0.9988607168197632
( O 0 0.024225648492574692
CT O 1 0.9999926090240479
) O 0 0.006909522227942944
or O 0 0.00771291833370924
MRI O 1 0.9992004036903381
analysis O 0 0.005731294862926006
, O 0 0.0012750158784911036
and O 0 0.0007691011996939778
that O 0 0.0008009379380382597
the O 0 0.001880540163256228
higher O 0 0.004644064698368311
level O 0 0.00337021891027689
of O 0 0.0026244695764034986
tau O 1 0.9982981085777283
reflects O 0 0.008892145939171314
the O 0 0.0018236135365441442
process O 0 0.0036347343120723963
of O 0 0.003798498772084713
neuronal B-Disease 1 0.9999642372131348
degeneration I-Disease 1 1.0
in O 0 0.014018842950463295
ALD B-Disease 1 1.0
. O 0 0.013538438826799393

Lorenzos O 1 0.9985129237174988
Oil O 0 0.013119535520672798
should O 0 0.002630262402817607
be O 0 0.0014556145761162043
given O 0 0.0025176028721034527
in O 0 0.001187582965940237
the O 0 0.0027093489188700914
early O 0 0.010263141244649887
stage O 0 0.023827359080314636
. O 0 0.003480222774669528
. O 0 0.00509968725964427

Nonsense O 0 0.22483600676059723
mutation O 1 0.9979346990585327
in O 0 0.0066754319705069065
exon O 1 0.944729745388031
4 O 0 0.010413207113742828
of O 0 0.002292400225996971
human O 0 0.013645599596202374
complement O 0 0.06356880068778992
C9 O 1 0.9999734163284302
gene O 1 0.9923626184463501
is O 0 0.0034573033917695284
the O 0 0.0025009422097355127
major O 0 0.009468775242567062
cause O 0 0.31594640016555786
of O 0 0.0015797504456713796
Japanese O 0 0.016444535925984383
complement B-Disease 1 0.8081462979316711
C9 I-Disease 1 0.9999996423721313
deficiency I-Disease 1 1.0
. O 0 0.009995232336223125

Deficiency B-Disease 1 0.9999977350234985
of I-Disease 0 0.002201995113864541
the I-Disease 0 0.0032038611825555563
ninth I-Disease 0 0.31120625138282776
component I-Disease 0 0.018793202936649323
of I-Disease 0 0.0018420167034491897
human I-Disease 0 0.012024627067148685
complement I-Disease 0 0.032560110092163086
( O 0 0.01245196908712387
C9 O 1 0.9999979734420776
) O 0 0.004584971349686384
is O 0 0.001903155934996903
the O 0 0.0017691953107714653
most O 0 0.003378563793376088
common O 0 0.015716861933469772
complement B-Disease 1 0.9993739724159241
deficiency I-Disease 1 1.0
in O 0 0.0029869854915887117
Japan O 0 0.005224624183028936
but O 0 0.0024199108593165874
is O 0 0.0036075771786272526
rare O 0 0.014467353001236916
in O 0 0.0013629228342324495
other O 0 0.0008249752572737634
countries O 0 0.0018807692686095834
. O 0 0.0053550382144749165

We O 0 0.0034285089932382107
studied O 0 0.004252235870808363
the O 0 0.002089789370074868
molecular O 0 0.013883923180401325
basis O 0 0.0020610950887203217
of O 0 0.00538825336843729
C9 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999998807907104
in O 0 0.0023384487722069025
four O 0 0.003415897488594055
Japanese O 0 0.02326686680316925
C9 B-Disease 1 0.9999974966049194
- I-Disease 1 0.9975762963294983
deficient I-Disease 1 0.9999994039535522
patients O 1 0.999997615814209
who O 0 0.005415271036326885
had O 0 0.22781118750572205
suffered O 1 1.0
from O 0 0.08128491789102554
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.013462536968290806

Direct O 0 0.019533468410372734
sequencing O 0 0.048749666661024094
of O 0 0.004700758960098028
amplified O 0 0.22030186653137207
C9 O 1 0.9989435076713562
cDNA O 0 0.13476713001728058
and O 0 0.0038166451267898083
DNA O 0 0.0336918942630291
revealed O 0 0.01625204086303711
a O 0 0.009641652926802635
nonsense O 0 0.05166838318109512
substitution O 0 0.049440011382102966
( O 0 0.011666379868984222
CGA O 0 0.3527854382991791
- O 0 0.07138539850711823
- O 0 0.09586356580257416
> O 1 0.992482602596283
TGA O 1 0.999713122844696
) O 0 0.006781264208257198
at O 0 0.006677974481135607
codon O 0 0.14855381846427917
95 O 0 0.021011557430028915
in O 0 0.004041776992380619
exon O 1 0.9947264790534973
4 O 0 0.008088627830147743
in O 0 0.0011897428194060922
the O 0 0.0025203328114002943
four O 0 0.009391325525939465
C9 B-Disease 1 0.9999973773956299
- I-Disease 1 0.5342922806739807
deficient I-Disease 1 0.9993036985397339
individuals O 0 0.010953468270599842
. O 0 0.00701199471950531

An O 0 0.016539063304662704
allele O 1 0.9993826150894165
- O 0 0.04017515480518341
specific O 0 0.013034787029027939
polymerase O 1 0.6497944593429565
chain O 0 0.09888659417629242
reaction O 0 0.0323154516518116
system O 0 0.009812611155211926
designed O 0 0.00569952093064785
to O 0 0.0023383772931993008
detect O 0 0.03343072906136513
exclusively O 0 0.004958035424351692
only O 0 0.0014155860990285873
one O 0 0.0011803528759628534
of O 0 0.0007941668154671788
the O 0 0.0026399472262710333
normal O 0 0.0169486366212368
and O 0 0.002592455828562379
mutant O 1 0.9999669790267944
alleles O 1 0.9999345541000366
indicated O 0 0.01153009943664074
that O 0 0.0008247978985309601
all O 0 0.0007133734179660678
the O 0 0.0021190273109823465
four O 0 0.0053751044906675816
patients O 1 0.9999792575836182
were O 0 0.0031557295005768538
homozygous O 1 0.99970942735672
for O 0 0.0018312940374016762
the O 0 0.005174451973289251
mutation O 1 0.9999874830245972
in O 0 0.0045683966018259525
exon O 1 0.9975438714027405
4 O 0 0.01093054749071598
and O 0 0.0010290085338056087
that O 0 0.0008866256684996188
the O 0 0.002736580092459917
parents O 0 0.010537932626903057
of O 0 0.002909374190494418
patient O 1 0.999993085861206
2 O 0 0.011791625060141087
were O 0 0.00408061221241951
heterozygous O 1 0.996482253074646
. O 0 0.009440958499908447

The O 0 0.007872947491705418
common O 0 0.020553262904286385
mutation O 1 0.9995260238647461
at O 0 0.009585371240973473
codon O 0 0.17750664055347443
95 O 0 0.021803395822644234
in O 0 0.004057832527905703
exon O 1 0.9974125027656555
4 O 0 0.0142873115837574
might O 0 0.00543597899377346
be O 0 0.0015356591902673244
responsible O 0 0.007477951236069202
for O 0 0.0016483401414006948
most O 0 0.004600294400006533
Japanese O 0 0.10062955319881439
C9 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
. O 0 0.005349204409867525
. O 0 0.0061483317986130714

BRCA1 O 1 0.9999959468841553
required O 0 0.010105988010764122
for O 0 0.0033011839259415865
transcription O 0 0.09637192636728287
- O 0 0.032555509358644485
coupled O 0 0.04680868983268738
repair O 1 0.7251918911933899
of O 0 0.004943778272718191
oxidative O 1 0.999924898147583
DNA O 0 0.10084549337625504
damage O 1 0.8500660061836243
. O 0 0.007404906675219536

The O 0 0.023355422541499138
breast B-Disease 1 1.0
and I-Disease 1 0.8308191299438477
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9999966621398926
gene O 1 0.9999240636825562
BRCA1 O 1 0.9999991655349731
encodes O 0 0.367897093296051
a O 0 0.017337845638394356
zinc O 1 0.993305504322052
finger O 1 0.9603510499000549
protein O 0 0.0378405898809433
of O 0 0.002274129306897521
unknown O 0 0.018823256716132164
function O 0 0.0162228811532259
. O 0 0.005646083038300276

Association O 0 0.01751828007400036
of O 0 0.0020985223818570375
the O 0 0.00907676387578249
BRCA1 O 1 0.9999998807907104
protein O 0 0.04420485347509384
with O 0 0.0014830606523901224
the O 0 0.0036546129267662764
DNA O 0 0.07358774542808533
repair O 1 0.9969899654388428
protein O 0 0.11600688099861145
Rad51 O 1 0.9995540976524353
and O 0 0.00236134952865541
changes O 0 0.0039654141291975975
in O 0 0.0010623038979247212
the O 0 0.002484608441591263
phosphorylation O 0 0.05103980749845505
and O 0 0.00234124599955976
cellular O 0 0.0395440012216568
localization O 0 0.03674393147230148
of O 0 0.0013383821351453662
the O 0 0.004108998458832502
protein O 0 0.05779794976115227
after O 0 0.018276523798704147
exposure O 1 0.6825498938560486
to O 0 0.004063843283802271
DNA O 0 0.05992264300584793
- O 0 0.045704081654548645
damaging O 0 0.09313233941793442
agents O 0 0.009651487693190575
are O 0 0.0011328948894515634
consistent O 0 0.007480931468307972
with O 0 0.0010735931573435664
a O 0 0.005143823567777872
role O 0 0.010633120313286781
for O 0 0.005716218147426844
BRCA1 O 1 0.9999998807907104
in O 0 0.006276707164943218
DNA O 0 0.0891776755452156
repair O 1 0.9867551922798157
. O 0 0.008471742272377014

Here O 0 0.005255215801298618
, O 0 0.001459332648664713
it O 0 0.0014129026094451547
is O 0 0.002482224488630891
shown O 0 0.006134355440735817
that O 0 0.003054816508665681
mouse O 1 0.99989914894104
embryonic O 1 0.9911515116691589
stem O 1 0.9802765846252441
cells O 1 0.8344026803970337
deficient B-Disease 1 0.99905925989151
in I-Disease 0 0.007315156515687704
BRCA1 I-Disease 1 1.0
are O 0 0.0030919485725462437
defective O 1 0.999874472618103
in O 0 0.001634892076253891
the O 0 0.0019528266275301576
ability O 0 0.005268672946840525
to O 0 0.000994366593658924
carry O 0 0.0042557260021567345
out O 0 0.004381662700325251
transcription O 0 0.13099831342697144
- O 0 0.027929183095693588
coupled O 0 0.050229430198669434
repair O 1 0.8525460362434387
of O 0 0.0040413374081254005
oxidative O 1 0.9999499320983887
DNA O 0 0.08152670413255692
damage O 1 0.9359360933303833
, O 0 0.0013950989814475179
and O 0 0.0010091487783938646
are O 0 0.0017844100948423147
hypersensitive O 1 0.9999874830245972
to O 0 0.006565465126186609
ionizing O 1 0.997097373008728
radiation O 0 0.3138877749443054
and O 0 0.0035322089679539204
hydrogen O 0 0.04657679796218872
peroxide O 0 0.14116305112838745
. O 0 0.00871918722987175

These O 0 0.0035081796813756227
results O 0 0.00866506714373827
suggest O 0 0.009785396046936512
that O 0 0.006120637059211731
BRCA1 O 1 0.9999997615814209
participates O 0 0.06700103729963303
, O 0 0.0024288876447826624
directly O 0 0.005563866812735796
or O 0 0.003876064671203494
indirectly O 0 0.0291898250579834
, O 0 0.0018475630786269903
in O 0 0.002727823331952095
transcription O 0 0.11457254737615585
- O 0 0.0346105732023716
coupled O 0 0.05163048580288887
repair O 1 0.556706428527832
of O 0 0.006340480409562588
oxidative O 1 0.9999246597290039
DNA O 0 0.11133958399295807
damage O 1 0.8092655539512634
. O 0 0.004117285832762718
. O 0 0.0069834524765610695

Truncation O 1 0.9977676868438721
mutations O 1 0.9920404553413391
in O 0 0.0027174626011401415
the O 0 0.0053726984187960625
transactivation O 1 0.9991979002952576
region O 0 0.013523047789931297
of O 0 0.004922893363982439
PAX6 O 1 0.9999990463256836
result O 0 0.014928574673831463
in O 0 0.003465771209448576
dominant O 1 0.761134147644043
- O 0 0.053539637476205826
negative O 0 0.06824224442243576
mutants O 1 0.9945864677429199
. O 0 0.00813536811619997

PAX6 O 1 0.9998979568481445
is O 0 0.007603836245834827
a O 0 0.011349118314683437
transcription O 0 0.07961305230855942
factor O 0 0.02629922889173031
with O 0 0.0016407555667683482
two O 0 0.002500290283933282
DNA O 0 0.0466192252933979
- O 0 0.03507133200764656
binding O 0 0.02674787864089012
domains O 0 0.03912505879998207
( O 0 0.007119170390069485
paired O 0 0.04738062247633934
box O 0 0.032731086015701294
and O 0 0.004725347738713026
homeobox O 1 0.9999622106552124
) O 0 0.004404776263982058
and O 0 0.0012707686983048916
a O 0 0.011873953975737095
proline O 1 0.9920496344566345
- O 0 0.04976850748062134
serine O 1 0.7833701372146606
- O 0 0.06872262805700302
threonine O 1 0.9484425187110901
( O 0 0.01483133528381586
PST O 1 0.9970836043357849
) O 0 0.008867129683494568
- O 0 0.03314448520541191
rich O 0 0.03616601228713989
transactivation O 1 0.9916957020759583
domain O 0 0.04670356959104538
. O 0 0.008408683352172375

PAX6 O 1 0.9999840259552002
regulates O 1 0.97489333152771
eye O 1 0.9980791807174683
development O 0 0.005843868479132652
in O 0 0.002705254824832082
animals O 0 0.014672593213617802
ranging O 0 0.0078459233045578
from O 0 0.005691028665751219
jellyfish O 1 0.9792400598526001
to O 0 0.003995589911937714
Drosophila O 1 0.5226364135742188
to O 0 0.0040869805961847305
humans O 0 0.031507689505815506
. O 0 0.007828020490705967

Heterozygous O 1 0.9993404746055603
mutations O 1 0.9918501973152161
in O 0 0.002321874024346471
the O 0 0.0045411791652441025
human O 0 0.0235904511064291
PAX6 O 1 0.9999995231628418
gene O 1 0.997510552406311
result O 0 0.008947937749326229
in O 0 0.0015473843086510897
various O 0 0.0025922663044184446
phenotypes O 1 0.9999303817749023
, O 0 0.0018933825194835663
including O 0 0.004009862430393696
aniridia B-Disease 1 0.9999990463256836
, O 0 0.005527293309569359
Peters B-Disease 1 0.9999783039093018
anomaly I-Disease 1 0.9999457597732544
, O 0 0.008629373274743557
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999697208404541
keratitis I-Disease 1 1.0
, O 0 0.0033872518688440323
and O 0 0.00456602917984128
familial B-Disease 1 1.0
foveal I-Disease 1 0.9999997615814209
dysplasia I-Disease 1 1.0
. O 0 0.013152544386684895

It O 0 0.004077531863003969
is O 0 0.0031189986038953066
believed O 0 0.006588860414922237
that O 0 0.0011302630882710218
the O 0 0.005125320982187986
mutated O 1 0.9999122619628906
allele O 1 0.998516857624054
of O 0 0.007530929520726204
PAX6 O 1 0.9999892711639404
produces O 0 0.03261421248316765
an O 0 0.004890745040029287
inactive O 1 0.928895890712738
protein O 0 0.04937446117401123
and O 0 0.0033294742461293936
aniridia B-Disease 1 0.9999905824661255
is O 0 0.008392062969505787
caused O 1 0.9989280104637146
due O 0 0.01289704442024231
to O 0 0.0037248041480779648
genetic O 0 0.18229283392429352
haploinsufficiency O 1 0.996728777885437
. O 0 0.010668795555830002

However O 0 0.006762303411960602
, O 0 0.0016110445139929652
several O 0 0.0041397749446332455
truncation O 1 0.9999315738677979
mutations O 1 0.9999114274978638
have O 0 0.002759503433480859
been O 0 0.0034634594339877367
found O 0 0.0037257240619510412
to O 0 0.0013470592675730586
occur O 0 0.008184263482689857
in O 0 0.0011853204341605306
the O 0 0.004644494503736496
C O 1 0.9866965413093567
- O 0 0.037516478449106216
terminal O 0 0.1727817803621292
half O 0 0.008244276978075504
of O 0 0.0045997146517038345
PAX6 O 1 0.9999994039535522
in O 0 0.0074668461456894875
patients O 1 0.9999923706054688
with O 0 0.004627271089702845
Aniridia B-Disease 1 0.9999991655349731
resulting O 0 0.0470697283744812
in O 0 0.004110938869416714
mutant O 1 0.9993539452552795
proteins O 0 0.01989605464041233
that O 0 0.0014652522513642907
retain O 0 0.013897888362407684
the O 0 0.004183297045528889
DNA O 0 0.05655446648597717
- O 0 0.035393137484788895
binding O 0 0.02123391442000866
domains O 0 0.026671508327126503
but O 0 0.0022410100791603327
have O 0 0.0019171879393979907
lost O 0 0.018257850781083107
most O 0 0.0019489735132083297
of O 0 0.001556066214106977
the O 0 0.006423898506909609
transactivation O 1 0.9993281364440918
domain O 0 0.04530590772628784
. O 0 0.008002993650734425

It O 0 0.006386196706444025
is O 0 0.003571504959836602
not O 0 0.00145907758269459
clear O 0 0.003663026262074709
whether O 0 0.0027720530051738024
such O 0 0.0020441708620637655
mutants O 1 0.999915361404419
really O 0 0.01274197269231081
behave O 0 0.016627417877316475
as O 0 0.0034925565123558044
loss O 0 0.04660447686910629
- O 0 0.016438452526926994
of O 0 0.0024451182689517736
- O 0 0.030302440747618675
function O 0 0.023760786280035973
mutants O 1 0.9790259003639221
as O 0 0.0033525624312460423
predicted O 0 0.019226273521780968
by O 0 0.006628516595810652
haploinsufficiency O 1 0.9981440305709839
. O 0 0.010317069478332996

Contrary O 0 0.013179972767829895
to O 0 0.0016545469406992197
this O 0 0.0017686598002910614
theory O 0 0.00400383397936821
, O 0 0.0010151307797059417
our O 0 0.0015449690399691463
data O 0 0.0019909976981580257
showed O 0 0.00576731888577342
that O 0 0.0011469427263364196
these O 0 0.0014497054507955909
mutants O 1 0.9993956089019775
are O 0 0.0024169073440134525
dominant O 0 0.16500483453273773
- O 0 0.028087545186281204
negative O 0 0.029581118375062943
in O 0 0.004540491849184036
transient O 1 0.9964572787284851
transfection O 1 0.9981843829154968
assays O 0 0.07321065664291382
when O 0 0.005673422943800688
they O 0 0.0013207971351221204
are O 0 0.0015377970412373543
coexpressed O 1 0.9988239407539368
with O 0 0.002722318284213543
wild O 0 0.06364116072654724
- O 0 0.12646515667438507
type O 1 0.9608784317970276
PAX6 O 1 0.999991774559021
. O 0 0.01345764845609665

We O 0 0.004194729961454868
found O 0 0.004447171930223703
that O 0 0.001074233092367649
the O 0 0.003500178689137101
dominant O 1 0.8925013542175293
- O 0 0.03981747850775719
negative O 0 0.04837976396083832
effects O 0 0.04668714478611946
result O 0 0.008429031819105148
from O 0 0.0020224140025675297
the O 0 0.003106399206444621
enhanced O 0 0.029582185670733452
DNA O 0 0.041696757078170776
binding O 0 0.013118492439389229
ability O 0 0.006419103592634201
of O 0 0.0012760637328028679
these O 0 0.0026306379586458206
mutants O 1 0.996659517288208
. O 0 0.0075255814008414745

Kinetic O 0 0.05149957910180092
studies O 0 0.0069949631579220295
of O 0 0.0019765605684369802
binding O 0 0.015452079474925995
and O 0 0.0029557154048234224
dissociation O 1 0.583179235458374
revealed O 0 0.014444436877965927
that O 0 0.0012269597500562668
various O 0 0.002467641606926918
truncation O 1 0.9998431205749512
mutants O 1 0.9959973096847534
have O 0 0.004822635557502508
3 O 0 0.015281335450708866
- O 0 0.02845824509859085
5 O 0 0.017502758651971817
- O 0 0.03243725746870041
fold O 0 0.04925854876637459
higher O 0 0.011689185164868832
affinity O 0 0.027462538331747055
to O 0 0.0014006397686898708
various O 0 0.0021100775338709354
DNA O 0 0.04300637170672417
- O 0 0.027357514947652817
binding O 0 0.01770549640059471
sites O 0 0.005007076542824507
when O 0 0.006215941160917282
compared O 0 0.0071685523726046085
with O 0 0.0013075454626232386
the O 0 0.0031053645070642233
wild O 0 0.09359931200742722
- O 0 0.06217857077717781
type O 1 0.9669222235679626
PAX6 O 1 0.9999871253967285
. O 0 0.013146165758371353

These O 0 0.0029858038760721684
results O 0 0.006170058622956276
provide O 0 0.0023314529098570347
a O 0 0.004302639048546553
new O 0 0.0026757875457406044
insight O 0 0.014591282233595848
into O 0 0.0024537714198231697
the O 0 0.002107534557580948
role O 0 0.006338545586913824
of O 0 0.0035902487579733133
mutant O 1 0.9999611377716064
PAX6 O 1 0.9999908208847046
in O 0 0.008114286698400974
causing O 1 0.999957799911499
aniridia B-Disease 1 0.9999985694885254
. O 0 0.005324517376720905
. O 0 0.00630530621856451

Reversal O 0 0.13699857890605927
of O 0 0.009323334321379662
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 0.003227975219488144
excellent O 0 0.016478966921567917
neuropsychologic O 1 0.9999686479568481
outcome O 0 0.012454080395400524
in O 0 0.0018661665963009
very B-Disease 0 0.00553433271124959
- I-Disease 0 0.027053935453295708
long I-Disease 0 0.019162805750966072
- I-Disease 0 0.043984610587358475
chain I-Disease 0 0.43746063113212585
acyl I-Disease 1 0.9876068234443665
- I-Disease 0 0.054487280547618866
coenzyme I-Disease 1 0.9725085496902466
A I-Disease 0 0.45348072052001953
dehydrogenase I-Disease 1 0.9999936819076538
deficiency I-Disease 1 0.9999998807907104
. O 0 0.01242341659963131

Very B-Disease 0 0.015274419449269772
- I-Disease 0 0.03364148736000061
long I-Disease 0 0.021665522828698158
- I-Disease 0 0.05508989468216896
chain I-Disease 1 0.7907487750053406
acyl I-Disease 1 0.9914105534553528
- I-Disease 0 0.05096994340419769
coenzyme I-Disease 1 0.961503803730011
A I-Disease 0 0.04173976555466652
dehydrogenase I-Disease 1 0.9997027516365051
( I-Disease 0 0.016452718526124954
VLCAD I-Disease 1 0.9999990463256836
) I-Disease 0 0.019627412781119347
deficiency I-Disease 1 1.0
is O 0 0.005515458527952433
a O 0 0.015511153265833855
disorder O 1 0.9999995231628418
of O 0 0.007317217066884041
fatty O 1 0.9999833106994629
acid O 1 0.9887774586677551
beta O 0 0.10711188614368439
oxidation O 0 0.06920462101697922
that O 0 0.001992135075852275
reportedly O 0 0.01639813929796219
has O 0 0.0027163915801793337
high O 0 0.004869464319199324
rates O 0 0.010072754696011543
of O 0 0.0037050978280603886
morbidity O 1 0.9999979734420776
and O 0 0.004184317775070667
mortality O 1 0.999015212059021
. O 0 0.007783510722219944

We O 0 0.004153696820139885
describe O 0 0.008185363374650478
the O 0 0.0021192096173763275
outcome O 0 0.008606282994151115
of O 0 0.001264791819266975
a O 0 0.006239749025553465
5 O 0 0.011182696558535099
- O 0 0.017786936834454536
year O 0 0.007676556706428528
- O 0 0.02520640753209591
old O 0 0.021623538807034492
girl O 1 0.9664268493652344
with O 0 0.009080165065824986
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 0.0074720075353980064
was O 0 0.006583649665117264
first O 0 0.0039086779579520226
seen O 0 0.00978013500571251
at O 0 0.0038811308331787586
5 O 0 0.006912454962730408
months O 0 0.006876273546367884
of O 0 0.0017151443753391504
age O 0 0.013415890745818615
with O 0 0.007767736446112394
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.6283985376358032
hepatomegaly B-Disease 1 1.0
, O 1 0.6354110836982727
encephalopathy B-Disease 1 1.0
, O 0 0.0045633683912456036
and O 0 0.004069679882377386
hypotonia B-Disease 1 0.9999921321868896
. O 0 0.009300055913627148

Biochemical O 0 0.07806646078824997
studies O 0 0.012814601883292198
indicated O 0 0.047545939683914185
VLCAD B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
caused O 1 0.9997840523719788
by O 0 0.00315074878744781
a O 0 0.007957995869219303
stable O 0 0.044962815940380096
yet O 0 0.017997892573475838
inactive O 1 0.9076981544494629
enzyme O 0 0.14570069313049316
. O 0 0.009372154250741005

Molecular O 0 0.07003749907016754
genetic O 0 0.04605330526828766
analysis O 0 0.004595461767166853
of O 0 0.002145428443327546
her O 0 0.01855441741645336
VLCAD O 1 0.999997615814209
gene O 1 0.9963657855987549
revealed O 0 0.022963298484683037
a O 0 0.013597676530480385
T1372C O 1 0.9995459914207458
( O 0 0.012332255020737648
F458L O 1 0.9997507929801941
) O 0 0.011157884262502193
missense O 1 0.9994906187057495
mutation O 1 0.9997610449790955
and O 0 0.002183874836191535
a O 0 0.014815375208854675
1668 O 1 0.9999630451202393
ACAG O 1 0.999982476234436
1669 O 1 0.9998413324356079
splice O 1 0.9932969212532043
site O 0 0.03708082064986229
mutation O 1 0.9988138675689697
. O 0 0.008183775469660759

After O 0 0.02420070581138134
initial O 0 0.03401985019445419
treatment O 1 0.9785005450248718
with O 0 0.005159637425094843
intravenous O 1 0.9999252557754517
glucose O 1 0.9883495569229126
and O 0 0.004098307806998491
carnitine O 1 0.9999946355819702
, O 0 0.0027360960375517607
the O 0 0.004805091768503189
patient O 1 0.9999632835388184
has O 0 0.005135994404554367
thrived O 0 0.04803795740008354
on O 0 0.002249782672151923
a O 0 0.0076738581992685795
low O 0 0.03944573923945427
- O 0 0.058915965259075165
fat O 1 0.9067893624305725
diet O 0 0.23941250145435333
supplemented O 0 0.023074021562933922
with O 0 0.0023974126670509577
medium O 0 0.017665153369307518
- O 0 0.04272674396634102
chain O 0 0.2867758870124817
triglyceride O 1 0.6324615478515625
oil O 0 0.01033490989357233
and O 0 0.0041282461024820805
carnitine O 1 0.9999088048934937
and O 0 0.003391075413674116
avoidance O 1 0.9102920293807983
of O 0 0.004362223204225302
fasting O 1 0.9934470057487488
. O 0 0.007001325488090515

Her O 0 0.41151246428489685
ventricular O 1 0.9999998807907104
hypertrophy O 1 0.9999986886978149
resolved O 0 0.045250557363033295
significantly O 0 0.023992018774151802
over O 0 0.004802589304745197
1 O 0 0.012180923484265804
year O 0 0.006030877586454153
, O 0 0.0022175086196511984
and O 0 0.003363486146554351
cognitively O 1 0.9999860525131226
, O 0 0.0026040025986731052
she O 0 0.0034980603959411383
is O 0 0.0019343993626534939
in O 0 0.0012034453684464097
the O 0 0.002508533885702491
superior O 0 0.01714499667286873
range O 0 0.004854057915508747
for O 0 0.0020756421145051718
age O 0 0.017784105613827705
. O 0 0.006098654121160507

Clinical O 1 0.7214582562446594
recognition O 0 0.018237635493278503
of O 0 0.0073378547094762325
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.004727529361844063
important O 0 0.0026257906574755907
because O 0 0.0030253601726144552
it O 0 0.0012057290878146887
is O 0 0.0014494301285594702
one O 0 0.0012442292645573616
of O 0 0.0008129450725391507
the O 0 0.0022964735981076956
few O 0 0.005054559092968702
directly O 0 0.01992194540798664
treatable O 1 1.0
causes O 1 0.9998363256454468
of O 0 0.008627351373434067
cardiomyopathy B-Disease 1 1.0
in O 0 0.004197093192487955
children O 0 0.014144412241876125
. O 0 0.0027954475954174995
. O 0 0.006076198071241379

Cloning O 0 0.05660329759120941
of O 0 0.0025569468270987272
a O 0 0.007105713710188866
novel O 0 0.014777018688619137
member O 0 0.0035668956115841866
of O 0 0.0009523704648017883
the O 0 0.0028865491040050983
low O 0 0.025520609691739082
- O 0 0.036259036511182785
density O 0 0.038459669798612595
lipoprotein O 1 0.9999268054962158
receptor O 1 0.9819965362548828
family O 0 0.02575543150305748
. O 0 0.007782686501741409

A O 0 0.037176940590143204
gene O 0 0.24286238849163055
encoding O 0 0.045050248503685
a O 0 0.011120676063001156
novel O 0 0.03709879517555237
transmembrane O 1 0.9773322939872742
protein O 0 0.056026358157396317
was O 0 0.007203254848718643
identified O 0 0.009869961068034172
by O 0 0.0034184192772954702
DNA O 0 0.02906370535492897
sequence O 0 0.012644239701330662
analysis O 0 0.0034531198907643557
within O 0 0.0023177533876150846
the O 0 0.004962513688951731
insulin B-Disease 1 0.9999868869781494
- I-Disease 1 0.7300633788108826
dependent I-Disease 1 0.9972314238548279
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 0.017942314967513084
IDDM B-Disease 1 0.9999887943267822
) O 0 0.010296077467501163
locus O 1 0.9999957084655762
IDDM4 O 1 0.9998965263366699
on O 0 0.010525351390242577
chromosome O 1 0.9995710253715515
11q13 O 1 0.9956877827644348
. O 0 0.010798106901347637

Based O 0 0.005571288522332907
on O 0 0.0023548388853669167
its O 0 0.006004608701914549
chromosomal O 1 0.9998842477798462
position O 0 0.0067975507117807865
, O 0 0.0015947272768244147
this O 0 0.003225921420380473
gene O 1 0.9561893343925476
is O 0 0.0031457743607461452
a O 0 0.004563065245747566
candidate O 0 0.01111432071775198
for O 0 0.002666157903149724
conferring O 1 0.8669030070304871
susceptibility O 1 0.9999897480010986
to O 0 0.011860037222504616
diabetes B-Disease 1 1.0
. O 0 0.011166699230670929

The O 0 0.012931144796311855
gene O 1 0.9238588809967041
, O 0 0.0042666965164244175
termed O 0 0.05771397799253464
low O 0 0.029871301725506783
- O 0 0.037844084203243256
density O 0 0.03854227811098099
lipoprotein O 1 0.9990139007568359
receptor O 1 0.8835365772247314
related O 0 0.02286546304821968
protein O 0 0.07170254737138748
5 O 0 0.018701061606407166
( O 0 0.010449262335896492
LRP5 O 1 0.9999759197235107
) O 0 0.004582350142300129
, O 0 0.0023853182792663574
encodes O 0 0.08205428719520569
a O 0 0.009749352931976318
protein O 0 0.044923704117536545
of O 0 0.0038371956907212734
1615 O 1 0.988419771194458
amino O 0 0.06070674583315849
acids O 0 0.029827799648046494
that O 0 0.0017519203247502446
contains O 0 0.004623521119356155
conserved O 0 0.0253615565598011
modules O 0 0.011873035691678524
which O 0 0.0015440653078258038
are O 0 0.0010821656323969364
characteristic O 0 0.01098366267979145
of O 0 0.0008900023531168699
the O 0 0.002921182429417968
low O 0 0.02597292698919773
- O 0 0.03787726163864136
density O 0 0.0417974479496479
lipoprotein O 1 0.9999806880950928
( O 0 0.030025539919734
LDL O 1 0.9999980926513672
) O 0 0.017222121357917786
receptor O 1 0.9972721934318542
family O 0 0.02236432395875454
. O 0 0.007748579140752554

These O 0 0.0027955409605056047
modules O 0 0.012428395450115204
include O 0 0.0030413984786719084
a O 0 0.01030005794018507
putative O 1 0.9313610792160034
signal O 0 0.046249374747276306
peptide O 0 0.09973299503326416
for O 0 0.003605632111430168
protein O 0 0.033002953976392746
export O 0 0.004929925315082073
, O 0 0.001789510133676231
four O 0 0.00597834587097168
epidermal O 1 0.999790608882904
growth O 0 0.02594378963112831
factor O 0 0.06029418110847473
( O 0 0.013926035724580288
EGF O 1 0.9999473094940186
) O 0 0.008247257210314274
repeats O 0 0.04374280944466591
with O 0 0.002835918916389346
associated O 0 0.013123889453709126
spacer O 1 0.8530970215797424
domains O 0 0.03503609076142311
, O 0 0.002396296476945281
three O 0 0.007072847336530685
LDL O 1 0.9999984502792358
- O 1 0.5245329737663269
receptor O 1 0.9943485856056213
( O 0 0.016266943886876106
LDLR O 1 0.9999141693115234
) O 0 0.008003449067473412
repeats O 0 0.042969826608896255
, O 0 0.0018033647211268544
a O 0 0.0064497338607907295
single O 0 0.021818943321704865
transmembrane O 1 0.964028537273407
spanning O 0 0.04158109053969383
domain O 0 0.024187607690691948
, O 0 0.001843252219259739
and O 0 0.0016690547345206141
a O 0 0.010362927801907063
cytoplasmic O 0 0.18835876882076263
domain O 0 0.04212244227528572
. O 0 0.00945752952247858

The O 0 0.00844503566622734
encoded O 0 0.04208884388208389
protein O 0 0.04207548126578331
has O 0 0.0036787220742553473
a O 0 0.004373723175376654
unique O 0 0.00555860809981823
organization O 0 0.005933982320129871
of O 0 0.003730520373210311
EGF O 1 0.9999935626983643
and O 0 0.007594823371618986
LDLR O 1 0.9999957084655762
repeats O 0 0.1308548003435135
; O 0 0.003821302205324173
therefore O 0 0.00606717262417078
, O 0 0.0043998099863529205
LRP5 O 1 0.999988317489624
likely O 0 0.013420258648693562
represents O 0 0.007597440853714943
a O 0 0.004023910965770483
new O 0 0.0027521855663508177
category O 0 0.012919682078063488
of O 0 0.0018464351305738091
the O 0 0.0074315196834504604
LDLR O 1 0.9999945163726807
family O 0 0.026914797723293304
. O 0 0.00784335471689701

Both O 0 0.004976916592568159
human O 0 0.010442813858389854
and O 0 0.004119216464459896
mouse O 1 0.9999924898147583
LRP5 O 1 0.9999938011169434
cDNAs O 1 0.9998156428337097
have O 0 0.0035193574149161577
been O 0 0.0054293167777359486
isolated O 0 0.02817232720553875
and O 0 0.0011670697713270783
the O 0 0.003159549552947283
encoded O 0 0.04346636310219765
mature O 0 0.051115188747644424
proteins O 0 0.018120121210813522
are O 0 0.0014470028690993786
95 O 0 0.015754615887999535
% O 0 0.005737433675676584
identical O 0 0.010019944980740547
, O 0 0.0017164127202704549
indicating O 0 0.013918057084083557
a O 0 0.0049311090260744095
high O 0 0.005484892521053553
degree O 0 0.004446593578904867
of O 0 0.002150907414034009
evolutionary O 0 0.0303664393723011
conservation O 0 0.01319593284279108
. O 0 0.0028065901715308428
. O 0 0.005676446948200464

The O 0 0.01755286380648613
APC B-Disease 1 0.9999678134918213
variants O 1 0.6037101149559021
I1307K O 1 0.9988206028938293
and O 0 0.0038625600282102823
E1317Q O 1 0.9996405839920044
are O 0 0.0016876261215656996
associated O 0 0.011784298345446587
with O 0 0.1483754962682724
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.0027877858374267817
but O 0 0.0015776227228343487
not O 0 0.0012102454202249646
always O 0 0.002641047351062298
with O 0 0.0014688614755868912
a O 0 0.006659196224063635
family O 0 0.014331399463117123
history O 0 0.007329273968935013
. O 0 0.007004216313362122

Classical O 0 0.06327321380376816
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 0.17165367305278778
FAP B-Disease 1 0.9999995231628418
) O 0 0.005329749546945095
is O 0 0.0020799420308321714
a O 0 0.005116601940244436
high O 0 0.011973390355706215
- O 1 0.5101569890975952
penetrance O 1 0.9999979734420776
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.999988317489624
disease I-Disease 1 1.0
that O 0 0.003957038279622793
predisposes O 1 0.9999974966049194
to O 0 0.001781779108569026
hundreds O 0 0.005321566015481949
or O 0 0.002812323858961463
thousands O 0 0.008534912019968033
of O 0 0.013003306463360786
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.06624943017959595
carcinoma I-Disease 1 1.0
and O 0 0.0016840221360325813
that O 0 0.001177460071630776
results O 0 0.006820229813456535
from O 0 0.005467667244374752
truncating O 1 0.9995930790901184
mutations O 1 0.998711347579956
in O 0 0.002546533942222595
the O 0 0.008112858980894089
APC B-Disease 1 0.9999967813491821
gene O 1 0.9918821454048157
. O 0 0.0103086456656456

A O 0 0.029549289494752884
variant O 1 0.7198295593261719
of O 0 0.0059623573906719685
FAP B-Disease 1 1.0
is O 0 0.12264813482761383
attenuated B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 0.003134862519800663
which O 0 0.0018280281219631433
results O 0 0.005849278531968594
from O 0 0.004636883269995451
germ O 1 0.9986165761947632
- O 0 0.03776917606592178
line O 0 0.018228352069854736
mutations O 1 0.9989427924156189
in O 0 0.0018945976626127958
the O 0 0.0028641722165048122
5 O 0 0.007740623317658901
and O 0 0.001304684323258698
3 O 0 0.007657651789486408
regions O 0 0.0065504414960742
of O 0 0.001470494782552123
the O 0 0.009406366385519505
APC B-Disease 1 0.9999992847442627
gene O 1 0.9967067837715149
. O 0 0.009528451599180698

Attenuated B-Disease 1 0.9999991655349731
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 0.9999998807907104
have O 0 0.0027678629849106073
" O 0 0.005522226449102163
multiple O 0 0.1469796746969223
" O 1 0.9794649481773376
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 0.008818340487778187
typically O 0 0.008622722700238228
fewer O 0 0.007068127393722534
than O 0 0.002672799862921238
100 O 0 0.007260436657816172
) O 0 0.003061375580728054
without O 0 0.003202510764822364
the O 0 0.00524367718026042
florid O 1 0.9980529546737671
phenotype O 1 0.9998974800109863
of O 0 0.0038126243744045496
classical O 0 0.019811350852251053
FAP B-Disease 1 0.9999997615814209
. O 0 0.010338681749999523

Another O 0 0.02065066620707512
group O 0 0.009202715940773487
of O 0 0.004121486097574234
patients O 1 0.9999827146530151
with O 0 0.0036128261126577854
multiple O 0 0.0980682373046875
adenomas B-Disease 1 0.9999988079071045
has O 0 0.006138659082353115
no O 0 0.004253928083926439
mutations O 1 0.9936835765838623
in O 0 0.0024504365865141153
the O 0 0.007914754562079906
APC B-Disease 1 0.9999996423721313
gene O 1 0.9994398951530457
, O 0 0.001873202621936798
and O 0 0.0012950191739946604
their O 0 0.0035784761421382427
phenotype O 1 0.9999994039535522
probably O 0 0.012810427695512772
results O 0 0.005985985044389963
from O 0 0.0025065061636269093
variation O 0 0.01673807017505169
at O 0 0.0038490728475153446
a O 0 0.010792908258736134
locus O 1 0.9999904632568359
, O 0 0.0038542833644896746
or O 0 0.0068216994404792786
loci O 1 0.9993890523910522
, O 0 0.002317412756383419
elsewhere O 0 0.005516431760042906
in O 0 0.0014593478990718722
the O 0 0.004759801551699638
genome O 1 0.6841307878494263
. O 0 0.008576399646699429

Recently O 0 0.03182345628738403
, O 0 0.002544841030612588
however O 0 0.0026528548914939165
, O 0 0.0016658160602673888
a O 0 0.009319134056568146
missense O 1 0.999350368976593
variant O 1 0.9066828489303589
of O 0 0.006969911511987448
APC B-Disease 1 0.9999996423721313
( O 0 0.014849906787276268
I1307K O 1 0.9998464584350586
) O 0 0.004360897466540337
was O 0 0.005905453581362963
described O 0 0.006472749635577202
that O 0 0.0012615005252882838
confers O 1 0.8873019814491272
an O 0 0.0021623405627906322
increased O 0 0.021163789555430412
risk O 1 0.9992169141769409
of O 0 0.015135119669139385
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.0032683485187590122
including O 0 0.0029577945824712515
multiple O 1 0.5056079626083374
adenomas B-Disease 1 0.9999994039535522
, O 0 0.0025171954184770584
in O 0 0.0033855473157018423
Ashkenazim O 1 0.9995855689048767
. O 0 0.008642257191240788

We O 0 0.003658874426037073
have O 0 0.002157278126105666
studied O 0 0.003536047413945198
a O 0 0.003354678861796856
set O 0 0.0018680993234738708
of O 0 0.0019026362570002675
164 O 1 0.9859315156936646
patients O 1 0.9999877214431763
with O 0 0.004302761517465115
multiple O 1 0.9996267557144165
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.005552069749683142
/ I-Disease 1 0.9996893405914307
or I-Disease 0 0.015708360821008682
carcinoma I-Disease 1 1.0
and O 0 0.0032406141981482506
analyzed O 0 0.03884580731391907
codons O 1 0.7165286540985107
1263 O 1 0.9945808053016663
- O 0 0.09673232585191727
1377 O 1 0.9958479404449463
( O 0 0.019134290516376495
exon O 1 0.9982006549835205
15G O 1 0.993915855884552
) O 0 0.00400596484541893
of O 0 0.001551411347463727
the O 0 0.007058399263769388
APC B-Disease 1 0.9999959468841553
gene O 1 0.9708330035209656
for O 0 0.006714492104947567
germ O 1 0.9616246819496155
- O 0 0.03856753185391426
line O 0 0.019178137183189392
variants O 0 0.05901775136590004
. O 0 0.007625550031661987

Three O 0 0.014632090926170349
patients O 1 0.9999221563339233
with O 0 0.00215098075568676
the O 0 0.005990349687635899
I1307K O 1 0.9999533891677856
allele O 1 0.9997429251670837
were O 0 0.0055382815189659595
detected O 0 0.06838502734899521
, O 0 0.0014494950883090496
each O 0 0.001707791117951274
of O 0 0.003476829268038273
Ashkenazi O 1 0.999832034111023
descent O 0 0.2100047767162323
. O 0 0.009727873839437962

Four O 0 0.013926572166383266
patients O 1 0.9999402761459351
had O 0 0.007379532791674137
a O 0 0.011407325975596905
germ O 1 0.9878458380699158
- O 0 0.03737640008330345
line O 0 0.02165057137608528
E1317Q O 1 0.9993966817855835
missense O 1 0.9990818500518799
variant O 1 0.8487337827682495
of O 0 0.005242438521236181
APC O 1 0.999998927116394
that O 0 0.0024933242239058018
was O 0 0.005812498740851879
not O 0 0.0013443422503769398
present O 0 0.002394645242020488
in O 0 0.0022121556103229523
controls O 0 0.02807033807039261
; O 0 0.002858928171917796
one O 0 0.0017426435369998217
of O 0 0.0010739343706518412
these O 0 0.0011323688086122274
individuals O 0 0.0034047269728034735
had O 0 0.004237166605889797
an O 0 0.002635563025251031
unusually O 0 0.030037516728043556
large O 0 0.003474427852779627
number O 0 0.002620603423565626
of O 0 0.00341842882335186
metaplastic B-Disease 1 0.9999995231628418
polyps I-Disease 1 0.9999984502792358
of I-Disease 0 0.0019170291488990188
the I-Disease 0 0.005567590706050396
colorectum I-Disease 1 0.9998050332069397
. O 0 0.009273330681025982

There O 0 0.0049141766503453255
is O 0 0.00294666551053524
increasing O 0 0.006379531230777502
evidence O 0 0.0019805063493549824
that O 0 0.000879882019944489
there O 0 0.001966911368072033
exist O 0 0.005601844284683466
germ O 1 0.9796304702758789
- O 0 0.027578147128224373
line O 0 0.011004834435880184
variants O 0 0.02817424200475216
of O 0 0.0016126296250149608
the O 0 0.007822688668966293
APC B-Disease 1 0.9999997615814209
gene O 1 0.9967525005340576
that O 0 0.004166431725025177
predispose O 1 0.9960463643074036
to O 0 0.0012411203933879733
the O 0 0.0012922959867864847
development O 0 0.002364533022046089
of O 0 0.0029276490677148104
multiple O 1 0.999488115310669
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.599477231502533
carcinoma I-Disease 1 1.0
, O 0 0.002093102317303419
but O 0 0.001405990682542324
without O 0 0.0023575513623654842
the O 0 0.004200179595500231
florid O 1 0.9999469518661499
phenotype O 1 0.9999731779098511
of O 0 0.003198106773197651
classical O 0 0.015395359136164188
FAP B-Disease 1 1.0
, O 0 0.002042854204773903
and O 0 0.0010304993484169245
possibly O 0 0.007703957613557577
with O 0 0.0008994485251605511
importance O 0 0.004996179137378931
for O 1 0.6051465272903442
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.9996217489242554
in O 0 0.0015998686430975795
the O 0 0.002617001300677657
general O 0 0.006903609726577997
population O 0 0.008800595998764038
. O 0 0.0025424312334507704
. O 0 0.004805816803127527

Genomic O 0 0.11951380223035812
structure O 0 0.008235654793679714
of O 0 0.0014311990235000849
the O 0 0.00452937139198184
human O 1 0.9554380774497986
congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999945163726807
diarrhea I-Disease 1 1.0
( O 0 0.3121315836906433
CLD B-Disease 1 0.9999998807907104
) O 0 0.015498772263526917
gene O 1 0.9910428524017334
. O 0 0.007990231737494469

Congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999927282333374
diarrhea I-Disease 1 1.0
( O 0 0.04502996429800987
CLD B-Disease 1 0.9999998807907104
) O 0 0.0078116524964571
is O 0 0.005959935951977968
caused O 1 0.9984708428382874
by O 0 0.006149350665509701
mutations O 1 0.9985841512680054
in O 0 0.0022966593969613314
a O 0 0.010836292989552021
gene O 1 0.9394473433494568
which O 0 0.004708013031631708
encodes O 0 0.19352254271507263
an O 0 0.018703842535614967
intestinal O 1 1.0
anion O 1 0.9976887702941895
transporter O 1 0.992827832698822
. O 0 0.012792463414371014

We O 0 0.0033751174341887236
report O 0 0.002677902113646269
here O 0 0.0013226595474407077
the O 0 0.0021501765586435795
complete O 0 0.008816133253276348
genomic O 0 0.08237587660551071
organization O 0 0.005603102967143059
of O 0 0.0012854253873229027
the O 0 0.004123931284993887
human O 0 0.027384107932448387
CLD B-Disease 1 0.9999988079071045
gene O 1 0.9969478249549866
which O 0 0.004914804361760616
spans O 0 0.04935736209154129
approximately O 0 0.016840342432260513
39kb O 1 0.999527096748352
, O 0 0.0024537877179682255
and O 0 0.0015777104999870062
comprises O 0 0.012453118339180946
21 O 0 0.027050448581576347
exons O 1 0.8760363459587097
. O 0 0.009851517155766487

All O 0 0.010608158074319363
exon O 1 0.9923179149627686
/ O 0 0.3638764023780823
intron O 1 0.9012684226036072
boundaries O 0 0.0066034141927957535
conform O 0 0.010067878291010857
to O 0 0.001731543685309589
the O 0 0.006353715900331736
GT O 1 0.9999897480010986
/ O 1 0.9952985644340515
AG O 1 0.9998821020126343
rule O 0 0.021727994084358215
. O 0 0.0074163200333714485

An O 0 0.004566774237900972
analysis O 0 0.003991902805864811
of O 0 0.001411722507327795
the O 0 0.005772893317043781
putative O 1 0.9952249526977539
promoter O 1 0.9709714651107788
region O 0 0.016574902459979057
sequence O 0 0.019198952242732048
shows O 0 0.0058177197352051735
a O 0 0.009726280346512794
putative O 1 0.9830703139305115
TATA O 1 0.999413013458252
box O 0 0.031069226562976837
and O 0 0.0027920962311327457
predicts O 0 0.0458473302423954
multiple O 0 0.022752759978175163
transcription O 0 0.10762540251016617
factor O 0 0.04532059282064438
binding O 0 0.017732860520482063
sites O 0 0.007431931793689728
. O 0 0.006779382936656475

The O 0 0.008786788210272789
genomic O 0 0.1393101066350937
structure O 0 0.009715892374515533
was O 0 0.0056600612588226795
determined O 0 0.00899610947817564
using O 0 0.0039099701680243015
DNA O 0 0.023888250812888145
from O 0 0.0020766903180629015
several O 0 0.0014493720373138785
sources O 0 0.002098626224324107
including O 0 0.0015234641032293439
multiple O 0 0.01310798991471529
large O 0 0.007970564067363739
- O 0 0.040042392909526825
insert O 1 0.8674970269203186
libaries O 1 0.9948189854621887
and O 0 0.0032505858689546585
genomic O 0 0.11823917925357819
DNA O 0 0.03719428554177284
from O 0 0.005516530945897102
Finnish O 1 0.9103834629058838
CLD B-Disease 1 0.9999997615814209
patients O 1 0.9999759197235107
and O 0 0.0037605264224112034
controls O 0 0.033422697335481644
. O 0 0.007597656454890966

Exon O 1 0.9874318838119507
- O 0 0.04263763874769211
specific O 0 0.0083340834826231
primers O 0 0.08713191747665405
developed O 0 0.010609614662826061
in O 0 0.001300578354857862
this O 0 0.0012401248095557094
study O 0 0.0031334995292127132
will O 0 0.0020752244163304567
facilitate O 0 0.022024577483534813
mutation O 1 0.9996950626373291
screening O 0 0.05218622460961342
studies O 0 0.005049798637628555
of O 0 0.0029861428774893284
patients O 1 0.9999945163726807
with O 0 0.0023736138828098774
the O 0 0.011598991230130196
disease O 1 1.0
. O 0 0.009771004319190979

Genomic O 0 0.13984064757823944
sequencing O 0 0.0413295142352581
of O 0 0.002301338128745556
a O 0 0.018243862316012383
BAC O 1 0.9999971389770508
clone O 1 0.9996993541717529
H O 1 0.9997783303260803
_ O 0 0.02127898670732975
RG364P16 O 1 0.9996058344841003
revealed O 0 0.017865430563688278
the O 0 0.0027929763309657574
presence O 0 0.00651222700253129
of O 0 0.0012499105650931597
another O 0 0.007695622276514769
, O 0 0.00289705628529191
highly O 0 0.023913124576210976
homologous O 0 0.3867439925670624
gene O 1 0.5635107159614563
3 O 0 0.00867895595729351
of O 0 0.00167616899125278
the O 0 0.010428701527416706
CLD B-Disease 1 0.9999996423721313
gene O 1 0.9978876709938049
, O 0 0.0024331409949809313
with O 0 0.0012504833284765482
a O 0 0.006046636495739222
similar O 0 0.00869525782763958
genomic O 0 0.10273844748735428
structure O 0 0.008844621479511261
, O 0 0.0016081248177215457
recently O 0 0.008024539798498154
identified O 0 0.0074301413260400295
as O 0 0.001816975069232285
the O 0 0.009115893393754959
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 1 0.9999933242797852
( O 0 0.016260122880339622
PDS B-Disease 1 0.9999998807907104
) O 0 0.005795609205961227
. O 0 0.0024525518529117107
. O 0 0.005064256023615599

The O 0 0.016255151480436325
APCI1307K O 1 0.9999728202819824
allele O 1 0.9999877214431763
and O 0 0.013513517566025257
cancer B-Disease 1 1.0
risk O 1 0.9988576173782349
in O 0 0.0017131541389971972
a O 0 0.0048734936863183975
community O 0 0.0075989579781889915
- O 0 0.0146788340061903
based O 0 0.0027454905211925507
study O 0 0.004540896508842707
of O 0 0.0031908750534057617
Ashkenazi O 1 0.9977401494979858
Jews O 0 0.014152365736663342
. O 0 0.008178512565791607

Mutations O 1 0.9989394545555115
in O 0 0.007939857430756092
APC O 1 0.9999562501907349
are O 0 0.003293700749054551
classically O 1 0.9974180459976196
associated O 0 0.013173548504710197
with O 0 0.008608129806816578
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.7400203347206116
FAP B-Disease 1 1.0
) O 0 0.005201286170631647
, O 0 0.001326106721535325
a O 0 0.007616310380399227
highly O 0 0.050671473145484924
penetrant O 1 0.9999998807907104
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999959468841553
disorder I-Disease 1 1.0
characterized O 1 0.9927610158920288
by O 0 0.006836780346930027
multiple O 1 0.9998015761375427
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 0 0.002125106519088149
, O 0 0.0020123973954468966
without O 0 0.007632105145603418
surgical O 1 0.9999936819076538
intervention O 0 0.28746557235717773
, O 0 0.001227454049512744
the O 0 0.0016119282227009535
development O 0 0.005023447331041098
of O 0 0.031336601823568344
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.020872656255960464
CRC B-Disease 1 0.9999693632125854
) O 0 0.007559541147202253
. O 0 0.006965909618884325

APC B-Disease 1 0.9995077848434448
is O 0 0.011730439960956573
a O 0 0.03261856362223625
tumour O 1 1.0
- O 1 0.9745451807975769
suppressor O 1 0.9999994039535522
gene O 1 0.9976710677146912
, O 0 0.002375798998400569
and O 0 0.002772522158920765
somatic O 1 0.9989407658576965
loss O 1 0.9735302329063416
occurs O 0 0.046842701733112335
in O 0 0.007666262332350016
tumours B-Disease 1 1.0
. O 0 0.010341495275497437

The O 0 0.020418792963027954
germline O 1 0.9998477697372437
T O 1 0.9998216032981873
- O 0 0.025747133418917656
to O 0 0.0031301199924200773
- O 0 0.023400289937853813
A O 0 0.02062712423503399
transversion O 1 0.998719334602356
responsible O 0 0.014257941395044327
for O 0 0.0020693116821348667
the O 0 0.008298490196466446
APC O 1 0.9999905824661255
I1307K O 1 0.9998106360435486
allele O 1 0.9983084201812744
converts O 0 0.02612035907804966
the O 0 0.004645421169698238
wild O 0 0.028992855921387672
- O 0 0.028804775327444077
type O 0 0.02977733314037323
sequence O 0 0.012417665682733059
to O 0 0.002011252101510763
a O 0 0.01466658990830183
homopolymer O 1 0.9999839067459106
tract O 1 0.9999985694885254
( O 0 0.019293809309601784
A8 O 1 0.9999949932098389
) O 0 0.0038136893417686224
that O 0 0.0015059994766488671
is O 0 0.0049667819403111935
genetically O 1 0.7406441569328308
unstable O 1 0.9934836030006409
and O 0 0.0029799388721585274
prone O 1 0.9984787106513977
to O 0 0.005673019215464592
somatic O 1 0.998276948928833
mutation O 1 0.9999245405197144
. O 0 0.008980156853795052

The O 0 0.018404001370072365
I1307K O 1 0.9990160465240479
allele O 1 0.9993433356285095
was O 0 0.013524893671274185
found O 0 0.006633522920310497
in O 0 0.0026233065873384476
6 O 0 0.017103776335716248
. O 0 0.007146219257265329

1 O 0 0.021700993180274963
% O 0 0.005641333758831024
of O 0 0.0033435868099331856
unselected O 1 0.9985937476158142
Ashkenazi O 1 0.9970447421073914
Jews O 0 0.009519161656498909
and O 0 0.0017683043843135238
higher O 0 0.009850329719483852
proportions O 0 0.3800004720687866
of O 0 0.004222619812935591
Ashkenazim O 1 0.9995278120040894
with O 0 0.0029448841232806444
family O 0 0.012780684046447277
or O 0 0.0035527318250387907
personal O 0 0.0077347299084067345
histories O 0 0.020052684471011162
of O 0 0.004282523412257433
CRC B-Disease 1 0.9999829530715942
( O 0 0.012790380045771599
ref O 1 0.9998489618301392
. O 0 0.004124109633266926
2 O 0 0.013294338248670101
) O 0 0.0046684094704687595
. O 0 0.005159918684512377

To O 0 0.004178646951913834
evaluate O 0 0.016159506514668465
the O 0 0.0032141064293682575
role O 0 0.007154925726354122
of O 0 0.0030501990113407373
I1307K O 1 0.9999943971633911
in O 0 0.008712101727724075
cancer B-Disease 1 1.0
, O 0 0.0026919981464743614
we O 0 0.003065829398110509
genotyped O 1 0.9994606375694275
5 O 0 0.017445409670472145
, O 0 0.006610894110053778
081 O 1 0.999874472618103
Ashkenazi O 1 0.9985283613204956
volunteers O 0 0.019492648541927338
in O 0 0.0018499697325751185
a O 0 0.00576081732288003
community O 0 0.008118621073663235
survey O 0 0.014626702293753624
. O 0 0.0067611029371619225

Risk O 1 0.853995144367218
of O 0 0.0040994929149746895
developing O 1 0.8213902115821838
colorectal B-Disease 1 1.0
, I-Disease 0 0.016526037827134132
breast I-Disease 1 1.0
and I-Disease 0 0.0024259628262370825
other I-Disease 0 0.0028196359053254128
cancers I-Disease 1 1.0
were O 0 0.002096352865919471
compared O 0 0.00960415881127119
between O 0 0.005809247959405184
genotyped O 1 0.9999643564224243
I1307K O 1 0.9999598264694214
carriers O 0 0.3843839466571808
and O 0 0.002227368066087365
non O 0 0.013989279977977276
- O 0 0.038660842925310135
carriers O 0 0.08895783871412277
and O 0 0.0011453217593953013
their O 0 0.0018254858441650867
first O 0 0.006324796937406063
- O 0 0.02637830562889576
degree O 0 0.01327567920088768
relatives O 0 0.030312055721879005
. O 0 0.008593111298978329

Sperm O 0 0.11099199205636978
DNA O 0 0.03931635990738869
analysis O 0 0.0046054343692958355
in O 0 0.0023604778107255697
a O 0 0.01720217987895012
Friedreich B-Disease 1 0.9999988079071045
ataxia I-Disease 1 1.0
premutation O 1 0.9999704360961914
carrier O 1 0.9933053851127625
suggests O 0 0.01581297442317009
both O 0 0.005168682895600796
meiotic O 1 0.9987334609031677
and O 0 0.0038235934916883707
mitotic O 1 0.9707626104354858
expansion O 0 0.011150247417390347
in O 0 0.0020119280088692904
the O 0 0.007639267016202211
FRDA B-Disease 1 0.9999969005584717
gene O 1 0.9984172582626343
. O 0 0.007801332976669073

Friedreich B-Disease 1 0.9999982118606567
ataxia I-Disease 1 0.9999998807907104
is O 0 0.010836543515324593
usually O 0 0.012043449096381664
caused O 1 0.9923254251480103
by O 0 0.002375782933086157
an O 0 0.0016491918358951807
expansion O 0 0.006227471865713596
of O 0 0.0014825890539214015
a O 0 0.010927427560091019
GAA O 1 0.885301411151886
trinucleotide O 1 0.9989331364631653
repeat O 0 0.07523456960916519
in O 0 0.006058552302420139
intron O 1 0.9908546209335327
1 O 0 0.010453779250383377
of O 0 0.0017032825853675604
the O 0 0.00845828652381897
FRDA B-Disease 1 0.9999982118606567
gene O 1 0.9963790774345398
. O 0 0.009111789986491203

Occasionally O 0 0.02388092316687107
, O 0 0.0021770924795418978
a O 0 0.006370306480675936
fully O 0 0.012845268473029137
expanded O 0 0.018315553665161133
allele O 1 0.999906063079834
has O 0 0.00631627906113863
been O 0 0.004892341326922178
found O 0 0.004490882623940706
to O 0 0.0016633017221465707
arise O 0 0.01460013072937727
from O 0 0.003026677994057536
a O 0 0.009445404633879662
premutation O 1 0.9958497285842896
of O 0 0.0026539377868175507
100 O 0 0.008232749067246914
or O 0 0.004989196080714464
less O 0 0.013566129840910435
triplet O 1 0.9990274906158447
repeats O 0 0.08421124517917633
. O 0 0.008548710495233536

We O 0 0.0033852695487439632
have O 0 0.002705763326957822
examined O 0 0.01796117052435875
the O 0 0.0036783379036933184
sperm O 0 0.05256545916199684
DNA O 0 0.024882115423679352
of O 0 0.0021938078571110964
a O 0 0.014862545765936375
premutation O 1 0.9999359846115112
carrier O 1 0.9953919649124146
. O 0 0.009201263077557087

This O 0 0.007888161577284336
mans O 1 0.8990542888641357
leucocyte O 1 0.9934588074684143
DNA O 0 0.05815650150179863
showed O 0 0.012255351059138775
one O 0 0.005084565375000238
normal O 0 0.03229277953505516
allele O 1 0.9980080723762512
and O 0 0.0019707304891198874
one O 0 0.0055448925122618675
allele O 1 0.9979046583175659
of O 0 0.0025064845103770494
approximately O 0 0.009366869926452637
100 O 0 0.01210401114076376
repeats O 0 0.07246443629264832
. O 0 0.00811869278550148

His O 0 0.014141540043056011
sperm O 0 0.06353817880153656
showed O 0 0.01058478094637394
an O 0 0.003605399513617158
expanded O 0 0.018674612045288086
allele O 1 0.9978160858154297
in O 0 0.0031354452949017286
a O 0 0.007678667549043894
tight O 0 0.019253302365541458
range O 0 0.006176711991429329
centering O 0 0.025950949639081955
on O 0 0.002149151870980859
a O 0 0.0046357954852283
size O 0 0.005521980579942465
of O 0 0.0020747347734868526
approximately O 0 0.016585515812039375
320 O 0 0.49731966853141785
trinucleotide O 1 0.9996694326400757
repeats O 0 0.10139716416597366
. O 0 0.010257243178784847

His O 0 0.01616576313972473
affected O 1 0.7605590224266052
son O 1 0.9901612997055054
has O 0 0.007619850337505341
repeat O 0 0.04875699803233147
sizes O 0 0.012860937975347042
of O 0 0.003711247816681862
1040 O 1 0.9995736479759216
and O 0 0.0038977949880063534
540 O 1 0.6521087884902954
. O 0 0.007881768979132175

These O 0 0.0022917750757187605
data O 0 0.0022168566938489676
suggest O 0 0.0057793427258729935
that O 0 0.0014564242446795106
expansion O 0 0.013184928335249424
occurs O 0 0.023011650890111923
in O 0 0.0017513817874714732
two O 0 0.001689438708126545
stages O 0 0.021153192967176437
, O 0 0.0013638135278597474
the O 0 0.0019741349387913942
first O 0 0.004199863877147436
during O 0 0.01346947904676199
meiosis O 1 0.9399113059043884
followed O 0 0.00955741386860609
by O 0 0.0027877723332494497
a O 0 0.007089771796017885
second O 0 0.01887466199696064
mitotic O 1 0.8767446875572205
expansion O 0 0.021994374692440033
. O 0 0.00758016761392355

We O 0 0.0034726306330412626
also O 0 0.0021549155935645103
show O 0 0.005002711433917284
that O 0 0.000897527439519763
in O 0 0.0010937267215922475
all O 0 0.001717108185403049
informative O 0 0.026399914175271988
carrier O 1 0.9940868616104126
father O 0 0.01870744489133358
to O 0 0.002971559064462781
affected O 1 0.858312726020813
child O 0 0.44266533851623535
transmissions O 0 0.0659964382648468
, O 0 0.0017648686189204454
with O 0 0.0012087638024240732
the O 0 0.002392346505075693
notable O 0 0.0050576841458678246
exception O 0 0.006694575306028128
of O 0 0.0011318189790472388
the O 0 0.004899564664810896
premutation O 1 0.9999953508377075
carrier O 1 0.9993835687637329
, O 0 0.0017591069918125868
the O 0 0.002798227360472083
expansion O 0 0.015457754023373127
size O 0 0.014261567033827305
decreases O 0 0.07271573692560196
. O 0 0.0033293887972831726
. O 0 0.005633565131574869

The O 0 0.012280808761715889
R496H O 1 0.9997619986534119
mutation O 1 0.9996623992919922
of O 0 0.0038085246924310923
arylsulfatase O 1 0.9998862743377686
A O 0 0.01415212731808424
does O 0 0.0037327148020267487
not O 0 0.0040079401805996895
cause O 1 0.9998311996459961
metachromatic B-Disease 1 0.9999994039535522
leukodystrophy I-Disease 1 0.9999997615814209
. O 0 0.0138096297159791

Deficiency B-Disease 1 0.9999995231628418
of I-Disease 0 0.005817446392029524
arylsulfatase I-Disease 1 0.9998074173927307
A I-Disease 0 0.03813522309064865
( O 0 0.014099732041358948
ARSA O 1 0.9999974966049194
) O 0 0.009657411836087704
enzyme O 0 0.14410746097564697
activity O 0 0.03719761595129967
causes O 1 0.9998959302902222
metachromatic B-Disease 1 0.9999978542327881
leukodystrophy I-Disease 1 0.9999998807907104
( O 0 0.030121125280857086
MLD B-Disease 1 0.9999972581863403
) O 0 0.010167785920202732
. O 0 0.007306037936359644

A O 0 0.01561088114976883
number O 0 0.004025889094918966
of O 0 0.006614746525883675
ARSA O 1 0.9999969005584717
gene O 1 0.9993958473205566
mutations O 1 0.9996787309646606
responsible O 0 0.018642615526914597
for O 0 0.005638036876916885
MLD B-Disease 1 0.9999996423721313
have O 0 0.004007905721664429
been O 0 0.0060251811519265175
identified O 0 0.01739838533103466
. O 0 0.005323186982423067

Recently O 0 0.03247322514653206
, O 0 0.0029708712827414274
the O 0 0.0058189439587295055
R496H O 1 0.9997450709342957
mutation O 1 0.9990944862365723
of O 0 0.0077895792201161385
ARSA O 1 0.9999935626983643
was O 0 0.009065795689821243
proposed O 0 0.0045365383848547935
to O 0 0.0008938355604186654
be O 0 0.0016975486651062965
a O 0 0.006696269381791353
cause O 0 0.3028719425201416
of O 0 0.007251599337905645
MLD B-Disease 1 0.9999998807907104
( O 0 0.016908159479498863
Draghia O 1 0.9998960494995117
et O 0 0.09889952093362808
al O 0 0.03041730634868145
. O 0 0.0031519876793026924
, O 0 0.0028981377836316824
1997 O 0 0.030825156718492508
) O 0 0.006494438741356134
. O 0 0.0071925753727555275

We O 0 0.004259469918906689
have O 0 0.002542980248108506
investigated O 0 0.023370269685983658
the O 0 0.008188866078853607
R496H O 1 0.9997976422309875
mutation O 1 0.9996232986450195
and O 0 0.0024048115592449903
found O 0 0.005931010004132986
this O 0 0.004717577248811722
mutation O 1 0.99980229139328
at O 0 0.004688554909080267
a O 0 0.006799579132348299
relatively O 0 0.009665089659392834
high O 0 0.007692916784435511
frequency O 0 0.02187732234597206
in O 0 0.00164264056365937
an O 0 0.0029364840593189
African O 0 0.016712937504053116
American O 0 0.008739165030419827
population O 0 0.01410271693021059
( O 0 0.010888365097343922
f O 0 0.10955061763525009
= O 0 0.05553781986236572
0 O 0 0.03032028116285801
. O 0 0.004092244431376457
09 O 1 0.790790855884552
, O 0 0.005184383597224951
n O 0 0.04718754440546036
= O 0 0.0553077831864357
61 O 0 0.04286175221204758
subjects O 0 0.0160589050501585
) O 0 0.005367711186408997
. O 0 0.0059013087302446365

The O 0 0.02593640796840191
ARSA O 1 0.9999638795852661
enzyme O 0 0.1831231266260147
activity O 0 0.012622588314116001
in O 0 0.001988012809306383
subjects O 0 0.005147875752300024
with O 0 0.0011332602007314563
and O 0 0.0009258046629838645
without O 0 0.002939350437372923
the O 0 0.00474122678861022
R496H O 1 0.999992847442627
mutation O 1 0.9999711513519287
was O 0 0.00980655662715435
determined O 0 0.009368281811475754
and O 0 0.001236383686773479
found O 0 0.003203919157385826
to O 0 0.0011151193175464869
be O 0 0.0022903450299054384
normal O 0 0.02291429601609707
. O 0 0.006925055291503668

It O 0 0.004621998406946659
is O 0 0.00343698775395751
therefore O 0 0.004177527967840433
concluded O 0 0.008625136688351631
that O 0 0.0011572708608582616
the O 0 0.004095576237887144
R496H O 1 0.9999675750732422
mutation O 1 0.9999501705169678
of O 0 0.007399342954158783
ARSA O 1 0.9999992847442627
does O 0 0.00642344169318676
not O 0 0.0025875973515212536
negatively O 0 0.03990675508975983
influence O 0 0.006363694090396166
the O 0 0.0024722302332520485
activity O 0 0.008284966461360455
of O 0 0.0039018841926008463
ARSA O 1 0.9999932050704956
and O 0 0.00198851409368217
is O 0 0.002257311251014471
not O 0 0.0013796088751405478
a O 0 0.006983336992561817
cause O 1 0.9288338422775269
of O 0 0.008326860144734383
MLD B-Disease 1 0.999996542930603

Down O 0 0.0367923378944397
- O 0 0.03306427597999573
regulation O 0 0.018681084737181664
of O 0 0.004240131471306086
transmembrane O 1 0.9950968623161316
carbonic O 1 0.9998216032981873
anhydrases O 1 0.9993973970413208
in O 0 0.015483195893466473
renal B-Disease 1 1.0
cell I-Disease 1 0.9998788833618164
carcinoma I-Disease 1 1.0
cell O 0 0.1635170429944992
lines O 0 0.009457769803702831
by O 0 0.0037034081760793924
wild O 0 0.03248435631394386
- O 0 0.05442201346158981
type O 1 0.607270359992981
von B-Disease 1 0.9977095127105713
Hippel I-Disease 1 0.9999700784683228
- I-Disease 1 0.5300672054290771
Lindau I-Disease 1 0.9998302459716797
transgenes O 1 0.9770787358283997
. O 0 0.011596470139920712

To O 0 0.006337972357869148
discover O 0 0.06367771327495575
genes O 0 0.08278785645961761
involved O 0 0.008899793028831482
in O 0 0.004257304593920708
von B-Disease 1 0.9966926574707031
Hippel I-Disease 1 0.9999457597732544
- I-Disease 0 0.43170443177223206
Lindau I-Disease 1 0.9999198913574219
( O 0 0.021157728508114815
VHL B-Disease 1 0.9999970197677612
) O 0 0.010179050266742706
- O 0 0.04527883231639862
mediated O 1 0.985451340675354
carcinogenesis O 1 0.9999216794967651
, O 0 0.001842252560891211
we O 0 0.0019347462803125381
used O 0 0.011542578227818012
renal B-Disease 1 1.0
cell I-Disease 1 0.9994798302650452
carcinoma I-Disease 1 1.0
cell O 0 0.09316784888505936
lines O 0 0.029739968478679657
stably O 1 0.9468798041343689
transfected O 1 0.9686281085014343
with O 0 0.005504019558429718
wild O 0 0.03858177363872528
- O 0 0.07192587852478027
type O 1 0.9828566908836365
VHL O 1 0.9999972581863403
- O 0 0.05685494840145111
expressing O 0 0.05887022241950035
transgenes O 1 0.9576568007469177
. O 0 0.011792364530265331

Large O 0 0.018844041973352432
- O 0 0.03368239477276802
scale O 0 0.026789996773004532
RNA O 0 0.12107593566179276
differential O 0 0.04360485449433327
display O 0 0.0062207914888858795
technology O 0 0.003417291911318898
applied O 0 0.0030583851039409637
to O 0 0.001140944310463965
these O 0 0.0014077323721721768
cell O 0 0.03489845246076584
lines O 0 0.01153416559100151
identified O 0 0.011937188915908337
several O 0 0.003881868440657854
differentially O 1 0.8772976398468018
expressed O 0 0.014426479116082191
genes O 0 0.06768256425857544
, O 0 0.0014378641499206424
including O 0 0.0014493720373138785
an O 0 0.004760648123919964
alpha O 1 0.7540059089660645
carbonic O 1 0.9988831877708435
anhydrase O 1 0.9999219179153442
gene O 1 0.9935351610183716
, O 0 0.005411060992628336
termed O 1 0.5559421181678772
CA12 O 1 0.999832272529602
. O 0 0.009839077480137348

The O 0 0.010322976857423782
deduced O 0 0.07385820895433426
protein O 0 0.05986177548766136
sequence O 0 0.019194357097148895
was O 0 0.006209063809365034
classified O 0 0.007146922871470451
as O 0 0.0016490212874487042
a O 0 0.005155375227332115
one O 0 0.004973734263330698
- O 0 0.028668582439422607
pass O 0 0.03347387909889221
transmembrane O 1 0.996996283531189
CA O 0 0.040236469358205795
possessing O 0 0.011608036234974861
an O 0 0.0032830266281962395
apparently O 0 0.02713635563850403
intact O 0 0.059317972511053085
catalytic O 0 0.0901963859796524
domain O 0 0.01632053591310978
in O 0 0.0015698964707553387
the O 0 0.0036893649958074093
extracellular O 0 0.22875747084617615
CA O 0 0.12801995873451233
module O 0 0.05420146882534027
. O 0 0.008222430013120174

Reintroduced O 1 0.9638820886611938
wild O 0 0.0640706941485405
- O 0 0.06853676587343216
type O 1 0.6450952291488647
VHL B-Disease 1 0.9999899864196777
strongly O 0 0.02646089904010296
inhibited O 0 0.33605334162712097
the O 0 0.004530676174908876
overexpression O 1 0.8907953500747681
of O 0 0.00179661950096488
the O 0 0.005412600934505463
CA12 O 1 0.9999974966049194
gene O 1 0.8361356854438782
in O 0 0.0017311695264652371
the O 0 0.005720881279557943
parental O 1 0.9999969005584717
renal B-Disease 1 1.0
cell I-Disease 1 0.9999865293502808
carcinoma I-Disease 1 1.0
cell O 0 0.3767821192741394
lines O 0 0.018383897840976715
. O 0 0.007164091803133488

Similar O 0 0.013318954035639763
results O 0 0.008130574598908424
were O 0 0.0019353402312844992
obtained O 0 0.004155271220952272
with O 0 0.0047578453086316586
CA9 O 1 0.999971866607666
, O 0 0.0038236279506236315
encoding O 0 0.042713433504104614
another O 0 0.016621911898255348
transmembrane O 1 0.9985020160675049
CA O 0 0.03347352519631386
with O 0 0.0016721229767426848
an O 0 0.004031968303024769
intact O 0 0.060786645859479904
catalytic O 0 0.32479429244995117
domain O 0 0.03851235657930374
. O 0 0.007352094165980816

Although O 0 0.008757887408137321
both O 0 0.002678862540051341
domains O 0 0.019390257075428963
of O 0 0.0019406825304031372
the O 0 0.009055465459823608
VHL B-Disease 1 0.9999994039535522
protein O 0 0.07392017543315887
contribute O 0 0.010671916417777538
to O 0 0.0016094266902655363
regulation O 0 0.012857074849307537
of O 0 0.003728868905454874
CA12 O 1 0.9999949932098389
expression O 0 0.02879769168794155
, O 0 0.001752505893819034
the O 0 0.004368017427623272
elongin O 1 0.9993376135826111
binding O 0 0.022263754159212112
domain O 0 0.020607929676771164
alone O 0 0.009546364657580853
could O 0 0.005903658922761679
effectively O 0 0.039002932608127594
regulate O 0 0.11593172699213028
CA9 O 1 0.9999557733535767
expression O 0 0.05325543135404587
. O 0 0.007624524179846048

We O 0 0.007252189796417952
mapped O 0 0.07036472856998444
CA12 O 1 0.9997838139533997
and O 0 0.009793526493012905
CA9 O 1 0.9999740123748779
loci O 1 0.9978466033935547
to O 0 0.008830982260406017
chromosome O 1 0.9988440275192261
bands O 0 0.040616147220134735
15q22 O 1 0.9979696869850159
and O 0 0.005229766946285963
17q21 O 1 0.9988105297088623
. O 0 0.00818624533712864

2 O 0 0.02215949445962906
respectively O 0 0.008812117390334606
, O 0 0.002405791077762842
regions O 0 0.01500408910214901
prone O 1 0.9922086000442505
to O 0 0.00295497034676373
amplification O 0 0.08581224083900452
in O 0 0.0019394560949876904
some O 0 0.003586370497941971
human O 0 0.041535329073667526
cancers B-Disease 1 0.9999996423721313
. O 0 0.008967404253780842

Additional O 0 0.008646850474178791
experiments O 0 0.012538612820208073
are O 0 0.001354802749119699
needed O 0 0.004693600814789534
to O 0 0.0012071633245795965
define O 0 0.006291350349783897
the O 0 0.002089910674840212
role O 0 0.006486087571829557
of O 0 0.0030682876240462065
CA O 1 0.9978461265563965
IX O 1 0.9999957084655762
and O 0 0.0041219755075871944
CA O 1 0.9783746600151062
XII O 1 0.9999675750732422
enzymes O 0 0.05055970326066017
in O 0 0.00172957475297153
the O 0 0.00234106439165771
regulation O 0 0.012342806905508041
of O 0 0.0025066398084163666
pH O 1 0.9980436563491821
in O 0 0.0017801393987610936
the O 0 0.004540791269391775
extracellular O 0 0.33562523126602173
microenvironment O 1 0.998846173286438
and O 0 0.001694264356046915
its O 0 0.0022133009042590857
potential O 0 0.010514351539313793
impact O 0 0.020129704847931862
on O 0 0.007661229465156794
cancer B-Disease 1 1.0
cell O 0 0.07882849872112274
growth O 0 0.017015280202031136
. O 0 0.007382565177977085

A O 0 0.04164302349090576
gene O 0 0.17591822147369385
encoding O 0 0.045151304453611374
a O 0 0.012939777225255966
transmembrane O 1 0.9510141611099243
protein O 0 0.0555855855345726
is O 0 0.005849788896739483
mutated O 1 0.99991774559021
in O 0 0.004755488596856594
patients O 1 0.9999964237213135
with O 0 0.015523494221270084
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 0.11631842702627182
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.8936021327972412
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 0.008089309558272362
. O 0 0.005985917057842016

Wolfram B-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
( O 0 0.037743937224149704
WFS B-Disease 1 0.9999970197677612
; O 0 0.02118314988911152
OMIM O 1 0.9999997615814209
222300 O 1 0.9996731281280518
) O 0 0.004232077859342098
is O 0 0.0030303664971143007
an O 0 0.010197121649980545
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 0.010443873703479767
by O 0 0.0038246018812060356
young O 0 0.20457661151885986
- O 1 0.7561793327331543
onset O 1 0.9999990463256836
non O 0 0.02557288110256195
- O 1 0.9822688102722168
immune O 1 1.0
insulin B-Disease 1 0.9999957084655762
- I-Disease 1 0.8934425711631775
dependent I-Disease 1 0.9942905902862549
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 0.008151119574904442
progressive O 1 0.999998927116394
optic B-Disease 1 1.0
atrophy I-Disease 1 0.9999995231628418
. O 0 0.014230870641767979

Linkage O 0 0.07723643630743027
to O 0 0.003553548827767372
markers O 0 0.028880184516310692
on O 0 0.008210054598748684
chromosome O 1 0.9999607801437378
4p O 1 0.999931812286377
was O 0 0.014097207225859165
confirmed O 0 0.01530652865767479
in O 0 0.0016289985505864024
five O 0 0.003391438163816929
families O 0 0.009831897914409637
. O 0 0.0066529447212815285

On O 0 0.0031814384274184704
the O 0 0.0017835405888035893
basis O 0 0.0019901320338249207
of O 0 0.00348631851375103
meiotic O 1 0.9999750852584839
recombinants O 1 0.9999457597732544
and O 0 0.010460439138114452
disease O 1 1.0
- O 0 0.06427265703678131
associated O 0 0.017779191955924034
haplotypes O 1 0.9976778626441956
, O 0 0.002066904678940773
the O 0 0.006605904083698988
WFS B-Disease 1 0.9999992847442627
gene O 1 0.9981607794761658
was O 0 0.012903759256005287
localized O 1 0.8197790384292603
to O 0 0.0025402409955859184
a O 0 0.0158566664904356
BAC O 1 0.9999692440032959
/ O 1 0.858092725276947
P1 O 1 0.9958594441413879
contig O 1 0.8762000799179077
of O 0 0.0028145795222371817
less O 0 0.006438843905925751
than O 0 0.004579925909638405
250 O 0 0.030668770894408226
kb O 1 0.9325822591781616
. O 0 0.011122127994894981

Mutations O 1 0.9975976347923279
in O 0 0.0031014964915812016
a O 0 0.009938581846654415
novel O 0 0.059723932296037674
gene O 1 0.9974621534347534
( O 0 0.012214931659400463
WFS1 O 1 0.9998409748077393
) O 0 0.00469335587695241
encoding O 0 0.031677670776844025
a O 0 0.012300003319978714
putative O 1 0.9456265568733215
transmembrane O 1 0.9874473214149475
protein O 0 0.04773491993546486
were O 0 0.0016549872234463692
found O 0 0.0031611942686140537
in O 0 0.0011067537125200033
all O 0 0.0014137189136818051
affected O 0 0.184360072016716
individuals O 0 0.0033404738642275333
in O 0 0.001931699807755649
six O 0 0.010186794213950634
WFS B-Disease 1 0.9999992847442627
families O 0 0.00998271256685257
, O 0 0.0016349467914551497
and O 0 0.0011165108298882842
these O 0 0.001964831491932273
mutations O 1 0.9998176693916321
were O 0 0.0018201146740466356
associated O 0 0.005519797094166279
with O 0 0.001831607660278678
the O 0 0.015520856715738773
disease O 1 1.0
phenotype O 1 0.9999996423721313
. O 0 0.008298058062791824

WFS1 O 1 0.9998651742935181
appears O 0 0.026219749823212624
to O 0 0.0024083114694803953
function O 0 0.009817462414503098
in O 0 0.0019588784780353308
survival O 0 0.05091223865747452
of O 0 0.003686595009639859
islet O 1 0.9997214674949646
beta O 1 0.6859052777290344
- O 0 0.055362995713949203
cells O 0 0.05925554037094116
and O 0 0.004210322629660368
neurons O 1 0.7969421148300171
. O 0 0.004784370306879282
. O 0 0.007052075583487749

Stable O 0 0.05773144215345383
interaction O 0 0.009585108608007431
between O 0 0.0018664870876818895
the O 0 0.0016666536685079336
products O 0 0.002760637318715453
of O 0 0.001013088272884488
the O 0 0.0058698998764157295
BRCA1 O 1 1.0
and O 0 0.011136523447930813
BRCA2 O 1 1.0
tumor B-Disease 1 1.0
suppressor O 1 0.9999990463256836
genes O 0 0.17720219492912292
in O 0 0.003593233646824956
mitotic O 1 0.9831066131591797
and O 0 0.005350696854293346
meiotic O 1 0.9999816417694092
cells O 0 0.2333068698644638
. O 0 0.008591324090957642

BRCA1 O 1 0.9999996423721313
and O 0 0.012005184777081013
BRCA2 O 1 0.9999996423721313
account O 0 0.006059195846319199
for O 0 0.0016498167533427477
most O 0 0.002768490929156542
cases O 0 0.007055134512484074
of O 0 0.0025362111628055573
familial O 1 0.9999997615814209
, O 0 0.0031084988731890917
early O 0 0.3822009265422821
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 0 0.0041222888976335526
/ I-Disease 1 0.9999504089355469
or I-Disease 1 0.9721588492393494
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.0025004451163113117
encode O 0 0.025155076757073402
products O 0 0.0037933439016342163
that O 0 0.0008295283187180758
each O 0 0.0018336453940719366
interact O 0 0.012069291435182095
with O 0 0.004122390877455473
hRAD51 O 1 0.9997488856315613
. O 0 0.008875708095729351

Results O 0 0.013132080435752869
presented O 0 0.005419854540377855
here O 0 0.002229779027402401
show O 0 0.007122406270354986
that O 0 0.004653868265450001
BRCA1 O 1 1.0
and O 0 0.006982797756791115
BRCA2 O 1 1.0
coexist O 0 0.031691256910562515
in O 0 0.0018854897934943438
a O 0 0.007289429195225239
biochemical O 0 0.041779182851314545
complex O 0 0.007825161330401897
and O 0 0.002433907240629196
colocalize O 1 0.9997616410255432
in O 0 0.005338591989129782
subnuclear O 1 0.9998247027397156
foci O 1 0.9810478091239929
in O 0 0.006597564555704594
somatic O 1 0.9957055449485779
cells O 0 0.0478176511824131
and O 0 0.0011875444324687123
on O 0 0.0015803409041836858
the O 0 0.003978744149208069
axial O 0 0.12140124291181564
elements O 0 0.004409734159708023
of O 0 0.002677754033356905
developing O 0 0.030223369598388672
synaptonemal O 1 0.9997205138206482
complexes O 0 0.06510874629020691
. O 0 0.0072680190205574036

Like O 0 0.042490482330322266
BRCA1 O 1 0.9999978542327881
and O 0 0.009997916407883167
RAD51 O 1 0.9999895095825195
, O 0 0.011357719078660011
BRCA2 O 1 0.9999997615814209
relocates O 1 0.9230108857154846
to O 0 0.00965825468301773
PCNA O 1 0.9993070363998413
+ O 0 0.10285965353250504
replication O 0 0.10629605501890182
sites O 0 0.006708318833261728
following O 0 0.010699146427214146
exposure O 0 0.07382048666477203
of O 0 0.0034229187294840813
S O 1 0.9971103072166443
phase O 0 0.05567339062690735
cells O 0 0.050056204199790955
to O 0 0.006636995822191238
hydroxyurea O 1 0.9992581009864807
or O 0 0.023050358518958092
UV O 1 0.9999418258666992
irradiation O 1 0.9246609210968018
. O 0 0.010095875710248947

Thus O 0 0.017523450776934624
, O 0 0.006545091047883034
BRCA1 O 1 1.0
and O 0 0.007861413061618805
BRCA2 O 1 1.0
participate O 0 0.008472086861729622
, O 0 0.0015504313632845879
together O 0 0.0017882446991279721
, O 0 0.0011697175214067101
in O 0 0.0015741444658488035
a O 0 0.010235686786472797
pathway O 1 0.9488818645477295
( O 0 0.011023610830307007
s O 0 0.11361377686262131
) O 0 0.004820297937840223
associated O 0 0.005644022487103939
with O 0 0.0011000087251886725
the O 0 0.00290529802441597
activation O 0 0.0633234828710556
of O 0 0.0020096602384001017
double O 0 0.026371529325842857
- O 0 0.04501180350780487
strand O 0 0.11034642904996872
break O 0 0.040294330567121506
repair O 1 0.8614016175270081
and O 0 0.004507139325141907
/ O 0 0.07679582387208939
or O 0 0.010887106880545616
homologous O 0 0.33533594012260437
recombination O 0 0.1837628334760666
. O 0 0.009756039828062057

Dysfunction O 1 0.9999822378158569
of O 0 0.003168291412293911
this O 0 0.0035169520415365696
pathway O 1 0.9831620454788208
may O 0 0.007513104472309351
be O 0 0.0013116152258589864
a O 0 0.004680085461586714
general O 0 0.007311255671083927
phenomenon O 0 0.031331129372119904
in O 0 0.0013204707065597177
the O 0 0.0018129234667867422
majority O 0 0.005708691664040089
of O 0 0.0014231244567781687
cases O 0 0.007594234310090542
of O 0 0.003837423399090767
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 0 0.0054953875951468945
/ I-Disease 1 0.9999573230743408
or I-Disease 1 0.986615777015686
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.004060912877321243
. O 0 0.005480833817273378

A O 0 0.032950326800346375
novel O 0 0.05287910997867584
Arg362Ser O 1 0.9997242093086243
mutation O 1 0.9984172582626343
in O 0 0.0024218959733843803
the O 0 0.0050008418038487434
sterol O 1 0.9987775683403015
27 O 0 0.04040069878101349
- O 0 0.07319790124893188
hydroxylase O 1 0.990451455116272
gene O 1 0.9900640845298767
( O 0 0.01778702810406685
CYP27 O 1 0.9996459484100342
) O 0 0.0058486019261181355
: O 0 0.0029730331152677536
its O 0 0.0030140853486955166
effects O 0 0.029265141114592552
on O 0 0.0034617914352566004
pre O 0 0.04639052599668503
- O 0 0.04007561504840851
mRNA O 0 0.08097612112760544
splicing O 0 0.11122357100248337
and O 0 0.004957872908562422
enzyme O 0 0.10650068521499634
activity O 0 0.015757421031594276
. O 0 0.007133217994123697

A O 0 0.026447437703609467
novel O 0 0.03348549082875252
C O 0 0.05858955159783363
to O 0 0.0025111937429755926
A O 0 0.01933211088180542
mutation O 1 0.9965957999229431
in O 0 0.0022068216931074858
the O 0 0.005260702688246965
sterol O 1 0.9985746145248413
27 O 0 0.036617208272218704
- O 0 0.07254322618246078
hydroxylase O 1 0.994392991065979
gene O 1 0.9945488572120667
( O 0 0.014380964450538158
CYP27 O 1 0.9999415874481201
) O 0 0.005241856444627047
was O 0 0.006235760636627674
identified O 0 0.010503017343580723
by O 0 0.004073324613273144
sequencing O 0 0.08441267162561417
amplified O 1 0.5410816073417664
CYP27 O 1 0.9995211362838745
gene O 1 0.8072351217269897
products O 0 0.0069513386115431786
from O 0 0.002601733198389411
a O 0 0.010221164673566818
patient O 1 0.999833345413208
with O 0 0.007114513777196407
cerebrotendinous B-Disease 1 0.9999990463256836
xanthomatosis I-Disease 1 0.9999966621398926
( O 0 0.02792295068502426
CTX B-Disease 1 0.999998927116394
) O 0 0.009434845298528671
. O 0 0.007007832173258066

The O 0 0.013287990354001522
mutation O 1 0.9991263747215271
changed O 0 0.015225697308778763
the O 0 0.006085430737584829
adrenodoxin O 1 0.9983882904052734
cofactor O 1 0.948005199432373
binding O 0 0.03756997361779213
residue O 0 0.13236083090305328
362Arg O 1 0.9817894101142883
to O 0 0.00594333978369832
362Ser O 1 0.9977411031723022
( O 0 0.01621810533106327
CGT O 1 0.9998192191123962
362Arg O 1 0.9972672462463379
to O 0 0.014364075846970081
AGT O 1 0.9999998807907104
362Ser O 1 0.9998652935028076
) O 0 0.006309824530035257
, O 0 0.0014745633816346526
and O 0 0.0010861834743991494
was O 0 0.005902895703911781
responsible O 0 0.015704166144132614
for O 0 0.005635321140289307
deficiency O 1 0.9999998807907104
in O 0 0.0026686922647058964
the O 0 0.005573552567511797
sterol O 1 0.9990776777267456
27 O 0 0.031218474730849266
- O 0 0.047406747937202454
hydroxylase O 1 0.9816686511039734
activity O 0 0.0110743697732687
, O 0 0.0015725536504760385
as O 0 0.002466927981004119
confirmed O 0 0.012553244829177856
by O 0 0.0026747037190943956
expression O 0 0.015506931580603123
of O 0 0.002581824781373143
mutant O 1 0.9976164102554321
cDNA O 0 0.1328030377626419
into O 0 0.01741713657975197
COS O 1 0.9996445178985596
- O 0 0.04925740510225296
1 O 0 0.02888454683125019
cells O 0 0.06927772611379623
. O 0 0.00890019629150629

Quantitative O 0 0.03909923881292343
analysis O 0 0.007985410280525684
showed O 0 0.00790133886039257
that O 0 0.001058087102137506
the O 0 0.002692897105589509
expression O 0 0.0208286140114069
of O 0 0.0044358111917972565
CYP27 O 1 0.9999862909317017
gene O 1 0.9490002393722534
mRNA O 0 0.03930234909057617
in O 0 0.0022306025493890047
the O 0 0.005723722279071808
patient O 1 0.9999364614486694
represented O 0 0.010635698214173317
52 O 0 0.034596629440784454
. O 0 0.006633114535361528

5 O 0 0.017979666590690613
% O 0 0.003638803493231535
of O 0 0.001434588572010398
the O 0 0.0038428285624831915
normal O 0 0.021110396832227707
level O 0 0.007101973984390497
. O 0 0.006132780108600855

As O 0 0.005060949362814426
the O 0 0.007073503453284502
mutation O 1 0.9998728036880493
occurred O 0 0.021411459892988205
at O 0 0.003561750752851367
the O 0 0.004740999545902014
penultimate O 1 0.9831318855285645
nucleotide O 0 0.08565589785575867
of O 0 0.005351214203983545
exon O 1 0.9972303509712219
6 O 0 0.02667117305099964
( O 0 0.00771621847525239
- O 0 0.02144213765859604
2 O 0 0.007447216659784317
position O 0 0.004581108223646879
of O 0 0.0028428512159734964
exon O 1 0.9952613711357117
6 O 0 0.02852523699402809
- O 0 0.054566673934459686
intron O 1 0.9994884729385376
6 O 0 0.03607191890478134
splice O 1 0.8223108649253845
site O 0 0.012364198453724384
) O 0 0.0027206565719097853
of O 0 0.001449122210033238
the O 0 0.005901964381337166
gene O 1 0.9991070628166199
, O 0 0.0018825799925252795
we O 0 0.0018850384512916207
hypothesized O 0 0.06378050148487091
that O 0 0.0016279729316011071
the O 0 0.006899778265506029
mutation O 1 0.9999924898147583
may O 0 0.01532717514783144
partially O 0 0.057256706058979034
affect O 0 0.015206847339868546
the O 0 0.00436283927410841
normal O 0 0.024623505771160126
splicing O 0 0.09446544200181961
efficiency O 0 0.014866657555103302
in O 0 0.004760284908115864
exon O 1 0.9952532052993774
6 O 0 0.015123937278985977
and O 0 0.0025820189621299505
cause O 1 0.8163513541221619
alternative O 0 0.01892038993537426
splicing O 0 0.12158523499965668
elsewhere O 0 0.010685275308787823
, O 0 0.0018051672959700227
which O 0 0.002189912600442767
resulted O 0 0.01958545856177807
in O 0 0.0025233186315745115
decreased O 0 0.3321544826030731
transcript O 0 0.023030031472444534
in O 0 0.002065582200884819
the O 0 0.005821035709232092
patient O 1 0.9999607801437378
. O 0 0.00732966186478734

Transfection O 0 0.363253116607666
of O 0 0.004842394031584263
constructed O 0 0.02085813321173191
minigenes O 1 0.9998328685760498
, O 0 0.0018551737302914262
with O 0 0.0012944639893248677
or O 0 0.002704998943954706
without O 0 0.0031337544787675142
the O 0 0.005323666613548994
mutation O 1 0.9999405145645142
, O 0 0.0026842437218874693
into O 0 0.009882748126983643
COS O 1 0.9998383522033691
- O 0 0.048139940947294235
1 O 0 0.023450620472431183
cells O 0 0.05030785873532295
confirmed O 0 0.012312313541769981
that O 0 0.0012609667610377073
the O 0 0.004933465272188187
mutant O 1 0.9998940229415894
minigene O 1 0.9959333539009094
was O 0 0.009301787242293358
responsible O 0 0.009499800391495228
for O 0 0.0016649281606078148
a O 0 0.007152486592531204
mRNA O 0 0.06208918243646622
species O 0 0.020681319758296013
alternatively O 0 0.03768257424235344
spliced O 0 0.0710187554359436
at O 0 0.0038780109025537968
an O 0 0.004997015465050936
activated O 1 0.9985860586166382
cryptic O 1 0.7113926410675049
5 O 0 0.018785540014505386
splice O 0 0.46570324897766113
site O 0 0.015696413815021515
88 O 0 0.053097158670425415
bp O 0 0.06009388342499733
upstream O 0 0.033695463091135025
from O 0 0.002400253200903535
the O 0 0.002908380003646016
3 O 0 0.010392236523330212
end O 0 0.008612722158432007
of O 0 0.004913629032671452
exon O 1 0.9988883137702942
6 O 0 0.027057260274887085
. O 0 0.00700034387409687

Our O 0 0.006020287983119488
data O 0 0.0031260254327207804
suggest O 0 0.005230166483670473
that O 0 0.001395931001752615
the O 0 0.00391410430893302
C O 0 0.06710381805896759
to O 0 0.0025750899221748114
A O 0 0.026827841997146606
mutation O 1 0.9994503855705261
at O 0 0.005222543142735958
the O 0 0.004566618707031012
penultimate O 1 0.9482053518295288
nucleotide O 0 0.07829917222261429
of O 0 0.004151805769652128
exon O 1 0.9902865886688232
6 O 0 0.010240508243441582
of O 0 0.0013596584321931005
the O 0 0.005608634557574987
CYP27 O 1 0.9999986886978149
gene O 1 0.9992062449455261
not O 0 0.0016877762973308563
only O 0 0.0029306989163160324
causes O 1 0.9997181296348572
the O 0 0.00793425366282463
deficiency B-Disease 1 1.0
in I-Disease 0 0.002052855445072055
the I-Disease 0 0.005243423394858837
sterol I-Disease 1 0.9993244409561157
27 I-Disease 0 0.03209444135427475
- I-Disease 0 0.046109639108181
hydroxylase I-Disease 1 0.9480319023132324
activity I-Disease 0 0.012640601955354214
, O 0 0.0018474425887688994
but O 0 0.0018534526461735368
also O 0 0.0028722097631543875
partially O 0 0.053537894040346146
leads O 0 0.016760263592004776
to O 0 0.002415324794128537
alternative O 0 0.015548157505691051
pre O 0 0.04880513250827789
- O 0 0.03434743359684944
mRNA O 0 0.064170241355896
splicing O 0 0.0668599084019661
of O 0 0.002405404346063733
the O 0 0.007241424173116684
gene O 1 0.985304057598114
. O 0 0.007502353750169277

To O 0 0.003399195848032832
our O 0 0.002869576681405306
knowledge O 0 0.003568957094103098
, O 0 0.001496706041507423
this O 0 0.0013784004840999842
is O 0 0.0020771350245922804
the O 0 0.0017257260624319315
first O 0 0.0029245130717754364
report O 0 0.003428991185501218
regarding O 0 0.00548702385276556
effects O 0 0.030015146359801292
on O 0 0.003251157235354185
pre O 0 0.04048585519194603
- O 0 0.03046882152557373
mRNA O 0 0.06498415768146515
splicing O 0 0.07572617381811142
of O 0 0.002425844082608819
a O 0 0.014087912626564503
mutation O 1 0.9978260397911072
at O 0 0.005917320027947426
the O 0 0.00454918947070837
- O 0 0.022440163418650627
2 O 0 0.00836136657744646
position O 0 0.004660326987504959
of O 0 0.0017846283735707402
a O 0 0.00861209537833929
5 O 0 0.01835436373949051
splice O 1 0.9041420221328735
site O 0 0.021627360954880714
. O 0 0.007467665709555149

ATM O 1 0.9456603527069092
germline O 1 0.9986615180969238
mutations O 1 0.9842968583106995
in O 0 0.004815578926354647
classical O 0 0.021315762773156166
ataxia B-Disease 1 1.0
- I-Disease 1 0.9998347759246826
telangiectasia I-Disease 1 1.0
patients O 1 0.9999902248382568
in O 0 0.001718476414680481
the O 0 0.0031985812820494175
Dutch O 0 0.0449921078979969
population O 0 0.012265716679394245
. O 0 0.006005777977406979

Germline O 1 0.9998635053634644
mutations O 1 0.9944993257522583
in O 0 0.0029972041957080364
the O 0 0.005487577524036169
ATM O 1 0.968542754650116
gene O 1 0.9926403164863586
are O 0 0.001072859624400735
responsible O 0 0.006963805295526981
for O 0 0.001541635487228632
the O 0 0.01667323149740696
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999501705169678
telangiectasia I-Disease 1 1.0
( O 0 0.0159334484487772
A B-Disease 1 0.9998146891593933
- I-Disease 1 0.9988889098167419
T I-Disease 1 0.9999961853027344
) O 0 0.007011273875832558
. O 0 0.0063058072701096535

In O 0 0.003399249166250229
our O 0 0.002886703936383128
study O 0 0.004528915975242853
, O 0 0.0011832190211862326
we O 0 0.0009999640751630068
have O 0 0.0013447022065520287
determined O 0 0.0065530696883797646
the O 0 0.004718763288110495
ATM O 1 0.9953765869140625
mutation O 1 0.999954342842102
spectrum O 0 0.03528159484267235
in O 0 0.0019762818701565266
19 O 0 0.00988795142620802
classical O 0 0.006654942408204079
A B-Disease 1 0.972588837146759
- I-Disease 1 0.9992212057113647
T I-Disease 1 0.9999997615814209
patients O 1 0.9999933242797852
, O 0 0.0016692031640559435
including O 0 0.0014263048069551587
some O 0 0.002480829367414117
immigrant O 0 0.05466416850686073
populations O 0 0.043240636587142944
, O 0 0.0017018296057358384
as O 0 0.0020184414461255074
well O 0 0.0014660605229437351
as O 0 0.0019948475528508425
12 O 0 0.005496649071574211
of O 0 0.0019039805047214031
Dutch O 0 0.027924688532948494
ethnic O 0 0.00916011817753315
origin O 0 0.0113063994795084
. O 0 0.007599921897053719

Both O 0 0.005259925965219736
the O 0 0.005747594404965639
protein O 0 0.07325965166091919
truncation O 1 0.9891668558120728
test O 0 0.02569585293531418
( O 0 0.010078481398522854
PTT O 1 0.9853894114494324
) O 0 0.0038317989092320204
and O 0 0.0011512202909216285
the O 0 0.004371713846921921
restriction O 0 0.07305394858121872
endonuclease O 1 0.9992207288742065
fingerprinting O 0 0.07289839535951614
( O 0 0.013752941973507404
REF O 1 0.9999372959136963
) O 0 0.005149424076080322
method O 0 0.005965752061456442
were O 0 0.0013656072551384568
used O 0 0.001656713429838419
and O 0 0.0012636574683710933
compared O 0 0.00716581754386425
for O 0 0.0012521883472800255
their O 0 0.0021569968666881323
detection O 0 0.040406398475170135
efficiency O 0 0.01174071617424488
, O 0 0.0029707327485084534
identifying O 0 0.03025815263390541
76 O 0 0.05837515741586685
% O 0 0.004975456744432449
and O 0 0.001348042511381209
60 O 0 0.006660843268036842
% O 0 0.002449589315801859
of O 0 0.0011430395534262061
the O 0 0.005521042738109827
mutations O 1 0.9999973773956299
, O 0 0.0022823407780379057
respectively O 0 0.010115465149283409
. O 0 0.005713758058845997

Most O 0 0.02071164920926094
patients O 1 0.9999806880950928
were O 0 0.0017481085378676653
found O 0 0.0033344340045005083
to O 0 0.0014556159731000662
be O 0 0.003078186884522438
compound O 0 0.04941017925739288
heterozygote O 1 0.9941204190254211
. O 0 0.013674194924533367

Seventeen O 0 0.12493521720170975
mutations O 1 0.9955428242683411
were O 0 0.0041580419056117535
distinct O 0 0.011137773282825947
, O 0 0.0014215221162885427
of O 0 0.0012653230223804712
which O 0 0.002336251549422741
10 O 0 0.004663721192628145
were O 0 0.0015636738389730453
not O 0 0.002359231933951378
reported O 0 0.015439898706972599
previously O 0 0.011033383198082447
. O 0 0.00723969005048275

Mutations O 1 0.9995287656784058
are O 0 0.0020666206255555153
small O 0 0.006827167700976133
deletions O 0 0.3545542061328888
or O 0 0.003844995517283678
point O 0 0.009958583861589432
mutations O 1 0.9993916749954224
frequently O 0 0.017033681273460388
affecting O 0 0.3616567850112915
splice O 1 0.9815050959587097
sites O 0 0.01030068937689066
. O 0 0.007018957287073135

Moreover O 0 0.02900776080787182
, O 0 0.0030048228800296783
a O 0 0.009095298126339912
16 O 0 0.014932580292224884
. O 0 0.006547851487994194

7 O 0 0.04247888922691345
- O 0 0.059682250022888184
kb O 1 0.8963336944580078
genomic O 0 0.1828376054763794
deletion O 0 0.360604852437973
of O 0 0.0018836376257240772
the O 0 0.0033316900953650475
3 O 0 0.008468657732009888
end O 0 0.005684998352080584
of O 0 0.0015959532465785742
the O 0 0.005415055435150862
gene O 1 0.9990746974945068
, O 0 0.0019316521938890219
most O 0 0.0027069407515227795
likely O 0 0.007702054921537638
a O 0 0.004741906188428402
result O 0 0.0076549602672457695
of O 0 0.0024742535315454006
recombination O 0 0.13823410868644714
between O 0 0.0024081110022962093
two O 0 0.0017666690982878208
LINE O 0 0.015385122038424015
elements O 0 0.004842894617468119
, O 0 0.002454156521707773
was O 0 0.010188817046582699
identified O 0 0.01860739290714264
. O 0 0.005817863158881664

The O 0 0.007366013713181019
most O 0 0.004763358272612095
frequently O 0 0.011361783370375633
found O 0 0.0138006079941988
mutation O 1 0.999964714050293
, O 0 0.0022914689034223557
identified O 0 0.008017770946025848
in O 0 0.0013117640046402812
three O 0 0.0023104159627109766
unrelated O 0 0.026071539148688316
Turkish O 0 0.02659236639738083
A B-Disease 1 0.9848226308822632
- I-Disease 1 0.9793294668197632
T I-Disease 1 0.9999899864196777
individuals O 0 0.006711166817694902
, O 0 0.0017978872638195753
was O 0 0.006707645487040281
previously O 0 0.005365675315260887
described O 0 0.005560237914323807
to O 0 0.000765743141528219
be O 0 0.0010154658230021596
a O 0 0.004329388495534658
Turkish O 0 0.01737293042242527
A B-Disease 1 0.9100991487503052
- I-Disease 1 0.9421656727790833
T I-Disease 1 0.9999923706054688
founder O 1 0.9654216766357422
mutation O 1 0.9999575614929199
. O 0 0.009856065735220909

The O 0 0.005171367898583412
presence O 0 0.00788822304457426
of O 0 0.0016678932588547468
a O 0 0.011162999086081982
founder O 1 0.9568943977355957
mutation O 1 0.9999583959579468
among O 0 0.006605065893381834
relatively O 0 0.007256117183715105
small O 0 0.004279567394405603
ethnic O 0 0.006970448885113001
population O 0 0.007458393927663565
groups O 0 0.00279440195299685
in O 0 0.00172131706494838
Western O 0 0.005901477299630642
Europe O 0 0.006177186034619808
could O 0 0.0035414614249020815
indicate O 0 0.008336369879543781
a O 0 0.006374736782163382
high O 0 0.012007554061710835
carrier O 1 0.9456301927566528
frequency O 0 0.02582051046192646
in O 0 0.0019101303769275546
such O 0 0.0016715910751372576
communities O 0 0.011461690068244934
. O 0 0.006664854008704424

In O 0 0.010731076821684837
patients O 1 0.9991984963417053
of O 0 0.002939402125775814
Dutch O 0 0.030406789854168892
ethnic O 0 0.008805651217699051
origin O 0 0.00942742358893156
, O 0 0.00195855600759387
however O 0 0.002896813675761223
, O 0 0.0014971191994845867
no O 0 0.0023038897197693586
significant O 0 0.008880289271473885
founder O 0 0.14301429688930511
effect O 0 0.015551106072962284
could O 0 0.0031012576073408127
be O 0 0.002455697627738118
identified O 0 0.016164926812052727
. O 0 0.006468902807682753

The O 0 0.008967138826847076
observed O 0 0.025531748309731483
genetic O 0 0.0776221975684166
heterogeneity O 0 0.1023758053779602
including O 0 0.0018748563015833497
the O 0 0.0024016040842980146
relative O 0 0.010350157506763935
high O 0 0.005767717491835356
percentage O 0 0.008359303697943687
of O 0 0.0033060498535633087
splice O 1 0.9969170093536377
- O 0 0.03779628500342369
site O 0 0.021066129207611084
mutations O 1 0.9999252557754517
had O 0 0.004769455641508102
no O 0 0.0023130387999117374
reflection O 0 0.015910647809505463
on O 0 0.001833036309108138
the O 0 0.007487406488507986
phenotype O 1 0.9999960660934448
. O 0 0.007947657257318497

All O 0 0.009424030780792236
patients O 1 0.9999216794967651
manifested O 1 0.8876424431800842
classical O 0 0.008045458234846592
A B-Disease 1 0.8003573417663574
- I-Disease 1 0.8651401400566101
T I-Disease 1 0.9999865293502808
and O 0 0.0023535240907222033
increased O 0 0.01995234191417694
cellular O 0 0.23703527450561523
radioresistant O 1 0.9960263967514038
DNA O 0 0.06855098903179169
synthesis O 0 0.04410155490040779
. O 0 0.008983273059129715

Determination O 0 0.021715229377150536
of O 0 0.0022157614585012197
the O 0 0.0035680755972862244
genomic O 0 0.09240377694368362
structure O 0 0.005943289026618004
of O 0 0.001245102845132351
the O 0 0.005915463902056217
COL4A4 O 1 0.9999872446060181
gene O 1 0.8197051286697388
and O 0 0.0011920040706172585
of O 0 0.0018251783913001418
novel O 1 0.7150894999504089
mutations O 1 0.9999994039535522
causing O 1 0.9999992847442627
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.012860537506639957

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.006414531264454126
a O 0 0.011553159914910793
progressive O 1 0.9999722242355347
hematuric B-Disease 1 0.9999972581863403
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.7691597938537598
by O 0 0.01031033881008625
glomerular B-Disease 1 0.9999994039535522
basement I-Disease 1 0.9945736527442932
membrane I-Disease 1 0.9947158694267273
abnormalities I-Disease 1 0.9999758005142212
and O 0 0.0021851398050785065
associated O 0 0.007374016102403402
with O 0 0.0030531438533216715
mutations O 1 0.9994058609008789
in O 0 0.002067534253001213
either O 0 0.003999350592494011
the O 0 0.004641983192414045
COL4A3 O 1 0.9999843835830688
or O 0 0.004506953060626984
the O 0 0.006946304347366095
COL4A4 O 1 0.9999990463256836
gene O 1 0.9939441084861755
, O 0 0.0016824635677039623
which O 0 0.0018199984915554523
encode O 0 0.022080300375819206
the O 0 0.004928634036332369
alpha3 O 1 0.9996992349624634
and O 0 0.004135366529226303
alpha4 O 1 0.9999773502349854
type O 1 0.9977994561195374
IV O 1 0.9999994039535522
collagen O 1 0.9999992847442627
chains O 1 0.5156939625740051
, O 0 0.002978363772854209
respectively O 0 0.010152062401175499
. O 0 0.005987079814076424

To O 0 0.0036403199192136526
date O 0 0.00829675979912281
, O 0 0.003963369410485029
mutation O 1 0.999983549118042
screening O 0 0.0400303490459919
in O 0 0.0012491120724007487
the O 0 0.0018371205078437924
two O 0 0.0024004043079912663
genes O 1 0.8633797764778137
has O 0 0.004563840571790934
been O 0 0.006517986301332712
hampered O 1 0.9980721473693848
by O 0 0.0024084339383989573
the O 0 0.0024629763793200254
lack O 0 0.006813066080212593
of O 0 0.002447504550218582
genomic O 1 0.8650635480880737
structure O 0 0.008632997050881386
information O 0 0.0018359300447627902
. O 0 0.00538907153531909

We O 0 0.003483771812170744
report O 0 0.0026006470434367657
here O 0 0.0014695024583488703
the O 0 0.002186550060287118
complete O 0 0.005741983652114868
characterization O 0 0.014658239670097828
of O 0 0.0011066904990002513
the O 0 0.003197368234395981
48 O 0 0.01991702988743782
exons O 0 0.09181462228298187
of O 0 0.0019031307892873883
the O 0 0.007596822455525398
COL4A4 O 1 0.9999994039535522
gene O 1 0.9993438124656677
, O 0 0.0020705312490463257
a O 0 0.007260583806782961
comprehensive O 0 0.027983279898762703
gene O 1 0.9958194494247437
screen O 0 0.02254233881831169
, O 0 0.0014785713283345103
and O 0 0.000790489895734936
the O 0 0.002462538657709956
subsequent O 0 0.019436899572610855
detection O 0 0.028006473556160927
of O 0 0.0017113715875893831
10 O 0 0.006529192440211773
novel O 0 0.04992537572979927
mutations O 1 0.9988981485366821
in O 0 0.002831344725564122
eight O 0 0.014820858836174011
patients O 1 1.0
diagnosed O 1 1.0
with O 0 0.0554480217397213
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.011971679516136646

Furthermore O 0 0.026804519817233086
, O 0 0.0020969132892787457
we O 0 0.0017614008393138647
identified O 0 0.009983913972973824
a O 0 0.00889887660741806
glycine O 0 0.11840030550956726
to O 0 0.004344271030277014
alanine O 0 0.11143020540475845
substitution O 0 0.027816975489258766
in O 0 0.002142909448593855
the O 0 0.005376230925321579
collagenous O 1 0.9997163414955139
domain O 0 0.025748666375875473
that O 0 0.0016700838459655643
is O 0 0.003437264123931527
apparently O 0 0.02102959342300892
silent O 0 0.04288411885499954
in O 0 0.0017389776185154915
the O 0 0.005982591770589352
heterozygous O 1 0.9999735355377197
carriers O 1 0.9143874645233154
, O 0 0.0021583111956715584
in O 0 0.0025996689219027758
11 O 0 0.012832112610340118
. O 0 0.006950664333999157

5 O 0 0.02019054815173149
% O 0 0.0038950503803789616
of O 0 0.0010942287044599652
all O 0 0.0016474740114063025
control O 0 0.0227541234344244
individuals O 0 0.004906164016574621
, O 0 0.0013302628649398685
and O 0 0.0007297223201021552
in O 0 0.001100379740819335
one O 0 0.002790597500279546
control O 0 0.02056172862648964
individual O 0 0.00728178396821022
homozygous O 1 0.9997445940971375
for O 0 0.002098869765177369
this O 0 0.0034811440855264664
glycine O 0 0.3070560395717621
substitution O 0 0.05383525416254997
. O 0 0.008724777027964592

There O 0 0.004600977525115013
has O 0 0.004068661015480757
been O 0 0.0038512200117111206
no O 0 0.0016496038297191262
previous O 0 0.0038122348487377167
finding O 0 0.005575030110776424
of O 0 0.0017881946405395865
a O 0 0.010858281515538692
glycine O 1 0.9052165150642395
substitution O 0 0.03719828650355339
that O 0 0.0018359945388510823
is O 0 0.002610574709251523
not O 0 0.001730591175146401
associated O 0 0.005843735300004482
with O 0 0.0012542646145448089
any O 0 0.0028012068942189217
obvious O 0 0.23177675902843475
phenotype O 1 0.9999933242797852
in O 0 0.005560611840337515
homozygous O 1 0.9998403787612915
individuals O 0 0.008284718729555607
. O 0 0.006669878493994474

Founder O 1 0.9810472130775452
BRCA1 O 1 0.9999998807907104
and O 0 0.011790369637310505
BRCA2 O 1 0.9999998807907104
mutations O 1 0.9983332753181458
in O 0 0.0029175858944654465
French O 0 0.08511270582675934
Canadian O 1 0.9991397857666016
breast B-Disease 1 1.0
and I-Disease 1 0.9638574123382568
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.01841804012656212
. O 0 0.00853524636477232

We O 0 0.00417231023311615
have O 0 0.0024990709498524666
identified O 0 0.011670471169054508
four O 0 0.003853252623230219
mutations O 1 0.9944013953208923
in O 0 0.001174767967313528
each O 0 0.0009519853629171848
of O 0 0.0013035329757258296
the O 0 0.2704792618751526
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
- O 1 0.9912473559379578
susceptibility O 1 0.9999829530715942
genes O 1 0.8771780133247375
, O 0 0.0065013086423277855
BRCA1 O 1 1.0
and O 0 0.007244671694934368
BRCA2 O 1 1.0
, O 0 0.0017481261165812612
in O 0 0.0015485688345506787
French O 0 0.3228338956832886
Canadian O 1 0.9998704195022583
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.07868970185518265
breast B-Disease 1 1.0
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.013649078086018562
from O 0 0.005403910297900438
Quebec O 1 0.9751765131950378
. O 0 0.008013319224119186

To O 0 0.0055731190368533134
identify O 0 0.022138869389891624
founder O 0 0.07338007539510727
effects O 0 0.08408564329147339
, O 0 0.0017931063193827868
we O 0 0.0018347051227465272
examined O 0 0.025462770834565163
independently O 0 0.013512722216546535
ascertained O 0 0.2803102433681488
French O 0 0.1040421575307846
Canadian O 1 0.9969208240509033
cancer B-Disease 1 1.0
families O 0 0.006187340244650841
for O 0 0.0011230369564145803
the O 0 0.0021281475201249123
distribution O 0 0.004194831475615501
of O 0 0.0009597418247722089
these O 0 0.0011465629795566201
eight O 0 0.009143133647739887
mutations O 1 0.9996888637542725
. O 0 0.007173899095505476

Mutations O 1 0.9956251978874207
were O 0 0.003550905967131257
found O 0 0.005200010724365711
in O 0 0.0020540780387818813
41 O 0 0.020819298923015594
of O 0 0.0027632166165858507
97 O 0 0.06830058246850967
families O 0 0.012323074974119663
. O 0 0.008866450749337673

Six O 0 0.0073751541785895824
of O 0 0.0021301566157490015
eight O 0 0.010088163428008556
mutations O 1 0.999789297580719
were O 0 0.0024817290250211954
observed O 0 0.011745790019631386
at O 0 0.00424977345392108
least O 0 0.009761273860931396
twice O 0 0.01849943771958351
. O 0 0.007374665234237909

The O 0 0.02321203425526619
BRCA1 O 1 0.9999998807907104
C4446T O 1 0.9999496936798096
mutation O 1 0.999910831451416
was O 0 0.007052786648273468
the O 0 0.002201883587986231
most O 0 0.0036068696063011885
common O 0 0.023055030032992363
mutation O 1 0.999996542930603
found O 0 0.005595971364527941
, O 0 0.0012439987622201443
followed O 0 0.00619336636736989
by O 0 0.0028936725575476885
the O 0 0.011015964671969414
BRCA2 O 1 1.0
8765delAG O 1 0.9999833106994629
mutation O 1 0.9999653100967407
. O 0 0.010724619030952454

Together O 0 0.005305084399878979
, O 0 0.002310694195330143
these O 0 0.003073388012126088
mutations O 1 0.9989609718322754
were O 0 0.0022359704598784447
found O 0 0.004483455326408148
in O 0 0.0019560896325856447
28 O 0 0.011130055412650108
of O 0 0.0023943264968693256
41 O 0 0.0262046679854393
families O 0 0.007172860205173492
identified O 0 0.009405344724655151
to O 0 0.0012792282504960895
have O 0 0.002124032936990261
a O 0 0.012753152288496494
mutation O 1 0.9999698400497437
. O 0 0.007628838066011667

The O 0 0.006935498211532831
odds O 0 0.0322704054415226
of O 0 0.0024412304628640413
detection O 0 0.027430959045886993
of O 0 0.0008470123284496367
any O 0 0.0009294965420849621
of O 0 0.0007852524286136031
the O 0 0.0027885071467608213
four O 0 0.00992324948310852
BRCA1 O 1 1.0
mutations O 1 0.9999692440032959
was O 0 0.011834079399704933
18 O 0 0.011037628166377544
. O 0 0.006393601186573505

7x O 1 0.9987319111824036
greater O 0 0.01060684584081173
if O 0 0.0033580316230654716
one O 0 0.00255626835860312
or O 0 0.0024463545996695757
more O 0 0.001848630141466856
cases O 0 0.013885020278394222
of O 0 0.026736678555607796
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.0020748295355588198
also O 0 0.0012464558240026236
present O 0 0.0016482365317642689
in O 0 0.0011666362406685948
the O 0 0.0038702860474586487
family O 0 0.018292240798473358
. O 0 0.007872147485613823

The O 0 0.008165612816810608
odds O 0 0.02813480608165264
of O 0 0.002548967022448778
detection O 0 0.023931272327899933
of O 0 0.0011560284765437245
any O 0 0.0010500806383788586
of O 0 0.0008954790537245572
the O 0 0.0033251354470849037
four O 0 0.012616142630577087
BRCA2 O 1 1.0
mutations O 1 0.9999384880065918
was O 0 0.01303448062390089
5 O 0 0.013770527206361294
. O 0 0.006685268599539995

3x O 1 0.9797142148017883
greater O 0 0.0091963279992342
if O 0 0.0028477422893047333
there O 0 0.001297207665629685
were O 0 0.0010605009738355875
at O 0 0.0020272298716008663
least O 0 0.004608741030097008
five O 0 0.003277264768257737
cases O 0 0.010985222645103931
of O 0 0.00830638874322176
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.00244159041903913
the O 0 0.0038403284270316362
family O 0 0.021888552233576775
. O 0 0.0071750846691429615

Interestingly O 0 0.0756588876247406
, O 0 0.0018472281517460942
the O 0 0.002079941099509597
presence O 0 0.006170252338051796
of O 0 0.0023443521931767464
a O 1 0.912574052810669
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
case O 0 0.03182898461818695
< O 1 0.9951227307319641
36 O 0 0.01800786703824997
years O 0 0.0037519277539104223
of O 0 0.0022503307554870844
age O 0 0.012842915952205658
was O 0 0.008362125605344772
strongly O 0 0.010542682372033596
predictive O 0 0.046384744346141815
of O 0 0.0012312853941693902
the O 0 0.0019806118216365576
presence O 0 0.005982937756925821
of O 0 0.0009202715009450912
any O 0 0.0011623584432527423
of O 0 0.000968992302659899
the O 0 0.0033287210389971733
eight O 0 0.011448860168457031
mutations O 1 0.9997681975364685
screened O 0 0.20843158662319183
. O 0 0.007361357565969229

Carriers O 0 0.07518862932920456
of O 0 0.001698717474937439
the O 0 0.003782976884394884
same O 0 0.00959061924368143
mutation O 1 0.999985933303833
, O 0 0.002267223782837391
from O 0 0.002074349671602249
different O 0 0.0013124976539984345
families O 0 0.00478953355923295
, O 0 0.0017857302445918322
shared O 0 0.008525729179382324
similar O 0 0.01011439599096775
haplotypes O 1 0.9990594983100891
, O 0 0.002202640287578106
indicating O 0 0.01008197944611311
that O 0 0.0010464664082974195
the O 0 0.004545737989246845
mutant O 1 0.9999518394470215
alleles O 1 0.9999582767486572
were O 0 0.0018875324167311192
likely O 0 0.005852545611560345
to O 0 0.00109964981675148
be O 0 0.0013503837399184704
identical O 0 0.006491599138826132
by O 0 0.0027856018859893084
descent O 0 0.02553519979119301
for O 0 0.002222684444859624
a O 0 0.01207321509718895
mutation O 1 0.9997676014900208
in O 0 0.0021062756422907114
the O 0 0.0033232001587748528
founder O 0 0.15064764022827148
population O 0 0.013628357090055943
. O 0 0.006617790088057518

The O 0 0.0044455761089921
identification O 0 0.007265896070748568
of O 0 0.0017251101089641452
common O 0 0.28544023633003235
BRCA1 O 1 1.0
and O 0 0.010093406774103642
BRCA2 O 1 1.0
mutations O 1 0.999947190284729
will O 0 0.0024530894588679075
facilitate O 0 0.011100160889327526
carrier O 1 0.8872639536857605
detection O 0 0.028910905122756958
in O 0 0.0018518795259296894
French O 0 0.21068379282951355
Canadian O 1 0.9994755387306213
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.08832746744155884
breast B-Disease 1 1.0
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.01845628209412098
. O 0 0.007978788577020168

Are O 0 0.0056449915282428265
Dp71 O 1 0.9995747208595276
and O 0 0.006098833400756121
Dp140 O 1 0.9999953508377075
brain O 1 0.9999898672103882
dystrophin O 1 0.9999300241470337
isoforms O 0 0.12170597165822983
related O 0 0.008721078746020794
to O 0 0.0027608892414718866
cognitive B-Disease 1 0.9811460971832275
impairment I-Disease 1 0.9999877214431763
in O 0 0.014742638915777206
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.6474486589431763

Molecular O 0 0.052218083292245865
study O 0 0.008149300701916218
and O 0 0.0027555774431675673
neuropsychological O 1 0.6309922337532043
analysis O 0 0.005357176996767521
were O 0 0.0015552605036646128
performed O 0 0.007783632725477219
concurrently O 0 0.0069687822833657265
on O 0 0.00253443606197834
49 O 0 0.4102693498134613
patients O 1 0.9999974966049194
with O 0 0.012935709208250046
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9308145642280579
DMD B-Disease 1 1.0
) O 0 0.005006544291973114
in O 0 0.0013646971201524138
order O 0 0.0020909998565912247
to O 0 0.0010380176827311516
find O 0 0.004340979736298323
a O 0 0.006333205848932266
molecular O 0 0.017629064619541168
explanation O 0 0.006782385520637035
for O 0 0.001291070831939578
the O 0 0.004679263569414616
cognitive B-Disease 1 0.9969794750213623
impairment I-Disease 1 0.9999587535858154
observed O 0 0.015278622508049011
in O 0 0.0026904523838311434
most O 0 0.05170184746384621
DMD B-Disease 1 1.0
patients O 1 0.9999996423721313
. O 0 0.008649373427033424

Complete O 0 0.01197847817093134
analysis O 0 0.004234679043292999
of O 0 0.0019270885968580842
the O 0 0.008755256421864033
dystrophin O 1 0.9999988079071045
gene O 1 0.9987499713897705
was O 0 0.008976605720818043
performed O 0 0.007242069113999605
to O 0 0.0013217541854828596
define O 0 0.006444113794714212
the O 0 0.002523965435102582
localization O 0 0.040420904755592346
of O 0 0.002622101688757539
deletions O 1 0.8458652496337891
and O 0 0.002505159005522728
duplications O 1 0.8739256858825684
in O 0 0.0019612533506006002
relation O 0 0.005493166856467724
to O 0 0.0011154137318953872
the O 0 0.003092933678999543
different O 0 0.0074085029773414135
DMD B-Disease 1 1.0
promoters O 1 0.9858227372169495
. O 0 0.009565839543938637

Qualitative O 0 0.02309531904757023
analysis O 0 0.004636592231690884
of O 0 0.0015374126378446817
the O 0 0.004688226152211428
Dp71 O 1 0.9995984435081482
transcript O 0 0.03387674689292908
and O 0 0.0016975881299003959
testing O 0 0.010974271222949028
for O 0 0.0009518759907223284
the O 0 0.00167084950953722
specific O 0 0.003000423312187195
first O 0 0.005587245803326368
exon O 1 0.9910216927528381
of O 0 0.0036831204779446125
Dp140 O 1 0.9997158646583557
were O 0 0.0020910524763166904
also O 0 0.0018074508989229798
carried O 0 0.0066717080771923065
out O 0 0.0047831060364842415
. O 0 0.006264209747314453

Neuropsychological O 1 0.943461000919342
analysis O 0 0.010994640178978443
assessed O 0 0.03420385718345642
verbal O 0 0.03899925574660301
and O 0 0.0036886660382151604
visuospatial O 1 0.9991395473480225
intelligence O 0 0.010662761516869068
, O 0 0.002754281973466277
verbal O 0 0.08557244390249252
memory O 1 0.6040706038475037
, O 0 0.0014003249816596508
and O 0 0.0012167001841589808
reading O 0 0.006713605485856533
skills O 0 0.011710390448570251
. O 0 0.006681062281131744

Comparison O 0 0.018193336203694344
of O 0 0.003277046838775277
molecular O 0 0.025393487885594368
and O 0 0.0026435856707394123
psychometric O 1 0.6902483701705933
findings O 0 0.012415468692779541
demonstrated O 0 0.011575131677091122
that O 0 0.002835035789757967
deletions O 0 0.10039731860160828
and O 0 0.00249686767347157
duplications O 1 0.9043416380882263
that O 0 0.001938347122631967
were O 0 0.003237991128116846
localized O 1 0.9638592600822449
in O 0 0.0024195013102144003
the O 0 0.006233155261725187
distal O 1 0.9999897480010986
part O 0 0.004626616835594177
of O 0 0.0014281959738582373
the O 0 0.005919373594224453
gene O 1 0.9995694756507874
seemed O 0 0.01262288074940443
to O 0 0.00146489089820534
be O 0 0.0031449326779693365
preferentially O 0 0.09296110272407532
associated O 0 0.00947269331663847
with O 0 0.0037664046976715326
cognitive B-Disease 1 0.9965255856513977
impairment I-Disease 1 0.9999706745147705
. O 0 0.008027086965739727

Two O 0 0.008050048723816872
altered O 0 0.07244053483009338
Dp71 O 1 0.9868484139442444
transcripts O 0 0.016944624483585358
and O 0 0.001879228511825204
two O 0 0.0030048999469727278
deleted O 0 0.08681153506040573
Dp140 O 1 0.99076908826828
DNA O 0 0.05410321429371834
sequences O 0 0.01992828957736492
were O 0 0.0015362793346866965
found O 0 0.0034990564454346895
in O 0 0.0013080112403258681
four O 0 0.004572722129523754
patients O 1 0.9999961853027344
with O 0 0.010478990152478218
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 0 0.011577460914850235

These O 0 0.003547627478837967
findings O 0 0.01092403195798397
suggest O 0 0.00595450634136796
that O 0 0.0013525922549888492
some O 0 0.002042910782620311
sequences O 0 0.019142094999551773
located O 0 0.007309615146368742
in O 0 0.002006347058340907
the O 0 0.006393025629222393
distal O 1 0.9999551773071289
part O 0 0.005758804734796286
of O 0 0.002094545867294073
the O 0 0.00635945051908493
gene O 1 0.9993745684623718
and O 0 0.001468895934522152
, O 0 0.001288754865527153
in O 0 0.0013941533397883177
particular O 0 0.004617932718247175
, O 0 0.002120369579643011
some O 0 0.006356428377330303
DMD B-Disease 1 1.0
isoforms O 1 0.7475316524505615
expressed O 0 0.007152754347771406
in O 0 0.002250123070552945
the O 0 0.008369737304747105
brain O 1 0.9999997615814209
may O 0 0.009377548471093178
be O 0 0.0015200445195659995
related O 0 0.003824788611382246
to O 0 0.001168540446087718
the O 0 0.003867468796670437
cognitive B-Disease 1 0.9960803389549255
impairment I-Disease 1 0.9999880790710449
associated O 0 0.017355753108859062
with O 0 0.007713320665061474
DMD B-Disease 1 1.0
. O 0 0.0058366586454212666
. O 0 0.00528246583417058

I1307K O 1 0.9994189739227295
APC O 1 0.9999626874923706
and O 0 0.007367220241576433
hMLH1 O 1 0.9998262524604797
mutations O 1 0.9936994314193726
in O 0 0.0023113712668418884
a O 0 0.007131350692361593
non O 0 0.012608696706593037
- O 0 0.022168371826410294
Jewish O 0 0.012067994102835655
family O 0 0.011554397642612457
with O 0 0.003210518043488264
hereditary B-Disease 1 0.9999991655349731
non I-Disease 1 0.8191013932228088
- I-Disease 1 0.9999966621398926
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.010638690553605556

We O 0 0.0036523703020066023
describe O 0 0.010205368511378765
a O 0 0.005797917954623699
French O 0 0.01877714693546295
Canadian O 0 0.07160962373018265
hereditary B-Disease 1 0.9999982118606567
non I-Disease 0 0.47564154863357544
- I-Disease 1 0.9999914169311523
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.5341653823852539
HNPCC B-Disease 1 1.0
) O 0 0.009761273860931396
kindred O 1 0.9998183846473694
which O 0 0.002553126309067011
carries O 0 0.011921895667910576
a O 0 0.007691395469009876
novel O 0 0.04104408249258995
truncating O 1 0.999859094619751
mutation O 1 0.9997870326042175
in O 0 0.006077890750020742
hMLH1 O 1 0.9987161159515381
. O 0 0.009056376293301582

Interestingly O 0 0.07725923508405685
, O 0 0.0027619819156825542
the O 0 0.007957476191222668
I1307K O 1 0.9999645948410034
APC O 1 0.9999926090240479
polymorphism O 1 0.9925687909126282
, O 0 0.0028371489606797695
associated O 0 0.005856680683791637
with O 0 0.001023722579702735
an O 0 0.002212239895015955
increased O 0 0.021397406235337257
risk O 1 0.9999129772186279
of O 1 0.500419557094574
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0030689267441630363
is O 0 0.0023329819086939096
also O 0 0.0012629582779482007
present O 0 0.00179398397449404
in O 0 0.001278554555028677
this O 0 0.00248580239713192
family O 0 0.017418090254068375
. O 0 0.006052594631910324

The O 0 0.017895080149173737
I1307K O 1 0.999640703201294
polymorphism O 1 0.9129927158355713
has O 0 0.005109233316034079
previously O 0 0.006492060609161854
only O 0 0.002109573222696781
been O 0 0.004685147665441036
identified O 0 0.009489710442721844
in O 0 0.0015237396582961082
individuals O 0 0.0029842290095984936
of O 0 0.002164714504033327
self O 0 0.37952443957328796
- O 0 0.06598611921072006
reported O 0 0.029322508722543716
Ashkenazi O 1 0.9980692267417908
Jewish O 0 0.01781204529106617
origins O 0 0.03423682600259781
. O 0 0.0075884368270635605

In O 0 0.003790533635765314
addition O 0 0.004185065161436796
, O 0 0.001301353331655264
in O 0 0.0012676861369982362
this O 0 0.0017566349124535918
family O 0 0.011534247547388077
, O 0 0.0016209918539971113
there O 0 0.0022382375318557024
appears O 0 0.013090797699987888
to O 0 0.0013517577899619937
be O 0 0.0014554162044078112
no O 0 0.0019859967287629843
relationship O 0 0.005745313595980406
between O 0 0.002027856418862939
the O 0 0.004774397239089012
I1307K O 1 0.9999628067016602
polymorphism O 1 0.9359824657440186
and O 0 0.0014495068462565541
the O 0 0.0024343125987797976
presence O 0 0.007645204663276672
or O 0 0.004171414766460657
absence O 0 0.025349654257297516
of O 0 0.006484458688646555
cancer B-Disease 1 1.0
. O 0 0.0030150627717375755
. O 0 0.005574757698923349

Identification O 0 0.016138093546032906
of O 0 0.0019132712623104453
a O 0 0.007695002947002649
novel O 0 0.037821996957063675
mutation O 1 0.9984250068664551
of O 0 0.001997830579057336
the O 0 0.005388897843658924
CPO O 1 0.9994943141937256
gene O 1 0.7310057282447815
in O 0 0.0018200185149908066
a O 0 0.00667409086599946
Japanese O 0 0.022800451144576073
hereditary B-Disease 1 0.999998927116394
coproporphyria I-Disease 1 0.99997878074646
family O 0 0.02209460735321045
. O 0 0.006534715183079243

Hereditary B-Disease 1 0.9999990463256836
coproporphyria I-Disease 1 0.9999693632125854
( O 0 0.018761929124593735
HCP B-Disease 1 0.999916672706604
) O 0 0.004394928924739361
is O 0 0.0034106855746358633
an O 0 0.008167914114892483
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.999980092048645
disease I-Disease 1 1.0
characterized O 1 0.6796355843544006
by O 0 0.0037786641623824835
a O 0 0.02325887233018875
deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.006418179254978895
coproporphyrinogen I-Disease 1 0.9999849796295166
oxidase I-Disease 1 0.9995999932289124
( O 0 0.01304391399025917
CPO O 1 0.9961835741996765
) O 0 0.007722617592662573
caused O 1 0.9249600768089294
by O 0 0.004098128527402878
a O 0 0.011795615777373314
mutation O 1 0.9991758465766907
in O 0 0.002969594905152917
the O 0 0.006790485233068466
CPO O 1 0.998157799243927
gene O 1 0.9547041058540344
. O 0 0.010175995528697968

Only O 0 0.0074254837818443775
11 O 0 0.01746302656829357
mutations O 1 0.9935573935508728
of O 0 0.001935467473231256
the O 0 0.00451246090233326
gene O 1 0.9996578693389893
have O 0 0.002094796160236001
been O 0 0.004748790990561247
reported O 0 0.012407368049025536
in O 0 0.008132882416248322
HCP B-Disease 1 0.9999994039535522
patients O 1 0.9999758005142212
. O 0 0.009593730792403221

We O 0 0.0039646215736866
report O 0 0.005219944752752781
another O 0 0.02033924125134945
mutation O 1 0.9996883869171143
in O 0 0.0027317253407090902
a O 0 0.006992969661951065
Japanese O 0 0.012780876830220222
family O 0 0.019835492596030235
. O 0 0.007279291283339262

Polymerase O 1 0.8088298439979553
chain O 0 0.13464432954788208
reaction O 0 0.041864581406116486
- O 0 0.029800143092870712
single O 0 0.027243943884968758
strand O 0 0.15317972004413605
conformational O 1 0.8526651859283447
polymorphism O 0 0.1419338434934616
and O 0 0.0017678702715784311
direct O 0 0.0065964339300990105
sequence O 0 0.020030688494443893
analyses O 0 0.012401245534420013
demonstrated O 0 0.012943926267325878
a O 0 0.01134395133703947
C O 0 0.07981173694133759
to O 0 0.005293195601552725
T O 1 0.9818496108055115
substitution O 0 0.033133309334516525
in O 0 0.0043916548602283
exon O 1 0.9732912182807922
1 O 0 0.009957428090274334
of O 0 0.0016089037526398897
the O 0 0.006468731444329023
CPO O 1 0.9967731833457947
gene O 1 0.8469587564468384
at O 0 0.008206742815673351
nucleotide O 0 0.09023240953683853
position O 0 0.010163084603846073
85 O 0 0.028545713052153587
, O 0 0.001882977201603353
which O 0 0.0019882642664015293
lies O 0 0.008612571284174919
in O 0 0.0015252685407176614
the O 0 0.004619073122739792
putative O 1 0.9942323565483093
presequence O 1 0.9983246922492981
for O 0 0.0028815055266022682
targeting O 0 0.01875610649585724
to O 0 0.004420180339366198
mitochondria O 0 0.16412173211574554
. O 0 0.008205932565033436

This O 0 0.0119957709684968
mutation O 1 0.999489426612854
changes O 0 0.007989347912371159
the O 0 0.0036906730383634567
codon O 0 0.13089966773986816
for O 0 0.0028736917302012444
glutamine O 0 0.0842055156826973
to O 0 0.0027099738363176584
a O 0 0.012380269356071949
termination O 1 0.7281023263931274
codon O 0 0.18144510686397552
at O 0 0.009671649895608425
amino O 0 0.0652036964893341
acid O 0 0.10115904361009598
position O 0 0.012931521050632
29 O 0 0.025606822222471237
. O 0 0.006768900901079178

MaeI O 1 0.9962785840034485
restriction O 0 0.04628987982869148
analysis O 0 0.005591695662587881
showed O 0 0.00795053131878376
two O 0 0.0013195340288802981
other O 0 0.0014340790221467614
carriers O 0 0.18664005398750305
in O 0 0.0015902172308415174
the O 0 0.0033112738747149706
family O 0 0.020375708118081093
. O 0 0.006048121489584446

The O 0 0.014368235133588314
C O 1 0.9768450260162354
- O 1 0.7287412881851196
T O 1 0.999925971031189
mutation O 1 0.9998384714126587
is O 0 0.004344397224485874
located O 0 0.006709019187837839
within O 0 0.0029543638229370117
a O 0 0.005860030185431242
recently O 0 0.014086626470088959
proposed O 0 0.00993687380105257
putative O 0 0.11533048003911972
alternative O 0 0.015821153298020363
translation O 0 0.01990538276731968
initiation O 0 0.11573341488838196
codon O 1 0.7825278043746948
( O 0 0.01985139772295952
TIC O 1 0.9999856948852539
- O 0 0.0456763356924057
1 O 0 0.018149303272366524
) O 0 0.0035616559907794
, O 0 0.0019227252341806889
supporting O 0 0.009685023687779903
that O 0 0.004908320959657431
TIC O 1 0.9999957084655762
- O 0 0.03268906846642494
1 O 0 0.01018653903156519
is O 0 0.0024035307578742504
the O 0 0.0028722232673317194
real O 0 0.018362494185566902
TIC O 1 0.9999678134918213
rather O 0 0.007328398991376162
than O 0 0.010402442887425423
TIC O 1 0.9999849796295166
- O 0 0.04160674661397934
2 O 0 0.013586200773715973
. O 0 0.0035038148052990437
. O 0 0.0058405897580087185

Human B-Disease 0 0.021364450454711914
complement I-Disease 0 0.035964030772447586
factor I-Disease 1 0.8494848608970642
H I-Disease 1 0.9999983310699463
deficiency I-Disease 1 1.0
associated O 0 0.02293732576072216
with O 0 0.05254979804158211
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.013142385520040989

This O 0 0.004300790373235941
study O 0 0.004742376506328583
reports O 0 0.003967802505940199
on O 0 0.0015016768593341112
six O 0 0.0037160355132073164
cases O 0 0.009215638972818851
of O 0 0.005279364995658398
deficiency B-Disease 1 1.0
in I-Disease 0 0.0021783029660582542
the I-Disease 0 0.0024112320970743895
human I-Disease 0 0.009949064813554287
complement I-Disease 0 0.027487805113196373
regulatory I-Disease 0 0.06244067847728729
protein I-Disease 0 0.0881839469075203
Factor I-Disease 1 0.8509030938148499
H I-Disease 1 0.9999526739120483
( O 0 0.023328302428126335
FH O 1 0.9999983310699463
) O 0 0.0038385195657610893
in O 0 0.0009188253898173571
the O 0 0.0014946551527827978
context O 0 0.003218706464394927
of O 0 0.0014269371749833226
an O 0 0.3429495394229889
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.010026250965893269

Five O 0 0.004626836162060499
of O 0 0.0015312719624489546
the O 0 0.0031212468165904284
cases O 0 0.008791678585112095
were O 0 0.0015062225284054875
observed O 0 0.00738161476328969
in O 0 0.001329233986325562
children O 0 0.006643223576247692
presenting O 0 0.013967355713248253
with O 0 0.013410734944045544
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.975512683391571
HUS B-Disease 1 1.0
) O 0 0.008669811300933361
. O 0 0.005965726915746927

Two O 0 0.002295183716341853
of O 0 0.001219739904627204
the O 0 0.0028148149140179157
children O 0 0.011039669625461102
exhibited O 0 0.10100088268518448
a O 0 0.03112911619246006
homozygous O 1 0.9999997615814209
deficiency O 1 1.0
characterized O 1 0.5458714962005615
by O 0 0.002646156819537282
the O 0 0.0021974926348775625
absence O 0 0.011188867501914501
of O 0 0.0012235838221386075
the O 0 0.002790982136502862
150 O 0 0.016169166192412376
- O 0 0.04386836290359497
kD O 1 0.632004976272583
form O 0 0.007468352559953928
of O 0 0.002371022943407297
Factor O 1 0.9972167015075684
H O 1 0.9999661445617676
and O 0 0.0016791676171123981
the O 0 0.002654798561707139
presence O 0 0.007342582568526268
, O 0 0.0019147559069097042
upon O 0 0.007339430972933769
immunoblotting O 1 0.9998434782028198
, O 0 0.001381919370032847
of O 0 0.0009514140547253191
the O 0 0.0035045258700847626
42 O 0 0.032059501856565475
- O 0 0.046988070011138916
kD O 1 0.9973207116127014
Factor O 1 0.5511453747749329
H O 1 0.9983238577842712
- O 0 0.03426392376422882
like O 0 0.011681145057082176
protein O 0 0.0694718286395073
1 O 0 0.017861690372228622
( O 0 0.01292100828140974
FHL O 1 0.9997764229774475
- O 0 0.046728819608688354
1 O 0 0.015826528891921043
) O 0 0.0029067418072372675
and O 0 0.0012410666095092893
other O 0 0.003184276632964611
FH O 1 0.9999963045120239
- O 0 0.054386068135499954
related O 0 0.02058829925954342
protein O 0 0.08754081279039383
( O 0 0.012777297757565975
FHR O 1 0.9998694658279419
) O 0 0.007710728794336319
bands O 0 0.025553585961461067
. O 0 0.00783876609057188

Southern O 0 0.041719093918800354
blot O 1 0.9969480633735657
and O 0 0.003494156524538994
PCR O 0 0.10716025531291962
analysis O 0 0.003935823682695627
of O 0 0.0014308650279417634
DNA O 0 0.019918734207749367
of O 0 0.0015002103755250573
one O 0 0.004932749085128307
patient O 1 0.9999704360961914
with O 0 0.006752737332135439
homozygous O 1 0.9999998807907104
deficiency O 1 1.0
ruled O 0 0.07459293305873871
out O 0 0.002514030784368515
the O 0 0.0020106961019337177
presence O 0 0.004947152454406023
of O 0 0.0011041326215490699
a O 0 0.004892759956419468
large O 0 0.006305658724159002
deletion O 1 0.8533121347427368
of O 0 0.0020934399217367172
the O 0 0.009547767229378223
FH O 1 0.999998927116394
gene O 1 0.9868086576461792
as O 0 0.002079808386042714
the O 0 0.0026050403248518705
underlying O 0 0.4792150855064392
defect O 1 0.9997434020042419
for O 0 0.002529166406020522
the O 0 0.010315204970538616
deficiency O 1 1.0
. O 0 0.009103544056415558

The O 0 0.004090575035661459
other O 0 0.0010668726172298193
four O 0 0.0023573089856654406
children O 0 0.007181279361248016
presented O 0 0.006006111856549978
with O 0 0.006371779832988977
heterozygous O 1 0.9999969005584717
deficiency O 1 1.0
and O 0 0.00264225946739316
exhibited O 0 0.017081907019019127
a O 0 0.007137853652238846
normal O 0 0.03113619238138199
immunoblotting O 1 0.9991088509559631
pattern O 0 0.02521338500082493
of O 0 0.0018954273546114564
proteins O 0 0.012863286770880222
of O 0 0.0015013738302513957
the O 0 0.008768302388489246
FH O 1 0.9999991655349731
family O 0 0.03740924596786499
. O 0 0.00995719339698553

Factor B-Disease 1 0.9947183728218079
H I-Disease 1 0.9999983310699463
deficiency I-Disease 1 0.9999998807907104
is O 0 0.0035994600038975477
the O 0 0.0025080731138587
only O 0 0.0043677473440766335
complement B-Disease 1 0.9963449835777283
deficiency I-Disease 1 1.0
associated O 0 0.013958682306110859
with O 0 0.006238491740077734
HUS B-Disease 1 1.0
. O 0 0.009437872096896172

These O 0 0.003124444279819727
observations O 0 0.007089986931532621
suggest O 0 0.006848617922514677
a O 0 0.005559038370847702
role O 0 0.00938099529594183
for O 0 0.004419378936290741
FH O 1 0.9999995231628418
and O 0 0.004959646612405777
/ O 1 0.923596203327179
or O 0 0.011456039734184742
FH O 1 0.9999988079071045
receptors O 0 0.27847328782081604
in O 0 0.0024727596901357174
the O 0 0.0055825719609856606
pathogenesis O 1 0.9999978542327881
of O 0 0.011435462161898613
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 0 0.005409262143075466
. O 0 0.006278705783188343

Further O 0 0.005877718795090914
evidence O 0 0.0021493318490684032
for O 0 0.0010175897041335702
a O 0 0.004664292559027672
major O 0 0.008625082671642303
ancient O 0 0.009524114429950714
mutation O 1 0.9999970197677612
underlying O 1 0.9998863935470581
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 0.011571133509278297
linkage O 1 0.8397772312164307
disequilibrium O 1 0.9901081323623657
studies O 0 0.005856719799339771
in O 0 0.0017492554616183043
the O 0 0.0029893037863075733
Japanese O 0 0.01144814770668745
population O 0 0.014160512015223503
. O 0 0.008253611624240875

The O 0 0.05224044248461723
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.31524786353111267
DM B-Disease 1 1.0
) O 0 0.016100743785500526
mutation O 1 0.9999481439590454
is O 0 0.004042197018861771
an O 0 0.004935656674206257
unstable O 1 0.9993987083435059
( O 0 0.014764112420380116
CTG O 1 0.9999260902404785
) O 0 0.008876086212694645
n O 0 0.03778510540723801
repeat O 0 0.045981477946043015
, O 0 0.0019787061028182507
present O 0 0.0027794046327471733
at O 0 0.002757829613983631
a O 0 0.0051446170546114445
copy O 0 0.012293030507862568
number O 0 0.0019252148922532797
of O 0 0.001906742574647069
5 O 0 0.015471533872187138
- O 0 0.026240602135658264
37 O 0 0.028966234996914864
repeats O 0 0.04585006460547447
on O 0 0.0038867483381181955
normal O 0 0.03262739256024361
chromosomes O 0 0.06716928631067276
but O 0 0.003909321967512369
amplified O 0 0.04158537834882736
to O 0 0.003000580472871661
50 O 0 0.014519277028739452
- O 0 0.03457555174827576
3000 O 0 0.09866584092378616
copies O 0 0.013631090521812439
on O 0 0.011432374827563763
DM B-Disease 1 0.9999996423721313
chromosomes O 0 0.1754993200302124
. O 0 0.011330760084092617

Previous O 0 0.014208479784429073
findings O 0 0.01216166652739048
in O 0 0.00410766014829278
Caucasian O 1 0.9498416185379028
populations O 0 0.02413143776357174
of O 0 0.0023261397145688534
a O 0 0.0659203827381134
DM B-Disease 1 1.0
founder O 1 0.9961293935775757
chromosome O 1 0.9998388290405273
raise O 0 0.0145485894754529
a O 0 0.005419838707894087
question O 0 0.0049554831348359585
about O 0 0.002077620243653655
the O 0 0.003829751629382372
molecular O 0 0.02176637016236782
events O 0 0.004600811284035444
involved O 0 0.004565751645714045
in O 0 0.0014518281677737832
the O 0 0.003722546622157097
expansion O 0 0.032654598355293274
mutation O 1 0.9999825954437256
. O 0 0.007684025447815657

To O 0 0.0032172277569770813
investigate O 0 0.010120599530637264
whether O 0 0.003124367445707321
a O 0 0.007900374941527843
founder O 0 0.16312384605407715
chromosome O 1 0.9971697926521301
for O 0 0.0029476771596819162
the O 0 0.012077013961970806
DM B-Disease 1 1.0
mutation O 1 0.9999946355819702
exists O 0 0.009415711276233196
in O 0 0.0013731621438637376
the O 0 0.0028052269481122494
Japanese O 0 0.01017112284898758
population O 0 0.0073823630809783936
, O 0 0.0016309227794408798
we O 0 0.002896105870604515
genotyped O 1 0.9983281493186951
families O 0 0.008359675295650959
using O 0 0.008955425582826138
polymorphic O 1 0.9988012313842773
markers O 0 0.04931645840406418
near O 0 0.01551855355501175
the O 0 0.004725553561002016
( O 0 0.010622691363096237
CTG O 1 0.9999020099639893
) O 0 0.00808790698647499
n O 0 0.03085465542972088
repeat O 0 0.04736647382378578
region O 0 0.009151868522167206
and O 0 0.00204677926376462
constructed O 0 0.018497129902243614
haplotypes O 1 0.9944120049476624
. O 0 0.008324708789587021

Six O 0 0.008576779626309872
different O 0 0.0026351932901889086
haplotypes O 1 0.6367841958999634
were O 0 0.0026378012262284756
found O 0 0.006241998169571161
and O 0 0.005676111206412315
DM B-Disease 1 1.0
alleles O 1 0.9999493360519409
were O 0 0.0039861854165792465
always O 0 0.010148204863071442
haplotype O 1 0.9975715279579163
A O 0 0.02108798362314701
. O 0 0.006554244086146355

To O 0 0.004236702341586351
find O 0 0.006262256298214197
an O 0 0.002142487559467554
origin O 0 0.0040621147491037846
of O 0 0.001361984759569168
the O 0 0.004249257501214743
( O 0 0.010344307869672775
CTG O 1 0.9999624490737915
) O 0 0.007502716034650803
n O 0 0.04233303666114807
repeat O 0 0.19228382408618927
mutation O 1 0.9995805621147156
and O 0 0.0013564288383349776
to O 0 0.0012830084888264537
investigate O 0 0.008268789388239384
the O 0 0.0023572819773107767
mechanism O 0 0.010556230321526527
of O 0 0.001221750397235155
the O 0 0.0030769784934818745
expansion O 0 0.029447944834828377
mutation O 1 0.999563992023468
in O 0 0.00223003257997334
the O 0 0.0028841798193752766
Japanese O 0 0.009412594139575958
population O 0 0.0063560036942362785
we O 0 0.0015236802864819765
have O 0 0.0019182692049071193
studied O 0 0.0056785354390740395
90 O 0 0.01572996936738491
Japanese O 0 0.03683575242757797
DM B-Disease 1 0.9999998807907104
families O 0 0.015627048909664154
comprising O 0 0.013881104066967964
190 O 0 0.05529976263642311
affected O 0 0.13480901718139648
and O 0 0.0030264302622526884
130 O 0 0.041960299015045166
unaffected O 1 0.9895581603050232
members O 0 0.006528276484459639
. O 0 0.007156199775636196

The O 0 0.006253236439079046
results O 0 0.010005905292928219
suggest O 0 0.006436442956328392
that O 0 0.0012650741264224052
a O 0 0.004159933887422085
few O 0 0.003228242276236415
common O 0 0.010989315807819366
ancestral O 0 0.44122281670570374
mutations O 1 0.9998874664306641
in O 0 0.0019878840539604425
both O 0 0.0030580884777009487
Caucasian O 1 0.9986926913261414
and O 0 0.0019294150406494737
Japanese O 0 0.011378640308976173
populations O 0 0.02818959206342697
have O 0 0.0024987927172333
originated O 0 0.012898426502943039
by O 0 0.0023839015047997236
expansion O 0 0.006533960346132517
of O 0 0.00133649876806885
an O 0 0.003508014138787985
ancestral O 0 0.06438048928976059
n O 0 0.06102142482995987
= O 0 0.049394842237234116
5 O 0 0.014826862141489983
repeat O 0 0.04357874020934105
to O 0 0.003438422456383705
n O 0 0.041835132986307144
= O 0 0.04303863272070885
19 O 0 0.02503342553973198
- O 0 0.031928613781929016
37 O 0 0.029592523351311684
copies O 0 0.01292404904961586
. O 0 0.0076051815412938595

These O 0 0.002544272458180785
data O 0 0.0029520865064114332
support O 0 0.007611014414578676
multistep O 0 0.11010529845952988
models O 0 0.009302929975092411
of O 0 0.0037152962759137154
triplet O 1 0.9998490810394287
repeat O 0 0.08175116032361984
expansion O 0 0.011918717063963413
that O 0 0.0011804911773651838
have O 0 0.0014710976975038648
been O 0 0.002544282004237175
proposed O 0 0.003336655907332897
for O 0 0.0013355381088331342
both O 0 0.006039756815880537
DM B-Disease 1 1.0
and O 0 0.009214654564857483
Friedreichs B-Disease 1 0.9999996423721313
ataxia I-Disease 1 0.9999998807907104
. O 0 0.005096337758004665
. O 0 0.00620319414883852

The O 0 0.007634872104972601
molecular O 0 0.019829880446195602
basis O 0 0.0038553013000637293
of O 0 0.007601720746606588
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.0022550635039806366
the O 0 0.002627973211929202
western O 0 0.008562891744077206
Cape O 1 0.9901575446128845
, O 0 0.002033133991062641
South O 0 0.0069490415044128895
Africa O 0 0.018134919926524162
. O 0 0.006858699023723602

Deficiency B-Disease 1 0.9999980926513672
of I-Disease 0 0.0026048694271594286
the I-Disease 0 0.003025918500497937
sixth I-Disease 0 0.033511921763420105
component I-Disease 0 0.018278727307915688
of I-Disease 0 0.001846065977588296
human I-Disease 0 0.011435339227318764
complement I-Disease 0 0.032861631363630295
( O 0 0.013484534807503223
C6 O 1 0.9999984502792358
) O 0 0.004606719594448805
has O 0 0.003304518526419997
been O 0 0.004740338306874037
reported O 0 0.009891034103929996
in O 0 0.0014202881138771772
a O 0 0.004077163990586996
number O 0 0.0017290710238739848
of O 0 0.001390824792906642
families O 0 0.005447060335427523
from O 0 0.002759187016636133
the O 0 0.003574010217562318
western O 0 0.010225463658571243
Cape O 1 0.9698957800865173
, O 0 0.0025123811792582273
South O 0 0.008152260445058346
Africa O 0 0.018221963196992874
. O 0 0.0067170304246246815

Meningococcal B-Disease 1 1.0
disease I-Disease 1 1.0
is O 0 0.012309159152209759
endemic O 1 0.9997116923332214
in O 0 0.001891353284008801
the O 0 0.003216942772269249
Cape O 1 0.907569944858551
and O 0 0.0011030476307496428
almost O 0 0.003779980354011059
all O 0 0.0014251562533900142
pedigrees O 0 0.06492629647254944
of O 0 0.002956904238089919
total O 0 0.025640202686190605
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 0.02079947665333748
C6Q0 O 1 0.9999979734420776
) O 0 0.004328093491494656
have O 0 0.0016280233394354582
been O 0 0.0047814673744142056
ascertained O 1 0.9660142660140991
because O 0 0.006050563417375088
of O 0 0.0057684448547661304
recurrent O 1 1.0
disease O 1 1.0
. O 0 0.012520479038357735

We O 0 0.0034677875228226185
have O 0 0.0032122598495334387
sequenced O 0 0.07477143406867981
the O 0 0.002882956760004163
expressed O 0 0.00822431594133377
exons O 0 0.09545987099409103
of O 0 0.00250679231248796
the O 0 0.009230375289916992
C6 O 1 0.999998927116394
gene O 1 0.9724464416503906
from O 0 0.0040976619347929955
selected O 0 0.00610341364517808
cases O 0 0.006597342435270548
and O 0 0.0009473406244069338
have O 0 0.0013023564824834466
found O 0 0.003993303515017033
three O 0 0.0025881046894937754
molecular O 0 0.04166875779628754
defects O 1 0.9998276233673096
leading O 0 0.008798698894679546
to O 0 0.0025034702848643064
total O 0 0.019576871767640114
deficiency O 1 1.0
879delG O 1 0.9999880790710449
, O 0 0.0022490527480840683
which O 0 0.001569900894537568
is O 0 0.0021020544227212667
the O 0 0.0026520020328462124
common O 0 0.014135465957224369
defect O 1 0.9997740387916565
in O 0 0.0017769496189430356
the O 0 0.0034725661389529705
Cape O 1 0.986322283744812
and O 0 0.002031614538282156
hitherto O 1 0.8133076429367065
unreported O 0 0.04098009318113327
, O 0 0.001759216538630426
and O 0 0.0021674020681530237
1195delC O 1 0.9999924898147583
and O 0 0.0034720480907708406
1936delG O 1 0.999994158744812
, O 0 0.002105153165757656
which O 0 0.0016292296350002289
have O 0 0.0017524291761219501
been O 0 0.0043478053994476795
previously O 0 0.006357085425406694
reported O 0 0.01121785119175911
in O 0 0.002482641488313675
African O 0 0.022256633266806602
- O 0 0.035364773124456406
Americans O 0 0.017520437017083168
. O 0 0.007967024110257626

We O 0 0.0038580361288040876
also O 0 0.0020467834547162056
show O 0 0.004670578986406326
that O 0 0.0012139559257775545
the O 0 0.0047453707084059715
879delG O 1 0.9999310970306396
and O 0 0.005124667659401894
1195delC O 1 0.9999990463256836
defects O 1 0.9999724626541138
are O 0 0.0014420917723327875
associated O 0 0.005429527722299099
with O 0 0.002631133422255516
characteristic O 1 0.8758328557014465
C6 O 1 0.9999994039535522
/ O 1 0.9928516745567322
C7 O 1 0.9999876022338867
region O 0 0.029821449890732765
DNA O 0 0.08064895868301392
marker O 1 0.9549666047096252
haplotypes O 1 0.9870495200157166
, O 0 0.0028020113240927458
although O 0 0.0040877764113247395
small O 0 0.004574780818074942
variations O 0 0.01032822486013174
were O 0 0.0021294085308909416
observed O 0 0.014800815843045712
. O 0 0.005195284262299538

The O 0 0.017886091023683548
1936delG O 1 0.9999058246612549
defect O 1 0.9998618364334106
was O 0 0.010885910131037235
observed O 0 0.011918582022190094
only O 0 0.0016515731113031507
once O 0 0.005270613357424736
in O 0 0.0015341662801802158
the O 0 0.003955640364438295
Cape O 1 0.9935178756713867
, O 0 0.001556991133838892
but O 0 0.001448355265893042
its O 0 0.0031013013795018196
associated O 0 0.013739638961851597
haplotype O 1 0.9997575879096985
could O 0 0.004225945565849543
be O 0 0.0027476924005895853
deduced O 0 0.04722430557012558
. O 0 0.0075864046812057495

The O 0 0.0037458245642483234
data O 0 0.002182625001296401
from O 0 0.001917586661875248
the O 0 0.0050564901903271675
haplotypes O 1 0.9987875819206238
indicate O 0 0.009234525263309479
that O 0 0.0007661409326829016
these O 0 0.0007090213475748897
three O 0 0.0027591371908783913
molecular O 0 0.041265685111284256
defects O 1 0.9989867806434631
account O 0 0.003976811654865742
for O 0 0.0017093727365136147
the O 0 0.004701754078269005
defects O 1 0.9997616410255432
in O 0 0.0013280848506838083
all O 0 0.0008966752211563289
the O 0 0.003586915321648121
38 O 0 0.1366526335477829
unrelated O 1 0.8746498823165894
C6Q0 O 1 0.9999890327453613
individuals O 0 0.006757908035069704
we O 0 0.001708208117634058
have O 0 0.0016274427762255073
studied O 0 0.00468563474714756
from O 0 0.0024400115944445133
the O 0 0.0053782532922923565
Cape O 1 0.9254431128501892
. O 0 0.008080464787781239

We O 0 0.003973041661083698
have O 0 0.0018008778570219874
also O 0 0.0017302302876487374
observed O 0 0.009324739687144756
the O 0 0.004705649800598621
879delG O 1 0.9997186064720154
defect O 1 0.991746187210083
in O 0 0.0019790027290582657
two O 0 0.002943730214610696
Dutch O 1 0.9680817127227783
C6 B-Disease 1 1.0
- I-Disease 1 0.9145305156707764
deficient I-Disease 1 0.9999861717224121
kindreds O 1 0.9974249601364136
, O 0 0.0022876900620758533
but O 0 0.002197220455855131
the O 0 0.005436922423541546
879delG O 1 0.9999792575836182
defect O 1 0.9991863369941711
in O 0 0.0027298915665596724
the O 0 0.005394387524574995
Cape O 1 0.9838030338287354
probably O 0 0.01541640143841505
did O 0 0.0036730917636305094
not O 0 0.0011736181331798434
come O 0 0.0024557749275118113
from O 0 0.00217648409307003
The O 0 0.0035282161552459
Netherlands O 0 0.015381927601993084
. O 0 0.003158065490424633
. O 0 0.006660460494458675

Complement B-Disease 1 0.9902869462966919
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.005864821374416351
seven O 0 0.0038173976354300976
further O 0 0.006576992105692625
molecular O 0 0.05459865927696228
defects O 1 0.9999228715896606
and O 0 0.0012321033282205462
their O 0 0.001875786460004747
associated O 0 0.014350959099829197
marker O 1 0.9920874238014221
haplotypes O 1 0.9943821430206299
. O 0 0.008984724059700966

Seven O 0 0.008445666171610355
further O 0 0.006383134983479977
molecular O 0 0.02356121316552162
bases O 0 0.00889400765299797
of O 0 0.0077033997513353825
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.003107154043391347
described O 0 0.015587963163852692
. O 0 0.00604417035356164

All O 0 0.0024009759072214365
these O 0 0.001067871111445129
new O 0 0.004993590991944075
molecular O 0 0.05061045289039612
defects O 1 0.999491810798645
involve O 0 0.01447160355746746
single O 0 0.02161780372262001
- O 0 0.036146774888038635
nucleotide O 0 0.08577726781368256
events O 0 0.007166065275669098
, O 0 0.0030368848238140345
deletions O 0 0.4516357481479645
and O 0 0.0018400836270302534
substitutions O 0 0.019308442249894142
, O 0 0.00114941387437284
some O 0 0.0010291242506355047
of O 0 0.0012610350968316197
which O 0 0.0035188361071050167
alter O 0 0.07347621023654938
splice O 1 0.970386266708374
sites O 0 0.006082685198634863
, O 0 0.0016335983527824283
and O 0 0.0015637760516256094
others O 0 0.007778460625559092
codons O 0 0.20895355939865112
. O 0 0.007894732058048248

They O 0 0.003277354873716831
are O 0 0.0009353384957648814
distributed O 0 0.007373638916760683
along O 0 0.004913864657282829
the O 0 0.010322997346520424
C7 O 1 0.9999998807907104
gene O 1 0.9987590312957764
, O 0 0.0023104622960090637
but O 0 0.002269401913508773
predominantly O 0 0.00948426965624094
towards O 0 0.004948213696479797
the O 0 0.003674296196550131
3 O 0 0.013587255030870438
end O 0 0.012760424986481667
. O 0 0.00578339584171772

All O 0 0.002378709614276886
were O 0 0.0017758876783773303
found O 0 0.0046151503920555115
in O 0 0.0026058806106448174
compound O 0 0.04621506854891777
heterozygous O 1 0.9960408210754395
individuals O 0 0.011389326304197311
. O 0 0.007175420876592398

The O 0 0.022204628214240074
C6 O 1 0.9999923706054688
/ O 1 0.992098331451416
C7 O 1 0.9999892711639404
marker O 1 0.8525300025939941
haplotypes O 1 0.9886885285377502
associated O 0 0.010722762905061245
with O 0 0.0020584193989634514
most O 0 0.010820750147104263
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999872446060181
are O 0 0.0022545745596289635
tabulated O 0 0.016918180510401726
. O 0 0.0029738445300608873
. O 0 0.005536986980587244

A O 0 0.029524192214012146
genome O 0 0.1898568719625473
- O 0 0.026263952255249023
wide O 0 0.01083866972476244
search O 0 0.011053953319787979
for O 0 0.004497457295656204
chromosomal O 1 0.9999879598617554
loci O 1 0.9996621608734131
linked O 0 0.054267384111881256
to O 0 0.005617305636405945
mental O 1 0.999993085861206
health O 1 0.9941843152046204
wellness O 1 0.999264657497406
in O 0 0.0022593485191464424
relatives O 0 0.015766406431794167
at O 0 0.003823426552116871
high O 0 0.009029234759509563
risk O 1 0.9984596967697144
for O 0 0.00962220411747694
bipolar B-Disease 1 1.0
affective I-Disease 1 0.9999998807907104
disorder I-Disease 1 1.0
among O 0 0.0044860499911010265
the O 0 0.0031071393750607967
Old O 0 0.02376965619623661
Order O 0 0.007163595873862505
Amish O 0 0.08382052183151245
. O 0 0.0072425417602062225

Bipolar B-Disease 1 1.0
affective I-Disease 1 0.9999996423721313
disorder I-Disease 1 1.0
( O 0 0.1747448742389679
BPAD B-Disease 1 1.0
; O 0 0.050612762570381165
manic B-Disease 1 1.0
- I-Disease 1 0.9999880790710449
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 0.005590047221630812
is O 0 0.004392138682305813
characterized O 0 0.04211551323533058
by O 0 0.002990992274135351
episodes O 0 0.02468325011432171
of O 0 0.003823070554062724
mania B-Disease 1 0.9999997615814209
and O 0 0.00436545442789793
/ O 1 0.9971134662628174
or O 0 0.011767702177166939
hypomania B-Disease 1 0.9999997615814209
interspersed O 0 0.034309934824705124
with O 0 0.002046847715973854
periods O 0 0.013312063179910183
of O 0 0.004976325668394566
depression B-Disease 1 1.0
. O 0 0.009375156834721565

Compelling O 0 0.02057611756026745
evidence O 0 0.004592257086187601
supports O 0 0.01003306545317173
a O 0 0.006310296710580587
significant O 0 0.010740531608462334
genetic O 0 0.04699372872710228
component O 0 0.017067860811948776
in O 0 0.001651646918617189
the O 0 0.004834876395761967
susceptibility O 1 0.9999783039093018
to O 0 0.0033461616840213537
develop O 0 0.03189102187752724
BPAD B-Disease 1 0.9999986886978149
. O 0 0.010102415457367897

To O 0 0.004584794864058495
date O 0 0.0069511933252215385
, O 0 0.0019587241113185883
however O 0 0.003451244905591011
, O 0 0.002326834946870804
linkage O 0 0.048782359808683395
studies O 0 0.0047221011482179165
have O 0 0.001612583757378161
attempted O 0 0.00945790484547615
only O 0 0.0018525337800383568
to O 0 0.0022746084723621607
identify O 0 0.028910178691148758
chromosomal O 1 0.9999388456344604
loci O 1 0.9994468092918396
that O 0 0.003475620411336422
cause O 1 0.9580647349357605
or O 0 0.0030022580176591873
increase O 0 0.0050582438707351685
the O 0 0.0035101049579679966
risk O 1 0.8004207611083984
of O 0 0.0029410868883132935
developing O 0 0.03452768921852112
BPAD B-Disease 1 0.9999997615814209
. O 0 0.010166129097342491

To O 0 0.0031021982431411743
determine O 0 0.0053184195421636105
whether O 0 0.002592407865449786
there O 0 0.0014843052485957742
could O 0 0.0031737717799842358
be O 0 0.0037754543591290712
protective O 1 0.9996902942657471
alleles O 1 0.9998921155929565
that O 0 0.0027463289443403482
prevent O 0 0.03620915487408638
or O 0 0.0040688179433345795
reduce O 0 0.014222031459212303
the O 0 0.0035385163500905037
risk O 1 0.676909327507019
of O 0 0.002491376595571637
developing O 0 0.03337306156754494
BPAD B-Disease 1 0.9999998807907104
, O 0 0.0022145293187350035
similar O 0 0.0030324156396090984
to O 0 0.001133601414039731
what O 0 0.0018919989233836532
is O 0 0.002553961705416441
observed O 0 0.006911059841513634
in O 0 0.0011563468724489212
other O 0 0.0026986736338585615
genetic B-Disease 1 0.9999992847442627
disorders I-Disease 1 1.0
, O 0 0.001436288352124393
we O 0 0.0013801107415929437
used O 0 0.00458240881562233
mental O 1 0.9999843835830688
health O 1 0.9993255138397217
wellness O 1 0.9999090433120728
( O 0 0.00535270432010293
absence O 0 0.01245938241481781
of O 0 0.0017235251143574715
any O 0 0.0070398724637925625
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 0 0.004278141539543867
as O 0 0.002011386211961508
the O 0 0.004884270019829273
phenotype O 1 0.9999897480010986
in O 0 0.002394523471593857
our O 0 0.005118908826261759
genome O 0 0.38825905323028564
- O 0 0.02990555390715599
wide O 0 0.02026689425110817
linkage O 0 0.0904916301369667
scan O 0 0.15392166376113892
of O 0 0.0017113740323111415
several O 0 0.00251278979703784
large O 0 0.010242896154522896
multigeneration O 1 0.9959396123886108
Old O 0 0.023893928155303
Order O 0 0.010546856559813023
Amish O 0 0.08673524111509323
pedigrees O 0 0.1924700140953064
exhibiting O 0 0.04284851253032684
an O 0 0.004952958319336176
extremely O 0 0.025316860526800156
high O 0 0.01827177032828331
incidence O 1 0.9997909665107727
of O 0 0.007545054890215397
BPAD B-Disease 1 0.9999994039535522
. O 0 0.011783921159803867

We O 0 0.004474612418562174
have O 0 0.0018318048678338528
found O 0 0.00445556128397584
strong O 0 0.0034539075568318367
evidence O 0 0.0014684575144201517
for O 0 0.0014362683286890388
a O 0 0.008332910016179085
locus O 1 0.9992122650146484
on O 0 0.009809553623199463
chromosome O 1 0.999943733215332
4p O 1 0.999873161315918
at O 0 0.012278946116566658
D4S2949 O 1 0.9914650321006775
( O 0 0.007086006458848715
maximum O 0 0.022854000329971313
GENEHUNTER O 1 0.9993758797645569
- O 0 0.035440824925899506
PLUS O 0 0.033027224242687225
nonparametric O 0 0.14700321853160858
linkage O 0 0.0702730044722557
score O 0 0.015970073640346527
= O 0 0.04544922336935997
4 O 0 0.014393255114555359
. O 0 0.0034364392049610615
05 O 1 0.9962261915206909
, O 0 0.007046281360089779
P O 1 0.9853529334068298
= O 0 0.04619009420275688
5 O 0 0.010897140018641949
. O 0 0.003448387375101447
22 O 0 0.01840467005968094
x O 0 0.05830029770731926
10 O 0 0.010478949174284935
( O 0 0.008257977664470673
- O 0 0.030642444267868996
4 O 0 0.02010875940322876
) O 0 0.006061718333512545
; O 0 0.006587000098079443
SIBPAL O 1 0.9997050166130066
Pempirical O 1 0.9777559041976929
value O 0 0.016696082428097725
< O 1 0.7281147837638855
3 O 0 0.020842771977186203
x O 0 0.06180829182267189
10 O 0 0.010836221277713776
( O 0 0.009109689854085445
- O 0 0.030804550275206566
5 O 0 0.017748631536960602
) O 0 0.005017254501581192
) O 0 0.0032528466545045376
and O 0 0.001566620427183807
suggestive O 0 0.03476739674806595
evidence O 0 0.00203244318254292
for O 0 0.0013912778813391924
a O 0 0.010601283051073551
locus O 1 0.9997567534446716
on O 0 0.010070630349218845
chromosome O 1 0.9997518658638
4q O 1 0.9991986155509949
at O 0 0.013775799423456192
D4S397 O 1 0.9981544613838196
( O 0 0.0076827239245176315
maximum O 0 0.022105436772108078
GENEHUNTER O 1 0.9996696710586548
- O 0 0.04074191674590111
PLUS O 0 0.03746877610683441
nonparametric O 0 0.15628506243228912
linkage O 0 0.08239969611167908
score O 0 0.01944003440439701
= O 0 0.04849110543727875
3 O 0 0.01237223669886589
. O 0 0.0029298767913132906
29 O 0 0.017686059698462486
, O 0 0.004344641696661711
P O 1 0.969053328037262
= O 0 0.05170360580086708
2 O 0 0.011211378499865532
. O 0 0.0035712439566850662
57 O 0 0.0413680374622345
x O 0 0.06489580869674683
10 O 0 0.011598372831940651
( O 0 0.009970156475901604
- O 0 0.03330296650528908
3 O 0 0.020728645846247673
) O 0 0.006798275746405125
; O 0 0.006706597749143839
SIBPAL O 1 0.9994124174118042
Pempirical O 1 0.9803611040115356
value O 0 0.019099893048405647
< O 1 0.76555997133255
1 O 0 0.02380989119410515
x O 0 0.06356510519981384
10 O 0 0.010618642903864384
( O 0 0.008534939028322697
- O 0 0.03130052238702774
3 O 0 0.01815146952867508
) O 0 0.004631964489817619
) O 0 0.002369894180446863
that O 0 0.0008089237962849438
are O 0 0.0009311974863521755
linked O 0 0.04226624593138695
to O 0 0.004447184968739748
mental O 1 0.9999727010726929
health O 1 0.9990139007568359
wellness O 1 0.9996312856674194
. O 0 0.0067100380547344685

These O 0 0.0028655927162617445
findings O 0 0.007890557870268822
are O 0 0.000968022970482707
consistent O 0 0.0062787593342363834
with O 0 0.0010869746329262853
the O 0 0.002969964873045683
hypothesis O 0 0.028017492964863777
that O 0 0.0015357995871454477
certain O 0 0.005990572273731232
alleles O 1 0.9998823404312134
could O 0 0.005796895828098059
prevent O 0 0.026879452168941498
or O 0 0.0035943351686000824
modify O 0 0.025559887290000916
the O 0 0.004335182718932629
clinical O 1 0.9969761371612549
manifestations O 1 0.8357516527175903
of O 0 0.004182478412985802
BPAD B-Disease 1 1.0
and O 0 0.002042601350694895
perhaps O 0 0.007589118555188179
other O 0 0.0016631094040349126
related O 0 0.02749878168106079
affective B-Disease 1 0.9999994039535522
disorders I-Disease 1 1.0
. O 0 0.010728055611252785

Segregation O 0 0.1613048017024994
distortion O 0 0.19770385324954987
in O 0 0.020481253042817116
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.016717569902539253

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.27385413646698
DM B-Disease 1 1.0
) O 0 0.0065468368120491505
is O 0 0.0039462498389184475
an O 0 0.009519706480205059
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999974966049194
disease I-Disease 1 1.0
which O 0 0.002689897082746029
, O 0 0.0010548331774771214
in O 0 0.001186720677651465
the O 0 0.0033790390007197857
typical O 0 0.03917136788368225
pedigree O 1 0.9952371120452881
, O 0 0.0016472653951495886
shows O 0 0.0036526289768517017
a O 0 0.004072701558470726
three O 0 0.002958813915029168
generation O 0 0.04325776547193527
anticipation O 0 0.07110875099897385
cascade O 0 0.29317358136177063
. O 0 0.010899072512984276

This O 0 0.004995563067495823
results O 0 0.007902086712419987
in O 0 0.005740775261074305
infertility B-Disease 1 1.0
and O 0 0.35266539454460144
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.033330097794532776
CDM B-Disease 1 0.9999830722808838
) O 0 0.0037977518513798714
with O 0 0.0011174370301887393
the O 0 0.003142882138490677
disappearance O 1 0.8320383429527283
of O 0 0.0075313132256269455
DM B-Disease 1 1.0
in O 0 0.00374804949387908
that O 0 0.003163257846608758
pedigree O 1 0.8546248078346252
. O 0 0.007218342740088701

The O 0 0.004811503458768129
concept O 0 0.007950297556817532
of O 0 0.002688331762328744
segregation O 1 0.8735641241073608
distortion O 1 0.8683487176895142
, O 0 0.002031309762969613
where O 0 0.0022618104703724384
there O 0 0.001559771946631372
is O 0 0.003665870986878872
preferential O 0 0.04166296496987343
transmission O 0 0.04737043008208275
of O 0 0.001407792791724205
the O 0 0.00260502053424716
larger O 0 0.014328502118587494
allele O 1 0.9993964433670044
at O 0 0.007099240552634001
the O 0 0.01341676153242588
DM B-Disease 1 1.0
locus O 1 0.9999579191207886
, O 0 0.0036059513222426176
has O 0 0.0032818035688251257
been O 0 0.003092491067945957
put O 0 0.0039164903573691845
forward O 0 0.003984585404396057
to O 0 0.0013120300136506557
explain O 0 0.00936768390238285
partially O 0 0.031941015273332596
the O 0 0.003505124943330884
maintenance O 0 0.05586643144488335
of O 0 0.004825985059142113
DM B-Disease 1 1.0
in O 0 0.003627056023105979
the O 0 0.0041059167124331
population O 0 0.012782459147274494
. O 0 0.008401025086641312

In O 0 0.0036972591187804937
a O 0 0.00761678209528327
survey O 0 0.013284370303153992
of O 0 0.005458848085254431
DM B-Disease 1 0.9999998807907104
in O 0 0.003950619138777256
Northern O 0 0.01421857625246048
Ireland O 0 0.017419438809156418
, O 0 0.0031994038727134466
59 O 0 0.04208403825759888
pedigrees O 0 0.2746288776397705
were O 0 0.004429485648870468
ascertained O 1 0.6629096269607544
. O 0 0.007000993471592665

Sibships O 1 0.9972344040870667
where O 0 0.005178636405616999
the O 0 0.0021886220201849937
status O 0 0.005105036776512861
of O 0 0.0008698214078322053
all O 0 0.0008836889173835516
the O 0 0.0021846177987754345
members O 0 0.0032978439703583717
had O 0 0.0048308721743524075
been O 0 0.004415384028106928
identified O 0 0.011261537671089172
were O 0 0.0017624541651457548
examined O 0 0.018827155232429504
to O 0 0.0013925177045166492
determine O 0 0.004149651154875755
the O 0 0.002948316279798746
transmission O 0 0.04690782353281975
of O 0 0.0020756253506988287
the O 0 0.009769316762685776
DM B-Disease 1 1.0
expansion O 0 0.017673349007964134
from O 0 0.005010484252125025
affected O 1 0.6982346177101135
parents O 0 0.010228963568806648
to O 0 0.0017971070483326912
their O 0 0.0031491422560065985
offspring O 1 0.9952743053436279
. O 0 0.006944100838154554

Where O 0 0.0067712292075157166
the O 0 0.005295289680361748
transmitting O 1 0.9704773426055908
parent O 1 0.9566386342048645
was O 0 0.01700633205473423
male O 0 0.03346662223339081
, O 0 0.0038278894498944283
58 O 0 0.044351015239953995
. O 0 0.0070808627642691135

3 O 0 0.01822320744395256
% O 0 0.004791716579347849
of O 0 0.0015760860405862331
the O 0 0.00536770885810256
offspring O 1 0.9814305901527405
were O 0 0.003493100870400667
affected O 0 0.12204615026712418
, O 0 0.0017146846512332559
and O 0 0.0008188054780475795
in O 0 0.0012028286000713706
the O 0 0.0018958242144435644
case O 0 0.0038816803134977818
of O 0 0.0012600518530234694
a O 0 0.008395430631935596
female O 0 0.03456145152449608
transmitting O 1 0.7844870686531067
parent O 1 0.9215202331542969
, O 0 0.005626328755170107
68 O 0 0.05317429453134537
. O 0 0.0070787034928798676

7 O 0 0.02916860207915306
% O 0 0.00719456747174263
were O 0 0.0037554707378149033
affected O 0 0.060625314712524414
. O 0 0.00819997675716877

Studies O 0 0.011178390122950077
on O 0 0.004958284553140402
meiotic O 1 0.9988620281219482
drive O 0 0.032405123114585876
in O 0 0.00827349629253149
DM B-Disease 1 0.9999997615814209
have O 0 0.0043921321630477905
shown O 0 0.009562013670802116
increased O 0 0.012438789010047913
transmission O 0 0.03729114681482315
of O 0 0.0014168268535286188
the O 0 0.002739108633249998
larger O 0 0.014074090868234634
allele O 1 0.9991305470466614
at O 0 0.006544613279402256
the O 0 0.011203736998140812
DM B-Disease 1 0.9999998807907104
locus O 1 0.9997867941856384
in O 0 0.005441883113235235
non O 0 0.026128096505999565
- O 1 0.9267182350158691
DM O 1 1.0
heterozygotes O 1 0.9996651411056519
for O 0 0.008687845431268215
CTGn O 1 0.9996470212936401
. O 0 0.00980443600565195

This O 0 0.004015450365841389
study O 0 0.004188253544270992
provides O 0 0.003971849102526903
further O 0 0.002329173730686307
evidence O 0 0.0020640308503061533
that O 0 0.0015330102760344744
the O 0 0.008299129083752632
DM B-Disease 1 1.0
expansion O 0 0.024618256837129593
tends O 0 0.027023877948522568
to O 0 0.001943741925060749
be O 0 0.00457605579867959
transmitted O 1 0.7284896373748779
preferentially O 0 0.1281934231519699
. O 0 0.008648950606584549

Diagnosis O 1 0.9999933242797852
of O 0 0.01276626531034708
hemochromatosis B-Disease 1 1.0
. O 0 0.011268760077655315

If O 0 0.019909415394067764
untreated O 1 0.9999970197677612
, O 0 0.010873318649828434
hemochromatosis B-Disease 1 1.0
can O 0 0.016802195459604263
cause O 1 0.999997615814209
serious O 1 0.9999916553497314
illness O 1 1.0
and O 0 0.0020100141409784555
early B-Disease 0 0.009673038497567177
death I-Disease 1 0.9974836707115173
, O 0 0.0013383777113631368
but O 0 0.0020051109604537487
the O 0 0.007656449917703867
disease O 1 1.0
is O 0 0.002947210567072034
still O 0 0.0042645372450351715
substantially O 0 0.1774260401725769
under O 0 0.01030090730637312
- O 1 0.9998008608818054
diagnosed O 1 1.0
. O 0 0.011559637263417244

The O 0 0.007108137011528015
cornerstone O 0 0.0405799075961113
of O 0 0.0035132155753672123
screening O 0 0.06021743640303612
and O 0 0.0015986383659765124
case O 0 0.008393866010010242
detection O 0 0.029405923560261726
is O 0 0.0019573408644646406
the O 0 0.0018391608027741313
measurement O 0 0.013581031002104282
of O 0 0.0031171725131571293
serum O 1 0.9998242259025574
transferrin O 1 0.9967910647392273
saturation O 0 0.33940839767456055
and O 0 0.0020386958494782448
the O 0 0.005312164779752493
serum O 1 0.9978393316268921
ferritin O 1 0.9969989061355591
level O 0 0.011622494086623192
. O 0 0.006494123954325914

Once O 0 0.01952686719596386
the O 0 0.008003592491149902
diagnosis O 1 0.9999971389770508
is O 0 0.005889605265110731
suspected O 0 0.06443416327238083
, O 0 0.0027583406772464514
physicians O 0 0.3458384871482849
must O 0 0.0030967765487730503
use O 0 0.004668158944696188
serum O 1 0.9984771609306335
ferritin O 1 0.9985402822494507
levels O 0 0.016348859295248985
and O 0 0.004250007681548595
hepatic O 1 0.9999998807907104
iron O 1 0.9226980805397034
stores O 0 0.013714210130274296
on O 0 0.00705153401941061
liver O 1 1.0
biopsy O 1 0.9999995231628418
specimens O 0 0.01944570802152157
to O 0 0.0020239544101059437
assess O 0 0.05787276849150658
patients O 1 0.9994778037071228
for O 0 0.001043387339450419
the O 0 0.001883123186416924
presence O 0 0.0065176901407539845
of O 0 0.0028004981577396393
iron B-Disease 1 0.998304009437561
overload I-Disease 1 0.9999231100082397
. O 0 0.008667307905852795

Liver O 1 1.0
biopsy O 1 0.9999992847442627
is O 0 0.003666188335046172
also O 0 0.0014615064719691873
used O 0 0.0012219749623909593
to O 0 0.0009434322128072381
establish O 0 0.0036329319700598717
the O 0 0.0023452064488083124
presence O 0 0.008516943082213402
or O 0 0.0038778765592724085
absence O 0 0.018655868247151375
of O 0 0.005195624195039272
cirrhosis B-Disease 1 1.0
, O 0 0.002617371967062354
which O 0 0.0020297879818826914
can O 0 0.003946173004806042
affect O 0 0.08205313235521317
prognosis O 1 0.9999997615814209
and O 0 0.002713473979383707
management O 0 0.022379357367753983
. O 0 0.007712754420936108

A O 0 0.036521658301353455
DNA O 0 0.06461691856384277
- O 0 0.020395640283823013
based O 0 0.003713076002895832
test O 0 0.008953787386417389
for O 0 0.0017751135164871812
the O 0 0.00813818909227848
HFE O 1 0.9999996423721313
gene O 1 0.9985167384147644
is O 0 0.00470625190064311
commercially O 0 0.01993202231824398
available O 0 0.003252545604482293
, O 0 0.0012536215363070369
but O 0 0.0012722257524728775
its O 0 0.0017800260102376342
place O 0 0.0027750201988965273
in O 0 0.0015926340129226446
the O 0 0.004841272719204426
diagnosis O 1 0.9999974966049194
of O 0 0.008136390708386898
hemochromatosis B-Disease 1 1.0
is O 0 0.00496830465272069
still O 0 0.004261542111635208
being O 0 0.007640427444130182
evaluated O 0 0.0461646169424057
. O 0 0.006070530042052269

Currently O 0 0.010594182647764683
, O 0 0.0017916543874889612
the O 0 0.0018592964624986053
most O 0 0.002280870918184519
useful O 0 0.004070468712598085
role O 0 0.006024449598044157
for O 0 0.0013838072773069143
this O 0 0.0018187470268458128
test O 0 0.008815500885248184
is O 0 0.001808750326745212
in O 0 0.001152722048573196
the O 0 0.0032306856010109186
detection O 0 0.03903859481215477
of O 0 0.006088814698159695
hemochromatosis B-Disease 1 1.0
in O 0 0.0029509051237255335
the O 0 0.0031471997499465942
family O 0 0.01110832393169403
members O 0 0.002792049665004015
of O 0 0.003240796271711588
patients O 1 0.9999914169311523
with O 0 0.0016104200622066855
a O 0 0.006312019657343626
proven O 0 0.02097703143954277
case O 0 0.005484401248395443
of O 0 0.002173792803660035
the O 0 0.01786722056567669
disease O 1 1.0
. O 0 0.00867178663611412

It O 0 0.003589469473809004
is O 0 0.0026940421666949987
crucial O 0 0.0086176423355937
to O 0 0.005323530174791813
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 0 0.2143988013267517
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9995625615119934
because O 0 0.016562052071094513
phlebotomy O 1 0.9999996423721313
therapy O 1 0.9999973773956299
can O 0 0.007137109525501728
avert O 1 0.9999974966049194
serious O 1 0.9999997615814209
chronic O 1 1.0
disease O 1 1.0
and O 0 0.0019436253933236003
can O 0 0.0020756786689162254
even O 0 0.00220228498801589
lead O 0 0.005705469287931919
to O 0 0.001976607134565711
normal O 0 0.018863800913095474
life O 0 0.01223175972700119
expectancy O 1 0.7525477409362793
. O 0 0.0030994301196187735
. O 0 0.0052436720579862595

Prevalence O 1 0.9864428043365479
of O 0 0.0036593214608728886
the O 0 0.009463365189731121
I1307K O 1 0.9999775886535645
APC B-Disease 1 0.9999959468841553
gene O 1 0.9937238097190857
variant O 1 0.8223882913589478
in O 0 0.003188102273270488
Israeli O 0 0.009307400323450565
Jews O 0 0.004649006761610508
of O 0 0.0012200191849842668
differing O 0 0.005699785891920328
ethnic O 0 0.005196156911551952
origin O 0 0.005542416591197252
and O 0 0.0022138128988444805
risk O 1 0.9999624490737915
for O 1 0.5048744678497314
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.01013286504894495

BACKGROUND O 0 0.03783924877643585
& O 0 0.03676337003707886
AIMS O 0 0.029332531616091728
Israeli O 0 0.012097740545868874
Jews O 0 0.005840987898409367
of O 0 0.0019822490867227316
European O 0 0.008786521852016449
birth O 1 0.9412868618965149
, O 0 0.0026650207582861185
i O 0 0.0077257608063519
. O 0 0.003011157503351569
e O 0 0.02467121183872223
. O 0 0.002429028507322073
, O 0 0.0028300040867179632
Ashkenazim O 1 0.9998855590820312
, O 0 0.0014692498371005058
have O 0 0.001189972274005413
the O 0 0.0035670443903654814
highest O 1 0.9998711347579956
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.999992847442627
of O 0 0.0015368632739409804
any O 0 0.00175970490090549
Israeli O 0 0.008074299432337284
ethnic O 0 0.0074980794452130795
group O 0 0.009940823540091515
. O 0 0.006285522598773241

The O 0 0.01909624971449375
I1307K O 1 0.9999266862869263
APC B-Disease 1 0.9999942779541016
gene O 1 0.9983055591583252
variant O 1 0.9839343428611755
was O 0 0.009961118921637535
found O 0 0.005410344805568457
in O 0 0.002871589967980981
6 O 0 0.017269283533096313
. O 0 0.006265889387577772

1 O 0 0.020190110430121422
% O 0 0.004537914879620075
of O 0 0.0017058190423995256
American O 0 0.006770709529519081
Jews O 0 0.005724270362406969
, O 0 0.0017579322448000312
28 O 0 0.008398391306400299
% O 0 0.0024171029217541218
of O 0 0.0012520672753453255
their O 0 0.011945678852498531
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 0.37039029598236084
, O 0 0.0018636678578332067
but O 0 0.0013778506545349956
not O 0 0.0009462517336942255
in O 0 0.0019232184858992696
non O 0 0.012249833904206753
- O 0 0.026079855859279633
Jews O 0 0.01387620996683836
. O 0 0.007695647422224283

We O 0 0.0047375112771987915
assessed O 0 0.026504985988140106
the O 0 0.008326434530317783
I1307K O 1 0.9998199343681335
prevalence O 1 0.9993103742599487
in O 0 0.0031928352545946836
Israeli O 0 0.010900091379880905
Jews O 0 0.005114066414535046
of O 0 0.0013617693912237883
differing O 0 0.006081227213144302
ethnic O 0 0.004956439603120089
origin O 0 0.0057538594119250774
and O 0 0.0022636079229414463
risk O 1 0.9999366998672485
for O 0 0.19294209778308868
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.010540145449340343

METHODS O 0 0.023210778832435608
DNA O 0 0.04753827676177025
samples O 0 0.015416494570672512
from O 0 0.0038574719801545143
500 O 0 0.021890433505177498
unrelated O 0 0.028262246400117874
Jews O 0 0.0057964446023106575
of O 0 0.0014060965040698647
European O 0 0.005020583048462868
or O 0 0.0047193169593811035
non O 0 0.013714127242565155
- O 0 0.018451550975441933
European O 0 0.006075097247958183
origin O 0 0.006100782193243504
, O 0 0.0013029644032940269
with O 0 0.001238649245351553
or O 0 0.002619517734274268
without O 0 0.002534568542614579
a O 0 0.0049266633577644825
personal O 0 0.006564190145581961
and O 0 0.0023167787585407495
/ O 0 0.48630622029304504
or O 0 0.0038655733224004507
family O 0 0.01015818677842617
history O 0 0.004805114585906267
of O 0 0.00401089945808053
neoplasia B-Disease 1 0.9999996423721313
, O 0 0.002168879611417651
were O 0 0.0016332071973010898
examined O 0 0.014449556358158588
for O 0 0.0012864712625741959
the O 0 0.004231663886457682
I1307K O 1 0.999876856803894
variant O 1 0.9906132221221924
by O 0 0.0028265612199902534
the O 0 0.0051694768480956554
allele O 1 0.9997878670692444
- O 0 0.03269607201218605
specific O 0 0.01039522048085928
oligonucleotide O 1 0.6315871477127075
( O 0 0.01745644025504589
ASO O 1 0.9994617104530334
) O 0 0.007650162559002638
method O 0 0.014140901155769825
. O 0 0.006903615780174732

RESULTS O 0 0.021478792652487755
In O 0 0.0025792070664465427
persons O 0 0.006676822900772095
at O 0 0.004309209529310465
average O 0 0.01490700151771307
risk O 1 0.9998058676719666
for O 0 0.052629489451646805
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0058518690057098866
I1307K O 1 0.9999212026596069
was O 0 0.009248470887541771
found O 0 0.0047581978142261505
in O 0 0.002069680253043771
5 O 0 0.012348068878054619
. O 0 0.006071913987398148

0 O 0 0.04529301077127457
% O 0 0.005809749010950327
of O 0 0.001916926121339202
120 O 0 0.011800325475633144
European O 0 0.004507211968302727
and O 0 0.0018334847409278154
1 O 0 0.01442151702940464
. O 0 0.006126299034804106

6 O 0 0.02641536295413971
% O 0 0.0056737130507826805
of O 0 0.003162690903991461
188 O 0 0.06725376099348068
non O 0 0.01699155941605568
- O 0 0.01989193633198738
European O 0 0.007806102745234966
Jews O 0 0.011822682805359364
( O 0 0.010530605912208557
P O 1 0.9940429329872131
= O 0 0.06083845719695091
0 O 0 0.030072573572397232
. O 0 0.004538978915661573
08 O 1 0.6160301566123962
) O 0 0.006829156074672937
. O 0 0.006944554392248392

It O 0 0.005974725820124149
occurred O 0 0.023814141750335693
in O 0 0.0025652104523032904
15 O 0 0.010989709757268429
. O 0 0.006501358468085527

4 O 0 0.022892341017723083
% O 0 0.004509568214416504
of O 0 0.001963684568181634
52 O 0 0.046020861715078354
Ashkenazi O 1 0.9971350431442261
Israelis O 0 0.02636813186109066
with O 0 0.008898371830582619
familial O 1 1.0
cancer B-Disease 1 1.0
( O 0 0.016737811267375946
P O 1 0.9996457099914551
= O 0 0.06516984850168228
0 O 0 0.031032614409923553
. O 0 0.004999769385904074
02 O 1 0.9999598264694214
) O 0 0.004250972531735897
and O 0 0.0013183319242671132
was O 0 0.00547757325693965
not O 0 0.002204091288149357
detected O 0 0.04764041677117348
in O 0 0.0027955302502959967
51 O 0 0.028790226206183434
non O 0 0.011441295966506004
- O 0 0.015808558091521263
European O 0 0.003950848244130611
Jews O 0 0.005680033005774021
at O 0 0.00586077431216836
increased O 1 0.9310157895088196
cancer B-Disease 1 1.0
risk O 1 0.9960899353027344
. O 0 0.008052517659962177

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999960660934448
occurred O 0 0.08026455342769623
personally O 0 0.030136747285723686
or O 0 0.0028237858787178993
in O 0 0.001257318421266973
the O 0 0.002265199087560177
families O 0 0.004792702849954367
of O 0 0.0016431466210633516
13 O 0 0.007504267618060112
of O 0 0.0017359554767608643
20 O 0 0.014085707254707813
Ashkenazi O 1 0.9999591112136841
I1307K O 1 0.9999890327453613
carriers O 1 0.9283474683761597
, O 0 0.0026057404465973377
8 O 0 0.009198577143251896
of O 0 0.001805565902031958
whom O 0 0.008780485950410366
also O 0 0.001646064454689622
had O 0 0.003879022551700473
a O 0 0.004865736234933138
personal O 0 0.006963135674595833
or O 0 0.0034409852232784033
family O 0 0.008743868209421635
history O 0 0.004177436698228121
of O 0 0.005794969387352467
noncolonic O 1 0.9999986886978149
neoplasia B-Disease 1 0.9999985694885254
. O 0 0.010478406213223934

CONCLUSIONS O 0 0.021645015105605125
The O 0 0.010281157679855824
I1307K O 1 0.9999793767929077
APC O 1 0.9999977350234985
variant O 1 0.9982171654701233
may O 0 0.007361232303082943
represent O 0 0.004190437961369753
a O 0 0.013204392977058887
susceptibility O 1 0.9999963045120239
gene O 1 0.9991225600242615
for O 0 0.00852146465331316
colorectal B-Disease 1 1.0
, I-Disease 0 0.0026069541927427053
or I-Disease 0 0.0022807156201452017
other I-Disease 0 0.0012583439238369465
, I-Disease 0 0.0045419856905937195
cancers I-Disease 1 1.0
in O 0 0.004400540608912706
Ashkenazi O 1 0.9999426603317261
Jews O 0 0.007602396886795759
, O 0 0.0016309414058923721
and O 0 0.00168757070787251
partially O 0 0.40250518918037415
explains O 0 0.0123655516654253
the O 0 0.002368878573179245
higher O 0 0.013739475980401039
incidence O 1 0.9999951124191284
of O 0 0.11630132794380188
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0028450987301766872
European O 0 0.005950416903942823
Israelis O 0 0.030858973041176796
. O 0 0.006485725287348032

Systematic O 0 0.04260598495602608
analysis O 0 0.007251090835779905
of O 0 0.003805737476795912
coproporphyrinogen O 1 0.9999340772628784
oxidase O 1 0.9999001026153564
gene O 1 0.9992890357971191
defects O 1 0.9998714923858643
in O 0 0.005342606920748949
hereditary B-Disease 1 0.9999996423721313
coproporphyria I-Disease 1 0.9999279975891113
and O 0 0.0055014886893332005
mutation O 1 0.9999749660491943
update O 0 0.05355321988463402
. O 0 0.007229798939079046

Hereditary B-Disease 1 0.9999903440475464
coproporphyria I-Disease 1 0.9999252557754517
( O 0 0.016845276579260826
HC B-Disease 1 0.9998705387115479
) O 0 0.004300649743527174
is O 0 0.0032155164517462254
an O 0 0.007807558868080378
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 0.009683120995759964
autosomal O 1 1.0
dominant O 1 0.9994402527809143
inheritance O 1 0.9999039173126221
caused O 1 0.9999512434005737
by O 0 0.006041124928742647
deficient B-Disease 1 0.9998109936714172
activity I-Disease 0 0.01025445107370615
of I-Disease 0 0.003406382165849209
coproporphyrinogen I-Disease 1 0.9999574422836304
III I-Disease 1 0.9998512268066406
oxidase I-Disease 1 0.9991365075111389
( O 0 0.015313572250306606
CPO O 1 0.9901694655418396
) O 0 0.00692411046475172
. O 0 0.005936036352068186

Clinical O 1 0.9769166111946106
manifestations O 0 0.14047139883041382
of O 0 0.0019823273178189993
the O 0 0.009694710373878479
disease O 1 1.0
are O 0 0.002100294688716531
characterized O 1 0.9316376447677612
by O 0 0.006586959585547447
acute O 1 1.0
attacks O 0 0.2041512131690979
of O 0 0.0061462740413844585
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 0.012764858081936836
precipitated O 1 0.9999955892562866
by O 0 0.005322443787008524
drugs O 0 0.1773149073123932
, O 0 0.0030334133189171553
fasting O 1 0.9820689558982849
, O 0 0.004680267069488764
cyclical O 1 0.9999797344207764
hormonal O 1 0.9999974966049194
changes O 0 0.009970208629965782
, O 0 0.0027914815582334995
or O 0 0.020886214450001717
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 0 0.007755918428301811

Skin O 1 1.0
photosensitivity O 1 0.9999992847442627
may O 0 0.016520172357559204
also O 0 0.0019299043342471123
be O 0 0.0015393515350297093
present O 0 0.003997070249170065
. O 0 0.005479090381413698

The O 0 0.005891780368983746
seven O 0 0.007438184227794409
exons O 1 0.557205080986023
, O 0 0.00247863563708961
the O 0 0.005699823144823313
exon O 1 0.9993769526481628
/ O 0 0.4192737638950348
intron O 1 0.9775295257568359
boundaries O 0 0.006427185609936714
and O 0 0.0012303136754781008
part O 0 0.0038966916035860777
of O 0 0.002284127054736018
3 O 0 0.016510406509041786
noncoding O 0 0.13755632936954498
sequence O 0 0.015170172788202763
of O 0 0.0015094688860699534
the O 0 0.005382061004638672
CPO O 1 0.9948257207870483
gene O 1 0.9295428395271301
were O 0 0.0026023148093372583
systematically O 0 0.022579539567232132
analyzed O 0 0.01140495017170906
by O 0 0.0030032347422093153
an O 0 0.004523497074842453
exon O 1 0.9935935139656067
- O 0 0.029308555647730827
by O 0 0.007087530102580786
- O 0 0.05426742881536484
exon O 1 0.9678956270217896
denaturing O 1 0.9867725968360901
gradient O 1 0.5145748853683472
gel O 1 0.956912636756897
electrophoresis O 0 0.3202471435070038
( O 0 0.01629459671676159
DGGE O 1 0.9995582699775696
) O 0 0.006502978503704071
strategy O 0 0.014547005295753479
followed O 0 0.0076185171492397785
by O 0 0.002525384770706296
direct O 0 0.00692411046475172
sequencing O 0 0.03552694618701935
in O 0 0.0019707847386598587
seven O 0 0.00641822163015604
unrelated O 0 0.18074098229408264
heterozygous O 1 0.999967098236084
HC B-Disease 1 0.9999943971633911
patients O 1 0.9999645948410034
from O 0 0.00438748300075531
France O 0 0.020732417702674866
, O 0 0.0026159859262406826
Holland O 1 0.7112894058227539
, O 0 0.0017118515679612756
and O 0 0.0017938831588253379
Czech O 0 0.01765112765133381
Republic O 0 0.010990082286298275
. O 0 0.006959835533052683

Seven O 0 0.016534999012947083
novel O 0 0.05169310420751572
mutations O 1 0.9991245865821838
and O 0 0.0016078002518042922
two O 0 0.0014045304851606488
new O 0 0.0046965377405285835
polymorphisms O 1 0.9946193695068359
were O 0 0.0043356576934456825
detected O 0 0.1356533318758011
. O 0 0.006540361326187849

Among O 0 0.009900569915771484
these O 0 0.003523242427036166
mutations O 1 0.9983589053153992
two O 0 0.0021819935645908117
are O 0 0.002825760282576084
missense O 1 0.9995130300521851
( O 0 0.012801999226212502
G197W O 1 0.9997708201408386
, O 0 0.006388133391737938
W427R O 1 0.999767005443573
) O 0 0.0044164047576487064
, O 0 0.0011024436680600047
two O 0 0.0010543829994276166
are O 0 0.0015627853572368622
nonsense O 0 0.05613522604107857
( O 0 0.00987801793962717
Q306X O 1 0.9999728202819824
, O 0 0.006277212407439947
Q385X O 1 0.9999620914459229
) O 0 0.004360048100352287
, O 0 0.001243031583726406
two O 0 0.0009970037499442697
are O 0 0.0012724378611892462
small O 0 0.008345058187842369
deletions O 1 0.9727923274040222
( O 0 0.011593285016715527
662de14bp O 1 0.9997003078460693
; O 0 0.007671448867768049
1168del3bp O 1 0.9963471293449402
removing O 0 0.03888711705803871
a O 0 0.01164163276553154
glycine O 0 0.1683235913515091
at O 0 0.00658169761300087
position O 0 0.010439671576023102
390 O 0 0.0786043107509613
) O 0 0.004198946990072727
, O 0 0.001168005052022636
and O 0 0.0009204894304275513
one O 0 0.002228272147476673
is O 0 0.0028089508414268494
a O 0 0.010942610912024975
splicing O 1 0.6446521282196045
mutation O 1 0.9998993873596191
( O 0 0.016302164644002914
IVS1 O 1 0.9999185800552368
- O 0 0.08161640912294388
15c O 1 0.990862250328064
- O 0 0.07984989136457443
- O 0 0.08695545792579651
> O 1 0.9971908926963806
g O 0 0.3948724567890167
) O 0 0.004064188804477453
which O 0 0.0018284703837707639
creates O 0 0.013712868094444275
a O 0 0.00643962761387229
new O 0 0.005854782182723284
acceptor O 1 0.8806432485580444
splice O 1 0.7348344326019287
site O 0 0.021634317934513092
. O 0 0.008482997305691242

The O 0 0.010137868113815784
pathological O 0 0.3426167964935303
significance O 0 0.004241955932229757
of O 0 0.0008657186408527195
the O 0 0.002499382011592388
point O 0 0.010657516308128834
mutations O 1 0.9999229907989502
G197W O 1 0.9998553991317749
, O 0 0.005156055558472872
W427R O 1 0.9999444484710693
, O 0 0.0014890067977830768
and O 0 0.000729972671251744
the O 0 0.0016872927080839872
in O 0 0.0025855686981230974
- O 0 0.030222564935684204
frame O 0 0.048123400658369064
deletion O 1 0.9956992864608765
390delGly O 1 0.9940885305404663
were O 0 0.00389437866397202
assessed O 0 0.01756257750093937
by O 0 0.002221615519374609
their O 0 0.0014260589377954602
respective O 0 0.006648899521678686
expression O 0 0.01598557084798813
in O 0 0.0016174043994396925
a O 0 0.0059593115001916885
prokaryotic O 0 0.06395190209150314
system O 0 0.008282053284347057
using O 0 0.004003206733614206
site O 0 0.013774522580206394
- O 0 0.031813349574804306
directed O 0 0.023334240540862083
mutagenesis O 1 0.659112811088562
. O 0 0.011808217503130436

These O 0 0.006722900550812483
mutations O 1 0.9990155696868896
resulted O 0 0.023233244195580482
in O 0 0.0015152314445003867
the O 0 0.0027103747706860304
absence O 0 0.024484025314450264
or O 0 0.003554466413334012
a O 0 0.006457726936787367
dramatic O 0 0.021820463240146637
decrease O 0 0.02748691290616989
of O 0 0.0037457426078617573
CPO O 1 0.9807779788970947
activity O 0 0.02316734753549099
. O 0 0.008427819237112999

The O 0 0.0057597714476287365
two O 0 0.004052576143294573
polymorphisms O 1 0.9253283143043518
were O 0 0.0043922425247728825
localized O 1 0.9787009358406067
in O 0 0.004251848440617323
noncoding O 0 0.17512774467468262
part O 0 0.004639793187379837
of O 0 0.00157028972171247
the O 0 0.006558113731443882
gene O 1 0.992743968963623
1 O 0 0.014917941763997078
) O 0 0.0039893765933811665
a O 0 0.013380932621657848
C O 1 0.7461197972297668
/ O 0 0.2201094776391983
G O 1 0.9708168506622314
polymorphism O 0 0.10774596780538559
in O 0 0.002541616326197982
the O 0 0.006353080738335848
promotor O 1 0.9992499947547913
region O 0 0.017229514196515083
, O 0 0.003430960001423955
142 O 0 0.067729152739048
bp O 0 0.060551874339580536
upstream O 0 0.03005256876349449
from O 0 0.0025757024995982647
the O 0 0.00473442068323493
transcriptional O 0 0.21066194772720337
initiation O 0 0.07598329335451126
site O 0 0.015267269685864449
( O 0 0.008820950984954834
- O 0 0.05572856590151787
142C O 1 0.9997736811637878
/ O 1 0.9817723035812378
G O 1 0.9954251646995544
) O 0 0.0046646688133478165
, O 0 0.0015369538450613618
and O 0 0.0015215534949675202
2 O 0 0.009825503453612328
) O 0 0.0032295528799295425
a O 0 0.0071476297453045845
6 O 0 0.018183374777436256
bp O 0 0.10112016648054123
deletion O 1 0.9829148054122925
polymorphism O 0 0.13392382860183716
in O 0 0.00205736281350255
the O 0 0.0035030152648687363
3 O 0 0.016533782705664635
noncoding O 0 0.1506846696138382
part O 0 0.0038268370553851128
of O 0 0.0014326497912406921
the O 0 0.0052531869150698185
CPO O 1 0.9996551275253296
gene O 1 0.9941504597663879
, O 0 0.0043396614491939545
574 O 1 0.9754672646522522
bp O 0 0.06590572744607925
downstream O 0 0.030768409371376038
of O 0 0.0012651825090870261
the O 0 0.002192093525081873
last O 0 0.005819730460643768
base O 0 0.005691666156053543
of O 0 0.0009708673460409045
the O 0 0.0030322845559567213
normal O 0 0.029863765463232994
termination O 1 0.9956673383712769
codon O 1 0.9509652256965637
( O 0 0.015231725759804249
+ O 0 0.11958341300487518
574 O 1 0.9894174933433533
delATTCTT O 1 0.9984797835350037
) O 0 0.00796378031373024
. O 0 0.006112665869295597

Five O 0 0.023233575746417046
intragenic O 1 0.9999227523803711
dimorphisms O 1 0.9993237257003784
are O 0 0.001813374226912856
now O 0 0.004166643600910902
well O 0 0.003108456963673234
characterized O 0 0.029869940131902695
and O 0 0.0010264565935358405
the O 0 0.0018336663488298655
high O 0 0.004966994281858206
degree O 0 0.0044460296630859375
of O 0 0.0034614361356943846
allelic O 1 0.9989175796508789
heterogeneity O 1 0.8708660006523132
in O 0 0.006526223383843899
HC B-Disease 1 0.9994875192642212
is O 0 0.0054927607998251915
demonstrated O 0 0.010981623083353043
with O 0 0.001520335441455245
seven O 0 0.002946128835901618
new O 0 0.002354932716116309
different O 0 0.002615421311929822
mutations O 1 0.9982043504714966
making O 0 0.0022958379704505205
a O 0 0.003108764300122857
total O 0 0.0027727093547582626
of O 0 0.0022300761193037033
nineteen O 1 0.9871687889099121
CPO O 1 0.9998551607131958
gene B-Disease 1 0.9998229146003723
defects I-Disease 1 0.9999814033508301
reported O 0 0.018594462424516678
so O 0 0.004214367363601923
far O 0 0.004718501586467028
. O 0 0.0027363081462681293
. O 0 0.006522440817207098

Coincidence O 0 0.039757758378982544
of O 0 0.0017613255186006427
two O 0 0.0022338256239891052
novel O 0 0.030866993591189384
arylsulfatase O 1 0.9994126558303833
A O 0 0.030845817178487778
alleles O 1 0.9993676543235779
and O 0 0.005625981837511063
mutation O 1 0.999937891960144
459 O 1 0.9964419007301331
+ O 1 0.9120065569877625
1G O 1 0.9999213218688965
> O 1 0.7410321235656738
A O 0 0.010511480271816254
within O 0 0.003468628041446209
a O 0 0.007595970761030912
family O 0 0.014536398462951183
with O 0 0.006526332348585129
metachromatic B-Disease 1 0.9999997615814209
leukodystrophy I-Disease 1 0.9999998807907104
: O 0 0.008136152289807796
molecular O 0 0.015297658741474152
basis O 0 0.0023158600088208914
of O 0 0.003574494505301118
phenotypic O 1 0.9989053010940552
heterogeneity O 1 0.9671684503555298
. O 0 0.008855086751282215

In O 0 0.004532521590590477
a O 0 0.008112110197544098
family O 0 0.010799587704241276
with O 0 0.0016367097850888968
three O 0 0.0029455646872520447
siblings O 1 0.9543553590774536
, O 0 0.001456772442907095
one O 0 0.002260123612359166
developed O 0 0.009331821464002132
classical O 0 0.007269770372658968
late O 0 0.05778275802731514
infantile O 1 0.9999998807907104
metachromatic B-Disease 1 0.9999996423721313
leukodystrophy I-Disease 1 0.9999997615814209
( O 0 0.037139974534511566
MLD B-Disease 1 0.9999984502792358
) O 0 0.00972324050962925
, O 0 0.00620828103274107
fatal O 1 0.9999994039535522
at O 0 0.007857635617256165
age O 0 0.015564309433102608
5 O 0 0.00983763299882412
years O 0 0.003952146973460913
, O 0 0.0017036759527400136
with O 0 0.0036712673027068377
deficient O 1 0.9999773502349854
arylsulfatase O 1 0.9995858073234558
A O 0 0.032541144639253616
( O 0 0.015273055993020535
ARSA O 1 0.9999825954437256
) O 0 0.005319890566170216
activity O 0 0.0076162745244801044
and O 0 0.002210573060438037
increased O 0 0.023115187883377075
galactosylsulfatide O 1 0.9996936321258545
( O 0 0.01856803148984909
GS O 1 0.9999972581863403
) O 0 0.015387910418212414
excretion O 1 0.9946708083152771
. O 0 0.010166087187826633

The O 0 0.004345937632024288
two O 0 0.0015874948585405946
other O 0 0.001947050797753036
siblings O 1 0.979583203792572
, O 0 0.003430226119235158
apparently O 0 0.08718482404947281
healthy O 1 0.9239961504936218
at O 0 0.005927480291575193
12 O 0 0.01137011032551527
( O 0 0.0074543398804962635
1 O 0 0.024579200893640518
/ O 0 0.15248210728168488
2 O 0 0.013118511065840721
) O 0 0.0028255186043679714
and O 0 0.0012409017654135823
15 O 0 0.0077698975801467896
years O 0 0.003966005519032478
, O 0 0.0019054580479860306
respectively O 0 0.0067680999636650085
, O 0 0.0014221544843167067
and O 0 0.0011500020045787096
their O 0 0.0021777786314487457
father O 0 0.47244399785995483
, O 0 0.002980610355734825
apparently O 0 0.04387827217578888
healthy O 1 0.5510887503623962
as O 0 0.0025281370617449284
well O 0 0.0017866418929770589
, O 0 0.0019205039134249091
presented O 0 0.011859186924993992
ARSA O 1 0.9999818801879883
and O 0 0.005802927538752556
GS O 1 0.9999192953109741
values O 0 0.006034300196915865
within O 0 0.00229139206930995
the O 0 0.0019665812142193317
range O 0 0.004822901450097561
of O 0 0.006019448861479759
MLD B-Disease 1 1.0
patients O 1 0.9999903440475464
. O 0 0.009851525537669659

Mutation O 1 0.9999620914459229
screening O 0 0.06038440018892288
and O 0 0.0018850213382393122
sequence O 0 0.01603003591299057
analysis O 0 0.0050869775004684925
disclosed O 0 0.017304912209510803
the O 0 0.002741597592830658
involvement O 0 0.014204739592969418
of O 0 0.0014664848567917943
three O 0 0.002662641927599907
different O 0 0.004340184852480888
ARSA O 1 0.9999977350234985
mutations O 1 0.9995920062065125
being O 0 0.005523357540369034
the O 0 0.002671408699825406
molecular O 0 0.013022352941334248
basis O 0 0.0019428207306191325
of O 0 0.0031460835598409176
intrafamilial O 1 0.99996018409729
phenotypic O 1 0.9991016387939453
heterogeneity O 1 0.6593237519264221
. O 0 0.008385630324482918

The O 0 0.009676310233771801
late O 0 0.05554860085248947
infantile O 1 1.0
patient O 1 0.9999992847442627
inherited O 1 0.9999616146087646
from O 0 0.0035597016103565693
his O 0 0.004980346187949181
mother O 0 0.12626250088214874
the O 0 0.0035751110408455133
frequent O 0 0.036673977971076965
0 O 0 0.0383012518286705
- O 0 0.040532875806093216
type O 0 0.3794768154621124
mutation O 1 0.9998154044151306
459 O 1 0.9848769903182983
+ O 1 0.6644524335861206
1G O 1 0.9999531507492065
> O 1 0.9832730293273926
A O 0 0.013907316140830517
, O 0 0.0016955561004579067
and O 0 0.001130746677517891
from O 0 0.0024676742032170296
his O 0 0.0040983157232403755
father O 0 0.030139431357383728
a O 0 0.007031264249235392
novel O 0 0.019294194877147675
, O 0 0.002714061178267002
single O 0 0.026255235075950623
basepair O 1 0.9986037611961365
microdeletion O 1 0.6218096017837524
of O 0 0.00531124509871006
guanine O 0 0.08500517159700394
at O 0 0.008777482435107231
nucleotide O 0 0.09472573548555374
7 O 0 0.01647665537893772
in O 0 0.004598933272063732
exon O 1 0.9853257536888123
1 O 0 0.028183838352560997
( O 0 0.011966677382588387
7delG O 1 0.9990453124046326
) O 0 0.007726619951426983
. O 0 0.005914726294577122

The O 0 0.005401839967817068
two O 0 0.005839171819388866
clinically O 1 0.9999511241912842
unaffected O 1 0.9984527826309204
siblings O 0 0.3823092579841614
carried O 0 0.008844712749123573
the O 0 0.006524745840579271
maternal O 1 0.9994358420372009
mutation O 1 0.9998601675033569
459 O 1 0.9917830228805542
+ O 1 0.7208359837532043
1G O 1 0.9999456405639648
> O 1 0.9755116701126099
A O 0 0.013372940942645073
and O 0 0.0015088766813278198
, O 0 0.0011515729129314423
on O 0 0.0014043987030163407
their O 0 0.0034193878527730703
paternal O 1 0.9995285272598267
allele O 1 0.9999011754989624
, O 0 0.0025953464210033417
a O 0 0.007527148816734552
novel O 0 0.02777722105383873
cytosine O 0 0.09272168576717377
to O 0 0.004590772558003664
thymidine O 0 0.3253524899482727
transition O 0 0.02335135079920292
at O 0 0.008420698344707489
nucleotide O 0 0.1470038890838623
2435 O 1 0.9939898252487183
in O 0 0.007832814007997513
exon O 1 0.9923250675201416
8 O 0 0.021774228662252426
, O 0 0.002813784871250391
resulting O 0 0.02133159339427948
in O 0 0.002539033070206642
substitution O 0 0.031542904675006866
of O 0 0.004644362255930901
alanine O 1 0.6991550922393799
464 O 1 0.9537758231163025
by O 0 0.013666589744389057
valine O 1 0.9964703321456909
( O 0 0.017099304124712944
A464V O 1 0.9984972476959229
) O 0 0.007880978286266327
. O 0 0.00655432790517807

The O 0 0.011207710951566696
fathers O 0 0.06114520505070686
genotype O 1 0.9998372793197632
thus O 0 0.010035545565187931
was O 0 0.017361357808113098
7delG O 1 0.9999568462371826
/ O 1 0.9301151633262634
A464V O 1 0.995189905166626
. O 0 0.010144229978322983

Mutation O 1 0.9999679327011108
A464V O 1 0.9994864463806152
was O 0 0.008859317749738693
not O 0 0.0013639245880767703
found O 0 0.0034670643508434296
in O 0 0.001731342519633472
18 O 0 0.013310754671692848
unrelated O 1 0.9859951138496399
MLD B-Disease 1 1.0
patients O 1 0.9999924898147583
and O 0 0.002408154308795929
50 O 0 0.013145768083631992
controls O 0 0.0275404155254364
. O 0 0.007157757878303528

A464V O 1 0.996634304523468
, O 0 0.003240103367716074
although O 0 0.004163099452853203
clearly O 0 0.012081099674105644
modifying O 1 0.5943372845649719
ARSA O 1 0.9999942779541016
and O 0 0.007623457815498114
GS O 1 0.9999983310699463
levels O 0 0.023558862507343292
, O 0 0.0029753351118415594
apparently O 0 0.022680943831801414
bears O 0 0.020414363592863083
little O 0 0.006878065411001444
significance O 0 0.004537171684205532
for O 0 0.0022015883587300777
clinical O 1 0.973883867263794
manifestation O 1 0.9971369504928589
of O 0 0.004486073739826679
MLD B-Disease 1 1.0
, O 0 0.0033733563032001257
mimicking O 0 0.4513830542564392
the O 0 0.005596778355538845
frequent O 1 0.949280858039856
ARSA O 1 0.9999992847442627
pseudodeficiency O 1 0.9999463558197021
allele O 1 0.9994438290596008
. O 0 0.010413787327706814

Our O 0 0.008257794193923473
results O 0 0.00872886087745428
demonstrate O 0 0.006018125452101231
that O 0 0.0009738480439409614
in O 0 0.0012061104644089937
certain O 0 0.004280994180589914
genetic O 0 0.30557841062545776
conditions O 0 0.050327010452747345
MLD B-Disease 1 0.9999994039535522
- O 0 0.049444735050201416
like O 0 0.01565111055970192
ARSA O 1 0.9999971389770508
and O 0 0.005986392963677645
GS O 1 0.9999829530715942
values O 0 0.007537375204265118
need O 0 0.0033861896954476833
not O 0 0.0011233885306864977
be O 0 0.0019420385360717773
paralleled O 0 0.09398549050092697
by O 0 0.008220801129937172
clinical O 1 0.9999864101409912
disease O 1 1.0
, O 0 0.0019339859718456864
a O 0 0.004177240654826164
finding O 0 0.0075867376290261745
with O 0 0.002479715971276164
serious O 1 0.9938097596168518
diagnostic O 1 0.82560133934021
and O 0 0.004437311086803675
prognostic O 1 0.9999858140945435
implications O 0 0.23584237694740295
. O 0 0.006559803616255522

Moreover O 0 0.02585567720234394
, O 0 0.0033324123360216618
further O 0 0.013321987353265285
ARSA O 1 0.9999755620956421
alleles O 1 0.9998353719711304
functionally O 1 0.642219066619873
similar O 0 0.006568059790879488
to O 0 0.0035567653831094503
A464V O 1 0.9999196529388428
might O 0 0.008537175133824348
exist O 0 0.0033351662568747997
which O 0 0.0014613171806558967
, O 0 0.0010885264491662383
together O 0 0.0016254002694040537
with O 0 0.0024092807434499264
0 O 0 0.0365833155810833
- O 0 0.04617501050233841
type O 1 0.827232301235199
mutations O 1 0.999742329120636
, O 0 0.0031029297970235348
may O 0 0.01583586074411869
cause O 1 0.9997183680534363
pathological O 1 0.9999885559082031
ARSA O 1 0.9999996423721313
and O 0 0.006266174837946892
GS O 1 0.9999991655349731
levels O 0 0.014695068821310997
, O 0 0.0013827492948621511
but O 0 0.001746435067616403
not O 0 0.0025655010249465704
clinical O 1 0.9995941519737244
outbreak O 1 0.9999996423721313
of O 0 0.0023812935687601566
the O 0 0.13443587720394135
disease O 1 1.0
. O 0 0.004640929866582155
. O 0 0.006261384580284357

Human O 0 0.08036356419324875
MLH1 O 1 0.9999996423721313
deficiency O 1 1.0
predisposes O 1 0.9999966621398926
to O 0 0.00889590848237276
hematological B-Disease 1 0.9999978542327881
malignancy I-Disease 1 0.9999998807907104
and O 0 0.01455515343695879
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.5317726731300354
1 I-Disease 0 0.019520383328199387
. O 0 0.005696119740605354

Heterozygous O 1 0.9997057318687439
germ O 1 0.9890206456184387
- O 0 0.05060084909200668
line O 0 0.021474458277225494
mutations O 1 0.9664027690887451
in O 0 0.00142372096888721
the O 0 0.0037198984064161777
DNA O 0 0.0651676207780838
mismatch O 1 0.9988903403282166
repair O 1 0.9962106943130493
genes O 0 0.09168273955583572
lead O 0 0.01291427668184042
to O 0 0.005446053110063076
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.011998121626675129

The O 0 0.03809443861246109
disease O 1 1.0
susceptibility O 1 0.9999901056289673
of O 0 0.00265516247600317
individuals O 0 0.00509308185428381
who O 0 0.006100602447986603
constitutionally O 1 0.5304552912712097
lack O 0 0.010596848092973232
both O 0 0.0027956312987953424
wild O 0 0.04528519883751869
- O 0 0.08948713541030884
type O 1 0.8277037143707275
alleles O 1 0.998736560344696
is O 0 0.007634301204234362
unknown O 0 0.022864939644932747
. O 0 0.006329060066491365

We O 0 0.00341534405015409
have O 0 0.0021622972562909126
identified O 0 0.009523676708340645
three O 0 0.0023663940373808146
offspring O 0 0.04824799299240112
in O 0 0.0022223314736038446
a O 0 0.0253607127815485
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.2535451352596283
who O 0 0.008492338471114635
developed O 1 0.7729661464691162
hematological B-Disease 1 0.9999997615814209
malignancy I-Disease 1 1.0
at O 0 0.006695235148072243
a O 0 0.00649319589138031
very O 0 0.00484479358419776
early O 0 0.011653510853648186
age O 0 0.01097478810697794
, O 0 0.0013211298501119018
and O 0 0.0009745181305333972
at O 0 0.002916864585131407
least O 0 0.004829450976103544
two O 0 0.000884649227373302
of O 0 0.0010860725305974483
them O 0 0.001217023003846407
displayed O 0 0.008632858283817768
signs O 0 0.019855741411447525
of O 0 0.007024502381682396
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9634327292442322
1 I-Disease 0 0.023516511544585228
( O 0 0.014458313584327698
NF1 B-Disease 1 0.9999954700469971
) O 0 0.008603553287684917
. O 0 0.00647040456533432

DNA O 0 0.07198312133550644
sequence O 0 0.024900684133172035
analysis O 0 0.006779052317142487
and O 0 0.003331215353682637
allele O 1 0.9991005659103394
- O 0 0.025433728471398354
specific O 0 0.005876682233065367
amplification O 0 0.05700184404850006
in O 0 0.0017412306042388082
two O 0 0.002022325526922941
siblings O 0 0.4368213713169098
revealed O 0 0.018723029643297195
a O 0 0.015280754305422306
homozygous O 1 0.9999115467071533
MLH1 O 1 0.9999971389770508
mutation O 1 0.9999111890792847
( O 0 0.01530014630407095
C676T O 1 0.9977390766143799
- O 0 0.06994568556547165
- O 0 0.08937840908765793
> O 1 0.9909279942512512
Arg226Stop O 1 0.9994730353355408
) O 0 0.00800382625311613
. O 0 0.0066020130179822445

Thus O 0 0.010492476634681225
, O 0 0.0019300641724839807
a O 0 0.010711378417909145
homozygous O 1 0.9992213249206543
germ O 1 0.9647752642631531
- O 0 0.04193877801299095
line O 0 0.03186384215950966
MLH1 O 1 0.999996542930603
mutation O 1 0.9999878406524658
and O 0 0.003961118403822184
consequent O 1 0.9999768733978271
mismatch O 1 0.9999958276748657
repair O 1 0.9999974966049194
deficiency O 1 1.0
results O 0 0.007444312330335379
in O 0 0.0017573642544448376
a O 0 0.014396950602531433
mutator O 1 0.9999972581863403
phenotype O 1 0.9999995231628418
characterized O 1 0.943129301071167
by O 0 0.01184577215462923
leukemia B-Disease 1 1.0
and O 0 0.004603760316967964
/ O 1 0.9997265934944153
or O 1 0.6973230838775635
lymphoma B-Disease 1 1.0
associated O 0 0.019026026129722595
with O 0 0.008569200523197651
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9335110783576965
1 I-Disease 0 0.014186670072376728
. O 0 0.0028422216419130564
. O 0 0.005319483578205109

Missense O 1 0.9991612434387207
mutations O 1 0.9950513243675232
in O 0 0.0022624172270298004
the O 0 0.00210465956479311
most O 0 0.002480184193700552
ancient O 0 0.0044748797081410885
residues O 0 0.022262871265411377
of O 0 0.0016034526051953435
the O 0 0.007856015115976334
PAX6 O 1 0.9999967813491821
paired O 0 0.07884186506271362
domain O 0 0.035879310220479965
underlie O 0 0.20570771396160126
a O 0 0.008901786990463734
spectrum O 0 0.03227343410253525
of O 0 0.0038158586248755455
human O 1 0.9898998141288757
congenital B-Disease 1 1.0
eye I-Disease 1 0.9999998807907104
malformations I-Disease 1 1.0
. O 0 0.009748240001499653

Mutations O 1 0.989085853099823
of O 0 0.0021528590004891157
the O 0 0.00388842704705894
human O 0 0.02478657104074955
PAX6 O 1 0.9999990463256836
gene O 1 0.9998308420181274
underlie O 1 0.9997536540031433
aniridia B-Disease 1 0.9999992847442627
( O 0 0.04219002276659012
congenital B-Disease 1 1.0
absence I-Disease 0 0.020485127344727516
of I-Disease 0 0.0018655298044905066
the I-Disease 0 0.00677570141851902
iris I-Disease 1 0.9999926090240479
) O 0 0.003732881508767605
, O 0 0.0014763872604817152
a O 0 0.006979115307331085
rare O 0 0.28595179319381714
dominant O 1 0.9970183372497559
malformation B-Disease 1 0.9999998807907104
of I-Disease 0 0.002377418801188469
the I-Disease 0 0.0066612218506634235
eye I-Disease 1 0.99998939037323
. O 0 0.007275433745235205

The O 0 0.007915095426142216
spectrum O 0 0.044816624373197556
of O 0 0.006755591370165348
PAX6 O 1 0.9999996423721313
mutations O 1 0.999923586845398
in O 0 0.010336300358176231
aniridia B-Disease 1 0.9999996423721313
patients O 1 0.9999940395355225
is O 0 0.005852632224559784
highly O 0 0.014527220278978348
biased O 0 0.025063473731279373
, O 0 0.002140866359695792
with O 0 0.0024404283612966537
92 O 0 0.0402107909321785
% O 0 0.0031694904901087284
of O 0 0.001049890648573637
all O 0 0.0020145224407315254
reported O 0 0.027248235419392586
mutations O 1 0.9998369216918945
leading O 0 0.012016619555652142
to O 0 0.003765946952626109
premature O 1 0.9980663657188416
truncation O 1 0.7922991514205933
of O 0 0.002070176415145397
the O 0 0.0041536688804626465
protein O 0 0.057138558477163315
( O 0 0.006371622905135155
nonsense O 0 0.044770754873752594
, O 0 0.0026313108392059803
splicing O 0 0.14243368804454803
, O 0 0.0035615714732557535
insertions O 1 0.5943784117698669
and O 0 0.0041594915091991425
deletions O 1 0.8224126100540161
) O 0 0.004286815878003836
and O 0 0.0012365116272121668
just O 0 0.005032683257013559
2 O 0 0.007894239388406277
% O 0 0.0035619097761809826
leading O 0 0.00761672155931592
to O 0 0.0018479798454791307
substitution O 0 0.022049134597182274
of O 0 0.001894999761134386
one O 0 0.005457310006022453
amino O 0 0.050442542880773544
acid O 0 0.06673294305801392
by O 0 0.003935083746910095
another O 0 0.01563786342740059
( O 0 0.01248557772487402
missense O 1 0.9992976188659668
) O 0 0.009639609605073929
. O 0 0.00629833061248064

The O 0 0.006378017365932465
extraordinary O 0 0.013501711189746857
conservation O 0 0.010527933947741985
of O 0 0.0021561922039836645
the O 0 0.01074899546802044
PAX6 O 1 0.9999912977218628
protein O 0 0.0639069601893425
at O 0 0.004653428681194782
the O 0 0.004756308626383543
amino O 0 0.06324540078639984
acid O 0 0.09396558254957199
level O 0 0.009212912060320377
amongst O 0 0.020783396437764168
vertebrates O 1 0.7444787621498108
predicts O 0 0.0339069664478302
that O 0 0.003822282189503312
pathological O 1 0.9999161958694458
missense O 1 0.9999691247940063
mutations O 1 0.9996962547302246
should O 0 0.0030311979353427887
in O 0 0.001579518080689013
fact O 0 0.0033663471695035696
be O 0 0.002095582662150264
common O 0 0.007817583158612251
even O 0 0.003784734755754471
though O 0 0.0033225100487470627
they O 0 0.0009997106390073895
are O 0 0.0009759461972862482
hardly O 0 0.016462182626128197
ever O 0 0.008884580805897713
seen O 0 0.01070242840796709
in O 0 0.006210705265402794
aniridia B-Disease 1 0.9999990463256836
patients O 1 0.9999834299087524
. O 0 0.010519508272409439

This O 0 0.005400259513407946
indicates O 0 0.014305273070931435
that O 0 0.001227585831657052
there O 0 0.0010935455793514848
is O 0 0.0026594868395477533
a O 0 0.007344442885369062
heavy O 0 0.1402176171541214
ascertainment O 1 0.9996517896652222
bias O 0 0.034331172704696655
in O 0 0.0018049712525680661
the O 0 0.0020566952880471945
selection O 0 0.008168045431375504
of O 0 0.0032072404865175486
patients O 1 0.9999974966049194
for O 0 0.006434638984501362
PAX6 O 1 0.9999996423721313
mutation O 1 0.9998588562011719
analysis O 0 0.005059640388935804
and O 0 0.0006618156912736595
that O 0 0.000677425239700824
the O 0 0.0030990324448794127
missing O 1 0.9286782145500183
PAX6 O 1 0.9999995231628418
missense O 1 0.9999954700469971
mutations O 1 0.9999322891235352
frequently O 0 0.0198579840362072
may O 0 0.016771841794252396
underlie O 1 0.9963356256484985
phenotypes O 1 0.997313916683197
distinct O 0 0.016070911660790443
from O 0 0.00555264949798584
textbook O 1 0.8010461926460266
aniridia B-Disease 1 0.9998595714569092
. O 0 0.011903361417353153

Here O 0 0.003206165973097086
we O 0 0.001234067021869123
present O 0 0.0019304887391626835
four O 0 0.0031716797966510057
novel O 0 0.2761620581150055
PAX6 O 1 0.9999994039535522
missense O 1 0.999990701675415
mutations O 1 0.9999030828475952
, O 0 0.0019900836050510406
two O 0 0.0010921800276264548
in O 0 0.0016634514322504401
association O 0 0.0098190288990736
with O 0 0.0037861012388020754
atypical O 1 0.9999995231628418
phenotypes O 1 0.9999954700469971
ectopia B-Disease 1 0.9999879598617554
pupillae I-Disease 1 0.9998788833618164
( O 0 0.00965501181781292
displaced B-Disease 1 0.7435845136642456
pupils I-Disease 0 0.04725705087184906
) O 0 0.00557760801166296
and O 0 0.008345361799001694
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999997615814209
( O 0 0.009676502086222172
searching B-Disease 0 0.047242745757102966
gaze I-Disease 1 0.9953568577766418
) O 0 0.0045833284966647625
, O 0 0.0012649566633626819
and O 0 0.0008490360924042761
two O 0 0.0010344175389036536
in O 0 0.0016446044901385903
association O 0 0.0075847674161195755
with O 0 0.0013400203315541148
more O 0 0.003755927551537752
recognizable O 1 0.9993690848350525
aniridia B-Disease 1 0.9999984502792358
phenotypes O 1 0.9998998641967773
. O 0 0.009951186366379261

Strikingly O 0 0.06643235683441162
, O 0 0.0021056481637060642
all O 0 0.001187593792565167
four O 0 0.004778967704623938
mutations O 1 0.9992891550064087
are O 0 0.0009419089183211327
located O 0 0.00484117167070508
within O 0 0.002019490348175168
the O 0 0.0061692432500422
PAX6 O 1 0.9999995231628418
paired O 0 0.11989235132932663
domain O 0 0.023311205208301544
and O 0 0.0020106567535549402
affect O 0 0.027074739336967468
amino O 0 0.06652022898197174
acids O 0 0.03812672197818756
which O 0 0.0016068897675722837
are O 0 0.000882562599144876
highly O 0 0.010202426463365555
conserved O 0 0.020538916811347008
in O 0 0.0014892747858539224
all O 0 0.0015334337949752808
known O 0 0.014042127877473831
paired O 0 0.055126216262578964
domain O 0 0.03767729923129082
proteins O 0 0.031083472073078156
. O 0 0.0071367183700203896

Our O 0 0.008646310307085514
results O 0 0.00866493210196495
support O 0 0.005180882290005684
the O 0 0.003126341849565506
hypothesis O 0 0.027158888056874275
that O 0 0.0013718635309487581
the O 0 0.002150559099391103
under O 0 0.004467022605240345
- O 0 0.013008790090680122
representation O 0 0.00543180713430047
of O 0 0.004098654258996248
missense O 1 0.999995231628418
mutations O 1 0.9999507665634155
is O 0 0.007526507135480642
caused O 1 0.9969590902328491
by O 0 0.006635622121393681
ascertainment O 1 0.9999607801437378
bias O 0 0.04310798645019531
and O 0 0.0012862274888902903
suggest O 0 0.0036720552016049623
that O 0 0.0009398171678185463
a O 0 0.003748588729649782
substantial O 0 0.01034833025187254
burden O 1 0.7432276606559753
of O 0 0.00501848291605711
PAX6 B-Disease 1 0.9999997615814209
- I-Disease 1 0.9877514839172363
related I-Disease 0 0.494971364736557
disease I-Disease 1 1.0
remains O 0 0.014689113013446331
to O 0 0.0013596946373581886
be O 0 0.0024150328245013952
uncovered O 0 0.02252732776105404
. O 0 0.0027558917645365
. O 0 0.004966227803379297

The O 0 0.014665369875729084
chromosomal O 1 0.9978923201560974
order O 0 0.00410649785771966
of O 0 0.0023141768760979176
genes O 1 0.5594090819358826
controlling O 0 0.35457804799079895
the O 0 0.004482452291995287
major O 0 0.03551963344216347
histocompatibility O 1 0.9999963045120239
complex O 0 0.013536514714360237
, O 0 0.0038362920749932528
properdin O 1 0.9998557567596436
factor O 0 0.3977898061275482
B O 1 0.9944474697113037
, O 0 0.002429520944133401
and O 0 0.003078936133533716
deficiency B-Disease 1 1.0
of I-Disease 0 0.0012772449990734458
the I-Disease 0 0.001922237453982234
second I-Disease 0 0.007083119358867407
component I-Disease 0 0.01715695858001709
of I-Disease 0 0.002173209562897682
complement I-Disease 0 0.026478955522179604
. O 0 0.005549522116780281

The O 0 0.005290123634040356
relationship O 0 0.008371724747121334
of O 0 0.0014540835982188582
the O 0 0.004673293326050043
genes O 0 0.39283984899520874
coding O 0 0.08409563452005386
for O 0 0.00442953035235405
HLA O 1 0.9999920129776001
to O 0 0.0023082089610397816
those O 0 0.0018154364079236984
coding O 0 0.05803467705845833
for O 0 0.004598130937665701
properdin O 1 0.9996610879898071
Factor O 0 0.4996291399002075
B O 1 0.9964926838874817
allotypes O 1 0.9993284940719604
and O 0 0.0020005498081445694
for O 0 0.0041146003641188145
deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.001444001798518002
the I-Disease 0 0.0018954328261315823
second I-Disease 0 0.0072286054491996765
component I-Disease 0 0.016460560262203217
of I-Disease 0 0.002293767873197794
complement I-Disease 0 0.044530902057886124
( O 0 0.014688477851450443
C2 O 1 0.9999982118606567
) O 0 0.005116512533277273
was O 0 0.005501728504896164
studied O 0 0.00363599369302392
in O 0 0.0014087650924921036
families O 0 0.004618518054485321
of O 0 0.0029454845935106277
patients O 1 0.9999996423721313
with O 0 0.011409524828195572
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 0 0.009115648455917835

Patients O 1 0.9998928308486938
were O 0 0.0023800430353730917
selected O 0 0.00528239831328392
because O 0 0.0038594806101173162
they O 0 0.0012345843715593219
were O 0 0.0024320369120687246
heterozygous O 1 0.9989770650863647
or O 0 0.00891517847776413
homozygous O 1 0.999762237071991
for O 0 0.01428714394569397
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.01230710744857788

12 O 0 0.016132885590195656
families O 0 0.007822289131581783
with O 0 0.0025733904913067818
15 O 0 0.013503458350896835
matings O 1 0.7744058966636658
informative O 0 0.03024902194738388
for O 0 0.009972996078431606
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.0050416141748428345
found O 0 0.00930372066795826
. O 0 0.006741802673786879

Of O 0 0.0066133057698607445
57 O 0 0.046856071799993515
informative O 0 0.04560910165309906
meioses O 1 0.9990121126174927
, O 0 0.0025036130100488663
two O 0 0.002192619489505887
crossovers O 0 0.040371038019657135
were O 0 0.0015298736980184913
noted O 0 0.0032843875233083963
between O 0 0.0028969512786716223
the O 0 0.015051518566906452
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 1 0.993623673915863
and O 0 0.0014957435196265578
the O 0 0.006192808039486408
HLA O 1 1.0
- O 1 0.6307488679885864
B O 1 0.9978875517845154
gene O 1 0.9753711223602295
, O 0 0.0019445522921159863
with O 0 0.001596499583683908
a O 0 0.008169591426849365
recombinant O 0 0.10100294649600983
fraction O 0 0.026151984930038452
of O 0 0.0036739190109074116
0 O 0 0.03753100335597992
. O 0 0.007078885100781918

035 O 1 0.9774596691131592
. O 0 0.01867830939590931

A O 0 0.040247637778520584
lod O 1 0.8700008392333984
score O 0 0.007257525809109211
of O 0 0.0018532269168645144
13 O 0 0.008592627942562103
was O 0 0.004426395986229181
calculated O 0 0.0064507052302360535
for O 0 0.001982148038223386
linkage O 0 0.059047967195510864
between O 0 0.013307943008840084
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.011938285082578659
HLA O 1 0.9999998807907104
- O 0 0.0719236209988594
B O 1 0.5975012183189392
at O 0 0.003517127363011241
a O 0 0.004974449053406715
maximum O 0 0.012501266784965992
likelihood O 0 0.023763339966535568
value O 0 0.002088928362354636
of O 0 0.0011433030012995005
the O 0 0.003522101091220975
recombinant O 0 0.2746535539627075
fraction O 0 0.0250852108001709
of O 0 0.003441119333729148
0 O 0 0.034022100269794464
. O 0 0.006841904483735561

04 O 1 0.9622111916542053
. O 0 0.01420244388282299

18 O 0 0.020196594297885895
families O 0 0.007129660341888666
with O 0 0.002270297845825553
21 O 0 0.016952188685536385
informative O 0 0.027801457792520523
matings O 0 0.20136721432209015
for O 0 0.001754819881170988
both O 0 0.0033920989371836185
properdin O 1 0.9999291896820068
Factor O 1 0.5402346253395081
B O 1 0.9912322163581848
allotype O 1 0.9966278672218323
and O 0 0.007785094901919365
HLA O 1 0.9999970197677612
- O 0 0.08349375426769257
B O 1 0.9036779403686523
were O 0 0.0031036201398819685
found O 0 0.008037786930799484
. O 0 0.006919161416590214

Of O 0 0.0048781526274979115
72 O 0 0.04564095288515091
informative O 0 0.04053669795393944
meioses O 1 0.9970683455467224
, O 0 0.002754086395725608
three O 0 0.004533595405519009
recombinants O 1 0.9989203214645386
were O 0 0.0026079723611474037
found O 0 0.005507719703018665
, O 0 0.0016961302608251572
giving O 0 0.005588754080235958
a O 0 0.008242812938988209
recombinant O 0 0.11454945057630539
fraction O 0 0.026899097487330437
of O 0 0.0036529048811644316
0 O 0 0.03410310298204422
. O 0 0.007046068087220192

042 O 1 0.9846568703651428
. O 0 0.018465012311935425

A O 0 0.03411445394158363
lod O 0 0.2259528487920761
score O 0 0.007466994691640139
of O 0 0.0018444343004375696
16 O 0 0.010958771221339703
between O 0 0.008503829129040241
HLA O 1 0.9999994039535522
- O 0 0.06737609952688217
B O 1 0.9622575044631958
and O 0 0.003618964459747076
Factor O 0 0.12081626802682877
B O 1 0.9822884798049927
allotypes O 1 0.9975530505180359
was O 0 0.007830108515918255
calculated O 0 0.007588455453515053
at O 0 0.002797492779791355
a O 0 0.0048548271879553795
maximum O 0 0.012542740441858768
likelihood O 0 0.02152131125330925
value O 0 0.0022282220888882875
of O 0 0.0012384438887238503
the O 0 0.0031777445692569017
recombinant O 0 0.16890040040016174
fraction O 0 0.024596592411398888
of O 0 0.0031111566349864006
0 O 0 0.0292801596224308
. O 0 0.005846775136888027

04 O 1 0.9863809943199158
. O 0 0.012615424580872059

A O 0 0.027379244565963745
crossover O 0 0.0648825615644455
was O 0 0.00833615567535162
shown O 0 0.005444268696010113
to O 0 0.0012895247200503945
have O 0 0.002102089114487171
occurred O 0 0.016326315701007843
between O 0 0.0028232838958501816
genes O 0 0.05806355178356171
for O 0 0.0025407420471310616
Factor O 0 0.08145076781511307
B O 1 0.9577816724777222
and O 0 0.005965924821794033
HLA O 1 0.9999997615814209
- O 0 0.09018999338150024
D O 1 0.9923803806304932
, O 0 0.001964446622878313
in O 0 0.0017675572307780385
which O 0 0.005629995372146368
HLA O 1 0.9999997615814209
- O 0 0.09090521931648254
D O 1 0.9994751811027527
segregared O 1 0.9988613128662109
with O 0 0.007914881221950054
HLA O 1 0.9999997615814209
- O 0 0.030810045078396797
A O 0 0.013206916861236095
and O 0 0.003891599364578724
B O 1 0.8865256309509277
. O 0 0.007917195558547974

These O 0 0.003167502349242568
studies O 0 0.004157797433435917
suggest O 0 0.005153796169906855
that O 0 0.0008911245968192816
the O 0 0.002352543408051133
genes O 0 0.05112335830926895
for O 0 0.0022101840004324913
Factor O 1 0.797950804233551
B O 1 0.999479353427887
and O 0 0.0109813641756773
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.0018080411246046424
located O 0 0.006077352445572615
outside O 0 0.0030045313760638237
those O 0 0.0015981848118826747
for O 0 0.004001706838607788
HLA O 1 0.9999997615814209
, O 0 0.0021653706207871437
that O 0 0.0008609355427324772
the O 0 0.0013902512146160007
order O 0 0.0021626409143209457
of O 0 0.0021653776057064533
genese O 1 0.9999817609786987
is O 0 0.011411391198635101
HLA O 1 0.9999966621398926
- O 0 0.03219123184680939
A O 0 0.015822041779756546
, O 0 0.003793597687035799
- O 0 0.03487090766429901
B O 1 0.9816160202026367
, O 0 0.0035106558352708817
- O 0 0.04360990226268768
D O 1 0.9759900569915771
, O 0 0.003353297244757414
Factor O 0 0.31384411454200745
B O 1 0.9952827095985413
allotype O 1 0.9998173117637634
, O 0 0.013488507829606533
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 0.0021090477239340544
that O 0 0.0008611311204731464
the O 0 0.0030350808519870043
genes O 0 0.1388169378042221
coding O 0 0.1391095519065857
for O 0 0.010446417145431042
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.004327358677983284
Factor O 1 0.9288896918296814
B O 1 0.9980499744415283
allotypes O 1 0.9963751435279846
are O 0 0.001416014856658876
approximately O 0 0.007180789485573769
3 O 0 0.014155467040836811
- O 0 0.0313105434179306
- O 0 0.02944692224264145
5 O 0 0.013628069311380386
centimorgans O 1 0.9658483266830444
from O 0 0.0034881283063441515
the O 0 0.006138958968222141
HLA O 1 0.9999988079071045
- O 0 0.024104546755552292
A O 0 0.014556242153048515
and O 0 0.005101541057229042
HLA O 1 0.9999992847442627
- O 0 0.3138871490955353
B O 1 0.9990066885948181
loci O 1 0.9996535778045654
, O 0 0.002080879407003522
and O 0 0.0008632062817923725
that O 0 0.0009082290926016867
the O 0 0.002855271100997925
apparent O 0 0.07500698417425156
lack O 0 0.00806890707463026
of O 0 0.002104502171278
recombinants O 1 0.9998675584793091
between O 0 0.002061728620901704
the O 0 0.003230796428397298
Factor O 0 0.39128395915031433
B O 1 0.9984147548675537
gene O 1 0.998701810836792
and O 0 0.011720064096152782
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 1 0.9997015595436096
suggests O 0 0.012690674513578415
that O 0 0.0009082871256396174
these O 0 0.000652556715067476
two O 0 0.0021731765009462833
genes O 0 0.07769398391246796
lie O 0 0.009934673085808754
in O 0 0.0016917007742449641
close O 0 0.007381795905530453
proximity O 0 0.012145544402301311
to O 0 0.0013992845779284835
one O 0 0.0032016965560615063
another O 0 0.011731530539691448
. O 0 0.00708995945751667

Distribution O 0 0.016497187316417694
of O 0 0.003562175203114748
emerin O 1 0.9993062019348145
and O 0 0.0038019646890461445
lamins O 1 0.9977884292602539
in O 0 0.0023964205756783485
the O 0 0.0043825493194162846
heart O 1 0.9999803304672241
and O 0 0.0015804509166628122
implications O 0 0.024378638714551926
for O 0 0.0031150956638157368
Emery B-Disease 1 0.9999611377716064
- I-Disease 1 0.9997075200080872
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.012866993434727192

Emerin O 1 0.9981130361557007
is O 0 0.006964484695345163
a O 0 0.007560363970696926
nuclear O 0 0.010151692666113377
membrane O 0 0.07063089311122894
protein O 0 0.03571316599845886
which O 0 0.001589628984220326
is O 0 0.0032433788292109966
missing O 0 0.0186799056828022
or O 0 0.005726488307118416
defective O 1 0.9997871518135071
in O 0 0.004363726358860731
Emery B-Disease 1 0.9999679327011108
- I-Disease 1 0.9996522665023804
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.22720317542552948
EDMD B-Disease 1 0.9999998807907104
) O 0 0.008278990164399147
. O 0 0.006407155655324459

It O 0 0.005007817409932613
is O 0 0.002633128548040986
one O 0 0.002757504116743803
member O 0 0.0038017716724425554
of O 0 0.0013308413326740265
a O 0 0.006299792788922787
family O 0 0.013448813930153847
of O 0 0.004983364138752222
lamina O 1 0.9999595880508423
- O 0 0.04333404451608658
associated O 0 0.01352740079164505
proteins O 0 0.018319405615329742
which O 0 0.0020429319702088833
includes O 0 0.006643359549343586
LAP1 O 1 0.9999927282333374
, O 0 0.004795256070792675
LAP2 O 1 0.9999803304672241
and O 0 0.006044928915798664
lamin O 1 0.9999847412109375
B O 1 0.9983394145965576
receptor O 1 0.9949813485145569
( O 0 0.02276688814163208
LBR O 1 0.9993112087249756
) O 0 0.009855471551418304
. O 0 0.00837690755724907

A O 0 0.019245436415076256
panel O 0 0.0110850278288126
of O 0 0.003086855635046959
16 O 0 0.029874060302972794
monoclonal O 1 0.9997902512550354
antibodies O 1 0.9995710253715515
( O 0 0.01450949814170599
mAbs O 1 0.9981611371040344
) O 0 0.005777925718575716
has O 0 0.0035063312388956547
been O 0 0.004622621927410364
mapped O 0 0.022225257009267807
to O 0 0.001523960498161614
six O 0 0.0028762053698301315
specific O 0 0.0024771681055426598
sites O 0 0.0032855302561074495
throughout O 0 0.004250094294548035
the O 0 0.005572629626840353
emerin O 1 0.9985005855560303
molecule O 0 0.059271588921546936
using O 0 0.012572024948894978
phage O 1 0.9902695417404175
- O 0 0.04555920884013176
displayed O 0 0.02400417998433113
peptide O 0 0.11913634836673737
libraries O 0 0.008869284763932228
and O 0 0.0015855024103075266
has O 0 0.002899313112720847
been O 0 0.002456613816320896
used O 0 0.0018581448821350932
to O 0 0.0029963040724396706
localize O 1 0.9973918199539185
emerin O 1 0.990452766418457
in O 0 0.0032189632765948772
human O 0 0.009436299093067646
and O 0 0.003954124636948109
rabbit O 1 0.9999996423721313
heart O 1 0.9999984502792358
. O 0 0.008577496744692326

Several O 0 0.013561459258198738
mAbs O 1 0.9605423808097839
against O 0 0.006464889273047447
different O 0 0.004131888039410114
emerin O 1 0.9999251365661621
epitopes O 1 0.9948305487632751
did O 0 0.005693606100976467
not O 0 0.00246255612000823
recognize O 0 0.021882664412260056
intercalated O 1 0.6516883373260498
discs O 0 0.026283329352736473
in O 0 0.002232918282970786
the O 0 0.006122319959104061
heart O 1 0.9999947547912598
, O 0 0.0027056641411036253
though O 0 0.004192308522760868
they O 0 0.00240738014690578
recognized O 0 0.0257691890001297
cardiomyocyte O 1 0.9994994401931763
nuclei O 0 0.04900594428181648
strongly O 0 0.011881577782332897
, O 0 0.0015152075793594122
both O 0 0.0015852050855755806
at O 0 0.0029741046018898487
the O 0 0.0036956961266696453
rim O 0 0.0346146821975708
and O 0 0.0016744246240705252
in O 0 0.0037608447019010782
intranuclear O 1 0.9998519420623779
spots O 0 0.05047140643000603
or O 0 0.006257338915020227
channels O 0 0.018770480528473854
. O 0 0.007634232752025127

A O 0 0.052258193492889404
polyclonal O 1 0.9998193383216858
rabbit O 1 0.9999527931213379
antiserum O 1 0.9981895089149475
against O 0 0.015270991250872612
emerin O 1 0.9991973042488098
did O 0 0.005962408147752285
recognize O 0 0.012483706697821617
both O 0 0.0021093704272061586
nuclear O 0 0.006848037242889404
membrane O 0 0.05010027438402176
and O 0 0.0031698853708803654
intercalated O 1 0.9814053177833557
discs O 0 0.02986597642302513
but O 0 0.00264262268319726
, O 0 0.0018427494214847684
after O 0 0.012424761429429054
affinity O 0 0.04786200821399689
purification O 0 0.03840329498052597
against O 0 0.0033477558754384518
a O 0 0.006660454906523228
pure O 0 0.020525041967630386
- O 0 0.042295608669519424
emerin O 1 0.995030403137207
band O 0 0.022390248253941536
on O 0 0.0020153748337179422
a O 0 0.005258566699922085
western O 0 0.01023511216044426
blot O 1 0.9997542500495911
, O 0 0.002173579763621092
it O 0 0.0027586084324866533
stained O 1 0.9824062585830688
only O 0 0.002240063389763236
the O 0 0.002923584310337901
nuclear O 0 0.009360084310173988
membrane O 0 0.0746055543422699
. O 0 0.008793103508651257

These O 0 0.002696954645216465
results O 0 0.00714298477396369
would O 0 0.0019474121509119868
not O 0 0.0012473162496462464
be O 0 0.0012799350079149008
expected O 0 0.004091575276106596
if O 0 0.005892592947930098
immunostaining O 1 0.9912460446357727
at O 0 0.010394140146672726
intercalated O 1 0.9725787043571472
discs O 0 0.026367470622062683
were O 0 0.0020948927849531174
due O 0 0.007166003808379173
to O 0 0.0012397044338285923
a O 0 0.0037432806566357613
product O 0 0.004179575480520725
of O 0 0.0015763584524393082
the O 0 0.0062421164475381374
emerin O 1 0.9999985694885254
gene O 1 0.9997619986534119
and O 0 0.0018139610765501857
, O 0 0.001707159448415041
therefore O 0 0.003934813197702169
, O 0 0.0014280445175245404
cast O 0 0.005452960263937712
some O 0 0.001854068599641323
doubt O 0 0.009825953282415867
upon O 0 0.0035156835801899433
the O 0 0.0026401907671242952
hypothesis O 0 0.03822038695216179
that O 0 0.0056703402660787106
cardiac B-Disease 1 1.0
defects I-Disease 1 0.9999855756759644
in O 0 0.005650282837450504
EDMD B-Disease 1 0.9999998807907104
are O 0 0.0026158278342336416
caused O 1 0.9943728446960449
by O 0 0.003329695900902152
absence O 0 0.015343669801950455
of O 0 0.0031200337689369917
emerin O 1 0.9994103908538818
from O 0 0.007257265504449606
intercalated O 1 0.9845584034919739
discs O 0 0.04122069478034973
. O 0 0.007769844960421324

Although O 0 0.016746075823903084
emerin O 1 0.9962020516395569
was O 0 0.008765795268118382
abundant O 0 0.007351837586611509
in O 0 0.0013337155105546117
the O 0 0.002963690785691142
membranes O 1 0.8058810830116272
of O 0 0.0038215722888708115
cardiomyocyte O 1 0.9999947547912598
nuclei O 0 0.03998731076717377
, O 0 0.0018906594486907125
it O 0 0.0018972324905917048
was O 0 0.0073016793467104435
absent O 0 0.025925420224666595
from O 0 0.002086681080982089
many O 0 0.0018899630522355437
non O 0 0.01595922000706196
- O 1 0.640751838684082
myocyte O 1 0.9999920129776001
cells O 0 0.059269219636917114
in O 0 0.0024556193966418505
the O 0 0.006277923472225666
heart O 1 0.999984622001648
. O 0 0.00867498479783535

This O 0 0.0044764988124370575
distribution O 0 0.008503202348947525
of O 0 0.0036097595002502203
emerin O 1 0.999900221824646
was O 0 0.007972723804414272
similar O 0 0.0027475852984935045
to O 0 0.0008713207789696753
that O 0 0.0009400209528394043
of O 0 0.0024664467200636864
lamin O 1 0.9999215602874756
A O 0 0.012130986899137497
, O 0 0.001839841017499566
a O 0 0.007132495287805796
candidate O 0 0.02822173945605755
gene O 1 0.9826001524925232
for O 0 0.0021536732092499733
an O 0 0.006617918144911528
autosomal O 1 0.9999963045120239
form O 0 0.011484900489449501
of O 0 0.004503618460148573
EDMD B-Disease 1 0.9999997615814209
. O 0 0.01097661629319191

In O 0 0.006141947116702795
contrast O 0 0.0144013287499547
, O 0 0.006717635318636894
lamin O 1 0.9999415874481201
B1 O 1 0.9999512434005737
was O 0 0.019221678376197815
absent O 0 0.04532666876912117
from O 0 0.006900608539581299
cardiomyocyte O 1 0.9994373917579651
nuclei O 0 0.03382911905646324
, O 0 0.0019050645641982555
showing O 0 0.010060148313641548
that O 0 0.004661848768591881
lamin O 1 0.9999849796295166
B1 O 1 0.9999961853027344
is O 0 0.0035765687935054302
not O 0 0.0010925167007371783
essential O 0 0.004116598516702652
for O 0 0.0013952809385955334
localization O 0 0.04313424229621887
of O 0 0.002478322247043252
emerin O 1 0.9994489550590515
to O 0 0.0016346648335456848
the O 0 0.004029728472232819
nuclear O 0 0.012578598223626614
lamina O 1 0.9993174076080322
. O 0 0.009428724646568298

Lamin O 1 0.9999030828475952
B1 O 1 0.9999295473098755
is O 0 0.005866860039532185
also O 0 0.0022930949926376343
almost O 0 0.008253144100308418
completely O 0 0.02158275432884693
absent O 0 0.050511445850133896
from O 0 0.011620745994150639
skeletal O 1 0.9999949932098389
muscle O 1 0.9999018907546997
nuclei O 0 0.05797366052865982
. O 0 0.0080513134598732

In O 0 0.01314128004014492
EDMD B-Disease 1 0.9999920129776001
, O 0 0.002365291118621826
the O 0 0.0018358338857069612
additional O 0 0.0033852660562843084
absence O 0 0.014358961023390293
of O 0 0.004474157467484474
lamin O 1 0.9999979734420776
B1 O 1 0.9999977350234985
from O 0 0.0099320188164711
heart O 1 0.9999967813491821
and O 0 0.006377192214131355
skeletal O 1 0.9999988079071045
muscle O 1 0.9999933242797852
nuclei O 0 0.03812791407108307
which O 0 0.002808528719469905
already O 0 0.00993096362799406
lack O 0 0.025240875780582428
emerin O 1 0.9999806880950928
may O 0 0.008851813152432442
offer O 0 0.002863512607291341
an O 0 0.002142562996596098
alternative O 0 0.008967027999460697
explanation O 0 0.008050339296460152
of O 0 0.001650749472901225
why O 0 0.007176046259701252
these O 0 0.00243582995608449
tissues O 1 0.9998728036880493
are O 0 0.0015172275016084313
particularly O 0 0.012306923978030682
affected O 1 0.9106225967407227
. O 0 0.003204906126484275
. O 0 0.005902232602238655

Genetic O 0 0.08622074872255325
mapping O 0 0.018078317865729332
of O 0 0.0015939250588417053
the O 0 0.005530653987079859
copper B-Disease 0 0.33919844031333923
toxicosis I-Disease 1 0.9999229907989502
locus O 1 0.9994107484817505
in O 0 0.00753599451854825
Bedlington O 1 0.9998992681503296
terriers O 1 0.9975544810295105
to O 0 0.008821442723274231
dog O 1 0.9998871088027954
chromosome O 1 0.9999144077301025
10 O 0 0.007242390885949135
, O 0 0.0010952090378850698
in O 0 0.0013801942113786936
a O 0 0.006159366574138403
region O 0 0.015601865947246552
syntenic O 1 0.9993540644645691
to O 0 0.0034700706601142883
human O 0 0.020516306161880493
chromosome O 1 0.9998390674591064
region O 0 0.02858908660709858
2p13 O 1 0.9999023675918579
- O 0 0.22173114120960236
p16 O 1 0.999526858329773
. O 0 0.01046561449766159

Abnormal O 1 0.9998557567596436
hepatic B-Disease 1 0.9999991655349731
copper I-Disease 0 0.10853283107280731
accumulation I-Disease 0 0.33000892400741577
is O 0 0.003240803722292185
recognized O 0 0.006763524375855923
as O 0 0.0023373097646981478
an O 0 0.007528787013143301
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 0.004260622896254063
man O 1 0.7033802270889282
, O 0 0.004755362402647734
mouse O 1 0.9999433755874634
, O 0 0.0053410460241138935
rat O 1 0.9999855756759644
and O 0 0.005342095624655485
dog O 1 0.9998155236244202
. O 0 0.00869035255163908

The O 0 0.007270669098943472
major O 0 0.016519559547305107
cause O 1 0.9756166934967041
of O 0 0.006722645368427038
hepatic B-Disease 1 1.0
copper I-Disease 0 0.3680952489376068
accumulation I-Disease 0 0.14697137475013733
in O 0 0.002400066703557968
man O 0 0.012230221182107925
is O 0 0.002417383249849081
a O 0 0.008476341143250465
dysfunctional O 1 0.9999831914901733
ATP7B O 1 0.9999997615814209
gene O 1 0.999489426612854
, O 0 0.007575627416372299
causing O 1 0.9999899864196777
Wilson B-Disease 1 0.9999904632568359
disease I-Disease 1 1.0
( O 0 0.03440483286976814
WD B-Disease 1 0.999998927116394
) O 0 0.00814858265221119
. O 0 0.00511563615873456

Mutations O 1 0.9962475895881653
in O 0 0.0034111172426491976
the O 0 0.007437367457896471
ATP7B O 1 0.9999861717224121
genes O 0 0.47390446066856384
have O 0 0.0022068824619054794
also O 0 0.001655668136663735
been O 0 0.004100694786757231
demonstrated O 0 0.009754547849297523
in O 0 0.0037227447610348463
mouse O 1 0.9998714923858643
and O 0 0.004930056165903807
rat O 1 0.9999545812606812
. O 0 0.010266948491334915

The O 0 0.020732054486870766
ATP7B O 1 0.9999947547912598
gene O 1 0.9991748929023743
has O 0 0.004739515017718077
been O 0 0.0043405224569141865
excluded O 0 0.014557145535945892
in O 0 0.0014211984816938639
the O 0 0.0024961603339761496
much O 0 0.007914019748568535
rarer O 1 0.9997175335884094
human O 0 0.01843457669019699
copper B-Disease 1 0.9282822012901306
overload I-Disease 1 0.9999988079071045
disease O 1 1.0
non B-Disease 0 0.0174925047904253
- I-Disease 0 0.02818964049220085
Indian I-Disease 0 0.020326655358076096
childhood I-Disease 1 0.9999508857727051
cirrhosis I-Disease 1 1.0
, O 0 0.003912255167961121
indicating O 0 0.06681062281131744
genetic O 1 0.9204936027526855
heterogeneity O 1 0.9545888304710388
. O 0 0.007042426150292158

By O 0 0.006583986338227987
investigating O 0 0.01629476435482502
the O 0 0.005047877784818411
common O 0 0.4833984076976776
autosomal O 1 1.0
recessive O 1 1.0
copper B-Disease 1 0.9967072606086731
toxicosis I-Disease 1 0.9999977350234985
( O 0 0.027463428676128387
CT B-Disease 1 0.9999964237213135
) O 0 0.0049856798723340034
in O 0 0.004178706556558609
Bedlington O 1 0.9999972581863403
terriers O 1 0.9997251629829407
, O 0 0.0022691404446959496
we O 0 0.0010269039776176214
have O 0 0.0013442232739180326
identified O 0 0.007313920650631189
a O 0 0.00393341388553381
new O 0 0.004428159445524216
locus O 1 0.9999297857284546
involved O 0 0.012133672833442688
in O 0 0.006383111234754324
progressive O 1 0.9999998807907104
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.00930765550583601

We O 0 0.005463384557515383
examined O 0 0.024835241958498955
whether O 0 0.004563589114695787
the O 0 0.010727740824222565
WD B-Disease 1 0.9999990463256836
gene O 1 0.9996683597564697
ATP7B O 1 0.9999010562896729
was O 0 0.010638413950800896
also O 0 0.0044752792455255985
causative O 1 0.992256760597229
for O 0 0.005865638609975576
CT B-Disease 1 0.9999653100967407
by O 0 0.003723498433828354
investigating O 0 0.015704676508903503
the O 0 0.007397241424769163
chromosomal O 1 0.9997692704200745
co O 0 0.04177945479750633
- O 0 0.030463991686701775
localization O 0 0.06236732378602028
of O 0 0.00447869673371315
ATP7B O 1 0.9999805688858032
and O 0 0.0055824872106313705
C04107 O 1 0.9958642721176147
, O 0 0.0023694962728768587
using O 0 0.004839545581489801
fluorescence O 0 0.08278267830610275
in O 0 0.004651984665542841
situ O 1 0.9209142327308655
hybridization O 0 0.09290032833814621
( O 0 0.010500004515051842
FISH O 0 0.042563583701848984
) O 0 0.005319731310009956
. O 0 0.006013609003275633

C04107 O 1 0.997042715549469
is O 0 0.005096545908600092
an O 0 0.0033751619048416615
anonymous O 0 0.04190206527709961
microsatellite O 1 0.9942881464958191
marker O 0 0.08077207207679749
closely O 0 0.010414051823318005
linked O 0 0.040625881403684616
to O 0 0.007356397341936827
CT B-Disease 1 0.99998939037323
. O 0 0.009031531400978565

However O 0 0.00935665424913168
, O 0 0.006647331174463034
BAC O 1 0.9999740123748779
clones O 1 0.9254708290100098
containing O 0 0.024435782805085182
ATP7B O 1 0.9997344613075256
and O 0 0.0041086431592702866
C04107 O 1 0.9973084926605225
mapped O 0 0.03074045106768608
to O 0 0.0020804675295948982
the O 0 0.007447029929608107
canine O 1 0.9999654293060303
chromosome O 1 0.9995796084403992
regions O 0 0.026845183223485947
CFA22q11 O 1 0.9994450211524963
and O 0 0.004607187584042549
CFA10q26 O 1 0.999946117401123
, O 0 0.0026539075188338757
respectively O 0 0.006165920756757259
, O 0 0.001789660775102675
demonstrating O 0 0.012681572698056698
that O 0 0.0041755749844014645
WD B-Disease 1 0.9999940395355225
cannot O 0 0.009282003156840801
be O 0 0.004067339468747377
homologous O 0 0.1253610998392105
to O 0 0.008166114799678326
CT B-Disease 1 0.9999085664749146
. O 0 0.010483835823833942

The O 0 0.010015243664383888
copper O 0 0.04103950411081314
transport O 0 0.024070074781775475
genes O 1 0.5606446266174316
CTR1 O 1 0.9999256134033203
and O 0 0.005362527444958687
CTR2 O 1 0.9999860525131226
were O 0 0.0021092763636261225
also O 0 0.0024000529665499926
excluded O 0 0.015953877940773964
as O 0 0.00250974390655756
candidate O 0 0.01911374181509018
genes O 0 0.1589772254228592
for O 0 0.00609190296381712
CT B-Disease 1 0.9999943971633911
since O 0 0.006715345196425915
they O 0 0.0009449084172956645
both O 0 0.0015498246066272259
mapped O 0 0.025477631017565727
to O 0 0.004606831818819046
canine O 1 0.9999810457229614
chromosome O 1 0.9998190999031067
region O 0 0.030065953731536865
CFA11q22 O 1 0.9996970891952515
. O 0 0.010684851557016373

2 O 0 0.03655974939465523
- O 0 0.04152747616171837
22 O 0 0.022750191390514374
. O 0 0.008172113448381424

5 O 0 0.030902430415153503
. O 0 0.009420467540621758

A O 0 0.030270712450146675
transcribed O 0 0.06485207378864288
sequence O 0 0.024168718606233597
identified O 0 0.011734806932508945
from O 0 0.0024371652398258448
the O 0 0.005329749546945095
C04107 O 1 0.999543309211731
- O 0 0.03288856893777847
containing O 0 0.020322971045970917
BAC O 1 0.9999860525131226
was O 0 0.009202802553772926
found O 0 0.004360082093626261
to O 0 0.0013005243381485343
be O 0 0.0023043565452098846
homologous O 0 0.07382237166166306
to O 0 0.002344780135899782
a O 0 0.010630716569721699
gene O 1 0.8153558969497681
expressed O 0 0.007737079635262489
from O 0 0.0043921987526118755
human O 0 0.02131217159330845
chromosome O 1 0.9998821020126343
2p13 O 1 0.9998408555984497
- O 0 0.10322284698486328
p16 O 1 0.9996398687362671
, O 0 0.0030481840949505568
a O 0 0.006148127838969231
region O 0 0.011823712848126888
devoid O 0 0.026402201503515244
of O 0 0.0013739505084231496
any O 0 0.0032401399221271276
positional O 1 0.613269031047821
candidate O 0 0.03359124809503555
genes O 0 0.21038246154785156
. O 0 0.008154335431754589

Molecular O 0 0.0425272062420845
analysis O 0 0.00565155828371644
of O 0 0.0019735535606741905
the O 0 0.008667312562465668
APC B-Disease 1 0.9999943971633911
gene O 1 0.916238009929657
in O 0 0.0058730728924274445
205 O 0 0.08027856796979904
families O 0 0.009381434880197048
: O 0 0.005339374765753746
extended O 0 0.028806284070014954
genotype O 1 0.9998934268951416
- O 1 0.6137170195579529
phenotype O 1 0.9999897480010986
correlations O 0 0.05676854029297829
in O 0 0.006065148860216141
FAP B-Disease 1 0.9999996423721313
and O 0 0.0016772121889516711
evidence O 0 0.0019119386561214924
for O 0 0.001041398267261684
the O 0 0.001953995320945978
role O 0 0.007692181039601564
of O 0 0.004018327686935663
APC B-Disease 1 0.9999964237213135
amino O 0 0.0762007087469101
acid O 0 0.36017587780952454
changes O 0 0.012630275450646877
in O 0 0.0137174092233181
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.9999946355819702
. O 0 0.010090700350701809

BACKGROUND O 0 0.04633598402142525
/ O 0 0.0499841533601284
AIMS O 0 0.018991641700267792
The O 0 0.0024379207752645016
development O 0 0.004232081584632397
of O 0 0.013533879071474075
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.0022227775771170855
a O 0 0.0056969355791807175
variable O 0 0.029056398198008537
range O 0 0.003675787476822734
of O 0 0.0021689983550459146
extracolonic O 1 0.9999781847000122
manifestations O 1 0.9982602000236511
in O 0 0.009475341998040676
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.8133327960968018
FAP B-Disease 1 1.0
) O 0 0.005309816915541887
is O 0 0.0019944601226598024
the O 0 0.0016932954313233495
result O 0 0.004485973622649908
of O 0 0.0007926094112917781
the O 0 0.002439359202980995
dominant O 1 0.9797914624214172
inheritance O 1 0.9983779191970825
of O 0 0.017081283032894135
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 0.06923583149909973
APC B-Disease 1 0.9999988079071045
) O 0 0.01315402239561081
gene O 1 0.9998278617858887
mutations O 1 0.9997259974479675
. O 0 0.007336134556680918

In O 0 0.003919929265975952
this O 0 0.0019267713651061058
study O 0 0.004088681656867266
, O 0 0.0017366416286677122
direct O 0 0.010274642147123814
mutation O 1 0.9997199177742004
analysis O 0 0.00369281112216413
of O 0 0.0011506687151268125
the O 0 0.006830343510955572
APC B-Disease 1 0.9999996423721313
gene O 1 0.9972164630889893
was O 0 0.006901491433382034
performed O 0 0.006825117394328117
to O 0 0.0018984589260071516
determine O 0 0.01589636504650116
genotype O 1 0.9998093247413635
- O 0 0.4138035774230957
phenotype O 1 0.9998878240585327
correlations O 0 0.04155373200774193
for O 0 0.002478797221556306
nine O 0 0.011765267699956894
extracolonic O 1 0.9998149275779724
manifestations O 1 0.8159906268119812
and O 0 0.0009059526491910219
to O 0 0.001184547320008278
investigate O 0 0.009165368974208832
the O 0 0.004090885631740093
incidence O 1 0.9999876022338867
of O 0 0.0048567005433142185
APC B-Disease 1 0.9999997615814209
mutations O 1 0.9986839890480042
in O 0 0.003919609356671572
non O 0 0.028480155393481255
- O 1 0.9999657869338989
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.011611493304371834

METHODS O 0 0.019006313756108284
The O 0 0.013620590791106224
APC B-Disease 1 0.9999784231185913
gene O 1 0.9930499792098999
was O 0 0.01031127292662859
analysed O 0 0.03184492513537407
in O 0 0.0033768820576369762
190 O 0 0.0491437092423439
unrelated O 0 0.15887638926506042
FAP B-Disease 1 0.9999951124191284
and O 0 0.0029567412566393614
15 O 0 0.009706954471766949
non O 0 0.027800604701042175
- O 1 0.9999456405639648
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.999974250793457
using O 0 0.009848242625594139
denaturing O 1 0.9972754120826721
gradient O 1 0.9158785939216614
gel O 1 0.9966513514518738
electrophoresis O 0 0.16873471438884735
, O 0 0.0026666852645576
the O 0 0.005116530228406191
protein O 0 0.07584841549396515
truncation O 1 0.9729282855987549
test O 0 0.01565343141555786
, O 0 0.00148473447188735
and O 0 0.001339035457931459
direct O 0 0.010965011082589626
sequencing O 0 0.06665433198213577
. O 0 0.007595356088131666

RESULTS O 0 0.058084748685359955
Chain O 0 0.38411301374435425
terminating O 0 0.09316373616456985
signals O 0 0.014682069420814514
were O 0 0.0015655882889404893
only O 0 0.002218530047684908
identified O 0 0.01163480244576931
in O 0 0.0037483132909983397
patients O 1 0.9999738931655884
belonging O 0 0.013018246740102768
to O 0 0.002031506272032857
the O 0 0.008328016847372055
FAP B-Disease 1 1.0
group O 0 0.018273616209626198
( O 0 0.012199372053146362
105 O 1 0.6253064870834351
patients O 1 0.9999914169311523
) O 0 0.00616186298429966
. O 0 0.006149992812424898

Amino O 0 0.1243986189365387
acid O 0 0.106521375477314
changes O 0 0.006489080842584372
were O 0 0.001593274064362049
identified O 0 0.008051694370806217
in O 0 0.0017850063741207123
four O 0 0.006450021173804998
patients O 1 0.9999963045120239
, O 0 0.0014981903368607163
three O 0 0.0014423157554119825
of O 0 0.0016130459262058139
whom O 0 0.009420559741556644
belonged O 0 0.014315461739897728
to O 0 0.0012645544484257698
the O 0 0.0026423376984894276
non O 0 0.015748320147395134
- O 1 0.8061087131500244
FAP O 1 0.9999998807907104
group O 0 0.01678537204861641
of O 0 0.15277954936027527
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999992847442627
. O 0 0.007499673403799534

Genotype O 1 0.999911904335022
- O 1 0.8793073296546936
phenotype O 1 0.9999876022338867
correlations O 0 0.07159801572561264
identified O 0 0.01786281354725361
significant O 0 0.006608244962990284
differences O 0 0.003464651294052601
in O 0 0.0010130956070497632
the O 0 0.0016242810525000095
nature O 0 0.0039090560749173164
of O 0 0.0012363961432129145
certain O 0 0.005850786808878183
extracolonic O 1 0.9999607801437378
manifestations O 1 0.9986466765403748
in O 0 0.009117035195231438
FAP B-Disease 1 1.0
patients O 1 0.9999909400939941
belonging O 0 0.015899039804935455
to O 0 0.0020780726335942745
three O 0 0.006302235182374716
mutation O 1 0.9998453855514526
subgroups O 0 0.11857718229293823
. O 0 0.008215503767132759

CONCLUSIONS O 0 0.0324862040579319
Extended O 0 0.04912205785512924
genotype O 1 0.9999125003814697
- O 0 0.46886733174324036
phenotype O 1 0.9999754428863525
correlations O 0 0.043371446430683136
made O 0 0.0014548745239153504
in O 0 0.0013347356580197811
this O 0 0.001519112614914775
study O 0 0.005129171535372734
may O 0 0.005101492628455162
have O 0 0.0011282762279734015
the O 0 0.0018838976975530386
potential O 0 0.006462923251092434
to O 0 0.001307005062699318
determine O 0 0.003267590655013919
the O 0 0.0016371679957956076
most O 0 0.002189828548580408
appropriate O 0 0.005611323285847902
surveillance O 0 0.023024264723062515
and O 0 0.004473359324038029
prophylactic O 1 0.999993085861206
treatment O 1 0.9999204874038696
regimens O 1 0.9998513460159302
for O 0 0.0020613374654203653
those O 0 0.004039575811475515
patients O 1 0.9999912977218628
with O 0 0.004987926688045263
mutations O 1 0.9999570846557617
associated O 0 0.008184932172298431
with O 0 0.0017913037445396185
life O 0 0.014666080474853516
threatening O 1 0.9987646341323853
conditions O 0 0.018537981435656548
. O 0 0.0065771290101110935

This O 0 0.004231784027069807
study O 0 0.004280441906303167
also O 0 0.001745298388414085
provided O 0 0.0022859263699501753
evidence O 0 0.0016283899312838912
for O 0 0.0012060002190992236
the O 0 0.003813044400885701
pathological O 1 0.9878902435302734
nature O 0 0.005576978903263807
of O 0 0.0021122009493410587
amino O 0 0.06699560582637787
acid O 0 0.10860496759414673
changes O 0 0.008067240007221699
in O 0 0.00341208977624774
APC O 1 0.9999953508377075
associated O 0 0.009107761085033417
with O 0 0.0016431879485026002
both O 0 0.004538077861070633
FAP B-Disease 1 0.9999998807907104
and O 0 0.0037600796204060316
non O 0 0.04020344465970993
- O 1 0.9998718500137329
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999984502792358
. O 0 0.004336785990744829
. O 0 0.005397266708314419

Inherited B-Disease 1 0.9999998807907104
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 0.30783963203430176
cancer B-Disease 1 1.0
risk O 1 0.9543721079826355
of O 0 0.002478352515026927
the O 0 0.009573820978403091
APC O 1 0.999998927116394
I1307K O 1 0.9996464252471924
polymorphism O 1 0.9067510366439819
. O 0 0.01135125383734703

Germ O 1 0.9566279053688049
- O 0 0.03691922128200531
line O 0 0.01104655396193266
and O 0 0.0035143676213920116
somatic O 1 0.9848949313163757
truncating O 1 0.9987653493881226
mutations O 1 0.9946469664573669
of O 0 0.0023556139785796404
the O 0 0.008849178440868855
APC B-Disease 1 0.9999996423721313
gene O 1 0.9922124743461609
are O 0 0.0013971944572404027
thought O 0 0.00793806929141283
to O 0 0.004036793485283852
initiate O 1 0.9963273406028748
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.9999998807907104
formation O 0 0.03894304111599922
in O 0 0.008986664935946465
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.013987504877150059
sporadic O 1 0.9999973773956299
colorectal O 1 1.0
carcinogenesis O 1 0.9999977350234985
, O 0 0.003937332890927792
respectively O 0 0.008796029724180698
. O 0 0.005255666561424732

Recently O 0 0.023932626470923424
, O 0 0.0021866769529879093
an O 0 0.004463500343263149
isoleucine O 1 0.9992504715919495
- O 0 0.05162372440099716
- O 0 0.06506693363189697
> O 1 0.9613931179046631
lysine O 1 0.9846737384796143
polymorphism O 0 0.19643238186836243
at O 0 0.011694822460412979
codon O 1 0.6369895935058594
1307 O 1 0.9945617318153381
( O 0 0.019797079265117645
I1307K O 1 0.9858002662658691
) O 0 0.0035377112217247486
of O 0 0.0015887325862422585
the O 0 0.007876363582909107
APC B-Disease 1 0.9999994039535522
gene O 1 0.9976606369018555
has O 0 0.006391153670847416
been O 0 0.004895502235740423
identified O 0 0.009752802550792694
in O 0 0.00220165541395545
6 O 0 0.014056739397346973
% O 0 0.007682312745600939
- O 0 0.02358628623187542
7 O 0 0.013954278081655502
% O 0 0.0035308408550918102
of O 0 0.001688920776359737
the O 0 0.0058316802605986595
Ashkenazi O 1 0.9991990923881531
Jewish O 0 0.016794662922620773
population O 0 0.01220086682587862
. O 0 0.006840313319116831

To O 0 0.004615474957972765
assess O 0 0.020335815846920013
the O 0 0.004148000385612249
risk O 0 0.32462137937545776
of O 0 0.0014962487621232867
this O 0 0.0026695618871599436
common O 0 0.024853605777025223
APC B-Disease 1 0.9999963045120239
allelic O 1 0.9998106360435486
variant O 1 0.9991586208343506
in O 0 0.016662953421473503
colorectal O 1 1.0
carcinogenesis O 1 0.9999979734420776
, O 0 0.00278778700158
we O 0 0.0011866461718454957
have O 0 0.0015250041615217924
analyzed O 0 0.011486866511404514
a O 0 0.0048516676761209965
large O 0 0.006184273865073919
cohort O 0 0.09818728268146515
of O 0 0.0043450938537716866
unselected O 1 0.9924113750457764
Ashkenazi O 1 0.9766907095909119
Jewish O 0 0.014524231664836407
subjects O 0 0.01132996380329132
with O 0 0.008308805525302887
adenomatous B-Disease 1 1.0
polyps I-Disease 1 0.9999998807907104
and O 0 0.0025301699060946703
. O 0 0.0038506744895130396
or O 1 0.9452426433563232
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.0021153551060706377
for O 0 0.0014540663687512279
the O 0 0.007767390459775925
APC O 1 0.999996542930603
I1307K O 1 0.9997782111167908
polymorphism O 1 0.9293659925460815
. O 0 0.010043484158813953

The O 0 0.017303718253970146
APC O 1 0.9999810457229614
I1307K O 1 0.9998923540115356
allele O 1 0.9999163150787354
was O 0 0.009599537588655949
identified O 0 0.012304355390369892
in O 0 0.002625345950946212
48 O 0 0.02286328375339508
( O 0 0.0050894226878881454
10 O 0 0.0058569530956447124
. O 0 0.0027843653224408627
1 O 0 0.012384496629238129
% O 0 0.0052310023456811905
) O 0 0.003537830663844943
of O 0 0.0038884305395185947
476 O 1 0.9999681711196899
patients O 1 0.9999948740005493
. O 0 0.007966817356646061

Compared O 0 0.01863095723092556
with O 0 0.001632061554118991
the O 0 0.0027725775726139545
frequency O 0 0.018886880949139595
in O 0 0.0014304807409644127
two O 0 0.0012621261412277818
separate O 0 0.004214771557599306
population O 0 0.008413996547460556
control O 0 0.01718783564865589
groups O 0 0.003451666096225381
, O 0 0.0019114181632176042
the O 0 0.007217723876237869
APC O 1 0.9999995231628418
I1307K O 1 0.9999803304672241
allele O 1 0.9999771118164062
is O 0 0.0049288771115243435
associated O 0 0.006104435306042433
with O 0 0.0009825658053159714
an O 0 0.0019496786408126354
estimated O 0 0.012022298760712147
relative O 0 0.01982119120657444
risk O 0 0.44497010111808777
of O 0 0.003196049714460969
1 O 0 0.017761820927262306
. O 0 0.006467302795499563

5 O 0 0.03707938268780708
- O 0 0.03831745684146881
1 O 0 0.022099267691373825
. O 0 0.006242560688406229

7 O 0 0.032434020191431046
for O 0 0.01455235667526722
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999994039535522
( O 0 0.009538806974887848
both O 0 0.0049673523753881454
P O 1 0.9989190101623535
= O 0 0.05933838710188866
. O 0 0.007478404324501753
01 O 1 0.9997716546058655
) O 0 0.007002644706517458
. O 0 0.005755878984928131

Furthermore O 0 0.026644280180335045
, O 0 0.002747019985690713
compared O 0 0.00914127565920353
with O 0 0.0029464804101735353
noncarriers O 1 0.9998555183410645
, O 0 0.008089900016784668
APC O 1 0.9999988079071045
I1307K O 1 0.9999651908874512
carriers O 1 0.571265697479248
had O 0 0.006692933384329081
increased O 0 0.008286502212285995
numbers O 0 0.004076523240655661
of O 0 0.0028379892464727163
adenomas B-Disease 1 0.9999997615814209
and O 0 0.03730461746454239
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999998807907104
per O 0 0.014978951774537563
patient O 1 0.9999302625656128
( O 0 0.012213929556310177
P O 1 0.9965518712997437
= O 0 0.05468810349702835
. O 0 0.006184813100844622
03 O 1 0.9988376498222351
) O 0 0.004542599897831678
, O 0 0.0015303893014788628
as O 0 0.0016411866527050734
well O 0 0.0013468362158164382
as O 0 0.002122111851349473
a O 0 0.007963870652019978
younger O 0 0.15101753175258636
age O 0 0.0170414038002491
at O 0 0.01194633636623621
diagnosis O 1 0.9999938011169434
. O 0 0.009154961444437504

We O 0 0.00455185491591692
conclude O 0 0.012627309188246727
that O 0 0.0014816533075645566
the O 0 0.006638753227889538
APC O 1 0.9999977350234985
I1307K O 1 0.9997984766960144
variant O 1 0.9985939860343933
leads O 0 0.019906122237443924
to O 0 0.003520146943628788
increased O 0 0.039856016635894775
adenoma B-Disease 1 1.0
formation O 0 0.031165089458227158
and O 0 0.001636605360545218
directly O 0 0.006221224553883076
contributes O 0 0.03417900949716568
to O 0 0.0027973358519375324
3 O 0 0.011681235395371914
% O 0 0.006487802602350712
- O 0 0.018952427431941032
4 O 0 0.009983664378523827
% O 0 0.002264526905491948
of O 0 0.0010893750004470348
all O 0 0.0025614872574806213
Ashkenazi O 1 0.9999902248382568
Jewish O 1 0.999589741230011
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.011097721755504608

The O 0 0.0066010127775371075
estimated O 0 0.016196953132748604
relative O 0 0.021874792873859406
risk O 1 0.8905466794967651
for O 0 0.0038634296506643295
carriers O 1 0.9854369759559631
may O 0 0.009485946968197823
justify O 0 0.017931142821907997
specific O 0 0.00790172815322876
clinical O 1 0.5626423954963684
screening O 0 0.039114657789468765
for O 0 0.0014640124281868339
the O 0 0.0031570647843182087
360 O 0 0.03262421861290932
, O 0 0.0025453397538512945
000 O 0 0.03062143176794052
Americans O 0 0.00733188958838582
expected O 0 0.00394829548895359
to O 0 0.0022856697905808687
harbor O 0 0.04718293249607086
this O 0 0.00532914325594902
allele O 1 0.9997538924217224
, O 0 0.002442726632580161
and O 0 0.002022792352363467
genetic O 0 0.0856485366821289
testing O 0 0.012298602610826492
in O 0 0.0010669652838259935
the O 0 0.0015745373675599694
setting O 0 0.003652609884738922
of O 0 0.0018316155765205622
long O 0 0.013770527206361294
- O 0 0.02327887900173664
term O 0 0.01728913187980652
- O 0 0.02316906861960888
outcome O 0 0.014773201197385788
studies O 0 0.004632086958736181
may O 0 0.006270523648709059
impact O 0 0.01907517947256565
significantly O 0 0.044421855360269547
on O 0 0.026040563359856606
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.9996939897537231
in O 0 0.0029195037204772234
this O 0 0.002249225042760372
population O 0 0.009432822465896606
. O 0 0.006154651753604412

Localization O 0 0.08714191615581512
of O 0 0.0038414255250245333
human O 0 0.02625052072107792
BRCA1 O 1 0.9999997615814209
and O 0 0.002108469605445862
its O 0 0.0031299712136387825
loss O 0 0.22846852242946625
in O 0 0.0017765099182724953
high O 0 0.006776965688914061
- O 0 0.017382634803652763
grade O 0 0.018610846251249313
, O 0 0.0021331352181732655
non B-Disease 0 0.016038550063967705
- I-Disease 1 0.9969730377197266
inherited I-Disease 1 0.9999998807907104
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.013014523312449455

Although O 0 0.005986688192933798
the O 0 0.002279881155118346
link O 0 0.01289445348083973
between O 0 0.00241669244132936
the O 0 0.010506793856620789
BRCA1 O 1 1.0
tumour B-Disease 1 1.0
- O 1 0.9928907155990601
suppressor O 1 0.9999995231628418
gene O 1 0.9989445805549622
and O 0 0.006765549071133137
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9972647428512573
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 0.004871312528848648
established O 0 0.005184658337384462
, O 0 0.0012182941427454352
the O 0 0.00252516265027225
role O 0 0.008252500556409359
, O 0 0.0015543397748842835
if O 0 0.0017545425798743963
any O 0 0.0011396929621696472
, O 0 0.0012049219803884625
of O 0 0.0029847624246031046
BRCA1 O 1 0.9999998807907104
in O 0 0.003787961322814226
non B-Disease 0 0.02595384791493416
- I-Disease 1 0.9997832179069519
familial I-Disease 1 1.0
cancers I-Disease 1 0.9999998807907104
is O 0 0.006259720306843519
unclear O 0 0.016622787341475487
. O 0 0.005941384471952915

BRCA1 O 1 0.9999998807907104
mutations O 1 0.9998972415924072
are O 0 0.00245619541965425
rare O 0 0.01790022663772106
in O 0 0.00381693197414279
sporadic B-Disease 1 0.9997038245201111
cancers I-Disease 1 0.9999998807907104
, O 0 0.0025756703689694405
but O 0 0.0026516590733081102
loss O 0 0.1692887842655182
of O 0 0.005731713958084583
BRCA1 O 1 1.0
resulting O 0 0.04870660975575447
from O 0 0.004061607178300619
reduced O 0 0.02661987952888012
expression O 0 0.024102335795760155
or O 0 0.00426983367651701
incorrect O 0 0.03280497342348099
subcellular O 0 0.10544505715370178
localization O 0 0.06748548150062561
is O 0 0.004732675384730101
postulated O 0 0.04270702973008156
to O 0 0.001297248643822968
be O 0 0.0008562023867852986
important O 0 0.0012274867622181773
in O 0 0.0016743323067203164
non B-Disease 0 0.01707575097680092
- I-Disease 1 0.9966202974319458
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.8788978457450867
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.009431201033294201

Epigenetic O 1 0.998992383480072
loss O 1 0.7145423293113708
, O 0 0.0026118929963558912
however O 0 0.003295611124485731
, O 0 0.0014026203425601125
has O 0 0.0025406600907444954
not O 0 0.0014302274212241173
received O 0 0.00846012681722641
general O 0 0.006399601697921753
acceptance O 0 0.024846775457262993
due O 0 0.008588818833231926
to O 0 0.0017609884962439537
controversy O 0 0.01802142709493637
regarding O 0 0.004314442165195942
the O 0 0.003921210765838623
subcellular O 0 0.0940016582608223
localization O 0 0.06654725968837738
of O 0 0.006896068342030048
BRCA1 O 1 1.0
proteins O 0 0.031148577108979225
, O 0 0.00167622952722013
reports O 0 0.003063957206904888
of O 0 0.0010228627361357212
which O 0 0.0016852907137945294
have O 0 0.002055798890069127
ranged O 0 0.017524072900414467
from O 0 0.002594108460471034
exclusively O 0 0.005437578074634075
nuclear O 0 0.003590267850086093
, O 0 0.0011863341787829995
to O 0 0.001790165901184082
conditionally O 0 0.44002285599708557
nuclear O 0 0.004576100967824459
, O 0 0.0010760731529444456
to O 0 0.0015301619423553348
the O 0 0.007123954128473997
ER O 1 0.9999556541442871
/ O 1 0.8001300096511841
golgi O 1 0.9908438920974731
, O 0 0.0027692990843206644
to O 0 0.00332190515473485
cytoplasmic O 0 0.3512563407421112
invaginations O 1 0.9271264672279358
into O 0 0.005862908437848091
the O 0 0.00538429943844676
nucleus O 0 0.07000517845153809
. O 0 0.008130006492137909

In O 0 0.003203348256647587
an O 0 0.0024035675451159477
attempt O 0 0.011845286935567856
to O 0 0.0019339242717251182
resolve O 0 0.011656827293336391
this O 0 0.0019466773374006152
issue O 0 0.004067335743457079
, O 0 0.0008393110474571586
we O 0 0.0008853601175360382
have O 0 0.0019565559923648834
comprehensively O 1 0.8106523752212524
characterized O 0 0.140223890542984
19 O 0 0.020793573930859566
anti O 1 0.5710641741752625
- O 1 0.9665446281433105
BRCA1 O 1 0.9999998807907104
antibodies O 1 0.9983934760093689
. O 0 0.008839438669383526

These O 0 0.004778219386935234
reagents O 0 0.04634848237037659
detect O 0 0.03828618302941322
a O 0 0.00952797383069992
220 O 0 0.04155691713094711
- O 0 0.05947244167327881
kD O 1 0.9745400547981262
protein O 0 0.09355657547712326
localized O 1 0.6433559060096741
in O 0 0.0028095596935600042
discrete O 0 0.026521535590291023
nuclear O 0 0.00891209114342928
foci O 0 0.09448052197694778
in O 0 0.002986407373100519
all O 0 0.0038729545194655657
epithelial O 1 0.9999784231185913
cell O 0 0.111408531665802
lines O 0 0.011181600391864777
, O 0 0.0014080862747505307
including O 0 0.0013224062277004123
those O 0 0.001610016101039946
derived O 0 0.014529988169670105
from O 0 0.015081536024808884
breast B-Disease 1 1.0
malignancies I-Disease 1 0.9998927116394043
. O 0 0.010620195418596268

Immunohistochemical O 1 0.9961018562316895
staining O 1 0.8938604593276978
of O 0 0.005240487400442362
human O 0 0.03645532205700874
breast O 1 1.0
specimens O 0 0.023295097053050995
also O 0 0.0027054864913225174
revealed O 0 0.07826686650514603
BRCA1 O 1 0.9999986886978149
nuclear O 0 0.01365953404456377
foci O 1 0.8856971859931946
in O 0 0.006969600450247526
benign O 1 0.9999997615814209
breast O 1 1.0
, O 0 0.02495221048593521
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 0.9999994039535522
and O 0 0.00306519097648561
low B-Disease 0 0.03131686523556709
- I-Disease 0 0.057220589369535446
grade I-Disease 1 0.6001006960868835
ductal I-Disease 1 0.9999997615814209
carcinomas I-Disease 1 0.999998927116394
. O 0 0.011626421473920345

Conversely O 1 0.5314159393310547
, O 0 0.009628749452531338
BRCA1 O 1 0.9999997615814209
expression O 0 0.040441494435071945
was O 0 0.009714309126138687
reduced O 0 0.026090040802955627
or O 0 0.00607189629226923
undetectable O 1 0.981023907661438
in O 0 0.0017573509830981493
the O 0 0.002025019843131304
majority O 0 0.00633317232131958
of O 0 0.0013404939090833068
high O 0 0.008958346210420132
- O 0 0.028434887528419495
grade O 0 0.04241906851530075
, O 0 0.009441711008548737
ductal B-Disease 1 1.0
carcinomas I-Disease 1 0.9999998807907104
, O 0 0.0031880734022706747
suggesting O 0 0.010289913043379784
that O 0 0.0015060709556564689
absence O 0 0.014801462180912495
of O 0 0.005122897680848837
BRCA1 O 1 1.0
may O 0 0.010819015093147755
contribute O 0 0.007493202108889818
to O 0 0.001204241649247706
the O 0 0.0034317229874432087
pathogenesis O 1 0.9999797344207764
of O 0 0.0016261240234598517
a O 0 0.004642017651349306
significant O 0 0.005022374913096428
percentage O 0 0.007580544333904982
of O 0 0.004511958919465542
sporadic B-Disease 1 0.9999690055847168
breast I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.005143640097230673
. O 0 0.005724210292100906

